
<html lang="en"     class="pb-page"  data-request-id="65972213-ab2d-47ab-bd16-a3cbcdbce454"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.0c00528;issue:issue:10.1021/jmcmar.2020.63.issue-17;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Centrally Active Multitarget Anti-Alzheimer Agents Derived from the Antioxidant Lead CR-6" /></meta><meta name="dc.Creator" content="F. Javier  Pérez-Areales" /></meta><meta name="dc.Creator" content="María  Garrido" /></meta><meta name="dc.Creator" content="Ester  Aso" /></meta><meta name="dc.Creator" content="Manuela  Bartolini" /></meta><meta name="dc.Creator" content="Angela  De Simone" /></meta><meta name="dc.Creator" content="Alba  Espargaró" /></meta><meta name="dc.Creator" content="Tiziana  Ginex" /></meta><meta name="dc.Creator" content="Raimon  Sabate" /></meta><meta name="dc.Creator" content="Belén  Pérez" /></meta><meta name="dc.Creator" content="Vincenza  Andrisano" /></meta><meta name="dc.Creator" content="Dolors  Puigoriol-Illamola" /></meta><meta name="dc.Creator" content="Mercè  Pallàs" /></meta><meta name="dc.Creator" content="F. Javier  Luque" /></meta><meta name="dc.Creator" content="María Isabel  Loza" /></meta><meta name="dc.Creator" content="José  Brea" /></meta><meta name="dc.Creator" content="Isidro  Ferrer" /></meta><meta name="dc.Creator" content="Francisco  Ciruela" /></meta><meta name="dc.Creator" content="Angel  Messeguer" /></meta><meta name="dc.Creator" content="Diego  Muñoz-Torrero" /></meta><meta name="dc.Description" content="Oxidative stress is a major pathogenic factor in Alzheimer’s disease, but it should not be tackled alone rather together with other key targets to derive effective treatments. The combination of th..." /></meta><meta name="Description" content="Oxidative stress is a major pathogenic factor in Alzheimer’s disease, but it should not be tackled alone rather together with other key targets to derive effective treatments. The combination of th..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 24, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c00528" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00528" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c00528" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00528" /></link>
        
    
    

<title>Centrally Active Multitarget Anti-Alzheimer Agents Derived from the Antioxidant Lead CR-6 | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c00528" /></meta><meta property="og:title" content="Centrally Active Multitarget Anti-Alzheimer Agents Derived from the Antioxidant Lead CR-6" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0022.jpeg" /></meta><meta property="og:description" content="Oxidative stress is a major pathogenic factor in Alzheimer’s disease, but it should not be tackled alone rather together with other key targets to derive effective treatments. The combination of the scaffold of the polar antioxidant lead 7-methoxy-2,2-dimethylchroman-6-ol (CR-6) with that of the lipophilic cholinesterase inhibitor 6-chlorotacrine results in compounds with favorable brain permeability and multiple activities in vitro (acetylcholinesterase, butyrylcholinesterase, β-site amyloid precursor protein (APP) cleaving enzyme-1 (BACE-1), and Aβ42 and tau aggregation inhibition). In in vivo studies on wild-type and APP/presenilin 1 (PS1) mice, two selected compounds were well tolerated and led to positive trends, albeit statistically nonsignificant in some cases, on memory performance, amyloid pathology (reduced amyloid burden and potentiated non-amyloidogenic APP processing), and oxidative stress (reduced cortical oxidized proteins and increased antioxidant enzymes superoxide dismutase 2 (SOD2), catalase, glutathione peroxidase 1 (GPX1), and heme oxygenase 1 (Hmox1) and transcription factor nuclear factor-erythroid 2-related factor 2 (Nrf2)). These compounds emerge as interesting brain-permeable multitarget compounds, with a potential as anti-Alzheimer agents beyond that of the original lead CR-6." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c00528"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00528">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c00528&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c00528&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c00528&amp;href=/doi/10.1021/acs.jmedchem.0c00528" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 9360-9390</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c00522" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c00543" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Centrally Active Multitarget Anti-Alzheimer Agents Derived from the Antioxidant Lead CR-6</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">F. Javier Pérez-Areales</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">F. Javier Pérez-Areales</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Medicinal Chemistry (CSIC Associated Unit), Faculty of Pharmacy and Food Sciences, and Institute of Biomedicine (IBUB), University of Barcelona (UB), E-08028 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=F.+Javier++P%C3%A9rez-Areales">F. Javier Pérez-Areales</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">María Garrido</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">María Garrido</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biological Chemistry, Institute of Advanced Chemistry of Catalonia (IQAC-CSIC), E-08034 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mar%C3%ADa++Garrido">María Garrido</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ester Aso</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ester Aso</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pathology and Experimental Therapeutics, Neurosciences Institute, University of Barcelona (UB) and Bellvitge University Hospital—IDIBELL, E-08908 L’Hospitalet de Llobregat, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ester++Aso">Ester Aso</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Manuela Bartolini</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Manuela Bartolini</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacy and Biotechnology, University of Bologna, I-40126 Bologna, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Manuela++Bartolini">Manuela Bartolini</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2890-3856" title="Orcid link">http://orcid.org/0000-0002-2890-3856</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Angela De Simone</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Angela De Simone</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Drug Science and Technology, University of Turin, I-10125 Torino, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Angela++De+Simone">Angela De Simone</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alba Espargaró</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alba Espargaró</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacy, Pharmaceutical Technology and Physical-Chemistry, Faculty of Pharmacy and Food Sciences, and Institute of Nanoscience and Nanotechnology (IN2UB), University of Barcelona (UB), E-08028 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alba++Espargar%C3%B3">Alba Espargaró</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tiziana Ginex</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tiziana Ginex</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Nutrition, Food Science and Gastronomy, Faculty of Pharmacy and Food Sciences, IBUB, and Institute of Theoretical and Computational Chemistry (IQTC), University of Barcelona (UB), E-08921 Santa Coloma de Gramenet, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tiziana++Ginex">Tiziana Ginex</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Raimon Sabate</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Raimon Sabate</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacy, Pharmaceutical Technology and Physical-Chemistry, Faculty of Pharmacy and Food Sciences, and Institute of Nanoscience and Nanotechnology (IN2UB), University of Barcelona (UB), E-08028 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Raimon++Sabate">Raimon Sabate</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3894-2362" title="Orcid link">http://orcid.org/0000-0003-3894-2362</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Belén Pérez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Belén Pérez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology, Therapeutics, and Toxicology, Autonomous University of Barcelona, E-08193 Bellaterra, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bel%C3%A9n++P%C3%A9rez">Belén Pérez</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Vincenza Andrisano</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Vincenza Andrisano</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department for Life Quality Studies, University of Bologna, I-47921 Rimini, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Vincenza++Andrisano">Vincenza Andrisano</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4396-1904" title="Orcid link">http://orcid.org/0000-0003-4396-1904</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dolors Puigoriol-Illamola</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dolors Puigoriol-Illamola</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmacology Section, Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, and Institute of Neuroscience (NeuroUB), University of Barcelona (UB), E-08028 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dolors++Puigoriol-Illamola">Dolors Puigoriol-Illamola</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mercè Pallàs</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mercè Pallàs</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmacology Section, Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, and Institute of Neuroscience (NeuroUB), University of Barcelona (UB), E-08028 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Merc%C3%A8++Pall%C3%A0s">Mercè Pallàs</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3095-4254" title="Orcid link">http://orcid.org/0000-0003-3095-4254</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">F. Javier Luque</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">F. Javier Luque</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Nutrition, Food Science and Gastronomy, Faculty of Pharmacy and Food Sciences, IBUB, and Institute of Theoretical and Computational Chemistry (IQTC), University of Barcelona (UB), E-08921 Santa Coloma de Gramenet, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=F.+Javier++Luque">F. Javier Luque</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8049-3567" title="Orcid link">http://orcid.org/0000-0002-8049-3567</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">María Isabel Loza</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">María Isabel Loza</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">BioFarma Research Group, Centro Singular de Investigación en Medicina Molecular y Enfermedades Crónicas (CIMUS), Universidade de Santiago de Compostela, Av. de Barcelona s/n, E-15782 Santiago de Compostela, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mar%C3%ADa+Isabel++Loza">María Isabel Loza</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">José Brea</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">José Brea</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">BioFarma Research Group, Centro Singular de Investigación en Medicina Molecular y Enfermedades Crónicas (CIMUS), Universidade de Santiago de Compostela, Av. de Barcelona s/n, E-15782 Santiago de Compostela, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jos%C3%A9++Brea">José Brea</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Isidro Ferrer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Isidro Ferrer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pathology and Experimental Therapeutics, Neurosciences Institute, University of Barcelona (UB) and Bellvitge University Hospital—IDIBELL, E-08908 L’Hospitalet de Llobregat, Spain</div><div class="loa-info-affiliations-info">CIBERNED, E-28031 Madrid, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Isidro++Ferrer">Isidro Ferrer</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Francisco Ciruela</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Francisco Ciruela</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pathology and Experimental Therapeutics, Neurosciences Institute, University of Barcelona (UB) and Bellvitge University Hospital—IDIBELL, E-08908 L’Hospitalet de Llobregat, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Francisco++Ciruela">Francisco Ciruela</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Angel Messeguer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Angel Messeguer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biological Chemistry, Institute of Advanced Chemistry of Catalonia (IQAC-CSIC), E-08034 Barcelona, Spain</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Angel++Messeguer">Angel Messeguer</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Diego Muñoz-Torrero</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Diego Muñoz-Torrero</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Laboratory of Medicinal Chemistry (CSIC Associated Unit), Faculty of Pharmacy and Food Sciences, and Institute of Biomedicine (IBUB), University of Barcelona (UB), E-08028 Barcelona, Spain</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#63070e160d0c19170c111106110c2316014d060716"><span class="__cf_email__" data-cfemail="5e3a332b3031242a312c2c3b2c311e2b3c703b3a2b">[email protected]</span></a>. Phone: (+34) 934024533.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Diego++Mu%C3%B1oz-Torrero">Diego Muñoz-Torrero</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8140-8555" title="Orcid link">http://orcid.org/0000-0002-8140-8555</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00528&amp;href=/doi/10.1021%2Facs.jmedchem.0c00528" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 9360–9390</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 24, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>31 March 2020</li><li><span class="item_label"><b>Published</b> online</span>24 July 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 September 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c00528" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00528</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9360%26pageCount%3D31%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DF.%2BJavier%2BP%25C3%25A9rez-Areales%252C%2BMar%25C3%25ADa%2BGarrido%252C%2BEster%2BAso%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D17%26contentID%3Dacs.jmedchem.0c00528%26title%3DCentrally%2BActive%2BMultitarget%2BAnti-Alzheimer%2BAgents%2BDerived%2Bfrom%2Bthe%2BAntioxidant%2BLead%2BCR-6%26numPages%3D31%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9390%26publicationDate%3DSeptember%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c00528"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1297</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">8</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c00528" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Centrally Active Multitarget Anti-Alzheimer Agents Derived from the Antioxidant Lead CR-6&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;F.&quot;,&quot;last_name&quot;:&quot;Javier Pérez-Areales&quot;},{&quot;first_name&quot;:&quot;María&quot;,&quot;last_name&quot;:&quot;Garrido&quot;},{&quot;first_name&quot;:&quot;Ester&quot;,&quot;last_name&quot;:&quot;Aso&quot;},{&quot;first_name&quot;:&quot;Manuela&quot;,&quot;last_name&quot;:&quot;Bartolini&quot;},{&quot;first_name&quot;:&quot;Angela&quot;,&quot;last_name&quot;:&quot;De Simone&quot;},{&quot;first_name&quot;:&quot;Alba&quot;,&quot;last_name&quot;:&quot;Espargaró&quot;},{&quot;first_name&quot;:&quot;Tiziana&quot;,&quot;last_name&quot;:&quot;Ginex&quot;},{&quot;first_name&quot;:&quot;Raimon&quot;,&quot;last_name&quot;:&quot;Sabate&quot;},{&quot;first_name&quot;:&quot;Belén&quot;,&quot;last_name&quot;:&quot;Pérez&quot;},{&quot;first_name&quot;:&quot;Vincenza&quot;,&quot;last_name&quot;:&quot;Andrisano&quot;},{&quot;first_name&quot;:&quot;Dolors&quot;,&quot;last_name&quot;:&quot;Puigoriol-Illamola&quot;},{&quot;first_name&quot;:&quot;Mercè&quot;,&quot;last_name&quot;:&quot;Pallàs&quot;},{&quot;first_name&quot;:&quot;F.&quot;,&quot;last_name&quot;:&quot;Javier Luque&quot;},{&quot;first_name&quot;:&quot;María&quot;,&quot;last_name&quot;:&quot;Isabel Loza&quot;},{&quot;first_name&quot;:&quot;José&quot;,&quot;last_name&quot;:&quot;Brea&quot;},{&quot;first_name&quot;:&quot;Isidro&quot;,&quot;last_name&quot;:&quot;Ferrer&quot;},{&quot;first_name&quot;:&quot;Francisco&quot;,&quot;last_name&quot;:&quot;Ciruela&quot;},{&quot;first_name&quot;:&quot;Angel&quot;,&quot;last_name&quot;:&quot;Messeguer&quot;},{&quot;first_name&quot;:&quot;Diego&quot;,&quot;last_name&quot;:&quot;Muñoz-Torrero&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;24&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;9360-9390&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c00528&quot;},&quot;abstract&quot;:&quot;Oxidative stress is a major pathogenic factor in Alzheimer’s disease, but it should not be tackled alone rather together with other key targets to derive effective treatments. The combination of the scaffold of the polar antioxidant lead 7-methoxy-2,2-dimethylchroman-6-ol (CR-6) with that of the lipophilic cholinesterase inhibitor 6-chlorotacrine results in compounds with favorable brain permeability and multiple activities in vitro (acetylcholinesterase, butyrylcholinesterase, β-site amyloid precursor protein (APP) cleaving enzyme-1 (BACE-1), and Aβ42 and tau aggregation inhibition). In in vivo studies on wild-type and APP/presenilin 1 (PS1) mice, two selected compounds were well tolerated and led to positive trends, albeit statistically nonsignificant in some cases, on memory performance, amyloid pathology (reduced amyloid burden and potentiated non-amyloidogenic APP processing), and oxidative stress (reduced cortical oxidized proteins and increased antioxidant enzymes superoxide dismutase 2 (SOD2), catalas&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00528&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00528" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00528&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00528" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00528&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00528" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00528&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00528&amp;href=/doi/10.1021/acs.jmedchem.0c00528" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c00528" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c00528" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00528&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c00528%26sid%3Dliteratum%253Aachs%26pmid%3D32706255%26genre%3Darticle%26aulast%3DP%25C3%25A9rez-Areales%26date%3D2020%26atitle%3DCentrally%2BActive%2BMultitarget%2BAnti-Alzheimer%2BAgents%2BDerived%2Bfrom%2Bthe%2BAntioxidant%2BLead%2BCR-6%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D17%26spage%3D9360%26epage%3D9390%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (12)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292169" title="Antioxidants">Antioxidants</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/17" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/jmcmar.2020.63.issue-17/20200910/jmcmar.2020.63.issue-17.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/medium/jm0c00528_0022.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00528&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Oxidative stress is a major pathogenic factor in Alzheimer’s disease, but it should not be tackled alone rather together with other key targets to derive effective treatments. The combination of the scaffold of the polar antioxidant lead 7-methoxy-2,2-dimethylchroman-6-ol (CR-6) with that of the lipophilic cholinesterase inhibitor 6-chlorotacrine results in compounds with favorable brain permeability and multiple activities in vitro (acetylcholinesterase, butyrylcholinesterase, β-site amyloid precursor protein (APP) cleaving enzyme-1 (BACE-1), and Aβ42 and tau aggregation inhibition). In in vivo studies on wild-type and APP/presenilin 1 (PS1) mice, two selected compounds were well tolerated and led to positive trends, albeit statistically nonsignificant in some cases, on memory performance, amyloid pathology (reduced amyloid burden and potentiated non-amyloidogenic APP processing), and oxidative stress (reduced cortical oxidized proteins and increased antioxidant enzymes superoxide dismutase 2 (SOD2), catalase, glutathione peroxidase 1 (GPX1), and heme oxygenase 1 (Hmox1) and transcription factor nuclear factor-erythroid 2-related factor 2 (Nrf2)). These compounds emerge as interesting brain-permeable multitarget compounds, with a potential as anti-Alzheimer agents beyond that of the original lead CR-6.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53501" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53501" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Treatment of Alzheimer’s disease (AD) remains one of our most urgent unmet medical needs. Indeed, the figures associated with AD are really worrying. It is the most prevalent chronic neurodegenerative disorder and the main cause of dementia. Currently, some 50 million people worldwide suffer from dementia, with around 35 million having AD.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> This number is estimated to triple to more than 150 million by 2050. The incidence is also reaching alarming proportions, with more than 10 million new cases per year. The huge incidence and prevalence of AD together with the fact that it is a fatal disease make it the seventh leading cause of death worldwide. However, unlike other major causes of death, AD cannot be cured, prevented, or even slowed down. Beyond its devastating effects on AD patients health, this pathology also strongly affects the quality of life of caregivers, who by more than 50% see how their social life, work, and even health are negatively affected as a consequence of their caring responsibilities.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> To further aggravate the situation, the economic burden of AD is really a major issue for health systems worldwide, with a total estimated cost of around U.S. $1 trillion, which is expected to double in just 10 years.</div><div class="NLM_p">Indeed, the devastating consequences of AD are due to the lack of effective drugs that can positively impact disease progression. Currently, only four drugs are available for AD management, namely, the acetylcholinesterase (AChE) inhibitors donepezil, rivastigmine, and galantamine and the glutamate <i>N</i>-methyl <span class="smallcaps smallerCapital">d</span>-aspartate (NMDA) receptor antagonist memantine, which are used to temporarily alleviate the cognitive and functional symptoms. Very intensive research efforts have been devoted in the past 2 decades to discovering disease-modifying drugs that could halt disease progression, mainly focused on interfering the biology of β-amyloid (Aβ) peptide, widely regarded as a key culprit of AD. Despite high expectations, all putative disease-modifying drug candidates have disappointingly failed to demonstrate efficacy in advanced clinical trials, which has made AD drug discovery one of the areas with the highest attrition rate, with a failure rate of 99.6% since the launching of memantine, so far the last approved drug.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In this scenario, it becomes evident that AD is a matter of tremendous social concern worldwide, with up to 95% of people thinking they will develop dementia in their lifetime and 25% thinking that there is nothing that can be done about it.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">To meet the desperate need for effective therapies, alternative ways to approach AD should be tested. There is a growing awareness that AD is a complex disorder in which multiple factors concur to the onset of the pathological scenario and that cannot be efficiently cured by modulating a single biological target or pathological event but with combinations of drugs<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> or with multitarget drugs, i.e., single molecules that are able to hit more than one target with a key role in the pathological network of AD.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Indeed, simultaneous modulation of several crucial biological targets of AD is being increasingly accepted as a realistic option to inflict a serious damage to the AD network and derive effective treatments.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> As a result, together with cancer, AD is the area in which the development of multitarget agents seems to have experienced a greater growth over the last 15 years.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><div class="NLM_p">Thus far, a large number of multitarget agents, usually designed by combination of different pharmacophores, have been developed to hit several key biological targets or pathological events of AD.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Apart from modulating Aβ biology (inhibition of Aβ formation by proteolytic cleavage of the amyloid precursor protein (APP) by the β-site APP cleaving enzyme-1 (BACE-1 or β-secretase) and γ-secretase or inhibition of Aβ aggregation), inhibition of cholinesterases (AChE and butyrylcholinesterase (BChE)) is also commonly considered for the design of multitarget anti-AD agents.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><div class="NLM_p">Another crucial pathological event of AD is oxidative stress. Because of its high demand for oxygen, high levels of peroxidizable lipids (polyunsaturated fatty acids), and deficiency of antioxidant defense systems, brain is highly vulnerable to oxidative stress.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Thus, increased levels of markers of cell component oxidation and altered levels of antioxidant enzymes are found in brains of AD patients. Indeed, increased levels of protein oxidation markers, such as carbonylated proteins, are found not only in AD brains but also in patients suffering from amnestic mild cognitive impairment (MCI). The latter finding supports the idea that oxidative stress is involved in the early stages of AD. Additionally, oxidative stress could be necessary for the deployment of other pathological mechanisms of AD, such as Aβ- and tau-induced neurotoxicity, which makes it a key pathogenic element in AD.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Removal or prevention of the formation of reactive oxygen species (ROS) may, hence, be helpful to halt AD progression. In this light, antioxidants have been evaluated as a potential treatment of AD or even MCI. However, results from clinical trials have been disappointing,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> with poor brain permeation likely accounting, at least in part, for the lack of clinical efficacy of antioxidants.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">This was a major drawback of the so-called 7-methoxy-2,2-dimethylchroman-6-ol (CR-6) (<b>1</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), the most potent antioxidant within a series of chroman derivatives developed by some of us. This compound showed a very interesting in vitro antioxidant profile, including inhibitory effect on lipid peroxidation<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and NO scavenging activity and protective effect against glutamate-induced neurotoxicity in cultured cerebellar neurons<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and against hydrogen peroxide-induced apoptosis in human neuroblastoma SH-SY5Y cells.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The neuroprotective effect of CR-6 has been also demonstrated in an in vivo study, which revealed a reduction of oxidative damage after a cerebral ischemia/reperfusion process in rats.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> However, despite the fact that CR-6 was detected in the brain, its concentration was not high enough to elicit the desired neuroprotective effects at the desired level. Indeed, the permeability (<i>P</i><sub>e</sub>) of CR-6 measured in the parallel artificial membrane permeation assay (PAMPA) for blood–brain barrier (BBB) had been found to be negligible (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). As a first attempt to overcome this limitation, the CR-6 scaffold has been recently conjugated with essential brain nutrients such as amino acids or glucose that are recognized by active transport systems (e.g., compound <b>2</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/medium/jm0c00528_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design strategy of the CR-6–chlorotacrine hybrids.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00528&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Apart from the limitation of poor brain permeation of most antioxidants, targeting oxidative stress alone does not seem to be a realistic option to derive a clinically efficacious treatment.<a onclick="showRef(event, 'cit9a'); return false;" href="javascript:void(0);" class="ref cit9a">(9a)</a> The use of antioxidant cocktails or combination of antioxidants with drugs targeting other underlying causes of AD has been proposed as a more realistic option to cope with the multifactorial nature of AD.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> However, the use of antioxidants in drug combinations would not avoid the brain permeation issues that is inherent to many antioxidants. A very convenient way to conciliate both needs is the design of hybrid compounds in which the antioxidant moiety is attached to a second, more lipophilic, pharmacophore, i.e., the design of lipophilic multitarget compounds featuring an antioxidant moiety, such as melatonin or trolox, among others.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><div class="NLM_p last">Herein, we describe the synthesis and in vitro and in vivo biological evaluation of a new class of multitarget hybrids that combine the scaffold of the polar non-brain-permeable antioxidant lead CR-6 with 6-chlorotacrine (<b>3</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), a very potent lipophilic AChE inhibitor, through linkers with different lengths and functionalities. We inferred that the 6-chlorotacrine moiety (<i>P</i><sub>e</sub> PAMPA-BBB = 26.1 × 10<sup>–6</sup> cm s<sup>–1</sup>) should impart brain permeability to the resulting CR-6-based hybrids, as well as a second biological activity (AChE inhibition) of interest for AD treatment.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Apart from the biological activities resulting from the modulation of the primary targets (antioxidant and anticholinesterase activities), we have quite consistently observed that hybrid compounds bearing two aromatic systems separated by linkers of suitable length are able to inhibit the aggregation of Aβ42 and tau,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> two key pathogenic actors in AD, as well as other nonrelated amyloidogenic proteins,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> thereby expanding their multitarget profile. Additionally, some of these hybrids, featuring a protonatable 6-chlorotacrine (<b>3</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), tacrine, or a structurally related huprine moiety have been found to inhibit BACE-1, the enzyme that catalyzes the first rate-limiting step of Aβ formation.<a onclick="showRef(event, 'cit19a cit19b ref21'); return false;" href="javascript:void(0);" class="ref cit19a cit19b ref21">(19a,b,21)</a> Thus, the novel CR-6–chlorotacrine hybrids reported herein were tested in vitro for their antioxidant effect; their inhibitory activities against human cholinesterases (hAChE and hBChE), Aβ42 and tau aggregation, and human BACE-1; and their brain permeabilities. The in vivo efficacy of two selected compounds was evaluated in APP/presenilin 1 (PS1) mice, a well-established mouse model of AD, in terms of their effect on cognition and markers of oxidative stress and amyloid pathology.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87304" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87304" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Design</h3><div class="NLM_p">The presence of a hydroxyl group at position 6 of the chroman scaffold of CR-6 is the most important structural feature for its antioxidant effects, and, hence, it had to be preserved in the hybrids. In contrast, derivatization of CR-6 by functionalization at position 2 does not affect the antioxidant activity.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Indeed, the previously mentioned CR-6 derivative <b>2</b>, functionalized at this position with an amino acid side chain, is equipotent to the lead CR-6 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Likewise, the CR-6 derivative <b>7</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>), substituted at position 2 of the chroman scaffold with an acetic acid chain, displays an even slightly higher antioxidant effect (half-maximal inhibitory concentration (IC<sub>50</sub>) 2,2-diphenyl-1-picrylhydrazyl (DPPH) = 8.4 μM).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> The carboxylic acid of compound <b>7</b> is ideal for the introduction of the linker attached to the 6-chlorotacrine moiety through an amide bond. Thus, compound <b>7</b> is selected as the starting material for the synthesis of a first series of CR-6–chlorotacrine hybrids featuring an amide functionality within the linker (hybrids <b>4a</b>–<b>d</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a> and <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). The synthesis of two other series of hybrids that featured a reverse amide (hybrids <b>5a</b>–<b>c</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a> and <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>) or an amine (hybrids <b>6a</b>–<b>d</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a> and <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>) within the linker is also envisaged, starting from the CR-6 derivatives <b>14</b> and <b>16</b>, respectively,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> to further assess the effect of the linker amide or a protonatable amino group on the interaction with the putative biological targets. We have developed other families of multitarget compounds featuring a chlorotacrine or huprine moiety linked to a second polycyclic pharmacophore through an amide-containing tether chain. These hybrids with a total linker length of 10–12 atoms, from the amino group of chlorotacrine or huprine to the other polycyclic system (counting the atoms of the amide group), are found to display a better overall biological profile including AChE, BACE-1, and/or Aβ42 and tau aggregation inhibition.<a onclick="showRef(event, 'cit19a cit19c cit19d'); return false;" href="javascript:void(0);" class="ref cit19a cit19c cit19d">(19a,c,d)</a> On the basis of these premises, our main interest is the synthesis of a parallel series of CR-6–chlorotacrine hybrids with total linker lengths of 10 atoms (<b>4</b>–<b>6a</b>, <b>11a</b>, <b>12a</b>), 11 atoms (<b>4</b>–<b>6b</b>, <b>11b</b>, <b>12b</b>), and 12 atoms (<b>4</b>–<b>6c</b>, <b>11c</b>, <b>12c</b>). Additionally, shorter homologues with a total linker length of nine atoms (<b>11e</b>, <b>12e</b>) and analogues containing an ethylene glycol group within the linker (<b>4d</b>, <b>6d</b>), aiming to increase aqueous (aq) solubility, are synthesized for some, but not all, of the series in light of their less favorable biological activities (see below).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/medium/jm0c00528_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0016.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the CR-6–(Chloro)tacrine Hybrids <b>4a</b>–<b>d</b>, <b>11a</b>–<b>c</b>, <b>11e</b>, <b>12a</b>–<b>c</b>, and <b>12e</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00528&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) diamine, 1-pentanol, reflux or closed vessel, 18–24 h, 59% (<b>10a</b>), 69% (<b>10b</b>), 59% (<b>10c</b>), 77% (<b>10d</b>), 32% (<b>10e</b>); (b) <b>7</b> or <b>8</b>, <i>N</i>-(3-dimethylaminopropyl)-<i>N</i>′-ethylcarbodiimide hydrochloride (EDC·HCl), 1-hydroxy-1<i>H</i>-benzotriazole (HOBt), Et<sub>3</sub>N, EtOAc/dimethylformamide (DMF), room temperature (rt), 15 min; then, <b>10a</b>–<b>e</b>, EtOAc/DMF, rt, 24 h, 67% (<b>4a</b>), 67% (<b>4b</b>), 86% (<b>4c</b>), 91% (<b>4d</b>), 83% (<b>11a</b>), 92% (<b>11b</b>), 90% (<b>11c</b>), 100% (<b>11e</b>); (c) H<sub>2</sub> (1 atm), 10% w/w Pd/C, EtOH, rt, overnight, 72% (<b>12a</b>), 99% (<b>12b</b>), 99% (<b>12c</b>), 99% (<b>12e</b>).</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/medium/jm0c00528_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0017.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of the CR-6–Chlorotacrine Hybrids <b>5a</b>–<b>c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00528&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <b>13a</b>–<b>c</b>, 40% methanolic KOH, reflux, 3 h; H<sub>2</sub>O, reflux, overnight; HCl in dioxane or Et<sub>2</sub>O; resulting carboxylic acid, EDC·HCl, HOBt, Et<sub>3</sub>N, EtOAc/DMF, rt, 15 min; then, <b>14</b>, EtOAc/DMF, rt, 24 h, 87% (<b>5a</b>), 55% (<b>5b</b>), 52% (<b>5c</b>).</p></p></figure><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/medium/jm0c00528_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0018.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of the CR-6–Chlorotacrine Hybrids <b>6a</b>–<b>d</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00528&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) H<sub>2</sub> (1 atm), 10% w/w Pd/C, tetrahydrofuran (THF), rt, overnight, 90%; (b) Et<sub>3</sub>N, CH<sub>3</sub>CN, 80 °C, 48 h, 24% (<b>6a</b>), 57% (<b>6b</b>), 59% (<b>6c</b>), 30% (<b>6d</b>).</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Synthesis</h3><div class="NLM_p">Hybrids <b>4a</b>–<b>d</b> were synthesized in racemic form in good yield (67–91%) in just one step, by <i>N</i>-(3-dimethylaminopropyl)-<i>N</i>′-ethylcarbodiimide hydrochloride (EDC·HCl)/1-hydroxy-1<i>H</i>-benzotriazole (HOBt)-mediated amide coupling of racemic carboxylic acid <b>7</b><a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> with the known aminoalkyltacrines <b>10a</b>–<b>c</b><a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and <b>10d</b>,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> which were readily prepared by aromatic nucleophilic substitution of dichloroacridine <b>9</b><a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> with commercially available diamines (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><div class="NLM_p">The yield of the latter amide coupling reactions could be still improved when protecting the hydroxyl group at position 6 of the chroman carboxylic acid. Thus, reaction of racemic O-benzylated carboxylic acid <b>8</b><a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> with amines <b>10a</b>–<b>c</b> and <b>10e</b><a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> in the presence of EDC·HCl and HOBt led to O-benzylated amides <b>11a</b>–<b>c</b> and <b>11e</b> in 83% to quantitative yield. With these amides in hand, we performed a double O-debenzylation/dechlorination reaction by hydrogenolysis under Pd/C catalysis, which afforded in excellent yields a parallel series of hybrids featuring the amide group at the linker and an unsubstituted tacrine unit (hybrids <b>12a</b>–<b>c</b> and <b>12e</b>, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><div class="NLM_p">The synthesis of the reverse amide hybrids <b>5a</b>–<b>c</b> was accomplished in two steps from the known cyanoalkyltacrines <b>13a</b>–<b>c</b>.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Alkaline hydrolysis of nitriles <b>13a</b>–<b>c</b>, followed by acidification with a dioxane or Et<sub>2</sub>O solution of HCl, led to the corresponding carboxylic acids, which were isolated in the form of quinoline hydrochloride salts. EDC/HOBt-mediated amide coupling of these crude carboxylic acids with racemic CR-6-derived primary amine <b>14</b><a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> afforded the target reverse amide hybrids <b>5a</b>–<b>c</b> in racemic form in moderate to good overall yields (52–87% overall from nitriles <b>13a</b>–<b>c</b>, <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>).</div><div class="NLM_p">Finally, racemic hybrids <b>6a</b>–<b>d</b> bearing a protonatable aliphatic secondary amine within the linker were synthesized in low to moderate yields (24–59%) by alkylation of the primary amines <b>10a</b>–<b>d</b><a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> with the new CR-6-derived tosylate <b>15</b>, which, in turn, was readily prepared by hydrogenolysis of its racemic O-benzylated precursor <b>16</b><a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).</div><div class="NLM_p last">The CR-6–chlorotacrine hybrids are chiral due to the presence of a stereocenter at position 2 of the chroman moiety. They were prepared and tested in racemic form. We envisaged the resolution of the CR-6-based racemic carboxylic acid <b>8</b>. However, different resolution attempts via formation of diastereomeric esters with the enantiopure alcohols (<i>S</i>)-3-hydroxy-4,4-dimethyl-1-phenylpyrrolidin-2-one ((<i>S</i>)-<i>N</i>-phenylpantolactam)<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and (1<i>R</i>,2<i>S</i>,5<i>R</i>)-2-isopropyl-5-methylcyclohexanol ((−)-menthol), followed by silica gel column chromatography separation, or via diastereomeric salts with (<i>S</i>)-(−)-1-phenyethylamine, followed by recrystallization, were fruitless. Taking into account these results and the fact that no big difference was expected for the enantiomers of the CR-6–chlorotacrine hybrids either in their antioxidant effects or in their AChE and BChE inhibitory activities, as predicted by molecular dynamics (MD) simulations (see below), we did not undertake further resolution attempts.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Purity of the Compounds</h3><div class="NLM_p last">Apart from the target CR-6–chlorotacrine hybrids (<b>4a</b>–<b>d</b>, <b>5a</b>–<b>c</b>, and <b>6a</b>–<b>d</b>) and the CR-6–tacrine hybrids <b>12a</b>–<b>c</b> and <b>12e</b>, we also subjected the O-benzylated CR-6–chlorotacrine hybrids <b>11a</b>–<b>c</b> and <b>11e</b> to biological evaluation. Even though the latter compounds should be devoid of antioxidant effect, due to the substitution at the key hydroxyl group of the chroman scaffold, we wanted to assess the effect of this substitution on the rest of biological activities under evaluation. All of these hybrids were transformed into the corresponding hydrochloride or dihydrochloride salts for their chemical characterization and biological profiling. The analytical samples of all of the tested hybrids possessed a purity >95%, according to NMR spectra with full assignments and high-performance liquid chromatography (HPLC)-UV/high-resolution mass spectrometry (HRMS) measurements (for more details, see the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> and <a href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_001.pdf" class="ext-link">Supporting Information</a>).</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> In Vitro hAChE and hBChE Inhibition</h3><div class="NLM_p">The anticholinesterase activity of the new hybrids was evaluated in vitro by the method of Ellman,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> using human recombinant AChE (hAChE) and BChE from human serum (hBChE). The parent 6-chlorotacrine (Cl-THA), tacrine (THA), and CR-6-derived carboxylic acid <b>7</b> and amine <b>14</b> were also tested as reference compounds.</div><div class="NLM_p">All CR-6–chlorotacrine hybrids (<b>4a</b>–<b>d</b>, <b>5a</b>–<b>c</b>, <b>6a</b>–<b>d</b>, <b>11a</b>–<b>c</b>, and <b>11e</b>) were more potent hAChE inhibitors than the parent Cl-THA (IC<sub>50</sub> = 14.5 nM), with IC<sub>50</sub> values in the single-digit nanomolar or subnanomolar range, with the sole exception of <b>4d</b>, featuring an ethylene glycol-containing linker (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The order of potencies among the different series was as follows: amines (<b>6a</b>–<b>d</b>) > amides (<b>4a</b>–<b>d</b>) > reverse amides (<b>5a</b>–<b>c</b>) > O-benzylated amides (<b>11a</b>–<b>c</b> and <b>11e</b>). In the oligomethylene-linked hybrids, all linker lengths were well tolerated, even though, in general, octa- and nona-methylene-linked hybrids were slightly more potent. Conversely, the presence of an ethylene glycol motif within the linker had a clear detrimental effect on hAChE inhibitory activity, with hybrids <b>4d</b> and <b>6d</b> being 13- and 69-fold less potent than their counterparts <b>4b</b> and <b>6b</b>, respectively, which have an equivalent linker length. Overall, the most potent CR-6–chlorotacrine hybrids for hAChE inhibition were the amines <b>6a</b> (IC<sub>50</sub> = 442 pM), <b>6b</b> (IC<sub>50</sub> = 121 pM), and <b>6c</b> (IC<sub>50</sub> = 272 pM), which were 33-, 120-, and 53-fold more potent than the parent Cl-THA, respectively.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro Biological Profiling of the Novel CR-6–(Chloro)tacrine Hybrids</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/medium/jm0c00528_0021.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">hAChE IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">hBChE IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">DPPH IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">BACE-1 IC<sub>50</sub> (μM) (% <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="80e9eee8e9e2e9f4e9efeec0b5">[email protected]</a> μM)<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">Aβ42 aggregation % <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="39505751505b504d505657790809">[email protected]</a> μM<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">tau aggregation % <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="573e393f3e353e233e3839176667">[email protected]</a> μM<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">PAMPA-BBB permeability<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4a</b></td><td class="colsep0 rowsep0" align="left">5.43 ± 0.27</td><td class="colsep0 rowsep0" align="left">79.1 ± 3.7</td><td class="colsep0 rowsep0" align="left">15.2 ± 5.6</td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left">9.7 ± 0.7 (CNS+)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4b</b></td><td class="colsep0 rowsep0" align="left">3.69 ± 0.19</td><td class="colsep0 rowsep0" align="left">170 ± 9</td><td class="colsep0 rowsep0" align="left">19.1 ± 5.6</td><td class="colsep0 rowsep0" align="left">(19.0)</td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left">15.0 ± 2.1</td><td class="colsep0 rowsep0" align="left">9.6 ± 0.6 (CNS+)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4c</b></td><td class="colsep0 rowsep0" align="left">2.05 ± 0.11</td><td class="colsep0 rowsep0" align="left">168 ± 5</td><td class="colsep0 rowsep0" align="left">13.4 ± 5.1</td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">11.2 ± 3.1</td><td class="colsep0 rowsep0" align="left">12.6 ± 3.3</td><td class="colsep0 rowsep0" align="left">8.2 ± 0.5 (CNS+)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4d</b></td><td class="colsep0 rowsep0" align="left">47.9 ± 2.5</td><td class="colsep0 rowsep0" align="left">1840 ± 130</td><td class="colsep0 rowsep0" align="left">16.8 ± 5.0</td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left">10.7 ± 2.0</td><td class="colsep0 rowsep0" align="left">7.0 ± 0.2 (CNS+)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5a</b></td><td class="colsep0 rowsep0" align="left">3.80 ± 0.24</td><td class="colsep0 rowsep0" align="left">102 ± 8</td><td class="colsep0 rowsep0" align="left">8.9 ± 1.6</td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left">7.8 ± 0.2 (CNS+)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5b</b></td><td class="colsep0 rowsep0" align="left">7.94 ± 0.31</td><td class="colsep0 rowsep0" align="left">187 ± 7</td><td class="colsep0 rowsep0" align="left">15.1 ± 2.3</td><td class="colsep0 rowsep0" align="left">(14.0)</td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left">12.5 ± 2.1</td><td class="colsep0 rowsep0" align="left">8.3 ± 1.3 (CNS+)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5c</b></td><td class="colsep0 rowsep0" align="left">6.23 ± 0.36</td><td class="colsep0 rowsep0" align="left">148 ± 4</td><td class="colsep0 rowsep0" align="left">13.1 ± 2.9</td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">11.0 ± 2.5</td><td class="colsep0 rowsep0" align="left">18.5 ± 3.1</td><td class="colsep0 rowsep0" align="left">8.7 ± 0.8 (CNS+)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6a</b></td><td class="colsep0 rowsep0" align="left">0.44 ± 0.04</td><td class="colsep0 rowsep0" align="left">17.4 ± 1.6</td><td class="colsep0 rowsep0" align="left">16.5 ± 3.7</td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">17.9 ± 4.0</td><td class="colsep0 rowsep0" align="left">29.0 ± 3.2</td><td class="colsep0 rowsep0" align="left">10.3 ± 0.2 (CNS+)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6b</b></td><td class="colsep0 rowsep0" align="left">0.12 ± 0.01</td><td class="colsep0 rowsep0" align="left">13.4 ± 0.9</td><td class="colsep0 rowsep0" align="left">6.9 ± 1.6</td><td class="colsep0 rowsep0" align="left">(24.8)</td><td class="colsep0 rowsep0" align="left">27.9 ± 3.3</td><td class="colsep0 rowsep0" align="left">35.5 ± 2.8</td><td class="colsep0 rowsep0" align="left">12.5 ± 0.6 (CNS+)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6c</b></td><td class="colsep0 rowsep0" align="left">0.27 ± 0.02</td><td class="colsep0 rowsep0" align="left">18.3 ± 0.4</td><td class="colsep0 rowsep0" align="left">18.5 ± 1.7</td><td class="colsep0 rowsep0" align="left">(28.1)</td><td class="colsep0 rowsep0" align="left">34.0 ± 2.8</td><td class="colsep0 rowsep0" align="left">48.2 ± 2.9</td><td class="colsep0 rowsep0" align="left">10.1 ± 1.3 (CNS+)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6d</b></td><td class="colsep0 rowsep0" align="left">8.35 ± 0.51</td><td class="colsep0 rowsep0" align="left">180 ± 9</td><td class="colsep0 rowsep0" align="left">17.8 ± 5.8</td><td class="colsep0 rowsep0" align="left">(19.9)</td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left">17.6 ± 3.3</td><td class="colsep0 rowsep0" align="left">9.7 ± 0.6 (CNS+)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11a</b></td><td class="colsep0 rowsep0" align="left">6.99 ± 0.35</td><td class="colsep0 rowsep0" align="left">51.0 ± 1.8</td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">12.5 ± 0.4</td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left">20.8 ± 2.5</td><td class="colsep0 rowsep0" align="left">11.5 ± 0.5 (CNS+)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11b</b></td><td class="colsep0 rowsep0" align="left">10.4 ± 0.6</td><td class="colsep0 rowsep0" align="left">100 ± 5</td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">8.31 ± 0.26</td><td class="colsep0 rowsep0" align="left">24.4 ± 2.9</td><td class="colsep0 rowsep0" align="left">40.4 ± 2.8</td><td class="colsep0 rowsep0" align="left">12.3 ± 0.2 (CNS+)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11c</b></td><td class="colsep0 rowsep0" align="left">7.89 ± 0.42</td><td class="colsep0 rowsep0" align="left">30.6 ± 2.2</td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">7.19 ± 0.12</td><td class="colsep0 rowsep0" align="left">41.8 ± 2.5</td><td class="colsep0 rowsep0" align="left">55.2 ± 2.1</td><td class="colsep0 rowsep0" align="left">10.4 ± 0.7 (CNS+)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11e</b></td><td class="colsep0 rowsep0" align="left">11.0 ± 0.6</td><td class="colsep0 rowsep0" align="left">201 ± 11</td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">18.0 ± 1.9</td><td class="colsep0 rowsep0" align="left">4.4 ± 3.0</td><td class="colsep0 rowsep0" align="left">12.9 ± 3.5</td><td class="colsep0 rowsep0" align="left">10.7 ± 1.0 (CNS+)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12a</b></td><td class="colsep0 rowsep0" align="left">111 ± 5</td><td class="colsep0 rowsep0" align="left">4.28 ± 0.31</td><td class="colsep0 rowsep0" align="left">13.6 ± 5.6</td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left">6.6 ± 0.8 (CNS+)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12b</b></td><td class="colsep0 rowsep0" align="left">69.8 ± 6.4</td><td class="colsep0 rowsep0" align="left">5.33 ± 0.49</td><td class="colsep0 rowsep0" align="left">19.4 ± 6.6</td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">17.4 ± 3.8</td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left">7.3 ± 0.9 (CNS+)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12c</b></td><td class="colsep0 rowsep0" align="left">57.8 ± 4.8</td><td class="colsep0 rowsep0" align="left">5.36 ± 0.24</td><td class="colsep0 rowsep0" align="left">14.7 ± 4.9</td><td class="colsep0 rowsep0" align="left">(6.75)</td><td class="colsep0 rowsep0" align="left">16.4 ± 3.6</td><td class="colsep0 rowsep0" align="left">12.7 ± 2.1</td><td class="colsep0 rowsep0" align="left">8.9 ± 0.5 (CNS+)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12e</b></td><td class="colsep0 rowsep0" align="left">275 ± 38</td><td class="colsep0 rowsep0" align="left">4.99 ± 0.36</td><td class="colsep0 rowsep0" align="left">22.9 ± 6.7</td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left">4.3 ± 0.3 (CNS±)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CR-6</td><td class="colsep0 rowsep0" align="left">nd<a class="ref internalNav" href="#t1fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">nd<a class="ref internalNav" href="#t1fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">17.4 ± 5.7</td><td class="colsep0 rowsep0" align="left">nd<a class="ref internalNav" href="#t1fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">nd<a class="ref internalNav" href="#t1fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">nd<a class="ref internalNav" href="#t1fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">0.25<a class="ref internalNav" href="#t1fn8" aria-label="h">h</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn9" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn9" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">14.9 ± 2.5</td><td class="colsep0 rowsep0" align="left">nd<a class="ref internalNav" href="#t1fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left">0.4 ± 0.02 (CNS−)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">>100 000<a class="ref internalNav" href="#t1fn10" aria-label="j">j</a></td><td class="colsep0 rowsep0" align="left">>23 000<a class="ref internalNav" href="#t1fn11" aria-label="k">k</a></td><td class="colsep0 rowsep0" align="left">14.0 ± 3.3</td><td class="colsep0 rowsep0" align="left">nd<a class="ref internalNav" href="#t1fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left">1.0 ± 0.05 (CNS−)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">THA</td><td class="colsep0 rowsep0" align="left">320 ± 10</td><td class="colsep0 rowsep0" align="left">35.2 ± 5.1</td><td class="colsep0 rowsep0" align="left">nd<a class="ref internalNav" href="#t1fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">na</td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left">22.5 ± 0.3 (CNS+)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Cl-THA</td><td class="colsep0 rowsep0" align="left">14.5 ± 0.9</td><td class="colsep0 rowsep0" align="left">505 ± 28</td><td class="colsep0 rowsep0" align="left">na<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">nd<a class="ref internalNav" href="#t1fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left"><10</td><td class="colsep0 rowsep0" align="left">26.1 ± 0.6 (CNS+)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> inhibitory concentration (nM) toward human recombinant AChE and BChE from human serum. IC<sub>50</sub> values are expressed as mean ± standard error of the mean (SEM) of at least two experiments, each performed in triplicate.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">IC<sub>50</sub> inhibitory concentration (μM) for DPPH radical scavenging activity. Values are expressed as mean ± standard deviation (SD) of single experiments performed in triplicate. Trolox (IC<sub>50</sub> = 15.7 ± 0.9 μM) was also used as a reference compound.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">IC<sub>50</sub> inhibitory concentration (μM) or % inhibition of human recombinant BACE-1 at 5 μM. Values are expressed as mean ± standard deviation (SD) of two independent experiments, each performed in triplicate. Myricetin (IC<sub>50</sub> = 3.82 ± 0.87 μM) was used as a reference compound.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">% inhibition of Aβ42 and tau protein aggregation at 10 μM in intact <i>Escherichia coli</i> cells. Values are expressed as mean ± SEM of nine independent experiments, each performed in duplicate. DP128<sup>20</sup> (% inhibition of Aβ42 and tau aggregation of 68.2 ± 2.1 and 72.2 ± 2.1, respectively, at 10 μM) was used as a reference compound.</p></div><div class="footnote" id="t1fn5"><sup><sup>e</sup></sup><p class="last">Permeability values (<i>P</i><sub>e</sub>, 10<sup>–6</sup> cm s<sup>–1</sup>) from the PAMPA-BBB assay. Values are expressed as the mean ± SD of three independent experiments, each performed in triplicate.</p></div><div class="footnote" id="t1fn6"><sup><sup>f</sup></sup><p class="last">Not active.</p></div><div class="footnote" id="t1fn7"><sup><sup>g</sup></sup><p class="last">Not determined.</p></div><div class="footnote" id="t1fn8"><sup><sup>h</sup></sup><p class="last">Value taken from ref <a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a>.</p></div><div class="footnote" id="t1fn9"><sup><sup>i</sup></sup><p class="last">Not active at 100 μM.</p></div><div class="footnote" id="t1fn10"><sup><sup>j</sup></sup><p class="last">IC<sub>50</sub> = 101 ± 9 μM.</p></div><div class="footnote" id="t1fn11"><sup><sup>k</sup></sup><p class="last">IC<sub>50</sub> = 23.2 ± 1.1 μM.</p></div></div></div><div class="NLM_p">Taking into account that the parent CR-6-based carboxylic acid <b>7</b> and amine <b>14</b> are essentially inactive or only very weakly active against hAChE, the fact that the vast majority of CR-6–chlorotacrine hybrids are more potent than 6-chlorotacrine indicates that the CR-6 scaffold of the novel hybrids positively contributes to their hAChE inhibitory potency, thereby highlighting the success of the hybridization strategy. It is well known that 6-chlorotacrine interacts at the so-called catalytic anionic site (CAS) of AChE, placed at the bottom of a 20 Å deep gorge.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> We anticipated that the higher potency of the novel CR-6–chlorotacrine hybrids might arise from the simultaneous binding to CAS by the 6-chlorotacrine moiety and to a secondary binding site, the peripheral anionic site (PAS), located at the entrance of the catalytic gorge, by the CR-6 scaffold, as found in other families of tacrine-based hybrids.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> In the case of hybrids <b>6a</b>–<b>c</b>, the presence of a basic aliphatic amino group within the linker, which should be protonated at physiological pH (and under the conditions of the assay of AChE inhibition), could enable additional interactions with aromatic or anionic midgorge residues, thereby leading to a triple-site binding mode.<a onclick="showRef(event, 'cit19b ref30'); return false;" href="javascript:void(0);" class="ref cit19b ref30">(19b,30)</a></div><div class="NLM_p">In 6-chlorotacrine-based hybrids, the chlorine atom, which is accommodated at a hydrophobic pocket within the CAS, greatly contributes to the inhibitory potency.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Thus, quite expectedly, hybrids <b>12a</b>–<b>c</b> and <b>12e</b>, which feature an unsubstituted tacrine moiety, were 20–30-fold less potent hAChE inhibitors than the 6-chlorotacrine-based counterparts (<b>4a</b>–<b>c</b>) but still more potent (up to 5-fold) than tacrine itself (IC<sub>50</sub> = 320 nM), further indicating a beneficial contribution of the CR-6 moiety and of the linker to the inhibitory activity toward hAChE.</div><div class="NLM_p">Because the levels of AChE diminish as AD progresses, hydrolysis of the neurotransmitter acetylcholine is increasingly operated by BChE, which, thereby, is also considered an important target for AD treatment.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> In contrast to the positive effect of the chlorine atom of 6-chlorotacrine on AChE inhibitory activity, its presence is detrimental for BChE inhibition, due to steric hindrance effects at the enzyme active site.<a onclick="showRef(event, 'cit19b ref30 ref33'); return false;" href="javascript:void(0);" class="ref cit19b ref30 ref33">(19b,30,33)</a> Thus, tacrine (IC<sub>50</sub> = 35.2 nM) is a clearly more potent hBChE inhibitor than 6-chlorotacrine (IC<sub>50</sub> = 505 nM). Accordingly, the CR-6–chlorotacrine hybrids were found to be less potent inhibitors toward hBChE than hAChE. Notwithstanding the AChE over BChE selectivity of these compounds, they still displayed potent hBChE inhibitory activity, with IC<sub>50</sub> values in the two-digit nanomolar range in most cases (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Indeed, all of them turned out to be more potent hBChE inhibitors (3–40-fold) than the parent 6-chlorotacrine, with the sole exception of hybrid <b>4d</b>, bearing an ethylene glycol motif within the linker. Very gratifyingly, some of them (<b>6a</b>–<b>c</b> and <b>11c</b>) were even slightly more potent hBChE inhibitors than tacrine, despite the presence of the chlorine atom at their tacrine moiety. Some trends observed for hAChE inhibition were also found for hBChE inhibition. Thus, the potency within the different series varied in the same order: amines > amides > reverse amides; within a given series, similar potencies were found for the different oligomethylene-linked homologues, and the presence of an ethylene glycol within the linker caused a drop of activity. The only difference was the slightly higher potency of the O-benzylated amides <b>11</b> relative to the O-deprotected counterparts <b>4</b>.</div><div class="NLM_p">Again, amines <b>6a</b> (IC<sub>50</sub> = 17.4 nM), <b>6b</b> (IC<sub>50</sub> = 13.4 nM), and <b>6c</b> (IC<sub>50</sub> = 18.3 nM) were the most potent CR-6–chlorotacrine hybrids for hBChE inhibition, being 29-, 38-, and 28-fold more potent than the parent 6-chlorotacrine and 2–3-fold more potent than tacrine.</div><div class="NLM_p">Obviously, the hBChE inhibitory activity was even higher in the CR-6–tacrine hybrids <b>12a</b>–<b>c</b> and <b>12e</b>, bearing a tacrine instead of a 6-chlorotacrine moiety. These hybrids displayed single-digit nanomolar hBChE inhibitory potencies, around 5 nM, i.e., potencies approximately 7-fold higher than that of tacrine.</div><div class="NLM_p">Like for hAChE inhibition, the CR-6-based carboxylic acid <b>7</b> was inactive for hBChE inhibition, whereas the amine <b>14</b> displayed only moderate potency (IC<sub>50</sub> = 23.2 μM).</div><div class="NLM_p">All together, these results suggest that introduction of an inactive or weakly active CR-6 moiety adequately linked to the structure of the potent hAChE and hBChE inhibitors 6-chlorotacrine and tacrine, respectively, significantly increases the anticholinesterase potencies of the resulting hybrids relative to both parent compounds.</div><div class="NLM_p">The mechanism of inhibition of hAChE by the most potent compound, <b>6b</b>, was investigated by kinetic and propidium displacement studies and by molecular dynamics simulations. Kinetic studies showed that <b>6b</b> acts as a mixed-type inhibitor of hAChE, hence presumably acting as a dual site inhibitor. It displayed an inhibitor dissociation constant (<i>K</i><sub>i</sub>) of 132 ± 36 pM and a dissociation constant for the enzyme–substrate–inhibitor complex (<i>K</i><sub>i</sub>′) equals 258 ± 2 pM (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, left). We had inferred that the 6-chlorotacrine moiety of the hybrids should interact at the CAS of AChE, whereas the CR-6 scaffold would be interacting at the PAS. To further confirm the interaction with PAS and estimate the inhibitor’s affinity for this site, the ability of <b>6b</b> to displace the known PAS ligand propidium was assessed (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, right). Hybrid <b>6b</b> showed a dissociation constant <i>K</i><sub>D</sub> = 2.03 ± 0.09 μM, which further confirmed the ability to interact with the PAS of AChE, albeit with a lower affinity than that of the specific PAS ligand propidium (<i>K</i><sub>D</sub> = 0.7 μM).</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/medium/jm0c00528_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Mechanism of inhibition of hAChE by hybrid <b>6b</b>. Left, overlaid Lineweaver–Burk reciprocal plots showing the variation of the initial velocity rate (<i>v</i>) as a function of increasing substrate (acetylthiocholine, ATCh) in the absence and presence of increasing concentrations of <b>6b</b>. The mechanism of inhibition was assessed by two independent experiments, each performed in triplicate. Right, propidium displacement studies to determine the affinity for the PAS of AChE: P and I stand for propidium iodide and inhibitor (<b>6b</b>), respectively; <i>F</i><sub>e</sub> is the initial fluorescence intensity when enzyme sites are saturated with P; <i>F</i><sub>P</sub> is the fluorescence intensity when propidium is completely displaced from the enzyme; and <i>F</i> denotes the fluorescence intensity after adding a determined amount of displacing agent during the titration experiment. Data are the average of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00528&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Finally, the binding mode and mechanism of inhibition of AChE by <b>6b</b> and its AChE over BChE selectivity were further studied by molecular dynamics (MD) simulations. In addition, MD were employed to decipher the molecular features responsible for the high BChE inhibitory activity of the most potent hybrid, <b>12a</b>. In these studies, the potential effect of the absolute configuration of the stereocenter at position 2 of the CR-6 moiety was assessed.</div><div class="NLM_p">The stability of all of the simulated enzyme–ligand complexes was confirmed by the root-mean-square deviation (RMSD) analysis of the residues that define the binding site after the rearrangement of the peripheral site and the concomitant accommodation of the CR-6 moiety along the AChE gorge (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_001.pdf" class="ext-link">Figure S1</a> of the Supporting Information). Representative snapshots of (<i>R</i>)-<b>6b</b> and (<i>S</i>)-<b>6b</b> bound to AChE derived from MD simulations are shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>. Both enantiomers of <b>6b</b> exhibit a very similar pattern of interactions except for the chroman moiety, which seems to take slightly different orientations along the gorge according to its stereochemistry. The 6-chlorotacrine moiety is stably stacked against Trp86 and Tyr337 in the CAS (average distances of 3.6 and 4.3 Å from the planes of the chlorotacrine ring to the indole and phenol rings, respectively). The chlorine atom is placed into a small hydrophobic cavity formed by Trp439, Pro446, and Tyr449. The protonated quinoline nitrogen atom of the chlorotacrine moiety is engaged in hydrogen-bonding interactions with the carbonyl oxygen of the catalytic residue His447 (average N···O distance of 2.8 Å). In addition, a salt bridge between the protonated aliphatic secondary amino group within the linker of <b>6b</b> and the carboxylate of Asp74 (average N···O distance of 2.7 Å) confers stability to the aliphatic linker along the gorge in both enantiomers. This might contribute to stabilize the gorge through a network of interactions reinforced by the salt bridge formed between Asp74 residues with (<i>R</i>)-<b>6b</b> and (<i>S</i>)-<b>6b</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). These interactions closely resemble those observed for the binding of tacrine–donepezil hybrids to hAChE.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> In contrast with the common pattern of interactions observed for the 6-chlorotacrine ring and the tether in the AChE complexes with (<i>R</i>)-<b>6b</b> and (<i>S</i>)-<b>6b</b>, binding of the chroman moiety exhibits slight differences for the two enantiomers. Thus, the CR-6 moiety is located close to Trp286, even though without forming stacking interactions with this latter residue, adopting distinct arrangements in the two complexes. In turn, this suggests that the CR-6 moiety has a weak contribution to the binding affinity, which may be understood from the larger flexibility of the peripheral site (PAS) compared to the tight packing observed at the CAS, and the solvent exposure of the CR-6 moiety bound to the PAS cavity.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/medium/jm0c00528_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Representative snapshots of the complexes of (A) (<i>R</i>)-<b>6b</b> and (B) (<i>S</i>)-<b>6b</b> bound to hAChE taken from molecular dynamics simulations (started from PDB structure <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Q83">1Q83</a>). Bottom panels show details of the interactions at the CAS and along the gorge. Density maps for structural water molecules (shown as red spheres) within the catalytic site are depicted as a red isomesh. Selected interactions are shown as yellow dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00528&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Notwithstanding its higher activity toward hAChE (IC<sub>50</sub> = 121 pM), hybrid <b>6b</b> can be definitively considered a very potent hBChE inhibitor (IC<sub>50</sub> = 13.4 nM). To shed light on the AChE over BChE selectivity of <b>6b</b>, its binding mode within BChE was also studied by MD simulations. Hybrid <b>6b</b> adopts an extended conformation along the gorge of BChE, which resembles the arrangement found in the AChE complex (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_001.pdf" class="ext-link">Figures S2 and S3</a> of the Supporting Information). The structural integrity of the binding mode in the three independent MD simulations is supported by the stability of the RMSD profiles (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_001.pdf" class="ext-link">Figure S2</a> of the Supporting Information). However, the lower inhibitory activity against BChE may be attributed to the loss of the hydrophobic subpocket that accommodates the chlorine atom of chlorotacrine due to replacement of Pro446 (in AChE) with Met437 (in BChE), necessary to stabilize the chlorine atom<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> as well as to the loss of the salt bridge formed between the protonated aliphatic nitrogen and Asp74, thus leading to the AChE over BChE selectivity profile of hybrid <b>6b</b>.</div><div class="NLM_p">Finally, MD simulations were also run for both enantiomers of the tacrine-based hybrid <b>12a</b>, which is a selective BChE inhibitor (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>; RMSD profiles are shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_001.pdf" class="ext-link">Figure S4</a> of the Supporting Information). A similar pattern of interactions was found for both enantiomers, especially regarding the chlorotacrine and tether moieties. The tacrine moiety of <b>12a</b> is stacked against Trp82 (average distance of 3.5 Å), with the protonated quinoline nitrogen atom being hydrogen-bonded to the carbonyl oxygen of His438 (average N···O distance of 2.9 Å for both enantiomers). The absence of the chlorine atom at the tacrine moiety prevents the steric clash with Met437, thus contributing to the 3-fold-enhanced BChE inhibitory activity of <b>12a</b> relative to <b>6b</b>. An extensive water-assisted hydrogen-bonding network involving Trp82, Tyr128, Glu197, and the aromatic amine nitrogen enables the stabilization of the protein–ligand complex. At the gorge, the linker amide group acts as a hydrogen-bond acceptor with Asn68 (average N···O distances of 3.0 Å for both enantiomers) and as a hydrogen-bond donor with Gln119/Ser287 (average N···O distances of 2.8 (Gln119) and 3.5 (Ser287) Å) in the <i>R</i>- and <i>S</i>-enantiomers, respectively. Finally, the CR-6 moiety of hybrid <b>12a</b> is located at the PAS and forms transient hydrogen-bonding interactions with the main chain of Thr284 and Val279 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A) and Val280 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B).</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/medium/jm0c00528_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Representative snapshots of the complexes of (A) (<i>R</i>)-<b>12a</b> and (B) (<i>S</i>)-<b>12a</b> bound to hBChE taken from molecular dynamics simulations (started from PDB structure <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5K5E">5K5E</a>). Bottom panels show details of the interactions at the catalytic site and along the gorge. Density maps for structural water molecules (shown as red spheres) within the catalytic site are depicted as a red isomesh. Selected interactions are shown as yellow dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00528&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Overall, both in vitro studies (kinetic and propidium displacement studies) and MD simulations support a multisite binding mode, with both pharmacophoric moieties and the functional group within the linker (amide or aliphatic amine) contributing to the stabilization of the binding. These multiple interactions account for the high inhibitory potency toward both enzymes.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> In Vitro Antioxidant Activity</h3><div class="NLM_p">The in vitro antioxidant activity of the novel hybrids was evaluated by the widely used DPPH assay, which is based on the ability of antioxidant compounds to donate a hydrogen atom to scavenging the 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Derivatization of the antioxidant lead CR-6 (IC<sub>50</sub> DPPH = 17.4 μM) by introduction of distinct side chains at position 2 is compatible with the retention of the antioxidant activity.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Indeed, the CR-6-derived carboxylic acid <b>7</b> and amine <b>14</b> display the same antioxidant activity as that of the lead (IC<sub>50</sub> = 14.9 and 14.0 μM, respectively). Likewise, all of the novel CR-6–chlorotacrine and CR-6–tacrine hybrids featuring a free hydroxyl group at position 6 of the CR-6 scaffold (<b>4a</b>–<b>d</b>, <b>5a</b>–<b>c</b>, <b>6a</b>–<b>d</b>, <b>12a</b>–<b>c</b>, and <b>12e</b>) retain the antioxidant activity of the parent CR-6 or are even slightly more potent, with IC<sub>50</sub> values in the 6.9–22.9 μM range (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). As expected, hybrids <b>11a</b>–<b>c</b> and <b>11e</b>, in which this key hydroxyl group is benzylated, were not active in this assay.</div><div class="NLM_p last">Thus, hybridization of the antioxidant lead CR-6 with 6-chlorotacrine or tacrine, devoid of antioxidant activity, resulted in compounds that displayed similar antioxidant activity to that of the lead or trolox (IC<sub>50</sub> = 15.7 μM).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> In Vitro BACE-1 Inhibition</h3><div class="NLM_p">BACE-1 is the enzyme involved in the first rate-limiting step of the formation of Aβ by proteolytic cleavage of APP, and, hence, it is also a very important biological target in AD drug discovery.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Different classes of (chloro)tacrine-based hybrids have been found to be able to inhibit BACE-1<a onclick="showRef(event, 'cit19b ref38'); return false;" href="javascript:void(0);" class="ref cit19b ref38">(19b,38)</a> with low micromolar potencies. We have recently found a novel class of hybrids bearing a huprine moiety, structurally related to 6-chlorotacrine, which displayed nanomolar BACE-1 inhibitory activity (IC<sub>50</sub> = 80 nM).<a onclick="showRef(event, 'cit19a ref21'); return false;" href="javascript:void(0);" class="ref cit19a ref21">(19a,21)</a> The 4-aminoquinoline system of the huprine moiety of these hybrids must be mostly protonated at physiological pH and in the acidic endosomal compartments (pH 4.5–6.5) where BACE-1 localizes. Molecular dynamics simulations have suggested that the protonated huprine moiety may establish a salt bridge with the aspartate residues of the catalytic dyad of BACE-1, whereas the second pharmacophore of these hybrids (the hydroxianthraquinone moiety of rhein) interacts with a transient secondary binding site, located at the edge of the catalytic site, mainly establishing a hydrogen bond between a carbonyl group of the hydroxianthraquinone moiety of the hybrid and the guanidinium group of Arg307.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><div class="NLM_p last">In this light, we screened the novel CR-6–(chloro)tacrine hybrids in vitro against human recombinant BACE-1, using the Panvera substrate. Most of the novel hybrids were found to be inactive or weak BACE-1 inhibitors, with percentages of inhibition below 30% at an inhibitor concentration of 5 μM. Only the O-benzylated hybrids <b>11a</b>–<b>c</b> and <b>11e</b> displayed moderate inhibitory potency, with IC<sub>50</sub> values from 7 to 18 μM (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), i.e., in the same range of potency of other (chloro)tacrine-based hybrids but seemingly less potent than the rhein–huprine hybrid. However, it must be mentioned that the assay conditions used to assess the BACE-1 inhibitory activity of these novel hybrids and others previously developed in our group, including the rhein–huprine hybrids, were different.<a onclick="showRef(event, 'cit19a cit19b cit19c'); return false;" href="javascript:void(0);" class="ref cit19a cit19b cit19c">(19a−c)</a> Previously, we had used the fluorogenic methoxycoumarin-Ser-Glu-Val-Asn-Leu∼Asp-Ala-Glu-Phe-Lys-dinitrophenyl (M-2420), which mimics the APP sequence comprising the Swedish mutation, as the substrate. The M-2420 substrate is widely used due to its high specificity, predictivity, and quenching efficacy. However, M-2420 is not suitable for the characterization of all types of BACE-1 inhibitors due to its poor selective wavelengths for fluorescence measurements (λ<sub>ex</sub>/λ<sub>em</sub> 320/420). Indeed, due to fluorescence interferences of the novel CR-6–chlorotacrine hybrids under those assay conditions, we performed a fluorescence resonance energy transfer (FRET) assay using the Panvera substrate, instead of M-2420. The Panvera substrate is an octapeptide (Glu-Val-Asn-Leu∼Asp-Ala-Glu-Phe) bearing the Swedish APP mutation. The <i>k</i><sub>cat</sub>/<i>K</i><sub>M</sub> value established for this sequence is 9.5-fold higher than that calculated for M-2420 decapeptide. On the contrary, the entire Panvera substrate is characterized by a reduced rate of substrate cleavage, which implies a longer incubation time than that required for the M-2420 substrate. This can be likely ascribed to some steric hindrance due to the presence of the bulky rhodamine fluorophore and quenching group of the Panvera substrate. Despite the lower predictivity of the assay with the Panvera substrate relative to that of the assay with M-2420, its highly selective wavelengths for fluorescence measurements enable the evaluation of the BACE-1 inhibitory activity for the majority of compounds, even those intrinsically colored.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a><sup><i>c</i></sup> By using the new conditions with the Panvera substrate, the IC<sub>50</sub> value of the rhein–huprine hybrid was 1.50 μM. Thus, the novel O-benzylated hybrids <b>11a</b>–<b>c</b> and <b>11e</b> were still less potent than the rhein–huprine hybrid when using the same assay conditions, with 5-fold lower potencies in the best cases (<b>11b</b> and <b>11c</b>).</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> In Cellulo Aβ42 and Tau Antiaggregating Activity</h3><div class="NLM_p">The evaluation of the antiaggregating activity of several classes of (chloro)tacrine- or related huprine-based hybrids developed over the years by our group has shown that many of them display moderate to good potencies,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> with percentages of inhibition up to 70–80% when tested at a 10 μM concentration in vitro or in a simplified in vivo model, namely, intact <i>E. coli</i> cells that overexpress the amyloidogenic protein, either Aβ42 or tau.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Interestingly, this antiaggregating activity was extensive to other completely unrelated amyloidogenic proteins associated with other neurologic and non-neurologic disorders and to fungal, yeast, and bacterial proteins. These findings made us hypothesize that common mechanisms exist that mediate the aggregation of amyloidogenic proteins, thereby making the development of amyloid aggregation pan-inhibitors possible.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><div class="NLM_p last">To further characterize the biological effects of the novel CR-6–(chloro)tacrine hybrids, their Aβ42 and tau antiaggregating activities were assessed in <i>E. coli</i> cells. The series of 6-chlorotacrine- and tacrine-based amides and reverse amides were found to be inactive. Similarly, the parent compounds 6-chlorotacrine and tacrine and the CR-6-derived carboxylic acid <b>7</b> and amine <b>14</b> were not active. Moderate antiaggregating potencies were found for the longer homologues of the series of amines (<b>6b</b> and <b>6c</b>) and O-benzylated amides (<b>11b</b> and <b>11c</b>), with percentages of inhibition around 30–50% at 10 μM (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Even if these activities were only moderate, they seem to arise from the molecular hybridization because, separately, none of the parent compounds is active in this assay. These results are in line with our hypothesis that hybrid compounds bearing two aromatic systems separated by linkers of suitable length display antiaggregating activity against amyloidogenic proteins, such as Aβ42 and tau.</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> In Vitro Brain Permeability</h3><div class="NLM_p">The ability to cross the BBB and enter the brain is a necessary condition for all drugs and candidates developed to treat central nervous system (CNS) diseases, such as AD. Indeed, poor brain permeability seems to be behind the failure of antioxidants in clinical trials against AD, in general, and is one of the major flaws of the antioxidant lead CR-6, in particular. When designing CR-6-based multitarget compounds, we had anticipated that its hybridization with the lipophilic AChE inhibitor 6-chlorotacrine should result in sufficiently increased lipophilicity to make the hybrids brain-permeable through passive diffusion. To validate our hypothesis and assess the suitability of the novel CR-6–chlorotacrine hybrids as potential anti-Alzheimer agents, their brain permeability was evaluated using the well-established PAMPA-BBB assay.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> The permeability (<i>P</i><sub>e</sub>) of the novel hybrids, the parent compounds 6-chlorotacrine and tacrine, the CR-6-derived carboxylic acid <b>7</b> and amine <b>14</b>, and 14 commercial drugs, used for assay validation, was measured through a lipid extract of porcine brain membrane. Based on the linear correlation between the reported and experimentally determined <i>P</i><sub>e</sub> values of the commercial drugs and the limits established by Di et al. for BBB permeation,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> the threshold for high BBB permeation (CNS+) was set at <i>P</i><sub>e</sub> (10<sup>–6</sup> cm s<sup>–1</sup>) > 5.2, whereas low BBB permeation (CNS−) was expected for compounds with <i>P</i><sub>e</sub> (10<sup>–6</sup> cm s<sup>–1</sup>) < 2.0.</div><div class="NLM_p last">Gratifyingly, all of the novel CR-6–chlorotacrine hybrids displayed PAMPA-BBB permeabilities well over the threshold for high permeation and between the <i>P</i><sub>e</sub> values of the parent polar CR-6-based intermediates <b>7</b> and <b>14</b> [<i>P</i><sub>e</sub> (10<sup>–6</sup> cm s<sup>–1</sup>) = 0.4 and 1.0, respectively, both CNS−] and those of the lipophilic 6-chlorotacrine and tacrine [<i>P</i><sub>e</sub> (10<sup>–6</sup> cm s<sup>–1</sup>) = 26.1 and 22.5, respectively, both CNS+]. Thus, <i>P</i><sub>e</sub> (10<sup>–6</sup> cm s<sup>–1</sup>) values in the range 7.0–12.5 were found for 6-chlorotacrine-based hybrids (<b>4a</b>–<b>d</b>, <b>5a</b>–<b>c</b>, <b>6a</b>–<b>d</b>, and O-benzylated hybrids <b>11a</b>–<b>c</b> and <b>11e</b>) and in the range 6.6–8.9 for tacrine-based hybrids (<b>12a</b>–<b>c</b>). Only the shorter homologue of the tacrine-based series, <b>12e</b>, showed an uncertain brain permeability (CNS±) with a <i>P</i><sub>e</sub> value slightly lower than that of the CNS+ threshold. Overall, these results suggested that molecular hybridization of CR-6 and 6-chlorotacrine resulted in brain-permeable compounds.</div></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> In Vivo Studies: Selection of Compounds</h3><div class="NLM_p">The antioxidant lead CR-6 had been found to exert, at some extent, neuroprotective effects in in vivo studies, despite its poor brain permeation.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> After having assessed in vitro the success of the hybridization strategy of CR-6 with 6-chlorotacrine, in terms of both multitarget profile and brain permeation, we decided to further advance to in vivo efficacy studies with selected compounds. Of the 19 novel CR-6–(chloro)tacrine hybrids, several compounds displayed an interesting in vitro multitarget profile and could be suitably selected for the in vivo studies. Indeed, many of the compounds displayed very potent hAChE and hBChE inhibitory activities and retained the antioxidant potency of the lead CR-6. This was certainly the case of amines <b>6a</b>–<b>c</b>, which were overall the most potent anticholinesterase compounds, with IC<sub>50</sub> values in the subnanomolar range for hAChE inhibition (0.12–0.44 nM) and low nanomolar range for hBChE inhibition (13.4–18.3 nM). However, these effects were largely disbalanced with their other activities, namely, antioxidant, BACE-1 inhibition, and antiaggregating potencies in the micromolar range. This might render difficult the selection of a proper dose for in vivo studies that could lead to antioxidant or anti-amyloid effects without the risk of cholinergic side effects. In contrast, the O-benzylated compounds <b>11a</b>–<b>c</b> were devoid of antioxidant activity but endowed with the best BACE-1 and Aβ42 and tau antiaggregating activities. Even if in the micromolar range, these activities were not so markedly disbalanced with their one- to two-digit nanomolar anticholinesterase potencies as they were in amines <b>6a</b>–<b>c</b>. Moreover, we speculated on the possibility that the O-benzylated hybrids <b>11</b> could be metabolically transformed, at least in part, into the O-debenzylated compounds, i.e., the corresponding hybrids of the amide series <b>4</b>, through a CYP-mediated O-dealkylation. This is a conceivable metabolic process as it would involve a benzylic position that, per se, is prone to CYP-mediated oxidation. This metabolic conversion would restore the free hydroxyl group at position 6 of the chroman scaffold. Thus, the generated metabolite would be able to exert antioxidant effects.</div><div class="NLM_p">In light of these considerations and also taking into consideration that they have the same total linker length and very similar anticholinesterase and antiaggregating potencies as those of the so far in vivo best-performing huprine-based multitarget compound developed by our group,<a onclick="showRef(event, 'cit19a'); return false;" href="javascript:void(0);" class="ref cit19a">(19a)</a> we selected hybrid <b>11b</b> and its O-debenzylated counterpart, <b>4b</b>, to be further advanced to in vivo efficacy studies. Each of these compounds displayed an interesting and distinct complementary mutitarget profile: <b>4b</b> displayed the initially pursued anticholinesterase/antioxidant/brain-permeable profile, while <b>11b</b> was devoid of antioxidant effect but exhibited additional moderate BACE-1 and Aβ42 and tau antiaggregating effects (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/medium/jm0c00528_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. In vitro biological profile of the selected compounds for in vivo efficacy studies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00528&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> In Vivo Assessment of Acute Toxicity and Dose Selection</h3><div class="NLM_p">The in vivo studies were performed as depicted in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>. First, a preliminary assessment of acute toxicity was carried out for the selection of the dose to be used in the chronic efficacy studies. For this purpose, three doses (5, 10, and 15 mg/kg) of the selected hybrids <b>4b</b> and <b>11b</b> were injected intraperitoneally (ip) to wild-type (WT) C57BL6/J mice, and their general health status based on the appearance of physical signs was monitored from 5 min to 24 h after injection (time points: 5 min, 10 min, 15 min, 30 min, 1 h, 2 h, 3 h, 6 h, 8 h, 24 h). The doses of 5 and 10 mg/kg of both hybrids were well tolerated. After ip injection of the highest dose of 15 mg/kg of <b>4b</b>, some side effects appeared, with the animals showing reduced locomotor activity, piloerection, ptosis, and tremor. All of these effects started disappearing 30 min later, and 3 h after administration, the animals were normally active, without any physical sign of unhealthy status. The highest dose of 15 mg/kg of the O-benzylated hybrid <b>11b</b> produced the same side effects but delayed in time, as they appeared 10–15 min after ip injection. Like with <b>4b</b>, the animals looked completely normal 3 h after the administration of <b>11b</b>. The delayed appearance of the same side effects could be related to the speculated metabolic conversion of <b>11b</b> into <b>4b</b>, which might be responsible for the transient side effects, with the delay of their appearance resulting from the time needed for the metabolic debenzylation process.</div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/medium/jm0c00528_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0007.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Flow diagram of in vivo efficacy studies with the novel CR-6–chlorotacrine hybrids <b>4b</b> and <b>11b</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00528&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Chronic In Vivo Efficacy Studies: Behavioral Studies</h3><div class="NLM_p">The in vivo proof of concept for the novel class of CR-6-based hybrids was performed using double-transgenic APP/PS1 mice, a well-established mouse model of AD. The main purpose of these studies was to determine whether the multiple activities found in vitro for the novel hybrids would impact the progression of the neurodegenerative process in vivo, i.e., to assess potential disease-modifying effects. To this end, 6-month-old WT and transgenic mice were daily administered with vehicle, <b>4b</b> (10 mg/kg, ip) or <b>11b</b> (10 mg/kg, ip), for 4 weeks. Following the chronic treatment, a 2-day washout period was applied,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> before animals’ cognitive performance evaluation.</div><div class="NLM_p">To assess the effects of <b>4b</b> and <b>11b</b> on cognitive performance, the two-object recognition test was used. One day after letting mice explore for 9 min a V-maze with two identical objects situated at the ends of the arms, one of the two familiar objects was replaced by a novel one and the mice were placed again for 9 min in the V-maze. The time spent exploring both objects was recorded to calculate an object recognition index (RI) as the difference between the time spent exploring the novel and the familiar object divided by the total time spent exploring the two objects. Low object RI values are indicative of memory impairment. Two-way analysis of variance (ANOVA) revealed a genotype effect (<i>F</i><sub>(1,24)</sub> = 8.241, <i>p</i> < 0.01) but no treatment effect or interaction between both factors. Subsequent post hoc analysis indicated a significant memory impairment in vehicle-treated APP/PS1 mice (<i>p</i> < 0.05, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>) when compared to corresponding WT littermates, but not in hybrid <b>4b</b>- and <b>11b</b>-treated APP/PS1 mice. Indeed, <b>4b</b>- and <b>11b</b>-treated APP/PS1 mice did not worsen their cognitive performance compared to treated WT littermates. Notably, although not statistically significant, hybrid <b>4b</b> showed a tendency to increase the RI in APP/PS1 relative to vehicle-treated mice, which might suggest cognitive enhancing properties of this compound (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>).</div><figure id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/medium/jm0c00528_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0008.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Memory performance in the two-object recognition test of male wild-type (WT vehicle, <i>n</i> = 6; WT <b>4b</b>, <i>n</i> = 5; WT <b>11b</b>, <i>n</i> = 6) and male APP/PS1 mice (APP/PS1 vehicle, <i>n</i> = 5; APP/PS1 <b>4b</b>, <i>n</i> = 7; APP/PS1 <b>11b</b>, <i>n</i> = 6) after chronic treatment with the novel hybrids <b>4b</b> and <b>11b</b> (10 mg/(kg day), 4 weeks, ip). APP/PS1 mice chronically treated with vehicle, but not with <b>4b</b> or <b>11b</b>, exhibit a significant reduction in the recognition index when compared to corresponding WT littermates. Data are expressed as the mean values ± SEM. Data were analyzed by two-way ANOVA with genotype (<i>p</i> < 0.01) and treatment as between factors, followed by two-tailed Student’s <i>t</i>-test to compare between genotypes (*<i>p</i> < 0.05).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00528&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Effects on Cortical APP/PS1 Mouse Amyloid Pathology</h3><div class="NLM_p">APP/PS1 mice already present amyloid plaques at the age of 6 months.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> The effects of treatment with hybrids <b>4b</b> and <b>11b</b> on the amyloidogenic and non-amyloidogenic pathways were assessed. To this end, once the behavioral experiments were completed, the animals were sacrificed and their brains were collected and processed for the quantification of several markers of amyloid pathology, namely, cortical amyloid burden and cortical soluble Aβ40 and Aβ42 levels. The gene expression of <i>Adam10</i> (<i>α-secretase</i>) and <i>Bace1</i> (<i>β-secretase</i>) and brain levels of ADAM10, BACE-1, sAPPα (a product resulting from APP cleavage by α-secretase, non-amyloidogenic pathway), and sAPPβ (a product resulting from APP cleavage by β-secretase, amyloidogenic pathway) were also quantified.</div><div class="NLM_p">First, the analysis of Aβ burden in the cortex of APP/PS1 mice treated with the novel hybrids, especially <b>4b</b>, indicated a tendency to decrease the Aβ content, although one-way ANOVA revealed that the changes were not statistically significant (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>A,B). Similarly, no significant difference was observed between vehicle and <b>4b</b>- or <b>11b</b>-treated APP/PS1 mice in the cortical soluble Aβ40 or Aβ42 levels, two of the most toxic forms of Aβ peptide (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>C).</div><figure id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/medium/jm0c00528_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0009.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (A) Representative images of Aβ immunoreactivity in cortical sections of male APP/PS1 mice subjected to chronic vehicle (<i>n</i> = 5), <b>4b</b> (<i>n</i> = 7), or <b>11b</b> (<i>n</i> = 6) treatment. The scale bar represents 200 μm. (B) Aβ burden quantification reveals a tendency to decrease in the cortex of <b>4b</b>-treated APP/PS1 mice. (C) Soluble Aβ<sub>40</sub> and Aβ<sub>42</sub> levels are not significantly modified by chronic <b>4b</b> or <b>11b</b> treatment in cortical homogenates of APP/PS1 mice. Data are expressed as the mean values ± SEM and were analyzed by one-way ANOVA with treatment as between factors (not significant in any case).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00528&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Next, while evaluation of <i>Adam10</i> in vehicle-treated animals revealed a reduction in APP/PS1 when compared with WT littermate mice, <i>Bace1</i> gene expression was higher in APP/PS1 mice (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>A,B). These results agreed with the expected preponderance of the amyloidogenic pathway of APP processing in APP/PS1 transgenic mice, leading to amyloid pathology. However, when evaluating the corresponding protein levels (ADAM10 and BACE-1), we could observe only a tendency, which not fully confirmed gene expression results (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>C,D). In <b>11b</b>-treated APP/PS1 mice, a significant increase of gene expression of <i>Adam10</i> was found, whereas in <b>4b</b>-treated mice, the increase was not statistically significant. In contrast, both compounds were found to be able to significantly reduce <i>Bace1</i> gene expression (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>A,B). However, these promising results regarding gene expression of <i>Adam10</i> (increased by hybrids <b>4b</b> and <b>11b</b>) and <i>Bace1</i> (decreased by <b>4b</b> and <b>11b</b>) did not correlate with the brain levels of the corresponding proteins ADAM10 and BACE-1, except in the case of hybrid <b>11b</b>, which also led to increased protein levels of ADAM10 (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>C,D). Overall, these results could be indicative that hybrids <b>4b</b> and <b>11b</b> might impinge into ADAM10 and BACE-1 expression processes (i.e., post-transcriptional, translational, and protein degradation regulation) controlling steady-state protein abundances, thus making it difficult to establish any correlation between mRNA expression and protein density, as suggested for some perturbed systems.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></div><figure id="fig9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/medium/jm0c00528_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0010.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Gene expression of (A) <i>Adam10</i> (<i>α-secretase</i>) and (B) <i>Bace1</i> (<i>β-secretase</i>); representative Western blot and quantification for (C) ADAM10, (D) BACE-1, (E) sAPPα, and (F) sAPPβ in cortical samples from treated male mice (WT vehicle, <i>n</i> = 6; WT <b>4b</b>, <i>n</i> = 5; WT <b>11b</b>, <i>n</i> = 6; APP/PS1 vehicle, <i>n</i> = 5; APP/PS1 <b>4b</b>, <i>n</i> = 7; APP/PS1 <b>11b</b>, <i>n</i> = 6). Data are expressed as the mean values ± SEM. Data were analyzed by two-way ANOVA with genotype and as between factors, followed by two-tailed Student’s <i>t</i>-test to compare between genotypes or Tukey’s post hoc test to compare between treatments. *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001; and ****<i>p</i> < 0.0001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00528&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Finally, regarding the soluble fragments arising from APP cleavage via α-secretase (non-amyloidogenic pathway, sAPPα) or via BACE-1 (amyloidogenic pathway, sAPPβ), nonsignificant differences were found among groups, except for <b>11b</b>, which significantly reduced sAPPβ protein levels in WT and APP/PS1 relative to vehicle-treated animals (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>E,F). Collectively, these results might point to a possible beneficial effect of <b>4b</b> and <b>11b</b> pushing up the non-amyloidogenic pathway, thus overcoming the deleterious effects of the amyloidogenic one.</div></div><div id="sec2_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Effects on Oxidative Stress Markers in the Cortex of APP/PS1 Mice</h3><div class="NLM_p">Antioxidants can exert their effects in vivo by directly preventing the formation or scavenging radicals and oxidant species and by upregulating the expression of antioxidant enzymes or inhibiting pro-oxidant enzymes.<a onclick="showRef(event, 'cit9a'); return false;" href="javascript:void(0);" class="ref cit9a">(9a)</a> Several of these markers of oxidative stress were evaluated in cortical samples of treated mice. Increased levels of markers of protein oxidation, such as protein carbonyls, are found in brains of AD and MCI patients. The level of carbonylated proteins generated by oxidative reactions was measured. Two-way ANOVA revealed a genotype effect (<i>F</i><sub>(1,24)</sub> = 3.784, <i>p</i> < 0.05), with APP/PS1 mice having clearly higher levels of oxidized proteins in the cortex than WT littermates (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>). The treatment of transgenic mice with the novel hybrids <b>4b</b> and <b>11b</b> led to a tendency to reduce the levels of oxidized proteins compared with the vehicle-treated group, but the decrease was not statistically significant (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>).</div><figure id="fig10" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/medium/jm0c00528_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0011.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. (A) Representative immunoblot for oxidized proteins (upper panel) and corresponding β-tubulin loading control (lower panel) from cortical samples of treated male mice (WT vehicle, <i>n</i> = 6; WT <b>4b</b>, <i>n</i> = 5; WT <b>11b</b>, <i>n</i> = 6; APP/PS1 vehicle, <i>n</i> = 5; APP/PS1 <b>4b</b>, <i>n</i> = 7; APP/PS1 <b>11b</b>, <i>n</i> = 6). Black triangular arrows indicate the molecular weight of proteins. (B) Optical density quantification of the immunoblots normalized with respect to the WT-vehicle group. Data are expressed as the mean values ± SEM and were analyzed by two-way ANOVA with genotype (<i>p</i> < 0.05) and treatment as between factors, followed by two-tailed Student’s <i>t</i>-test to compare between genotypes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00528&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The enzyme superoxide dismutase 2 (SOD2) is involved in scavenging ROS produced by the mitochondrial electron transport chain, which are markedly overproduced in the surrounding Aβ deposition areas.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> The levels of SOD2 around Aβ plaques were analyzed by double immunostaining in brain tissue of APP/PS1 mice. A tendency to increase the levels of the antioxidative enzyme SOD2 was found in <b>11b</b>-treated animals, even though it did not reach statistical significance (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>).</div><figure id="fig11" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/medium/jm0c00528_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0012.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. (A) Representative images of double SOD2 (green) and Aβ (red) immunostaining in cortical sections of male APP/PS1 mice chronically treated with vehicle (<i>n</i> = 5), <b>4b</b> (<i>n</i> = 7), or <b>11b</b> (<i>n</i> = 6). The scale bar represents 50 μm. (B) Quantification of the SOD2 staining around the Aβ plaques reveals a tendency to increase the levels of this enzyme involved in ROS neutralization in <b>11b</b>-treated APP/PS1 mice with respect to vehicle-treated mice, but this increase does not reach the statistical significance. Data are expressed as the mean values ± SEM and were analyzed by one-way ANOVA with treatment as between factors (not significant).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00528&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Despite the lack of statistical significance, we observed a tendency to decrease oxidized proteins in both <b>4b</b>- and <b>11b</b>-treated APP/PS1 mice and to increase the antioxidant enzyme SOD2 after treatment with <b>11b</b>. The nuclear factor-erythroid 2-related factor 2 (Nrf2) is an emerging regulator of cellular oxidative stress as it controls the expression of an array of antioxidant genes, such as heme oxygenase 1 (Hmox1) and several genes related to glutathione production and regeneration, among others. To shed light into the mechanisms behind the in vivo antioxidant effects of the novel hybrids, Nrf2 protein levels in the cortex of treated animals were determined (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>A). Interestingly, the treatment with hybrid <b>11b</b> led to significantly increased total levels of the transcription factor Nrf2 in APP/PS1 mice. The enzymes catalase and glutathione peroxidase 1 (GPX1) are also part of the protective antioxidant system. The levels of the antioxidant enzyme catalase increased after treatment with both <b>4b</b> and <b>11b</b>, although it did not reach significance (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>B), whereas GPX1 protein levels were significantly increased in <b>4b</b>-treated APP/PS1 mice (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>C). Moreover, gene expression for inducible nitric oxide synthase (<i>iNOS</i>) and <i>Hmox1</i> was evaluated. <i>iNOS</i> gene expression was not modified with treatments, but <i>Hmox1</i> expression was significantly increased in <b>4b</b>-treated animals (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>D,E).</div><figure id="fig12" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/medium/jm0c00528_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0013.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Representative Western blot and quantification for Nrf2 (A), catalase (B), and GPX1 (C) in cortical samples from treated male mice (WT vehicle, <i>n</i> = 6; WT <b>4b</b>, <i>n</i> = 5; WT <b>11b</b>, <i>n</i> = 6; APP/PS1 vehicle, <i>n</i> = 5; APP/PS1 <b>4b</b>, <i>n</i> = 7; APP/PS1 <b>11b</b>, <i>n</i> = 6). Data show a tendency to increase in antioxidant defense markers in APP/PS1 mice treated with the novel hybrids <b>4b</b> or <b>11b</b>. Moreover, <b>4b</b> treatment increases GPX1 levels in APP/PS1 mice compared to the vehicle group. Representative gene expression of <i>Hmox1</i> (D) and <i>iNOS</i> (E). Hybrids <b>4b</b> and <b>11b</b> seem to increase <i>Hmox1</i> and <i>iNOS</i> gene expression, but only <b>4b</b> in the first case reaches statistical significance. Data are expressed as the mean values ± SEM and were analyzed by two-way ANOVA with genotype and as between factors, followed by two-tailed Student’s <i>t</i>-test to compare between genotypes or Tukey’s post hoc test to compare between treatments. *<i>p</i> < 0.05, **<i>p</i> < 0.01, and ***<i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00528&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">While nonsignificant positive tendencies were found for several oxidative stress markers in treated APP/PS1 mice, compound <b>4b</b> did significantly increase GPX1 protein levels and <i>Hmox1</i> expression, whereas <b>11b</b> treatment led to a significant increase of Nrf2 protein levels. These results might suggest that <b>4b</b> and <b>11b</b> exert antioxidant effects in vivo either directly increasing detoxifying enzymes against redox misbalance or inducing a slow antioxidant response by modulation of the Nrf2 pathway.</div></div><div id="sec2_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Plasma and Microsomal Stability Studies and Metabolite Identification</h3><div class="NLM_p">Metabolism of drugs, while increasing their polarity to speed clearance from the organism, can lead to active metabolites that contribute to the final biological effect or to reactive metabolites that can cause harmful effects. The latter seems to be the case for tacrine, the first drug approved for the treatment of AD, which was withdrawn from the market due to induction of hepatotoxicity in 30% of patients. Its toxic effect seems to be largely dependent on the formation of toxic metabolites. Indeed, some metabolites arising from microsomal hydroxylation at positions 1, 2, 4, and 7 of tacrine have been suggested to account for its hepatotoxic effects.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> However, these toxic effects are not shared by all tacrine derivatives. For example, a recently reported family of trolox–tacrine hybrids, featuring a chroman-based trolox moiety, a tacrine or 6-chlorotacrine unit, and oligomethylene linkers functionalized with an amide group were found to be in general less toxic to human hepatoma HepG2 cells than tacrine and 6-chlorotacrine.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> The almost negligible toxicity on human hepatic cells of some of these compounds could be ascribed to the formation of nontoxic metabolites, as suggested by in vitro microsomal stability studies. After 1 h of incubation of one of these trolox–chlorotacrine hybrids (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>) with human liver microsomes, no significant metabolic changes in the 6-chlorotacrine unit of the hybrid were found, i.e., potentially toxic hydroxylated tacrine metabolites were not formed.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Instead, the main metabolite resulted from the reactivity of the chroman trolox moiety, namely, a <i>p</i>-benzoquinone arising from oxidative ring opening (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>).<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> The oxidative opening of the chroman ring might be another potential focus of reactive metabolites and, hence, of toxicity, as the benzoquinone could react as a Michael acceptor with nucleophilic protein residues. However, this did not seem to be the case, in light of the reported negligible toxicity of the trolox–tacrine hybrid both in vitro against human hepatocytes and also in acute toxicity studies on rats.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></div><figure id="fig13" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/medium/jm0c00528_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0014.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Reported metabolic transformation of chroman derivatives.<a onclick="showRef(event, 'ref46 ref47 ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref46 ref47 ref48 ref49">(46−49)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00528&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">This type of <i>p</i>-benzoquinone metabolite has been also reported for other chroman derivatives, such as the naturally occurring γ-tocopherol and α-tocopherol. Actually, in the latter case, the <i>p</i>-benzoquinone has been found to be the major metabolite in vivo (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>).<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Interestingly, not only does the <i>p</i>-benzoquinone metabolite of α-tocopherol not cause toxicity but also it is efficiently reduced by several biological systems, including rat liver microsomal, mitochondrial, and cytosolic preparations, to form the corresponding hydroquinone metabolite, which is indeed more important for the antioxidant activity than α-tocopherol itself.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></div><div class="NLM_p">Likewise, it has been reported that incubation of CR-6 with rat liver microsomes leads to the formation of the <i>p</i>-benzoquinone metabolite, in equilibrium with its ring-closed spiro derivative arising from a nonenzymatically promoted cyclization, and the corresponding hydroquinone (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>).<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Also in this case, the formation of the potentially toxic benzoquinone did not seem to be an issue, as the in vivo toxicity of CR-6 is very low.</div><div class="NLM_p">In light of these precedents, it seemed quite likely that the structurally related CR-6–chlorotacrine hybrids could undergo a similar metabolic fate. Notwithstanding that, the stability of the CR-6–chlorotacrine hybrid <b>4b</b> in biological media was assessed. In particular, we determined its stability in human, mouse, and rat plasma and liver microsomes, and we performed a qualitative determination of its metabolites after incubation with human, mouse, and rat liver microsomes.</div><div class="NLM_p">The plasma stability of compound <b>4b</b> was assessed by incubating it at 37 °C at different times (0, 60, 180, and 360 min) in human, mouse, and rat plasma and determining the residual amount of compound (expressed as residual percentage over starting amount) by ultraperformance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). Compound <b>4b</b> turned out to be fully stable up to 6 h in human, mouse, and rat plasma (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Stability of Compound <b>4b</b> in Human, Mouse, and Rat Plasma at 37 °C<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left"> </th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">remaining percentage (%) of compound <b>4b</b></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left"> </th><th class="colsep0 rowsep0" align="center" char=".">0 min</th><th class="colsep0 rowsep0" align="center" char=".">60 min</th><th class="colsep0 rowsep0" align="center" char=".">180 min</th><th class="colsep0 rowsep0" align="center" char=".">360 min</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human plasma</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse plasma</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat plasma</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">98</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Values are expressed as the mean of two independent experiments, each performed in triplicate.</p></div></div></div><div class="NLM_p">Next, the microsomal stability of compound <b>4b</b> was assessed by incubating it at 37 °C at different times (0, 10, 20, 40, and 60 min) with human, mouse, and rat liver microsomes, using testosterone as a reference compound of known short half-life. The stability parameters are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Stability of Compound <b>4b</b> in Human, Mouse, and Rat Liver Microsomes at 37 °C<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">human microsomes</th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">mouse microsomes</th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">rat microsomes</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center" char=".">residual amount (%)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> (min)</th><th class="colsep0 rowsep0" align="center" char=".">CL<sub>int</sub> [μL/(min/mg protein)]</th><th class="colsep0 rowsep0" align="center" char=".">residual amount (%)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> (min)</th><th class="colsep0 rowsep0" align="center" char=".">CL<sub>int</sub> [μL/(min/mg protein)]</th><th class="colsep0 rowsep0" align="center" char=".">residual amount (%)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> (min)</th><th class="colsep0 rowsep0" align="center" char=".">CL<sub>int</sub> [μL/(min/mg protein)]</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4b</b></td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="char" char=".">12.6</td><td class="colsep0 rowsep0" align="char" char=".">55.2</td><td class="colsep0 rowsep0" align="char" char=".">55.2</td><td class="colsep0 rowsep0" align="char" char=".">50.5</td><td class="colsep0 rowsep0" align="char" char=".">13.7</td><td class="colsep0 rowsep0" align="char" char=".">36.5</td><td class="colsep0 rowsep0" align="char" char=".">42.4</td><td class="colsep0 rowsep0" align="char" char=".">16.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">testosterone</td><td class="colsep0 rowsep0" align="char" char=".">6.1</td><td class="colsep0 rowsep0" align="char" char=".">9.9</td><td class="colsep0 rowsep0" align="char" char=".">69.7</td><td class="colsep0 rowsep0" align="char" char=".">14.7</td><td class="colsep0 rowsep0" align="char" char=".">13.7</td><td class="colsep0 rowsep0" align="char" char=".">50.7</td><td class="colsep0 rowsep0" align="char" char=".">2.9</td><td class="colsep0 rowsep0" align="char" char=".">2.4</td><td class="colsep0 rowsep0" align="char" char=".">286.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Values are expressed as the mean of two independent experiments, each performed in triplicate.</p></div></div></div><div class="NLM_p">Compound <b>4b</b> was apparently transformed to a great extent upon incubation with human liver microsomes, with 44.0, 18.6, and 3.6% of the initial amount of compound remaining unaltered after 20 min, 40 min, and 1 h, respectively. These results imply a short half-life (12.6 min) and a high microsomal intrinsic clearance (CL<sub>int</sub>). In contrast, compound <b>4b</b> turned out to be much more stable after incubation with mouse and rat liver microsomes, where half-lives of 50.5 and 42.4 min, respectively, were found, with a significant amount of <b>4b</b>, 55.2 and 36.5%, respectively, remaining unchanged after 1 h (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). The stability of <b>4b</b> was particularly favorable in mouse liver microsomes, from which it can be categorized as a low-clearance compound [CL<sub>int</sub> < 15 μL/(min/mg protein)].<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div><div class="NLM_p">Finally, the supernatants of the microsomal stability assays with human, mouse, and rat liver microsomes were qualitatively analyzed using a UPLC-MS/MS system to identify potential metabolites of <b>4b</b>. As expected, the <i>p</i>-benzoquinone metabolite <b>M1</b> resulting from oxidative opening of the chroman ring, likely together with its ring-closed spiro derivative <b>M2</b>, seemed to have been formed (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>). Interestingly, the hydroquinone metabolite <b>M3</b> resulting from reduction of <b>M1</b> was also found, as it was 6-chlorotacrine (<b>M4</b>), whereas, as it had been reported for the trolox–tacrine hybrids, potentially toxic hydroxylated tacrine metabolites were not detected.</div><figure id="fig14" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/medium/jm0c00528_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0015.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Metabolites of compound <b>4b</b> found after incubation with human, mouse, and rat liver microsomes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00528&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>4b</b> and metabolites <b>M1</b>–<b>M3</b> have similar structures, and all of them, as well as metabolite <b>M4</b>, should have a very similar degree of ionization. Even though the analysis was only qualitative, a rough comparison of the MS peak areas of <b>4b</b> and its metabolites seems to indicate that (i) compound <b>4b</b> was more abundant than any metabolite at all of the tested times in mouse and rat liver microsomes but not in human liver microsomes after 40 min incubation and (ii) metabolite <b>M4</b> (6-chlorotacrine) seemed to be clearly less abundant than <b>M1</b>–<b>M2</b> and <b>M3</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_001.pdf" class="ext-link">Table S4</a> in the Supporting Information).</div><div class="NLM_p last">The favorable stability of compound <b>4b</b> found in mouse plasma and mouse liver microsomes might suggest that the effects observed in the in vivo efficacy studies in mice should mostly derive from <b>4b</b> itself. Like for other chroman derivatives (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>), the <i>p</i>-benzoquinone resulting from oxidative ring opening seems to be a major metabolite, which could contribute to the biological activity. Thus, we cannot rule out the possibility that this metabolite, after reduction to the corresponding hydroquinone, can be, in part, responsible for the in vivo effects on oxidative stress markers, as reported for α-tocopherol. By contrast, it is not very likely that this metabolite retains the anticholinesterase activity of the parent compound <b>4b</b> because its benzoquinone ring should protrude from the mouth of the gorge of hAChE (see <a href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_001.pdf" class="ext-link">Figure S5</a> in the Supporting Information). Finally, the fact that hydroxylated tacrine metabolites are not formed from <b>4b</b> seems to be in line with its apparent lack of toxicity in mice after 4 weeks of treatment.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31338" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31338" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Because oxidative stress has a prominent role in the multifactorial pathogenesis of AD, antioxidant agents are regarded as a promising therapeutic strategy. However, antioxidants have failed to demonstrate efficacy in clinical trials so far. These failures could be ascribed to the poor brain permeability of antioxidants and to the fact that other pathogenic mechanisms of AD should be hit in addition to oxidative stress to efficiently cope with the multifactorial nature of this disease. Here, we have shown that molecular hybridization of the promising but non-brain-permeable antioxidant lead CR-6 with the potent lipophilic AChE inhibitor 6-chlorotacrine is a good approach to overcome both limitations. On the one hand, the resulting CR-6–chlorotacrine hybrids displayed favorable brain permeabilities, as measured in the in vitro PAMPA-BBB assay. On the other hand, the novel hybrids displayed multiple biological activities in vitro, including picomolar-to-nanomolar hAChE and nanomolar hBChE inhibitory activities, apart from the antioxidant effect. Indeed, the combination of the CR-6 and 6-chlorotacrine scaffolds had a synergistic effect, with the hybrids being up to 120- and 40-fold more potent toward hAChE and hBChE than the parent 6-chlorotacrine, while retaining or displaying slightly improved antioxidant activity relative to the lead CR-6. Interestingly, some hybrids exhibited moderate in vitro activities against other key targets, such as BACE-1 and Aβ42 and tau aggregation. Chronic in vivo efficacy studies with two selected compounds in double-transgenic APP/PS1 mice have shown positive tendencies in improving cognition, amyloid pathology (reduction of amyloid burden and potentiation of the non-amyloidogenic APP processing pathway), and oxidative stress (reduction of the levels of oxidized proteins and increase of the levels of antioxidant enzymes). Even though most of the observed in vivo effects did not reach statistical significance, it was found that compounds <b>4b</b> and <b>11b</b> significantly reduced <i>Bace1</i> gene expression, with the latter compound also reducing brain sAPPβ protein levels and increasing <i>Adam10</i> gene expression. Significant in vivo effects were also found regarding some oxidative stress markers, namely, increased brain GPX1 protein levels and <i>Hmox1</i> expression, and increased Nrf2 protein levels upon treatment with <b>4b</b> and <b>11b</b>, respectively. By virtue of their moderate in vivo effects, these compounds constitute interesting brain-permeable multitarget anti-Alzheimer leads.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86581" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86581" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Chemistry</h3><div class="NLM_p">All reagents and solvents were obtained from commercial suppliers and used without further purification. The progress of the reactions was monitored by thin-layer chromatography (TLC) on aluminum-backed sheets with silica gel 60 F<sub>254</sub> (Merck, ref 1.05554) using CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 95:5:1 (<b>4a</b>–<b>d</b>, <b>12a</b>–<b>c</b>, <b>12e</b>, and <b>5a</b>–<b>c</b>) or 90:10:1 (<b>6a</b>–<b>d</b>, <b>11a</b>–<b>c</b>, and <b>11e</b>) as a solvent system. The spots were visualized by UV irradiation and/or 1% aq KMnO<sub>4</sub>, followed by charring with a heat gun. Column chromatography was performed on silica gel 60 AC.C (35–70 mesh, safety data sheet (SDS), ref 2000027). Melting points were determined in open capillary tubes with an MFB 595010M Gallenkamp melting point apparatus. IR spectra were run on a PerkinElmer Spectrum RX I spectrophotometer. Absorption values are expressed as wavenumbers (cm<sup>–1</sup>); only significant absorption bands are given. Furthermore, 400 MHz <sup>1</sup>H/100.6 MHz <sup>13</sup>C NMR spectra were recorded on a Varian Mercury 400 spectrometer, at the Centres Cientı́fics i Tecnològics of the University of Barcelona (CCiTUB). The chemical shifts are reported in ppm (δ scale) relative to solvent signals (CD<sub>3</sub>OD at 3.31 and 49.0 ppm in the <sup>1</sup>H and <sup>13</sup>C NMR spectra, respectively), and coupling constants are reported in hertz (Hz). Assignments given for the NMR spectra of the new compounds have been carried out by comparison with the NMR data of compounds <b>4b</b>, <b>4d</b>, <b>5b</b>, <b>6b</b>, <b>6d</b>, and <b>11b</b>, which, in turn, were assigned on the basis of correlation spectroscopy (COSY) <sup>1</sup>H/<sup>1</sup>H (standard procedures) and COSY <sup>1</sup>H/<sup>13</sup>C (gHSQC and gHMBC sequences) experiments. High-resolution mass spectra were carried out at the CCiTUB with an LC/MSD TOF Agilent Technologies spectrometer. Analytical reversed-phase (RP) HPLC was performed with a Hewlett Packard series 110 modular system equipped with a UV detector 1315A, using an RP Kromasil 100 C18 (15 × 0.46 cm<sup>2</sup>, 5 μm) column, CH<sub>3</sub>CN/H<sub>2</sub>O mixtures containing 0.1% trifluoroacetic acid (TFA) (gradient from 20 to 100% CH<sub>3</sub>CN in 20 min) as the eluent, a flow of 1 mL/min, λ = 254 nm. The analytical samples of all of the compounds that were subjected to pharmacological evaluation possessed a purity ≥95% as evidenced by HPLC measurements.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> <i>N</i>-{7-[(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]heptyl}-2-(6-hydroxy-7-methoxy-2-methylchroman-2-yl)acetamide (<b>4a</b>)</h4><div class="NLM_p">A solution of carboxylic acid <b>7</b> (166 mg, 0.66 mmol) in a mixture of EtOAc (9.7 mL) and DMF (0.5 mL) was treated with <i>N</i>-(3-dimethylaminopropyl)-<i>N</i>′-ethylcarbodiimide hydrochloride (EDC·HCl, 153 mg, 0.80 mmol), Et<sub>3</sub>N (0.18 mL, 131 mg, 1.30 mmol), and 1-hydroxy-1<i>H</i>-benzotriazole (HOBt, 134 mg, 0.99 mmol). The resulting mixture was stirred at rt for 15 min and then treated with a suspension of amine <b>10a</b> (250 mg, 0.72 mmol) in a mixture of EtOAc (10 mL) and DMF (1.5 mL). The reaction mixture was stirred at rt for 1 day and was concentrated in vacuo to give a dark brown solid (763 mg), which was purified by column chromatography (35–70 μm silica gel, hexane/EtOAc/Et<sub>3</sub>N mixtures, gradient elution). On elution with hexane/EtOAc/Et<sub>3</sub>N 20:80:0.2, amide <b>4a</b> (254 mg, 67% yield) was isolated as a white solid; <i>R</i><sub><i>f</i></sub> 0.62 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 95:5:1).</div><div class="NLM_p last">A solution of <b>4a</b> (237 mg, 0.41 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) was filtered through a 0.22 μm poly(vinylidene difluoride) (PVDF) filter, treated with HCl/Et<sub>2</sub>O (1.35 N, 0.9 mL), and evaporated under reduced pressure. The resulting solid was washed with pentane (3 × 2 mL) to give, after drying at 40 °C/30 Torr for 48 h, <b>4a</b>·HCl (232 mg) as a yellowish solid: mp 122–126 °C; IR (attenuated total reflection (ATR)) ν 3600–2200 (max at 3244, 3065, 2927, 2852, N–H, N<sup>+</sup>–H, O–H, C–H st), 1632, 1573, 1509 (C═O, Ar–C–C, Ar–C–N st) cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.31 (s, 3H, 2-CH<sub>3</sub>), 1.31–1.41 (complex signal, 6H, 3′-H<sub>2</sub>, 4′-H<sub>2</sub>, 5′-H<sub>2</sub>), 1.49 (tt, <i>J</i> = <i>J</i>′ = 6.8 Hz, 2H, 2′-H<sub>2</sub>), superimposed in part 1.77 (dt, <i>J</i> = 13.2 Hz, <i>J</i>′ = 6.8 Hz, 1H, 3-H<sub>A</sub>), 1.79 (m, 2H, 6′-H<sub>2</sub>), 1.89 (dt, <i>J</i> = 13.2 Hz, <i>J</i>′ = 7.2 Hz, 1H, 3-H<sub>B</sub>), 1.91–2.00 (complex signal, 4H, 2″-H<sub>2</sub>, 3″-H<sub>2</sub>), 2.44 (d, <i>J</i> = 13.6 Hz, 1H, 2-CH<sub>A</sub>-CO), 2.48 (d, <i>J</i> = 13.6 Hz, 1H, 2-CH<sub>B</sub>-CO), 2.61 (dd, <i>J</i> = 7.2 Hz, <i>J</i>′ = 6.8 Hz, 2H, 4-H<sub>2</sub>), 2.65 (t, <i>J</i> = 6.4 Hz, 2H, 1″-H<sub>2</sub>), 2.99 (t, <i>J</i> = 5.6 Hz, 2H, 4″-H<sub>2</sub>), 3.16 (dt, <i>J</i> = 13.6 Hz, <i>J</i>′ = 6.8 Hz, 1H, 1′-H<sub>A</sub>), 3.20 (dt, <i>J</i> = 13.6 Hz, <i>J</i>′ = 6.8 Hz, 1H, 1′-H<sub>B</sub>), 3.73 (s, 3H, 7-OCH<sub>3</sub>), 3.89 (t, <i>J</i> = 7.2 Hz, 2H, 7′-H<sub>2</sub>), 4.85 (s, NH, <sup>+</sup>NH, OH), 6.31 (s, 1H, 8-H), 6.44 (s, 1H, 5-H), 7.55 (dd, <i>J</i> = 9.2 Hz, <i>J</i>′ = 2.0 Hz, 1H, 7″-H), 7.77 (d, <i>J</i> = 2.0 Hz, 1H, 5″-H), 8.36 (d, <i>J</i> = 9.2 Hz, 1H, 8″-H); <sup>13</sup>C NMR (100.6 MHz, CD<sub>3</sub>OD) δ 21.7 (CH<sub>2</sub>, C3″), 22.4 (CH<sub>2</sub>, C4), 22.8 (CH<sub>2</sub>, C2″), 24.5 (CH<sub>3</sub>, 2-CH<sub>3</sub>), 24.7 (CH<sub>2</sub>, C1″), 27.6 (CH<sub>2</sub>, C5′), 27.7 (CH<sub>2</sub>, C4′), 29.3 (CH<sub>2</sub>, C4″), 29.9 (CH<sub>2</sub>, C3′), 30.3 (CH<sub>2</sub>, C2′), 31.3 (CH<sub>2</sub>, C6′), 32.3 (CH<sub>2</sub>, C3), 40.1 (CH<sub>2</sub>, C1′), 47.5 (CH<sub>2</sub>, 2-<i>C</i>H<sub>2</sub>-CO), 49.3 (CH<sub>2</sub>, C7′), 56.4 (CH<sub>3</sub>, 7-OCH<sub>3</sub>), 75.6 (C, C2), 102.2 (CH, C8), 113.3 (C, C9a″), 113.4 (C, C4a), 115.4 (C, C8a″), 116.1 (CH, C5), 119.1 (CH, C5″), 126.8 (CH, C7″), 128.7 (CH, C8″), 140.1 (C, C6″), 140.5 (C, C10a″), 141.1 (C, C6), 147.4 (C, C8a), 148.3 (C, C7), 152.1 (C, C4a″), 157.8 (C, C9″), 172.4 (C, CONH); HRMS (electrospray ionization (ESI)) calcd for (C<sub>33</sub>H<sub>42</sub><sup>35</sup>ClN<sub>3</sub>O<sub>4</sub> + H<sup>+</sup>): 580.2937, found 580.2927; HPLC purity 100%.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> <i>N</i>-{8-[(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]octyl}-2-(6-hydroxy-7-methoxy-2-methylchroman-2-yl)acetamide (<b>4b</b>)</h4><div class="NLM_p">It was prepared as described for <b>4a</b>. From carboxylic acid <b>7</b> (120 mg, 0.48 mmol) and amine <b>10b</b> (188 mg, 0.52 mmol), a brown sticky solid (624 mg) was obtained and subjected to column chromatography purification (35–70 μm silica gel, hexane/EtOAc/Et<sub>3</sub>N mixtures, gradient elution). On elution with hexane/EtOAc/Et<sub>3</sub>N 20:80:0.2, amide <b>4b</b> (189 mg, 67% yield) was isolated as a yellowish solid; <i>R</i><sub><i>f</i></sub> 0.63 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 95:5:1).</div><div class="NLM_p last"><b>4b</b>·HCl: beige solid; mp 127–130 °C; IR (ATR) ν 3600–2200 (max at 3244, 3059, 2927, 2854, N–H, N<sup>+</sup>–H, O–H, C–H st), 1632, 1573, 1510 (C═O, Ar–C–C, Ar–C–N st) cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.27–1.34 (complex signal, 6H, 3′-H<sub>2</sub>, 4′-H<sub>2</sub>, 5′-H<sub>2</sub>), 1.31 (s, 3H, 2-CH<sub>3</sub>), 1.39 (tt, <i>J</i> = <i>J</i>′ = 6.8 Hz, 2H, 6′-H<sub>2</sub>), 1.48 (tt, <i>J</i> = <i>J</i>′ = 6.8 Hz, 2H, 2′-H<sub>2</sub>), superimposed in part 1.75 (dt, <i>J</i> = 13.6 Hz, <i>J</i>′ = 6.8 Hz, 1H, 3-H<sub>A</sub>), 1.80 (tt, <i>J</i> = 7.2 Hz, <i>J</i>′ = 6.8 Hz, 2H, 7′-H<sub>2</sub>), 1.89 (dt, <i>J</i> = 13.6 Hz, <i>J</i>′ = 6.8 Hz, 1H, 3-H<sub>B</sub>), 1.92–2.00 (complex signal, 4H, 2″-H<sub>2</sub>, 3″-H<sub>2</sub>), 2.44 (d, <i>J</i> = 13.6 Hz, 1H, 2-CH<sub>A</sub>-CO), 2.48 (d, <i>J</i> = 13.6 Hz, 1H, 2-CH<sub>B</sub>-CO), 2.62 (t, <i>J</i> = 6.8 Hz, 2H, 4-H<sub>2</sub>), 2.66 (t, <i>J</i> = 5.6 Hz, 2H, 1″-H<sub>2</sub>), 2.99 (t, <i>J</i> = 6.0 Hz, 2H, 4″-H<sub>2</sub>), 3.16 (dt, <i>J</i> = 13.6 Hz, <i>J</i>′ = 6.8 Hz, 1H, 1′-H<sub>A</sub>), 3.20 (dt, <i>J</i> = 13.6 Hz, <i>J</i>′ = 6.8 Hz, 1H, 1′-H<sub>B</sub>), 3.75 (s, 3H, 7-OCH<sub>3</sub>), 3.90 (t, <i>J</i> = 7.2 Hz, 2H, 8′-H<sub>2</sub>), 4.85 (s, NH, <sup>+</sup>NH, OH), 6.32 (s, 1H, 8-H), 6.44 (s, 1H, 5-H), 7.55 (dd, <i>J</i> = 9.2 Hz, <i>J</i>′ = 2.4 Hz, 1H, 7″-H), 7.76 (d, <i>J</i> = 2.4 Hz, 1H, 5″-H), 8.36 (d, <i>J</i> = 9.2 Hz, 1H, 8″-H); <sup>13</sup>C NMR (100.6 MHz, CD<sub>3</sub>OD) δ 21.8 (CH<sub>2</sub>, C3″), 22.4 (CH<sub>2</sub>, C4), 22.8 (CH<sub>2</sub>, C2″), 24.62 (CH<sub>3</sub>, 2-CH<sub>3</sub>), 24.64 (CH<sub>2</sub>, C1″), 27.5 (CH<sub>2</sub>, C6′), 27.7 (CH<sub>2</sub>, C5′), 29.3 (CH<sub>2</sub>, C4″), 30.1 (CH<sub>2</sub>), 30.2 (CH<sub>2</sub>) (C3′, C4′), 30.4 (CH<sub>2</sub>, C2′), 31.3 (CH<sub>2</sub>, C7′), 32.3 (CH<sub>2</sub>, C3), 40.2 (CH<sub>2</sub>, C1′), 47.4 (CH<sub>2</sub>, 2-<i>C</i>H<sub>2</sub>-CO), 49.3 (CH<sub>2</sub>, C8′), 56.4 (CH<sub>3</sub>, 7-OCH<sub>3</sub>), 75.6 (C, C2), 102.2 (CH, C8), 113.3 (C, C9a″), 113.4 (C, C4a), 115.4 (C, C8a″), 116.1 (CH, C5), 119.1 (CH, C5″), 126.7 (CH, C7″), 128.8 (CH, C8″), 140.1 (C, C6″), 140.5 (C, C10a″), 141.1 (C, C6), 147.4 (C, C8a), 148.3 (C, C7), 152.0 (C, C4a″), 157.8 (C, C9″), 172.4 (C, CONH); HRMS (ESI) calcd for (C<sub>34</sub>H<sub>44</sub><sup>35</sup>ClN<sub>3</sub>O<sub>4</sub> + H<sup>+</sup>): 594.3093, found 594.3096; HPLC purity 96%.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> <i>N</i>-{9-[(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]nonyl}-2-(6-hydroxy-7-methoxy-2-methylchroman-2-yl)acetamide (<b>4c</b>)</h4><div class="NLM_p">It was prepared as described for <b>4a</b>. From carboxylic acid <b>7</b> (163 mg, 0.65 mmol) and amine <b>10c</b> (266 mg, 0.71 mmol), a brown sticky solid (828 mg) was obtained and subjected to column chromatography purification (35–70 μm silica gel, hexane/EtOAc/Et<sub>3</sub>N mixtures, gradient elution). On elution with hexane/EtOAc/Et<sub>3</sub>N 20:80:0.2, amide <b>4c</b> (338 mg, 86% yield) was isolated as a white solid; <i>R</i><sub><i>f</i></sub> 0.66 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 95:5:1).</div><div class="NLM_p last"><b>4c</b>·HCl: light yellow solid; mp 104–106 °C; IR (ATR) ν 3600–2200 (max at 3244, 3065, 2924, 2852, N–H, N<sup>+</sup>–H, O–H, C–H st), 1632, 1573, 1510 (C═O, Ar–C–C, Ar–C–N st) cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.23–1.33 (complex signal, 8H, 3′-H<sub>2</sub>, 4′-H<sub>2</sub>, 5′-H<sub>2</sub>, 6′-H<sub>2</sub>), 1.32 (s, 3H, 2-CH<sub>3</sub>), 1.40 (tt, <i>J</i> = <i>J</i>′ = 7.2 Hz, 2H, 7′-H<sub>2</sub>), 1.48 (tt, <i>J</i> = <i>J</i>′ = 6.8 Hz, 2H, 2′-H<sub>2</sub>), superimposed in part 1.77 (dt, <i>J</i> = 13.6 Hz, <i>J</i>′ = 6.8 Hz, 1H, 3-H<sub>A</sub>), 1.80 (tt, <i>J</i> = <i>J</i>′ = 7.2 Hz, 2H, 8′-H<sub>2</sub>), 1.90 (dt, <i>J</i> = 13.6 Hz, <i>J</i>′ = 7.2 Hz, 1H, 3-H<sub>B</sub>), 1.92–2.00 (complex signal, 4H, 2″-H<sub>2</sub>, 3″-H<sub>2</sub>), 2.44 (d, <i>J</i> = 13.2 Hz, 1H, 2-CH<sub>A</sub>-CO), 2.49 (d, <i>J</i> = 13.2 Hz, 1H, 2-CH<sub>B</sub>-CO), 2.63 (dd, <i>J</i> = 7.2 Hz, <i>J</i>′ = 6.8 Hz, 2H, 4-H<sub>2</sub>), 2.67 (t, <i>J</i> = 5.2 Hz, 2H, 1″-H<sub>2</sub>), 2.99 (t, <i>J</i> = 5.2 Hz, 2H, 4″-H<sub>2</sub>), 3.16 (dt, <i>J</i> = 13.6 Hz, <i>J</i>′ = 6.8 Hz, 1H, 1′-H<sub>A</sub>), 3.20 (dt, <i>J</i> = 13.6 Hz, <i>J</i>′ = 6.8 Hz, 1H, 1′-H<sub>B</sub>), 3.75 (s, 3H, 7-OCH<sub>3</sub>), 3.92 (t, <i>J</i> = 7.2 Hz, 2H, 9′-H<sub>2</sub>), 4.85 (s, NH, <sup>+</sup>NH, OH), 6.34 (s, 1H, 8-H), 6.45 (s, 1H, 5-H), 7.56 (dd, <i>J</i> = 9.2 Hz, <i>J</i>′ = 2.0 Hz, 1H, 7″-H), 7.76 (d, <i>J</i> = 2.0 Hz, 1H, 5″-H), 8.38 (d, <i>J</i> = 9.2 Hz, 1H, 8″-H); <sup>13</sup>C NMR (100.6 MHz, CD<sub>3</sub>OD) δ 21.7 (CH<sub>2</sub>, C3″), 22.4 (CH<sub>2</sub>, C4), 22.8 (CH<sub>2</sub>, C2″), 24.6 (CH<sub>3</sub>, 2-CH<sub>3</sub>), 24.7 (CH<sub>2</sub>, C1″), 27.6 (CH<sub>2</sub>, C7′), 27.8 (CH<sub>2</sub>, C6′), 29.3 (CH<sub>2</sub>, C4″), 30.1 (CH<sub>2</sub>), 30.2 (CH<sub>2</sub>) (C3′, C4′), 30.38 (CH<sub>2</sub>), 30.42 (CH<sub>2</sub>) (C2′, C5′), 31.3 (CH<sub>2</sub>, C8′), 32.3 (CH<sub>2</sub>, C3), 40.2 (CH<sub>2</sub>, C1′), 47.4 (CH<sub>2</sub>, 2-<i>C</i>H<sub>2</sub>-CO), 49.3 (CH<sub>2</sub>, C9′), 56.4 (CH<sub>3</sub>, 7-OCH<sub>3</sub>), 75.6 (C, C2), 102.2 (CH, C8), 113.31 (C, C9a″), 113.35 (C, C4a), 115.4 (C, C8a″), 116.1 (CH, C5), 119.1 (CH, C5″), 126.7 (CH, C7″), 128.8 (CH, C8″), 140.1 (C, C6″), 140.5 (C, C10a″), 141.1 (C, C6), 147.4 (C, C8a), 148.3 (C, C7), 152.0 (C, C4a″), 157.8 (C, C9″), 172.4 (C, CONH); HRMS (ESI) calcd for (C<sub>35</sub>H<sub>46</sub><sup>35</sup>ClN<sub>3</sub>O<sub>4</sub> + H<sup>+</sup>): 608.3250, found 608.3243; HPLC purity 99%.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> <i>N</i>-{8-[(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]-3,6-dioxaoctyl}-2-(6-hydroxy-7-methoxy-2-methylchroman-2-yl)acetamide (<b>4d</b>)</h4><div class="NLM_p">It was prepared as described for <b>4a</b>. From carboxylic acid <b>7</b> (130 mg, 0.52 mmol) and amine <b>10d</b> (206 mg, 0.57 mmol), a brown sticky solid (617 mg) was obtained and subjected to column chromatography purification (35–70 μm silica gel, hexane/EtOAc/Et<sub>3</sub>N mixtures, gradient elution). On elution with hexane/EtOAc/Et<sub>3</sub>N 10:90:0.2 to 0:100:0.2, amide <b>4d</b> (281 mg, 91% yield) was isolated as a light brown sticky solid; <i>R</i><sub><i>f</i></sub> 0.79 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 95:5:1).</div><div class="NLM_p last"><b>4d</b>·HCl: brown solid; mp 55–57 °C; IR (ATR) ν 3600–2400 (max at 3362, 3250, 3068, 2921, 2860, N–H, N<sup>+</sup>–H, O–H, C–H st), 1630, 1572, 1509 (C═O, Ar–C–C, Ar–C–N st) cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.28 (s, 3H, 2-CH<sub>3</sub>), 1.68 (dt, <i>J</i> = 13.6 Hz, <i>J</i>′ = 6.8 Hz, 1H, 3-H<sub>A</sub>), 1.81 (dt, <i>J</i> = 13.6 Hz, <i>J</i>′ = 6.8 Hz, 1H, 3-H<sub>B</sub>), 1.89–2.00 (complex signal, 4H, 2″-H<sub>2</sub>, 3″-H<sub>2</sub>), 2.36 (d, <i>J</i> = 13.6 Hz, 1H, 2-CH<sub>A</sub>-CO), 2.46 (d, <i>J</i> = 13.6 Hz, 1H, 2-CH<sub>B</sub>-CO), 2.53 (t, <i>J</i> = 6.8 Hz, 2H, 4-H<sub>2</sub>), 2.63 (t, <i>J</i> = 6.0 Hz, 2H, 1″-H<sub>2</sub>), 2.98 (t, <i>J</i> = 5.6 Hz, 2H, 4″-H<sub>2</sub>), 3.33 (dt, <i>J</i> = 14.0 Hz, <i>J</i>′ = 5.2 Hz, 1H, 1′-H<sub>A</sub>), 3.40 (dt, <i>J</i> = 14.0 Hz, <i>J</i>′ = 5.2 Hz, 1H, 1′-H<sub>B</sub>), 3.53 (t, <i>J</i> = 5.2 Hz, 2H, 2′-H<sub>2</sub>), 3.62 (m, 2H), 3.66 (m, 2H) (4′-H<sub>2</sub>, 5′-H<sub>2</sub>), 3.71 (s, 3H, 7-OCH<sub>3</sub>), 3.84 (t, <i>J</i> = 5.2 Hz, 2H, 7′-H<sub>2</sub>), 4.10 (t, <i>J</i> = 5.2 Hz, 2H, 8′-H<sub>2</sub>), 4.85 (s, NH, <sup>+</sup>NH, OH), 6.33 (s, 1H, 8-H), 6.35 (s, 1H, 5-H), 7.52 (dd, <i>J</i> = 9.2 Hz, <i>J</i>′ = 2.0 Hz, 1H, 7″-H), 7.74 (d, <i>J</i> = 2.0 Hz, 1H, 5″-H), 8.41 (d, <i>J</i> = 9.2 Hz, 1H, 8″-H); <sup>13</sup>C NMR (100.6 MHz, CD<sub>3</sub>OD) δ 21.7 (CH<sub>2</sub>, C3″), 22.2 (CH<sub>2</sub>, C4), 22.7 (CH<sub>2</sub>, C2″), 24.4 (CH<sub>3</sub> + CH<sub>2</sub>, 2-CH<sub>3</sub>, C1″), 29.3 (CH<sub>2</sub>, C4″), 32.6 (CH<sub>2</sub>, C3), 40.2 (CH<sub>2</sub>, C1′), 46.7 (CH<sub>2</sub>, 2-<i>C</i>H<sub>2</sub>-CO), 49.3 (CH<sub>2</sub>, C8′), 56.5 (CH<sub>3</sub>, 7-OCH<sub>3</sub>), 70.2 (CH<sub>2</sub>, C7′), 70.4 (CH<sub>2</sub>, C2′), 71.0 (CH<sub>2</sub>), 71.3 (CH<sub>2</sub>) (C4′, C5′), 75.4 (C, C2), 102.5 (CH, C8), 113.4 (C, C4a), 113.6 (C, C9a″), 115.6 (C, C8a″), 116.0 (CH, C5), 119.1 (CH, C5″), 126.7 (CH, C7″), 128.9 (CH, C8″), 140.0 (C, C6″), 140.4 (C, C10a″), 141.2 (C, C6), 146.9 (C, C8a), 148.2 (C, C7), 152.3 (C, C4a″), 158.3 (C, C9″), 172.7 (C, CONH); HRMS (ESI) calcd for (C<sub>32</sub>H<sub>40</sub><sup>35</sup>ClN<sub>3</sub>O<sub>6</sub> + H<sup>+</sup>): 598.2678, found 598.2692; HPLC purity 96%.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 7-[(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]-<i>N</i>-[2-(6-hydroxy-7-methoxy-2-methylchroman-2-yl)ethyl]heptanamide (<b>5a</b>)</h4><div class="NLM_p">To a solution of nitrile <b>13a</b> (462 mg, 1.35 mmol) in MeOH (2 mL), a 40% methanolic solution of KOH (3.7 mL) was added. The resulting suspension was stirred under reflux for 3 h, then treated with H<sub>2</sub>O (4.7 mL), and stirred under reflux overnight. The resulting solution was cooled to rt and evaporated under reduced pressure. The residue was treated with HCl/dioxane (4 M, 6.8 mL), and the solution was concentrated <i>in vacuo</i> to give crude 7-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]heptanoic acid, in the form of hydrochloride salt, as a yellow solid (2.46 g), which was used in the following step without further purification.</div><div class="NLM_p">From this crude carboxylic acid, the target amide <b>5a</b> was prepared as described for <b>4a</b>. From crude carboxylic acid (2.46 g) and amine <b>14</b> (159 mg, 0.68 mmol), a brown sticky solid (3.30 g) was obtained and subjected to column chromatography purification (35–70 μm silica gel, hexane/EtOAc/Et<sub>3</sub>N mixtures, gradient elution). On elution with hexane/EtOAc/Et<sub>3</sub>N 0:100:0.2, amide <b>5a</b> (337 mg, 87% overall yield) was isolated as a light yellow solid; <i>R</i><sub><i>f</i></sub> 0.57 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 95:5:1).</div><div class="NLM_p last"><b>5a</b>·HCl: yellow solid; mp 121–123 °C; IR (ATR) ν 3600–2400 (max at 3245, 3068, 2926, 2850, N–H, N<sup>+</sup>–H, O–H, C–H st), 1630, 1572, 1509 (C═O, Ar–C–C, Ar–C–N st) cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.25 (s, 3H, 2″-CH<sub>3</sub>), superimposed in part 1.35 (tt, <i>J</i> = <i>J</i>′ = 7.2 Hz, 2H), 1.43 (tt, <i>J</i> = <i>J</i>′ = 7.2 Hz, 2H) (4-H<sub>2</sub>, 5-H<sub>2</sub>), 1.59 (tt, <i>J</i> = <i>J</i>′ = 7.2 Hz, 2H, 3-H<sub>2</sub>), 1.70 (dt, <i>J</i> = 13.6 Hz, <i>J</i>′ = 6.8 Hz, 1H, 3″-H<sub>A</sub>), 1.72–1.86 (complex signal, 5H, 6-H<sub>2</sub>, 2″-CH<sub>2</sub>, 3″-H<sub>B</sub>), 1.90–2.00 (complex signal, 4H, 2′-H<sub>2</sub>, 3′-H<sub>2</sub>), 2.16 (t, <i>J</i> = 7.2 Hz, 2H, 2-H<sub>2</sub>), 2.60 (t, <i>J</i> = 6.8 Hz, 2H, 4″-H<sub>2</sub>), 2.66 (br t, <i>J</i> = 5.6 Hz, 2H, 1′-H<sub>2</sub>), 2.99 (br t, <i>J</i> = 5.6 Hz, 2H, 4′-H<sub>2</sub>), 3.27 (ddd, <i>J</i> = 13.2 Hz, <i>J</i>′ = 9.2 Hz, <i>J</i>″ = 6.0 Hz, 1H, C<i>H</i><sub><i>A</i></sub>-NHCO), 3.39 (ddd, <i>J</i> = 13.2 Hz, <i>J</i>′ = 9.2 Hz, <i>J</i>″ = 6.0 Hz, 1H, C<i>H</i><sub><i>B</i></sub>-NHCO), 3.74 (s, 3H, 7″-OCH<sub>3</sub>), 3.90 (t, <i>J</i> = 7.2 Hz, 2H, 7-H<sub>2</sub>), 4.86 (s, NH, <sup>+</sup>NH, OH), 6.30 (s, 1H, 8″-H), 6.42 (s, 1H, 5″-H), 7.55 (dd, <i>J</i> = 9.2 Hz, <i>J</i>′ = 2.0 Hz, 1H, 7′-H), 7.76 (d, <i>J</i> = 2.0 Hz, 1H, 5′-H), 8.36 (d, <i>J</i> = 9.2 Hz, 1H, 8′-H); <sup>13</sup>C NMR (100.6 MHz, CD<sub>3</sub>OD) δ 21.7 (CH<sub>2</sub>, C3′), 22.3 (CH<sub>2</sub>, C4″), 22.8 (CH<sub>2</sub>, C2′), 24.3 (CH<sub>3</sub>, 2″-CH<sub>3</sub>), 24.7 (CH<sub>2</sub>, C1′), 26.7 (CH<sub>2</sub>, C3), 27.4 (CH<sub>2</sub>, C5), 29.3 (CH<sub>2</sub>, C4′), 29.7 (CH<sub>2</sub>, C4), 31.1 (CH<sub>2</sub>, C6), 32.6 (CH<sub>2</sub>, C3″), 35.9 (CH<sub>2</sub>, <i>C</i>H<sub>2</sub>-NHCO), 36.9 (CH<sub>2</sub>, C2), 39.4 (CH<sub>2</sub>, 2″-CH<sub>2</sub>), 49.1 (CH<sub>2</sub>, C7), 56.3 (CH<sub>3</sub>, 7″-OCH<sub>3</sub>), 75.8 (C, C2″), 102.2 (CH, C8″), 113.3 (C, C9a′), 113.4 (C, C4a″), 115.4 (C, C8a′), 116.1 (CH, C5″), 119.1 (CH, C5′), 126.8 (CH, C7′), 128.8 (CH, C8′), 140.1 (C, C6′), 140.5 (C, C10a′), 140.8 (C, C6″), 147.7 (C, C8a″), 148.3 (C, C7″), 152.0 (C, C4a′), 157.8 (C, C9′), 175.9 (C, C1); HRMS (ESI) calcd for (C<sub>33</sub>H<sub>42</sub><sup>35</sup>ClN<sub>3</sub>O<sub>4</sub> + H<sup>+</sup>): 580.2937, found 580.2946; HPLC purity 96%.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 8-[(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]-<i>N</i>-[2-(6-hydroxy-7-methoxy-2-methylchroman-2-yl)ethyl]octanamide (<b>5b</b>)</h4><div class="NLM_p">It was prepared as described for <b>5a</b>. From nitrile <b>13b</b> (367 mg, 1.03 mmol), crude 8-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]octanoic acid, in the form of hydrochloride salt, was obtained as a yellow solid (1.93 g) and used in the following step without further purification. From crude carboxylic acid (1.93 g) and amine <b>14</b> (100 mg, 0.43 mmol), a brown sticky solid (2.29 g) was obtained and subjected to column chromatography purification (35–70 μm silica gel, hexane/EtOAc/Et<sub>3</sub>N mixtures, gradient elution). On elution with hexane/EtOAc/Et<sub>3</sub>N 20:80:0.2, amide <b>5b</b> (139 mg, 55% overall yield) was isolated as a yellow solid; <i>R</i><sub><i>f</i></sub> 0.67 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 95:5:1).</div><div class="NLM_p last"><b>5b</b>·HCl: yellow solid; mp 72–74 °C; IR (ATR) ν 3600–2200 (max at 3245, 3063, 2921, 2850, N–H, N<sup>+</sup>–H, O–H, C–H st), 1630, 1572, 1509 (C═O, Ar–C–C, Ar–C–N st) cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.25 (s, 3H, 2″-CH<sub>3</sub>), 1.28–1.44 (complex signal, 6H, 4-H<sub>2</sub>, 5-H<sub>2</sub>, 6-H<sub>2</sub>), 1.57 (tt, <i>J</i> = <i>J</i>′ = 7.2 Hz, 2H, 3-H<sub>2</sub>), 1.69 (dt, <i>J</i> = 13.2 Hz, <i>J</i>′ = 6.4 Hz, 1H, 3″-H<sub>A</sub>), 1.71–1.86 (complex signal, 5H, 7-H<sub>2</sub>, 2″-CH<sub>2</sub>, 3″-H<sub>B</sub>), 1.92–2.00 (complex signal, 4H, 2′-H<sub>2</sub>, 3′-H<sub>2</sub>), 2.16 (t, <i>J</i> = 7.2 Hz, 2H, 2-H<sub>2</sub>), 2.61 (t, <i>J</i> = 6.4 Hz, 2H, 4″-H<sub>2</sub>), 2.66 (br t, <i>J</i> = 5.6 Hz, 2H, 1′-H<sub>2</sub>), 2.99 (br t, <i>J</i> = 5.6 Hz, 2H, 4′-H<sub>2</sub>), 3.29 (ddd, <i>J</i> = 13.6 Hz, <i>J</i>′ = 8.8 Hz, <i>J</i>″ = 6.4 Hz, 1H, C<i>H</i><sub><i>A</i></sub>-NHCO), 3.40 (ddd, <i>J</i> = 13.6 Hz, <i>J</i>′ = 9.2 Hz, <i>J</i>″ = 6.0 Hz, 1H, C<i>H</i><sub><i>B</i></sub>-NHCO), 3.75 (s, 3H, 7″-OCH<sub>3</sub>), 3.91 (t, <i>J</i> = 7.2 Hz, 2H, 8-H<sub>2</sub>), 4.87 (s, NH, <sup>+</sup>NH, OH), 6.30 (s, 1H, 8″-H), 6.43 (s, 1H, 5″-H), 7.56 (dd, <i>J</i> = 9.2 Hz, <i>J</i>′ = 2.0 Hz, 1H, 7′-H), 7.77 (d, <i>J</i> = 2.0 Hz, 1H, 5′-H), 8.37 (d, <i>J</i> = 9.2 Hz, 1H, 8′-H); <sup>13</sup>C NMR (100.6 MHz, CD<sub>3</sub>OD) δ 21.8 (CH<sub>2</sub>, C3′), 22.3 (CH<sub>2</sub>, C4″), 22.8 (CH<sub>2</sub>, C2′), 24.2 (CH<sub>3</sub>, 2″-CH<sub>3</sub>), 24.7 (CH<sub>2</sub>, C1′), 26.7 (CH<sub>2</sub>, C3), 27.5 (CH<sub>2</sub>, C6), 29.3 (CH<sub>2</sub>, C4′), 29.9 (CH<sub>2</sub>), 30.0 (CH<sub>2</sub>) (C4, C5), 31.4 (CH<sub>2</sub>, C7), 32.6 (CH<sub>2</sub>, C3″), 36.0 (CH<sub>2</sub>, <i>C</i>H<sub>2</sub>-NHCO), 37.0 (CH<sub>2</sub>, C2), 39.4 (CH<sub>2</sub>, 2″-CH<sub>2</sub>), 49.3 (CH<sub>2</sub>, C8), 56.3 (CH<sub>3</sub>, 7″-OCH<sub>3</sub>), 75.8 (C, C2″), 102.2 (CH, C8″), 113.3 (C, C9a′), 113.4 (C, C4a″), 115.4 (C, C8a′), 116.1 (CH, C5″), 119.1 (CH, C5′), 126.8 (CH, C7′), 128.8 (CH, C8′), 140.1 (C, C6′), 140.5 (C, C10a′), 140.8 (C, C6″), 147.7 (C, C8a″), 148.3 (C, C7″), 152.1 (C, C4a′), 157.8 (C, C9′), 176.1 (C, C1); HRMS (ESI) calcd for (C<sub>34</sub>H<sub>44</sub><sup>35</sup>ClN<sub>3</sub>O<sub>4</sub> + H<sup>+</sup>): 594.3093, found 594.3092; HPLC purity 97%.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 9-[(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]-<i>N</i>-[2-(6-hydroxy-7-methoxy-2-methylchroman-2-yl)ethyl]nonanamide (<b>5c</b>)</h4><div class="NLM_p">It was prepared as described for <b>5a</b>. From nitrile <b>13c</b> (315 mg, 0.85 mmol), crude 9-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]nonanoic acid, in the form of hydrochloride salt, was obtained as a light yellow solid (1.55 g) and used in the following step without further purification. From crude carboxylic acid (1.55 g) and amine <b>14</b> (133 mg, 0.57 mmol), a brown oily residue (2.21 g) was obtained and subjected to column chromatography purification (35–70 μm silica gel, hexane/EtOAc/Et<sub>3</sub>N mixtures, gradient elution). On elution with hexane/EtOAc/Et<sub>3</sub>N 10:90:0.2, amide <b>5c</b> (189 mg, 52% overall yield) was isolated as a light yellow solid; <i>R</i><sub><i>f</i></sub> 0.69 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 95:5:1).</div><div class="NLM_p last"><b>5c</b>·HCl: yellow solid; mp 107–111 °C; IR (ATR) ν 3600–2200 (max at 3314, 3242, 3057, 2921, 2849, N–H, N<sup>+</sup>–H, O–H, C–H st), 1625, 1571, 1518 (C═O, Ar–C–C, Ar–C–N st) cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.26 (s, 3H, 2″-CH<sub>3</sub>), 1.26–1.38 (complex signal, 6H, 4-H<sub>2</sub>, 5-H<sub>2</sub>, 6-H<sub>2</sub>), superimposed in part 1.42 (tt, <i>J</i> = <i>J</i>′ = 7.2 Hz, 2H, 7-H<sub>2</sub>), 1.57 (tt, <i>J</i> = <i>J</i>′ = 7.2 Hz, 2H, 3-H<sub>2</sub>), 1.72 (dt, <i>J</i> = 13.6 Hz, <i>J</i>′ = 6.8 Hz, 1H, 3″-H<sub>A</sub>), 1.74–1.87 (complex signal, 5H, 8-H<sub>2</sub>, 2″-CH<sub>2</sub>, 3″-H<sub>B</sub>), 1.91–2.00 (complex signal, 4H, 2′-H<sub>2</sub>, 3′-H<sub>2</sub>), 2.16 (t, <i>J</i> = 7.2 Hz, 2H, 2-H<sub>2</sub>), 2.61 (t, <i>J</i> = 6.8 Hz, 2H, 4″-H<sub>2</sub>), 2.66 (br t, <i>J</i> = 6.0 Hz, 2H, 1′-H<sub>2</sub>), 2.99 (br t, <i>J</i> = 6.0 Hz, 2H, 4′-H<sub>2</sub>), 3.29 (ddd, <i>J</i> = 13.2 Hz, <i>J</i>′ = 9.2 Hz, <i>J</i>″ = 6.4 Hz, 1H, C<i>H</i><sub><i>A</i></sub>-NHCO), 3.41 (ddd, <i>J</i> = 13.2 Hz, <i>J</i>′ = 9.2 Hz, <i>J</i>″ = 6.4 Hz, 1H, C<i>H</i><sub><i>B</i></sub>-NHCO), 3.75 (s, 3H, 7″-OCH<sub>3</sub>), 3.91 (t, <i>J</i> = 7.2 Hz, 2H, 9-H<sub>2</sub>), 4.87 (s, NH, <sup>+</sup>NH, OH), 6.30 (s, 1H, 8″-H), 6.44 (s, 1H, 5″-H), 7.56 (dd, <i>J</i> = 9.2 Hz, <i>J</i>′ = 2.4 Hz, 1H, 7′-H), 7.77 (d, <i>J</i> = 2.4 Hz, 1H, 5′-H), 8.37 (d, <i>J</i> = 9.2 Hz, 1H, 8′-H); <sup>13</sup>C NMR (100.6 MHz, CD<sub>3</sub>OD) δ 21.8 (CH<sub>2</sub>, C3′), 22.3 (CH<sub>2</sub>, C4″), 22.8 (CH<sub>2</sub>, C2′), 24.2 (CH<sub>3</sub>, 2″-CH<sub>3</sub>), 24.7 (CH<sub>2</sub>, C1′), 26.8 (CH<sub>2</sub>, C3), 27.6 (CH<sub>2</sub>, C7), 29.3 (CH<sub>2</sub>, C4′), 30.00 (CH<sub>2</sub>), 30.02 (CH<sub>2</sub>), 30.1 (CH<sub>2</sub>) (C4, C5, C6), 31.3 (CH<sub>2</sub>, C8), 32.6 (CH<sub>2</sub>, C3″), 36.1 (CH<sub>2</sub>, <i>C</i>H<sub>2</sub>-NHCO), 37.0 (CH<sub>2</sub>, C2), 39.4 (CH<sub>2</sub>, 2″-CH<sub>2</sub>), 49.3 (CH<sub>2</sub>, C9), 56.3 (CH<sub>3</sub>, 7″-OCH<sub>3</sub>), 75.8 (C, C2″), 102.2 (CH, C8″), 113.3 (C, C9a′), 113.4 (C, C4a″), 115.4 (C, C8a′), 116.1 (CH, C5″), 119.1 (CH, C5′), 126.8 (CH, C7′), 128.8 (CH, C8′), 140.1 (C, C6′), 140.5 (C, C10a′), 140.8 (C, C6″), 147.7 (C, C8a″), 148.3 (C, C7″), 152.0 (C, C4a′), 157.8 (C, C9′), 176.2 (C, C1); HRMS (ESI) calcd for (C<sub>35</sub>H<sub>46</sub><sup>35</sup>ClN<sub>3</sub>O<sub>4</sub> + H<sup>+</sup>): 608.3250, found 608.3259; HPLC purity 99%.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> <i>N</i>-(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)-<i>N</i>′-[2-(6-hydroxy-7-methoxy-2-methylchroman-2-yl)ethyl]heptane-1,7-diamine (<b>6a</b>)</h4><div class="NLM_p">A solution of tosylate <b>15</b> (175 mg, 0.44 mmol) in dry CH<sub>3</sub>CN (1.5 mL) was added to a suspension of amine <b>10a</b> (461 mg, 1.33 mmol) and anhyd Et<sub>3</sub>N (0.07 mL, 51 mg, 0.50 mmol) in dry CH<sub>3</sub>CN (2 mL). The reaction mixture was stirred at 80 °C for 48 h and then concentrated <i>in vacuo</i> to give a dark brown oil (789 mg), which was purified by column chromatography (35–70 μm silica gel, CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH mixtures, gradient elution). On elution with CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 99:1:0.4 to 98:2:0.4, amine <b>6a</b> (61 mg, 24% yield) was isolated as a beige solid; <i>R</i><sub><i>f</i></sub> 0.76 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 90:10:1).</div><div class="NLM_p last">A solution of <b>6a</b> (37 mg, 0.07 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1 mL) was filtered through a 0.2 μm PTFE filter, treated with HCl/Et<sub>2</sub>O (1.35 N, 0.4 mL), and evaporated under reduced pressure. The resulting solid was washed with pentane (3 × 2 mL) to give, after drying at 40 °C/30 Torr for 48 h, <b>6a</b>·2HCl (34 mg) as a beige solid: mp 160–163 °C; IR (ATR) ν 3600–2200 (max at 3240, 2930, 2852, 2780, 2604, 2496, N–H, N<sup>+</sup>–H, O–H, C–H st), 1628, 1573, 1509 (Ar–C–C, Ar–C–N st) cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.30 (s, 3H, 2″-CH<sub>3</sub>), 1.39–1.51 (complex signal, 6H, 3-H<sub>2</sub>, 4-H<sub>2</sub>, 5-H<sub>2</sub>), 1.71 (m, 2H, 6-H<sub>2</sub>), superimposed in part 1.80 (dt, <i>J</i> = 13.6 Hz, <i>J</i>′ = 6.8 Hz, 1H, 3″-H<sub>A</sub>), 1.82–1.88 (complex signal, 3H, 2-H<sub>2</sub>, 3″-H<sub>B</sub>), 1.90–2.00 (complex signal, 5H, 2′-H<sub>2</sub>, 3′-H<sub>2</sub>, 2″-C<i>H</i><sub>A</sub>-CH<sub>2</sub>-NH), 2.07 (dt, <i>J</i> = 14.4 Hz, <i>J</i>′ = 6.8 Hz, 1H, 2″-C<i>H</i><sub>B</sub>-CH<sub>2</sub>-NH), 2.64–2.72 (complex signal, 4H, 1′-H<sub>2</sub>, 4″-H<sub>2</sub>), 2.97–3.05 (complex signal, 4H, 7-H<sub>2</sub>, 4′-H<sub>2</sub>), 3.21 (t, <i>J</i> = 7.6 Hz, 2H, 2″-CH<sub>2</sub>-C<i>H</i><sub>2</sub>-NH), 3.76 (s, 3H, 7″-OCH<sub>3</sub>), 3.94 (t, <i>J</i> = 7.6 Hz, 2H, 1-H<sub>2</sub>), 4.86 (s, NH, <sup>+</sup>NH, <sup>+</sup>NH<sub>2</sub>, OH), 6.35 (s, 1H, 8″-H), 6.48 (s, 1H, 5″-H), 7.56 (dd, <i>J</i> = 9.2 Hz, <i>J</i>′ = 1.6 Hz, 1H, 7′-H), 7.79 (d, <i>J</i> = 1.6 Hz, 1H, 5′-H), 8.39 (d, <i>J</i> = 9.2 Hz, 1H, 8′-H); <sup>13</sup>C NMR (100.6 MHz, CD<sub>3</sub>OD) δ 21.7 (CH<sub>2</sub>, C3′), 22.2 (CH<sub>2</sub>, C4″), 22.9 (CH<sub>2</sub>, C2′), 23.7 (CH<sub>3</sub>, 2″-CH<sub>3</sub>), 24.8 (CH<sub>2</sub>, C1′), 27.2 (CH<sub>2</sub>, C6), 27.4 (CH<sub>2</sub>), 27.5 (CH<sub>2</sub>) (C3, C5), 29.3 (CH<sub>2</sub>, C4′), 29.7 (CH<sub>2</sub>, C4), 31.3 (CH<sub>2</sub>, C2), 32.6 (CH<sub>2</sub>, C3″), 36.4 (CH<sub>2</sub>, 2″-<i>C</i>H<sub>2</sub>-CH<sub>2</sub>-NH), 44.7 (CH<sub>2</sub>, 2″-CH<sub>2</sub>-<i>C</i>H<sub>2</sub>-NH), 48.9 (CH<sub>2</sub>, C7), 49.1 (CH<sub>2</sub>, C1), 56.4 (CH<sub>3</sub>, 7″-OCH<sub>3</sub>), 75.3 (C, C2″), 102.2 (CH, C8″), 113.32 (C), 113.34 (C) (C9a′, C4a″), 115.4 (C, C8a′), 116.2 (CH, C5″), 119.1 (CH, C5′), 126.8 (CH, C7′), 128.8 (CH, C8′), 140.0 (C, C6′), 140.5 (C, C10a′), 141.3 (C, C6″), 147.2 (C, C8a″), 148.4 (C, C7″), 152.1 (C, C4a′), 157.8 (C, C9′); HRMS (ESI) calcd for (C<sub>33</sub>H<sub>44</sub><sup>35</sup>ClN<sub>3</sub>O<sub>3</sub> + H<sup>+</sup>): 566.3144, found 566.3138; HPLC purity 98%.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> <i>N</i>-(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)-<i>N</i>′-[2-(6-hydroxy-7-methoxy-2-methylchroman-2-yl)ethyl]octane-1,8-diamine (<b>6b</b>)</h4><div class="NLM_p">It was prepared as described for <b>6a</b>. From tosylate <b>15</b> (170 mg, 0.43 mmol) and amine <b>10b</b> (467 mg, 1.30 mmol), a brown oily residue (678 mg) was obtained and subjected to column chromatography purification (35–70 μm silica gel, CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH mixtures, gradient elution). On elution with CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 99:1:0.4, amine <b>6b</b> (143 mg, 57% yield) was isolated as a beige solid; <i>R</i><sub><i>f</i></sub> 0.74 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 90:10:1).</div><div class="NLM_p last"><b>6b</b>·2HCl: light yellow solid; mp 147–149 °C; IR (ATR) ν 3600–2200 (max at 3240, 2930, 2852, 2780, N–H, N<sup>+</sup>–H, O–H, C–H st), 1630, 1573, 1511 (Ar–C–C, Ar–C–N st) cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.30 (s, 3H, 2″-CH<sub>3</sub>), 1.36–1.52 (complex signal, 8H, 3-H<sub>2</sub>, 4-H<sub>2</sub>, 5-H<sub>2</sub>, 6-H<sub>2</sub>), 1.69 (m, 2H, 7-H<sub>2</sub>), superimposed in part 1.78 (dt, <i>J</i> = 13.6 Hz, <i>J</i>′ = 6.8 Hz, 1H, 3″-H<sub>A</sub>), 1.80–1.88 (complex signal, 3H, 2-H<sub>2</sub>, 3″-H<sub>B</sub>), 1.92–2.00 (complex signal, 5H, 2′-H<sub>2</sub>, 3′-H<sub>2</sub>, 2″-C<i>H</i><sub>A</sub>-CH<sub>2</sub>-NH), 2.07 (dt, <i>J</i> = 13.6 Hz, <i>J</i>′ = 7.2 Hz, 1H, 2″-C<i>H</i><sub>B</sub>-CH<sub>2</sub>-NH), 2.65–2.72 (complex signal, 4H, 1′-H<sub>2</sub>, 4″-H<sub>2</sub>), 2.96–3.04 (complex signal, 4H, 8-H<sub>2</sub>, 4′-H<sub>2</sub>), 3.21 (t, <i>J</i> = 8.0 Hz, 2H, 2″-CH<sub>2</sub>-C<i>H</i><sub>2</sub>-NH), 3.76 (s, 3H, 7″-OCH<sub>3</sub>), 3.94 (t, <i>J</i> = 6.8 Hz, 2H, 1-H<sub>2</sub>), 4.86 (s, NH, <sup>+</sup>NH, <sup>+</sup>NH<sub>2</sub>, OH), 6.36 (s, 1H, 8″-H), 6.49 (s, 1H, 5″-H), 7.56 (dd, <i>J</i> = 9.2 Hz, <i>J</i>′ = 2.4 Hz, 1H, 7′-H), 7.79 (d, <i>J</i> = 2.4 Hz, 1H, 5′-H), 8.39 (d, <i>J</i> = 9.2 Hz, 1H, 8′-H); <sup>13</sup>C NMR (100.6 MHz, CD<sub>3</sub>OD) δ 21.8 (CH<sub>2</sub>, C3′), 22.2 (CH<sub>2</sub>, C4″), 22.9 (CH<sub>2</sub>, C2′), 23.7 (CH<sub>3</sub>, 2″-CH<sub>3</sub>), 24.8 (CH<sub>2</sub>, C1′), 27.2 (CH<sub>2</sub>, C7), 27.5 (CH<sub>2</sub>), 27.6 (CH<sub>2</sub>) (C3, C6), 29.3 (CH<sub>2</sub>, C4′), 30.0 (CH<sub>2</sub>), 30.1 (CH<sub>2</sub>) (C4, C5), 31.4 (CH<sub>2</sub>, C2), 32.6 (CH<sub>2</sub>, C3″), 36.4 (CH<sub>2</sub>, 2″-<i>C</i>H<sub>2</sub>-CH<sub>2</sub>-NH), 44.7 (CH<sub>2</sub>, 2″-CH<sub>2</sub>-<i>C</i>H<sub>2</sub>-NH), 49.2 (CH<sub>2</sub>, C8), 49.3 (CH<sub>2</sub>, C1), 56.4 (CH<sub>3</sub>, 7″-OCH<sub>3</sub>), 75.4 (C, C2″), 102.2 (CH, C8″), 113.3 (2C, C9a′, C4a″), 115.4 (C, C8a′), 116.2 (CH, C5″), 119.1 (CH, C5′), 126.8 (CH, C7′), 128.8 (CH, C8′), 140.1 (C, C6′), 140.5 (C, C10a′), 141.3 (C, C6″), 147.2 (C, C8a″), 148.4 (C, C7″), 152.1 (C, C4a′), 157.8 (C, C9′); HRMS (ESI) calcd for (C<sub>34</sub>H<sub>46</sub><sup>35</sup>ClN<sub>3</sub>O<sub>3</sub> + H<sup>+</sup>): 580.3300, found 580.3302; HPLC purity 98%.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> <i>N</i>-(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)-<i>N</i>′-[2-(6-hydroxy-7-methoxy-2-methylchroman-2-yl)ethyl]nonane-1,9-diamine (<b>6c</b>)</h4><div class="NLM_p">It was prepared as described for <b>6a</b>. From tosylate <b>15</b> (142 mg, 0.36 mmol) and amine <b>10c</b> (403 mg, 1.08 mmol), a brown oily residue (544 mg) was obtained and subjected to column chromatography purification (35–70 μm silica gel, CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH mixtures, gradient elution). On elution with CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 99.3:0.7:0.4 to 99:1:0.4, amine <b>6c</b> (125 mg, 59% yield) was isolated as a beige sticky solid; <i>R</i><sub><i>f</i></sub> 0.76 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 90:10:1).</div><div class="NLM_p last"><b>6c</b>·2HCl: beige solid; mp 153–157 °C; IR (ATR) ν 3600–2200 (max at 3229, 2925, 2852, 2785, N–H, N<sup>+</sup>–H, O–H, C–H st), 1628, 1571, 1509 (Ar–C–C, Ar–C–N st) cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.30 (s, 3H, 2″-CH<sub>3</sub>), 1.32–1.50 (complex signal, 10H, 3-H<sub>2</sub>, 4-H<sub>2</sub>, 5-H<sub>2</sub>, 6-H<sub>2</sub>, 7-H<sub>2</sub>), 1.68 (m, 2H, 8-H<sub>2</sub>), superimposed in part 1.79 (dt, <i>J</i> = 13.2 Hz, <i>J</i>′ = 6.4 Hz, 1H, 3″-H<sub>A</sub>), 1.80–1.90 (complex signal, 3H, 2-H<sub>2</sub>, 3″-H<sub>B</sub>), 1.90–2.01 (complex signal, 5H, 2′-H<sub>2</sub>, 3′-H<sub>2</sub>, 2″-C<i>H</i><sub>A</sub>-CH<sub>2</sub>-NH), 2.06 (dt, <i>J</i> = 13.6 Hz, <i>J</i>′ = 7.6 Hz, 1H, 2″-C<i>H</i><sub>B</sub>-CH<sub>2</sub>-NH), 2.64–2.74 (complex signal, 4H, 1′-H<sub>2</sub>, 4″-H<sub>2</sub>), 2.97–3.03 (complex signal, 4H, 9-H<sub>2</sub>, 4′-H<sub>2</sub>), 3.22 (t, <i>J</i> = 7.6 Hz, 2H, 2″-CH<sub>2</sub>-C<i>H</i><sub>2</sub>-NH), 3.77 (s, 3H, 7″-OCH<sub>3</sub>), 3.94 (t, <i>J</i> = 7.6 Hz, 2H, 1-H<sub>2</sub>), 4.85 (s, NH, <sup>+</sup>NH, <sup>+</sup>NH<sub>2</sub>, OH), 6.36 (s, 1H, 8″-H), 6.50 (s, 1H, 5″-H), 7.56 (dd, <i>J</i> = 9.2 Hz, <i>J</i>′ = 2.0 Hz, 1H, 7′-H), 7.79 (d, <i>J</i> = 2.0 Hz, 1H, 5′-H), 8.39 (d, <i>J</i> = 9.2 Hz, 1H, 8′-H); <sup>13</sup>C NMR (100.6 MHz, CD<sub>3</sub>OD) δ 21.8 (CH<sub>2</sub>, C3′), 22.2 (CH<sub>2</sub>, C4″), 22.9 (CH<sub>2</sub>, C2′), 23.7 (CH<sub>3</sub>, 2″-CH<sub>3</sub>), 24.7 (CH<sub>2</sub>, C1′), 27.3 (CH<sub>2</sub>, C8), 27.5 (CH<sub>2</sub>), 27.7 (CH<sub>2</sub>) (C3, C7), 29.3 (CH<sub>2</sub>, C4′), 30.1 (CH<sub>2</sub>), 30.2 (CH<sub>2</sub>), 30.4 (CH<sub>2</sub>) (C4, C5, C6), 31.4 (CH<sub>2</sub>, C2), 32.6 (CH<sub>2</sub>, C3″), 36.5 (CH<sub>2</sub>, 2″-<i>C</i>H<sub>2</sub>-CH<sub>2</sub>-NH), 44.7 (CH<sub>2</sub>, 2″-CH<sub>2</sub>-<i>C</i>H<sub>2</sub>-NH), 48.9 (CH<sub>2</sub>), 49.1 (CH<sub>2</sub>) (C1, C9), 56.4 (CH<sub>3</sub>, 7″-OCH<sub>3</sub>), 75.4 (C, C2″), 102.2 (CH, C8″), 113.4 (2C, C9a′, C4a″), 115.5 (C, C8a′), 116.2 (CH, C5″), 119.2 (CH, C5′), 126.8 (CH, C7′), 128.8 (CH, C8′), 140.1 (C, C6′), 140.6 (C, C10a′), 141.3 (C, C6″), 147.2 (C, C8a″), 148.4 (C, C7″), 152.2 (C, C4a′), 157.8 (C, C9′); HRMS (ESI) calcd for (C<sub>35</sub>H<sub>48</sub><sup>35</sup>ClN<sub>3</sub>O<sub>3</sub> + H<sup>+</sup>): 594.3457, found 594.3461; HPLC purity 97%.</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> <i>N</i>-(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)-<i>N</i>′-[2-(6-hydroxy-7-methoxy-2-methylchroman-2-yl)ethyl]-3,6-dioxaoctane-1,8-diamine (<b>6d</b>)</h4><div class="NLM_p">It was prepared as described for <b>6a</b>. From tosylate <b>15</b> (200 mg, 0.51 mmol) and amine <b>10d</b> (553 mg, 1.52 mmol), a brown sticky solid (763 mg) was obtained and subjected to column chromatography purification (35–70 μm silica gel, CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH mixtures, gradient elution). On elution with CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 99.3:0.7:0.4 to 99:1:0.4, amine <b>6d</b> (90 mg, 30% yield) was isolated as a brown solid; <i>R</i><sub><i>f</i></sub> 0.77 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 90:10:1).</div><div class="NLM_p last"><b>6d</b>·2HCl: brown sticky solid; IR (ATR) ν 3600–2200 (max at 3369, 3250, 2919, 2857, 2790, N–H, N<sup>+</sup>–H, O–H, C–H st), 1630, 1576, 1509 (Ar–C–C, Ar–C–N st) cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.27 (s, 3H, 2″-CH<sub>3</sub>), 1.74 (dt, <i>J</i> = 14.0 Hz, <i>J</i>′ = 6.4 Hz, 1H, 3″-H<sub>A</sub>), 1.79 (dt, <i>J</i> = 14.0 Hz, <i>J</i>′ = 6.4 Hz, 1H, 3″-H<sub>B</sub>), 1.92–2.00 (complex signal, 5H, 2′-H<sub>2</sub>, 3′-H<sub>2</sub>, 2″-C<i>H</i><sub>A</sub>-CH<sub>2</sub>-NH), 2.05 (dt, <i>J</i> = 14.0 Hz, <i>J</i>′ = 6.8 Hz, 1H, 2″-C<i>H</i><sub>B</sub>-CH<sub>2</sub>-NH), 2.56 (dt, <i>J</i> = 12.0 Hz, <i>J</i>′ = 6.4 Hz, 1H, 4″-H<sub>A</sub>), 2.60–2.70 (complex signal, 3H, 1′-H<sub>2</sub>, 4″-H<sub>B</sub>), 3.01 (br t, <i>J</i> = 5.6 Hz, 2H, 4′-H<sub>2</sub>), 3.25 (t, <i>J</i> = 4.8 Hz, 2H, 8-H<sub>2</sub>), superimposed in part 3.31 (m, 2H, 2″-CH<sub>2</sub>-C<i>H</i><sub>2</sub>-NH), 3.66–3.73 (complex signal, 4H, 4-H<sub>2</sub>, 7-H<sub>2</sub>), 3.71 (s, 3H, 7″-OCH<sub>3</sub>), 3.77 (t, <i>J</i> = 4.8 Hz, 2H, 5-H<sub>2</sub>), 3.88 (m, 2H, 2-H<sub>2</sub>), 4.11 (t, <i>J</i> = 4.8 Hz, 2H, 1-H<sub>2</sub>), 4.85 (s, NH, <sup>+</sup>NH, <sup>+</sup>NH<sub>2</sub>, OH), 6.31 (s, 1H, 8″-H), 6.40 (s, 1H, 5″-H), 7.54 (dd, <i>J</i> = 9.2 Hz, <i>J</i>′ = 2.0 Hz, 1H, 7′-H), 7.78 (d, <i>J</i> = 2.0 Hz, 1H, 5′-H), 8.43 (d, <i>J</i> = 9.2 Hz, 1H, 8′-H); <sup>13</sup>C NMR (100.6 MHz, CD<sub>3</sub>OD) δ 21.7 (CH<sub>2</sub>, C3′), 22.1 (CH<sub>2</sub>, C4″), 22.8 (CH<sub>2</sub>, C2′), 23.4 (CH<sub>3</sub>, 2″-CH<sub>3</sub>), 24.6 (CH<sub>2</sub>, C1′), 29.3 (CH<sub>2</sub>, C4′), 32.6 (CH<sub>2</sub>, C3″), 36.4 (CH<sub>2</sub>, 2″-<i>C</i>H<sub>2</sub>-CH<sub>2</sub>-NH), 44.8 (CH<sub>2</sub>, 2″-CH<sub>2</sub>-<i>C</i>H<sub>2</sub>-NH), 48.5 (CH<sub>2</sub>, C8), 49.1 (CH<sub>2</sub>, C1), 56.5 (CH<sub>3</sub>, 7″-OCH<sub>3</sub>), 66.8 (CH<sub>2</sub>, C4), 70.4 (CH<sub>2</sub>, C2), 71.3 (CH<sub>2</sub>), 71.4 (CH<sub>2</sub>) (C5, C7), 75.9 (C, C2″), 102.3 (CH, C8″), 113.4 (C, C9a′), 113.7 (C, C4a″), 115.6 (C, C8a′), 116.1 (CH, C5″), 119.2 (CH, C5′), 126.8 (CH, C7′), 128.8 (CH, C8′), 140.1 (C, C6′), 140.4 (C, C10a′), 141.4 (C, C6″), 146.8 (C, C8a″), 148.3 (C, C7″), 152.4 (C, C4a′), 158.2 (C, C9′); HRMS (ESI) calcd for (C<sub>32</sub>H<sub>42</sub><sup>35</sup>ClN<sub>3</sub>O<sub>5</sub> + H<sup>+</sup>): 584.2886, found 584.2879; HPLC purity 98%.</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> <i>N</i>-{7-[(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]heptyl}-2-(6-benzyloxy-7-methoxy-2-methylchroman-2-yl)acetamide (<b>11a</b>)</h4><div class="NLM_p">It was prepared as described for <b>4a</b>. From carboxylic acid <b>8</b> (200 mg, 0.58 mmol) and amine <b>10a</b> (222 mg, 0.64 mmol), a brown solid (784 mg) was obtained and subjected to column chromatography purification (35–70 μm silica gel, CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH mixtures, gradient elution). On elution with CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 100:0:0.4 to 95:5:0.4, amide <b>11a</b> (326 mg, 83% yield) was isolated as a light yellow solid; <i>R</i><sub><i>f</i></sub> 0.73 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 90:10:1).</div><div class="NLM_p last"><b>11a</b>·HCl: light yellow solid; mp 107–109 °C; IR (ATR) ν 3600–2200 (max at 3255, 3053, 2929, 2852, N–H, N<sup>+</sup>–H, C–H st), 1632, 1568, 1512 (C═O, Ar–C–C, Ar–C–N st) cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.27–1.38 (complex signal, 6H, 3′-H<sub>2</sub>, 4′-H<sub>2</sub>, 5′-H<sub>2</sub>), 1.33 (s, 3H, 2-CH<sub>3</sub>), 1.48 (tt, <i>J</i> = <i>J</i>′ = 6.8 Hz, 2H, 2′-H<sub>2</sub>), superimposed in part 1.75 (tt, <i>J</i> = <i>J</i>′ = 6.4 Hz, 2H, 6′-H<sub>2</sub>), 1.80 (dt, <i>J</i> = 13.6 Hz, <i>J</i>′ = 5.6 Hz, 1H, 3-H<sub>A</sub>), superimposed in part 1.90 (dt, <i>J</i> = 13.6 Hz, <i>J</i>′ = 5.6 Hz, 1H, 3-H<sub>B</sub>), 1.88–1.98 (complex signal, 4H, 2″-H<sub>2</sub>, 3″-H<sub>2</sub>), 2.45 (d, <i>J</i> = 13.6 Hz, 1H, 2-CH<sub>A</sub>-CO), 2.53 (d, <i>J</i> = 13.6 Hz, 1H, 2-CH<sub>B</sub>-CO), 2.61 (t, <i>J</i> = 6.0 Hz, 2H, 1″-H<sub>2</sub>), 2.67 (m, 2H, 4-H<sub>2</sub>), 2.94 (t, <i>J</i> = 5.6 Hz, 2H, 4″-H<sub>2</sub>), 3.14 (dt, <i>J</i> = 13.6 Hz, <i>J</i>′ = 6.4 Hz, 1H, 1′-H<sub>A</sub>), 3.25 (dt, <i>J</i> = 13.6 Hz, <i>J</i>′ = 6.4 Hz, 1H, 1′-H<sub>B</sub>), 3.76 (s, 3H, 7-OCH<sub>3</sub>), 3.86 (t, <i>J</i> = 7.6 Hz, 2H, 7′-H<sub>2</sub>), 4.85 (s, NH, <sup>+</sup>NH), 4.89 (d, <i>J</i> = 11.6 Hz, 1H, 6-OCH<sub>A</sub>), 4.93 (d, <i>J</i> = 11.6 Hz, 1H, 6-OCH<sub>B</sub>), 6.41 (s, 1H, 8-H), 6.67 (s, 1H, 5-H), 7.22–7.32 [complex signal, 3H, benzyl 3(5)-H, benzyl 4-H], 7.35 [dd, <i>J</i> = 8.4 Hz, <i>J</i>′ = 1.6 Hz, 2H, benzyl 2(6)-H], 7.53 (dd, <i>J</i> = 9.2 Hz, <i>J</i>′ = 2.0 Hz, 1H, 7″-H), 7.71 (d, <i>J</i> = 2.0 Hz, 1H, 5″-H), 8.33 (d, <i>J</i> = 9.2 Hz, 1H, 8″-H); <sup>13</sup>C NMR (100.6 MHz, CD<sub>3</sub>OD) δ 21.7 (CH<sub>2</sub>, C3″), 22.4 (CH<sub>2</sub>, C4), 22.8 (CH<sub>2</sub>, C2″), 24.63 (CH<sub>2</sub>, C1″), 24.64 (CH<sub>3</sub>, 2-CH<sub>3</sub>), 27.7 (CH<sub>2</sub>), 27.8 (CH<sub>2</sub>) (C4′, C5′), 29.3 (CH<sub>2</sub>, C4″), 30.0 (CH<sub>2</sub>, C3′), 30.3 (CH<sub>2</sub>, C2′), 31.3 (CH<sub>2</sub>, C6′), 32.0 (CH<sub>2</sub>, C3), 40.1 (CH<sub>2</sub>, C1′), 47.7 (CH<sub>2</sub>, 2-<i>C</i>H<sub>2</sub>-CO), 49.3 (CH<sub>2</sub>, C7′), 56.5 (CH<sub>3</sub>, 7-OCH<sub>3</sub>), 73.5 (CH<sub>2</sub>, 6-OCH<sub>2</sub>), 75.9 (C, C2), 103.1 (CH, C8), 113.2 (2C, C9a″, C4a), 115.4 (C, C8a″), 117.7 (CH, C5), 119.1 (CH, C5″), 126.7 (CH, C7″), 128.7 [3CH, benzyl C2(6), benzyl C4], 128.8 (CH, C8″), 129.3 [2CH, benzyl C3(5)], 138.9 (C, benzyl C1), 140.1 (C, C6″), 140.5 (C, C10a″), 143.3 (C, C6), 149.3 (C, C8a), 151.0 (C, C7), 151.9 (C, C4a″), 157.6 (C, C9″), 172.3 (C, CONH); HRMS (ESI) calcd for (C<sub>40</sub>H<sub>48</sub><sup>35</sup>ClN<sub>3</sub>O<sub>4</sub> + H<sup>+</sup>): 670.3406, found 670.3400; HPLC purity 97%.</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> <i>N</i>-{8-[(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]octyl}-2-(6-benzyloxy-7-methoxy-2-methylchroman-2-yl)acetamide (<b>11b</b>)</h4><div class="NLM_p">It was prepared as described for <b>4a</b>. From carboxylic acid <b>8</b> (100 mg, 0.29 mmol) and amine <b>10b</b> (116 mg, 0.32 mmol), a brown solid (462 mg) was obtained and subjected to column chromatography purification (35–70 μm silica gel, CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH mixtures, gradient elution). On elution with CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 100:0:0.4, amide <b>11b</b> (183 mg, 92% yield) was isolated as a yellow solid; <i>R</i><sub><i>f</i></sub> 0.73 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 90:10:1).</div><div class="NLM_p last"><b>11b</b>·HCl: light yellow solid; mp 127–129 °C; IR (ATR) ν 3600–2200 (max at 3261, 3053, 2924, 2852, N–H, N<sup>+</sup>–H, C–H st), 1632, 1571, 1510 (C═O, Ar–C–C, Ar–C–N st) cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.20–1.34 (complex signal, 6H, 3′-H<sub>2</sub>, 4′-H<sub>2</sub>, 5′-H<sub>2</sub>), 1.33 (s, 3H, 2-CH<sub>3</sub>), 1.37 (tt, <i>J</i> = <i>J</i>′ = 6.8 Hz, 2H, 6′-H<sub>2</sub>), 1.48 (tt, <i>J</i> = <i>J</i>′ = 6.8 Hz, 2H, 2′-H<sub>2</sub>), superimposed in part 1.77 (tt, <i>J</i> = 7.2 Hz, <i>J</i>′ = 6.8 Hz, 2H, 7′-H<sub>2</sub>), 1.79 (dt, <i>J</i> = 13.6 Hz, <i>J</i>′ = 6.8 Hz, 1H, 3-H<sub>A</sub>), superimposed in part 1.90 (dt, <i>J</i> = 13.6 Hz, <i>J</i>′ = 6.8 Hz, 1H, 3-H<sub>B</sub>), 1.87–1.99 (complex signal, 4H, 2″-H<sub>2</sub>, 3″-H<sub>2</sub>), 2.45 (d, <i>J</i> = 13.6 Hz, 1H, 2-CH<sub>A</sub>-CO), 2.53 (d, <i>J</i> = 13.6 Hz, 1H, 2-CH<sub>B</sub>-CO), 2.61 (t, <i>J</i> = 5.6 Hz, 2H, 1″-H<sub>2</sub>), 2.67 (m, 2H, 4-H<sub>2</sub>), 2.94 (t, <i>J</i> = 6.0 Hz, 2H, 4″-H<sub>2</sub>), 3.14 (dt, <i>J</i> = 13.6 Hz, <i>J</i>′ = 6.8 Hz, 1H, 1′-H<sub>A</sub>), 3.25 (dt, <i>J</i> = 13.6 Hz, <i>J</i>′ = 6.8 Hz, 1H, 1′-H<sub>B</sub>), 3.77 (s, 3H, 7-OCH<sub>3</sub>), 3.85 (t, <i>J</i> = 7.2 Hz, 2H, 8′-H<sub>2</sub>), 4.85 (s, NH, <sup>+</sup>NH), 4.89 (d, <i>J</i> = 12.0 Hz, 1H, 6-OCH<sub>A</sub>), 4.93 (d, <i>J</i> = 12.0 Hz, 1H, 6-OCH<sub>B</sub>), 6.42 (s, 1H, 8-H), 6.67 (s, 1H, 5-H), 7.18–7.30 [complex signal, 3H, benzyl 3(5)-H, benzyl 4-H], 7.35 [dm, <i>J</i> = 8.0 Hz, 2H, benzyl 2(6)-H], 7.52 (dd, <i>J</i> = 9.2 Hz, <i>J</i>′ = 2.0 Hz, 1H, 7″-H), 7.72 (d, <i>J</i> = 2.0 Hz, 1H, 5″-H), 8.33 (d, <i>J</i> = 9.2 Hz, 1H, 8″-H); <sup>13</sup>C NMR (100.6 MHz, CD<sub>3</sub>OD) δ 21.7 (CH<sub>2</sub>, C3″), 22.4 (CH<sub>2</sub>, C4), 22.8 (CH<sub>2</sub>, C2″), 24.62 (CH<sub>2</sub>, C1″), 24.63 (CH<sub>3</sub>, 2-CH<sub>3</sub>), 27.6 (CH<sub>2</sub>, C6′), 27.8 (CH<sub>2</sub>, C5′), 29.3 (CH<sub>2</sub>, C4″), 30.2 (CH<sub>2</sub>), 30.3 (CH<sub>2</sub>) (C3′, C4′), 30.4 (CH<sub>2</sub>, C2′), 31.4 (CH<sub>2</sub>, C7′), 32.0 (CH<sub>2</sub>, C3), 40.2 (CH<sub>2</sub>, C1′), 47.7 (CH<sub>2</sub>, 2-<i>C</i>H<sub>2</sub>-CO), 49.3 (CH<sub>2</sub>, C8′), 56.5 (CH<sub>3</sub>, 7-OCH<sub>3</sub>), 73.4 (CH<sub>2</sub>, 6-OCH<sub>2</sub>), 75.9 (C, C2), 103.0 (CH, C8), 113.17 (C), 113.20 (C) (C4a, C9a″), 115.3 (C, C8a″), 117.5 (CH, C5), 119.1 (CH, C5″), 126.7 (CH, C7″), 128.7 [3CH, benzyl C2(6), benzyl C4], 128.8 (CH, C8″), 129.3 [2CH, benzyl C3(5)], 138.9 (C, benzyl C1), 140.0 (C, C6″), 140.5 (C, C10a″), 143.3 (C, C6), 149.3 (C, C8a), 150.9 (C, C7), 151.9 (C, C4a″), 157.6 (C, C9″), 172.3 (C, CONH); HRMS (ESI) calcd for (C<sub>41</sub>H<sub>50</sub><sup>35</sup>ClN<sub>3</sub>O<sub>4</sub> + H<sup>+</sup>): 684.3562, found 684.3563; HPLC purity 99%.</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> <i>N</i>-{9-[(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]nonyl}-2-(6-benzyloxy-7-methoxy-2-methylchroman-2-yl)acetamide (<b>11c</b>)</h4><div class="NLM_p">It was prepared as described for <b>4a</b>. From carboxylic acid <b>8</b> (128 mg, 0.37 mmol) and amine <b>10c</b> (154 mg, 0.41 mmol), a brown oily residue (521 mg) was obtained and subjected to column chromatography purification (35–70 μm silica gel, CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH mixtures, gradient elution). On elution with CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 100:0:0.4–99:1:0.4, amide <b>11c</b> (236 mg, 90% yield) was isolated as a light yellow solid; <i>R</i><sub><i>f</i></sub> 0.74 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 90:10:1).</div><div class="NLM_p last"><b>11c</b>·HCl: light yellow solid; mp 107–109 °C; IR (ATR) <i>ν</i> 3600–2200 (max at 3244, 3053, 2924, 2852, N–H, N<sup>+</sup>–H, C–H st), 1633, 1573, 1510 (C═O, Ar–C–C, Ar–C–N st) cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.18–1.36 (complex signal, 8H, 3′-H<sub>2</sub>, 4′-H<sub>2</sub>, 5′-H<sub>2</sub>, 6′-H<sub>2</sub>), 1.33 (s, 3H, 2-CH<sub>3</sub>), 1.39 (tt, <i>J</i> = 7.6 Hz, <i>J</i>′ = 6.8 Hz, 2H, 7′-H<sub>2</sub>), 1.48 (tt, <i>J</i> = <i>J</i>′ = 6.8 Hz, 2H, 2′-H<sub>2</sub>), superimposed in part 1.77 (tt, <i>J</i> = 7.6 Hz, <i>J</i>′ = 7.2 Hz, 2H, 8′-H<sub>2</sub>), 1.80 (dt, <i>J</i> = 13.2 Hz, <i>J</i>′ = 6.0 Hz, 1H, 3-H<sub>A</sub>), superimposed in part 1.90 (dt, <i>J</i> = 13.2 Hz, <i>J</i>′ = 6.0 Hz, 1H, 3-H<sub>B</sub>), 1.87–1.98 (complex signal, 4H, 2″-H<sub>2</sub>, 3″-H<sub>2</sub>), 2.45 (d, <i>J</i> = 13.6 Hz, 1H, 2-CH<sub>A</sub>-CO), 2.52 (d, <i>J</i> = 13.6 Hz, 1H, 2-CH<sub>B</sub>-CO), 2.63 (t, <i>J</i> = 5.2 Hz, 2H, 1″-H<sub>2</sub>), 2.69 (m, 2H, 4-H<sub>2</sub>), 2.95 (t, <i>J</i> = 6.0 Hz, 2H, 4″-H<sub>2</sub>), 3.14 (dt, <i>J</i> = 13.2 Hz, <i>J</i>′ = 6.8 Hz, 1H, 1′-H<sub>A</sub>), 3.23 (dt, <i>J</i> = 13.2 Hz, <i>J</i>′ = 6.8 Hz, 1H, 1′-H<sub>B</sub>), 3.77 (s, 3H, 7-OCH<sub>3</sub>), 3.87 (t, <i>J</i> = 7.2 Hz, 2H, 9′-H<sub>2</sub>), 4.85 (s, NH, <sup>+</sup>NH), 4.91 (d, <i>J</i> = 12.4 Hz, 1H, 6-OCH<sub>A</sub>), 4.94 (d, <i>J</i> = 12.4 Hz, 1H, 6-OCH<sub>B</sub>), 6.42 (s, 1H, 8-H), 6.68 (s, 1H, 5-H), 7.22 (br t, <i>J</i> = 7.2 Hz, 1H, benzyl 4-H), 7.27 [dd, <i>J</i> = <i>J</i>′ = 7.2 Hz, 2H, benzyl 3(5)-H], 7.36 [br d, <i>J</i> = 7.2 Hz, 2H, benzyl 2(6)-H], 7.53 (dd, <i>J</i> = 9.2 Hz, <i>J</i>′ = 2.0 Hz, 1H, 7″-H), 7.73 (d, <i>J</i> = 2.0 Hz, 1H, 5″-H), 8.34 (d, <i>J</i> = 9.2 Hz, 1H, 8″-H); <sup>13</sup>C NMR (100.6 MHz, CD<sub>3</sub>OD) δ 21.8 (CH<sub>2</sub>, C3″), 22.5 (CH<sub>2</sub>, C4), 22.8 (CH<sub>2</sub>, C2″), 24.56 (CH<sub>3</sub>, 2-CH<sub>3</sub>), 24.63 (CH<sub>2</sub>, C1″), 27.7 (CH<sub>2</sub>, C7′), 27.9 (CH<sub>2</sub>, C6′), 29.3 (CH<sub>2</sub>, C4″), 30.2 (CH<sub>2</sub>), 30.3 (CH<sub>2</sub>), 30.4 (CH<sub>2</sub>), 30.5 (CH<sub>2</sub>) (C2′, C3′, C4′, C5′), 31.3 (CH<sub>2</sub>, C8′), 32.1 (CH<sub>2</sub>, C3), 40.2 (CH<sub>2</sub>, C1′), 47.7 (CH<sub>2</sub>, 2-<i>C</i>H<sub>2</sub>-CO), 49.3 (CH<sub>2</sub>, C9′), 56.4 (CH<sub>3</sub>, 7-OCH<sub>3</sub>), 73.5 (CH<sub>2</sub>, 6-OCH<sub>2</sub>), 75.9 (C, C2), 103.0 (CH, C8), 113.2 (C, C9a″), 113.3 (C, C4a), 115.4 (C, C8a″), 117.6 (CH, C5), 119.2 (CH, C5″), 126.7 (CH, C7″), 128.78 (CH, C8″), 128.81 [3CH, benzyl C2(6), benzyl C4], 129.3 [2CH, benzyl C3(5)], 139.0 (C, benzyl C1), 140.1 (C, C6″), 140.6 (C, C10a″), 143.4 (C, C6), 149.3 (C, C8a), 150.9 (C, C7), 152.0 (C, C4a″), 157.7 (C, C9″), 172.3 (C, CONH); HRMS (ESI) calcd for (C<sub>42</sub>H<sub>52</sub><sup>35</sup>ClN<sub>3</sub>O<sub>4</sub> + H<sup>+</sup>): 698.3719, found 698.3714; HPLC purity 97%.</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> <i>N</i>-{6-[(6-Chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]hexyl}-2-(6-benzyloxy-7-methoxy-2-methylchroman-2-yl)acetamide (<b>11e</b>)</h4><div class="NLM_p">It was prepared as described for <b>4a</b>. From carboxylic acid <b>8</b> (100 mg, 0.29 mmol) and amine <b>10e</b> (107 mg, 0.32 mmol), a brown solid (463 mg) was obtained and subjected to column chromatography purification (35–70 μm silica gel, CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH mixtures, gradient elution). On elution with CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 100:0:0.4, amide <b>11e</b> (191 mg, quantitative yield) was isolated as a light yellow solid; <i>R</i><sub><i>f</i></sub> 0.73 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 90:10:1).</div><div class="NLM_p last"><b>11e</b>·HCl: light yellow solid; mp 126–128 °C; IR (ATR) ν 3600–2200 (max at 3250, 3048, 2928, 2852, N–H, N<sup>+</sup>–H, C–H st), 1632, 1573, 1510 (C═O, Ar–C–C, Ar–C–N st) cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.31 (s, 3H, 2-CH<sub>3</sub>), 1.34–1.44 (complex signal, 4H, 3′-H<sub>2</sub>, 4′-H<sub>2</sub>), 1.51 (tt, <i>J</i> = <i>J</i>′ = 6.8 Hz, 2H, 2′-H<sub>2</sub>), 1.70 (tt, <i>J</i> = 7.2 Hz, <i>J</i>′ = 6.8 Hz, 2H, 5′-H<sub>2</sub>), 1.80 (dt, <i>J</i> = 13.6 Hz, <i>J</i>′ = 6.0 Hz, 1H, 3-H<sub>A</sub>), superimposed in part 1.93 (dt, <i>J</i> = 13.6 Hz, <i>J</i>′ = 6.0 Hz, 1H, 3-H<sub>B</sub>), 1.85–1.96 (complex signal, 4H, 2″-H<sub>2</sub>, 3″-H<sub>2</sub>), 2.45 (d, <i>J</i> = 13.6 Hz, 1H, 2-CH<sub>A</sub>-CO), 2.53 (d, <i>J</i> = 13.6 Hz, 1H, 2-CH<sub>B</sub>-CO), superimposed in part 2.61 (m, 2H, 4-H<sub>2</sub>), 2.65 (br t, <i>J</i> = 6.4 Hz, 2H, 1″-H<sub>2</sub>), 2.90 (t, <i>J</i> = 5.6 Hz, 2H, 4″-H<sub>2</sub>), 3.14 (dt, <i>J</i> = 13.6 Hz, <i>J</i>′ = 6.8 Hz, 1H, 1′-H<sub>A</sub>), 3.28 (dt, <i>J</i> = 13.6 Hz, <i>J</i>′ = 6.8 Hz, 1H, 1′-H<sub>B</sub>), 3.75 (s, 3H, 7-OCH<sub>3</sub>), 3.80 (t, <i>J</i> = 7.2 Hz, 2H, 6′-H<sub>2</sub>), 4.83 (d, <i>J</i> = 12.0 Hz, 1H, 6-OCH<sub>A</sub>), 4.85 (s, NH, <sup>+</sup>NH), 4.91 (d, <i>J</i> = 12.0 Hz, 1H, 6-OCH<sub>B</sub>), 6.40 (s, 1H, 8-H), 6.62 (s, 1H, 5-H), 7.22–7.31 [complex signal, 3H, benzyl 3(5)-H, benzyl 4-H], 7.35 [dd, <i>J</i> = 8.0 Hz, <i>J</i>′ = 1.6 Hz, 2H, benzyl 2(6)-H], 7.52 (dd, <i>J</i> = 9.2 Hz, <i>J</i>′ = 2.0 Hz, 1H, 7″-H), 7.71 (d, <i>J</i> = 2.0 Hz, 1H, 5″-H), 8.28 (d, <i>J</i> = 9.2 Hz, 1H, 8″-H); <sup>13</sup>C NMR (100.6 MHz, CD<sub>3</sub>OD) δ 21.7 (CH<sub>2</sub>, C3″), 22.4 (CH<sub>2</sub>, C4), 22.8 (CH<sub>2</sub>, C2″), 24.56 (CH<sub>2</sub>, C1″), 24.64 (CH<sub>3</sub>, 2-CH<sub>3</sub>), 27.36 (CH<sub>2</sub>), 27.39 (CH<sub>2</sub>) (C3′, C4′), 29.2 (CH<sub>2</sub>, C4″), 30.3 (CH<sub>2</sub>, C2′), 31.3 (CH<sub>2</sub>, C5′), 31.9 (CH<sub>2</sub>, C3), 40.0 (CH<sub>2</sub>, C1′), 47.8 (CH<sub>2</sub>, 2-<i>C</i>H<sub>2</sub>-CO), 49.3 (CH<sub>2</sub>, C6′), 56.5 (CH<sub>3</sub>, 7-OCH<sub>3</sub>), 73.5 (CH<sub>2</sub>, 6-OCH<sub>2</sub>), 75.9 (C, C2), 103.1 (CH, C8), 113.2 (2C, C4a, C9a″), 115.3 (C, C8a″), 117.7 (CH, C5), 119.1 (CH, C5″), 126.7 (CH, C7″), 128.7 [3CH, benzyl C2(6), benzyl C4], 128.8 (CH, C8″), 129.3 [2CH, benzyl C3(5)], 138.9 (C, benzyl C1), 140.0 (C, C6″), 140.4 (C, C10a″), 143.3 (C, C6), 149.3 (C, C8a), 150.9 (C, C7), 151.9 (C, C4a″), 157.5 (C, C9″), 172.3 (C, CONH); HRMS (ESI) calcd for (C<sub>39</sub>H<sub>46</sub><sup>35</sup>ClN<sub>3</sub>O<sub>4</sub> + H<sup>+</sup>): 656.3249, found 656.3238; HPLC purity 99%.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> <i>N</i>-{7-[(1,2,3,4-Tetrahydroacridin-9-yl)amino]heptyl}-2-(6-hydroxy-7-methoxy-2-methylchroman-2-yl)acetamide (<b>12a</b>)</h4><div class="NLM_p">A solution of amide <b>11a</b> (123 mg, 0.19 mmol) in degassed EtOH (3 mL) was added to a suspension of 10% w/w Pd/C in EtOH (1.5 mL). The mixture was stirred at rt and atmospheric pressure of H<sub>2</sub> overnight. An additional portion of catalyst was added, and the mixture was allowed to react under the same conditions overnight. The resulting mixture was filtered through a plug of Celite and washed with EtOH (3 × 5 mL). The filtrate was evaporated in vacuo to afford hybrid <b>12a</b> (73 mg, 72% yield) as a light yellow solid; <i>R</i><sub><i>f</i></sub> 0.27 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 95:5:1).</div><div class="NLM_p last"><b>12a</b>·HCl: light yellow solid; mp 115–118 °C; IR (ATR) ν 3600–2200 (max at 3248, 3092, 2930, 2852, N–H, N<sup>+</sup>–H, O–H, C–H st), 1634, 1574, 1520 (C═O, Ar–C–C, Ar–C–N st) cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.31 (s, 3H, 2-CH<sub>3</sub>), 1.32–1.41 (complex signal, 6H, 3′-H<sub>2</sub>, 4′-H<sub>2</sub>, 5′-H<sub>2</sub>), 1.49 (tt, <i>J</i> = <i>J</i>′ = 7.2 Hz, 2H, 2′-H<sub>2</sub>), 1.72–1.82 (complex signal, 3H, 3-H<sub>A</sub>, 6′-H<sub>2</sub>), 1.83–1.91 (m, 1H, 3-H<sub>B</sub>), 1.92–2.00 (complex signal, 4H, 2″-H<sub>2</sub>, 3″-H<sub>2</sub>), 2.44 (d, <i>J</i> = 13.6 Hz, 1H, 2-CH<sub>A</sub>-CO), 2.49 (d, <i>J</i> = 13.6 Hz, 1H, 2-CH<sub>B</sub>-CO), 2.62 (t, <i>J</i> = 6.0 Hz, 2H, 4-H<sub>2</sub>), 2.68 (t, <i>J</i> = 5.6 Hz, 2H, 1″-H<sub>2</sub>), 3.00 (t, <i>J</i> = 6.0 Hz, 2H, 4″-H<sub>2</sub>), 3.18 (m, 2H, 1′-H<sub>2</sub>), 3.74 (s, 3H, 7-OCH<sub>3</sub>), 3.91 (t, <i>J</i> = 7.2 Hz, 2H, 7′-H<sub>2</sub>), 4.85 (s, NH, <sup>+</sup>NH, OH), 6.33 (s, 1H, 8-H), 6.45 (s, 1H, 5-H), 7.58 (ddd, <i>J</i> = 8.8 Hz, <i>J</i>′ = 7.2 Hz, <i>J</i>″ = 1.2 Hz, 1H, 7″-H), 7.74 (dd, <i>J</i> = 8.4 Hz, <i>J</i>′ = 1.2 Hz, 1H, 5″-H), 7.84 (ddd, <i>J</i> = 8.4 Hz, <i>J</i>′ = 7.2 Hz, <i>J</i>″ = 1.2 Hz, 1H, 6″-H), 8.37 (d, <i>J</i> = 8.8 Hz, 1H, 8″-H); <sup>13</sup>C NMR (100.6 MHz, CD<sub>3</sub>OD) δ 21.8 (CH<sub>2</sub>, C3″), 22.4 (CH<sub>2</sub>, C4), 23.0 (CH<sub>2</sub>, C2″), 24.4 (CH<sub>3</sub>, 2-CH<sub>3</sub>), 24.9 (CH<sub>2</sub>, C1″), 27.6 (CH<sub>2</sub>, C5′), 27.7 (CH<sub>2</sub>, C4′), 29.3 (CH<sub>2</sub>, C4″), 29.9 (CH<sub>2</sub>, C3′), 30.2 (CH<sub>2</sub>, C2′), 31.4 (CH<sub>2</sub>, C6′), 32.3 (CH<sub>2</sub>, C3), 40.4 (CH<sub>2</sub>, C1′), 47.3 (CH<sub>2</sub>, 2-<i>C</i>H<sub>2</sub>-CO), 49.1 (CH, C7′), 56.4 (CH<sub>3</sub>, 7-OCH<sub>3</sub>), 75.5 (C, C2), 102.2 (CH, C8), 112.8 (C, C9a″), 113.3 (C, C4a), 116.1 (CH, C5), 117.0 (C, C8a″), 120.1 (CH, C5″), 126.3 (CH, C7″), 126.5 (CH, C8″), 134.0 (CH, C6″), 139.7 (C, C10a″), 141.1 (C, C6), 147.3 (C, C8a), 148.3 (C, C7), 151.6 (C, C4a″), 157.9 (C, C9″), 172.7 (C, CONH); HRMS (ESI) calcd for (C<sub>33</sub>H<sub>43</sub>N<sub>3</sub>O<sub>4</sub>+ H<sup>+</sup>): 546.3332, found 546.3290; HPLC purity 100%.</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> <i>N</i>-{8-[(1,2,3,4-Tetrahydroacridin-9-yl)amino]octyl}-2-(6-hydroxy-7-methoxy-2-methylchroman-2-yl)acetamide (<b>12b</b>)</h4><div class="NLM_p">It was prepared as described for <b>12a</b>. From <b>11b</b> (56 mg, 0.08 mmol), amide <b>12b</b> (46 mg, 99% yield) was isolated as a light green solid; <i>R</i><sub><i>f</i></sub> 0.26 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 95:5:1).</div><div class="NLM_p last"><b>12b</b>·HCl: light green solid; mp 104–107 °C; IR (ATR) ν 3600–2200 (max at 3249, 3090, 2927, 2852, N–H, N<sup>+</sup>–H, O–H, C–H st), 1634, 1575, 1519 (C═O, Ar–C–C, Ar–C–N st) cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.25–1.34 (complex signal, 9H, 2-CH<sub>3</sub>, 3′-H<sub>2</sub>, 4′-H<sub>2</sub>, 5′-H<sub>2</sub>), 1.38 (m, 2H, 6′-H<sub>2</sub>), 1.47 (m, 2H, 2′-H<sub>2</sub>), 1.72–1.84 (complex signal, 3H, 3-H<sub>A</sub>, 7′-H<sub>2</sub>), 1.87 (m, 1H, 3-H<sub>B</sub>), 1.91–2.01 (complex signal, 4H, 2″-H<sub>2</sub>, 3″-H<sub>2</sub>), 2.44 (d, <i>J</i> = 13.2 Hz, 1H, 2-CH<sub>A</sub>-CO), 2.48 (d, <i>J</i> = 13.2 Hz, 1H, 2-CH<sub>B</sub>-CO), 2.62 (t, <i>J</i> = 6.4 Hz, 2H, 4-H<sub>2</sub>), 2.69 (t, <i>J</i> = 5.6 Hz, 2H, 1″-H<sub>2</sub>), 3.00 (t, <i>J</i> = 6.0 Hz, 2H, 4″-H<sub>2</sub>), 3.17 (m, 2H, 1′-H<sub>2</sub>), 3.75 (s, 3H, 7-OCH<sub>3</sub>), 3.91 (t, <i>J</i> = 7.2 Hz, 2H, 8′-H<sub>2</sub>), 4.85 (s, NH, <sup>+</sup>NH, OH), 6.34 (s, 1H, 8-H), 6.45 (s, 1H, 5-H), 7.58 (ddd, <i>J =</i> 8.8 Hz, <i>J</i>′ = 7.2 Hz, <i>J</i>″ = 1.2 Hz, 1H, 7″-H), 7.74 (dd, <i>J</i> = 8.4 Hz, <i>J</i>′ = 1.2 Hz, 1H, 5″-H), 7.84 (ddd, <i>J</i> = 8.4 Hz, <i>J</i>′ = 7.2 Hz, <i>J</i>″ = 1.2 Hz, 1H, 6″-H), 8.34 (br d, <i>J</i> = 8.8 Hz, 1H, 8″-H); <sup>13</sup>C NMR (100.6 MHz, CD<sub>3</sub>OD) δ 21.8 (CH<sub>2</sub>, C3″), 22.4 (CH<sub>2</sub>, C4), 23.0 (CH<sub>2</sub>, C2″), 24.5 (CH<sub>3</sub>, 2-CH<sub>3</sub>), 24.8 (CH<sub>2</sub>, C1″), 27.6 (CH<sub>2</sub>, C6′), 27.7 (CH<sub>2</sub>, C5′), 29.3 (CH<sub>2</sub>, C4″), 30.1 (CH<sub>2</sub>), 30.2 (CH<sub>2</sub>) (C3′, C4′), 30.3 (CH<sub>2</sub>, C2′), 31.5 (CH<sub>2</sub>, C7′), 32.3 (CH<sub>2</sub>, C3), 40.3 (CH<sub>2</sub>, C1′), 47.4 (CH<sub>2</sub>, 2-<i>C</i>H<sub>2</sub>-CO), 49.2 (CH, C8′), 56.4 (CH<sub>3</sub>, 7-OCH<sub>3</sub>), 75.6 (C, C2), 102.2 (CH, C8), 112.8 (C, C9a″), 113.3 (C, C4a), 116.1 (CH, C5), 117.0 (C, C8a″), 120.1 (CH, C5″), 126.3 (CH, C7″), 126.5 (CH, C8″), 134.1 (CH, C6″), 139.7 (C, C10a″), 141.1 (C, C6), 147.3 (C, C8a), 148.3 (C, C7), 151.6 (C, C4a″), 157.9 (C, C9″), 172.6 (C, CONH); HRMS (ESI) calcd for (C<sub>34</sub>H<sub>45</sub>N<sub>3</sub>O<sub>4</sub>+ H<sup>+</sup>): 560.3488, found 560.3496; HPLC purity 97%.</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> <i>N</i>-{9-[(1,2,3,4-Tetrahydroacridin-9-yl)amino]nonyl}-2-(6-hydroxy-7-methoxy-2-methylchroman-2-yl)acetamide (<b>12c</b>)</h4><div class="NLM_p">It was prepared as described for <b>12a</b>. From <b>11c</b> (65 mg, 0.09 mmol), amide <b>12c</b> (53 mg, 99% yield) was isolated as a light yellow solid; <i>R</i><sub><i>f</i></sub> 0.25 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 95:5:1).</div><div class="NLM_p last"><b>12c</b>·HCl: light yellow solid; mp 105–108 °C; IR (ATR) <i>ν</i> 3600–2200 (max at 3250, 3098, 2929, 2852, N–H, N<sup>+</sup>–H, O–H, C–H st), 1633, 1572, 1515 (C═O, Ar–C–C, Ar–C–N st) cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.21–1.35 (complex signal, 11H, 2-CH<sub>3</sub>, 3′-H<sub>2</sub>, 4′-H<sub>2</sub>, 5′-H<sub>2</sub>, 6′-H<sub>2</sub>,), 1.39 (m, 2H, 7′-H<sub>2</sub>), 1.47 (tt, <i>J</i> = <i>J</i>′ = 6.8 Hz, 2H, 2′-H<sub>2</sub>), 1.73–1.90 (complex signal, 4H, 3-H<sub>2</sub>, 8′-H<sub>2</sub>), 1.93–2.02 (complex signal, 4H, 2″-H<sub>2</sub>, 3″-H<sub>2</sub>), 2.44 (d, <i>J</i> = 13.6 Hz, 1H, 2-CH<sub>A</sub>-CO), 2.49 (d, <i>J</i> = 13.6 Hz, 1H, 2-CH<sub>B</sub>-CO), 2.63 (t, <i>J</i> = 6.8 Hz, 2H, 4-H<sub>2</sub>), 2.70 (t, <i>J</i> = 5.2 Hz, 2H, 1″-H<sub>2</sub>), 3.01 (t, <i>J</i> = 6.8 Hz, 2H, 4″-H<sub>2</sub>), 3.18 (m, 2H, 1′-H<sub>2</sub>), 3.76 (s, 3H, 7-OCH<sub>3</sub>), 3.93 (t, <i>J</i> = 7.2 Hz, 2H, 9′-H<sub>2</sub>), 4.85 (s, NH, <sup>+</sup>NH, OH), 6.34 (s, 1H, 8-H), 6.45 (s, 1H, 5-H), 7.58 (ddd, <i>J</i> = 8.8 Hz, <i>J</i>′ = 6.8 Hz, <i>J</i>″ = 1.2 Hz, 1H, 7″-H), 7.74 (dd, <i>J</i> = 8.4 Hz, <i>J</i>′ = 1.2 Hz, 1H, 5″-H), 7.85 (ddd, <i>J</i> = 8.4 Hz, <i>J</i>′ = 6.8 Hz, <i>J</i>″ = 1.2 Hz, 1H, 6″-H), 8.39 (br d, <i>J</i> = 8.8 Hz, 1H, 8″-H); <sup>13</sup>C NMR (100.6 MHz, CD<sub>3</sub>OD) δ 21.8 (CH<sub>2</sub>, C3″), 22.4 (CH<sub>2</sub>, C4), 23.0 (CH<sub>2</sub>, C2″), 24.4 (CH<sub>3</sub>, 2-CH<sub>3</sub>), 24.9 (CH<sub>2</sub>, C1″), 27.6 (CH<sub>2</sub>, C7′), 27.8 (CH<sub>2</sub>, C6′), 29.3 (CH<sub>2</sub>, C4″), 30.1 (CH<sub>2</sub>), 30.2 (2CH<sub>2</sub>) (C2′, C3′, C4′), 30.4 (CH<sub>2</sub>, C5′), 31.5 (CH<sub>2</sub>, C8′), 32.3 (CH<sub>2</sub>, C3), 40.6 (CH<sub>2</sub>, C1′), 47.2 (CH<sub>2</sub>, 2-<i>C</i>H<sub>2</sub>-CO), 49.2 (CH, C9′), 56.4 (CH<sub>3</sub>, 7-OCH<sub>3</sub>), 75.5 (C, C2), 102.2 (CH, C8), 112.8 (C, C9a″), 113.3 (C, C4a), 116.0 (CH, C5), 117.0 (C, C8a″), 120.1 (CH, C5″), 126.3 (CH, C7″), 126.5 (CH, C8″), 134.0 (CH, C6″), 139.7 (C, C10a″), 141.1 (C, C6), 147.2 (C, C8a), 148.3 (C, C7), 151.6 (C, C4a″), 157.9 (C, C9″), 172.8 (C, CONH); HRMS (ESI) calcd for (C<sub>35</sub>H<sub>47</sub>N<sub>3</sub>O<sub>4</sub>+ H<sup>+</sup>): 574.3645, found 574.3655; HPLC purity 99%.</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> <i>N</i>-{6-[(1,2,3,4-Tetrahydroacridin-9-yl)amino]hexyl}-2-(6-hydroxy-7-methoxy-2-methylchroman-2-yl)acetamide (<b>12e</b>)</h4><div class="NLM_p">It was prepared as described for <b>12a</b>. From <b>11e</b> (43 mg, 0.07 mmol), amide <b>12e</b> (35 mg, 99% yield) was isolated as a light yellow solid; <i>R</i><sub><i>f</i></sub> 0.27 (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH 95:5:1).</div><div class="NLM_p last"><b>12e</b>·HCl: light yellow solid; mp 117–120 °C; IR (ATR) ν 3600–2200 (max at 3236, 3081, 2930, 2856, N–H, N<sup>+</sup>–H, O–H, C–H st), 1633, 1573, 1519 (C═O, Ar–C–C, Ar–C–N st) cm<sup>–1</sup>; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.29 (s, 3H, 2-CH<sub>3</sub>), 1.34–1.46 (complex signal, 4H, 3′-H<sub>2</sub>, 4′-H<sub>2</sub>), 1.52 (tt, <i>J</i> = <i>J</i>′ = 6.8 Hz, 2H, 2′-H<sub>2</sub>), 1.70–1.81 (complex signal, 3H, 3-H<sub>A</sub>, 5′-H<sub>2</sub>), 1.89 (m, 1H, 3-H<sub>B</sub>), 1.93–2.01 (complex signal, 4H, 2″-H<sub>2</sub>, 3″-H<sub>2</sub>), 2.43 (d, <i>J</i> = 13.2 Hz, 1H, 2-CH<sub>A</sub>-CO), 2.49 (d, <i>J</i> = 13.2 Hz, 1H, 2-CH<sub>B</sub>-CO), 2.59 (m, 2H, 4-H<sub>2</sub>), 2.68 (t, <i>J</i> = 5.6 Hz, 2H, 1″-H<sub>2</sub>), 3.00 (t, <i>J</i> = 6.0 Hz, 2H, 4″-H<sub>2</sub>), 3.20 (m, 2H, 1′-H<sub>2</sub>), 3.72 (s, 3H, 7-OCH<sub>3</sub>), 3.85 (t, <i>J</i> = 7.6 Hz, 2H, 6′-H<sub>2</sub>), 4.85 (s, NH, <sup>+</sup>NH, OH), 6.32 (s, 1H, 8-H), 6.41 (s, 1H, 5-H), 7.57 (ddd, <i>J</i> = 8.8 Hz, <i>J</i>′ = 7.2 Hz, <i>J</i>″ = 1.2 Hz, 1H, 7″-H), 7.73 (dd, <i>J</i> = 8.4 Hz, <i>J</i>′ = 1.2 Hz, 1H, 5″-H), 7.84 (ddd, <i>J</i> = 8.4 Hz, <i>J</i>′ = 7.2 Hz, <i>J</i>″ = 1.2 Hz, 1H, 6″-H), 8.34 (br d, <i>J</i> = 8.8 Hz, 1H, 8″-H); <sup>13</sup>C NMR (100.6 MHz, CD<sub>3</sub>OD) δ 21.8 (CH<sub>2</sub>, C3″), 22.4 (CH<sub>2</sub>, C4), 23.0 (CH<sub>2</sub>, C2″), 24.5 (CH<sub>3</sub>, 2-CH<sub>3</sub>), 24.8 (CH<sub>2</sub>, C1″), 27.3 (CH<sub>2</sub>), 27.4 (CH<sub>2</sub>) (C3′, C4′), 29.3 (CH<sub>2</sub>, C4″), 30.2 (CH<sub>2</sub>, C2′), 31.4 (CH<sub>2</sub>, C5′), 32.2 (CH<sub>2</sub>, C3), 40.1 (CH<sub>2</sub>, C1′), 47.5 (CH<sub>2</sub>, 2-<i>C</i>H<sub>2</sub>-CO), 49.0 (CH, C6′), 56.4 (CH<sub>3</sub>, 7-OCH<sub>3</sub>), 75.1 (C, C2), 102.2 (CH, C8), 112.8 (C, C9a″), 113.4 (C, C4a), 116.1 (CH, C5), 117.0 (C, C8a″), 120.1 (CH, C5″), 126.3 (CH, C7″), 126.5 (CH, C8″), 134.0 (CH, C6″), 139.8 (C, C10a″), 141.1 (C, C6), 147.4 (C, C8a), 148.3 (C, C7), 151.6 (C, C4a″), 157.9 (C, C9″), 172.6 (C, CONH); HRMS (ESI) calcd for (C<sub>32</sub>H<sub>41</sub>N<sub>3</sub>O<sub>4</sub>+ H<sup>+</sup>): 532.3175, found 532.3165; HPLC purity 99%.</div></div><div id="sec4_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 2-(6-Hydroxy-7-methoxy-2-methylchroman-2-yl)ethyl <i>p</i>-Toluenesulfonate (<b>15</b>)</h4><div class="NLM_p last">A solution of O-benzyl-protected tosylate <b>16</b> (1.07 g, 2.22 mmol) in THF (15 mL) was added to a suspension of 10% w/w Pd/C (110 mg) in degassed THF (2 mL) under an argon atmosphere. The resulting mixture was stirred under 1 atm of H<sub>2</sub> overnight, then filtered through a plug of Celite, and washed with THF (3 × 5 mL). The filtrate was evaporated at reduced pressure to yield tosylate <b>15</b> (782 mg, 90% yield) as a light green solid; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.23 (s, 3H, 2-CH<sub>3</sub>), 1.72 (m, 2H, 3-H<sub>2</sub>), 1.91 (m, 1H), 1.99 (m, 1H) (2-C<i>H</i><sub>2</sub>-CH<sub>2</sub>-OTs), 2.43 (s, 3H, tosyl CH<sub>3</sub>), 2.62 (m, 2H, 4-H<sub>2</sub>), 3.80 (s, 3H, 7-OCH<sub>3</sub>), 3.97 (m, 2H, 2-CH<sub>2</sub>-C<i>H</i><sub>2</sub>-OTs), 6.25 (s, 1H, 8-H), 6.56 (s, 1H, 5-H), 7.31 [d, <i>J</i> = 8.0 Hz, 2H, tosyl 3(5)-H], 7.76 [d, <i>J</i> = 8.0 Hz, 2H, tosyl 2(6)-H]; <sup>13</sup>C NMR (100.6 MHz, CDCl<sub>3</sub>) δ 21.4 (CH<sub>3</sub>, tosyl CH<sub>3</sub>), 21.8 (CH<sub>2</sub>, C4), 24.2 (CH<sub>3</sub>, 2-CH<sub>3</sub>), 31.7 (CH<sub>2</sub>, C3), 38.2 (CH<sub>2</sub>, 2-<i>C</i>H<sub>2</sub>-CH<sub>2</sub>-OTs), 56.0 (CH<sub>3</sub>, 7-OCH<sub>3</sub>), 67.6 (CH<sub>2</sub>, 2-CH<sub>2</sub>-<i>C</i>H<sub>2</sub>-OTs), superimposed with solvent signal 76.7 (C, C2), 100.5 (CH, C8), 112.3 (C, C4a), 114.2 (CH, C5), 128.0 (CH), 129.9 (CH) (tosyl CH), 133.2 (C, tosyl C4), 139.4 (C, tosyl C1), 144.9 (C, C6), 145.9 (C), 146.3 (C) (C7, C8a); HRMS (ESI) calcd for (C<sub>20</sub>H<sub>24</sub>O<sub>6</sub>S + H<sup>+</sup>): 393.1372, found 393.1336.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> In Vitro Biological Studies and Molecular Modeling</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> AChE and BChE Inhibition Assay</h4><div class="NLM_p last">The inhibitory activity of the target CR-6–chlorotacrine hybrids toward human recombinant AChE and human serum BChE (Sigma, Milan, Italy) was evaluated spectrophotometrically by the method of Ellman et al.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The enzyme stock solutions were prepared by dissolving enzyme lyophilized powders in 0.1% Triton X-100/0.1 M potassium phosphate, pH 8.0 (for hAChE) or in 0.1% aq gelatin (for hBChE). The stock solutions of the target compounds (1 mM) were prepared in MeOH. The assay solution consisted of 340 μM 5,5′-dithiobis(2-nitrobenzoic acid) (DTNB), 0.02 unit/mL hAChE or hBChE, and 550 μM acetylthiocholine iodide (substrate for hAChE) or butyrylthiocholine iodide (substrate for hBChE) in 0.1 M potassium phosphate, pH 8.0. Assay solutions with and without the target compounds were preincubated at 37 °C for 20 min, before the addition of the substrate. Blank solutions containing all components except the enzymes were prepared in parallel to correct for nonenzymatic hydrolysis of the substrates. Initial rates were monitored at 412 nm with a Jasco V-530 double-beam spectrophotometer equipped with thermostated cuvette holders (37 °C). At least five increasing concentrations of the target compounds, which led to 20–80% inhibition of the enzymatic activities, were assayed. IC<sub>50</sub> values were calculated using Microcal Origin 3.5 software (Microcal Software, Inc.) and are expressed as mean ± standard error of the mean (SEM) of at least two experiments, each performed in triplicate.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> Kinetic Analysis of AChE Inhibition</h4><div class="NLM_p">To estimate the mechanism of action of hybrid <b>6b</b>, Lineweaver–Burk double reciprocal plots were constructed at a relatively low concentration of substrate (0.110–0.553 mM) using the same experimental conditions reported for the hAChE inhibition assay. The plots were assessed by a weighted least-squares analysis that assumed the variance of the velocity (<i>v</i>) to be a constant percentage of <i>v</i> for the entire data set. To confirm the mode of inhibition, the Cornish-Bowden plot was obtained by plotting <i>S</i>/<i>v</i> (substrate/velocity ratio) versus inhibitor concentration.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Data analysis was performed with GraphPad Prism 4.03 software (GraphPad Software Inc.). The mechanism of inhibition was assessed by two independent experiments, each performed in triplicate.</div><div class="NLM_p last">Calculation of the inhibitor constant (<i>K</i><sub>i</sub>) value was carried out by replotting slopes of lines from the Lineweaver–Burk plot versus the inhibitor concentration and <i>K</i><sub>i</sub> was determined as the intersect on the negative <i>x</i>-axis. The <i>K</i><sub>i</sub>′ (dissociation constant for the enzyme–substrate–inhibitor complex) value was determined by plotting the apparent 1/<i>v</i><sub>max</sub> versus inhibitor concentration.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> Propidium Displacement Studies</h4><div class="NLM_p last">The affinity of hybrid <b>6b</b> for the peripheral anionic site (PAS) of <i>Electrophorus electricus</i> AChE (EeAChE) (type VI-S, Sigma-Aldrich) was tested using propidium iodide (P) (Sigma-Aldrich), a known PAS-specific ligand as previously described by Taylor et al.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> A shift in the excitation wavelength follows the complexation of propidium iodide and AChE.<a onclick="showRef(event, 'cit53a'); return false;" href="javascript:void(0);" class="ref cit53a">(53a)</a> The fluorescence intensity was monitored by a Jasco 6200 spectrofluorometer (Jasco Europe, Italy) using a 0.5 mL quartz cuvette at rt. EeAChE (2 mM) was first incubated with 8 μM propidium iodide in 1 mM Tris–HCl, pH 8.0 at rt. The stock solution (4 mM) of the inhibitor was prepared in MeOH. In the back-titration experiments of the propidium–AChE complex by <b>6b</b>, aliquots of the tested inhibitor (8–56 μM, final concentration) were added successively, and fluorescence emission was monitored at 635 nm upon excitation at 535 nm. Blanks containing propidium alone, inhibitor plus propidium, and EeAChE alone were prepared, and fluorescence emission was determined. Raw data were processed following the method of Taylor and Lappi<a onclick="showRef(event, 'cit53b'); return false;" href="javascript:void(0);" class="ref cit53b">(53b)</a> to estimate <i>K</i><sub>D</sub> values assuming a dissociation constant value of propidium from EeAChE equals 0.7 μM.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a><i>K</i><sub>D</sub> values are expressed as mean ± standard deviation (SD) of three independent experiments.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> Molecular Modeling Studies</h4><div class="NLM_p">The PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Q83">1Q83</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5K5E">5K5E</a>, which correspond to the X-ray crystallographic structures of mouse AChE<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> and human BChE<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> enzymes, were chosen to build up the initial models of the complexes with the selected target compounds (<b>6b</b>, <b>12a</b>). The <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Q83">1Q83</a> structure was chosen for two reasons. First, the mouse enzyme is highly similar to the human AChE (97.5% sequence identity with hAChE), and, particularly, there is complete identity regarding the residues that shape the binding (catalytic, midgorge and peripheral) site. Second, the presence of the 3,8-diamino-6-phenyl-5-{6-{1-{2-[(1,2,3,4-tetrahydro-9-acridinyl)amino]ethyl}-1<i>H</i>-1,2,3-triazol-5-yl}hexyl}phenanthridinium (<i>syn</i>-TZ2PA6) ligand in <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Q83">1Q83</a> widens the peripheral site, which thus permitted a better accommodation of the target hybrids in the enzyme. A similar rationale motivated the choice of the X-ray structure <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5K5E">5K5E</a>, which contains the [(2<i>R</i>)-oxolan-2-yl]methyl-4-(9-ethylcarbazol-3-yl)-2-methyl-5-oxidanylidene-4,6,7,8 tetrahydro-1<i>H</i>-quinoline-3 carboxylate ligand, for BChE. The positioning of the chlorotacrine moiety of the selected hybrids in the catalytic site (and Tyr337, which exhibits a pronounced ligand-dependent conformation) was assisted by the X-ray structure <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1E66">1E66</a>, which corresponds to the complex of huprine X (containing a chlorotacrine moiety) bound to the <i>Torpedo californica</i> AChE enzyme<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and the complex of tacrine with human BChE (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BDS">4BDS</a>).<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a></div><div class="NLM_p">To achieve a suitable binding mode, compounds <b>6b</b> and <b>12a</b> were manually docked into the binding site of the two proteins following the same protocol reported in previous works.<a onclick="showRef(event, 'cit19c ref58'); return false;" href="javascript:void(0);" class="ref cit19c ref58">(19c,58)</a> Amber14<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> was used to perform MD simulations on the previously generated ligand–protein complexes previously generated by docking analysis. In this context, the general Amber force field (GAFF)<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> was used to parameterize the ligands, and the partial charges were derived at the HF/6-31G(d) level with Gaussian09,<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> after preliminary optimization of the molecular structure, using the restrained electrostatic potential (RESP)<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> fitting method implemented in Gaussian09 and Antechamber.</div><div class="NLM_p">Classical MD simulations were carried out to explore the stability of the complexes for both enantiomers of hybrids <b>6b</b> and <b>12a</b>. To check the structural integrity of the binding mode, MD simulations were run in triplicate for each enantiomeric species. For simulations with AChE, the protonation states reported in previous works were adopted.<a onclick="showRef(event, 'ref35 ref58'); return false;" href="javascript:void(0);" class="ref ref35 ref58">(35,58)</a> Protonation states for BChE at neutral pH were optimized in accordance with the p<i>K</i><sub>a</sub> values estimated by PROPKA.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></div><div class="NLM_p">All complexes were solvated with a truncated octahedral (TIP3P)<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> water box with a layer of 20 Å and neutralized by adding Na<sup>+</sup> (for AChE) or Cl<sup>–</sup> (for BChE) counterions. To maintain the protein structural integrity, the native water network around the chlorotacrine moiety, which mediates relevant interactions with the enzyme, was retained during generation of the starting protein–ligand models.</div><div class="NLM_p">The complexes were energy-minimized by following a three-stage protocol that involved first all hydrogen atoms, then water molecules, and finally all of the systems with a maximum number of minimization cycles of 10 000 for the latter stage. Prior to MD simulations, a preliminary equilibration of the system from 0 to 300 K was accomplished in six steps, the first being performed at constant volume and the rest at constant pressure. Inspection of the X-ray crystallographic structures of several tacrine-based dual binding site AChEIs revealed that the tacrine unit shares a common binding mode, which in turn mimics the pose found for the AChE and BChE complexes with tacrine.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Accordingly, suitable restraints were imposed to the interactions formed by the chlorotacrine moiety in the catalytic site during equilibration to avoid artefactual structural changes due to the accommodation of the rest of the hybrid compound along the enzyme’s gorge. These restraints were gradually reduced and finally eliminated during the first 15 ns of the MD production.</div><div class="NLM_p last">The SHAKE algorithm<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> was applied to constrain bonds involving hydrogen atoms. Periodic boundary conditions at constant volume were imposed on the system during the MD simulations. Cutoff for the nonbonded interactions was set to 10 Å. The electrostatic interactions beyond the cutoff within the periodic box were computed by applying the particle mesh Ewald (PME) method.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> Langevin dynamics with a collision frequency of 1.0 was applied for temperature regulation during the heating. Finally, 50 ns of MD simulations at constant volume and temperature (300 K) using the weak-coupling algorithm<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> with a time constant of 10.0 were run in triplicate for a total of 150 ns for AChE–(<i>R</i>)-<b>6b</b>, AChE–(<i>S</i>)-<b>6b</b>, BChE–(<i>R</i>)-<b>6b</b>, BChE–(<i>S</i>)-<b>6b</b>, BChE–(<i>R</i>)-<b>12a</b>, and BChE–(<i>S</i>)-<b>12a</b> complexes. The time step for saving of trajectory was set to 2 ps. Evaluation of complex stability during MD simulations by means of RMSD analysis for the protein backbone and heavy atoms and for the binding site (protein environment around 8.0 Å from the ligand) as well as water electron density analysis (grid option in the cpptraj module) was performed using the CPPTRAJ module of Amber14.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> DPPH Assay for Antioxidant Activity</h4><div class="NLM_p">The 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical assay<a onclick="showRef(event, 'ref36 ref69'); return false;" href="javascript:void(0);" class="ref ref36 ref69">(36,69)</a> is a simple method to determine the antioxidant capacity. DPPH, trolox, and MeOH were purchased from Sigma-Aldrich (Spain). Following the standard procedure, 2 mL of the antioxidant solution at different concentrations (from 0 to 120 μM) in previously degassed MeOH was mixed with 2 mL of a 140 μM DPPH methanolic solution. After stirring at rt in the absence of light for 1 h, the absorbance was measured at 515 nm in a SpectraMax M5 instrument (Molecular Devices, Sunnyvale) using quartz cuvettes. CR-6 (<b>1</b>) was used as the positive control, and the absorbance of MeOH was measured as a blank. The percentage of absorbance decrease of the DPPH radical (%<i>I</i>) was calculated using the following expression: <i>I</i> (%) = (<i>A</i><sub>0</sub> – <i>A</i><sub>t</sub>/<i>A</i><sub>0</sub>) × 100, where <i>A</i><sub>0</sub> and <i>A</i><sub>t</sub> represent the absorbance of DPPH in the absence of antioxidant and in the presence of a fixed antioxidant concentration after 60 min, respectively.</div><div class="NLM_p last">The half-maximal inhibitory concentration (IC<sub>50</sub>) values were estimated from the corresponding dose–response curves, using computer software GraphPad Prism 5.03 for Windows (GraphPad Software, San Diego), and are expressed as mean ± standard deviation of single experiments performed in triplicate.</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> BACE-1 Inhibition Assay</h4><div class="NLM_p last">The inhibitory activity of the target CR-6–chlorotacrine hybrids toward human recombinant BACE-1 (β-secretase, Invitrogen) was evaluated by employing Panvera peptide as the substrate.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> The substrate (10 μL, 250 nM final concentration) was added to 10 μL of the solution of the target compounds or buffer in control wells (20 mM NaOAc, pH 4.5, containing 0.1% w/v 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS)). The BACE-1 enzyme (10 μL, 12.91 mU) was added to start the reaction. The enzyme was left to react at 37 °C for 1 h. The fluorescence signal was read at λ<sub>em</sub> = 544 nm (λ<sub>ex</sub> = 590 nm) after adding 10 μL of STOP solution (2.5 M NaOAc). The dimethyl sulfoxide (DMSO) concentration in the final mixture was maintained below 5% (v/v) to guarantee no significant loss of enzyme activity. The fluorescence intensities with and without inhibitor were compared, and the percent of inhibition due to the presence of the target compounds was calculated. The background signal was measured in control wells that contained all of the reagents, except BACE-1, and was subtracted. The percent of inhibition due to the presence of increasing concentrations of the test compounds was calculated by the following expression: 100 – (IF<sub>i</sub>/IF<sub>o</sub> × 100), where IF<sub>i</sub> and IF<sub>o</sub> are the fluorescence intensities obtained for BACE-1 in the presence and in the absence of inhibitor, respectively. The IC<sub>50</sub> values were extrapolated from the corresponding dose–response curves. Results are expressed as mean ± standard error of the mean (SEM) of at least two experiments, each performed in triplicate. Data analysis was performed with GraphPad Prism 4.03 software (GraphPad Software Inc.).</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> Aβ42 and Tau Aggregation Inhibition Assay in <i>E. coli</i> Cells</h4><div class="NLM_p">The Aβ42 and tau antiaggregating activities of the target compounds were assessed in <i>E. coli</i> cells, as previously described.<a onclick="showRef(event, 'ref20 ref39'); return false;" href="javascript:void(0);" class="ref ref20 ref39">(20,39)</a><i>E. coli</i> BL21 (DE3) competent cells were transformed with the pET28a vector (Novagen, Inc., Madison, WI), which carries the DNA sequence of Aβ42, or with pTARA, which contains the RNA-polymerase gene of T7 phage (T7RP) under the control of the promoter PBAD, and were then transformed with the pRKT42 vector, encoding four repeats of tau protein in two inserts. M9 minimal medium (10 mL) containing 50 μg/mL kanamycin (for Aβ42 overexpression) or 0.5% of glucose, 50 μg/mL ampicillin, and 12.5 μg/mL chloramphenicol (for tau overexpression) was inoculated with a colony of BL21 (DE3) cells bearing the plasmids. To fresh M9 minimal medium containing 50 μg/mL kanamycin and 250 μM Th-S (for Aβ42 assay) or 0.5% of glucose, 50 μg/mL ampicillin, 12.5 μg/mL chloramphenicol, and 250 μM Th-S (for tau assay), the volume of overnight culture necessary to get a 1:500 dilution was added. The cultures were grown at 37 °C and 250 rpm overnight until cell density reached OD<sub>600</sub> = 0.6. A volume of 980 μL of the cultures was transferred into 1.5 mL Eppendorf tubes that contained 10 μL of a solution of the target compound in DMSO and 10 μL of isopropyl 1-thio-β-<span class="smallcaps smallerCapital">d</span>-galactopyranoside (IPTG) at 100 mM (for Aβ42 assay) or 10 μL of arabinose at 25% (for tau assay), leading to a final inhibitor concentration of 10 μM. The resulting cultures were grown at 37 °C and 1400 rpm with a thermomixer (Eppendorf, Hamburg, Germany) overnight. The same amount of DMSO without the target compound was added to the sample as a negative control (maximal amount of Aβ42 or tau), whereas noninduced samples (in the absence of IPTG or arabinose) were prepared as positive controls (absence of Aβ42 or tau) and to assess the potential intrinsic toxicity of the target compounds.</div><div class="NLM_p last">The inhibitory activity of the target compounds on Aβ42 or tau aggregation was assessed by a previously reported fluorescence assay,<a onclick="showRef(event, 'ref20 ref39'); return false;" href="javascript:void(0);" class="ref ref20 ref39">(20,39)</a> using a 2500 mM stock solution of thioflavin-S (Th-S, T1892, Sigma, St. Louis, MO) in double-distilled water (Milli-Q system, Millipore) and measuring the Th-S spectra on an Aminco-Bowman series 2 luminescence spectrophotometer (Aminco-Bowman AB2, SLM Aminco, Rochester, NY) in the range 460–600 nm at 25 °C, with an excitation wavelength of 440 nm, slit widths of 4 nm, and an emission wavelength of 485 nM. The results are the average of nine independent experiments, each performed in duplicate. As a positive control, we used DP128, a known Aβ42 and tau antiaggregating compound,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> for which percentages of inhibition of 68.2 ± 2.1 and 72.2 ± 2.1, respectively, were obtained.</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> PAMPA-BBB Assay for Brain Permeability</h4><div class="NLM_p last">The brain permeability (<i>P</i><sub>e</sub>) of the target compounds was assessed by the in vitro parallel artificial membrane permeability assay, for blood–brain barrier penetration, of Di et al.,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> using a lipid extract of porcine brain membrane in a mixture phosphate-buffered saline (PBS)/EtOH 70:30. After assay validation by comparison of the experimental and reported <i>P</i><sub>e</sub> values of a set of 14 commercial drugs (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_001.pdf" class="ext-link">Table S1</a> of the Supporting Information), the following correlation was obtained: <i>P</i><sub>e</sub> (exp) = 1.5758<i>P</i><sub>e</sub> (lit) – 1.1459 (<i>R</i><sup>2</sup> = 0.9241). From this equation and considering the limits established by Di et al. for BBB permeation,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> the threshold for high BBB permeation (CNS+) was set at <i>P</i><sub>e</sub> (10<sup>–6</sup> cm s<sup>–1</sup>) > 5.16, whereas the range for low BBB permeation (CNS−) was set at <i>P</i><sub>e</sub> (10<sup>–6</sup> cm s<sup>–1</sup>) < 2.01 and that for uncertain BBB permeation (CNS±) at 5.16 > <i>P</i><sub>e</sub> (10<sup>–6</sup> cm s<sup>–1</sup>) > 2.01. Three independent experiments, each performed in triplicate, were carried out for each compound.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> In Vivo Efficacy Studies</h3><div id="sec4_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> Animals</h4><div class="NLM_p last">The experiments were carried out on male APP/PS1 mice<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> and wild-type (WT) littermates (C57Bl6J background, bred in own colony located in the University of Barcelona animal facilities) aged 6 months at the beginning of the study. The University of Barcelona Committee on Animal Use and Care approved the protocol (number 411/18). Following the approved experimental protocol, all animals were supervised daily to assess signs of adverse effects during the treatment. A retrospective analysis of the protocol demonstrated that no corrective measures (i.e., use of analgesics) were needed. Animals were housed and tested in compliance with the guidelines provided by the Guide for the Care and Use of Laboratory Animals<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> and following the European Union directives (2010/63/EU). Animals were maintained under standard animal housing conditions in a normal 12 h dark–light cycle with free access to food and water.</div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> Acute Toxicity Studies and Dose Selection</h4><div class="NLM_p last">A preliminary study was performed to evaluate the acute toxicity of the novel hybrids <b>4b</b> and <b>11b</b> and to select the dose to be used in the chronic efficacy studies. Three doses (5, 10, and 15 mg/kg) of <b>4b</b> and <b>11b</b> were prepared by dissolving the novel hybrids in 1% DMSO and 99% saline. Then, they were injected intraperitoneally (ip) in a volume of 10 mL/kg body weight to male WT mice aged 6 months (<i>n</i> = 4 per compound and dose, total number of animals = 24). Animals were observed by experimented researchers blind to the treatment for the appearance of any physical sign 5 min, 10 min, 15 min, 30 min, 1 h, 2 h, 3 h, 6 h, 8 h, and 24 h after drug administration.</div></div><div id="sec4_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> Chronic Pharmacological Treatment</h4><div class="NLM_p last">The novel hybrids <b>4b</b> and <b>11b</b> (10 mg/kg) were dissolved in 1% DMSO and 99% saline and were injected intraperitoneally (ip) in a volume of 10 mL/kg body weight. Animals were treated once daily for 4 weeks with compounds <b>4b</b> and <b>11b</b> or the corresponding vehicle (WT vehicle, <i>n</i> = 6; WT <b>4b</b>, <i>n</i> = 5; WT <b>11b</b>, <i>n</i> = 6; APP/PS1 vehicle, <i>n</i> = 5; APP/PS1 <b>4b</b>, <i>n</i> = 7; APP/PS1 <b>11b</b>, <i>n</i> = 6). After 2 days of washing period, animals were subjected to behavioral evaluation.</div></div><div id="sec4_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> Behavioral Evaluation of Cognitive Performance</h4><div class="NLM_p last">Memory performance was evaluated with the two-object recognition test. On day 1, mice were placed for 9 min in a V-maze, in which two identical objects were situated at the ends of the arms; the time that the mice spent exploring each object was recorded. Then, 24 h after the training session, animals were placed again for 9 min in the V-maze, with one of the two familiar objects replaced by a novel object. The time that the animals spent exploring the two objects was recorded, and an object recognition index (RI) was calculated as the difference between the time spent exploring the novel object (<i>T</i><sub>N</sub>) and the familiar object (<i>T</i><sub>F</sub>) divided by the total time spent exploring the two objects [RI = (<i>T</i><sub>N</sub> – <i>T</i><sub>F</sub>)/(<i>T</i><sub>N</sub> + <i>T</i><sub>F</sub>)]. Animals exhibiting memory impairments revealed a lower object recognition index.</div></div><div id="sec4_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> Tissue Collection</h4><div class="NLM_p last">At the end of the behavioral testing, the animals were sacrificed and their brains were removed. One brain hemisphere was dissected on ice, immediately frozen, and stored at −80 °C until processing for the protein or RNA quantification. The other brain hemisphere was fixed in 4% paraformaldehyde and processed for immunohistochemistry.</div></div><div id="sec4_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> Aβ Immunohistochemistry</h4><div class="NLM_p last">Tissue samples were embedded in paraffin, and coronal sections (4 μm) were cut with a microtome. Dewaxed sections were incubated with 98% formic acid (3 min) and then treated with citrate buffer (20 min) to enhance antigenicity. Then, the endogenous peroxidases were blocked by incubation in 10% MeOH–1% H<sub>2</sub>O<sub>2</sub> solution (15 min). Sections were blocked with 3% normal horse serum solution and then incubated at 4 °C overnight with the primary antibody against Aβ (1:50, Dako, Clone 6F/3D). Sections were subsequently rinsed and incubated with a biotinylated secondary antibody (Dako), followed by EnVision+ system peroxidase (Dako) and finally with the chromogen diaminobenzidine and H<sub>2</sub>O<sub>2</sub>. Sections were lightly counterstained with hematoxylin. After staining, the sections were dehydrated and cover-slipped for microscopic observation. The Aβ burden in the cortex was calculated as the percentage of the Aβ deposition area with respect to the total area in nine representative pictures by each animal, corresponding to the main regions where Aβ deposition was observed in APP/PS1 mice. Sections from all of the APP/PS1 animals were evaluated using the Analysis tool of Adobe Photoshop CS4 software.</div></div><div id="sec4_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> Aβ Soluble Quantification: Enzyme-Linked Immunosorbent Assay (ELISA)</h4><div class="NLM_p last">Fresh-frozen mouse brain cortex was homogenized in 4 volumes (w/v) of TBS extraction buffer (140 mM NaCl, 3 mM KCl, 25 mM Tris (pH 7.4), 5 mM ethylenediaminetetraacetic acid (EDTA), and protease inhibitor cocktail (Roche Molecular Systems)). The homogenate was spun at 100 000<i>g</i> × 1 h, and the supernatant was saved as the soluble fraction for Aβ quantification. Aβ<sub>40</sub> and Aβ<sub>42</sub> Human ELISA kits (Invitrogen Corporation) were used to quantify the levels of Aβ<sub>40</sub> and Aβ<sub>42</sub> peptides in the brain soluble fractions. Quantitative determination was carried out according to the manufacturer’s instructions. Aβ<sub>40</sub> and Aβ<sub>42</sub> levels were normalized to the total amount of protein from each individual sample (BCA method, Thermo Fisher Scientific).</div></div><div id="sec4_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> Protein Oxidation Quantification</h4><div class="NLM_p last">The levels of the carbonyl groups introduced into proteins by oxidative reactions were measured using the OxyBlot protein oxidation detection kit (S7150, Merck Millipore) following the manufacturer’s instructions. Briefly, frozen samples of the cortex were homogenized in Laemmli buffer (62.5 mM Tris–Cl, pH 6.8, containing 2% sodium dodecyl sulfate (SDS), 10% glycerol, 0.002% bromophenol blue, and 50 mM DTT). Protein concentration was determined with the bicinchoninic acid (BCA) method. Equal amounts of protein (20 μg) for each sample were prepared for derivatization. The carbonyl groups in the protein side chains were derivatized to 2,4-dinitrophenylhydrazone (DNP-hydrazone) by reaction with 2,4-dinitrophenylhydrazine (DNPH). The DNP-derivatized protein samples were loaded and separated by electrophoresis on sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) (10%) gels and transferred onto PVDF membranes (Amersham, Germany). Nonspecific bindings were blocked by incubation in 3% nonfat milk in PBS containing 0.2% Tween for 1 h at room temperature. After washing, membranes were incubated overnight at 4 °C with the primary antibody against the DNP moiety of the proteins. Protein loading was monitored using an antibody against β-tubulin (1:10 000, Abcam, U.K.). Membranes were then incubated for 1 h with an anti-rabbit horseradish peroxidase (HRP)-conjugated secondary antibody (1:2000, Dako), and immunocomplexes were revealed by chemiluminescence reagent (ECL, Amersham). Densitometric quantification was carried out with ImageJ software (NIH). Bands were normalized to β-tubulin.</div></div><div id="sec4_2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> SOD2 and Aβ Double-Immunofluorescence</h4><div class="NLM_p last">Dewaxed sections were stained with a saturated solution of Sudan black B (Merck) for 30 min to block the autofluorescence of lipofuscin granules present in cell bodies, then rinsed in 70% EtOH, and washed in distilled water. The sections were treated with 98% formic acid (3 min) and with citrate buffer to enhance antigenicity and then incubated at 4 °C overnight with combinations of primary antibodies against Aβ (1:50, Dako) and the enzyme superoxide dismutase type 2 (SOD2, 1:500, Stressgen-Gentaur, Belgium). After washing, the sections were incubated with Alexa488 or Alexa546 (1:400, Molecular Probes) fluorescence secondary antibodies against the corresponding host species. After washing, the sections were mounted in Immuno-Fluore mounting medium (ICN Biomedicals), sealed, and dried overnight. Sections were examined with an Olympus BX51 microscope, and five representative pictures taken from the cortex of each animal (<i>n</i> = 5 per group) were subjected to densitometric quantification using the Adobe Photoshop CS4 software. The SOD2 immunostaining was in reference to the Aβ plaque area in each picture.</div></div><div id="sec4_2_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> Western Blotting Analysis</h4><div class="NLM_p last">Tissue samples were homogenized in lysis buffer (Tris–HCl, pH 7.4, 50 mM; NaCl 150 mM; EDTA 5 mM; and 1× Triton X-100) containing phosphatase and protease inhibitors (Cocktail II, Sigma). The protein concentration was determined by the Bradford method. Aliquots of 15 μg of cortical protein extraction per sample were used. Protein samples were separated by SDS-PAGE (8–14%) and transferred onto poly(vinylidene difluoride) (PVDF) membranes (Millipore). Afterward, membranes were blocked in 5% nonfat milk in Tris-buffered saline (TBS) solution containing 0.1% Tween 20 for 1 h at room temperature, followed by overnight incubation at 4 °C with the primary antibody listed in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_001.pdf" class="ext-link">Table S2</a> of the Supporting Information. Then, membranes were washed and incubated with the secondary antibody (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_001.pdf" class="ext-link">Table S2</a>) for 1 h at room temperature. Immunoreactive proteins were visualized with the chemiluminescence-based ChemiLucent detection kit, following the manufacturer’s protocol (ECL kit, Millipore), and digital images were acquired using the ChemiDoc XRS+ system (BioRad). Semiquantitative analyses were done using ImageLab software (BioRad), and results were expressed in arbitrary units, considering control protein levels as 100%. Protein loading was routinely monitored by immunodetection of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) or β-tubulin.</div></div><div id="sec4_2_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> RNA Extraction and Gene Expression Determination by Quantitative Polymerase Chain Reaction (qPCR)</h4><div class="NLM_p last">Total RNA isolation was carried out using the TRIsure reagent according to the manufacturer’s instructions (Bioline reagent, U.K.). The yield, purity, and quality of RNA were determined spectrophotometrically with a NanoDrop ND-1000 (Thermo Scientific) apparatus. RNAs with A260/280 ratios higher than 1.9 were selected. Reverse-transcription polymerase chain reaction (RT-PCR) was performed as follows: 2 μg of messenger RNA (mRNA) was reverse-transcribed using a high-capacity complementary DNA (cDNA) reverse transcription kit (Applied Biosystems). Real-time quantitative PCR (qPCR) was used to quantify the mRNA expression of oxidative stress and inflammatory genes listed in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_001.pdf" class="ext-link">Table S3</a> of the Supporting Information. SYBRGreen qPCR was performed in a Step One Plus detection system (Applied Biosystems) employing SYBRGreen PCR master mix (Applied Biosystems). Each reaction mixture contained 2 μg of complementary DNA (cDNA). Data were analyzed utilizing the comparative cycle threshold (Ct) method (ΔΔCt), where the housekeeping gene expression (β-actin) was used to normalize differences in sample loading and preparation. Each sample was analyzed in duplicate, and results represented the n-fold difference of transcription levels among different samples.</div></div><div id="sec4_2_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> Statistical Analyses</h4><div class="NLM_p last">Behavioral, western blotting, and qPCR data were analyzed by two-way ANOVA with genotype and treatment as between factors, followed by Tukey’s post hoc test or two-tailed Student’s t-test when required. Aβ and SOD2 quantifications were analyzed by one-way ANOVA. The statistical outliers were determined with Grubbs’ test and subsequently removed from the analysis. In all of the experiments, the significance level was set at <i>p</i> < 0.05.</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Plasma and Microsomal Stability and Metabolite Identification</h3><div id="sec4_2_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> Stability at Human, Mouse, and Rat Plasma</h4><div class="NLM_p">Human, mouse, and rat plasma pooled from healthy donors, extracted in citrate tubes, was employed in the assay. Plates containing 10 μM compound <b>4b</b> in plasma (total volume: 50 μL) were incubated at 37 °C at different times (0, 60, 180, and 360 min). Then, acetonitrile (100 μL) was added for precipitating plasma protein, and the plate was centrifuged at 46000<i>g</i> for 60 min at 5 °C. The supernatant was taken and analyzed by UPLC-MS/MS for sample quantification, using reverse-phase Acquity UPLC BEH C18 1.7 μm (2.1 mm × 50 mm, Waters) as the stationary phase, 0.1% formic acid in water (A)/0.1% formic acid in acetonitrile (B) as the mobile phase, a flow of 0.6 mL/min, and the gradient indicated in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Gradient Used in the UPLC-MS/MS Analysis for Plasma Stability Studies</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">time (min)</th><th class="colsep0 rowsep0" align="center" char=".">A (%)</th><th class="colsep0 rowsep0" align="center" char=".">B (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">95</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="char" char=".">95</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">2.1</td><td class="colsep0 rowsep0" align="char" char=".">95</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char=".">95</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr></tbody></table></div></div><div class="NLM_p last">The chromatographic equipment employed was a Waters Acquity UPLC QSM. Compound concentrations were calculated from the MS peak areas. Values are expressed as the mean of two independent experiments, each performed in triplicate.</div></div><div id="sec4_2_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> Stability at Human, Mouse, and Rat Liver Microsomes</h4><div class="NLM_p">Human, mouse, and rat microsomes from Tebu-Xenotech were employed in the assay, containing 20 mg/mL protein.</div><div class="NLM_p">The quantities of reagents, microsomes, and compound <b>4b</b> detailed in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a> were added to each well of a 96-well microplate.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Quantities of Reagents, Microsomes, and Compound <b>4b</b> Used in the Microsomal Stability Assays</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left"> </th><th class="colsep0 rowsep0" align="center" char=".">blank (μL)</th><th class="colsep0 rowsep0" align="center" char=".">human (μL)</th><th class="colsep0 rowsep0" align="center" char=".">mouse (μL)</th><th class="colsep0 rowsep0" align="center" char=".">rat (μL)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">phosphate buffer Na/K 50 mM pH 7.4</td><td class="colsep0 rowsep0" align="char" char=".">295</td><td class="colsep0 rowsep0" align="char" char=".">283.5</td><td class="colsep0 rowsep0" align="char" char=".">301.3</td><td class="colsep0 rowsep0" align="char" char=".">301.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MgCl<sub>2</sub> 30 mM</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NADP 10 mM</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">glucose 6-P 100 mM</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">glucose 6-P DH 20 U/mL</td><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="char" char=".">25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">water</td><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human microsomes</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">36.5</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse microsomes</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">18.7</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat microsomes</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">18.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">compound <b>4b</b> 5 μM</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr></tbody></table></div></div><div class="NLM_p">Plates were incubated at 37 °C, and samples (75 μL) were taken at 0, 10, 20, 40, and 60 min. Samples were transferred to a microplate followed by successive addition of acetonitrile (75 μL) and H<sub>2</sub>O (30 μL) for inactivating the microsomes and for improving the chromatographic conditions, respectively, and were kept at 4 °C. When all of the samples were taken, the plate was centrifuged at 46 000<i>g</i> for 30 min at 15 °C. The supernatant was taken and was analyzed in a UPLC-MS/MS system, using reverse-phase Acquity UPLC BEH C18 1.7 μm (2.1 mm × 50 mm, Waters) as the stationary phase, 0.1% formic acid in water (A)/0.1% formic acid in acetonitrile (B) as the mobile phase, a flow of 0.6 mL/min, and the gradient indicated in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Gradient Used in the UPLC-MS/MS Analysis for Microsomal Stability Studies</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">time (min)</th><th class="colsep0 rowsep0" align="center" char=".">A (%)</th><th class="colsep0 rowsep0" align="center" char=".">B (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">95</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="char" char=".">95</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">2.6</td><td class="colsep0 rowsep0" align="char" char=".">95</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">95</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr></tbody></table></div></div><div class="NLM_p last">The chromatographic equipment employed was a Waters Acquity UPLC QSM. Compound concentrations were calculated from the MS peak areas. Metabolic stability was calculated from the logarithm of the remaining compound at each of the times evaluated. Values are expressed as the mean of two independent experiments, each performed in triplicate.</div></div><div id="sec4_2_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> Metabolite Identification in Human, Mouse, and Rat Liver Microsomes</h4><div class="NLM_p">The supernatants of the microsomal stability assays with human, mouse, and rat liver microsomes were analyzed using a UPLC-MS/MS system consisting of a Waters Acquity H-Class UPLC and a Xevo TQ-D triple quadrupole mass spectrometer, equipped with an electrospray ionization (ESI) source (Waters Corporation, Milford, MA). Chromatographic separation was achieved using an Acquity UPLC BEH C18 (1.7 μm, 2.1 mm × 50 mm) column, with a UPLC mobile phase A consisting of 0.1% formic acid in water, a mobile phase B consisting of 0.1% formic acid in acetonitrile, the gradient indicated in <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>, and an injection volume of 4 μL.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Gradient Used in the UPLC-MS/MS Analysis for Metabolite Identification</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">time (min)</th><th class="colsep0 rowsep0" align="center" char=".">A (%)</th><th class="colsep0 rowsep0" align="center" char=".">B (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">95</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="char" char=".">95</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">2.1</td><td class="colsep0 rowsep0" align="char" char=".">95</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">95</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr></tbody></table></div></div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i77"><a href="/doi/suppl/10.1021/acs.jmedchem.0c00528" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02582" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02582" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c00528?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00528</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">RMSD analyses of the binding of <b>6b</b> to hAChE and hBChE and of <b>12a</b> to hBChE; MD-averaged <b>6b</b>–hBChE complexes; PAMPA-BBB permeabilities of commercial drugs used for assay validation; antibodies and primers used in Western blot and qPCR studies; relative MS peak areas in the identification of metabolites in human, mouse, and rat liver microsomes; binding mode of the <i>p</i>-benzoquinone metabolite of <b>4b</b> within hAChE; and copies of <sup>1</sup>H and <sup>13</sup>C NMR spectra and HPLC chromatograms of target compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_002.xls" class="ext-link">XLS</a>)</p></li><li><p class="inline">FigS2A_R_pose1 (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_003.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">FigS2A_R_pose2 (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_004.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">FigS2A_R_pose3 (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_005.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">FigS2B_S_pose1 (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_006.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">FigS2B_S_pose2 (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_007.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">FigS2B_S_pose3 (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_008.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Fig3A_R-6b+AChE (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_009.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Fig3B_S-6b+AChE (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_010.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Fig4A_R-12a+BChE (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_011.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">Fig4B_S-12a+BChE (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_012.pdb" class="ext-link">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_001.pdf">jm0c00528_si_001.pdf (5.92 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_002.xls">jm0c00528_si_002.xls (26.0 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_003.pdb">jm0c00528_si_003.pdb (664.14 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_004.pdb">jm0c00528_si_004.pdb (664.14 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_005.pdb">jm0c00528_si_005.pdb (664.14 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_006.pdb">jm0c00528_si_006.pdb (664.14 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_007.pdb">jm0c00528_si_007.pdb (664.14 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_008.pdb">jm0c00528_si_008.pdb (664.14 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_009.pdb">jm0c00528_si_009.pdb (661.93 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_010.pdb">jm0c00528_si_010.pdb (661.93 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_011.pdb">jm0c00528_si_011.pdb (663.75 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_012.pdb">jm0c00528_si_012.pdb (663.75 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c00528" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38737" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38737" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Diego Muñoz-Torrero</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Medicinal Chemistry (CSIC Associated Unit), Faculty of Pharmacy
and Food Sciences, and Institute of Biomedicine (IBUB), University of Barcelona (UB), E-08028 Barcelona, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8140-8555" title="Orcid link">http://orcid.org/0000-0002-8140-8555</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#3e5a534b5051444a514c4c5b4c517e4b5c105b5a4b"><span class="__cf_email__" data-cfemail="6b0f061e0504111f0419190e19042b1e09450e0f1e">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">F. Javier Pérez-Areales</span> - <span class="hlFld-Affiliation affiliation">Laboratory
of Medicinal Chemistry (CSIC Associated Unit), Faculty of Pharmacy
and Food Sciences, and Institute of Biomedicine (IBUB), University of Barcelona (UB), E-08028 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">María Garrido</span> - <span class="hlFld-Affiliation affiliation">Department
of Biological Chemistry, Institute of Advanced
Chemistry of Catalonia (IQAC-CSIC), E-08034 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ester Aso</span> - <span class="hlFld-Affiliation affiliation">Department
of Pathology and Experimental Therapeutics, Neurosciences Institute, University of Barcelona (UB) and Bellvitge University
Hospital—IDIBELL, E-08908 L’Hospitalet de Llobregat, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Manuela Bartolini</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacy and Biotechnology, University
of Bologna, I-40126 Bologna, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2890-3856" title="Orcid link">http://orcid.org/0000-0002-2890-3856</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Angela De Simone</span> - <span class="hlFld-Affiliation affiliation">Department
of Drug Science and Technology, University
of Turin, I-10125 Torino, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alba Espargaró</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacy, Pharmaceutical Technology and Physical-Chemistry, Faculty
of Pharmacy and Food Sciences, and Institute of Nanoscience and Nanotechnology
(IN2UB), University of Barcelona (UB), E-08028 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tiziana Ginex</span> - <span class="hlFld-Affiliation affiliation">Department
of Nutrition, Food Science and Gastronomy, Faculty of Pharmacy and
Food Sciences, IBUB, and Institute of Theoretical and Computational
Chemistry (IQTC), University of Barcelona
(UB), E-08921 Santa Coloma de Gramenet, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Raimon Sabate</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacy, Pharmaceutical Technology and Physical-Chemistry, Faculty
of Pharmacy and Food Sciences, and Institute of Nanoscience and Nanotechnology
(IN2UB), University of Barcelona (UB), E-08028 Barcelona, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3894-2362" title="Orcid link">http://orcid.org/0000-0003-3894-2362</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Belén Pérez</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, Therapeutics, and Toxicology, Autonomous University of Barcelona, E-08193 Bellaterra, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vincenza Andrisano</span> - <span class="hlFld-Affiliation affiliation">Department
for Life Quality Studies, University of
Bologna, I-47921 Rimini, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4396-1904" title="Orcid link">http://orcid.org/0000-0003-4396-1904</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dolors Puigoriol-Illamola</span> - <span class="hlFld-Affiliation affiliation">Pharmacology
Section, Department of Pharmacology, Toxicology and Therapeutic Chemistry,
Faculty of Pharmacy and Food Sciences, and Institute of Neuroscience
(NeuroUB), University of Barcelona (UB), E-08028 Barcelona, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mercè Pallàs</span> - <span class="hlFld-Affiliation affiliation">Pharmacology
Section, Department of Pharmacology, Toxicology and Therapeutic Chemistry,
Faculty of Pharmacy and Food Sciences, and Institute of Neuroscience
(NeuroUB), University of Barcelona (UB), E-08028 Barcelona, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3095-4254" title="Orcid link">http://orcid.org/0000-0003-3095-4254</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">F. Javier Luque</span> - <span class="hlFld-Affiliation affiliation">Department
of Nutrition, Food Science and Gastronomy, Faculty of Pharmacy and
Food Sciences, IBUB, and Institute of Theoretical and Computational
Chemistry (IQTC), University of Barcelona
(UB), E-08921 Santa Coloma de Gramenet, Spain</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8049-3567" title="Orcid link">http://orcid.org/0000-0002-8049-3567</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">María Isabel Loza</span> - <span class="hlFld-Affiliation affiliation">BioFarma
Research Group, Centro Singular de Investigación en Medicina
Molecular y Enfermedades Crónicas (CIMUS), Universidade de Santiago de Compostela, Av. de Barcelona s/n, E-15782 Santiago de Compostela, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">José Brea</span> - <span class="hlFld-Affiliation affiliation">BioFarma
Research Group, Centro Singular de Investigación en Medicina
Molecular y Enfermedades Crónicas (CIMUS), Universidade de Santiago de Compostela, Av. de Barcelona s/n, E-15782 Santiago de Compostela, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Isidro Ferrer</span> - <span class="hlFld-Affiliation affiliation">Department
of Pathology and Experimental Therapeutics, Neurosciences Institute, University of Barcelona (UB) and Bellvitge University
Hospital—IDIBELL, E-08908 L’Hospitalet de Llobregat, Spain</span>; 
    <span class="hlFld-Affiliation affiliation">CIBERNED, E-28031 Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francisco Ciruela</span> - <span class="hlFld-Affiliation affiliation">Department
of Pathology and Experimental Therapeutics, Neurosciences Institute, University of Barcelona (UB) and Bellvitge University
Hospital—IDIBELL, E-08908 L’Hospitalet de Llobregat, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Angel Messeguer</span> - <span class="hlFld-Affiliation affiliation">Department
of Biological Chemistry, Institute of Advanced
Chemistry of Catalonia (IQAC-CSIC), E-08034 Barcelona, Spain</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e10995-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i79">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52032" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52032" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by Ministerio de Ciencia, Innovación y Universidades (MCIU), Agencia Estatal de Investigación (AEI) and FEDER (SAF2017-82771-R, MDM-2017-0767) and Generalitat de Catalunya (GC) (2017SGR106, 2017SGR1746). Fellowships from GC to F.J.P.-A. and from MCIU to D.P.-I. are gratefully acknowledged.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">β-amyloid peptide</p></td></tr><tr><td class="NLM_term">AChE</td><td class="NLM_def"><p class="first last">acetylcholinesterase</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">APP</td><td class="NLM_def"><p class="first last">amyloid precursor protein</p></td></tr><tr><td class="NLM_term">ATCh</td><td class="NLM_def"><p class="first last">acetylthiocholine</p></td></tr><tr><td class="NLM_term">BACE-1</td><td class="NLM_def"><p class="first last">β-site APP cleaving enzyme</p></td></tr><tr><td class="NLM_term">BChE</td><td class="NLM_def"><p class="first last">butyrylcholinesterase</p></td></tr><tr><td class="NLM_term">CAS</td><td class="NLM_def"><p class="first last">catalytic anionic site</p></td></tr><tr><td class="NLM_term">Cl-THA</td><td class="NLM_def"><p class="first last">6-chlorotacrine</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">DNP</td><td class="NLM_def"><p class="first last">2,4-dinitrophenyl</p></td></tr><tr><td class="NLM_term">DPPH</td><td class="NLM_def"><p class="first last">2,2-diphenyl-1-picrylhydrazyl</p></td></tr><tr><td class="NLM_term">DTNB</td><td class="NLM_def"><p class="first last">5,5′-dithiobis(2-nitrobenzoic acid)</p></td></tr><tr><td class="NLM_term">EeAChE</td><td class="NLM_def"><p class="first last"><i>E. electricus</i> acetylcholinesterase</p></td></tr><tr><td class="NLM_term">ELISA</td><td class="NLM_def"><p class="first last">enzyme-linked immunosorbent assay</p></td></tr><tr><td class="NLM_term">GAFF</td><td class="NLM_def"><p class="first last">general Amber force field</p></td></tr><tr><td class="NLM_term">GAPDH</td><td class="NLM_def"><p class="first last">glyceraldehyde-3-phosphate dehydrogenase</p></td></tr><tr><td class="NLM_term">GPX1</td><td class="NLM_def"><p class="first last">glutathione peroxidase 1</p></td></tr><tr><td class="NLM_term">hAChE</td><td class="NLM_def"><p class="first last">human acetylcholinesterase</p></td></tr><tr><td class="NLM_term">hBChE</td><td class="NLM_def"><p class="first last">human butyrylcholinesterase</p></td></tr><tr><td class="NLM_term">Hmox1</td><td class="NLM_def"><p class="first last">heme oxygenase 1</p></td></tr><tr><td class="NLM_term">HNE</td><td class="NLM_def"><p class="first last">4-hydroxy-2-nonenal</p></td></tr><tr><td class="NLM_term">iNOS</td><td class="NLM_def"><p class="first last">inducible nitric oxide synthase</p></td></tr><tr><td class="NLM_term">ip</td><td class="NLM_def"><p class="first last">intraperitoneally</p></td></tr><tr><td class="NLM_term">IPTG</td><td class="NLM_def"><p class="first last">isopropyl 1-thio-β-<span class="smallcaps smallerCapital">d</span>-galactopyranoside</p></td></tr><tr><td class="NLM_term">MCI</td><td class="NLM_def"><p class="first last">mild cognitive impairment</p></td></tr><tr><td class="NLM_term">MD</td><td class="NLM_def"><p class="first last">molecular dynamics</p></td></tr><tr><td class="NLM_term">Nrf2</td><td class="NLM_def"><p class="first last">nuclear factor-erythroid 2-related factor 2</p></td></tr><tr><td class="NLM_term">PAMPA-BBB</td><td class="NLM_def"><p class="first last">parallel artificial membrane permeation assay for blood–brain barrier</p></td></tr><tr><td class="NLM_term">PAS</td><td class="NLM_def"><p class="first last">peripheral anionic site</p></td></tr><tr><td class="NLM_term"><i>P</i><sub>e</sub></td><td class="NLM_def"><p class="first last">permeability</p></td></tr><tr><td class="NLM_term">PME</td><td class="NLM_def"><p class="first last">particle mesh Ewald</p></td></tr><tr><td class="NLM_term">qPCR</td><td class="NLM_def"><p class="first last">quantitative polymerase chain reaction</p></td></tr><tr><td class="NLM_term">RESP</td><td class="NLM_def"><p class="first last">restrained electrostatic potential</p></td></tr><tr><td class="NLM_term">RI</td><td class="NLM_def"><p class="first last">recognition index</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">RT-PCR</td><td class="NLM_def"><p class="first last">reverse transcription polymerase chain reaction</p></td></tr><tr><td class="NLM_term">SD</td><td class="NLM_def"><p class="first last">standard deviation</p></td></tr><tr><td class="NLM_term">SDS-PAGE</td><td class="NLM_def"><p class="first last">sodium dodecyl sulfate polyacrylamide gel electrophoresis</p></td></tr><tr><td class="NLM_term">SOD2</td><td class="NLM_def"><p class="first last">superoxide dismutase 2</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">standard error of the mean</p></td></tr><tr><td class="NLM_term">TBS</td><td class="NLM_def"><p class="first last">Tris-buffered saline</p></td></tr><tr><td class="NLM_term">THA</td><td class="NLM_def"><p class="first last">tacrine</p></td></tr><tr><td class="NLM_term">Th-S</td><td class="NLM_def"><p class="first last">thioflavin-S</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin-layer chromatography</p></td></tr><tr><td class="NLM_term">WT</td><td class="NLM_def"><p class="first last">wild type</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i81">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05105" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05105" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 71 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Alzheimer’s Disease
International</span>.  <i>World Alzheimer Report
2018: The State of the Art of Dementia Research: New Frontiers</i>; <span class="NLM_publisher-name">Alzheimer’s Disease International</span>: <span class="NLM_publisher-loc">London</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=Alzheimer%E2%80%99s+Disease%0AInternational&title=World+Alzheimer+Report%0A2018%3A+The+State+of+the+Art+of+Dementia+Research%3A+New+Frontiers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26btitle%3DWorld%2520Alzheimer%2520Report%250A2018%253A%2520The%2520State%2520of%2520the%2520Art%2520of%2520Dementia%2520Research%253A%2520New%2520Frontiers%26pub%3DAlzheimer%25E2%2580%2599s%2520Disease%2520International%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Alzheimer’s Disease
International</span>.  <i>World Alzheimer Report
2019: Attitudes to Dementia</i>; <span class="NLM_publisher-name">Alzheimer’s
Disease International</span>: <span class="NLM_publisher-loc">London</span>, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=Alzheimer%E2%80%99s+Disease%0AInternational&title=World+Alzheimer+Report%0A2019%3A+Attitudes+to+Dementia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26btitle%3DWorld%2520Alzheimer%2520Report%250A2019%253A%2520Attitudes%2520to%2520Dementia%26pub%3DAlzheimer%25E2%2580%2599s%250ADisease%2520International%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cavalli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognesi, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minarini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumiatti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Recanatini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melchiorre, C.</span></span> <span> </span><span class="NLM_article-title">Multi-target-directed ligands to combat neurodegenerative diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">372</span>, <span class="refDoi"> DOI: 10.1021/jm7009364</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm7009364" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=347-372&author=A.+Cavalliauthor=M.+L.+Bolognesiauthor=A.+Minariniauthor=M.+Rosiniauthor=V.+Tumiattiauthor=M.+Recanatiniauthor=C.+Melchiorre&title=Multi-target-directed+ligands+to+combat+neurodegenerative+diseases&doi=10.1021%2Fjm7009364"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target-Directed Ligands to Combat Neurodegenerative Diseases</span></div><div class="casAuthors">Cavalli, Andrea; Bolognesi, Maria Laura; Minarini, Anna; Rosini, Michela; Tumiatti, Vincenzo; Recanatini, Maurizio; Melchiorre, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-372</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The authors review the investigations reported in the past decade that illustrate the ability of medicinal chemists to design multi-target-directed ligands (MTDLs) to confront neurodegenerative diseases.  The authors briefly illustrate the multifactorial nature of these diseases before discussing the possible development of MTDLs in light of the known mol. bases of the main neurodegenerative pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYY0I0UHEir7Vg90H21EOLACvtfcHk0lh6XKLoI_Q-bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D&md5=c682235151489316d043cf97f78e56f3</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fjm7009364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7009364%26sid%3Dliteratum%253Aachs%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DMulti-target-directed%2520ligands%2520to%2520combat%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D347%26epage%3D372%26doi%3D10.1021%2Fjm7009364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lemke, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serrano, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chioua, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ismaili, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez-Grau, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beadle, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vetman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dato, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartz, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elsinghorst, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iriepa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wille, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marco-Contelles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gütschow, M.</span></span> <span> </span><span class="NLM_article-title">Chromenones as multineurotargeting inhibitors of human enzymes</span>. <i>ACS Omega</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">22161</span>– <span class="NLM_lpage">22168</span>, <span class="refDoi"> DOI: 10.1021/acsomega.9b03409</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsomega.9b03409" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlGgtLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2019&pages=22161-22168&author=C.+Lemkeauthor=J.+Christmannauthor=J.+Yinauthor=J.+M.+Alonsoauthor=E.+Serranoauthor=M.+Chiouaauthor=L.+Ismailiauthor=M.+A.+Mart%C3%ADnez-Grauauthor=C.+D.+Beadleauthor=T.+Vetmanauthor=F.+M.+Datoauthor=U.+Bartzauthor=P.+W.+Elsinghorstauthor=M.+Pietschauthor=C.+E.+M%C3%BCllerauthor=I.+Iriepaauthor=T.+Willeauthor=J.+Marco-Contellesauthor=M.+G%C3%BCtschow&title=Chromenones+as+multineurotargeting+inhibitors+of+human+enzymes&doi=10.1021%2Facsomega.9b03409"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Chromenones as Multineurotargeting Inhibitors of Human Enzymes</span></div><div class="casAuthors">Lemke, Carina; Christmann, Joscha; Yin, Jiafei; Alonso, Jose M.; Serrano, Estefania; Chioua, Mourad; Ismaili, Lhassane; Martinez-Grau, Maria Angeles; Beadle, Christopher D.; Vetman, Tatiana; Dato, Florian M.; Bartz, Ulrike; Elsinghorst, Paul W.; Pietsch, Markus; Mueller, Christa E.; Iriepa, Isabel; Wille, Timo; Marco-Contelles, Jose; Guetschow, Michael</div><div class="citationInfo"><span class="NLM_cas:title">ACS Omega</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">22161-22168</span>CODEN:
                <span class="NLM_cas:coden">ACSODF</span>;
        ISSN:<span class="NLM_cas:issn">2470-1343</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The complex nature of multifactorial diseases, such as Morbus Alzheimer, has produced a strong need to design multitarget-directed ligands to address the involved complementary pathways.  A purposive structural modification of a tetratarget small-mol. contilisant and generated a combinatorial library of substituted chromen-4-ones I (R = pyrrolidin-1-yl, piperidin-1-yl, morpholin-4-yl, etc.; n = 2, 3, 4, 5) is reported.  The compds. comprise a basic moiety which is linker-connected to the 6-position of the heterocyclic chromenone core.  The syntheses were accomplished by Mitsunobu- or Williamson-type ether formations.  The resulting library members were evaluated at a panel of seven human enzymes, all of which being involved in the pathophysiol. of neurodegeneration.  A concomitant inhibition of human acetylcholinesterase and human monoamine oxidase B, with IC50 values of 5.58 and 7.20 μM, resp., was achieved with the dual-target 6-(4-(piperidin-1-yl)butoxy)-4H-chromen-4-one.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrT8Gk0MaAG-LVg90H21EOLACvtfcHk0lhRy4YNZsp9UQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlGgtLrJ&md5=c085988b2602da09746e24c4616becd7</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1021%2Facsomega.9b03409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsomega.9b03409%26sid%3Dliteratum%253Aachs%26aulast%3DLemke%26aufirst%3DC.%26aulast%3DChristmann%26aufirst%3DJ.%26aulast%3DYin%26aufirst%3DJ.%26aulast%3DAlonso%26aufirst%3DJ.%2BM.%26aulast%3DSerrano%26aufirst%3DE.%26aulast%3DChioua%26aufirst%3DM.%26aulast%3DIsmaili%26aufirst%3DL.%26aulast%3DMart%25C3%25ADnez-Grau%26aufirst%3DM.%2BA.%26aulast%3DBeadle%26aufirst%3DC.%2BD.%26aulast%3DVetman%26aufirst%3DT.%26aulast%3DDato%26aufirst%3DF.%2BM.%26aulast%3DBartz%26aufirst%3DU.%26aulast%3DElsinghorst%26aufirst%3DP.%2BW.%26aulast%3DPietsch%26aufirst%3DM.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DIriepa%26aufirst%3DI.%26aulast%3DWille%26aufirst%3DT.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DG%25C3%25BCtschow%26aufirst%3DM.%26atitle%3DChromenones%2520as%2520multineurotargeting%2520inhibitors%2520of%2520human%2520enzymes%26jtitle%3DACS%2520Omega%26date%3D2019%26volume%3D4%26spage%3D22161%26epage%3D22168%26doi%3D10.1021%2Facsomega.9b03409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, A. S. C.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of orally bioavailable quinoline–indole derivatives as innovative multitarget-directed ligands: promotion of cell proliferation in the adult murine hippocampus for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1871</span>– <span class="NLM_lpage">1894</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01417</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01417" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVGktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=1871-1894&author=Z.+Wangauthor=J.+Huauthor=X.+Yangauthor=X.+Fengauthor=X.+Liauthor=L.+Huangauthor=A.+S.+C.+Chan&title=Design%2C+synthesis%2C+and+evaluation+of+orally+bioavailable+quinoline%E2%80%93indole+derivatives+as+innovative+multitarget-directed+ligands%3A+promotion+of+cell+proliferation+in+the+adult+murine+hippocampus+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.7b01417"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Evaluation of Orally Bioavailable Quinoline-Indole Derivatives as Innovative Multitarget-Directed Ligands: Promotion of Cell Proliferation in the Adult Murine Hippocampus for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Wang, Zhiren; Hu, Jinhui; Yang, Xiaoping; Feng, Xing; Li, Xingshu; Huang, Ling; Chan, Albert S. C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1871-1894</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of quinoline-indole derivs., e.g., I, were synthesized and evaluated as multitarget-directed ligands for the treatment of Alzheimer's disease (AD).  Biol. evaluation revealed that the derivs. had multifunctional profiles including antioxidant effects, blood-brain barrier (BBB) penetration, biometal chelation, Aβ aggregation modulation, neurotrophic and neuroprotective properties.  Moreover, several representative target derivs. demonstrated hippocampal cell proliferation in living adult mice by intracerebroventricular (icv) injection or oral administration.  Further drug-like property anal. demonstrated that the optimized compd., I (WI-1758), had liver microsomal metabolic stability, was well tolerated (>2000 mg/kg), and had a rational pharmacokinetic profile, as well as an oral bioavailability of 14.1% and a pos. log BB (-0.19) to cross the BBB in vivo.  Pharmacodynamics studies demonstrated that chronic oral administration of I·HCl substantially ameliorated the cognitive and spatial memory deficits in APP/PS1 AD mice and noticeably reduced overall cerebral β-amyloid deposits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWqZm6XKZY47Vg90H21EOLACvtfcHk0lhRy4YNZsp9UQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVGktrg%253D&md5=7a152c6307ee80a9e334225776d55d25</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01417%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DFeng%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DChan%26aufirst%3DA.%2BS.%2BC.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520orally%2520bioavailable%2520quinoline%25E2%2580%2593indole%2520derivatives%2520as%2520innovative%2520multitarget-directed%2520ligands%253A%2520promotion%2520of%2520cell%2520proliferation%2520in%2520the%2520adult%2520murine%2520hippocampus%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D1871%26epage%3D1894%26doi%3D10.1021%2Facs.jmedchem.7b01417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span> <span> </span><span class="NLM_article-title">Multitarget anti-Alzheimer Hybrid Compounds: Do They Work in Vivo?</span>. In  <i>Design of Hybrid Molecules for Drug Development</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, M.</span></span>, Ed.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Amsterdam</span>, <span class="NLM_year">2017</span>; pp  <span class="NLM_fpage">167</span>– <span class="NLM_lpage">192</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2FB978-0-08-101011-2.00006-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=167-192&author=D.+Mu%C3%B1oz-Torreroauthor=M.+Decker&title=Design+of+Hybrid+Molecules+for+Drug+Development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FB978-0-08-101011-2.00006-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-08-101011-2.00006-4%26sid%3Dliteratum%253Aachs%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DMultitarget%2520anti-Alzheimer%2520Hybrid%2520Compounds%253A%2520Do%2520They%2520Work%2520in%2520Vivo%253F%26btitle%3DDesign%2520of%2520Hybrid%2520Molecules%2520for%2520Drug%2520Development%26aulast%3DDecker%26aufirst%3DM.%26pub%3DElsevier%26date%3D2017%26spage%3D167%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bajda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Łażewska, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godyń, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaręba, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuder, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagenow, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Łątka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stawarska, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stark, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieć-Kononowicz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malawska, B.</span></span> <span> </span><span class="NLM_article-title">Search for new multi-target compounds against Alzheimer’s disease among histamine H3 receptor ligands</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>185</i></span>, <span class="NLM_elocation-id">111785</span> <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.111785</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2Fj.ejmech.2019.111785" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=31669851" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitVGmtbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=2020&author=M.+Bajdaauthor=D.+%C5%81a%C5%BCewskaauthor=J.+Gody%C5%84author=P.+Zar%C4%99baauthor=K.+Kuderauthor=S.+Hagenowauthor=K.+%C5%81%C4%85tkaauthor=E.+Stawarskaauthor=H.+Starkauthor=K.+Kie%C4%87-Kononowiczauthor=B.+Malawska&title=Search+for+new+multi-target+compounds+against+Alzheimer%E2%80%99s+disease+among+histamine+H3+receptor+ligands&doi=10.1016%2Fj.ejmech.2019.111785"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Search for new multi-target compounds against Alzheimer's disease among histamine H3 receptor ligands</span></div><div class="casAuthors">Bajda, Marek; Lazewska, Dorota; Godyn, Justyna; Zareba, Paula; Kuder, Kamil; Hagenow, Stefanie; Latka, Kamil; Stawarska, Ewelina; Stark, Holger; Kiec-Kononowicz, Katarzyna; Malawska, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">185</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">111785</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Multitarget-directed ligands seem to be an interesting approach to the treatment of complex disorders such as Alzheimer's disease.  The aim of the present study was to find novel multifunctional compds. in a nonimidazole histamine H3 receptor ligand library.  Docking-based virtual screening was applied for selection of twenty-six hits which were subsequently evaluated in Ellman's assay for the inhibitory potency toward acetyl- (AChE) and butyrylcholinesterase (BuChE).  The virtual screening with high success ratio enabled to choose multitarget-directed ligands.  Based on docking results, all selected ligands were able to bind both catalytic and peripheral sites of AChE and BuChE.  The most promising derivs. combined the flavone moiety via a six carbon atom linker with a heterocyclic moiety, such as azepane, piperidine or 3-methylpiperidine.  They showed the highest inhibitory activities toward cholinesterases as well as well-balanced potencies against H3R and both enzymes.  Two derivs. were chosen - 5 (IC50 = 0.46μM (AChE); 0.44μM (BuChE); Ki = 159.8 nM (H3R)) and 17 (IC50 = 0.50μM (AChE); 0.76μM (BuChE); Ki = 228.2 nM (H3R)), and their inhibition mechanism was evaluated in kinetic studies.  Both compds. displayed noncompetitive mode of AChE and BuChE inhibition.  Compds. 5 and 17 might serve as good lead structures for further optimization and development of novel multitarget anti-Alzheimer's agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUpZqYTa3jErVg90H21EOLACvtfcHk0lgPhx5bSBVPGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitVGmtbnJ&md5=dab560ad799afa024d4b594403a14701</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.111785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.111785%26sid%3Dliteratum%253Aachs%26aulast%3DBajda%26aufirst%3DM.%26aulast%3D%25C5%2581a%25C5%25BCewska%26aufirst%3DD.%26aulast%3DGody%25C5%2584%26aufirst%3DJ.%26aulast%3DZar%25C4%2599ba%26aufirst%3DP.%26aulast%3DKuder%26aufirst%3DK.%26aulast%3DHagenow%26aufirst%3DS.%26aulast%3D%25C5%2581%25C4%2585tka%26aufirst%3DK.%26aulast%3DStawarska%26aufirst%3DE.%26aulast%3DStark%26aufirst%3DH.%26aulast%3DKie%25C4%2587-Kononowicz%26aufirst%3DK.%26aulast%3DMalawska%26aufirst%3DB.%26atitle%3DSearch%2520for%2520new%2520multi-target%2520compounds%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%2520among%2520histamine%2520H3%2520receptor%2520ligands%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2020%26volume%3D185%26doi%3D10.1016%2Fj.ejmech.2019.111785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mesiti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavarria, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaspar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcaro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span> <span> </span><span class="NLM_article-title">The chemistry toolbox of multitarget-directed ligands for Alzheimer’s disease</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>181</i></span>, <span class="NLM_elocation-id">111572</span> <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.111572</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2Fj.ejmech.2019.111572" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=31404859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFyjsrvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=2019&author=F.+Mesitiauthor=D.+Chavarriaauthor=A.+Gasparauthor=S.+Alcaroauthor=F.+Borges&title=The+chemistry+toolbox+of+multitarget-directed+ligands+for+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2019.111572"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">The chemistry toolbox of multitarget-directed ligands for Alzheimer's disease</span></div><div class="casAuthors">Mesiti, Francesco; Chavarria, Daniel; Gaspar, Alexandra; Alcaro, Stefano; Borges, Fernanda</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">181</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">111572</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  The discovery and development of multitarget-directed ligands (MTDLs) is a promising strategy to find new therapeutic solns. for neurodegenerative diseases (NDs), in particular for Alzheimer's disease (AD).  Currently approved drugs for the clin. management of AD are based on a single-target strategy and focus on restoring neurotransmitter homeostasis.  Finding disease-modifying therapies AD and other NDs remains an urgent unmet clin. need.  The growing consensus that AD is a multifactorial disease, with several interconnected and deregulated pathol. pathways, boosted an intensive research in the design of MTDLs.  Due to this scientific boom, the knowledge behind the development of MTDLs remains diffuse and lacks balanced guidelines.  To rationalize the large amt. of data obtained in this field, the authors herein revise the progress made over the last 5 years on the development of MTDLs inspired by drugs approved for AD.  Due to their putative therapeutic benefit in AD, MTDLs based on MAO-B inhibitors will also be discussed in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGret0oXDxuClLVg90H21EOLACvtfcHk0lgPhx5bSBVPGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFyjsrvE&md5=e2703287dc0dbdc2be5ea7b5e9e9fee1</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.111572&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.111572%26sid%3Dliteratum%253Aachs%26aulast%3DMesiti%26aufirst%3DF.%26aulast%3DChavarria%26aufirst%3DD.%26aulast%3DGaspar%26aufirst%3DA.%26aulast%3DAlcaro%26aufirst%3DS.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3DThe%2520chemistry%2520toolbox%2520of%2520multitarget-directed%2520ligands%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D181%26doi%3D10.1016%2Fj.ejmech.2019.111572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span> <span> </span><span class="NLM_article-title">Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer’s disease</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>169</i></span>,  <span class="NLM_fpage">200</span>– <span class="NLM_lpage">223</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.02.076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2Fj.ejmech.2019.02.076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=30884327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1MXltFGhs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2019&pages=200-223&author=T.+Wangauthor=X.+Liuauthor=J.+Guanauthor=S.+Geauthor=M.-B.+Wuauthor=J.+Linauthor=L.+Yang&title=Advancement+of+multi-target+drug+discoveries+and+promising+applications+in+the+field+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2019.02.076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer's disease</span></div><div class="casAuthors">Wang, Tao; Liu, Xiao-huan; Guan, Jing; Ge, Shun; Wu, Mian-Bin; Lin, Jian-ping; Yang, Li-rong</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">200-223</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Complex diseases (e.g., Alzheimer's disease) or infectious diseases are usually caused by complicated and varied factors, including environmental and genetic factors.  Multi-target (polypharmacol.) drugs have been suggested and have emerged as powerful and promising alternative paradigms in modern medicinal chem. for the development of versatile chemotherapeutic agents to solve these medical challenges.  The multifunctional agents capable of modulating multiple biol. targets simultaneously display great advantages of higher efficacy, improved safety profile, and simpler administration compared to single-targeted agents.  Therefore, multifunctional agents would certainly open novel avenues to rationally design the next generation of more effective but less toxic therapeutic agents.  Herein, the authors review the recent progress made in the discovery and design processes of selective multi-targeted agents, esp. the successful application of multi-target drugs for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraLSyazoHkBbVg90H21EOLACvtfcHk0lgPhx5bSBVPGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXltFGhs7g%253D&md5=11e82288f25c5b2421184be0c568f9f8</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.02.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.02.076%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DGuan%26aufirst%3DJ.%26aulast%3DGe%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DM.-B.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DL.%26atitle%3DAdvancement%2520of%2520multi-target%2520drug%2520discoveries%2520and%2520promising%2520applications%2520in%2520the%2520field%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D169%26spage%3D200%26epage%3D223%26doi%3D10.1016%2Fj.ejmech.2019.02.076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gontijo, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viegas, F. P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortiz, C. J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Freitas Silva, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damasio, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosa, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campos, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couto, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tranches Dias, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viegas, C.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Molecular hybridization as a tool in the design of multi-target directed drug candidates for neurodegenerative diseases</span>. <i>Curr. Neuropharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">348</span>– <span class="NLM_lpage">407</span>, <span class="refDoi"> DOI: 10.2174/1385272823666191021124443</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.2174%2F1385272823666191021124443" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=31631821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtVyiurfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2020&pages=348-407&author=V.+S.+Gontijoauthor=F.+P.+D.+Viegasauthor=C.+J.+C.+Ortizauthor=M.+de+Freitas+Silvaauthor=C.+M.+Damasioauthor=M.+C.+Rosaauthor=T.+G.+Camposauthor=D.+S.+Coutoauthor=K.+S.+Tranches+Diasauthor=C.+Viegas&title=Molecular+hybridization+as+a+tool+in+the+design+of+multi-target+directed+drug+candidates+for+neurodegenerative+diseases&doi=10.2174%2F1385272823666191021124443"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6dR"><div class="casContent"><span class="casTitleNuber">6d</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Hybridization as a Tool in the Design of Multi-target Directed Drug Candidates for Neurodegenerative Diseases</span></div><div class="casAuthors">Gontijo, Vanessa Silva; Dias Viegas, Flavia P.; Cristancho Ortiz, Cindy Juliet; de Freitas Silva, Matheus; Damasio, Caio Miranda; Rosa, Mayara Chagas; Campos, Thamara Gaspar; Couto, Dyecika Souza; Tranches Dias, Kris Simone; Viegas, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">Current Neuropharmacology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">348-407</span>CODEN:
                <span class="NLM_cas:coden">CNUEAN</span>;
        ISSN:<span class="NLM_cas:issn">1875-6190</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Neurodegenerative Diseases (NDs) are progressive multifactorial neurol. pathologies related to neuronal impairment and functional loss from different brain regions.  Currently, no effective treatments are available for any NDs, and this lack of efficacy has been attributed to the multitude of interconnected factors involved in their pathophysiol.  In the last two decades, a new approach for the rational design of new drug candidates, also called multitarget-directed ligands (MTDLs) strategy, has emerged and has been used in the design and for the development of a variety of hybrid compds. capable to act simultaneously in diverse biol. targets.  Based on the polypharmacol. concept, this new paradigm has been thought as a more secure and effective way for modulating concomitantly two or more biochem. pathways responsible for the onset and progress of NDs, trying to overcome low therapeutical effectiveness.  As a complement to our previous review article (Curr. Med. Chem. 2007, 14 (17), 1829-1852. https://doi.org/10.2174/092986707781058805), herein we aimed to cover the period from 2008 to 2019 and highlight the most recent advances of the exploitation of Mol. Hybridization (MH) as a tool in the rational design of innovative multifunctional drug candidate prototypes for the treatment of NDs, specially focused on AD, PD, HD and ALS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMj4ASlxgG-LVg90H21EOLACvtfcHk0li_KylSOg1Tag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtVyiurfI&md5=82ca2f766a86b5329719aa4ae2bb1d6c</span></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=10.2174%2F1385272823666191021124443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1385272823666191021124443%26sid%3Dliteratum%253Aachs%26aulast%3DGontijo%26aufirst%3DV.%2BS.%26aulast%3DViegas%26aufirst%3DF.%2BP.%2BD.%26aulast%3DOrtiz%26aufirst%3DC.%2BJ.%2BC.%26aulast%3Dde%2BFreitas%2BSilva%26aufirst%3DM.%26aulast%3DDamasio%26aufirst%3DC.%2BM.%26aulast%3DRosa%26aufirst%3DM.%2BC.%26aulast%3DCampos%26aufirst%3DT.%2BG.%26aulast%3DCouto%26aufirst%3DD.%2BS.%26aulast%3DTranches%2BDias%26aufirst%3DK.%2BS.%26aulast%3DViegas%26aufirst%3DC.%26atitle%3DMolecular%2520hybridization%2520as%2520a%2520tool%2520in%2520the%2520design%2520of%2520multi-target%2520directed%2520drug%2520candidates%2520for%2520neurodegenerative%2520diseases%26jtitle%3DCurr.%2520Neuropharmacol.%26date%3D2020%26volume%3D18%26spage%3D348%26epage%3D407%26doi%3D10.2174%2F1385272823666191021124443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gandini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tedesco, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Gonzalez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campillo, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaldivar-Diez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuccheri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feoli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castellano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petralla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moda, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Legname, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognesi, M. L.</span></span> <span> </span><span class="NLM_article-title">Tau-centric multitarget approach for Alzheimer’s disease: Development of first-in-class dual glycogen synthase kinase 3β and tau-aggregation inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">7640</span>– <span class="NLM_lpage">7656</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00610</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00610" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVChu7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=7640-7656&author=A.+Gandiniauthor=M.+Bartoliniauthor=D.+Tedescoauthor=L.+Martinez-Gonzalezauthor=C.+Rocaauthor=N.+E.+Campilloauthor=J.+Zaldivar-Diezauthor=C.+Perezauthor=G.+Zuccheriauthor=A.+Mitiauthor=A.+Feoliauthor=S.+Castellanoauthor=S.+Petrallaauthor=B.+Montiauthor=M.+Rossiauthor=F.+Modaauthor=G.+Legnameauthor=A.+Martinezauthor=M.+L.+Bolognesi&title=Tau-centric+multitarget+approach+for+Alzheimer%E2%80%99s+disease%3A+Development+of+first-in-class+dual+glycogen+synthase+kinase+3%CE%B2+and+tau-aggregation+inhibitors&doi=10.1021%2Facs.jmedchem.8b00610"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6eR"><div class="casContent"><span class="casTitleNuber">6e</span><div class="casTitle"><span class="NLM_cas:atitle">Tau-Centric Multitarget Approach for Alzheimer's Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors</span></div><div class="casAuthors">Gandini, Annachiara; Bartolini, Manuela; Tedesco, Daniele; Martinez-Gonzalez, Loreto; Roca, Carlos; Campillo, Nuria E.; Zaldivar-Diez, Josefa; Perez, Concepcion; Zuccheri, Giampaolo; Miti, Andrea; Feoli, Alessandra; Castellano, Sabrina; Petralla, Sabrina; Monti, Barbara; Rossi, Martina; Moda, Fabio; Legname, Giuseppe; Martinez, Ana; Bolognesi, Maria Laura</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7640-7656</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Several findings propose the altered tau protein network as an important target for Alzheimer's disease (AD).  Particularly, two points of pharmacol. intervention can be envisaged: inhibition of phosphorylating tau kinase GSK-3β and tau aggregation process.  On the basis of this consideration and on the authors' interest in multitarget paradigms in AD, the authors report on the discovery of 2,4-thiazolidinedione derivs. endowed with such a profile. 28 and 30 displayed micromolar IC50 values toward GSK-3β, together with the capacity of inhibiting AcPHF6 aggregation of 60% and 80% at 10 μM, resp.  In addn., they showed PAMPA-BBB permeability, together with a suitable cellular safety profile. 30 also displayed inhibition of both K18 and full-length tau aggregations.  Finally, both compds. were able to improve cell viability in an okadaic acid-induced neurodegeneration cell model.  To the best of the authors' knowledge, 28 and 30 are the first balanced, nontoxic, dual-acting compds. hitting tau cascade at two different hubs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6bQV6XoAhyrVg90H21EOLACvtfcHk0li_KylSOg1Tag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVChu7%252FL&md5=34b7e2f2556f3e96c768dd87fb3f0e6d</span></div><a href="/servlet/linkout?suffix=cit6e&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00610%26sid%3Dliteratum%253Aachs%26aulast%3DGandini%26aufirst%3DA.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DTedesco%26aufirst%3DD.%26aulast%3DMartinez-Gonzalez%26aufirst%3DL.%26aulast%3DRoca%26aufirst%3DC.%26aulast%3DCampillo%26aufirst%3DN.%2BE.%26aulast%3DZaldivar-Diez%26aufirst%3DJ.%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DZuccheri%26aufirst%3DG.%26aulast%3DMiti%26aufirst%3DA.%26aulast%3DFeoli%26aufirst%3DA.%26aulast%3DCastellano%26aufirst%3DS.%26aulast%3DPetralla%26aufirst%3DS.%26aulast%3DMonti%26aufirst%3DB.%26aulast%3DRossi%26aufirst%3DM.%26aulast%3DModa%26aufirst%3DF.%26aulast%3DLegname%26aufirst%3DG.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26atitle%3DTau-centric%2520multitarget%2520approach%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Development%2520of%2520first-in-class%2520dual%2520glycogen%2520synthase%2520kinase%25203%25CE%25B2%2520and%2520tau-aggregation%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D7640%26epage%3D7656%26doi%3D10.1021%2Facs.jmedchem.8b00610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ran, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James Chou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span> <span> </span><span class="NLM_article-title">Tacrine-hydroxamate derivatives as multitarget-directed ligands for the treatment of Alzheimer’s disease: design, synthesis, and biological evaluation</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>98</i></span>, <span class="NLM_elocation-id">103721</span> <span class="refDoi"> DOI: 10.1016/j.bioorg.2020.103721</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2Fj.bioorg.2020.103721" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=32193030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlt1eltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2020&author=A.+Xuauthor=F.+Heauthor=X.+Zhangauthor=X.+Liauthor=Y.+Ranauthor=C.+Weiauthor=C.+James+Chouauthor=R.+Zhangauthor=J.+Wu&title=Tacrine-hydroxamate+derivatives+as+multitarget-directed+ligands+for+the+treatment+of+Alzheimer%E2%80%99s+disease%3A+design%2C+synthesis%2C+and+biological+evaluation&doi=10.1016%2Fj.bioorg.2020.103721"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Tacrine-hydroxamate derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation</span></div><div class="casAuthors">Xu, Ana; He, Feng; Zhang, Xiangna; Li, Xiaoyang; Ran, Yingying; Wei, Chao; James Chou, C.; Zhang, Rui; Wu, Jingde</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103721</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In order to develop multitarget-directed ligands as potential treatments for Alzheimer's disease, twenty-eight new tacrine-hydroxamate derivs. were designed, synthesized, and biol. evaluated.  As expected, most of the compds. exhibited inhibitory activities against cholinesterases (ChEs) and histone deacetylase (HDACs).  Among the tested compds., I showed not only potent and selective inhibition on AChE at sub-nanomolar potency (AChEIC50 = 0.12 nM, BChEIC50 = 361.52 nM) but also potent inhibition on HDAC (IC50 = 0.23 nM).  Moreover, I exhibited inhibitory activity on Aβ1-42 self-aggregation as well as disaggregation activity on pre-formed Aβ fibrils.  Furthermore, I exhibited antioxidant activity and metal chelating properties.  Further mechanistic studies demonstrated that I is a pan-inhibitor of HDACs and a mixed-type inhibitor for AChE.  It was shown that I is a BBB penetrant by online prediction.  Taken together, the results indicate that I can serve as a lead compd. to develop promising candidate analogs as AD therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLE3wLayb4i7Vg90H21EOLACvtfcHk0li_KylSOg1Tag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlt1eltLw%253D&md5=e2b820af806ce7651f90fc66d4a1f1cb</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2020.103721&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2020.103721%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DA.%26aulast%3DHe%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DRan%26aufirst%3DY.%26aulast%3DWei%26aufirst%3DC.%26aulast%3DJames%2BChou%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DJ.%26atitle%3DTacrine-hydroxamate%2520derivatives%2520as%2520multitarget-directed%2520ligands%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520design%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%26jtitle%3DBioorg.%2520Chem.%26date%3D2020%26volume%3D98%26doi%3D10.1016%2Fj.bioorg.2020.103721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Duarte, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutiérrez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adasme-Carreño, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Gutierrez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alzate-Morales, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santana, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Álvarez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matos, M. J.</span></span> <span> </span><span class="NLM_article-title">Novel coumarin-quinoline hybrids: design of multitarget compounds for Alzheimer’s disease</span>. <i>ChemistrySelect</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">551</span>– <span class="NLM_lpage">558</span>, <span class="refDoi"> DOI: 10.1002/slct.201803222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1002%2Fslct.201803222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVOgtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2019&pages=551-558&author=Y.+Duarteauthor=A.+Fonsecaauthor=M.+Guti%C3%A9rrezauthor=F.+Adasme-Carre%C3%B1oauthor=C.+Mu%C3%B1oz-Gutierrezauthor=J.+Alzate-Moralesauthor=L.+Santanaauthor=E.+Uriarteauthor=R.+%C3%81lvarezauthor=M.+J.+Matos&title=Novel+coumarin-quinoline+hybrids%3A+design+of+multitarget+compounds+for+Alzheimer%E2%80%99s+disease&doi=10.1002%2Fslct.201803222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Coumarin-Quinoline Hybrids: Design of Multitarget Compounds for Alzheimer's Disease</span></div><div class="casAuthors">Duarte, Yorley; Fonseca, Andre; Gutierrez, Margarita; Adasme-Carreno, Francisco; Munoz-Gutierrez, Camila; Alzate-Morales, Jans; Santana, Lourdes; Uriarte, Eugenio; Alvarez, Rocio; Matos, Maria Joao</div><div class="citationInfo"><span class="NLM_cas:title">ChemistrySelect</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">551-558</span>CODEN:
                <span class="NLM_cas:coden">CHEMUD</span>;
        ISSN:<span class="NLM_cas:issn">2365-6549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is the most prevalent neurodegenerative disease, presenting the most devastating consequences on human health and life quality.  Coumarin-quinoline hybrids were synthesized following a very efficient and versatile strategy.  Small structural variations contributed to dual acetyl/butyrylcholinesterases (AChE/BuChE) activity or selectivity towards one of these enzymes.  In addn., some of the studied compds. are interesting iron chelators, presenting a tendency to be neuroprotective.  Moreover, the compds. are not cytotoxic for SH-SY5Y neuroblastoma cells.  Compd. 9c proved to be the most interesting compd. of the studied series.  This compd. is selective against AChE and proved to be an excellent iron chelating agent (iron chelation at 100 μM=72.87%).  Mol. docking studies were performed to establish the nature of the interaction between the studied compds. and the binding pockets, leading to a rationalization of structure-activity relationships.  Compd. 9c forms a well-defined π-stacking interaction with Phe330 and interacts with Tyr121 residue via a hydrogen bond, while the inactive compds. cannot establish these interactions.  Important preliminary results against different targets, as well as some structure-activity relationships, were concluded from the exptl. results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpO_EBmjZxDfbVg90H21EOLACvtfcHk0lhr6wFTvdl0iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVOgtbw%253D&md5=299c5cfca47a068c32fe204044cc31bd</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1002%2Fslct.201803222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fslct.201803222%26sid%3Dliteratum%253Aachs%26aulast%3DDuarte%26aufirst%3DY.%26aulast%3DFonseca%26aufirst%3DA.%26aulast%3DGuti%25C3%25A9rrez%26aufirst%3DM.%26aulast%3DAdasme-Carre%25C3%25B1o%26aufirst%3DF.%26aulast%3DMu%25C3%25B1oz-Gutierrez%26aufirst%3DC.%26aulast%3DAlzate-Morales%26aufirst%3DJ.%26aulast%3DSantana%26aufirst%3DL.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3D%25C3%2581lvarez%26aufirst%3DR.%26aulast%3DMatos%26aufirst%3DM.%2BJ.%26atitle%3DNovel%2520coumarin-quinoline%2520hybrids%253A%2520design%2520of%2520multitarget%2520compounds%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DChemistrySelect%26date%3D2019%26volume%3D4%26spage%3D551%26epage%3D558%26doi%3D10.1002%2Fslct.201803222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span> <span> </span><span class="NLM_article-title">Multi-target design strategies for the improved treatment of Alzheimer’s disease</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>176</i></span>,  <span class="NLM_fpage">228</span>– <span class="NLM_lpage">247</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.05.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2Fj.ejmech.2019.05.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=31103902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1MXpvVGnsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2019&pages=228-247&author=P.+Zhangauthor=S.+Xuauthor=Z.+Zhuauthor=J.+Xu&title=Multi-target+design+strategies+for+the+improved+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2019.05.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target design strategies for the improved treatment of Alzheimer's disease</span></div><div class="casAuthors">Zhang, Pengfei; Xu, Shengtao; Zhu, Zheying; Xu, Jinyi</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">228-247</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a multifactorial syndrome resulting in profound misery and poses a substantial burden on human health, economy, and society throughout the world.  Based on the numerous AD-related targets in the disease network, multi-target design strategy is a crucial direction to seek for enhanced therapy, and multi-target drugs have the ability to regulate more targets than single-target drugs, affecting the disease network with more potency.  Herein, we highlight nine major targets assocd. with AD, which are acetylcholine esterase (AChE), beta-site amyloid precursor protein cleaving enzyme 1 (β-secretase, BACE-1), glycogen synthase kinase 3 beta (GSK-3β), monoamine oxidases (MAOs), metal ions in the brain, N-methyl-D-aspartate (NMDA) receptor, 5-hydroxytryptamine (5-HT) receptors, the third subtype of histamine receptor (H3 receptor), and phosphodiesterases (PDEs), and their resp. relationship to the disease network.  Furthermore, eleven multi-target design strategies classified by the involvement of AChE and related promising compds. for improved therapy of AD in recent years are described based on the nine major targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRXynXSn84-bVg90H21EOLACvtfcHk0lhr6wFTvdl0iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXpvVGnsb8%253D&md5=86555914b4ef65fae2d38caedb87f1aa</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.05.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.05.020%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DJ.%26atitle%3DMulti-target%2520design%2520strategies%2520for%2520the%2520improved%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D176%26spage%3D228%26epage%3D247%26doi%3D10.1016%2Fj.ejmech.2019.05.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lalut, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karila, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecoutey, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nachon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sussman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dallemagne, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rochais, C.</span></span> <span> </span><span class="NLM_article-title">Novel multitarget-directed ligands targeting acetylcholinesterase and σ1 receptors as lead compounds for treatment of Alzheimer’s disease: synthesis, evaluation, and structural characterization of their complexes with acetylcholinesterase</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>162</i></span>,  <span class="NLM_fpage">234</span>– <span class="NLM_lpage">248</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.10.064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2Fj.ejmech.2018.10.064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=30447434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1ChsbjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=2019&pages=234-248&author=J.+Lalutauthor=G.+Santoniauthor=D.+Karilaauthor=C.+Lecouteyauthor=A.+Davisauthor=F.+Nachonauthor=I.+Silmanauthor=J.+Sussmanauthor=M.+Weikauthor=T.+Mauriceauthor=P.+Dallemagneauthor=C.+Rochais&title=Novel+multitarget-directed+ligands+targeting+acetylcholinesterase+and+%CF%831+receptors+as+lead+compounds+for+treatment+of+Alzheimer%E2%80%99s+disease%3A+synthesis%2C+evaluation%2C+and+structural+characterization+of+their+complexes+with+acetylcholinesterase&doi=10.1016%2Fj.ejmech.2018.10.064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7dR"><div class="casContent"><span class="casTitleNuber">7d</span><div class="casTitle"><span class="NLM_cas:atitle">Novel multitarget-directed ligands targeting acetylcholinesterase and σ1 receptors as lead compounds for treatment of Alzheimer's disease: Synthesis, evaluation, and structural characterization of their complexes with acetylcholinesterase</span></div><div class="casAuthors">Lalut, Julien; Santoni, Gianluca; Karila, Delphine; Lecoutey, Cedric; Davis, Audrey; Nachon, Florian; Silman, Israel; Sussman, Joel; Weik, Martin; Maurice, Tangui; Dallemagne, Patrick; Rochais, Christophe</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">162</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">234-248</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Pleiotropic intervention may be a requirement for effective limitation of the progression of multifactorial diseases such as Alzheimer's disease.  One approach to such intervention is to design a single chem. entity capable of acting on two or more targets of interest, which are accordingly known as multi-target directed ligands (MTDLs).  We recently described donecopride, the first MTDL able to simultaneously inhibit acetylcholinesterase and act as an agonist of the 5-HT4 receptor, which displays promising activities in vivo.  Pharmacomodulation of donecopride allowed us to develop a novel series of indole derivs. possessing interesting in vitro activities toward AChE and the σ1 receptor.  The crystal structures of complexes of the most promising compds. with Torpedo californica AChE were solved in order to further understand their mode of inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp9tmUk8w_j7Vg90H21EOLACvtfcHk0lhr6wFTvdl0iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1ChsbjF&md5=79dec73e1bf82d5d1b893a81366ea5ef</span></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.10.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.10.064%26sid%3Dliteratum%253Aachs%26aulast%3DLalut%26aufirst%3DJ.%26aulast%3DSantoni%26aufirst%3DG.%26aulast%3DKarila%26aufirst%3DD.%26aulast%3DLecoutey%26aufirst%3DC.%26aulast%3DDavis%26aufirst%3DA.%26aulast%3DNachon%26aufirst%3DF.%26aulast%3DSilman%26aufirst%3DI.%26aulast%3DSussman%26aufirst%3DJ.%26aulast%3DWeik%26aufirst%3DM.%26aulast%3DMaurice%26aufirst%3DT.%26aulast%3DDallemagne%26aufirst%3DP.%26aulast%3DRochais%26aufirst%3DC.%26atitle%3DNovel%2520multitarget-directed%2520ligands%2520targeting%2520acetylcholinesterase%2520and%2520%25CF%25831%2520receptors%2520as%2520lead%2520compounds%2520for%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520synthesis%252C%2520evaluation%252C%2520and%2520structural%2520characterization%2520of%2520their%2520complexes%2520with%2520acetylcholinesterase%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D162%26spage%3D234%26epage%3D248%26doi%3D10.1016%2Fj.ejmech.2018.10.064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pisani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iacobazzi, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rullo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farina, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denora, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cellamare, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altomare, C. D.</span></span> <span> </span><span class="NLM_article-title">Investigating alkyl nitrates as nitric oxide releasing precursors of multitarget acetylcholinesterase-monoamine oxidase B inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>161</i></span>,  <span class="NLM_fpage">292</span>– <span class="NLM_lpage">309</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.10.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2Fj.ejmech.2018.10.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=30366255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVSlsLvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2019&pages=292-309&author=L.+Pisaniauthor=R.+M.+Iacobazziauthor=M.+Cattoauthor=M.+Rulloauthor=R.+Farinaauthor=N.+Denoraauthor=S.+Cellamareauthor=C.+D.+Altomare&title=Investigating+alkyl+nitrates+as+nitric+oxide+releasing+precursors+of+multitarget+acetylcholinesterase-monoamine+oxidase+B+inhibitors&doi=10.1016%2Fj.ejmech.2018.10.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7eR"><div class="casContent"><span class="casTitleNuber">7e</span><div class="casTitle"><span class="NLM_cas:atitle">Investigating alkyl nitrates as nitric oxide releasing precursors of multitarget acetylcholinesterase-monoamine oxidase B inhibitors</span></div><div class="casAuthors">Pisani, Leonardo; Iacobazzi, Rosa Maria; Catto, Marco; Rullo, Mariagrazia; Farina, Roberta; Denora, Nunzio; Cellamare, Saverio; Altomare, Cosimo Damiano</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">292-309</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Herein we envisaged the possibility of exploiting alkyl nitrates as precursors of alc.-bearing dual inhibitors targeting acetylcholinesterase (AChE) and monoamine oxidase B (MAO B), key enzymes in neurodegenerative syndromes such as Alzheimer's disease (AD), through biotransformation unmasking an alc. function upon nitric oxide (NO) release.  The cooperation to neuroprotection of low fluxes of NO and target enzymes' inhibition by the alc. metabolites might return a multitargeting effect.  The in vitro screening towards ChEs and MAOs of a collection of 21 primary alcs. disclosed a subset of dual inhibitors, among which three diverse chemotypes were selected to study the corresponding nitrates.  Nitrate 14 proved to be a brain permeant, potent AChE-MAO B inhibitor by itself.  Moreover, it protected human SH-SY5Y lines against rotenone and hydrogen peroxide with a poor inherent cytotoxicity and showed a slow conversion profile to its alc. metabolite 9d that still behaved as bimodal and neuroprotective mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1S4JAn66ncbVg90H21EOLACvtfcHk0liD-u2szdEwdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVSlsLvK&md5=67fbdaa172ec319a6c4223df42c6e9f5</span></div><a href="/servlet/linkout?suffix=cit7e&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.10.016%26sid%3Dliteratum%253Aachs%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DIacobazzi%26aufirst%3DR.%2BM.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DRullo%26aufirst%3DM.%26aulast%3DFarina%26aufirst%3DR.%26aulast%3DDenora%26aufirst%3DN.%26aulast%3DCellamare%26aufirst%3DS.%26aulast%3DAltomare%26aufirst%3DC.%2BD.%26atitle%3DInvestigating%2520alkyl%2520nitrates%2520as%2520nitric%2520oxide%2520releasing%2520precursors%2520of%2520multitarget%2520acetylcholinesterase-monoamine%2520oxidase%2520B%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D161%26spage%3D292%26epage%3D309%26doi%3D10.1016%2Fj.ejmech.2018.10.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mezeiova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chalupova, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nepovimova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorecki, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prchal, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malinak, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuca, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soukup, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korabecny, J.</span></span> <span> </span><span class="NLM_article-title">Donepezil derivatives targeting amyloid-β cascade in Alzheimer’s disease</span>. <i>Curr. Alzheimer Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">772</span>– <span class="NLM_lpage">800</span>, <span class="refDoi"> DOI: 10.2174/1567205016666190228122956</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.2174%2F1567205016666190228122956" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=30819078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitVymtLnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2019&pages=772-800&author=E.+Mezeiovaauthor=K.+Chalupovaauthor=E.+Nepovimovaauthor=L.+Goreckiauthor=L.+Prchalauthor=D.+Malinakauthor=K.+Kucaauthor=O.+Soukupauthor=J.+Korabecny&title=Donepezil+derivatives+targeting+amyloid-%CE%B2+cascade+in+Alzheimer%E2%80%99s+disease&doi=10.2174%2F1567205016666190228122956"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7fR"><div class="casContent"><span class="casTitleNuber">7f</span><div class="casTitle"><span class="NLM_cas:atitle">Donepezil Derivatives Targeting Amyloid-β Cascade in Alzheimer's Disease</span></div><div class="casAuthors">Mezeiova, Eva; Chalupova, Katarina; Nepovimova, Eugenie; Gorecki, Lukas; Prchal, Lukas; Malinak, David; Kuca, Kamil; Soukup, Ondrej; Korabecny, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">772-800</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's Disease (AD) is a neurodegenerative disorder with an increasing impact on society.  Because currently available therapy has only a short-term effect, a huge no. of novel compds. are developed every year exploiting knowledge of the various aspects of AD pathophysiol.  To better address the pathol. complexity of AD, one of the most extensively pursued strategies by medicinal chemists is based on Multi-target-directed Ligands (MTDLs).  Donepezil is one of the currently approved drugs for AD therapy acting as an acetylcholinesterase inhibitor.  In this review, we have made an extensive literature survey focusing on donepezil-derived MTDL hybrids primarily targeting on different levels cholinesterases and amyloid beta (Aβ) peptide.  The targeting includes direct interaction of the compds. with Aβ, AChE-induced Aβ aggregation, inhibition of BACE-1 enzyme, and modulation of biometal balance thus impeding Aβ assembly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLMwWvPdLefLVg90H21EOLACvtfcHk0liD-u2szdEwdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitVymtLnM&md5=c4c83de08738d56bafeb9224d6d5f9e8</span></div><a href="/servlet/linkout?suffix=cit7f&amp;dbid=16384&amp;doi=10.2174%2F1567205016666190228122956&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1567205016666190228122956%26sid%3Dliteratum%253Aachs%26aulast%3DMezeiova%26aufirst%3DE.%26aulast%3DChalupova%26aufirst%3DK.%26aulast%3DNepovimova%26aufirst%3DE.%26aulast%3DGorecki%26aufirst%3DL.%26aulast%3DPrchal%26aufirst%3DL.%26aulast%3DMalinak%26aufirst%3DD.%26aulast%3DKuca%26aufirst%3DK.%26aulast%3DSoukup%26aufirst%3DO.%26aulast%3DKorabecny%26aufirst%3DJ.%26atitle%3DDonepezil%2520derivatives%2520targeting%2520amyloid-%25CE%25B2%2520cascade%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2019%26volume%3D16%26spage%3D772%26epage%3D800%26doi%3D10.2174%2F1567205016666190228122956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Areales, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turcu, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barniol-Xicota, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pont, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pivetta, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espargaró, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Simone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrisano, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabate, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sureda, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vázquez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span> <span> </span><span class="NLM_article-title">A novel class of multitarget anti-Alzheimer benzohomoadamantane–chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>180</i></span>,  <span class="NLM_fpage">613</span>– <span class="NLM_lpage">626</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.07.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2Fj.ejmech.2019.07.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=31351393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVGrsbfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2019&pages=613-626&author=F.+J.+P%C3%A9rez-Arealesauthor=A.+L.+Turcuauthor=M.+Barniol-Xicotaauthor=C.+Pontauthor=D.+Pivettaauthor=A.+Espargar%C3%B3author=M.+Bartoliniauthor=A.+De+Simoneauthor=V.+Andrisanoauthor=B.+P%C3%A9rezauthor=R.+Sabateauthor=F.+X.+Suredaauthor=S.+V%C3%A1zquezauthor=D.+Mu%C3%B1oz-Torrero&title=A+novel+class+of+multitarget+anti-Alzheimer+benzohomoadamantane%E2%80%93chlorotacrine+hybrids+modulating+cholinesterases+and+glutamate+NMDA+receptors&doi=10.1016%2Fj.ejmech.2019.07.051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7gR"><div class="casContent"><span class="casTitleNuber">7g</span><div class="casTitle"><span class="NLM_cas:atitle">A novel class of multitarget anti-Alzheimer benzohomoadamantane-chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors</span></div><div class="casAuthors">Perez-Areales, F. Javier; Turcu, Andreea L.; Barniol-Xicota, Marta; Pont, Caterina; Pivetta, Deborah; Espargaro, Alba; Bartolini, Manuela; De Simone, Angela; Andrisano, Vincenza; Perez, Belen; Sabate, Raimon; Sureda, Francesc X.; Vazquez, Santiago; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">613-626</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The development of multitarget compds. against multifactorial diseases, such as Alzheimer's disease, is an area of very intensive research, due to the expected superior therapeutic efficacy that should arise from the simultaneous modulation of several key targets of the complex pathol. network.  Here we describe the synthesis and multitarget biol. profiling of a new class of compds. designed by mol. hybridization of an NMDA receptor antagonist fluorobenzohomoadamantanamine with the potent acetylcholinesterase (AChE) inhibitor 6-chlorotacrine, using two different linker lengths and linkage positions, to preserve or not the memantine-like polycyclic unsubstituted primary amine.  The best hybrids, e.g., I, exhibit greater potencies than parent compds. against AChE (IC50 0.33 nM in the best case, 44-fold increased potency over 6-chlorotacrine), butyrylcholinesterase (IC50 21 nM in the best case, 24-fold increased potency over 6-chlorotacrine), and NMDA receptors (IC50 0.89 μM in the best case, 2-fold increased potency over the parent benzohomoadamantanamine and memantine), which suggests an additive effect of both pharmacophoric moieties in the interaction with the primary targets.  Moreover, most of these compds. have been predicted to be brain permeable.  This set of biol. properties makes them promising leads for further anti-Alzheimer drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQXvbwMzIWJbVg90H21EOLACvtfcHk0lizhqiqLt1M1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVGrsbfP&md5=676e6005d48fa5fdc44a967801d79ca0</span></div><a href="/servlet/linkout?suffix=cit7g&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.07.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.07.051%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A9rez-Areales%26aufirst%3DF.%2BJ.%26aulast%3DTurcu%26aufirst%3DA.%2BL.%26aulast%3DBarniol-Xicota%26aufirst%3DM.%26aulast%3DPont%26aufirst%3DC.%26aulast%3DPivetta%26aufirst%3DD.%26aulast%3DEspargar%25C3%25B3%26aufirst%3DA.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DP%25C3%25A9rez%26aufirst%3DB.%26aulast%3DSabate%26aufirst%3DR.%26aulast%3DSureda%26aufirst%3DF.%2BX.%26aulast%3DV%25C3%25A1zquez%26aufirst%3DS.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DA%2520novel%2520class%2520of%2520multitarget%2520anti-Alzheimer%2520benzohomoadamantane%25E2%2580%2593chlorotacrine%2520hybrids%2520modulating%2520cholinesterases%2520and%2520glutamate%2520NMDA%2520receptors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D180%26spage%3D613%26epage%3D626%26doi%3D10.1016%2Fj.ejmech.2019.07.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Domenico, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barone, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perluigi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butterfield, D. A.</span></span> <span> </span><span class="NLM_article-title">Strategy to reduce free radical species in Alzheimer’s disease: an update of selected antioxidants</span>. <i>Expert Rev. Neurother.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1586/14737175.2015.955853</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1586%2F14737175.2015.955853" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=25243342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsFChuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=19-40&author=F.+Di%0ADomenicoauthor=E.+Baroneauthor=M.+Perluigiauthor=D.+A.+Butterfield&title=Strategy+to+reduce+free+radical+species+in+Alzheimer%E2%80%99s+disease%3A+an+update+of+selected+antioxidants&doi=10.1586%2F14737175.2015.955853"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Strategy to reduce free radical species in Alzheimer's disease: an update of selected antioxidants</span></div><div class="casAuthors">Di Domenico, Fabio; Barone, Eugenio; Perluigi, Marzia; Butterfield, D. Allan</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Neurotherapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-40</span>CODEN:
                <span class="NLM_cas:coden">ERNXAR</span>;
        ISSN:<span class="NLM_cas:issn">1473-7175</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD), characterized by progressive loss of memory, language, reasoning and other cognitive functions, including dementia, is characterized pathol. by the presence of senile plaques, neurofibrillary tangles and synapse loss.  Increased oxidative/nitrosative stress, decreased antioxidants, mitochondrial damage and other factors play major roles in the development and progression of AD.  Strategies to reduce pro-oxidant species to ameliorate AD pathol. have been proposed with mixed results.  In this review, the authors focus on the most recent in vitro and in vivo antioxidant approaches for removing oxidant species with relevance to AD, including N-acetyl-l-cysteine, vitamin D, vitamin E, ferulic acid, tricyclodecan-9-yl-xanthogenate, selenium and melatonin as therapeutic stratagems in AD management.  In addn., the authors reviewed the most effective mitochondria targeted antioxidants such as coenzyme Q10 and lipoic acid.  The authors suggest the use of multitargeted approaches by formulas contg. one or more antioxidant compds. may be more promising than single-agent approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF8woGMiCOhbVg90H21EOLACvtfcHk0lizhqiqLt1M1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsFChuw%253D%253D&md5=76d9f5344f84fb79e37c0b118145ae32</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1586%2F14737175.2015.955853&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737175.2015.955853%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BDomenico%26aufirst%3DF.%26aulast%3DBarone%26aufirst%3DE.%26aulast%3DPerluigi%26aufirst%3DM.%26aulast%3DButterfield%26aufirst%3DD.%2BA.%26atitle%3DStrategy%2520to%2520reduce%2520free%2520radical%2520species%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520an%2520update%2520of%2520selected%2520antioxidants%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2015%26volume%3D15%26spage%3D19%26epage%3D40%26doi%3D10.1586%2F14737175.2015.955853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Rosini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simoni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minarini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melchiorre, C.</span></span> <span> </span><span class="NLM_article-title">Oxidative stress in Alzheimer’s disease: are we connecting the dots?</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">2821</span>– <span class="NLM_lpage">2831</span>, <span class="refDoi"> DOI: 10.1021/jm400970m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400970m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1ejt7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2821-2831&author=M.+Rosiniauthor=E.+Simoniauthor=A.+Milelliauthor=A.+Minariniauthor=C.+Melchiorre&title=Oxidative+stress+in+Alzheimer%E2%80%99s+disease%3A+are+we+connecting+the+dots%3F&doi=10.1021%2Fjm400970m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative Stress in Alzheimer's Disease: Are We Connecting the Dots?</span></div><div class="casAuthors">Rosini, Michela; Simoni, Elena; Milelli, Andrea; Minarini, Anna; Melchiorre, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2821-2831</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Redox impairment is a prominent feature of Alzheimer's disease (AD).  It has led to the "oxidative stress hypothesis", which proposes antioxidants as beneficial therapeutic tools in AD treatment.  To date, a wide variety of antioxidants have been examd. as neuroprotectants.  However, success has been elusive in clin. trials.  Several factors have contributed to this failure, including the complexity of the redox system in vivo.  Potentially crit. aspects include the fine-tuned equil. between antioxidant defenses and free radical prodn., the lack of specific antioxidant target(s), and the inherent difficulty in delivering antioxidants where they are needed.  Herein, the authors highlight significant progress in the field.  Future directions of antioxidant research are also presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonuV4RR1IRPLVg90H21EOLACvtfcHk0lioX4gXDBR0RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1ejt7fM&md5=907927f3b3b6d6bcb1402fedf6080e35</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1021%2Fjm400970m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400970m%26sid%3Dliteratum%253Aachs%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DSimoni%26aufirst%3DE.%26aulast%3DMilelli%26aufirst%3DA.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DOxidative%2520stress%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520are%2520we%2520connecting%2520the%2520dots%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2821%26epage%3D2831%26doi%3D10.1021%2Fjm400970m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">von
Bernhardi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eugenín, J.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s disease: redox dysregulation as a common denominator for diverse pathogenic mechanisms</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">974</span>– <span class="NLM_lpage">1031</span>, <span class="refDoi"> DOI: 10.1089/ars.2011.4082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1089%2Fars.2011.4082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=22122400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1Witr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2012&pages=974-1031&author=R.+von%0ABernhardiauthor=J.+Eugen%C3%ADn&title=Alzheimer%E2%80%99s+disease%3A+redox+dysregulation+as+a+common+denominator+for+diverse+pathogenic+mechanisms&doi=10.1089%2Fars.2011.4082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's Disease: Redox Dysregulation As a Common Denominator for Diverse Pathogenic Mechanisms</span></div><div class="casAuthors">von Bernhardi, Rommy; Eugenin, Jaime</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">974-1031</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is the most common cause of dementia and a progressive neurodegeneration that appears to result from multiple pathogenic mechanisms (including protein misfolding/aggregation, involved in both amyloid β-dependent senile plaques and tau-dependent neurofibrillary tangles), metabolic and mitochondrial dysfunction, excitoxicity, calcium handling impairment, glial cell dysfunction, neuroinflammation, and oxidative stress.  Oxidative stress, which could be secondary to several of the other pathophysiol. mechanisms, appears to be a major determinant of the pathogenesis and progression of AD.  The identification of oxidized proteins common for mild cognitive impairment and AD suggests that key oxidn. pathways are triggered early and are involved in the initial progression of the neurodegenerative process.  Abundant data support that oxidative stress, also considered as a main factor for aging, the major risk factor for AD, can be a common key element capable of articulating the divergent nature of the proposed pathogenic factors.  Pathogenic mechanisms influence each other at different levels.  Evidence suggests that it will be difficult to define a single-target therapy resulting in the arrest of progression or the improvement of AD deterioration.  Since oxidative stress is present from early stages of disease, it appears as one of the main targets to be included in a clin. trial.  Exploring the articulation of AD pathogenic mechanisms by oxidative stress will provide clues for better understanding the pathogenesis and progression of this dementing disorder and for the development of effective therapies to treat this disease.  Antioxid. Redox Signal. 16, 974-1031.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpryYzkfbRDM7Vg90H21EOLACvtfcHk0lioX4gXDBR0RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1Witr8%253D&md5=185ff14a3d3192a5a1ef186bf5ad3385</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1089%2Fars.2011.4082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2011.4082%26sid%3Dliteratum%253Aachs%26aulast%3Dvon%2BBernhardi%26aufirst%3DR.%26aulast%3DEugen%25C3%25ADn%26aufirst%3DJ.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520redox%2520dysregulation%2520as%2520a%2520common%2520denominator%2520for%2520diverse%2520pathogenic%2520mechanisms%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2012%26volume%3D16%26spage%3D974%26epage%3D1031%26doi%3D10.1089%2Fars.2011.4082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mecocci, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polidori, M. C.</span></span> <span> </span><span class="NLM_article-title">Antioxidant clinical trials in mild cognitive impairment and Alzheimer’s disease</span>. <i>Biochim. Biophys. Acta, Mol. Basis Dis.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>1822</i></span>,  <span class="NLM_fpage">631</span>– <span class="NLM_lpage">638</span>, <span class="refDoi"> DOI: 10.1016/j.bbadis.2011.10.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2Fj.bbadis.2011.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=22019723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1GrtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1822&publication_year=2012&pages=631-638&author=P.+Mecocciauthor=M.+C.+Polidori&title=Antioxidant+clinical+trials+in+mild+cognitive+impairment+and+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bbadis.2011.10.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease</span></div><div class="casAuthors">Mecocci, Patrizia; Polidori, Maria Cristina</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">1822</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">631-638</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a highly disabling progressive neurodegenerative disorder characterized by a steadily growing no. of patients, by the absence of a cure for the disease and by great difficulties in diagnosing in the preclin. phase.  Progresses in defining the complex etiopathogenesis of AD consider oxidative stress a core aspect as far as both AD onset and progression are concerned.  However, clin. trials of antioxidants in AD have brought conflicting conclusions.  In this review, we report the main results of clin. trials with antioxidants in mild cognitive impairment (MCI) and AD.  Although available data do not warrant the doubtless use of antioxidants in AD, they are characterized by extremely poor comparability and the absence of a substantial clin. benefit of antioxidants in AD is not disproved to date.  Furthermore, the role of vascular damage that contributes to oxidative stress in AD should be addressed in testing antioxidant treatments.  This article is part of a Special Issue entitled: Antioxidants and Antioxidant Treatment in Disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCzulb0gczwrVg90H21EOLACvtfcHk0lioX4gXDBR0RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1GrtbY%253D&md5=516667c4e9e8840318acc5f92cf325a6</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.bbadis.2011.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbadis.2011.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DMecocci%26aufirst%3DP.%26aulast%3DPolidori%26aufirst%3DM.%2BC.%26atitle%3DAntioxidant%2520clinical%2520trials%2520in%2520mild%2520cognitive%2520impairment%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D2012%26volume%3D1822%26spage%3D631%26epage%3D638%26doi%3D10.1016%2Fj.bbadis.2011.10.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kukreti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saso, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kukreti, S.</span></span> <span> </span><span class="NLM_article-title">Oxidative stress: a key modulator in neurodegenerative diseases</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>24</i></span>, <span class="NLM_elocation-id">1583</span> <span class="refDoi"> DOI: 10.3390/molecules24081583</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.3390%2Fmolecules24081583" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1MXpslyhtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2019&author=A.+Singhauthor=R.+Kukretiauthor=L.+Sasoauthor=S.+Kukreti&title=Oxidative+stress%3A+a+key+modulator+in+neurodegenerative+diseases&doi=10.3390%2Fmolecules24081583"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress: a key modulator in neurodegenerative diseases</span></div><div class="casAuthors">Singh, Anju; Kukreti, Ritushree; Saso, Luciano; Kukreti, Shrikant</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1583</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Oxidative stress is proposed as a regulatory element in ageing and various neurol. disorders.  The excess of oxidants causes a redn. of antioxidants, which in turn produce an oxidn.-redn. imbalance in organisms.  Paucity of the antioxidant system generates oxidative-stress, characterized by elevated levels of reactive species (oxygen, hydroxyl free radical, and so on).  Mitochondria play a key role in ATP supply to cells via oxidative phosphorylation, as well as synthesis of essential biol. mols.  Various redox reactions catalyzed by enzymes take place in the oxidative phosphorylation process.  An inefficient oxidative phosphorylation may generate reactive oxygen species (ROS), leading to mitochondrial dysfunction.  Mitochondrial redox metab., phospholipid metab., and proteolytic pathways are found to be the major and potential source of free radicals.  A lower concn. of ROS is essential for normal cellular signaling, whereas the higher concn. and long-time exposure of ROS cause damage to cellular macromols. such as DNA, lipids and proteins, ultimately resulting in necrosis and apoptotic cell death.  Normal and proper functioning of the central nervous system (CNS) is entirely dependent on the chem. integrity of brain.  It is well established that the brain consumes a large amt. of oxygen and is highly rich in lipid content, becoming prone to oxidative stress.  A high consumption of oxygen leads to excessive prodn. of ROS.  Apart from this, the neuronal membranes are found to be rich in polyunsatd. fatty acids, which are highly susceptible to ROS.  Various neurodegenerative diseases such as Parkinson's disease (PD), Alzheimer's disease (AD), Huntington's disease (HD), and amyotrophic lateral sclerosis (ALS), among others, can be the result of biochem. alteration (due to oxidative stress) in bimol. components.  There is a need to understand the processes and role of oxidative stress in neurodegenerative diseases.  This review is an effort towards improving our understanding of the pivotal role played by OS in neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGEciNcg9o1bVg90H21EOLACvtfcHk0lhF0NmHtQO7nA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXpslyhtLo%253D&md5=0ad3baa7ddcf0a81b3f22db5c51a2880</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.3390%2Fmolecules24081583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules24081583%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DA.%26aulast%3DKukreti%26aufirst%3DR.%26aulast%3DSaso%26aufirst%3DL.%26aulast%3DKukreti%26aufirst%3DS.%26atitle%3DOxidative%2520stress%253A%2520a%2520key%2520modulator%2520in%2520neurodegenerative%2520diseases%26jtitle%3DMolecules%26date%3D2019%26volume%3D24%26doi%3D10.3390%2Fmolecules24081583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Casas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorchs, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Baeza, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teixidor, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messeguer, A.</span></span> <span> </span><span class="NLM_article-title">Inhibition of rat liver microsomal lipid peroxidation elicited by simple 2,2-dimethylchromenes and chromans structurally related to precocenes</span>. <i>J. Agric. Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">585</span>– <span class="NLM_lpage">590</span>, <span class="refDoi"> DOI: 10.1021/jf00016a011</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jf00016a011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADyaK38XhvV2gsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1992&pages=585-590&author=J.+Casasauthor=G.+Gorchsauthor=F.+S%C3%A1nchez-Baezaauthor=P.+Teixidorauthor=A.+Messeguer&title=Inhibition+of+rat+liver+microsomal+lipid+peroxidation+elicited+by+simple+2%2C2-dimethylchromenes+and+chromans+structurally+related+to+precocenes&doi=10.1021%2Fjf00016a011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of rat liver microsomal lipid peroxidation elicited by simple 2,2-dimethylchromenes and chromans structurally related to precocenes</span></div><div class="casAuthors">Casas, Josefina; Gorchs, Gloria; Sanchez-Baeza, Francisco; Teixidor, Pilar; Messeguer, Angel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Agricultural and Food Chemistry</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">585-90</span>CODEN:
                <span class="NLM_cas:coden">JAFCAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8561</span>.
    </div><div class="casAbstract">The effects on rat liver microsomal lipid peroxidn. elicited by 2,2-dimethylchromenes and chromans structurally related to precocenes was investigated in NADPH-dependent incubations by using the thiobarbituric acid-reactive substances (TBARS) and oxygen uptake rate tests as evaluation methods.  Precocene II (I) exhibited an unexpected inhibitory activity on lipid peroxidn. (IC50 = 11.4 μM, TBARS prodn. test).  Among the compds. tested, those which had a hydroxyl group on the arom. ring, particularly at the C-6 position (i.e., 6-hydroxy-7-methoxy-2,2-dimethyl-1-2H-benzopyran and its 3,4-dihydro deriv. (II), appeared to be the best inhibitors.  In this context, the inhibitory effect elicited by the hydroxychroman II (IC50 = 0.3 μM, TBARS prodn. test) was higher than that shown by BHT.  These results suggested that the lipid peroxidn. inhibitory effect exhibited by I and related derivs. could be due to a vitamin E-like free radical scavenger-based mechanism.  The identification of phenolic metabolites in the incubations performed with I or its benzopyranyl analogs lacking arom. hydroxyl substituents supported the above postulated mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoymXzIKzsb97Vg90H21EOLACvtfcHk0lhF0NmHtQO7nA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XhvV2gsLs%253D&md5=d615c730eef799809508446c3102eb34</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjf00016a011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf00016a011%26sid%3Dliteratum%253Aachs%26aulast%3DCasas%26aufirst%3DJ.%26aulast%3DGorchs%26aufirst%3DG.%26aulast%3DS%25C3%25A1nchez-Baeza%26aufirst%3DF.%26aulast%3DTeixidor%26aufirst%3DP.%26aulast%3DMesseguer%26aufirst%3DA.%26atitle%3DInhibition%2520of%2520rat%2520liver%2520microsomal%2520lipid%2520peroxidation%2520elicited%2520by%2520simple%25202%252C2-dimethylchromenes%2520and%2520chromans%2520structurally%2520related%2520to%2520precocenes%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D1992%26volume%3D40%26spage%3D585%26epage%3D590%26doi%3D10.1021%2Fjf00016a011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Montoliu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llansola, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sáez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yenes, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messeguer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felipo, V.</span></span> <span> </span><span class="NLM_article-title">Prevention of glutamate neurotoxicity in cultured neurons by 3,4-dihydro-6-hydroxy-7-methoxy-2,2-dimethyl-1(2H)-benzopyran (CR-6), a scavenger of nitric oxide</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">255</span>– <span class="NLM_lpage">261</span>, <span class="refDoi"> DOI: 10.1016/S0006-2952(99)00104-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2FS0006-2952%2899%2900104-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10423166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADyaK1MXktVSjsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1999&pages=255-261&author=C.+Montoliuauthor=M.+Llansolaauthor=R.+S%C3%A1ezauthor=S.+Yenesauthor=A.+Messeguerauthor=V.+Felipo&title=Prevention+of+glutamate+neurotoxicity+in+cultured+neurons+by+3%2C4-dihydro-6-hydroxy-7-methoxy-2%2C2-dimethyl-1%282H%29-benzopyran+%28CR-6%29%2C+a+scavenger+of+nitric+oxide&doi=10.1016%2FS0006-2952%2899%2900104-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Prevention of glutamate neurotoxicity in cultured neurons by 3,4-dihydro-6-hydroxy-7-methoxy-2,2-dimethyl-1(2H)-benzopyran (CR-6), a scavenger of nitric oxide</span></div><div class="casAuthors">Montoliu, Carmina; Llansola, Marta; Saez, Rosana; Yenes, Susana; Messeguer, Angel; Felipo, Vicente</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">255-261</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Glutamate neurotoxicity in cerebellar neurons in culture is mediated by excessive prodn. of nitric oxide (NO).  We anticipated that 3,4-dihydro-6-hydroxy-7-methoxy-2,2-dimethyl-1(2H)-benzopyran (CR-6) could act as a scavenger of NO since it contains a position (C-5) highly activated towards nitration reaction.  The aim of this work was to assess whether CR-6 acts as an NO scavenger and prevents glutamate neurotoxicity in cultures of cerebellar neurons.  It was shown that CR-6 reduced, in a dose-dependent manner, glutamate-induced formation of cGMP (EC50 ≈ 15 μM) and prevented glutamate neurotoxicity.  The protection was ≈50% at 3-10 μM and nearly complete at 100 μM.  CR-6 did not prevent glutamate-induced activation of NO synthase, but interfered with the glutamate-NO-cGMP pathway at a later step.  CR-6 reduced the formation of cGMP induced by S-nitroso-N-acetylpenicillamine (SNAP), an NO-generating agent, indicating that CR-6 acts as a scavenger of NO in cultured neurons.  This was further supported by expts. showing that in neurons treated with CR-6 and glutamate, the 5-nitro deriv. of CR-6 was formed, as detd. by GC-MS analyses.  Moreover, in vitro incubation of CR-6 with SNAP also produced the 5-nitroderivative, thus confirming that CR-6 directly reacts with NO.  The results reported indicate that CR-6 acts as an NO scavenger in neurons and prevents glutamate neurotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo7e9KdvBwArVg90H21EOLACvtfcHk0lhF0NmHtQO7nA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktVSjsro%253D&md5=a0fec322f97a773359d2819e81ab03cf</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0006-2952%2899%2900104-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-2952%252899%252900104-5%26sid%3Dliteratum%253Aachs%26aulast%3DMontoliu%26aufirst%3DC.%26aulast%3DLlansola%26aufirst%3DM.%26aulast%3DS%25C3%25A1ez%26aufirst%3DR.%26aulast%3DYenes%26aufirst%3DS.%26aulast%3DMesseguer%26aufirst%3DA.%26aulast%3DFelipo%26aufirst%3DV.%26atitle%3DPrevention%2520of%2520glutamate%2520neurotoxicity%2520in%2520cultured%2520neurons%2520by%25203%252C4-dihydro-6-hydroxy-7-methoxy-2%252C2-dimethyl-1%25282H%2529-benzopyran%2520%2528CR-6%2529%252C%2520a%2520scavenger%2520of%2520nitric%2520oxide%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1999%26volume%3D58%26spage%3D255%26epage%3D261%26doi%3D10.1016%2FS0006-2952%2899%2900104-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanvicens, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gómez-Vicente, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messeguer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cotter, T. G.</span></span> <span> </span><span class="NLM_article-title">The radical scavenger CR-6 protects SH-SY5Y neuroblastoma cells from oxidative stress-induced apoptosis: effect on survival pathways</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">735</span>– <span class="NLM_lpage">747</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2006.03914.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1111%2Fj.1471-4159.2006.03914.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=16787420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD28XovFGhsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2006&pages=735-747&author=N.+Sanvicensauthor=V.+G%C3%B3mez-Vicenteauthor=A.+Messeguerauthor=T.+G.+Cotter&title=The+radical+scavenger+CR-6+protects+SH-SY5Y+neuroblastoma+cells+from+oxidative+stress-induced+apoptosis%3A+effect+on+survival+pathways&doi=10.1111%2Fj.1471-4159.2006.03914.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The radical scavenger CR-6 protects SH-SY5Y neuroblastoma cells from oxidative stress-induced apoptosis: effect on survival pathways</span></div><div class="casAuthors">Sanvicens, Nuria; Gomez-Vicente, Violeta; Messeguer, Angel; Cotter, Thomas G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">735-747</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Reactive oxygen species (ROS) and oxidative stress have long been linked to cell death of neurons in many neurodegenerative conditions.  However, the exact mol. mechanisms triggered by oxidative stress in neurodegeneration are at present unclear.  In the current work we have used the human neuroblastoma SH-SY5Y cell line as a model for studying the mol. events occurring after inducing apoptosis with H2O2.  We show that treatment of SH-SY5Y cells with H2O2 up-regulates survival pathways during early stages of apoptosis.  Subsequently, the decline of anti-apoptotic protein levels leads to the activation of the calcium-dependent proteases calpains and the cysteine proteases caspases.  Addnl., we demonstrate that CR-6 (3,4-dihydro-6-hydroxy-7-methoxy-2,2-dimethyl-1(2H)-benzopyran) acts as a scavenger of ROS and prevents apoptosis by enhancing and prolonging up-regulation of survival pathways.  Furthermore, we show that pre-treatment of SH-SY5Y cells with a cocktail contg. CR-6, the pan-caspase inhibitor zVAD-fmk (zVal-Ala-Asp-fluoro-methylketone) and the calpain inhibitor SJA6017 confers almost total protection against apoptosis.  In summary, the present work characterizes the mol. mechanisms involved in oxidative stress-induced apoptosis in SH-SY5Y cells.  Our findings highlight the relevance of CR-6, alone or in combination with other drugs, as potential therapeutic strategy for the treatment of neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyFGSaGpP8f7Vg90H21EOLACvtfcHk0lj6iyYRDoWXVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XovFGhsLc%253D&md5=22053eb8352d45afcdc8749eec93681c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.03914.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.03914.x%26sid%3Dliteratum%253Aachs%26aulast%3DSanvicens%26aufirst%3DN.%26aulast%3DG%25C3%25B3mez-Vicente%26aufirst%3DV.%26aulast%3DMesseguer%26aufirst%3DA.%26aulast%3DCotter%26aufirst%3DT.%2BG.%26atitle%3DThe%2520radical%2520scavenger%2520CR-6%2520protects%2520SH-SY5Y%2520neuroblastoma%2520cells%2520from%2520oxidative%2520stress-induced%2520apoptosis%253A%2520effect%2520on%2520survival%2520pathways%26jtitle%3DJ.%2520Neurochem.%26date%3D2006%26volume%3D98%26spage%3D735%26epage%3D747%26doi%3D10.1111%2Fj.1471-4159.2006.03914.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Asensio, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de la
Rosa, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez-Altayó, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorina, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messeguer, À.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vila, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chamorro, À.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Planas, A. M.</span></span> <span> </span><span class="NLM_article-title">Antioxidant CR-6 protects against reperfusion injury after a transient episode of focal brain ischemia in rats</span>. <i>J. Cereb. Blood Flow Metab.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">638</span>– <span class="NLM_lpage">652</span>, <span class="refDoi"> DOI: 10.1038/jcbfm.2009.237</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1038%2Fjcbfm.2009.237" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=19904289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisF2htbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=638-652&author=F.+J.+P%C3%A9rez-Asensioauthor=X.+de+la%0ARosaauthor=F.+Jim%C3%A9nez-Altay%C3%B3author=R.+Gorinaauthor=E.+Mart%C3%ADnezauthor=%C3%80.+Messeguerauthor=E.+Vilaauthor=%C3%80.+Chamorroauthor=A.+M.+Planas&title=Antioxidant+CR-6+protects+against+reperfusion+injury+after+a+transient+episode+of+focal+brain+ischemia+in+rats&doi=10.1038%2Fjcbfm.2009.237"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Antioxidant CR-6 protects against reperfusion injury after a transient episode of focal brain ischemia in rats</span></div><div class="casAuthors">Perez-Asensio, Fernando J.; de la Rosa, Xavier; Jimenez-Altayo, Francesc; Gorina, Roser; Martinez, Emili; Messeguer, Angel; Vila, Elisabet; Chamorro, Angel; Planas, Anna M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow & Metabolism</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">638-652</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Oxidative and nitrosative stress are targets for intervention after ischemia/reperfusion.  The aim of this study was to explore the effect of CR-6, a vitamin-E analog that is antioxidant and scavenger of nitrogen-reactive species.  Sprague-Dawley rats had the middle cerebral artery (MCA) occluded either for 90 mins or permanently.  Cortical perfusion was continuously monitored by laser-Doppler flowmetry.  CR-6 (100 mg/kg) was administered orally either at 2 and 8 h after MCA occlusion, or at 2 h only.  Infarct vol., neurol. deficit, and signs of reperfusion injury were evaluated.  CR-6 was detected in plasma and brain by HPLC.  CR-6 reduced glutathione consumption in the ischemic brain and superoxide generation in the isolated MCA.  CR-6 decreased infarct vol. and attenuated the neurol. deficit at 1 and 7 days after ischemia/reperfusion, but not after permanent ischemia.  Immediately after reperfusion, cortical blood flow values returned to their baseline (±20%) in several animals, whereas others showed hyper-perfusion (>20% of baseline).  Reactive hyperemia was assocd. with adverse events such as increased cortical BBB leakage, edema, protein nitrotyrosination, COX-2 expression, and neutrophil accumulation; and with a poorer outcome, and CR-6 attenuated these effects.  In conclusion, oral CR-6 administration after transient ischemia protects the brain from reperfusion injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqefaGrWNPBZ7Vg90H21EOLACvtfcHk0lj6iyYRDoWXVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisF2htbc%253D&md5=9e09296f0d11cc38e98f64911f174a10</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fjcbfm.2009.237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fjcbfm.2009.237%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A9rez-Asensio%26aufirst%3DF.%2BJ.%26aulast%3Dde%2Bla%2BRosa%26aufirst%3DX.%26aulast%3DJim%25C3%25A9nez-Altay%25C3%25B3%26aufirst%3DF.%26aulast%3DGorina%26aufirst%3DR.%26aulast%3DMart%25C3%25ADnez%26aufirst%3DE.%26aulast%3DMesseguer%26aufirst%3D%25C3%2580.%26aulast%3DVila%26aufirst%3DE.%26aulast%3DChamorro%26aufirst%3D%25C3%2580.%26aulast%3DPlanas%26aufirst%3DA.%2BM.%26atitle%3DAntioxidant%2520CR-6%2520protects%2520against%2520reperfusion%2520injury%2520after%2520a%2520transient%2520episode%2520of%2520focal%2520brain%2520ischemia%2520in%2520rats%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D2010%26volume%3D30%26spage%3D638%26epage%3D652%26doi%3D10.1038%2Fjcbfm.2009.237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vázquez-Jiménez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrido, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miceli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prats, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer-Montiel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teixidó, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimeno, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messeguer, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and in vitro, ex-vivo and in vivo activity of hybrid compounds linking a potent ROS and RNS scavenger activity with diverse substrates addressed to pass across the blood-brain barrier</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">788</span>– <span class="NLM_lpage">802</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.08.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2Fj.ejmech.2016.08.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=27541262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlOrt7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2016&pages=788-802&author=L.+V%C3%A1zquez-Jim%C3%A9nezauthor=M.+Garridoauthor=M.+Miceliauthor=E.+Pratsauthor=A.+Ferrer-Montielauthor=M.+Teixid%C3%B3author=C.+Jimenoauthor=A.+Messeguer&title=Synthesis+and+in+vitro%2C+ex-vivo+and+in+vivo+activity+of+hybrid+compounds+linking+a+potent+ROS+and+RNS+scavenger+activity+with+diverse+substrates+addressed+to+pass+across+the+blood-brain+barrier&doi=10.1016%2Fj.ejmech.2016.08.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in vitro, ex-vivo and in vivo activity of hybrid compounds linking a potent ROS and RNS scavenger activity with diverse substrates addressed to pass across the blood-brain barrier</span></div><div class="casAuthors">Vazquez-Jimenez, Laura; Garrido, Maria; Miceli, Martina; Prats, Eva; Ferrer-Montiel, Antonio; Teixido, Meritxell; Jimeno, Ciril; Messeguer, Angel</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">788-802</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The synthesis of a small library of CR-6 (a potent ROS and RNS scavenger agent) derivs. bearing covalent linkage with different endogen nutrients that have specific transport through the blood-brain barrier (BBB) is reported.  The synthetic sequence involved the prepn. of a common precursor ester 6 derived from CR-6, which was easily converted into the carboxylic acid 7a or the amino deriv. 11, for its further coupling with the required substrates through amide bonds.  Antioxidant in vitro (DPPH) and cellular assays (CAA) with the SH-S5SY cell line performed on these library members revealed that the couplings did not affect the antioxidant activity elicited by CR-6 itself.  More interestingly, results from the i.p. administration of selected library components in rats showed that compds. 2b, 2c and 2d were able to pass across the BBB.  In particular, the amino acid compd. 2d was the most penetrating deriv. (15.8 ± 1.7 nmol/g brain with respect to the 4.0 ± 1.2 nmol/g brain found for the parent CR-6).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2lUfcMzU5WrVg90H21EOLACvtfcHk0libLp2ACPOSlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlOrt7vL&md5=b44d3cf711192dffccdf982db5df9456</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.08.007%26sid%3Dliteratum%253Aachs%26aulast%3DV%25C3%25A1zquez-Jim%25C3%25A9nez%26aufirst%3DL.%26aulast%3DGarrido%26aufirst%3DM.%26aulast%3DMiceli%26aufirst%3DM.%26aulast%3DPrats%26aufirst%3DE.%26aulast%3DFerrer-Montiel%26aufirst%3DA.%26aulast%3DTeixid%25C3%25B3%26aufirst%3DM.%26aulast%3DJimeno%26aufirst%3DC.%26aulast%3DMesseguer%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520in%2520vitro%252C%2520ex-vivo%2520and%2520in%2520vivo%2520activity%2520of%2520hybrid%2520compounds%2520linking%2520a%2520potent%2520ROS%2520and%2520RNS%2520scavenger%2520activity%2520with%2520diverse%2520substrates%2520addressed%2520to%2520pass%2520across%2520the%2520blood-brain%2520barrier%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D123%26spage%3D788%26epage%3D802%26doi%3D10.1016%2Fj.ejmech.2016.08.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanhed, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kansara, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mecwan, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Upadhyay, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prajapati, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murumkar, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, M. R.</span></span> <span> </span><span class="NLM_article-title">Novel multitarget directed triazinoindole derivatives as anti-Alzheimer agents</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">3635</span>– <span class="NLM_lpage">3661</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.9b00226</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.9b00226" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtl2jtLrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=3635-3661&author=D.+V.+Patelauthor=N.+R.+Patelauthor=A.+M.+Kanhedauthor=S.+P.+Patelauthor=A.+Sinhaauthor=D.+D.+Kansaraauthor=A.+R.+Mecwanauthor=S.+B.+Patelauthor=P.+N.+Upadhyayauthor=K.+B.+Patelauthor=D.+B.+Shahauthor=N.+K.+Prajapatiauthor=P.+R.+Murumkarauthor=K.+V.+Patelauthor=M.+R.+Yadav&title=Novel+multitarget+directed+triazinoindole+derivatives+as+anti-Alzheimer+agents&doi=10.1021%2Facschemneuro.9b00226"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17a</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Multitarget Directed Triazinoindole Derivatives as Anti-Alzheimer Agents</span></div><div class="casAuthors">Patel, Dushyant V.; Patel, Nirav R.; Kanhed, Ashish M.; Patel, Sagar P.; Sinha, Anshuman; Kansara, Deep D.; Mecwan, Annie R.; Patel, Sarvangee B.; Upadhyay, Pragnesh N.; Patel, Kishan B.; Shah, Dharti B.; Prajapati, Navnit K.; Murumkar, Prashant R.; Patel, Kirti V.; Yadav, Mange Ram</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3635-3661</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The multifaceted nature of Alzheimer's disease (AD) demands treatment with multitarget-directed ligands (MTDLs) to confront the key pathol. aberrations.  A novel series of triazinoindole derivs. were designed and synthesized.  In vitro studies revealed that all the compds. showed moderate to good anticholinesterase activity; the most active compd. 23e showed an IC50 value of 0.56 ± 0.02 μM for AChE and an IC50 value of 1.17 ± 0.09 μM for BuChE.  These derivs. are also endowed with potent antioxidant activity.  To understand the plausible binding mode of the compd. 23e, mol. docking studies and mol. dynamics simulation studies were performed, and the results indicated significant interactions of 23e within the active sites of AChE as well as BuChE.  Compd. 23e successfully diminished H2O2-induced oxidative stress in SH-SY5Y cells and displayed excellent neuroprotective activity against H2O2 as well as Aβ-induced toxicity in SH-SY5Y cells in a concn. dependent manner.  Furthermore, it did not show any significant toxicity in neuronal SH-SY5Y cells in the cytotoxicity assay.  Compd. 23e did not show any acute toxicity in rats at doses up to 2000 mg/kg, and it significantly reversed scopolamine-induced memory deficit in mice model.  Addnl., compd. 23e showed notable in silico ADMET properties.  Taken collectively, these findings project compd. 23e as a potential balanced MTDL in the evolution process of novel anti-AD drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFrn4aKD5fUrVg90H21EOLACvtfcHk0libLp2ACPOSlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtl2jtLrP&md5=662353ea8e5f6d29d01ee1e4456dbaee</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.9b00226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.9b00226%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DD.%2BV.%26aulast%3DPatel%26aufirst%3DN.%2BR.%26aulast%3DKanhed%26aufirst%3DA.%2BM.%26aulast%3DPatel%26aufirst%3DS.%2BP.%26aulast%3DSinha%26aufirst%3DA.%26aulast%3DKansara%26aufirst%3DD.%2BD.%26aulast%3DMecwan%26aufirst%3DA.%2BR.%26aulast%3DPatel%26aufirst%3DS.%2BB.%26aulast%3DUpadhyay%26aufirst%3DP.%2BN.%26aulast%3DPatel%26aufirst%3DK.%2BB.%26aulast%3DShah%26aufirst%3DD.%2BB.%26aulast%3DPrajapati%26aufirst%3DN.%2BK.%26aulast%3DMurumkar%26aufirst%3DP.%2BR.%26aulast%3DPatel%26aufirst%3DK.%2BV.%26aulast%3DYadav%26aufirst%3DM.%2BR.%26atitle%3DNovel%2520multitarget%2520directed%2520triazinoindole%2520derivatives%2520as%2520anti-Alzheimer%2520agents%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2019%26volume%3D10%26spage%3D3635%26epage%3D3661%26doi%3D10.1021%2Facschemneuro.9b00226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Nesi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sestito, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Digiacomo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rapposelli, S.</span></span> <span> </span><span class="NLM_article-title">Oxidative stress, mitochondrial abnormalities and proteins deposition: multitarget approaches in Alzheimer’s disease</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">3062</span>– <span class="NLM_lpage">3079</span>, <span class="refDoi"> DOI: 10.2174/1568026617666170607114232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.2174%2F1568026617666170607114232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=28595557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A280%3ADC%252BC1cnmsVWlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=3062-3079&author=G.+Nesiauthor=S.+Sestitoauthor=M.+Digiacomoauthor=S.+Rapposelli&title=Oxidative+stress%2C+mitochondrial+abnormalities+and+proteins+deposition%3A+multitarget+approaches+in+Alzheimer%E2%80%99s+disease&doi=10.2174%2F1568026617666170607114232"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative Stress, Mitochondrial Abnormalities and Proteins Deposition: Multitarget Approaches in Alzheimer's Disease</span></div><div class="casAuthors">Nesi Giulia; Sestito Simona; Digiacomo Maria; Rapposelli Simona</div><div class="citationInfo"><span class="NLM_cas:title">Current topics in medicinal chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">3062-3079</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alzheimer Diseases (AD) is a multifactorial pathology characterized by a complex etiology.  The hallmarks of AD, such as Aβ deposits in senile plaque and Neurofibrillary Tangles (NFT), are strongly intertwined with Reactive Oxygen Species (ROS) production and oxidative stress (OS), which are considered the common effectors of the cascade of degenerative events.  An increasing body of evidence reveals that both mitochondrial abnormalities and metal accumulations synergistically act as major producers of ROS, thus contributing to neuronal toxicity.  Consequently, the detrimental role of ROS production together with the neurodegenerative events involved in AD has been widely investigated as new potential therapeutic strategies.  This review will concisely summarize the link between OS and the hallmarks of AD, emphasizing on their strong correlation with neurodegenerative events and elucidating the pivotal role of ROS in AD pathology.  Furthermore, through this review, we will provide a short account of some of the efforts, challenges and opportunities in developing multitarget drugs by addressing ROS production, metal accumulation and protein depositions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQhCycVI-AnQSnGiHuhFGv8fW6udTcc2eaSp35nh8hB9bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cnmsVWlsA%253D%253D&md5=657c47e53aa814d02ce01df506044eb0</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.2174%2F1568026617666170607114232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026617666170607114232%26sid%3Dliteratum%253Aachs%26aulast%3DNesi%26aufirst%3DG.%26aulast%3DSestito%26aufirst%3DS.%26aulast%3DDigiacomo%26aufirst%3DM.%26aulast%3DRapposelli%26aufirst%3DS.%26atitle%3DOxidative%2520stress%252C%2520mitochondrial%2520abnormalities%2520and%2520proteins%2520deposition%253A%2520multitarget%2520approaches%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2017%26volume%3D17%26spage%3D3062%26epage%3D3079%26doi%3D10.2174%2F1568026617666170607114232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit17c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Franco, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernández-Bachiller, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernández-Ledesma, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolomé, B.</span></span> <span> </span><span class="NLM_article-title">Novel tacrine–melatonin hybrids as dual-acting drugs for Alzheimer disease, with improved acetylcholinesterase inhibitory and antioxidant properties</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">459</span>– <span class="NLM_lpage">462</span>, <span class="refDoi"> DOI: 10.1021/jm050746d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050746d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlWmurfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=459-462&author=M.+I.+Rodr%C3%ADguez-Francoauthor=M.+I.+Fern%C3%A1ndez-Bachillerauthor=C.+P%C3%A9rezauthor=B.+Hern%C3%A1ndez-Ledesmaauthor=B.+Bartolom%C3%A9&title=Novel+tacrine%E2%80%93melatonin+hybrids+as+dual-acting+drugs+for+Alzheimer+disease%2C+with+improved+acetylcholinesterase+inhibitory+and+antioxidant+properties&doi=10.1021%2Fjm050746d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17cR"><div class="casContent"><span class="casTitleNuber">17c</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Tacrine-Melatonin Hybrids as Dual-Acting Drugs for Alzheimer Disease, with Improved Acetylcholinesterase Inhibitory and Antioxidant Properties</span></div><div class="casAuthors">Rodriguez-Franco, Maria Isabel; Fernandez-Bachiller, Maria Isabel; Perez, Concepcion; Hernandez-Ledesma, Blanca; Bartolome, Begona</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">459-462</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tacrine and melatonin are well-known drugs with activities as an acetylcholinesterase (AChE) inhibitor and free radical scavenger, resp.  In this work, the authors report new hybrids of both drugs that display higher in vitro properties than the sum of their parts.  As selective inhibitors of human AChE, their IC50 values range from sub-nanomolar to picomolar.  They exhibit a higher oxygen radical absorbance capacity than does melatonin and are predicted to be able to cross the blood-brain barrier to reach their targets in the central nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJx8cNT0dPfrVg90H21EOLACvtfcHk0lh9B9PqZFTDfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlWmurfM&md5=ee924cb63a2f3263853a6449e40cb69f</span></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=10.1021%2Fjm050746d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050746d%26sid%3Dliteratum%253Aachs%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DFern%25C3%25A1ndez-Bachiller%26aufirst%3DM.%2BI.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%26aulast%3DHern%25C3%25A1ndez-Ledesma%26aufirst%3DB.%26aulast%3DBartolom%25C3%25A9%26aufirst%3DB.%26atitle%3DNovel%2520tacrine%25E2%2580%2593melatonin%2520hybrids%2520as%2520dual-acting%2520drugs%2520for%2520Alzheimer%2520disease%252C%2520with%2520improved%2520acetylcholinesterase%2520inhibitory%2520and%2520antioxidant%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D459%26epage%3D462%26doi%3D10.1021%2Fjm050746d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit17d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fernández-Bachiller, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campillo, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Páez, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González-Muñoz, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Usán, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Palomero, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villarroya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Franco, M. I.</span></span> <span> </span><span class="NLM_article-title">Tacrine-melatonin hybrids as multifunctional agents for Alzheimer’s disease, with cholinergic, antioxidant, and neuroprotective properties</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">828</span>– <span class="NLM_lpage">841</span>, <span class="refDoi"> DOI: 10.1002/cmdc.200800414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1002%2Fcmdc.200800414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=19308922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD1MXls1Kgt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=828-841&author=M.+I.+Fern%C3%A1ndez-Bachillerauthor=C.+P%C3%A9rezauthor=N.+E.+Campilloauthor=J.+A.+P%C3%A1ezauthor=G.+C.+Gonz%C3%A1lez-Mu%C3%B1ozauthor=P.+Us%C3%A1nauthor=E.+Garc%C3%ADa-Palomeroauthor=M.+G.+L%C3%B3pezauthor=M.+Villarroyaauthor=A.+G.+Garc%C3%ADaauthor=A.+Mart%C3%ADnezauthor=M.+I.+Rodr%C3%ADguez-Franco&title=Tacrine-melatonin+hybrids+as+multifunctional+agents+for+Alzheimer%E2%80%99s+disease%2C+with+cholinergic%2C+antioxidant%2C+and+neuroprotective+properties&doi=10.1002%2Fcmdc.200800414"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17dR"><div class="casContent"><span class="casTitleNuber">17d</span><div class="casTitle"><span class="NLM_cas:atitle">Tacrine-Melatonin Hybrids as Multifunctional Agents for Alzheimer's Disease, with Cholinergic, Antioxidant, and Neuroprotective Properties</span></div><div class="casAuthors">Fernandez-Bachiller, Maria Isabel; Perez, Concepcion; Campillo, Nuria Eugenia; Paez, Juan Antonio; Gonzalez-Munoz, Gema Cristina; Usan, Paola; Garcia-Palomero, Esther; Lopez, Manuela G.; Villarroya, Mercedes; Garcia, Antonio G.; Martinez, Ana; Rodriguez-Franco, Maria Isabel</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">828-841</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Tacrine-melatonin hybrids are potential multifunctional drugs for Alzheimer's disease that may simultaneously palliate intellectual deficits and protect the brain against both β-amyloid peptide and oxidative stress.  Mol. modeling studies show that they target both the catalytic active site (CAS) and the peripheral anionic site (PAS) of AChE.  They are nontoxic and may be able to penetrate the CNS, according to in vitro PAMPA-BBB assays.  Tacrine-melatonin hybrids were designed and synthesized as new multifunctional drug candidates for Alzheimer's disease.  These compds. may simultaneously palliate intellectual deficits and protect the brain against both β-amyloid (Aβ) peptide and oxidative stress.  They show improved cholinergic and antioxidant properties, and are more potent and selective inhibitors of human acetylcholinesterase (hAChE) than tacrine.  They also capture free radicals better than melatonin.  Mol. modeling studies show that these hybrids target both the catalytic active site (CAS) and the peripheral anionic site (PAS) of AChE.  At sub-micromolar concns. they efficiently displace the binding of propidium iodide from the PAS and could thus inhibit Aβ peptide aggregation promoted by AChE.  Moreover, they also inhibit Aβ self-aggregation and display neuroprotective properties in a human neuroblastoma line against cell death induced by various toxic insults, such as Aβ25-35, H2O2, and rotenone.  Finally, they exhibit low toxicity and may be able to penetrate the central nervous system according to an in vitro parallel artificial membrane permeability assay for the blood-brain barrier (PAMPA-BBB).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf8mEFq1tgJ7Vg90H21EOLACvtfcHk0lh9B9PqZFTDfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXls1Kgt7g%253D&md5=67c7f37e4d3ec3b28387d1b2d19abbbd</span></div><a href="/servlet/linkout?suffix=cit17d&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200800414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200800414%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez-Bachiller%26aufirst%3DM.%2BI.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%26aulast%3DCampillo%26aufirst%3DN.%2BE.%26aulast%3DP%25C3%25A1ez%26aufirst%3DJ.%2BA.%26aulast%3DGonz%25C3%25A1lez-Mu%25C3%25B1oz%26aufirst%3DG.%2BC.%26aulast%3DUs%25C3%25A1n%26aufirst%3DP.%26aulast%3DGarc%25C3%25ADa-Palomero%26aufirst%3DE.%26aulast%3DL%25C3%25B3pez%26aufirst%3DM.%2BG.%26aulast%3DVillarroya%26aufirst%3DM.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DA.%2BG.%26aulast%3DMart%25C3%25ADnez%26aufirst%3DA.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26atitle%3DTacrine-melatonin%2520hybrids%2520as%2520multifunctional%2520agents%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%252C%2520with%2520cholinergic%252C%2520antioxidant%252C%2520and%2520neuroprotective%2520properties%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D828%26epage%3D841%26doi%3D10.1002%2Fcmdc.200800414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panda, G.</span></span> <span> </span><span class="NLM_article-title">Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer’s disease (1998–2018)</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">895</span>– <span class="NLM_lpage">930</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2019.01.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2Fj.bmc.2019.01.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=30744931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1MXivVWlt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2019&pages=895-930&author=P.+Mishraauthor=A.+Kumarauthor=G.+Panda&title=Anti-cholinesterase+hybrids+as+multi-target-directed+ligands+against+Alzheimer%E2%80%99s+disease+%281998%E2%80%932018%29&doi=10.1016%2Fj.bmc.2019.01.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer's disease (1998-2018)</span></div><div class="casAuthors">Mishra, Pankaj; Kumar, Amit; Panda, Gautam</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">895-930</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a genetically complex, progressive and irreversible neurodegenerative disorder of the brain which involves multiple assocd. etiol. targets.  The complex pathogenesis of AD gave rise to multi-target-directed ligands (MTDLs) principle to combat this dreaded disease.  Within this approach, the design and synthesis of hybrids prevailed greatly because of their capability to simultaneously target the intertwined pathogenesis components of the disease.  The hybrids include pharmacophoric hybridization of two or more established chem. scaffolds endowed with the desired pharmacol. properties into a single moiety.  In AD, the primary foundation of medication therapy and drug design strategies includes the inhibition of cholinesterase (ChE) enzymes.  Hence the development of ChE inhibition based hybrids is the central choice of AD medicinal chem. research.  To illustrate the progress of ChE inhibition based hybrids and novel targets, we reviewed the medicinal chem. and pharmacol. properties of the multi-target mols. published since 1998-Dec. 2018.  We hope that this article will allow the readers to easily follow the evolution of this prominent medicinal chem. approach to develop a more efficient inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp6n_9YGJjsrVg90H21EOLACvtfcHk0lh9B9PqZFTDfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXivVWlt7g%253D&md5=5941878ce58266e56b041f4d239d2b63</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2019.01.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2019.01.025%26sid%3Dliteratum%253Aachs%26aulast%3DMishra%26aufirst%3DP.%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DPanda%26aufirst%3DG.%26atitle%3DAnti-cholinesterase%2520hybrids%2520as%2520multi-target-directed%2520ligands%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%2520%25281998%25E2%2580%25932018%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2019%26volume%3D27%26spage%3D895%26epage%3D930%26doi%3D10.1016%2Fj.bmc.2019.01.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Viayna, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sola, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Simone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tapia-Rojas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serrano, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabaté, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juárez-Jiménez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrisano, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clos, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inestrosa, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span> <span> </span><span class="NLM_article-title">Synthesis and multitarget biological profiling of a novel family of rhein derivatives as disease-modifying anti-Alzheimer agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">2549</span>– <span class="NLM_lpage">2567</span>, <span class="refDoi"> DOI: 10.1021/jm401824w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401824w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtVeqsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2549-2567&author=E.+Viaynaauthor=I.+Solaauthor=M.+Bartoliniauthor=A.+De+Simoneauthor=C.+Tapia-Rojasauthor=F.+G.+Serranoauthor=R.+Sabat%C3%A9author=J.+Ju%C3%A1rez-Jim%C3%A9nezauthor=B.+P%C3%A9rezauthor=F.+J.+Luqueauthor=V.+Andrisanoauthor=M.+V.+Closauthor=N.+C.+Inestrosaauthor=D.+Mu%C3%B1oz-Torrero&title=Synthesis+and+multitarget+biological+profiling+of+a+novel+family+of+rhein+derivatives+as+disease-modifying+anti-Alzheimer+agents&doi=10.1021%2Fjm401824w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19a</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Multitarget Biological Profiling of a Novel Family of Rhein Derivatives As Disease-Modifying Anti-Alzheimer Agents</span></div><div class="casAuthors">Viayna, Elisabet; Sola, Irene; Bartolini, Manuela; De Simone, Angela; Tapia-Rojas, Cheril; Serrano, Felipe G.; Sabate, Raimon; Juarez-Jimenez, Jordi; Perez, Belen; Luque, F. Javier; Andrisano, Vincenza; Clos, M. Victoria; Inestrosa, Nibaldo C.; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2549-2567</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have synthesized a family of rhein-huprine hybrids I [X = (CH2)n, n = 5-11; X = CH2-p-phenylene-CH2] to hit several key targets for Alzheimer's disease.  Biol. screening performed in vitro and in Escherichia coli cells has shown that these hybrids exhibit potent inhibitory activities against human acetylcholinesterase, butyrylcholinesterase, and BACE-1, dual Aβ42 and tau antiaggregating activity, and brain permeability.  Ex vivo studies with the leads (+)- and (-)-I [X = (CH2)9] (II) in brain slices of C57bl6 mice have revealed that they efficiently protect against the Aβ-induced synaptic dysfunction, preventing the loss of synaptic proteins and/or have a pos. effect on the induction of long-term potentiation.  In vivo studies in APP-PS1 transgenic mice treated i.p. for 4 wk with (+)- and (-)-II have shown a central sol. Aβ lowering effect, accompanied by an increase in the levels of mature amyloid precursor protein (APP).  Thus, (+)- and (-)-II emerge as very promising disease-modifying anti-Alzheimer drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeoyGkrcOQArVg90H21EOLACvtfcHk0ljVGtUm46LJug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtVeqsrc%253D&md5=711450b3c2289a3fb2037d536e9a7a7b</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1021%2Fjm401824w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401824w%26sid%3Dliteratum%253Aachs%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DSola%26aufirst%3DI.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DTapia-Rojas%26aufirst%3DC.%26aulast%3DSerrano%26aufirst%3DF.%2BG.%26aulast%3DSabat%25C3%25A9%26aufirst%3DR.%26aulast%3DJu%25C3%25A1rez-Jim%25C3%25A9nez%26aufirst%3DJ.%26aulast%3DP%25C3%25A9rez%26aufirst%3DB.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DSynthesis%2520and%2520multitarget%2520biological%2520profiling%2520of%2520a%2520novel%2520family%2520of%2520rhein%2520derivatives%2520as%2520disease-modifying%2520anti-Alzheimer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2549%26epage%3D2567%26doi%3D10.1021%2Fjm401824w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit19b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Galdeano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viayna, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sola, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Formosa, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camps, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clos, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Relat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrisano, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmona, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minguillón, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González-Muñoz, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Franco, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bidon-Chanal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span> <span> </span><span class="NLM_article-title">Huprine–tacrine heterodimers as anti-amyloidogenic compounds of potential interest against Alzheimer’s and prion diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">661</span>– <span class="NLM_lpage">669</span>, <span class="refDoi"> DOI: 10.1021/jm200840c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200840c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ersLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=661-669&author=C.+Galdeanoauthor=E.+Viaynaauthor=I.+Solaauthor=X.+Formosaauthor=P.+Campsauthor=A.+Badiaauthor=M.+V.+Closauthor=J.+Relatauthor=M.+Ratiaauthor=M.+Bartoliniauthor=F.+Manciniauthor=V.+Andrisanoauthor=M.+Salmonaauthor=C.+Minguill%C3%B3nauthor=G.+C.+Gonz%C3%A1lez-Mu%C3%B1ozauthor=M.+I.+Rodr%C3%ADguez-Francoauthor=A.+Bidon-Chanalauthor=F.+J.+Luqueauthor=D.+Mu%C3%B1oz-Torrero&title=Huprine%E2%80%93tacrine+heterodimers+as+anti-amyloidogenic+compounds+of+potential+interest+against+Alzheimer%E2%80%99s+and+prion+diseases&doi=10.1021%2Fjm200840c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19b</span><div class="casTitle"><span class="NLM_cas:atitle">Huprine-Tacrine Heterodimers as Anti-Amyloidogenic Compounds of Potential Interest against Alzheimer's and Prion Diseases</span></div><div class="casAuthors">Galdeano, Carles; Viayna, Elisabet; Sola, Irene; Formosa, Xavier; Camps, Pelayo; Badia, Albert; Clos, M. Victoria; Relat, Julia; Ratia, Miriam; Bartolini, Manuela; Mancini, Francesca; Andrisano, Vincenza; Salmona, Mario; Minguillon, Cristina; Gonzalez-Munoz, Gema C.; Rodriguez-Franco, M. Isabel; Bidon-Chanal, Axel; Luque, F. Javier; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">661-669</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A family of huprine-tacrine heterodimers has been developed to simultaneously block the active and peripheral sites of acetylcholinesterase (AChE).  Their dual site binding for AChE, supported by kinetic and mol. modeling studies, results in a highly potent inhibition of the catalytic activity of human AChE and, more importantly, in the in vitro neutralization of the pathol. chaperoning effect of AChE toward the aggregation of both the β-amyloid peptide (Aβ) and a prion peptide with a key role in the aggregation of the prion protein.  Huprine-tacrine heterodimers take on added value in that they display a potent in vitro inhibitory activity toward human butyrylcholinesterase, self-induced Aβ aggregation, and β-secretase.  Finally, they are able to cross the blood-brain barrier, as predicted in an artificial membrane model assay and demonstrated in ex vivo expts. with OF1 mice, reaching their multiple biol. targets in the central nervous system.  Overall, these compds. are promising lead compds. for the treatment of Alzheimer's and prion diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSrojS0ckMVLVg90H21EOLACvtfcHk0ljVGtUm46LJug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ersLnN&md5=e0fbec47bca527df4e8ed73c847383e9</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1021%2Fjm200840c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200840c%26sid%3Dliteratum%253Aachs%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DSola%26aufirst%3DI.%26aulast%3DFormosa%26aufirst%3DX.%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DBadia%26aufirst%3DA.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DRelat%26aufirst%3DJ.%26aulast%3DRatia%26aufirst%3DM.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DSalmona%26aufirst%3DM.%26aulast%3DMinguill%25C3%25B3n%26aufirst%3DC.%26aulast%3DGonz%25C3%25A1lez-Mu%25C3%25B1oz%26aufirst%3DG.%2BC.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DBidon-Chanal%26aufirst%3DA.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DHuprine%25E2%2580%2593tacrine%2520heterodimers%2520as%2520anti-amyloidogenic%2520compounds%2520of%2520potential%2520interest%2520against%2520Alzheimer%25E2%2580%2599s%2520and%2520prion%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D661%26epage%3D669%26doi%3D10.1021%2Fjm200840c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit19c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Camps, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Formosa, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galdeano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramı́rez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gómez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isambert, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavilla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clos, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrisano, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arce, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Franco, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huertas, Ó.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dafni, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span> <span> </span><span class="NLM_article-title">Pyrano[3,2-c]quinoline–6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and β-amyloid-directed anti-Alzheimer compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">5365</span>– <span class="NLM_lpage">5379</span>, <span class="refDoi"> DOI: 10.1021/jm900859q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900859q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsFaktLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5365-5379&author=P.+Campsauthor=X.+Formosaauthor=C.+Galdeanoauthor=D.+Mu%C3%B1oz-Torreroauthor=L.+Ram%C4%B1%CC%81rezauthor=E.+G%C3%B3mezauthor=N.+Isambertauthor=R.+Lavillaauthor=A.+Badiaauthor=M.+V.+Closauthor=M.+Bartoliniauthor=F.+Manciniauthor=V.+Andrisanoauthor=M.+P.+Arceauthor=M.+I.+Rodr%C3%ADguez-Francoauthor=%C3%93.+Huertasauthor=T.+Dafniauthor=F.+J.+Luque&title=Pyrano%5B3%2C2-c%5Dquinoline%E2%80%936-chlorotacrine+hybrids+as+a+novel+family+of+acetylcholinesterase-+and+%CE%B2-amyloid-directed+anti-Alzheimer+compounds&doi=10.1021%2Fjm900859q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19cR"><div class="casContent"><span class="casTitleNuber">19c</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrano[3,2-c]quinoline-6-Chlorotacrine Hybrids as a Novel Family of Acetylcholinesterase- and β-Amyloid-Directed Anti-Alzheimer Compounds</span></div><div class="casAuthors">Camps, Pelayo; Formosa, Xavier; Galdeano, Carles; Munoz-Torrero, Diego; Ramirez, Lorena; Gomez, Elena; Isambert, Nicolas; Lavilla, Rodolfo; Badia, Albert; Clos, M. Victoria; Bartolini, Manuela; Mancini, Francesca; Andrisano, Vincenza; Arce, Mariana P.; Rodriguez-Franco, M. Isabel; Huertas, Oscar; Dafni, Thomai; Luque, F. Javier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5365-5379</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two isomeric series of dual binding site acetylcholinesterase (AChE) inhibitors have been designed, synthesized, and tested for their ability to inhibit AChE, butyrylcholinesterase, AChE-induced and self-induced β-amyloid (Aβ) aggregation, and β-secretase (BACE-1) and to cross blood-brain barrier.  The new hybrids consist of a unit of 6-chlorotacrine and a multicomponent reaction-derived pyrano[3,2-c]quinoline scaffold as the active-site and peripheral-site interacting moieties, resp., connected through an oligomethylene linker contg. an amido group at variable position.  Indeed, mol. modeling and kinetic studies have confirmed the dual site binding of these compds.  The new hybrids, and particularly I, retain the potent and selective human AChE inhibitory activity of the parent 6-chlorotacrine while exhibiting a significant in vitro inhibitory activity toward the AChE-induced and self-induced Aβ aggregation and toward BACE-1, as well as ability to enter the central nervous system, which makes them promising anti-Alzheimer lead compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0N9CfOYI1erVg90H21EOLACvtfcHk0lh0XThoCMTuMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsFaktLg%253D&md5=f2bfb696419b7634076cf7a16a4ae94b</span></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=10.1021%2Fjm900859q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900859q%26sid%3Dliteratum%253Aachs%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DFormosa%26aufirst%3DX.%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DRam%25C4%25B1%25CC%2581rez%26aufirst%3DL.%26aulast%3DG%25C3%25B3mez%26aufirst%3DE.%26aulast%3DIsambert%26aufirst%3DN.%26aulast%3DLavilla%26aufirst%3DR.%26aulast%3DBadia%26aufirst%3DA.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DArce%26aufirst%3DM.%2BP.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DHuertas%26aufirst%3D%25C3%2593.%26aulast%3DDafni%26aufirst%3DT.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26atitle%3DPyrano%255B3%252C2-c%255Dquinoline%25E2%2580%25936-chlorotacrine%2520hybrids%2520as%2520a%2520novel%2520family%2520of%2520acetylcholinesterase-%2520and%2520%25CE%25B2-amyloid-directed%2520anti-Alzheimer%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5365%26epage%3D5379%26doi%3D10.1021%2Fjm900859q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit19d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Di Pietro, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Areales, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juárez-Jiménez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espargaró, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clos, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavilla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabaté, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span> <span> </span><span class="NLM_article-title">Tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrids as a new family of anti-Alzheimer agents targeting β-amyloid, tau, and cholinesterase pathologies</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">117</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.07.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2Fj.ejmech.2014.07.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=25016233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Grs7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2014&pages=107-117&author=O.+Di+Pietroauthor=F.+J.+P%C3%A9rez-Arealesauthor=J.+Ju%C3%A1rez-Jim%C3%A9nezauthor=A.+Espargar%C3%B3author=M.+V.+Closauthor=B.+P%C3%A9rezauthor=R.+Lavillaauthor=R.+Sabat%C3%A9author=F.+J.+Luqueauthor=D.+Mu%C3%B1oz-Torrero&title=Tetrahydrobenzo%5Bh%5D%5B1%2C6%5Dnaphthyridine-6-chlorotacrine+hybrids+as+a+new+family+of+anti-Alzheimer+agents+targeting+%CE%B2-amyloid%2C+tau%2C+and+cholinesterase+pathologies&doi=10.1016%2Fj.ejmech.2014.07.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19dR"><div class="casContent"><span class="casTitleNuber">19d</span><div class="casTitle"><span class="NLM_cas:atitle">Tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrids as a new family of anti-Alzheimer agents targeting β-amyloid, tau, and cholinesterase pathologies</span></div><div class="casAuthors">Di Pietro, Ornella; Perez-Areales, F. Javier; Juarez-Jimenez, Jordi; Espargaro, Alba; Clos, M. Victoria; Perez, Belen; Lavilla, Rodolfo; Sabate, Raimon; Luque, F. Javier; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">107-117</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Optimization of an essentially inactive 3,4-dihydro-2H-pyrano[3,2-c]quinoline carboxylic ester deriv. as acetylcholinesterase (AChE) peripheral anionic site (PAS)-binding motif by double O → NH bioisosteric replacement, combined with mol. hybridization with the AChE catalytic anionic site (CAS) inhibitor 6-chlorotacrine and mol. dynamics-driven optimization of the length of the linker has resulted in the development of the trimethylene-linked 1,2,3,4-tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrid I as a picomolar inhibitor of human AChE (hAChE).  The tetra-, penta-, and octamethylene-linked homologs I [X = (CH2)4, (CH2)5, (CH2)8] have been also synthesized for comparison purposes, and found to retain the nanomolar hAChE inhibitory potency of the parent 6-chlorotacrine.  Further biol. profiling of hybrids I has shown that they are also potent inhibitors of human butyrylcholinesterase and moderately potent Aβ42 and tau antiaggregating agents, with IC50 values in the submicromolar and low micromolar range, resp.  Also, in vitro studies using an artificial membrane model have predicted a good brain permeability for hybrids I, and hence, their ability to reach their targets in the central nervous system.  The multitarget profile of the novel hybrids makes them promising leads for developing anti-Alzheimer drug candidates with more balanced biol. activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOcQV1Ii0VkbVg90H21EOLACvtfcHk0lh0XThoCMTuMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Grs7fI&md5=c52fbb0243247cd8088d94a368c33186</span></div><a href="/servlet/linkout?suffix=cit19d&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.07.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.07.021%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BPietro%26aufirst%3DO.%26aulast%3DP%25C3%25A9rez-Areales%26aufirst%3DF.%2BJ.%26aulast%3DJu%25C3%25A1rez-Jim%25C3%25A9nez%26aufirst%3DJ.%26aulast%3DEspargar%25C3%25B3%26aufirst%3DA.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DP%25C3%25A9rez%26aufirst%3DB.%26aulast%3DLavilla%26aufirst%3DR.%26aulast%3DSabat%25C3%25A9%26aufirst%3DR.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DTetrahydrobenzo%255Bh%255D%255B1%252C6%255Dnaphthyridine-6-chlorotacrine%2520hybrids%2520as%2520a%2520new%2520family%2520of%2520anti-Alzheimer%2520agents%2520targeting%2520%25CE%25B2-amyloid%252C%2520tau%252C%2520and%2520cholinesterase%2520pathologies%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D84%26spage%3D107%26epage%3D117%26doi%3D10.1016%2Fj.ejmech.2014.07.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Espargaró, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pont, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabate, R.</span></span> <span> </span><span class="NLM_article-title">Amyloid pan-inhibitors: one family of compounds to cope with all conformational diseases</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1311</span>– <span class="NLM_lpage">1317</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.8b00398</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.8b00398" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVCisbnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=1311-1317&author=A.+Espargar%C3%B3author=C.+Pontauthor=P.+Gamezauthor=D.+Mu%C3%B1oz-Torreroauthor=R.+Sabate&title=Amyloid+pan-inhibitors%3A+one+family+of+compounds+to+cope+with+all+conformational+diseases&doi=10.1021%2Facschemneuro.8b00398"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid Pan-inhibitors: One Family of Compounds To Cope with All Conformational Diseases</span></div><div class="casAuthors">Espargaro, Alba; Pont, Caterina; Gamez, Patrick; Munoz-Torrero, Diego; Sabate, Raimon</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1311-1317</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Amyloids are ubiquitous protein aggregates sharing common internal structural features; they are present in all organisms, from prokaryotes to eukaryotes, where they play physiol. or pathol. roles.  Importantly, amyloids, which are generated by aggregation of a range of distinct proteins, could be a key factor in a no. of major human disorders, the so-called conformational diseases.  Because all amyloids exhibit similar cross-β motifs, one may envisage that mols. capable of blocking the formation of β-sheet structures could abolish aggregation of all amyloid proteins, albeit with different efficacies.  Herein, two different β-sheet blockers were tested against a selection of amyloidogenic proteins, encompassing all the major types of amyloid-based disorders.  Anal. of their blocking efficiency, using a simple but contrasted cell-based screening procedure, unequivocally confirms that they indeed behave as aggregation pan-inhibitors.  The significant inhibitory effects obsd. for these compds. against all tested amyloidogenic proteins could spur a broader biol. evaluation of other known and new amyloid aggregation inhibitors to further det. the potential use of this class of compds. for the universal treatment of conformational diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgY8Nl1j3237Vg90H21EOLACvtfcHk0lh0XThoCMTuMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVCisbnN&md5=51e904c0d077435c27bd3fd11df07f5e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.8b00398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.8b00398%26sid%3Dliteratum%253Aachs%26aulast%3DEspargar%25C3%25B3%26aufirst%3DA.%26aulast%3DPont%26aufirst%3DC.%26aulast%3DGamez%26aufirst%3DP.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DSabate%26aufirst%3DR.%26atitle%3DAmyloid%2520pan-inhibitors%253A%2520one%2520family%2520of%2520compounds%2520to%2520cope%2520with%2520all%2520conformational%2520diseases%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2019%26volume%3D10%26spage%3D1311%26epage%3D1317%26doi%3D10.1021%2Facschemneuro.8b00398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Pietro, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juárez-Jiménez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laughton, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span> <span> </span><span class="NLM_article-title">Unveiling a novel transient druggable pocket in BACE-1 through molecular simulations: conformational analysis and binding mode of multisite inhibitors</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>, <span class="NLM_elocation-id">e0177683</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0177683</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1371%2Fjournal.pone.0177683" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=28505196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsF2nsrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&author=O.+Di%0APietroauthor=J.+Ju%C3%A1rez-Jim%C3%A9nezauthor=D.+Mu%C3%B1oz-Torreroauthor=C.+A.+Laughtonauthor=F.+J.+Luque&title=Unveiling+a+novel+transient+druggable+pocket+in+BACE-1+through+molecular+simulations%3A+conformational+analysis+and+binding+mode+of+multisite+inhibitors&doi=10.1371%2Fjournal.pone.0177683"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Unveiling a novel transient druggable pocket in bace-1 through molecular simulations: conformational analysis and binding mode of multisite inhibitors</span></div><div class="casAuthors">Di Pietro, Ornella; Juarez-Jimenez, Jordi; Munoz-Torrero, Diego; Laughton, Charles A.; Luque, F. Javier</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e0177683/1-e0177683/22</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The crit. role of BACE-1 in the formation of neurotoxic β-amyloid peptides in the brain makes it an attractive target for an efficacious treatment of Alzheimer's disease.  However, the development of clin. useful BACE-1 inhibitors has proven to be extremely challenging.  In this study we examine the binding mode of a novel potent inhibitor (compd. 1, with IC50 80 nM) designed by synergistic combination of two fragments-huprine and rhein- that individually are endowed with very low activity against BACE-1.  Examn. of crystal structures reveals no appropriate binding site large enough to accommodate 1.  Therefore we have examd. the conformational flexibility of BACE-1 through extended mol. dynamics simulations, paying attention to the highly flexible region shaped by loops 8-14, 154-169 and 307-318.  The anal. of the protein dynamics, together with studies of pocket druggability, has allowed us to detect the transient formation of a secondary binding site, which contains Arg307 as a key residue for the interaction with small mols., at the edge of the catalytic cleft.  The formation of this druggable "floppy" pocket would enable the binding of multisite inhibitors targeting both catalytic and secondary sites.  Mol. dynamics simulations of BACE-1 bound to huprine-rhein hybrid compds. support the feasibility of this hypothesis.  The results provide a basis to explain the high inhibitory potency of the two enantiomeric forms of 1, together with the large dependence on the length of the oligomethylenic linker.  Furthermore, the multisite hypothesis has allowed us to rationalize the inhibitory potency of a series of tacrine-chromene hybrid compds., specifically regarding the apparent lack of sensitivity of the inhibition const. to the chem. modifications introduced in the chromene unit.  Overall, these findings pave the way for the exploration of novel functionalities in the design of optimized BACE-1 multisite inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPkTHdHnmrSrVg90H21EOLACvtfcHk0lg6dENFk00Bhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsF2nsrrL&md5=bf8948c5989a213ae21b2570ae96d993</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0177683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0177683%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BPietro%26aufirst%3DO.%26aulast%3DJu%25C3%25A1rez-Jim%25C3%25A9nez%26aufirst%3DJ.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DLaughton%26aufirst%3DC.%2BA.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26atitle%3DUnveiling%2520a%2520novel%2520transient%2520druggable%2520pocket%2520in%2520BACE-1%2520through%2520molecular%2520simulations%253A%2520conformational%2520analysis%2520and%2520binding%2520mode%2520of%2520multisite%2520inhibitors%26jtitle%3DPLoS%2520One%26date%3D2017%26volume%3D12%26doi%3D10.1371%2Fjournal.pone.0177683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Ruiz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Palomero, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorronsoro, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">del Monte-Millán, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenzuela, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Usán, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Austria, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrisano, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bidon-Chanal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orozco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez, A.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors: new disease-modifying agents for Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">7223</span>– <span class="NLM_lpage">7233</span>, <span class="refDoi"> DOI: 10.1021/jm0503289</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0503289" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtV2nu7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7223-7233&author=P.+Mu%C3%B1oz-Ruizauthor=L.+Rubioauthor=E.+Garc%C3%ADa-Palomeroauthor=I.+Dorronsoroauthor=M.+del+Monte-Mill%C3%A1nauthor=R.+Valenzuelaauthor=P.+Us%C3%A1nauthor=C.+de+Austriaauthor=M.+Bartoliniauthor=V.+Andrisanoauthor=A.+Bidon-Chanalauthor=M.+Orozcoauthor=F.+J.+Luqueauthor=M.+Medinaauthor=A.+Mart%C3%ADnez&title=Design%2C+synthesis%2C+and+biological+evaluation+of+dual+binding+site+acetylcholinesterase+inhibitors%3A+new+disease-modifying+agents+for+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm0503289"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of Dual Binding Site Acetylcholinesterase Inhibitors: New Disease-Modifying Agents for Alzheimer's Disease</span></div><div class="casAuthors">Munoz-Ruiz, Pilar; Rubio, Laura; Garcia-Palomero, Esther; Dorronsoro, Isabel; Monte-Millan, Maria del; Valenzuela, Rita; Usan, Paola; de Austria, Celia; Bartolini, Manuela; Andrisano, Vincenza; Bidon-Chanal, Axel; Orozco, Modesto; Luque, F. Javier; Medina, Miguel; Martinez, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7223-7233</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">New dual binding site acetylcholinesterase (AChE) inhibitors have been designed and synthesized as new potent drugs that may simultaneously alleviate cognitive deficits and behave as disease-modifying agents by inhibiting the β-amyloid (Aβ) peptide aggregation through binding to both catalytic and peripheral sites of the enzyme.  Particularly, compds. 5 and 6 emerged as the most potent heterodimers reported so far, displaying IC50 values for AChE inhibition of 20 and 60 pM, resp.  More importantly, these dual AChE inhibitors inhibit the AChE-induced Aβ peptide aggregation with IC50 values 1 order of magnitude lower than that of propidium, thus being the most potent derivs. with this activity reported up to date.  We therefore conclude that these compds. are very promising disease-modifying agents for the treatment of Alzheimer's disease (AD).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryN7Kwa5OXZ7Vg90H21EOLACvtfcHk0lg6dENFk00Bhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtV2nu7%252FO&md5=bb5781896d759075a46bbe2222bbca03</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm0503289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0503289%26sid%3Dliteratum%253Aachs%26aulast%3DMu%25C3%25B1oz-Ruiz%26aufirst%3DP.%26aulast%3DRubio%26aufirst%3DL.%26aulast%3DGarc%25C3%25ADa-Palomero%26aufirst%3DE.%26aulast%3DDorronsoro%26aufirst%3DI.%26aulast%3Ddel%2BMonte-Mill%25C3%25A1n%26aufirst%3DM.%26aulast%3DValenzuela%26aufirst%3DR.%26aulast%3DUs%25C3%25A1n%26aufirst%3DP.%26aulast%3Dde%2BAustria%26aufirst%3DC.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBidon-Chanal%26aufirst%3DA.%26aulast%3DOrozco%26aufirst%3DM.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DMedina%26aufirst%3DM.%26aulast%3DMart%25C3%25ADnez%26aufirst%3DA.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520dual%2520binding%2520site%2520acetylcholinesterase%2520inhibitors%253A%2520new%2520disease-modifying%2520agents%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7223%26epage%3D7233%26doi%3D10.1021%2Fjm0503289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pi, R.</span>; <span class="NLM_string-name">Ye, M.</span>; <span class="NLM_string-name">Cheng, Z.</span>; <span class="NLM_string-name">Liu, P.</span></span> <span> </span><span class="NLM_article-title">Preparation of Tacrine–Ferulic Acid Containing Compounds for Treatment of Alzheimer’s Disease</span>. <span class="NLM_patent">CN101284812 A</span>, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=R.+Pi&author=M.+Ye&author=Z.+Cheng&author=P.+Liu&title=Preparation+of+Tacrine%E2%80%93Ferulic+Acid+Containing+Compounds+for+Treatment+of+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPi%26aufirst%3DR.%26atitle%3DPreparation%2520of%2520Tacrine%25E2%2580%2593Ferulic%2520Acid%2520Containing%2520Compounds%2520for%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, M.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.-F.</span></span> <span> </span><span class="NLM_article-title">A Facile synthesis of bis-tacrine isosteres</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">1815</span>– <span class="NLM_lpage">1818</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(00)00036-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2FS0040-4039%2800%2900036-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD3cXitFyjtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2000&pages=1815-1818&author=M.-K.+Huauthor=C.-F.+Lu&title=A+Facile+synthesis+of+bis-tacrine+isosteres&doi=10.1016%2FS0040-4039%2800%2900036-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A facile synthesis of bis-tacrine isosteres</span></div><div class="casAuthors">Hu, Ming-Kuan; Lu, Chih-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1815-1818</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">An efficient synthesis of highly potent and selective acetylcholinesterase (AChE) inhibitors (no data), bis-tacrines and their isosteres I (R = H, Cl, F; Y = CH, N; m = 0, 1, 2; n = 6, 7, 8), was accomplished by bis-amination of 9-chloro-tetrahydroacridine and its analogs.  The crit. intermediates were concisely prepd. in situ by heating the corresponding ortho-amino arom. acids and cycloketones in the presence of phosphorus oxychloride.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreB1JHH-X0lLVg90H21EOLACvtfcHk0lg6dENFk00Bhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXitFyjtLo%253D&md5=b1e8ac5bd3aea126380ae89bcaa9f165</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2800%2900036-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252800%252900036-8%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DM.-K.%26aulast%3DLu%26aufirst%3DC.-F.%26atitle%3DA%2520Facile%2520synthesis%2520of%2520bis-tacrine%2520isosteres%26jtitle%3DTetrahedron%2520Lett.%26date%3D2000%26volume%3D41%26spage%3D1815%26epage%3D1818%26doi%3D10.1016%2FS0040-4039%2800%2900036-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sola, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artigas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Areales, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viayna, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clos, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of N-cyanoalkyl-, N-aminoalkyl-, and N-guanidinoalkyl-substituted 4-aminoquinoline derivatives as potent, selective, brain permeable antitrypanosomal agents</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">5162</span>– <span class="NLM_lpage">5171</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.08.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2Fj.bmc.2016.08.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=27591008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVCgsrfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=5162-5171&author=I.+Solaauthor=A.+Artigasauthor=M.+C.+Taylorauthor=F.+J.+P%C3%A9rez-Arealesauthor=E.+Viaynaauthor=M.+V.+Closauthor=B.+P%C3%A9rezauthor=C.+W.+Wrightauthor=J.+M.+Kellyauthor=D.+Mu%C3%B1oz-Torrero&title=Synthesis+and+biological+evaluation+of+N-cyanoalkyl-%2C+N-aminoalkyl-%2C+and+N-guanidinoalkyl-substituted+4-aminoquinoline+derivatives+as+potent%2C+selective%2C+brain+permeable+antitrypanosomal+agents&doi=10.1016%2Fj.bmc.2016.08.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of N-cyanoalkyl-, N-aminoalkyl- and N-guanidinoalkyl-substituted 4-aminoquinoline derivatives as potent, selective, brain permeable antitrypanosomal agents</span></div><div class="casAuthors">Sola, Irene; Artigas, Albert; Taylor, Martin C.; Perez-Areales, F. Javier; Viayna, Elisabet; Clos, M. Victoria; Perez, Belen; Wright, Colin W.; Kelly, John M.; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5162-5171</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The evaluation of a small inhouse library and a second generation of newly synthesized derivs., which was led to the identification of 13 side chain modified 4-aminoquinolines I [R = H, n = 7, 9; R = Cl, n = 7, 8, 9], II [R1 = H, n = 7, 9; R1 = Cl, n = 9] and III [R2 = H, n = 7, 9; R2 = Cl, n = 9] with submicromolar potencies against T. brucei was described.  Among these compds., the guanidinononyltacrine III [R2 = H, n = 9] exhibited a 5-fold increased antitrypanosomal potency, 10-fold increased selectivity and 100-fold decreased anticholinesterasic activity relative to the parent huprine Y.  Its biol. profile, lower mol. wt. relative to dimeric compds., reduced lipophilicity and ease of synthesis, made it an interesting anti-HAT lead, amenable to further optimization to eliminate its remaining anticholinesterasic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG3NNWlrfvILVg90H21EOLACvtfcHk0lgS92Yqivew9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVCgsrfK&md5=a1a2ded9007bbbefcc2e45992609fdb9</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.08.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.08.036%26sid%3Dliteratum%253Aachs%26aulast%3DSola%26aufirst%3DI.%26aulast%3DArtigas%26aufirst%3DA.%26aulast%3DTaylor%26aufirst%3DM.%2BC.%26aulast%3DP%25C3%25A9rez-Areales%26aufirst%3DF.%2BJ.%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DP%25C3%25A9rez%26aufirst%3DB.%26aulast%3DWright%26aufirst%3DC.%2BW.%26aulast%3DKelly%26aufirst%3DJ.%2BM.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520N-cyanoalkyl-%252C%2520N-aminoalkyl-%252C%2520and%2520N-guanidinoalkyl-substituted%25204-aminoquinoline%2520derivatives%2520as%2520potent%252C%2520selective%252C%2520brain%2520permeable%2520antitrypanosomal%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D5162%26epage%3D5171%26doi%3D10.1016%2Fj.bmc.2016.08.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Camps, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez, L.</span></span> <span> </span><span class="NLM_article-title">Stereoselective synthesis of both enantiomers of N-Boc-α-aryl-γ-aminobutyric acids</span>. <i>Tetrahedron Asymmetry</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">311</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1016/j.tetasy.2003.10.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2Fj.tetasy.2003.10.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktVSrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2004&pages=311-321&author=P.+Campsauthor=D.+Mu%C3%B1oz-Torreroauthor=L.+S%C3%A1nchez&title=Stereoselective+synthesis+of+both+enantiomers+of+N-Boc-%CE%B1-aryl-%CE%B3-aminobutyric+acids&doi=10.1016%2Fj.tetasy.2003.10.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26aR"><div class="casContent"><span class="casTitleNuber">26a</span><div class="casTitle"><span class="NLM_cas:atitle">Stereoselective synthesis of both enantiomers of N-Boc-α-aryl-γ-aminobutyric acids</span></div><div class="casAuthors">Camps, Pelayo; Munoz-Torrero, Diego; Sanchez, Laura</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron: Asymmetry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">311-321</span>CODEN:
                <span class="NLM_cas:coden">TASYE3</span>;
        ISSN:<span class="NLM_cas:issn">0957-4166</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Esterification of racemic α-aryl-β-cyanopropionic acid chlorides with either (R)- or (S)-N-phenylpantolactam as the chiral auxiliary in the presence of Et3N resulted in the predominant formation of (αR,3'R)- or (αS,3'S)-configured pantolactam cyano ester, resp., in nearly quant. yields with diastereomeric ratios of up to 93:7.  Column chromatog. of the diastereoenriched cyano esters, followed by hydrolysis of the resulting diastereopure cyano esters under essentially nonracemizing conditions gave enantiopure α-aryl-β-cyanopropionic acids, which were readily converted in high yields into enantiopure (αR)- and (αS)-configured N-tert-butoxycarbonyl-α-aryl-γ-aminobutyric acid (GABA) derivs. of potential biol. interest.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSo6e3H77ZnbVg90H21EOLACvtfcHk0liQ0U7oksEdhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktVSrtw%253D%253D&md5=1eb714608405f93ea77dffa5c259cad4</span></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.1016%2Fj.tetasy.2003.10.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetasy.2003.10.035%26sid%3Dliteratum%253Aachs%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DS%25C3%25A1nchez%26aufirst%3DL.%26atitle%3DStereoselective%2520synthesis%2520of%2520both%2520enantiomers%2520of%2520N-Boc-%25CE%25B1-aryl-%25CE%25B3-aminobutyric%2520acids%26jtitle%3DTetrahedron%2520Asymmetry%26date%3D2004%26volume%3D15%26spage%3D311%26epage%3D321%26doi%3D10.1016%2Fj.tetasy.2003.10.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit26b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Camps, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span> <span> </span><span class="NLM_article-title">Synthesis and applications of (R)- and (S)-pantolactone as chiral auxiliaries</span>. <i>Curr. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1339</span>– <span class="NLM_lpage">1380</span>, <span class="refDoi"> DOI: 10.2174/1385272043369944</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.2174%2F1385272043369944" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntFOmt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2004&pages=1339-1380&author=P.+Campsauthor=D.+Mu%C3%B1oz-Torrero&title=Synthesis+and+applications+of+%28R%29-+and+%28S%29-pantolactone+as+chiral+auxiliaries&doi=10.2174%2F1385272043369944"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26bR"><div class="casContent"><span class="casTitleNuber">26b</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and applications of (R)- and (S)-pantolactone as chiral auxiliaries</span></div><div class="casAuthors">Camps, Pelayo; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">Current Organic Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1339-1380</span>CODEN:
                <span class="NLM_cas:coden">CORCFE</span>;
        ISSN:<span class="NLM_cas:issn">1385-2728</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Chiral auxiliary-based reactions constitute one the most intense research areas in org. chem.  During the last three decades (R)-pantolactone and to a minor extent its (S)-enantiomer were used as very efficient chiral auxiliaries, thus contributing to the development of chiral auxiliary-based asym. synthesis as a common approach for the prepn. of enantiomerically pure compds.  This review covers the syntheses of both (R)- and (S)-pantolactone, as well as their applications not only as chiral auxiliaries in asym. synthesis, but also in racemate resolns. and as chiral templates.  The development and applications of several analogs of pantolactone with improved profile is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYMAZXVBvvXLVg90H21EOLACvtfcHk0liQ0U7oksEdhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntFOmt7o%253D&md5=e9063f3bed14f6ad7d5976f8abc732c8</span></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=10.2174%2F1385272043369944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1385272043369944%26sid%3Dliteratum%253Aachs%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DSynthesis%2520and%2520applications%2520of%2520%2528R%2529-%2520and%2520%2528S%2529-pantolactone%2520as%2520chiral%2520auxiliaries%26jtitle%3DCurr.%2520Org.%2520Chem.%26date%3D2004%26volume%3D8%26spage%3D1339%26epage%3D1380%26doi%3D10.2174%2F1385272043369944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ellman, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courtney, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andres, V.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Featherstone, R. M.</span></span> <span> </span><span class="NLM_article-title">A new and rapid colorimetric determination of acetylcholinesterase activity</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1961</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">88</span>– <span class="NLM_lpage">95</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(61)90145-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2F0006-2952%2861%2990145-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=13726518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADyaF3MXht1Gns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1961&pages=88-95&author=G.+L.+Ellmanauthor=K.+D.+Courtneyauthor=V.+Andresauthor=R.+M.+Featherstone&title=A+new+and+rapid+colorimetric+determination+of+acetylcholinesterase+activity&doi=10.1016%2F0006-2952%2861%2990145-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A new and rapid colorimetric determination of acetylcholinesterase activity</span></div><div class="casAuthors">Ellman, George L.; Courtney, K. Diane; Andres, Valentino, Jr.; Featherstone, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">88-95</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">A photometric method for detg. acetylcholinesterase activity of tissue exts., homogenates, cell suspensions, etc. was described.  The enzyme activity of acetylcholinesterase was measured by following the increase of yellow color produced from thiocholine when it reacts with dithiobisnitrobenzoate ion, based on the reactions: acetylthiocholine (enzyme.rdblhar.) thioeholine + acetate.  Thiocholine + dithiobisnitrobenzoate .rdblhar. yellow color.  The method was used to study the enzyme in human erythrocytes and homogenates of rat brain, kidney, lungs, liver, and muscle tissue.  Hydrolysis rates [(moles/l./min.) × 10-6/g. tissue] by these homogenates of tissues on acetylthiocholine were 10.31, 0.28, 1.63, 1.07, and 1.82, and on butyrylthiocholine were 0.31, 0.21, 0.54, 0.65, and 0.12, resp.  Data obtained with acetylthiocholine as substrate were similar to those with acetylcholine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq21LY6gwNKrVg90H21EOLACvtfcHk0liQ0U7oksEdhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3MXht1Gns7o%253D&md5=46f891b7e338036a7c7d4333b82b6874</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2861%2990145-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252861%252990145-9%26sid%3Dliteratum%253Aachs%26aulast%3DEllman%26aufirst%3DG.%2BL.%26aulast%3DCourtney%26aufirst%3DK.%2BD.%26aulast%3DAndres%26aufirst%3DV.%26aulast%3DFeatherstone%26aufirst%3DR.%2BM.%26atitle%3DA%2520new%2520and%2520rapid%2520colorimetric%2520determination%2520of%2520acetylcholinesterase%2520activity%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1961%26volume%3D7%26spage%3D88%26epage%3D95%26doi%3D10.1016%2F0006-2952%2861%2990145-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wlodek, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antosiewicz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCammon, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straatsma, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilson, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briggs, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humblet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sussman, J. L.</span></span> <span> </span><span class="NLM_article-title">Binding of tacrine and 6-chlorotacrine by acetylcholinesterase</span>. <i>Biopolymers</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">117</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1097-0282(199601)38:13.0.CO;2-#</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1002%2F%28SICI%291097-0282%28199601%2938%3A1%3C109%3A%3AAID-BIP9%3E3.0.CO%3B2-%23" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=8679940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADyaK28XpvVen" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1996&pages=109-117&author=S.+T.+Wlodekauthor=J.+Antosiewiczauthor=J.+A.+McCammonauthor=T.+P.+Straatsmaauthor=M.+K.+Gilsonauthor=J.+M.+Briggsauthor=C.+Humbletauthor=J.+L.+Sussman&title=Binding+of+tacrine+and+6-chlorotacrine+by+acetylcholinesterase&doi=10.1002%2F%28SICI%291097-0282%28199601%2938%3A13.0.CO%3B2-%23"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Binding of tacrine and 6-chlorotacrine by acetylcholinesterase</span></div><div class="casAuthors">Wlodek, S. T.; Antosiewicz, J.; McCammon, J. A.; Straatsma, T. P.; Gilson, M. K.; Briggs, J. M.; Humblet, C.; Sussman, J. L.</div><div class="citationInfo"><span class="NLM_cas:title">Biopolymers</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">109-17</span>CODEN:
                <span class="NLM_cas:coden">BIPMAA</span>;
        ISSN:<span class="NLM_cas:issn">0006-3525</span>.
    
            (<span class="NLM_cas:orgname">Wiley</span>)
        </div><div class="casAbstract">Multiconfiguration thermodn. integration was used to det. the relative binding strength of tacrine and 6-chlorotacrine by Torpedo californica acetylcholinesterase.  6-Chlorotacrine appears to be bound stronger by 0.7 kcal/mol than unsubstituted tacrine when the active site triad residue His-440 is deprotonated.  This result is in excellent agreement with exptl. inhibition data on elec. eel acetylcholinesterase.  Electrostatic Poisson-Boltzmann calcns. confirm that order of binding strength, resulting in ΔG of binding of -2.9 and -3.3 kcal/mol for tacrine and chlorotacrine, resp., and suggest inhibitor binding does not occur when His-440 is charged.  The results suggest that electron d. redistribution upon tacrine chlorination is mainly responsible for the increased attraction potential between protonated inhibitor mol. and adjacent arom. groups of Phe-330 and Trp-84.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyOgkYp6yoQbVg90H21EOLACvtfcHk0lgzj-7W2KtpgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XpvVen&md5=1bd5e7dd789fbca5832152ed75db0f5b</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0282%28199601%2938%3A1%3C109%3A%3AAID-BIP9%3E3.0.CO%3B2-%23&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0282%2528199601%252938%253A1%253C109%253A%253AAID-BIP9%253E3.0.CO%253B2-%2523%26sid%3Dliteratum%253Aachs%26aulast%3DWlodek%26aufirst%3DS.%2BT.%26aulast%3DAntosiewicz%26aufirst%3DJ.%26aulast%3DMcCammon%26aufirst%3DJ.%2BA.%26aulast%3DStraatsma%26aufirst%3DT.%2BP.%26aulast%3DGilson%26aufirst%3DM.%2BK.%26aulast%3DBriggs%26aufirst%3DJ.%2BM.%26aulast%3DHumblet%26aufirst%3DC.%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26atitle%3DBinding%2520of%2520tacrine%2520and%25206-chlorotacrine%2520by%2520acetylcholinesterase%26jtitle%3DBiopolymers%26date%3D1996%26volume%3D38%26spage%3D109%26epage%3D117%26doi%3D10.1002%2F%28SICI%291097-0282%28199601%2938%3A13.0.CO%3B2-%23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Scheiner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolles, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunesch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabissi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinelli, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naldi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petralla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poeta, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falkeis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vieth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maitra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, M.</span></span> <span> </span><span class="NLM_article-title">Dual-acting cholinesterase–human cannabinoid receptor 2 ligands show pronounced neuroprotection in vitro and overadditive and disease-modifying neuroprotective effects in vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">9078</span>– <span class="NLM_lpage">9102</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00623</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00623" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFCrs7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=9078-9102&author=M.+Scheinerauthor=D.+Dollesauthor=S.+Guneschauthor=M.+Hoffmannauthor=M.+Nabissiauthor=O.+Marinelliauthor=M.+Naldiauthor=M.+Bartoliniauthor=S.+Petrallaauthor=E.+Poetaauthor=B.+Montiauthor=C.+Falkeisauthor=M.+Viethauthor=H.+H%C3%BCbnerauthor=P.+Gmeinerauthor=R.+Maitraauthor=T.+Mauriceauthor=M.+Decker&title=Dual-acting+cholinesterase%E2%80%93human+cannabinoid+receptor+2+ligands+show+pronounced+neuroprotection+in+vitro+and+overadditive+and+disease-modifying+neuroprotective+effects+in+vivo&doi=10.1021%2Facs.jmedchem.9b00623"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29aR"><div class="casContent"><span class="casTitleNuber">29a</span><div class="casTitle"><span class="NLM_cas:atitle">Dual-Acting Cholinesterase-Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo</span></div><div class="casAuthors">Scheiner, Matthias; Dolles, Dominik; Gunesch, Sandra; Hoffmann, Matthias; Nabissi, Massimo; Marinelli, Oliviero; Naldi, Marina; Bartolini, Manuela; Petralla, Sabrina; Poeta, Eleonora; Monti, Barbara; Falkeis, Christina; Vieth, Michael; Huebner, Harald; Gmeiner, Peter; Maitra, Rangan; Maurice, Tangui; Decker, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">9078-9102</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have designed and synthesized a series of 14 hybrid mols. out of the cholinesterase (ChE) inhibitor tacrine and a benzimidazole-based human cannabinoid receptor subtype 2 (hCB2R) agonist and investigated them in vitro and in vivo.  The compds. are potent ChE inhibitors, and for the most promising hybrids, the mechanism of human acetylcholinesterase (hAChE) inhibition as well as their ability to interfere with AChE-induced aggregation of β-amyloid (Aβ), and Aβ self-aggregation was assessed.  All hybrids were evaluated for affinity and selectivity for hCB1R and hCB2R.  To ensure that the hybrids retained their agonist character, the expression of cAMP-regulated genes was quantified, and potency and efficacy were detd.  Addnl., the effects of the hybrids on microglia activation and neuroprotection on HT-22 cells were investigated.  The most promising in vitro hybrids showed pronounced neuroprotection in an Alzheimer's mouse model at low dosage (0.1 mg/kg, i.p.), lacking hepatotoxicity even at high dose (3 mg/kg, i.p.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGRfz6xatTXLVg90H21EOLACvtfcHk0lgzj-7W2KtpgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFCrs7%252FM&md5=f0148c8ba51a2d0cbe83a26bb388a446</span></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00623%26sid%3Dliteratum%253Aachs%26aulast%3DScheiner%26aufirst%3DM.%26aulast%3DDolles%26aufirst%3DD.%26aulast%3DGunesch%26aufirst%3DS.%26aulast%3DHoffmann%26aufirst%3DM.%26aulast%3DNabissi%26aufirst%3DM.%26aulast%3DMarinelli%26aufirst%3DO.%26aulast%3DNaldi%26aufirst%3DM.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DPetralla%26aufirst%3DS.%26aulast%3DPoeta%26aufirst%3DE.%26aulast%3DMonti%26aufirst%3DB.%26aulast%3DFalkeis%26aufirst%3DC.%26aulast%3DVieth%26aufirst%3DM.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26aulast%3DMaitra%26aufirst%3DR.%26aulast%3DMaurice%26aufirst%3DT.%26aulast%3DDecker%26aufirst%3DM.%26atitle%3DDual-acting%2520cholinesterase%25E2%2580%2593human%2520cannabinoid%2520receptor%25202%2520ligands%2520show%2520pronounced%2520neuroprotection%2520in%2520vitro%2520and%2520overadditive%2520and%2520disease-modifying%2520neuroprotective%2520effects%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D9078%26epage%3D9102%26doi%3D10.1021%2Facs.jmedchem.9b00623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit29b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Maspero, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volpato, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cirillo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan Chen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messerer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotriffer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Amici, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzgrabe, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dallanoce, C.</span></span> <span> </span><span class="NLM_article-title">Tacrine-xanomeline and tacrine-iperoxo hybrid ligands: synthesis and biological evaluation at acetylcholinesterase and M1 muscarinic acetylcholine receptors</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">103633</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2020.103633</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2Fj.bioorg.2020.103633" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=32032848" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisV2ntbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2020&pages=103633&author=M.+Masperoauthor=D.+Volpatoauthor=D.+Cirilloauthor=N.+Yuan+Chenauthor=R.+Messererauthor=C.+Sotrifferauthor=M.+De+Amiciauthor=U.+Holzgrabeauthor=C.+Dallanoce&title=Tacrine-xanomeline+and+tacrine-iperoxo+hybrid+ligands%3A+synthesis+and+biological+evaluation+at+acetylcholinesterase+and+M1+muscarinic+acetylcholine+receptors&doi=10.1016%2Fj.bioorg.2020.103633"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29bR"><div class="casContent"><span class="casTitleNuber">29b</span><div class="casTitle"><span class="NLM_cas:atitle">Tacrine-xanomeline and tacrine-iperoxo hybrid ligands: Synthesis and biological evaluation at acetylcholinesterase and M1 muscarinic acetylcholine receptors</span></div><div class="casAuthors">Maspero, Marco; Volpato, Daniela; Cirillo, Davide; Yuan Chen, Natalia; Messerer, Regina; Sotriffer, Christoph; De Amici, Marco; Holzgrabe, Ulrike; Dallanoce, Clelia</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103633</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A set of new hybrid derivs., in which apolymethylene spacer chain of variable length connected the pharmacophoric moiety of xanomeline are synthesized ,anM1/M4preferring orthosteric muscarinic agonist, with that of tacrine, a well-known acetylcholinesterase (AChE) inhibitor abletoallosterically modulatemuscarinicacetylcholinereceptors(mAChRs).  When tested in vitro in a colorimetric assay for their ability to inhibit AChE, the new compds. showed higher or similar potency compared to that of tacrine.  Docking analyses were performed on the most potent inhibitors to rationalize their exptl. inhibitory power against AChE.  Next, the signaling cascade at M1 mAChRs by exploring the interaction of Gαq-PLC-β3 proteins through split luciferase assays and the myo-Inositol 1 phosphate (IP1) accumulation in cells is evaluated.  The results were compared with those obtained on the known derivs., two quite potent AChE inhibitors in which tacrine is linked to iperoxo, an exceptionally potent muscarinic orthosteric activator.  Interestingly, it was found that iprexo tacrine hybrids behaved as partial agonists of the M1 mAChR, at variance with hybrids contg. xanomeline as the orthosteric mol. fragment, which were all unable to activate the receptor subtype response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphmTAZqGXNK7Vg90H21EOLACvtfcHk0lgzj-7W2KtpgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisV2ntbk%253D&md5=8ac4f30f17c6ea4d4db5a148cf91095a</span></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2020.103633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2020.103633%26sid%3Dliteratum%253Aachs%26aulast%3DMaspero%26aufirst%3DM.%26aulast%3DVolpato%26aufirst%3DD.%26aulast%3DCirillo%26aufirst%3DD.%26aulast%3DYuan%2BChen%26aufirst%3DN.%26aulast%3DMesserer%26aufirst%3DR.%26aulast%3DSotriffer%26aufirst%3DC.%26aulast%3DDe%2BAmici%26aufirst%3DM.%26aulast%3DHolzgrabe%26aufirst%3DU.%26aulast%3DDallanoce%26aufirst%3DC.%26atitle%3DTacrine-xanomeline%2520and%2520tacrine-iperoxo%2520hybrid%2520ligands%253A%2520synthesis%2520and%2520biological%2520evaluation%2520at%2520acetylcholinesterase%2520and%2520M1%2520muscarinic%2520acetylcholine%2520receptors%26jtitle%3DBioorg.%2520Chem.%26date%3D2020%26volume%3D96%26spage%3D103633%26doi%3D10.1016%2Fj.bioorg.2020.103633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit29c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fancellu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chand, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomás, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlandini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piemontese, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardoso, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaves, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, M. A.</span></span> <span> </span><span class="NLM_article-title">Novel tacrine–benzofuran hybrids as potential multi-target drug candidates for the treatment of Alzheimer’s disease</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">211</span>– <span class="NLM_lpage">226</span>, <span class="refDoi"> DOI: 10.1080/14756366.2019.1689237</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1080%2F14756366.2019.1689237" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=31760822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1amurjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2020&pages=211-226&author=G.+Fancelluauthor=K.+Chandauthor=D.+Tom%C3%A1sauthor=E.+Orlandiniauthor=L.+Piemonteseauthor=D.+F.+Silvaauthor=S.+M.+Cardosoauthor=S.+Chavesauthor=M.+A.+Santos&title=Novel+tacrine%E2%80%93benzofuran+hybrids+as+potential+multi-target+drug+candidates+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1080%2F14756366.2019.1689237"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29cR"><div class="casContent"><span class="casTitleNuber">29c</span><div class="casTitle"><span class="NLM_cas:atitle">Novel tacrine-benzofuran hybrids as potential multi-target drug candidates for the treatment of Alzheimer's Disease</span></div><div class="casAuthors">Fancellu, Gaia; Chand, Karam; Tomas, Daniel; Orlandini, Elisabetta; Piemontese, Luca; Silva, Diana F.; Cardoso, Sandra M.; Chaves, Silvia; Santos, M. Amelia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">211-226</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Pursuing the widespread interest on multi-target drugs to combat Alzheimer's disease (AD), a new series of hybrids was designed and developed based on the repositioning of the well-known acetylcholinesterase (AChE) inhibitor, tacrine (TAC), by its coupling to benzofuran (BF) derivs.  The BF framework aims to endow the conjugate mols. with ability for inhibition of AChE (bimodal way) and of amyloid-beta peptide aggregation, besides providing metal (Fe, Cu) chelating ability and concomitant extra anti-oxidant activity, for the hybrids with hydroxyl substitution.  The new TAC-BF conjugates showed very good activity for AChE inhibition (sub-micromolar range) and good capacity for the inhibition of self- and Cu-mediated Aβ aggregation, with dependence on the linker size and substituent groups of each main moiety.  Neuroprotective effects were also found for the compds. through viability assays of neuroblastoma cells, after Aβ1-42 induced toxicity.  Structure-activity relationship anal. provides insights on the best structural parameters, to take in consideration for future studies in view of potential applications in AD therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqc04kwJBmWDrVg90H21EOLACvtfcHk0lh67eErEcyPMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1amurjO&md5=bb015d132ddbc0efa4e3af677ddeedcd</span></div><a href="/servlet/linkout?suffix=cit29c&amp;dbid=16384&amp;doi=10.1080%2F14756366.2019.1689237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756366.2019.1689237%26sid%3Dliteratum%253Aachs%26aulast%3DFancellu%26aufirst%3DG.%26aulast%3DChand%26aufirst%3DK.%26aulast%3DTom%25C3%25A1s%26aufirst%3DD.%26aulast%3DOrlandini%26aufirst%3DE.%26aulast%3DPiemontese%26aufirst%3DL.%26aulast%3DSilva%26aufirst%3DD.%2BF.%26aulast%3DCardoso%26aufirst%3DS.%2BM.%26aulast%3DChaves%26aufirst%3DS.%26aulast%3DSantos%26aufirst%3DM.%2BA.%26atitle%3DNovel%2520tacrine%25E2%2580%2593benzofuran%2520hybrids%2520as%2520potential%2520multi-target%2520drug%2520candidates%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2020%26volume%3D35%26spage%3D211%26epage%3D226%26doi%3D10.1080%2F14756366.2019.1689237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit29d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newell, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span> <span> </span><span class="NLM_article-title">Tacrine–hydrogen sulfide donor hybrid ameliorates cognitive impairment in the aluminum chloride mouse model of Alzheimer’s disease</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">3500</span>– <span class="NLM_lpage">3509</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.9b00120</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.9b00120" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVyjs7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=3500-3509&author=X.+Chengauthor=J.+Guauthor=Y.+Pangauthor=J.+Liuauthor=T.+Xuauthor=X.+Liauthor=Y.+Huaauthor=K.+A.+Newellauthor=X.-F.+Huangauthor=Y.+Yuauthor=Y.+Liu&title=Tacrine%E2%80%93hydrogen+sulfide+donor+hybrid+ameliorates+cognitive+impairment+in+the+aluminum+chloride+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facschemneuro.9b00120"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29dR"><div class="casContent"><span class="casTitleNuber">29d</span><div class="casTitle"><span class="NLM_cas:atitle">Tacrine-Hydrogen Sulfide Donor Hybrid Ameliorates Cognitive Impairment in the Aluminum Chloride Mouse Model of Alzheimer's Disease</span></div><div class="casAuthors">Cheng, Xiao-jing; Gu, Jing-xue; Pang, Yi-peng; Liu, Jiao; Xu, Ting; Li, Xin-rui; Hua, Yu-zhou; Newell, Kelly A.; Huang, Xu-Feng; Yu, Yinghua; Liu, Yi</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3500-3509</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a neurodegenerative disorder, characterized by progressive loss of memory and cognitive function, and is assocd. with the deficiency of synaptic acetylcholine, as well as chronic neuroinflammation.  Tacrine, a potent acetylcholinesterase (AChE) inhibitor, was previously a prescribed clin. therapeutic agent for AD, but was recently withdrawn because it caused widespread hepatotoxicity.  Hydrogen sulfide (H2S) has neuroprotective, hepatoprotective and anti-inflammatory effects.  In this study, we synthesized a new compd., a tacrine- H2S donor hybrid (THS) by introducing H2S-releasing moieties (ACS81) to tacrine.  Subsequently, pharmacol. and biol. evaluations of THS were conducted in the aluminum trichloride (AlCl3)-induced AD mice model.  We found that THS (15mmol/kg) improved cognitive and locomotor activity in AD mice in the step-through test and open field test resp.  THS showed strong AChE inhibitory activity in the serum and hippocampus of AD mice and induced increased hippocampal H2S levels.  Furthermore, THS reduced mRNA expression of the proinflammatory cytokines, TNF-α, IL-6, and IL-1β and increased synapse-assocd. proteins (synaptophysin and postsynaptic d. protein 95) in the hippocampus of AD mice.  Importantly, THS, unlike tacrine, did not increase liver transaminases (alanine transaminase and aspartate transaminase) or proinflammatory cytokines, indicating THS is much safer than tacrine.  Therefore, the multifunctional effects of this new hybrid compd. of tacrine and H2S indicate it is a promising compd. for further research into the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe7gbzMI_ZO7Vg90H21EOLACvtfcHk0lh67eErEcyPMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVyjs7jK&md5=c71d4daf33dc809487d9b0e06fb276ec</span></div><a href="/servlet/linkout?suffix=cit29d&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.9b00120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.9b00120%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DGu%26aufirst%3DJ.%26aulast%3DPang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DHua%26aufirst%3DY.%26aulast%3DNewell%26aufirst%3DK.%2BA.%26aulast%3DHuang%26aufirst%3DX.-F.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DY.%26atitle%3DTacrine%25E2%2580%2593hydrogen%2520sulfide%2520donor%2520hybrid%2520ameliorates%2520cognitive%2520impairment%2520in%2520the%2520aluminum%2520chloride%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2019%26volume%3D10%26spage%3D3500%26epage%3D3509%26doi%3D10.1021%2Facschemneuro.9b00120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Savini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaeta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fattorusso, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catalanotti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campiani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiasserini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellerano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novellino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKissic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saxena, A.</span></span> <span> </span><span class="NLM_article-title">Specific targeting of acetylcholinesterase and butyrylcholinesterase recognition sites. Rational design of novel, selective, and highly potent cholinesterase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">4</span>, <span class="refDoi"> DOI: 10.1021/jm0255668</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0255668" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpt1yntb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1-4&author=L.+Saviniauthor=A.+Gaetaauthor=C.+Fattorussoauthor=B.+Catalanottiauthor=G.+Campianiauthor=L.+Chiasseriniauthor=C.+Pelleranoauthor=E.+Novellinoauthor=D.+McKissicauthor=A.+Saxena&title=Specific+targeting+of+acetylcholinesterase+and+butyrylcholinesterase+recognition+sites.+Rational+design+of+novel%2C+selective%2C+and+highly+potent+cholinesterase+inhibitors&doi=10.1021%2Fjm0255668"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Specific Targeting of Acetylcholinesterase and Butyrylcholinesterase Recognition Sites. Rational Design of Novel, Selective, and Highly Potent Cholinesterase Inhibitors</span></div><div class="casAuthors">Savini, Luisa; Gaeta, Alessandra; Fattorusso, Caterina; Catalanotti, Bruno; Campiani, Giuseppe; Chiasserini, Luisa; Pellerano, Cesare; Novellino, Ettore; McKissic, Dawn; Saxena, Ashima</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-4</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tacrine-based AChE and BuChE inhibitors were designed by investigating the topol. of the active site gorge of the two enzymes.  The homobivalent ligands characterized by a nitrogen-bridged atom at the tether level could be considered among the most potent and selective cholinesterase inhibitors described to date.  The nitrogen-contg. homobivalent ligands and the sulfur-contg. ligand validated the hypothesis of extra sites of interaction in the AChE and BuChE active site gorges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-lepg2tVtZLVg90H21EOLACvtfcHk0lh67eErEcyPMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpt1yntb8%253D&md5=1d9abc2e1f63f01686a7c4a79bab57c9</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm0255668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0255668%26sid%3Dliteratum%253Aachs%26aulast%3DSavini%26aufirst%3DL.%26aulast%3DGaeta%26aufirst%3DA.%26aulast%3DFattorusso%26aufirst%3DC.%26aulast%3DCatalanotti%26aufirst%3DB.%26aulast%3DCampiani%26aufirst%3DG.%26aulast%3DChiasserini%26aufirst%3DL.%26aulast%3DPellerano%26aufirst%3DC.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DMcKissic%26aufirst%3DD.%26aulast%3DSaxena%26aufirst%3DA.%26atitle%3DSpecific%2520targeting%2520of%2520acetylcholinesterase%2520and%2520butyrylcholinesterase%2520recognition%2520sites.%2520Rational%2520design%2520of%2520novel%252C%2520selective%252C%2520and%2520highly%2520potent%2520cholinesterase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1%26epage%3D4%26doi%3D10.1021%2Fjm0255668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Recanatini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavalli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belluti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piazzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rampa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobbi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrisano, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavrini, V.</span></span> <span> </span><span class="NLM_article-title">SAR of 9-amino-1,2,3,4-tetrahydroacridine-based acetylcholinesterase inhibitors: synthesis, enzyme inhibitory activity, QSAR, and structure-based CoMFA of tacrine analogues</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">2007</span>– <span class="NLM_lpage">2018</span>, <span class="refDoi"> DOI: 10.1021/jm990971t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990971t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD3cXis1Gnu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2007-2018&author=M.+Recanatiniauthor=A.+Cavalliauthor=F.+Bellutiauthor=L.+Piazziauthor=A.+Rampaauthor=A.+Bisiauthor=S.+Gobbiauthor=P.+Valentiauthor=V.+Andrisanoauthor=M.+Bartoliniauthor=V.+Cavrini&title=SAR+of+9-amino-1%2C2%2C3%2C4-tetrahydroacridine-based+acetylcholinesterase+inhibitors%3A+synthesis%2C+enzyme+inhibitory+activity%2C+QSAR%2C+and+structure-based+CoMFA+of+tacrine+analogues&doi=10.1021%2Fjm990971t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31aR"><div class="casContent"><span class="casTitleNuber">31a</span><div class="casTitle"><span class="NLM_cas:atitle">SAR of 9-Amino-1,2,3,4-tetrahydroacridine-Based Acetylcholinesterase Inhibitors: Synthesis, Enzyme Inhibitory Activity, QSAR, and Structure-Based CoMFA of Tacrine Analogues</span></div><div class="casAuthors">Recanatini, Maurizio; Cavalli, Andrea; Belluti, Federica; Piazzi, Lorna; Rampa, Angela; Bisi, Alessandra; Gobbi, Silvia; Valenti, Piero; Andrisano, Vincenza; Bartolini, Manuela; Cavrini, Vanni</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2007-2018</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this study, we attempted to derive a comprehensive SAR picture for the class of acetylcholinesterase (AChE) inhibitors related to tacrine, a drug currently in use for the treatment of the Alzheimer's disease.  Toward this aim, we synthesized and tested a series of 9-amino-1,2,3,4-tetrahydroacridine derivs. substituted at positions 6 and 7 of the acridine nucleus and bearing selected groups on the 9-amino function.  By means of the Hansch approach, QSAR equations were obtained, quant. accounting for both the detrimental steric effect of substituents in position 7 and the favorable electron-attracting effect exerted by substituents in positions 6 and 7 of the 9-amino-1,2,3,4-tetrahydroacridine derivs.  The three-dimensional (3D) properties of the inhibitors were taken into consideration by performing a comparative mol. field anal. (CoMFA) on the series of AChE inhibitors made by twelve 9-amino-1,2,3,4-tetrahydroacridines and thirteen 11H-indeno[1,2-b]quinolin-10-ylamines previously developed in our lab.  The alignment of the mols. to be submitted to the CoMFA procedure was carried out by taking advantage of docking models calcd. for the interactions of both the unsubstituted 9-amino-1,2,3,4-tetrahydroacridine and 11H-indeno[1,2-b]quinolin-10-ylamine with the target enzyme.  A highly significant CoMFA model was obtained using the steric field alone, and the features of such a 3D QSAR model were compared with the classical QSAR equations previously calcd.  The two models appeared to be consistent with one another, with the following main aspects in common: (a) individuation of the strongly neg. contribution of substituents in position 7 of tacrine, and (b) tentative assignment of hydrophobic character to the favorable effect exerted by the substituents in position 6.  Finally, to test the predictive ability of the QSAR models, 6-bromo-9-amino-1,2,3,4-tetrahydroacridine, a new tacrine deriv. designed on the basis of both classical and 3D QSAR equations was synthesized and kinetically evaluated.  This compd. was predicted to have a pIC50 value of 7.31 by the classical QSAR model and 7.40 by the CoMFA model; its exptl. IC50 value was equal to 0.066 (±0.009) μM, which corresponds to a pIC50 of 7.18, and shows reasonable agreement with the predicted AChE inhibition data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3DgmKhtx11LVg90H21EOLACvtfcHk0lhaYx5G63G_tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXis1Gnu74%253D&md5=f9e8a7eb7bb347bfd80953e2870a789c</span></div><a href="/servlet/linkout?suffix=cit31a&amp;dbid=16384&amp;doi=10.1021%2Fjm990971t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990971t%26sid%3Dliteratum%253Aachs%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DPiazzi%26aufirst%3DL.%26aulast%3DRampa%26aufirst%3DA.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DValenti%26aufirst%3DP.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DCavrini%26aufirst%3DV.%26atitle%3DSAR%2520of%25209-amino-1%252C2%252C3%252C4-tetrahydroacridine-based%2520acetylcholinesterase%2520inhibitors%253A%2520synthesis%252C%2520enzyme%2520inhibitory%2520activity%252C%2520QSAR%252C%2520and%2520structure-based%2520CoMFA%2520of%2520tacrine%2520analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2007%26epage%3D2018%26doi%3D10.1021%2Fjm990971t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit31b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wlodek, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antosiewicz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCammon, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straatsma, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilson, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briggs, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humblet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sussman, J. L.</span></span> <span> </span><span class="NLM_article-title">Binding of tacrine and 6-chlorotacrine by acetylcholinesterase</span>. <i>Biopolymers</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">117</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1097-0282(199601)38:13.0.CO;2-#</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1002%2F%28SICI%291097-0282%28199601%2938%3A1%3C109%3A%3AAID-BIP9%3E3.0.CO%3B2-%23" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=8679940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADyaK28XpvVen" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1996&pages=109-117&author=S.+T.+Wlodekauthor=J.+Antosiewiczauthor=J.+A.+McCammonauthor=T.+P.+Straatsmaauthor=M.+K.+Gilsonauthor=J.+M.+Briggsauthor=C.+Humbletauthor=J.+L.+Sussman&title=Binding+of+tacrine+and+6-chlorotacrine+by+acetylcholinesterase&doi=10.1002%2F%28SICI%291097-0282%28199601%2938%3A13.0.CO%3B2-%23"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31bR"><div class="casContent"><span class="casTitleNuber">31b</span><div class="casTitle"><span class="NLM_cas:atitle">Binding of tacrine and 6-chlorotacrine by acetylcholinesterase</span></div><div class="casAuthors">Wlodek, S. T.; Antosiewicz, J.; McCammon, J. A.; Straatsma, T. P.; Gilson, M. K.; Briggs, J. M.; Humblet, C.; Sussman, J. L.</div><div class="citationInfo"><span class="NLM_cas:title">Biopolymers</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">109-17</span>CODEN:
                <span class="NLM_cas:coden">BIPMAA</span>;
        ISSN:<span class="NLM_cas:issn">0006-3525</span>.
    
            (<span class="NLM_cas:orgname">Wiley</span>)
        </div><div class="casAbstract">Multiconfiguration thermodn. integration was used to det. the relative binding strength of tacrine and 6-chlorotacrine by Torpedo californica acetylcholinesterase.  6-Chlorotacrine appears to be bound stronger by 0.7 kcal/mol than unsubstituted tacrine when the active site triad residue His-440 is deprotonated.  This result is in excellent agreement with exptl. inhibition data on elec. eel acetylcholinesterase.  Electrostatic Poisson-Boltzmann calcns. confirm that order of binding strength, resulting in ΔG of binding of -2.9 and -3.3 kcal/mol for tacrine and chlorotacrine, resp., and suggest inhibitor binding does not occur when His-440 is charged.  The results suggest that electron d. redistribution upon tacrine chlorination is mainly responsible for the increased attraction potential between protonated inhibitor mol. and adjacent arom. groups of Phe-330 and Trp-84.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyOgkYp6yoQbVg90H21EOLACvtfcHk0lhaYx5G63G_tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XpvVen&md5=1bd5e7dd789fbca5832152ed75db0f5b</span></div><a href="/servlet/linkout?suffix=cit31b&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0282%28199601%2938%3A1%3C109%3A%3AAID-BIP9%3E3.0.CO%3B2-%23&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0282%2528199601%252938%253A1%253C109%253A%253AAID-BIP9%253E3.0.CO%253B2-%2523%26sid%3Dliteratum%253Aachs%26aulast%3DWlodek%26aufirst%3DS.%2BT.%26aulast%3DAntosiewicz%26aufirst%3DJ.%26aulast%3DMcCammon%26aufirst%3DJ.%2BA.%26aulast%3DStraatsma%26aufirst%3DT.%2BP.%26aulast%3DGilson%26aufirst%3DM.%2BK.%26aulast%3DBriggs%26aufirst%3DJ.%2BM.%26aulast%3DHumblet%26aufirst%3DC.%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26atitle%3DBinding%2520of%2520tacrine%2520and%25206-chlorotacrine%2520by%2520acetylcholinesterase%26jtitle%3DBiopolymers%26date%3D1996%26volume%3D38%26spage%3D109%26epage%3D117%26doi%3D10.1002%2F%28SICI%291097-0282%28199601%2938%3A13.0.CO%3B2-%23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stiller, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endres, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheiner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunesch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotriffer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, M.</span></span> <span> </span><span class="NLM_article-title">Highly selective butyrylcholinesterase inhibitors with tunable duration of action by chemical modification of transferable carbamate units exhibit pronounced neuroprotective effect in an Alzheimer’s disease mouse model</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">9116</span>– <span class="NLM_lpage">9140</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01012</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFCrs7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=9116-9140&author=M.+Hoffmannauthor=C.+Stillerauthor=E.+Endresauthor=M.+Scheinerauthor=S.+Guneschauthor=C.+Sotrifferauthor=T.+Mauriceauthor=M.+Decker&title=Highly+selective+butyrylcholinesterase+inhibitors+with+tunable+duration+of+action+by+chemical+modification+of+transferable+carbamate+units+exhibit+pronounced+neuroprotective+effect+in+an+Alzheimer%E2%80%99s+disease+mouse+model&doi=10.1021%2Facs.jmedchem.9b01012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32aR"><div class="casContent"><span class="casTitleNuber">32a</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Selective Butyrylcholinesterase Inhibitors with Tunable Duration of Action by Chemical Modification of Transferable Carbamate Units Exhibit Pronounced Neuroprotective Effect in an Alzheimer's Disease Mouse Model</span></div><div class="casAuthors">Hoffmann, Matthias; Stiller, Carina; Endres, Erik; Scheiner, Matthias; Gunesch, Sandra; Sotriffer, Christoph; Maurice, Tangui; Decker, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">9116-9140</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this study, the carbamate structure of pseudo-irreversible butyrylcholinesterase (BChE) inhibitors was optimized with regard to a longer binding to the enzyme.  A set of compds. bearing different heterocycles (e.g., morpholine, tetrahydroisoquinoline, benzimidazole, piperidine) and alkylene spacers (2 to 10 methylene groups between carbamate and heterocycle) in the carbamate residue was synthesized and characterized in vitro for their binding affinity, binding kinetics, and carbamate hydrolysis.  These novel BChE inhibitors are highly selective for hBChE over human acetycholinesterase (hAChE), yielding short-, medium-, and long-acting nanomolar hBChE inhibitors (with a half-life of the carbamoylated enzyme ranging from 1 to 28 h).  The inhibitors show neuroprotective properties in a murine hippocampal cell line and a pharmacol. mouse model of Alzheimer's disease (AD), suggesting a significant benefit of BChE inhibition for a disease-modifying treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXA4e0pcqAhrVg90H21EOLACvtfcHk0lhaYx5G63G_tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFCrs7zO&md5=458d5ab7ffce4864702a39d981b6dc29</span></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01012%26sid%3Dliteratum%253Aachs%26aulast%3DHoffmann%26aufirst%3DM.%26aulast%3DStiller%26aufirst%3DC.%26aulast%3DEndres%26aufirst%3DE.%26aulast%3DScheiner%26aufirst%3DM.%26aulast%3DGunesch%26aufirst%3DS.%26aulast%3DSotriffer%26aufirst%3DC.%26aulast%3DMaurice%26aufirst%3DT.%26aulast%3DDecker%26aufirst%3DM.%26atitle%3DHighly%2520selective%2520butyrylcholinesterase%2520inhibitors%2520with%2520tunable%2520duration%2520of%2520action%2520by%2520chemical%2520modification%2520of%2520transferable%2520carbamate%2520units%2520exhibit%2520pronounced%2520neuroprotective%2520effect%2520in%2520an%2520Alzheimer%25E2%2580%2599s%2520disease%2520mouse%2520model%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D9116%26epage%3D9140%26doi%3D10.1021%2Facs.jmedchem.9b01012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit32b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Darvesh, S.</span></span> <span> </span><span class="NLM_article-title">Butyrylcholinesterase as a diagnostic and therapeutic target for Alzheimer’s disease</span>. <i>Curr. Alzheimer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1173</span>– <span class="NLM_lpage">1177</span>, <span class="refDoi"> DOI: 10.2174/1567205013666160404120542</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.2174%2F1567205013666160404120542" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=27040140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVOiu7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2016&pages=1173-1177&author=S.+Darvesh&title=Butyrylcholinesterase+as+a+diagnostic+and+therapeutic+target+for+Alzheimer%E2%80%99s+disease&doi=10.2174%2F1567205013666160404120542"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32bR"><div class="casContent"><span class="casTitleNuber">32b</span><div class="casTitle"><span class="NLM_cas:atitle">Butyrylcholinesterase as a Diagnostic and Therapeutic Target for Alzheimer's Disease</span></div><div class="casAuthors">Darvesh, Sultan</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1173-1177</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">The serine hydrolase butyrylcholinesterase (BChE), like the related enzyme acetylcholinesterase (AChE), co-regulates metab. of the neurotransmitter acetylcholine.  In the human brain BChE is mainly expressed in white matter and glia and in distinct populations of neurons in regions that are important in cognition and behavior, functions compromised in Alzheimer's disease (AD).  AD is a neurodegenerative disorder causing dementia with no cure nor means for definitive diagnosis during life.  In AD, BChE is found in assocn. with pathol., such as -amyloid (A) plaques, particularly in the cerebral cortex where BChE is not normally found in quantity.  Up to 30% of cognitively normal older adults have abundant A deposition in the brain.  We have designed an imaging agent that can detect, through autoradiog., BChE-assocd. A plaques in the cerebral cortex of AD brains, but does not visualize A plaques in brains of cognitively normal individuals.  Furthermore, in an AD mouse model with BChE gene knocked out, there are up to 70% fewer fibrillar A brain plaques, suggesting diminished BChE activity could prove beneficial as a curative approach to AD.  To that end, we have examd. numerous N-10-carbonyl phenothiazines that are specific inhibitors of human BChE, revealing important details of the enzyme's active site gorge.  These phenothiazines can be designed without potential side effects caused by neurotransmitter receptor interactions.  In conclusion, BChE is potentially an important target for diagnosis and treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpd5KdWGb-He7Vg90H21EOLACvtfcHk0ljhsYyqpnRwkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVOiu7vP&md5=f3db5212c9d4c0f697011addeebd6c03</span></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=10.2174%2F1567205013666160404120542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1567205013666160404120542%26sid%3Dliteratum%253Aachs%26aulast%3DDarvesh%26aufirst%3DS.%26atitle%3DButyrylcholinesterase%2520as%2520a%2520diagnostic%2520and%2520therapeutic%2520target%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2016%26volume%3D13%26spage%3D1173%26epage%3D1177%26doi%3D10.2174%2F1567205013666160404120542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elsinghorst, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cieslik, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohr, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tränkle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gütschow, M.</span></span> <span> </span><span class="NLM_article-title">First gallamine–tacrine hybrid: design and characterization at cholinesterases and the M<sub>2</sub> muscarinic receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">5685</span>– <span class="NLM_lpage">5695</span>, <span class="refDoi"> DOI: 10.1021/jm070859s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070859s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFOitbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5685-5695&author=P.+W.+Elsinghorstauthor=J.+S.+Cieslikauthor=K.+Mohrauthor=C.+Tr%C3%A4nkleauthor=M.+G%C3%BCtschow&title=First+gallamine%E2%80%93tacrine+hybrid%3A+design+and+characterization+at+cholinesterases+and+the+M2+muscarinic+receptor&doi=10.1021%2Fjm070859s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">First Gallamine-Tacrine Hybrid: Design and Characterization at Cholinesterases and the M2 Muscarinic Receptor</span></div><div class="casAuthors">Elsinghorst, Paul W.; Cieslik, Julia S.; Mohr, Klaus; Traenkle, Christian; Guetschow, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5685-5695</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Gallamine and tacrine are allosteric antagonists at muscarinic M2 acetylcholine receptors and inhibitors of acetylcholinesterase.  At both acetylcholine-binding proteins, gallamine and tacrine are known to occupy two different binding sites: in M2 receptors within the allosteric binding area and in acetylcholinesterase at its catalytic and its peripheral site.  To find new ligands of both targets, the authors designed a gallamine-tacrine dimer and several derived hybrid compds. to address the two binding sites.  Their M2 receptor allosteric and acetylcholinesterase inhibitory potential was detd.  The hybrid compds. revealed an allosteric potency in the low nanomolar range exceeding the allosteric potency of gallamine and tacrine by factors of 100 and 4800, resp.  Cholinesterase inhibition was augmented by hybrid formation, and all compds. exhibited IC50 values in the lower nanomolar range.  Thus, gallamine-tacrine hybrid formation is a valuable approach toward high affinity ligands concurrently targeting these acetylcholine-binding proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1Rozawsc7bLVg90H21EOLACvtfcHk0ljhsYyqpnRwkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFOitbvN&md5=a6497e4ea0a428470c3476ea5ad2700e</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm070859s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070859s%26sid%3Dliteratum%253Aachs%26aulast%3DElsinghorst%26aufirst%3DP.%2BW.%26aulast%3DCieslik%26aufirst%3DJ.%2BS.%26aulast%3DMohr%26aufirst%3DK.%26aulast%3DTr%25C3%25A4nkle%26aufirst%3DC.%26aulast%3DG%25C3%25BCtschow%26aufirst%3DM.%26atitle%3DFirst%2520gallamine%25E2%2580%2593tacrine%2520hybrid%253A%2520design%2520and%2520characterization%2520at%2520cholinesterases%2520and%2520the%2520M2%2520muscarinic%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5685%26epage%3D5695%26doi%3D10.1021%2Fjm070859s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Camps, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Formosa, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galdeano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gómez, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarpellini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viayna, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clos, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camins, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallàs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrisano, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estelrich, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lizondo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bidon-Chanal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span> <span> </span><span class="NLM_article-title">Novel donepezil-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced β-amyloid aggregation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">3588</span>– <span class="NLM_lpage">3598</span>, <span class="refDoi"> DOI: 10.1021/jm8001313</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8001313" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD1cXms1Gisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3588-3598&author=P.+Campsauthor=X.+Formosaauthor=C.+Galdeanoauthor=T.+G%C3%B3mezauthor=D.+Mu%C3%B1oz-Torreroauthor=M.+Scarpelliniauthor=E.+Viaynaauthor=A.+Badiaauthor=M.+V.+Closauthor=A.+Caminsauthor=M.+Pall%C3%A0sauthor=M.+Bartoliniauthor=F.+Manciniauthor=V.+Andrisanoauthor=J.+Estelrichauthor=M.+Lizondoauthor=A.+Bidon-Chanalauthor=F.+J.+Luque&title=Novel+donepezil-based+inhibitors+of+acetyl-+and+butyrylcholinesterase+and+acetylcholinesterase-induced+%CE%B2-amyloid+aggregation&doi=10.1021%2Fjm8001313"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34aR"><div class="casContent"><span class="casTitleNuber">34a</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Donepezil-Based Inhibitors of Acetyl- and Butyrylcholinesterase and Acetylcholinesterase-Induced β-Amyloid Aggregation</span></div><div class="casAuthors">Camps, Pelayo; Formosa, Xavier; Galdeano, Carles; Gomez, Tania; Munoz-Torrero, Diego; Scarpellini, Michele; Viayna, Elisabet; Badia, Albert; Clos, M. Victoria; Camins, Antoni; Pallas, Merce; Bartolini, Manuela; Mancini, Francesca; Andrisano, Vincenza; Estelrich, Joan; Lizondo, Monica; Bidon-Chanal, Axel; Luque, F. Javier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3588-3598</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of donepezil-tacrine hybrids, e.g. I, designed to simultaneously interact with the active, peripheral and midgorge binding sites of acetylcholinesterase (AChE) have been synthesized and tested for their ability to inhibit AChE, butyrylcholinesterase (BChE), and AChE-induced Aβ aggregation.  These compds. consist of a unit of tacrine or 6-chlorotacrine, which occupies the same position as tacrine at the AChE active site, and the 5,6-dimethoxy-2-[(4-piperidinyl)methyl]-1-indanone moiety of donepezil (or the indane deriv. thereof), whose position along the enzyme gorge and the peripheral site can be modulated by a suitable tether that connects tacrine and donepezil fragments.  All of the new compds. are highly potent inhibitors of bovine and human AChE and BChE, exhibiting IC50 values in the subnanomolar or low nanomolar range in most cases.  Moreover, six out of the eight hybrids of the series, particularly those bearing an indane moiety, exhibit a significant Aβ antiaggregating activity, which makes them promising anti-Alzheimer drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsEDGOt9jXTLVg90H21EOLACvtfcHk0ljhsYyqpnRwkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXms1Gisbc%253D&md5=a27c555a51f971ff6c642f832d761aab</span></div><a href="/servlet/linkout?suffix=cit34a&amp;dbid=16384&amp;doi=10.1021%2Fjm8001313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8001313%26sid%3Dliteratum%253Aachs%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DFormosa%26aufirst%3DX.%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DG%25C3%25B3mez%26aufirst%3DT.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DScarpellini%26aufirst%3DM.%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DBadia%26aufirst%3DA.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DCamins%26aufirst%3DA.%26aulast%3DPall%25C3%25A0s%26aufirst%3DM.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DEstelrich%26aufirst%3DJ.%26aulast%3DLizondo%26aufirst%3DM.%26aulast%3DBidon-Chanal%26aufirst%3DA.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26atitle%3DNovel%2520donepezil-based%2520inhibitors%2520of%2520acetyl-%2520and%2520butyrylcholinesterase%2520and%2520acetylcholinesterase-induced%2520%25CE%25B2-amyloid%2520aggregation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3588%26epage%3D3598%26doi%3D10.1021%2Fjm8001313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit34b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorronsoro, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Palomero, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Monte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bidon-Chanal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orozco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez, A.</span></span> <span> </span><span class="NLM_article-title">Donepezil-tacrine hybrid related derivatives as new dual binding site inhibitors of AChE</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">6588</span>– <span class="NLM_lpage">6597</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2005.09.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2Fj.bmc.2005.09.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=16230018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFyksrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=6588-6597&author=D.+Alonsoauthor=I.+Dorronsoroauthor=L.+Rubioauthor=P.+Mu%C3%B1ozauthor=E.+Garc%C3%ADa-Palomeroauthor=M.+Del+Monteauthor=A.+Bidon-Chanalauthor=M.+Orozcoauthor=F.+J.+Luqueauthor=A.+Castroauthor=M.+Medinaauthor=A.+Mart%C3%ADnez&title=Donepezil-tacrine+hybrid+related+derivatives+as+new+dual+binding+site+inhibitors+of+AChE&doi=10.1016%2Fj.bmc.2005.09.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34bR"><div class="casContent"><span class="casTitleNuber">34b</span><div class="casTitle"><span class="NLM_cas:atitle">Donepezil-tacrine hybrid related derivatives as new dual binding site inhibitors of AChE</span></div><div class="casAuthors">Alonso, D.; Dorronsoro, I.; Rubio, L.; Munoz, P.; Garcia-Palomero, E.; Del Monte, M.; Bidon-Chanal, A.; Orozco, M.; Luque, F. J.; Castro, A.; Medina, M.; Martinez, A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6588-6597</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A new series of donepezil-tacrine hybrid related derivs. have been synthesized as dual acetylcholinesterase inhibitors that could bind simultaneously to the peripheral and catalytic sites of the enzyme.  These new hybrids combined a tacrine, 6-chlorotacrine or acridine unit as catalytic binding site and indanone (the heterocycle present in donepezil) or phthalimide moiety as peripheral binding site of the enzyme, connected through a different linker tether length.  One of the synthesized compds. emerged as a potent and selective AChE inhibitor, which is able to displace propidium in a competition assay.  These results seem to confirm the ability of this inhibitor to bind simultaneously to both sites of the enzyme and make it a promising lead for developing disease-modifying drugs for the future treatment of Alzheimer's disease.  To gain insight into the mol. determinants that modulate the inhibitory activity of these compds., a mol. modeling study was performed to explore their binding to the enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp_JWdGHk3L7Vg90H21EOLACvtfcHk0liYuvbmeWl8HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFyksrnL&md5=ce98b55631de4dbe9f52a89889b3e204</span></div><a href="/servlet/linkout?suffix=cit34b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2005.09.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2005.09.029%26sid%3Dliteratum%253Aachs%26aulast%3DAlonso%26aufirst%3DD.%26aulast%3DDorronsoro%26aufirst%3DI.%26aulast%3DRubio%26aufirst%3DL.%26aulast%3DMu%25C3%25B1oz%26aufirst%3DP.%26aulast%3DGarc%25C3%25ADa-Palomero%26aufirst%3DE.%26aulast%3DDel%2BMonte%26aufirst%3DM.%26aulast%3DBidon-Chanal%26aufirst%3DA.%26aulast%3DOrozco%26aufirst%3DM.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DCastro%26aufirst%3DA.%26aulast%3DMedina%26aufirst%3DM.%26aulast%3DMart%25C3%25ADnez%26aufirst%3DA.%26atitle%3DDonepezil-tacrine%2520hybrid%2520related%2520derivatives%2520as%2520new%2520dual%2520binding%2520site%2520inhibitors%2520of%2520AChE%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D6588%26epage%3D6597%26doi%3D10.1016%2Fj.bmc.2005.09.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dvir, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barril, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orozco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camps, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberry, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sussman, J. L.</span></span> <span> </span><span class="NLM_article-title">3D structure of <i>Torpedo californica</i> acetylcholinesterase complexed with huprine X at 2.1 Å resolution: kinetic and molecular dynamic correlates</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">2970</span>– <span class="NLM_lpage">2981</span>, <span class="refDoi"> DOI: 10.1021/bi011652i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi011652i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD38Xps1altw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=2970-2981&author=H.+Dvirauthor=D.+M.+Wongauthor=M.+Harelauthor=X.+Barrilauthor=M.+Orozcoauthor=F.+J.+Luqueauthor=D.+Mu%C3%B1oz-Torreroauthor=P.+Campsauthor=T.+L.+Rosenberryauthor=I.+Silmanauthor=J.+L.+Sussman&title=3D+structure+of+Torpedo+californica+acetylcholinesterase+complexed+with+huprine+X+at+2.1+%C3%85+resolution%3A+kinetic+and+molecular+dynamic+correlates&doi=10.1021%2Fbi011652i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">3D Structure of Torpedo californica acetylcholinesterase complexed with huprine X at 2.1 Å resolution: Kinetic and molecular dynamic correlates</span></div><div class="casAuthors">Dvir, H.; Wong, D. M.; Harel, M.; Barril, X.; Orozco, M.; Luque, F. J.; Munoz-Torrero, D.; Camps, P.; Rosenberry, T. L.; Silman, I.; Sussman, J. L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2970-2981</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Huprine X (HX) is a novel acetylcholinesterase (AChE) inhibitor, with one of the highest affinities reported for a reversible inhibitor.  HX is a synthetic hybrid that contains the 4-aminoquinoline substructure of one anti-Alzheimer drug, tacrine, and a carbobicyclic moiety resembling that of another AChE inhibitor, (-)-huperzine A.  Cocrystn. of HX with T. californica AChE yielded crystals whose 3-dimensional (3D) structure was detd. to 2.1 Å resoln.  The inhibitor was found to bind to the anionic site and also to hinder access to the esteratic site.  Its arom. portion occupied the same binding site as tacrine, stacking between the arom. rings of Trp-84 and Phe-330, whereas the carbobicyclic unit occupied the same binding pocket as (-)-huperzine A.  Its Cl substituent was found to lie in a hydrophobic pocket interacting with the rings of arom. residues Trp-432 and Phe-330 and with the Me groups of Met-436 and Ile-439.  Steady-state inhibition data showed that HX bound to human AChE and Torpedo AChE 28- and 54-fold, resp., more tightly than tacrine.  This difference apparently stems from the fact that the aminoquinoline moiety of HX makes interactions similar to those made by tacrine, but that addnl. bonds to the enzyme are made by the huperzine-like substructure and the Cl atom.  Furthermore, both tacrine and HX bound more tightly to Torpedo AChE than to human AChE, suggesting that their quinoline substructures interact better with Phe-330 than with Tyr-337, the corresponding residue in the human AChE structure.  Both (-)-huperzine A and HX displayed slow binding properties, but only binding of the former caused a peptide flip of Gly-117.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqVXtCPjzM1LVg90H21EOLACvtfcHk0liYuvbmeWl8HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xps1altw%253D%253D&md5=ea8b56b44818d899843be48d59fa2553</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fbi011652i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi011652i%26sid%3Dliteratum%253Aachs%26aulast%3DDvir%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DD.%2BM.%26aulast%3DHarel%26aufirst%3DM.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DOrozco%26aufirst%3DM.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DRosenberry%26aufirst%3DT.%2BL.%26aulast%3DSilman%26aufirst%3DI.%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26atitle%3D3D%2520structure%2520of%2520Torpedo%2520californica%2520acetylcholinesterase%2520complexed%2520with%2520huprine%2520X%2520at%25202.1%2520%25C3%2585%2520resolution%253A%2520kinetic%2520and%2520molecular%2520dynamic%2520correlates%26jtitle%3DBiochemistry%26date%3D2002%26volume%3D41%26spage%3D2970%26epage%3D2981%26doi%3D10.1021%2Fbi011652i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Blois, M. S.</span></span> <span> </span><span class="NLM_article-title">Antioxidant determinations by the use of a stable free radical</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1958</span>,  <span class="NLM_volume"><i>181</i></span>,  <span class="NLM_fpage">1199</span>– <span class="NLM_lpage">1200</span>, <span class="refDoi"> DOI: 10.1038/1811199a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1038%2F1811199a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADyaG1cXptF2ntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=1958&pages=1199-1200&author=M.+S.+Blois&title=Antioxidant+determinations+by+the+use+of+a+stable+free+radical&doi=10.1038%2F1811199a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36aR"><div class="casContent"><span class="casTitleNuber">36a</span><div class="casTitle"><span class="NLM_cas:atitle">Antioxidant determinations by the use of a stable free radical</span></div><div class="casAuthors">Blois, Marsden S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1958</span>),
    <span class="NLM_cas:volume">181</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1199-200</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The 2,2-diphenyl-1-picrylhydrazyl free radical (I) will oxidize (and be decolored by) cysteine, glutathione, ascorbic acid, tocopherol, polyhydroxy aromatic compds. (hydroquinone, pyrogallol, etc.), and aromatic amines (p-phenylenediamine, p-aminophenol, etc.), commonly employed antioxidants.  The SH groups of proteins are oxidized, though probably not quantitatively, since proteins are pptd. under the conditions of testing.  I does not have a high enough oxidation-reduction potential to oxidize glucose, and does not, apparently, under ordinary conditions, oxidize purines, pyrimidines, or aromatic compds. with only a single hydroxyl group, as in tyrosine.  At 517 mμ and at a pH of 5.0-6.5 (acetate buffer) quant. measurements of antioxidants can be made based on the decolorization of I in concns. of approx. 5 × 10-4M.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZKlbXv_jIw7Vg90H21EOLACvtfcHk0liYuvbmeWl8HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG1cXptF2ntw%253D%253D&md5=58b5d2491941b7e53ec794e2e0e76b7c</span></div><a href="/servlet/linkout?suffix=cit36a&amp;dbid=16384&amp;doi=10.1038%2F1811199a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F1811199a0%26sid%3Dliteratum%253Aachs%26aulast%3DBlois%26aufirst%3DM.%2BS.%26atitle%3DAntioxidant%2520determinations%2520by%2520the%2520use%2520of%2520a%2520stable%2520free%2520radical%26jtitle%3DNature%26date%3D1958%26volume%3D181%26spage%3D1199%26epage%3D1200%26doi%3D10.1038%2F1811199a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit36b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Brand-Williams, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuvelier, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berset, C.</span></span> <span> </span><span class="NLM_article-title">Use of a free radical method to evaluate antioxidant activity</span>. <i>LWT—Food Sci. Technol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">30</span>, <span class="refDoi"> DOI: 10.1016/S0023-6438(95)80008-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2FS0023-6438%2895%2980008-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADyaK2MXjvV2itLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1995&pages=25-30&author=W.+Brand-Williamsauthor=M.+E.+Cuvelierauthor=C.+Berset&title=Use+of+a+free+radical+method+to+evaluate+antioxidant+activity&doi=10.1016%2FS0023-6438%2895%2980008-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36bR"><div class="casContent"><span class="casTitleNuber">36b</span><div class="casTitle"><span class="NLM_cas:atitle">Use of a free radical method to evaluate antioxidant activity</span></div><div class="casAuthors">Brand-WIlliams, W.; Cuvelier, M. E.; Berset, C.</div><div class="citationInfo"><span class="NLM_cas:title">Food Science & Technology (London)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-30</span>CODEN:
                <span class="NLM_cas:coden">LBWTAP</span>;
        ISSN:<span class="NLM_cas:issn">0023-6438</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">The antiradical activities of various antioxidants were detd. using the free radical, 2,2-Diphenyl-1-picrylhydrazyl (DPPH•).  In its radical form, DPPH• has an absorption band at 515 nm which disappears upon redn. by an antiradical compd.  Twenty compds. were reacted with the DPPH• and shown to follow one of three possible reaction kinetic types.  Ascorbic acid, isoascorbic acid and isoeugenol reacted quickly with the DPPH•, reaching a steady state immediately.  Rosmarinic acid and δ-tocopherol reacted a little slower and reached a steady state within 30 min.  The remaining compds. reacted more progressively with the DPPH•, reaching a steady state in 1-6 h.  Caffeic acid, gentisic acid and gallic acid showed the highest antiradical activities with a stoichiometry of 4 to 6 reduced DPPH• mols. per mol. of antioxidant.  Vanillin, phenol, γ-resorcylic acid and vanillic acid were found to be poor antiradical compds.  The stoichiometry for the other 13 phenolic compds. varied from one to three reduced DPPH• mols. per mol. of antioxidant.  Possible mechanisms are proposed to explain the exptl. results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdgt6zsPPpvLVg90H21EOLACvtfcHk0ljxo2N5xjlm6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjvV2itLw%253D&md5=0568c73ee9d55ec1d5b72153416e7e4a</span></div><a href="/servlet/linkout?suffix=cit36b&amp;dbid=16384&amp;doi=10.1016%2FS0023-6438%2895%2980008-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0023-6438%252895%252980008-5%26sid%3Dliteratum%253Aachs%26aulast%3DBrand-Williams%26aufirst%3DW.%26aulast%3DCuvelier%26aufirst%3DM.%2BE.%26aulast%3DBerset%26aufirst%3DC.%26atitle%3DUse%2520of%2520a%2520free%2520radical%2520method%2520to%2520evaluate%2520antioxidant%2520activity%26jtitle%3DLWT%25E2%2580%2594Food%2520Sci.%2520Technol.%26date%3D1995%26volume%3D28%26spage%3D25%26epage%3D30%26doi%3D10.1016%2FS0023-6438%2895%2980008-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span> <span> </span><span class="NLM_article-title">Structure-based survey of the binding modes of BACE1 inhibitors</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">880</span>– <span class="NLM_lpage">889</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.8b00420</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.8b00420" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVyhsrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=880-889&author=H.+Huauthor=Z.+Chenauthor=X.+Xuauthor=Y.+Xu&title=Structure-based+survey+of+the+binding+modes+of+BACE1+inhibitors&doi=10.1021%2Facschemneuro.8b00420"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37aR"><div class="casContent"><span class="casTitleNuber">37a</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Survey of the Binding Modes of BACE1 Inhibitors</span></div><div class="casAuthors">Hu, Hangchen; Chen, Zhaoqiang; Xu, Xiang; Xu, Yechun</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">880-889</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  BACE1 is a key aspartic protease that cleaves the amyloid precursor protein to generate of the amyloid peptide that is believed to be responsible for the Alzheimer's disease amyloid cascade.  It is thus recognized as a promising therapeutic target for Alzheimer's disease treatment, and large efforts have been made in the discovery of novel BACE1 inhibitors.  This Review presents a systematic mining of BACE1 inhibitors based on 354 crystal structures of the BACE1 catalytic domain in complex with ligands in the Protein Data Bank.  A thorough exploration on the frequency as well as the patterns of residue-ligand interactions enables us to subdivide the ligand binding pocket into 10 subsites and then identify favorable substructures of ligands for each subsite.  In addn., it is found that the assembly of subsites with an 8-like shape is responsible to bind all inhibitors and four major ligand binding modes are revealed.  Thus, such a systematic survey deepens our understanding of the structural requirements for establishment of BACE1-ligand interactions that det. the affinity of a ligand to BACE1, which is pivotal for structure-based lead optimization and design of novel inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwvv_EbX_3ALVg90H21EOLACvtfcHk0ljxo2N5xjlm6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVyhsrfF&md5=3157eb17033dae864aee238751e055ca</span></div><a href="/servlet/linkout?suffix=cit37a&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.8b00420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.8b00420%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DY.%26atitle%3DStructure-based%2520survey%2520of%2520the%2520binding%2520modes%2520of%2520BACE1%2520inhibitors%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2019%26volume%3D10%26spage%3D880%26epage%3D889%26doi%3D10.1021%2Facschemneuro.8b00420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit37b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hsiao, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rombouts, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span> <span> </span><span class="NLM_article-title">New evolutions in the BACE1 inhibitor field from 2014 to 2018</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">761</span>– <span class="NLM_lpage">777</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.12.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2Fj.bmcl.2018.12.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=30709653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlCmu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=761-777&author=C.-C.+Hsiaoauthor=F.+Romboutsauthor=H.+J.+M.+Gijsen&title=New+evolutions+in+the+BACE1+inhibitor+field+from+2014+to+2018&doi=10.1016%2Fj.bmcl.2018.12.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37bR"><div class="casContent"><span class="casTitleNuber">37b</span><div class="casTitle"><span class="NLM_cas:atitle">New evolutions in the BACE1 inhibitor field from 2014 to 2018</span></div><div class="casAuthors">Hsiao, Chien-Chi; Rombouts, Frederik; Gijsen, Harrie J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">761-777</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors offer the potential of disease-modifying treatment for Alzheimer's disease (AD).  Since 2014, major breakthroughs have appeared in the field of BACE1 inhibitors.  This review provides an overview of amidine-based BACE1 inhibitors between 2014 and 2018.  Herein are summarized (i) the structure-activity relationship, (ii) the physiol. results and (iii) the potential risks from a lack of selectivity.  This review also summarizes clin. scope, results and outlook of the compds. that have been or are currently under development in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3OfI_B-BJ-LVg90H21EOLACvtfcHk0ljxo2N5xjlm6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlCmu7s%253D&md5=049eda6ce97b31a04b5b579afd3e11e5</span></div><a href="/servlet/linkout?suffix=cit37b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.12.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.12.049%26sid%3Dliteratum%253Aachs%26aulast%3DHsiao%26aufirst%3DC.-C.%26aulast%3DRombouts%26aufirst%3DF.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3DNew%2520evolutions%2520in%2520the%2520BACE1%2520inhibitor%2520field%2520from%25202014%2520to%25202018%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D29%26spage%3D761%26epage%3D777%26doi%3D10.1016%2Fj.bmcl.2018.12.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit37c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mancini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Simone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrisano, V.</span></span> <span> </span><span class="NLM_article-title">Beta-secretase as a target for Alzheimer’s disease drug discovery: an overview of in vitro methods for characterization of inhibitors</span>. <i>Anal. Bioanal. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>400</i></span>,  <span class="NLM_fpage">1979</span>– <span class="NLM_lpage">1996</span>, <span class="refDoi"> DOI: 10.1007/s00216-011-4963-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1007%2Fs00216-011-4963-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=21503735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvVaqs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=400&publication_year=2011&pages=1979-1996&author=F.+Manciniauthor=A.+De+Simoneauthor=V.+Andrisano&title=Beta-secretase+as+a+target+for+Alzheimer%E2%80%99s+disease+drug+discovery%3A+an+overview+of+in+vitro+methods+for+characterization+of+inhibitors&doi=10.1007%2Fs00216-011-4963-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37cR"><div class="casContent"><span class="casTitleNuber">37c</span><div class="casTitle"><span class="NLM_cas:atitle">Beta-secretase as a target for Alzheimer's disease drug discovery: an overview of in vitro methods for characterization of inhibitors</span></div><div class="casAuthors">Mancini, Francesca; De Simone, Angela; Andrisano, Vincenza</div><div class="citationInfo"><span class="NLM_cas:title">Analytical and Bioanalytical Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">400</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1979-1996</span>CODEN:
                <span class="NLM_cas:coden">ABCNBP</span>;
        ISSN:<span class="NLM_cas:issn">1618-2642</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  β-Secretase 1 (BACE1) is the enzyme involved in the abnormal prodn. of the amyloidogenic peptide Aβ42, one of the major causes of histol. hallmarks of Alzheimer's disease.  Thus, BACE1 represents a key target protein in the development of new potential drugs for the non-symptomatic treatment of Alzheimer's disease.  Since the discovery of BACE1 one decade ago, both in the pharmaceutical industry and in academia there was an intense search for novel inhibitors to be developed as new effective drugs.  There is a great deal of interest in the discovery of selective non-peptide BACE1 inhibitors with a new chem. skeleton, suited for central nervous system penetration and endowed with more appropriate pharmacokinetic properties.  Therefore, the selection of appropriate methods for screening and characterization of BACE1 inhibitors is crucial.  This review focuses on the description of the in vitro methods to test BACE1 activity and inhibition, with particular emphasis on fluorescence resonance energy transfer (FRET) methods, aiming at critically highlighting advantages and drawbacks.  An overview of BACE1 inhibitors is given, underlying the variability of the FRET methods reported in the literature, and the structure evolution of inhibitors active in cellular cultures and in vivo, from peptide to small synthetic and natural structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2vOWtGCN8erVg90H21EOLACvtfcHk0ljxo2N5xjlm6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvVaqs70%253D&md5=49509fa46d06db030b5e549c5af2e002</span></div><a href="/servlet/linkout?suffix=cit37c&amp;dbid=16384&amp;doi=10.1007%2Fs00216-011-4963-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00216-011-4963-x%26sid%3Dliteratum%253Aachs%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DAndrisano%26aufirst%3DV.%26atitle%3DBeta-secretase%2520as%2520a%2520target%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520drug%2520discovery%253A%2520an%2520overview%2520of%2520in%2520vitro%2520methods%2520for%2520characterization%2520of%2520inhibitors%26jtitle%3DAnal.%2520Bioanal.%2520Chem.%26date%3D2011%26volume%3D400%26spage%3D1979%26epage%3D1996%26doi%3D10.1007%2Fs00216-011-4963-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fernández-Bachiller, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monjas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rademann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Franco, M. I.</span></span> <span> </span><span class="NLM_article-title">New tacrine–4-oxo-4H-chromene hybrids as multifunctional agents for the treatment of Alzheimer’s disease, with cholinergic, antioxidant, and β-amyloid-reducing properties</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1303</span>– <span class="NLM_lpage">1317</span>, <span class="refDoi"> DOI: 10.1021/jm201460y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201460y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC38XntFKisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1303-1317&author=M.+I.+Fern%C3%A1ndez-Bachillerauthor=C.+P%C3%A9rezauthor=L.+Monjasauthor=J.+Rademannauthor=M.+I.+Rodr%C3%ADguez-Franco&title=New+tacrine%E2%80%934-oxo-4H-chromene+hybrids+as+multifunctional+agents+for+the+treatment+of+Alzheimer%E2%80%99s+disease%2C+with+cholinergic%2C+antioxidant%2C+and+%CE%B2-amyloid-reducing+properties&doi=10.1021%2Fjm201460y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38aR"><div class="casContent"><span class="casTitleNuber">38a</span><div class="casTitle"><span class="NLM_cas:atitle">New Tacrine-4-Oxo-4H-chromene Hybrids as Multifunctional Agents for the Treatment of Alzheimer's Disease, with Cholinergic, Antioxidant, and β-Amyloid-Reducing Properties</span></div><div class="casAuthors">Fernandez-Bachiller, Maria Isabel; Perez, Concepcion; Monjas, Leticia; Rademann, Jorg; Rodriguez-Franco, Maria Isabel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1303-1317</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">By using fragments endowed with interesting and complementary properties for the treatment of Alzheimer's disease (AD), a new family of tacrine-4-oxo-4H-chromene hybrids has been designed, synthesized, and evaluated biol.  The tacrine fragment was selected for its inhibition of cholinesterases, and the flavonoid scaffold derived from 4-oxo-4H -chromene was chosen for its radical capture and β-secretase 1 (BACE-1) inhibitory activities.  At nano- and picomolar concns., the new tacrine-4-oxo-4H-chromene hybrids inhibit human acetyl- and butyrylcholinesterase (h-AChE and h-BuChE), being more potent than the parent inhibitor, tacrine.  They are also potent inhibitors of human BACE-1, better than the parent flavonoid, apigenin.  They show interesting antioxidant properties and could be able to penetrate into the CNS according to the in vitro PAMPA-BBB assay.  Among the hybrids investigated, 6-hydroxy-4-oxo- N-{10-[(1,2,3,4-tetrahydroacridin-9-yl)amino]decyl}-4 H-chromene-2-carboxamide (I) shows potent combined inhibition of human BACE-1 and ChEs, as well as good antioxidant and CNS-permeable properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiMx-NagCpeLVg90H21EOLACvtfcHk0lisha7zMria-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntFKisw%253D%253D&md5=9391af9439e43f5eda518919839bd473</span></div><a href="/servlet/linkout?suffix=cit38a&amp;dbid=16384&amp;doi=10.1021%2Fjm201460y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201460y%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez-Bachiller%26aufirst%3DM.%2BI.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%26aulast%3DMonjas%26aufirst%3DL.%26aulast%3DRademann%26aufirst%3DJ.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26atitle%3DNew%2520tacrine%25E2%2580%25934-oxo-4H-chromene%2520hybrids%2520as%2520multifunctional%2520agents%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%252C%2520with%2520cholinergic%252C%2520antioxidant%252C%2520and%2520%25CE%25B2-amyloid-reducing%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1303%26epage%3D1317%26doi%3D10.1021%2Fjm201460y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit38b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, N. T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsim, K. W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youdim, M. B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Y.</span></span> <span> </span><span class="NLM_article-title">Promising anti-Alzheimer’s dimer bis(7)-tacrine reduces β-amyloid generation by directly inhibiting BACE-1 activity</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>366</i></span>,  <span class="NLM_fpage">631</span>– <span class="NLM_lpage">636</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2007.11.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2Fj.bbrc.2007.11.068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=18039469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD1cXivVeitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2008&pages=631-636&author=H.+Fuauthor=W.+Liauthor=J.+Luoauthor=N.+T.+K.+Leeauthor=M.+Liauthor=K.+W.+K.+Tsimauthor=Y.+Pangauthor=M.+B.+H.+Youdimauthor=Y.+Han&title=Promising+anti-Alzheimer%E2%80%99s+dimer+bis%287%29-tacrine+reduces+%CE%B2-amyloid+generation+by+directly+inhibiting+BACE-1+activity&doi=10.1016%2Fj.bbrc.2007.11.068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38bR"><div class="casContent"><span class="casTitleNuber">38b</span><div class="casTitle"><span class="NLM_cas:atitle">Promising anti-Alzheimer's dimer bis(7)-tacrine reduces β-amyloid generation by directly inhibiting BACE-1 activity</span></div><div class="casAuthors">Fu, Hongjun; Li, Wenming; Luo, Jialie; Lee, Nelson T. K.; Li, Mingtao; Tsim, Karl W. K.; Pang, Yuanping; Youdim, Moussa B. H.; Han, Yifan</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">366</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">631-636</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The regulation of α-, β-, (BACE-1), and γ-secretase activities to alter β-amyloid (Aβ) generation is considered to be one of the most promising disease-modifying therapeutics for Alzheimer's disease.  In this study, the effect and mechanisms of bis(7)-tacrine (a promising anti-Alzheimer's dimer) on Aβ generation were investigated.  Bis(7)-tacrine (0.1-3 μM) substantially reduced the amts. of both secreted and intracellular Aβ in Neuro2a APPswe cells without altering the expression of APP. sAPPα and CTFα increased, while sAPPβ and CTFβ decreased significantly in Neuro2a APPswe cells following the treatment with bis(7)-tacrine, indicating that bis(7)-tacrine might activate α-secretase and/or inhibit BACE-1 activity.  Furthermore, bis(7)-tacrine concn.-dependently inhibited BACE-1 activity in cultured cells, and also in recombinant human BACE-1 in a non-competitive manner with an IC50 of 7.5 μM, but did not directly affect activities of BACE-2, Cathepsin D, α- or γ-secretase.  Taken together, our results not only suggest that bis(7)-tacrine may reduce the biosynthesis of Aβ mainly by directly inhibiting BACE-1 activity, but also provide new insights into the rational design of novel anti-Alzheimer's dimers that might have disease-modifying properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-O2pNL8PuuLVg90H21EOLACvtfcHk0lisha7zMria-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXivVeitQ%253D%253D&md5=b449178e17faab740f72afe5b7fd101f</span></div><a href="/servlet/linkout?suffix=cit38b&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2007.11.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2007.11.068%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DN.%2BT.%2BK.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DTsim%26aufirst%3DK.%2BW.%2BK.%26aulast%3DPang%26aufirst%3DY.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26aulast%3DHan%26aufirst%3DY.%26atitle%3DPromising%2520anti-Alzheimer%25E2%2580%2599s%2520dimer%2520bis%25287%2529-tacrine%2520reduces%2520%25CE%25B2-amyloid%2520generation%2520by%2520directly%2520inhibiting%2520BACE-1%2520activity%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2008%26volume%3D366%26spage%3D631%26epage%3D636%26doi%3D10.1016%2Fj.bbrc.2007.11.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Espargaró, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Pietro, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabate, R.</span></span> <span> </span><span class="NLM_article-title">Ultra rapid in vivo screening for anti-Alzheimer anti-amyloid drugs</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">23349</span> <span class="refDoi"> DOI: 10.1038/srep23349</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1038%2Fsrep23349" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=27000658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvVers7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&author=A.+Espargar%C3%B3author=A.+Medinaauthor=O.+Di+Pietroauthor=D.+Mu%C3%B1oz-Torreroauthor=R.+Sabate&title=Ultra+rapid+in+vivo+screening+for+anti-Alzheimer+anti-amyloid+drugs&doi=10.1038%2Fsrep23349"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39aR"><div class="casContent"><span class="casTitleNuber">39a</span><div class="casTitle"><span class="NLM_cas:atitle">Ultra rapid in vivo screening for anti-Alzheimer anti-amyloid drugs</span></div><div class="casAuthors">Espargaro, Alba; Medina, Aina; Di Pietro, Ornella; Munoz-Torrero, Diego; Sabate, Raimon</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">23349</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">More than 46 million people worldwide suffer from Alzheimer's disease.  A large no. of potential treatments have been proposed; among these, the inhibition of the aggregation of amyloid β-peptide (Aβ), considered one of the main culprits in Alzheimer's disease.  Limitations in monitoring the aggregation of Aβ in cells and tissues restrict the screening of anti-amyloid drugs to in vitro studies in most cases.  We have developed a simple but powerful method to track Aβ aggregation in vivo in real-time, using bacteria as in vivo amyloid reservoir.  We use the specific amyloid dye Thioflavin-S (Th-S) to stain bacterial inclusion bodies (IBs), in this case mainly formed of Aβ in amyloid conformation.  Th-S binding to amyloids leads to an increment of fluorescence that can be monitored.  The quantification of the Th-S fluorescence along the time allows tracking Aβ aggregation and the effect of potential anti-aggregating agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdTgLJrIvKz7Vg90H21EOLACvtfcHk0lisha7zMria-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvVers7w%253D&md5=15f43a569820e604bad4c4ec7e6a6649</span></div><a href="/servlet/linkout?suffix=cit39a&amp;dbid=16384&amp;doi=10.1038%2Fsrep23349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep23349%26sid%3Dliteratum%253Aachs%26aulast%3DEspargar%25C3%25B3%26aufirst%3DA.%26aulast%3DMedina%26aufirst%3DA.%26aulast%3DDi%2BPietro%26aufirst%3DO.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DSabate%26aufirst%3DR.%26atitle%3DUltra%2520rapid%2520in%2520vivo%2520screening%2520for%2520anti-Alzheimer%2520anti-amyloid%2520drugs%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26doi%3D10.1038%2Fsrep23349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit39b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pouplana, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espargaró, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galdeano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viayna, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sola, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ventura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabate, R.</span></span> <span> </span><span class="NLM_article-title">Thioflavin-S staining of bacterial inclusion bodies for the fast, simple, and inexpensive screening of amyloid aggregation inhibitors</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1152</span>– <span class="NLM_lpage">1159</span>, <span class="refDoi"> DOI: 10.2174/09298673113206660256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.2174%2F09298673113206660256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=24059241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtlyrtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=1152-1159&author=S.+Pouplanaauthor=A.+Espargar%C3%B3author=C.+Galdeanoauthor=E.+Viaynaauthor=I.+Solaauthor=S.+Venturaauthor=D.+Mu%C3%B1oz-Torreroauthor=R.+Sabate&title=Thioflavin-S+staining+of+bacterial+inclusion+bodies+for+the+fast%2C+simple%2C+and+inexpensive+screening+of+amyloid+aggregation+inhibitors&doi=10.2174%2F09298673113206660256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39bR"><div class="casContent"><span class="casTitleNuber">39b</span><div class="casTitle"><span class="NLM_cas:atitle">Thioflavin-S Staining of Bacterial Inclusion Bodies for the Fast, Simple, and Inexpensive Screening of Amyloid Aggregation Inhibitors</span></div><div class="casAuthors">Pouplana, S.; Espargaro, A.; Galdeano, C.; Viayna, E.; Sola, I.; Ventura, S.; Munoz-Torrero, D.; Sabate, R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1152-1159</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Amyloid aggregation is linked to a large no. of human disorders, from neurodegenerative diseases as Alzheimer's disease (AD) or spongiform encephalopathies to non-neuropathic localized diseases as type II diabetes and cataracts.  Because the formation of insol. inclusion bodies (IBs) during recombinant protein prodn. in bacteria has been recently shown to share mechanistic features with amyloid self-assembly, bacteria have emerged as a tool to study amyloid aggregation.  Herein we present a fast, simple, inexpensive and quant. method for the screening of potential anti-aggregating drugs.  This method is based on monitoring the changes in the binding of thioflavin-S to intracellular IBs in intact Escherichia coli cells in the presence of small chem. compds.  This in vivo technique fairly recapitulates previous in vitro data.  Here we mainly use the Alzheimer's related β -amyloid peptide as a model system, but the technique can be easily implemented for screening inhibitors relevant for other conformational diseases simply by changing the recombinant amyloid protein target.  Indeed, we show that this methodol. can be also applied to the evaluation of inhibitors of the aggregation of tau protein, another amyloidogenic protein with a key role in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpcODp_BtMQrVg90H21EOLACvtfcHk0livlnJ_D7pekQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtlyrtLs%253D&md5=c8c28e9aac732ce9000afc90cf7309fd</span></div><a href="/servlet/linkout?suffix=cit39b&amp;dbid=16384&amp;doi=10.2174%2F09298673113206660256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F09298673113206660256%26sid%3Dliteratum%253Aachs%26aulast%3DPouplana%26aufirst%3DS.%26aulast%3DEspargar%25C3%25B3%26aufirst%3DA.%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DSola%26aufirst%3DI.%26aulast%3DVentura%26aufirst%3DS.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DSabate%26aufirst%3DR.%26atitle%3DThioflavin-S%2520staining%2520of%2520bacterial%2520inclusion%2520bodies%2520for%2520the%2520fast%252C%2520simple%252C%2520and%2520inexpensive%2520screening%2520of%2520amyloid%2520aggregation%2520inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2014%26volume%3D21%26spage%3D1152%26epage%3D1159%26doi%3D10.2174%2F09298673113206660256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McConnell, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, G. T.</span></span> <span> </span><span class="NLM_article-title">High throughput artificial membrane permeability assay for blood–brain barrier</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">232</span>, <span class="refDoi"> DOI: 10.1016/S0223-5234(03)00012-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2FS0223-5234%2803%2900012-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=12667689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=223-232&author=L.+Diauthor=E.+H.+Kernsauthor=K.+Fanauthor=O.+J.+McConnellauthor=G.+T.+Carter&title=High+throughput+artificial+membrane+permeability+assay+for+blood%E2%80%93brain+barrier&doi=10.1016%2FS0223-5234%2803%2900012-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">High throughput artificial membrane permeability assay for blood-brain barrier</span></div><div class="casAuthors">Di, Li; Kerns, Edward H.; Fan, Kristi; McConnell, Oliver J.; Carter, Guy T.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">223-232</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">The recent advances in high throughput screening for biol. activities and combinatorial chem. have greatly expanded the no. of drug candidates.  Rapid screening for BBB penetration potential early in drug discovery programs provides important information for compd. selection and guidance of synthesis for desirable CNS properties.  In this paper, we discuss a modification of the parallel artificial membrane permeation assay (PAMPA) for the prediction of blood-brain barrier penetration (PAMPA-BBB).  The assay was developed with 30 structurally diverse com. drugs and validated with 14 Wyeth Research compds.  The PAMPA-BBB assay has the advantages of: predicting passive blood-brain barrier penetration with high success, high throughput, low cost, and reproducibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZCg9Ka4mziLVg90H21EOLACvtfcHk0livlnJ_D7pekQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D&md5=d228d5808ba8df23deed92c5e2bf3863</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2FS0223-5234%2803%2900012-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0223-5234%252803%252900012-6%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DMcConnell%26aufirst%3DO.%2BJ.%26aulast%3DCarter%26aufirst%3DG.%2BT.%26atitle%3DHigh%2520throughput%2520artificial%2520membrane%2520permeability%2520assay%2520for%2520blood%25E2%2580%2593brain%2520barrier%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2003%26volume%3D38%26spage%3D223%26epage%3D232%26doi%3D10.1016%2FS0223-5234%2803%2900012-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sola, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aso, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frattini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-González, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espargaró, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabaté, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Pietro, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clos, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span> <span> </span><span class="NLM_article-title">Novel levetiracetam derivatives that are effective against the Alzheimer-like phenotype in mice: synthesis, in vitro, ex vivo, and in vivo efficacy studies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6018</span>– <span class="NLM_lpage">6032</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00624</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00624" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFOlsLnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6018-6032&author=I.+Solaauthor=E.+Asoauthor=D.+Frattiniauthor=I.+L%C3%B3pez-Gonz%C3%A1lezauthor=A.+Espargar%C3%B3author=R.+Sabat%C3%A9author=O.+Di+Pietroauthor=F.+J.+Luqueauthor=M.+V.+Closauthor=I.+Ferrerauthor=D.+Mu%C3%B1oz-Torrero&title=Novel+levetiracetam+derivatives+that+are+effective+against+the+Alzheimer-like+phenotype+in+mice%3A+synthesis%2C+in+vitro%2C+ex+vivo%2C+and+in+vivo+efficacy+studies&doi=10.1021%2Facs.jmedchem.5b00624"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Levetiracetam Derivatives That Are Effective against the Alzheimer-like Phenotype in Mice: Synthesis, in Vitro, ex Vivo, and in Vivo Efficacy Studies</span></div><div class="casAuthors">Sola, Irene; Aso, Ester; Frattini, Daniela; Lopez-Gonzalez, Irene; Espargaro, Alba; Sabate, Raimon; Di Pietro, Ornella; Luque, F. Javier; Clos, M. Victoria; Ferrer, Isidro; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6018-6032</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have synthesized a series of heptamethylene-linked levetiracetam-huprine and levetiracetam-(6-chloro)tacrine hybrids to hit amyloid, tau, and cholinergic pathologies as well as β-amyloid (Aβ)-induced epileptiform activity, some of the mechanisms that eventually lead to cognitive deficits in Alzheimer's disease patients.  These hybrids are potent inhibitors of human acetylcholinesterase and butyrylcholinesterase in vitro and moderately potent Aβ42 and tau antiaggregating agents in a simple E. coli model of amyloid aggregation.  Ex vivo detn. of the brain acetylcholinesterase inhibitory activity of these compds. after i.p. injection to C57BL6J mice has demonstrated their ability to enter the brain.  The levetiracetam-huprine hybrid I significantly reduced the incidence of epileptic seizures, cortical amyloid burden, and neuroinflammation in APP/PS1 mice after a 4-wk treatment with a 5 mg/kg dose.  Moreover, the hybrid I rescued transgenic mice from cognitive deficits, thereby emerging as an interesting disease-modifying anti-Alzheimer drug candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqd__ieGH6QxrVg90H21EOLACvtfcHk0livlnJ_D7pekQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFOlsLnM&md5=f275a5233c2cdd59410e22b615634698</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00624%26sid%3Dliteratum%253Aachs%26aulast%3DSola%26aufirst%3DI.%26aulast%3DAso%26aufirst%3DE.%26aulast%3DFrattini%26aufirst%3DD.%26aulast%3DL%25C3%25B3pez-Gonz%25C3%25A1lez%26aufirst%3DI.%26aulast%3DEspargar%25C3%25B3%26aufirst%3DA.%26aulast%3DSabat%25C3%25A9%26aufirst%3DR.%26aulast%3DDi%2BPietro%26aufirst%3DO.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DFerrer%26aufirst%3DI.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DNovel%2520levetiracetam%2520derivatives%2520that%2520are%2520effective%2520against%2520the%2520Alzheimer-like%2520phenotype%2520in%2520mice%253A%2520synthesis%252C%2520in%2520vitro%252C%2520ex%2520vivo%252C%2520and%2520in%2520vivo%2520efficacy%2520studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6018%26epage%3D6032%26doi%3D10.1021%2Facs.jmedchem.5b00624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Borchelt, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratovitski, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Lare, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sisodia, S. S.</span></span> <span> </span><span class="NLM_article-title">Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">939</span>– <span class="NLM_lpage">945</span>, <span class="refDoi"> DOI: 10.1016/S0896-6273(00)80974-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2FS0896-6273%2800%2980974-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=9354339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADyaK2sXntFersbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1997&pages=939-945&author=D.+R.+Borcheltauthor=T.+Ratovitskiauthor=J.+van+Lareauthor=M.+K.+Leeauthor=V.+Gonzalesauthor=N.+A.+Jenkinsauthor=N.+G.+Copelandauthor=D.+L.+Priceauthor=S.+S.+Sisodia&title=Accelerated+amyloid+deposition+in+the+brains+of+transgenic+mice+coexpressing+mutant+presenilin+1+and+amyloid+precursor+proteins&doi=10.1016%2FS0896-6273%2800%2980974-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins</span></div><div class="casAuthors">Borchelt, David R.; Ratovitski, Tamara; Van Lare, Judy; Lee, Michael K.; Gonzales, Vicki; Jenkins, Nancy A.; Copeland, Neal G.; Price, Donald L.; Sisodia, Sangram S.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">939-945</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Missense mutations in two related genes, termed presenilin 1 (PS1) and presenilin 2 (PS2), cause dementia in a subset of early-onset familial Alzheimer's disease (FAD) pedigrees.  In a variety of exptl. in vitro and in vivo settings, FAD-linked presenilin variants influence the processing of the amyloid precursor protein (APP), leading to elevated levels of the highly fibrilogenic Aβ1-42 peptides that are preferentially deposited in the brains of Alzheimer Disease (AD) patients.  In this report, we demonstrate that transgenic animals that coexpress an FAD-linked human PS1 variant (A246E) and a chimeric mouse/human APP harboring mutations linked to Swedish FAD kindreds (APP swe) develop numerous amyloid deposits much earlier than age-matched mice expressing APP swe and wild-type Hu PS1 or APP swe alone.  These results provide evidence for the view that one pathogenic mechanism by which FAD-linked mutant PS1 causes AD is to accelerate the rate of β-amyloid deposition in brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE6fPtRz3ferVg90H21EOLACvtfcHk0ljrO37JVRbafA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXntFersbo%253D&md5=8377c31c3b35cb4cdca7d648f2161062</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2FS0896-6273%2800%2980974-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0896-6273%252800%252980974-5%26sid%3Dliteratum%253Aachs%26aulast%3DBorchelt%26aufirst%3DD.%2BR.%26aulast%3DRatovitski%26aufirst%3DT.%26aulast%3Dvan%2BLare%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DM.%2BK.%26aulast%3DGonzales%26aufirst%3DV.%26aulast%3DJenkins%26aufirst%3DN.%2BA.%26aulast%3DCopeland%26aufirst%3DN.%2BG.%26aulast%3DPrice%26aufirst%3DD.%2BL.%26aulast%3DSisodia%26aufirst%3DS.%2BS.%26atitle%3DAccelerated%2520amyloid%2520deposition%2520in%2520the%2520brains%2520of%2520transgenic%2520mice%2520coexpressing%2520mutant%2520presenilin%25201%2520and%2520amyloid%2520precursor%2520proteins%26jtitle%3DNeuron%26date%3D1997%26volume%3D19%26spage%3D939%26epage%3D945%26doi%3D10.1016%2FS0896-6273%2800%2980974-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vogel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcotte, E. M.</span></span> <span> </span><span class="NLM_article-title">Insights into the regulation of protein abundance from proteomic and transcriptomic analyses</span>. <i>Nat. Rev. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">227</span>– <span class="NLM_lpage">232</span>, <span class="refDoi"> DOI: 10.1038/nrg3185</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1038%2Fnrg3185" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=22411467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1Wgurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=227-232&author=C.+Vogelauthor=E.+M.+Marcotte&title=Insights+into+the+regulation+of+protein+abundance+from+proteomic+and+transcriptomic+analyses&doi=10.1038%2Fnrg3185"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into the regulation of protein abundance from proteomic and transcriptomic analyses</span></div><div class="casAuthors">Vogel, Christine; Marcotte, Edward M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Genetics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">227-232</span>CODEN:
                <span class="NLM_cas:coden">NRGAAM</span>;
        ISSN:<span class="NLM_cas:issn">1471-0056</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Recent advances in next-generation DNA sequencing and proteomics provide an unprecedented ability to survey mRNA and protein abundances.  Such proteome-wide surveys are illuminating the extent to which different aspects of gene expression help to regulate cellular protein abundances.  Current data demonstrate a substantial role for regulatory processes occurring after mRNA is made - i.e., post-transcriptional, translational and protein degrdn. regulation - in controlling steady-state protein abundances.  Intriguing observations are also emerging in relation to cells following perturbation, single-cell studies and the apparent evolutionary conservation of protein and mRNA abundances.  Here, we summarize current understanding of the major factors regulating protein expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNVg9UPb6f0rVg90H21EOLACvtfcHk0ljrO37JVRbafA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1Wgurs%253D&md5=cc06a788506765eb137f9d42461586c8</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fnrg3185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrg3185%26sid%3Dliteratum%253Aachs%26aulast%3DVogel%26aufirst%3DC.%26aulast%3DMarcotte%26aufirst%3DE.%2BM.%26atitle%3DInsights%2520into%2520the%2520regulation%2520of%2520protein%2520abundance%2520from%2520proteomic%2520and%2520transcriptomic%2520analyses%26jtitle%3DNat.%2520Rev.%2520Genet.%26date%3D2012%26volume%3D13%26spage%3D227%26epage%3D232%26doi%3D10.1038%2Fnrg3185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheignon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnefont-Rousselot, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faller, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hureau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collin, F.</span></span> <span> </span><span class="NLM_article-title">Oxidative stress and the amyloid beta peptide in Alzheimer’s disease</span>. <i>Redox Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">450</span>– <span class="NLM_lpage">464</span>, <span class="refDoi"> DOI: 10.1016/j.redox.2017.10.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2Fj.redox.2017.10.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=29080524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslans73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=450-464&author=C.+Cheignonauthor=M.+Tomasauthor=D.+Bonnefont-Rousselotauthor=P.+Fallerauthor=C.+Hureauauthor=F.+Collin&title=Oxidative+stress+and+the+amyloid+beta+peptide+in+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.redox.2017.10.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress and the amyloid beta peptide in Alzheimer's disease</span></div><div class="casAuthors">Cheignon, C.; Tomas, M.; Bonnefont-Rousselot, D.; Faller, P.; Hureau, C.; Collin, F.</div><div class="citationInfo"><span class="NLM_cas:title">Redox Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">450-464</span>CODEN:
                <span class="NLM_cas:coden">RBEIB3</span>;
        ISSN:<span class="NLM_cas:issn">2213-2317</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Oxidative stress is known to play an important role in the pathogenesis of a no. of diseases.  In particular, it is linked to the etiol. of Alzheimer's disease (AD), an age-related neurodegenerative disease and the most common cause of dementia in the elderly.  Histopathol. hallmarks of AD are intracellular neurofibrillary tangles and extracellular formation of senile plaques composed of the amyloid-beta peptide (Aβ) in aggregated form along with metal-ions such as copper, iron or zinc.  Redox active metal ions, as for example copper, can catalyze the prodn. of Reactive Oxygen Species (ROS) when bound to the amyloid-β (Aβ).  The ROS thus produced, in particular the hydroxyl radical which is the most reactive one, may contribute to oxidative damage on both the Aβ peptide itself and on surrounding mol. (proteins, lipids, ...).  This review highlights the existing link between oxidative stress and AD, and the consequences towards the Aβ peptide and surrounding mols. in terms of oxidative damage.  In addn., the implication of metal ions in AD, their interaction with the Aβ peptide and redox properties leading to ROS prodn. are discussed, along with both in vitro and in vivo oxidn. of the Aβ peptide, at the mol. level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAsJM-PSPjNrVg90H21EOLACvtfcHk0ljrO37JVRbafA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslans73L&md5=f61600ab9e355cd49838961d26de5c4f</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.redox.2017.10.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.redox.2017.10.014%26sid%3Dliteratum%253Aachs%26aulast%3DCheignon%26aufirst%3DC.%26aulast%3DTomas%26aufirst%3DM.%26aulast%3DBonnefont-Rousselot%26aufirst%3DD.%26aulast%3DFaller%26aufirst%3DP.%26aulast%3DHureau%26aufirst%3DC.%26aulast%3DCollin%26aufirst%3DF.%26atitle%3DOxidative%2520stress%2520and%2520the%2520amyloid%2520beta%2520peptide%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DRedox%2520Biol.%26date%3D2018%26volume%3D14%26spage%3D450%26epage%3D464%26doi%3D10.1016%2Fj.redox.2017.10.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Patocka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuca, K.</span></span> <span> </span><span class="NLM_article-title">Possible role of hydroxylated metabolites of tacrine in drug toxicity and therapy of Alzheimer’s disease</span>. <i>Curr. Drug Metab.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">332</span>– <span class="NLM_lpage">335</span>, <span class="refDoi"> DOI: 10.2174/138920008784220619</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.2174%2F138920008784220619" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=18473751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD1cXls1aitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=332-335&author=J.+Patockaauthor=D.+Junauthor=K.+Kuca&title=Possible+role+of+hydroxylated+metabolites+of+tacrine+in+drug+toxicity+and+therapy+of+Alzheimer%E2%80%99s+disease&doi=10.2174%2F138920008784220619"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45aR"><div class="casContent"><span class="casTitleNuber">45a</span><div class="casTitle"><span class="NLM_cas:atitle">Possible role of hydroxylated metabolites of tacrine in drug toxicity and therapy of Alzheimer's disease</span></div><div class="casAuthors">Patocka, Jiri; Jun, Daniel; Kuca, Kamil</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">332-335</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Tacrine belongs to the group of acetylcholinesterase (AChE) inhibitors used as drugs for treatment of Alzheimer's disease (AD).  The formation of hydroxyderivatives of tacrine is well-established step in the metabolization of this drug in liver by microsomal cytochrome P 450 enzymes family.  Genetic polymorphism of cytochrome P 450 enzymes is probably responsible for balance between a no. of stable and non-toxic metabolites and highly protein-reactive and toxic ones.  By this manner may be explained why the hepatotoxicity of tacrine was obsd. only in the part of persons and why not every patient with AD responds to the treatment by this drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUeG2em7see7Vg90H21EOLACvtfcHk0lj02aEBk9sxFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXls1aitb4%253D&md5=90794c1e82da53f0506f31d7400b260c</span></div><a href="/servlet/linkout?suffix=cit45a&amp;dbid=16384&amp;doi=10.2174%2F138920008784220619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920008784220619%26sid%3Dliteratum%253Aachs%26aulast%3DPatocka%26aufirst%3DJ.%26aulast%3DJun%26aufirst%3DD.%26aulast%3DKuca%26aufirst%3DK.%26atitle%3DPossible%2520role%2520of%2520hydroxylated%2520metabolites%2520of%2520tacrine%2520in%2520drug%2520toxicity%2520and%2520therapy%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2008%26volume%3D9%26spage%3D332%26epage%3D335%26doi%3D10.2174%2F138920008784220619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit45b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Spaldin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madden, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pool, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolf, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B.</span></span> <span> </span><span class="NLM_article-title">The effect of enzyme inhibition on the metabolism and activation of tacrine by human liver microsomes</span>. <i>Br. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2125.1994.tb04316.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1111%2Fj.1365-2125.1994.tb04316.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=7946932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADyaK2cXmt1Squ7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1994&pages=15-22&author=V.+Spaldinauthor=S.+Maddenauthor=W.+Poolauthor=T.+Woolfauthor=B.+Park&title=The+effect+of+enzyme+inhibition+on+the+metabolism+and+activation+of+tacrine+by+human+liver+microsomes&doi=10.1111%2Fj.1365-2125.1994.tb04316.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45bR"><div class="casContent"><span class="casTitleNuber">45b</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of enzyme inhibition on the metabolism and activation of tacrine by human liver microsomes</span></div><div class="casAuthors">Spaldin, Vanessa; Madden, Stephen; Pool, William F.; Woolf, Thomas F.; Park, B. Kevin</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-22</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    </div><div class="casAbstract">Tacrine (1,2,3,4-tetrahydro-9-aminoacridine-hydrochloride: THA) underwent metab. in vitro by a panel (n = 12) of human liver microsomes genotyped for CYP2D6, in the presence of NADPH, to both protein-reactive and stable metabolites.  There was considerable variation in the extent of THA metab. amongst human livers.  Protein-reactive metabolite formation showed a 10-fold variation (0.6 ± 0.1%-5.2 ± 0.8% of incubated radioactivity mg-1 protein) while stable metabolites showed a 3-fold variation (24.3 ± 1.7%-78.6 ± 2.6% of incubated radioactivity).  Using cytochrome P 450 isoform specific inhibitors, CYP1A2 was identified as the major enzyme involved in all routes of THA metab.  There was a high correlation between arom. and alicyclic hydroxylation (r = 0.92, P < 0.0001) consistent with these biotransformations being catalyzed by the same enzymes.  Enoxacin (ENOX), cimetidine (CIM) and chloroquine (CQ) inhibited THA metab. by a preferential decrease in the bioactivation to protein-reactive, and hence potentially toxic, species.  The inhibitory potency of ENOX and CIM was increased significantly upon pre-incubation with microsomes and NADPH.  Covalent binding correlated with 7-OH-THA formation before (r = 0.792, P < 0.0001) and after (r = 0.73, P < 0.0001) inhibition by CIM, consistent with a two-step mechanism in the formation of protein-reactive metabolite(s) via a 7-OH intermediate.  The use of enzyme inhibitors may provide a useful tool for examg. the relationship between the metab. and toxicity of THA in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8-WddvBnzXLVg90H21EOLACvtfcHk0lj02aEBk9sxFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmt1Squ7g%253D&md5=bb873b19f38a811b9e3c88cac7df91ac</span></div><a href="/servlet/linkout?suffix=cit45b&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.1994.tb04316.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.1994.tb04316.x%26sid%3Dliteratum%253Aachs%26aulast%3DSpaldin%26aufirst%3DV.%26aulast%3DMadden%26aufirst%3DS.%26aulast%3DPool%26aufirst%3DW.%26aulast%3DWoolf%26aufirst%3DT.%26aulast%3DPark%26aufirst%3DB.%26atitle%3DThe%2520effect%2520of%2520enzyme%2520inhibition%2520on%2520the%2520metabolism%2520and%2520activation%2520of%2520tacrine%2520by%2520human%2520liver%2520microsomes%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D1994%26volume%3D38%26spage%3D15%26epage%3D22%26doi%3D10.1111%2Fj.1365-2125.1994.tb04316.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit45c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Madden, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolf, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pool, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. K.</span></span> <span> </span><span class="NLM_article-title">An investigation into the formation of stable, protein-reactive and cytotoxic metabolites from tacrine in vitro</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">20</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(93)90342-T</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2F0006-2952%2893%2990342-T" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=8347124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADyaK3sXlvFGmtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1993&pages=13-20&author=S.+Maddenauthor=T.+F.+Woolfauthor=W.+F.+Poolauthor=B.+K.+Park&title=An+investigation+into+the+formation+of+stable%2C+protein-reactive+and+cytotoxic+metabolites+from+tacrine+in+vitro&doi=10.1016%2F0006-2952%2893%2990342-T"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45cR"><div class="casContent"><span class="casTitleNuber">45c</span><div class="casTitle"><span class="NLM_cas:atitle">An investigation into the formation of stable, protein-reactive and cytotoxic metabolites from tacrine in vitro: studies with human and rat liver microsomes</span></div><div class="casAuthors">Madden, Stephen; Woolf, Thomas F.; Pool, William F.; Park, B. Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-20</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">Tacrine (1,2,3,4-tetrahydro-9-aminoacridine hydrochloride; THA) is known to undergo extensive oxidative metab. to a variety of mono- and dihydroxylated metabolites in animals and humans.  The potential for tacrine to undergo metab. to stable, protein-reactive and cytotoxic metabolites has been investigated in incubations with human and rat liver microsomes.  Using lymphocytes as sensitive markers to quantify cytotoxicity, THA (50 μM) underwent NADPH-dependent bioactivation to a cytotoxic metabolite(s).  Stable and protein-reactive metabolites were also formed in microsomes from both species.  These accounted for 28.2 and 1.22% of incubated radioactivity in human microsomes and 6.4 and 0.4% of incubated radioactivity in rat microsomes.  Reduced glutathione (500 μM) completely blocked NADPH-dependent cytotoxicity and inhibited protein-reactive metabolite formation by 60%.  Ascorbic acid (500 μM) inhibited the generation of cytotoxic and protein-reactive metabolites by 75 and 35%, resp.  Cyclohexene oxide was without effect.  Human serum albumin was found to protect the lymphocytes against toxicity.  In microsomes prepd. from the livers of four donors known to have been smokers there were no significant differences in the generation of metabolites from THA compared with microsomes prepd. from livers of non-smokers.  Enoxacin, a specific inhibitor of cytochrome P 450 1A2 significantly inhibited all routes of THA metab.  The authors have therefore demonstrated that THA may be oxidatively metabolized to stable, protein-reactive and cytotoxic metabolites in human and rat liver microsomes.  A no. of inhibitors may affect these processes, whilst inhibition by enoxacin indicates a role for cytochrome P 450 1A2 in THA metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBVISRfdBJzrVg90H21EOLACvtfcHk0lj02aEBk9sxFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXlvFGmtbw%253D&md5=7394d4697031eb18e4daada87d00f539</span></div><a href="/servlet/linkout?suffix=cit45c&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2893%2990342-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252893%252990342-T%26sid%3Dliteratum%253Aachs%26aulast%3DMadden%26aufirst%3DS.%26aulast%3DWoolf%26aufirst%3DT.%2BF.%26aulast%3DPool%26aufirst%3DW.%2BF.%26aulast%3DPark%26aufirst%3DB.%2BK.%26atitle%3DAn%2520investigation%2520into%2520the%2520formation%2520of%2520stable%252C%2520protein-reactive%2520and%2520cytotoxic%2520metabolites%2520from%2520tacrine%2520in%2520vitro%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1993%26volume%3D46%26spage%3D13%26epage%3D20%26doi%3D10.1016%2F0006-2952%2893%2990342-T" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nepovimova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korabecny, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolezal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babkova, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ondrejicek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sepsova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hrabinova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soukup, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bukum, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jost, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muckova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malinak, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuca, K.</span></span> <span> </span><span class="NLM_article-title">Tacrine–trolox hybrids: A novel class of centrally active, nonhepatotoxic multi-target-directed ligands exerting anticholinesterase and antioxidant activities with low in vivo toxicity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8985</span>– <span class="NLM_lpage">9003</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01325</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01325" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslWlt7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8985-9003&author=E.+Nepovimovaauthor=J.+Korabecnyauthor=R.+Dolezalauthor=K.+Babkovaauthor=A.+Ondrejicekauthor=D.+Junauthor=V.+Sepsovaauthor=A.+Horovaauthor=M.+Hrabinovaauthor=O.+Soukupauthor=N.+Bukumauthor=P.+Jostauthor=L.+Muckovaauthor=J.+Kassaauthor=D.+Malinakauthor=M.+Andrsauthor=K.+Kuca&title=Tacrine%E2%80%93trolox+hybrids%3A+A+novel+class+of+centrally+active%2C+nonhepatotoxic+multi-target-directed+ligands+exerting+anticholinesterase+and+antioxidant+activities+with+low+in+vivo+toxicity&doi=10.1021%2Facs.jmedchem.5b01325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Tacrine-trolox hybrids: a novel class of centrally active, nonhepatotoxic multi-target-directed ligands exerting anticholinesterase and antioxidant activities with low in vivo toxicity</span></div><div class="casAuthors">Nepovimova, Eugenie; Korabecny, Jan; Dolezal, Rafael; Babkova, Katerina; Ondrejicek, Ales; Jun, Daniel; Sepsova, Vendula; Horova, Anna; Hrabinova, Martina; Soukup, Ondrej; Bukum, Neslihan; Jost, Petr; Muckova, Lubica; Kassa, Jiri; Malinak, David; Andrs, Martin; Kuca, Kamil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8985-9003</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Coupling of two distinct pharmacophores, tacrine and trolox, endowed with different biol. properties, afforded 21 hybrid compds. as novel multifunctional candidates against Alzheimer's disease.  Several of them showed improved inhibitory properties toward acetylcholinesterase (AChE) in relation to tacrine.  These hybrids also scavenged free radicals.  Mol. modeling studies in tandem with kinetic anal. exhibited that these hybrids target both catalytic active site as well as peripheral anionic site of AChE.  In addn., incorporation of the moiety bearing antioxidant abilities displayed negligible toxicity on human hepatic cells.  This striking effect was explained by formation of nontoxic metabolites after 1 h incubation in human liver microsomes system.  Finally, tacrine-trolox hybrids exhibited low in vivo toxicity after i.m. administration in rats and potential to penetrate across blood-brain barrier.  All of these outstanding in vitro results in combination with promising in vivo outcomes highlighted deriv. I as the lead structure worthy of further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWjX4tC8Sy17Vg90H21EOLACvtfcHk0lionTKm0cnf3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslWlt7vI&md5=550bddcd59b5bbb90d77e67faca28839</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01325%26sid%3Dliteratum%253Aachs%26aulast%3DNepovimova%26aufirst%3DE.%26aulast%3DKorabecny%26aufirst%3DJ.%26aulast%3DDolezal%26aufirst%3DR.%26aulast%3DBabkova%26aufirst%3DK.%26aulast%3DOndrejicek%26aufirst%3DA.%26aulast%3DJun%26aufirst%3DD.%26aulast%3DSepsova%26aufirst%3DV.%26aulast%3DHorova%26aufirst%3DA.%26aulast%3DHrabinova%26aufirst%3DM.%26aulast%3DSoukup%26aufirst%3DO.%26aulast%3DBukum%26aufirst%3DN.%26aulast%3DJost%26aufirst%3DP.%26aulast%3DMuckova%26aufirst%3DL.%26aulast%3DKassa%26aufirst%3DJ.%26aulast%3DMalinak%26aufirst%3DD.%26aulast%3DAndrs%26aufirst%3DM.%26aulast%3DKuca%26aufirst%3DK.%26atitle%3DTacrine%25E2%2580%2593trolox%2520hybrids%253A%2520A%2520novel%2520class%2520of%2520centrally%2520active%252C%2520nonhepatotoxic%2520multi-target-directed%2520ligands%2520exerting%2520anticholinesterase%2520and%2520antioxidant%2520activities%2520with%2520low%2520in%2520vivo%2520toxicity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8985%26epage%3D9003%26doi%3D10.1021%2Facs.jmedchem.5b01325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kamal-Eldin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appelqvist, L.-Å.</span></span> <span> </span><span class="NLM_article-title">The chemistry and antioxidant properties of tocopherols and tocotrienols</span>. <i>Lipids</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">671</span>– <span class="NLM_lpage">701</span>, <span class="refDoi"> DOI: 10.1007/BF02522884</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1007%2FBF02522884" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=8827691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADyaK28XktlKkt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1996&pages=671-701&author=A.+Kamal-Eldinauthor=L.-%C3%85.+Appelqvist&title=The+chemistry+and+antioxidant+properties+of+tocopherols+and+tocotrienols&doi=10.1007%2FBF02522884"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47aR"><div class="casContent"><span class="casTitleNuber">47a</span><div class="casTitle"><span class="NLM_cas:atitle">The chemistry and antioxidant properties of tocopherols and tocotrienols</span></div><div class="casAuthors">Kamal-Eldin, Afaf; Appelqvist, Lars-Aake</div><div class="citationInfo"><span class="NLM_cas:title">Lipids</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">671-701</span>CODEN:
                <span class="NLM_cas:coden">LPDSAP</span>;
        ISSN:<span class="NLM_cas:issn">0024-4201</span>.
    
            (<span class="NLM_cas:orgname">AOCS Press</span>)
        </div><div class="casAbstract">A review, with 324 refs.  This article is a review of the fundamental chem. of the tocopherols and tocotrienols relevant to their antioxidant action.  Despite the general agreement that α-tocopherol is the most efficient antioxidant and vitamin E homolog in vivo, there was always a considerable discrepancy in its "abs." and "relative" antioxidant effectiveness in vitro, esp. when compared to γ-tocopherol.  Many chem., phys., biochem., physicochem., and other factors seem responsible for the obsd. discrepancy between the relative antioxidant potencies of the tocopherols in vivo and in vitro.  This paper aims at highlighting some possible reasons for the obsd. differences between the tocopherols (α-, β-, γ-, and δ-) in relation to their interactions with the important chem. species involved in lipid peroxidn., specifically trace metal ions, singlet oxygen, nitrogen oxides, and antioxidant synergists.  Although literature reports related to the chem. of the tocotrienols are quite meager, they also were included in the discussion in virtue of their structural and functional resemblance to the tocopherols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRb1rKjoGt-rVg90H21EOLACvtfcHk0lionTKm0cnf3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XktlKkt74%253D&md5=8b442b54e788f8003569a50ec6ac0182</span></div><a href="/servlet/linkout?suffix=cit47a&amp;dbid=16384&amp;doi=10.1007%2FBF02522884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02522884%26sid%3Dliteratum%253Aachs%26aulast%3DKamal-Eldin%26aufirst%3DA.%26aulast%3DAppelqvist%26aufirst%3DL.-%25C3%2585.%26atitle%3DThe%2520chemistry%2520and%2520antioxidant%2520properties%2520of%2520tocopherols%2520and%2520tocotrienols%26jtitle%3DLipids%26date%3D1996%26volume%3D31%26spage%3D671%26epage%3D701%26doi%3D10.1007%2FBF02522884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit47b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Christen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodall, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shigenaga, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Southwell-Keely, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duncan, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ames, B. N.</span></span> <span> </span><span class="NLM_article-title">γ-Tocopherol traps mutagenic electrophiles such as NOx and complements α-tocopherol: Physiological implications</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">3217</span>– <span class="NLM_lpage">3222</span>, <span class="refDoi"> DOI: 10.1073/pnas.94.7.3217</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1073%2Fpnas.94.7.3217" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=9096373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADyaK2sXisVKgur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=3217-3222&author=S.+Christenauthor=A.+A.+Woodallauthor=M.+K.+Shigenagaauthor=P.+T.+Southwell-Keelyauthor=M.+W.+Duncanauthor=B.+N.+Ames&title=%CE%B3-Tocopherol+traps+mutagenic+electrophiles+such+as+NOx+and+complements+%CE%B1-tocopherol%3A+Physiological+implications&doi=10.1073%2Fpnas.94.7.3217"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47bR"><div class="casContent"><span class="casTitleNuber">47b</span><div class="casTitle"><span class="NLM_cas:atitle">γ-Tocopherol traps mutagenic electrophiles such as NOx and complements α-tocopherol: physiological implications</span></div><div class="casAuthors">Christen, Stephan; Woodall, Alan A.; Shigenaga, Mark K.; Southwell-Keely, Peter T.; Duncan, Mark W.; Ames, Bruce N.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3217-3222</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Peroxynitrite, a powerful mutagenic oxidant and nitrating species, is formed by the near diffusion-limited reaction of ·NO and O2-· during activation of phagocytes.  Chronic inflammation induced by phagocytes is a major contributor to cancer and other degenerative diseases.  We examd. how γ-tocopherol (γT), the principal form of vitamin E in the United States diet, and α-tocopherol (αT), the major form in supplements, protect against peroxynitrite-induced lipid oxidn.  Lipid hydroperoxide formation in liposomes (but not isolated low-d. lipoprotein) exposed to peroxynitrite or the ·NO and O2-· generator SIN-1 (3-morpholinosydnonimine) was inhibited more effectively by γT than αT.  More importantly, nitration of γT at the nucleophilic 5-position, which proceeded in both liposomes and human low d. lipoprotein at yields of ≈50% and ≈70%, resp., was not affected by the presence of αT.  These results suggest that despite αT's action as an antioxidant γT is required to effectively remove the peroxynitrite-derived nitrating species.  We postulate that γT acts in vivo as a trap for membrane-sol. electrophilic nitrogen oxides and other electrophilic mutagens, forming stable carbon-centered adducts through the nucleophilic 5-position, which is blocked in αT.  Because large doses of dietary αT displace γT in plasma and other tissues, the current wisdom of vitamin E supplementation with primarily αT should be reconsidered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooNMZj00oHr7Vg90H21EOLACvtfcHk0liWY0OGhLLNDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXisVKgur4%253D&md5=4b9507680802d7a9639c5b46bdc858bd</span></div><a href="/servlet/linkout?suffix=cit47b&amp;dbid=16384&amp;doi=10.1073%2Fpnas.94.7.3217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.94.7.3217%26sid%3Dliteratum%253Aachs%26aulast%3DChristen%26aufirst%3DS.%26aulast%3DWoodall%26aufirst%3DA.%2BA.%26aulast%3DShigenaga%26aufirst%3DM.%2BK.%26aulast%3DSouthwell-Keely%26aufirst%3DP.%2BT.%26aulast%3DDuncan%26aufirst%3DM.%2BW.%26aulast%3DAmes%26aufirst%3DB.%2BN.%26atitle%3D%25CE%25B3-Tocopherol%2520traps%2520mutagenic%2520electrophiles%2520such%2520as%2520NOx%2520and%2520complements%2520%25CE%25B1-tocopherol%253A%2520Physiological%2520implications%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1997%26volume%3D94%26spage%3D3217%26epage%3D3222%26doi%3D10.1073%2Fpnas.94.7.3217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolton, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burr, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liebler, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span> <span> </span><span class="NLM_article-title">The reduction of α-tocopherolquinone by human NAD(P)H:quinone oxidoreductase: The role of α-tocopherolhydroquinone as a cellular antioxidant</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">300</span>– <span class="NLM_lpage">305</span>, <span class="refDoi"> DOI: 10.1124/mol.52.2.300</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1124%2Fmol.52.2.300" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=9271353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADyaK2sXlvVeisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1997&pages=300-305&author=D.+Siegelauthor=E.+M.+Boltonauthor=J.+A.+Burrauthor=D.+C.+Lieblerauthor=D.+Ross&title=The+reduction+of+%CE%B1-tocopherolquinone+by+human+NAD%28P%29H%3Aquinone+oxidoreductase%3A+The+role+of+%CE%B1-tocopherolhydroquinone+as+a+cellular+antioxidant&doi=10.1124%2Fmol.52.2.300"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48aR"><div class="casContent"><span class="casTitleNuber">48a</span><div class="casTitle"><span class="NLM_cas:atitle">The reduction of α-tocopherolquinone by human NAD(P)H:quinone oxidoreductase: the role of α-tocopherolhydroquinone as a cellular antioxidant</span></div><div class="casAuthors">Siegel, David; Bolton, Emiko M.; Burr, Jeanne A.; Liebler, Daniel C.; Ross, David</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">300-305</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">α-Tocopherolquinone (TQ), a product of α-tocopherol oxidn., can function as an antioxidant after redn. to α-tocopherolhydroquinone (TQH2).  We examd. the ability of human NAD(P)H:quinone oxidoreductase (NQO1) to catalyze the redn. of TQ to TQH2 in cell-free and cellular systems.  In reactions with purified human NQO1, TQ was reduced to TQH2.  Kinetic parameters for the redn. of TQ by NQO1 (Km = 370 μM; Kcat = 5.6×103 min-1; Kcat/Km = 15 min-1 · μM-1) indicate that NQO1 can efficiently reduce TQ to TQH2.  A comparison of the rate of redn. of TQ and coenzyme Q10 by NQO1 showed that TQ is reduced more efficiently than coenzyme Q10.  Expts. with either Chinese hamster ovary (CHO) cells stably transfected with human NQO1 or CHO cell sonicates demonstrated a correlation between NQO1 activity and TQ redn. to TQH2.  CHO cells with elevated NQO1 generated and maintained higher levels of TQH2 after treatment with TQ relative to NQO1-deficient CHO cells.  TQH2 generated from NQO1-mediated redn. of TQ prevented cumene hydroperoxide-induced lipid peroxidn. in rat liver microsomes.  In addn., cumene hydroperoxide-induced lipid peroxidn. was inhibited more efficiently by TQ in CHO cell lines with elevated NQO1 activity.  These data demonstrate that NQO1 can reduce TQ to TQH2 and that TQH2 can function as an efficient antioxidant.  This work suggests that one of the physiol. functions of NQO1 may be to regenerate antioxidant forms of α-tocopherol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7hheEy1pEkrVg90H21EOLACvtfcHk0liWY0OGhLLNDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlvVeisL0%253D&md5=e47dd2badd49122471d740cbe00eee22</span></div><a href="/servlet/linkout?suffix=cit48a&amp;dbid=16384&amp;doi=10.1124%2Fmol.52.2.300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.52.2.300%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DBolton%26aufirst%3DE.%2BM.%26aulast%3DBurr%26aufirst%3DJ.%2BA.%26aulast%3DLiebler%26aufirst%3DD.%2BC.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3DThe%2520reduction%2520of%2520%25CE%25B1-tocopherolquinone%2520by%2520human%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%253A%2520The%2520role%2520of%2520%25CE%25B1-tocopherolhydroquinone%2520as%2520a%2520cellular%2520antioxidant%26jtitle%3DMol.%2520Pharmacol.%26date%3D1997%26volume%3D52%26spage%3D300%26epage%3D305%26doi%3D10.1124%2Fmol.52.2.300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit48b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kohar, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baca, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suarna, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stocker, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Southwell-Keely, P. T.</span></span> <span> </span><span class="NLM_article-title">Is α-tocopherol a reservoir for α-tocopheryl hydroquinone?</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">197</span>– <span class="NLM_lpage">207</span>, <span class="refDoi"> DOI: 10.1016/0891-5849(95)00010-U</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2F0891-5849%2895%2900010-U" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=7649491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADyaK2MXmsFKntbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1995&pages=197-207&author=I.+Koharauthor=M.+Bacaauthor=C.+Suarnaauthor=R.+Stockerauthor=P.+T.+Southwell-Keely&title=Is+%CE%B1-tocopherol+a+reservoir+for+%CE%B1-tocopheryl+hydroquinone%3F&doi=10.1016%2F0891-5849%2895%2900010-U"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48bR"><div class="casContent"><span class="casTitleNuber">48b</span><div class="casTitle"><span class="NLM_cas:atitle">Is α-tocopherol a reservoir for α-tocopheryl hydroquinone?</span></div><div class="casAuthors">Kohar, Indra; Baca, Manuel; Suarna, Cacang; Stocker, Roland; Southwell-Keely, Peter T.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">197-207</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The products of oxidn. of the α-tocopherol model compd., 2,2,5,7,8-pentamethyl-6-chromanol (PH) by t-Bu hydroperoxide in chloroform varied with the amt. of water present.  In the presence of a trace of water, the main products were the spirodimer (PSD) and spirotrimer (PST).  As the content of water increased, the main product became 2-(3-hydroxy-3-methylbutyl)-3,5,6-trimethyl-1,4-benzoquinone (PQ).  Oxidn. of PH in aq. liposome suspension also produced PQ as the major product.  These results suggested that, in aq. solns., the major oxidn. product of PH would be PQ and of α-tocopherol (TH) would be α-tocopheryl quinone (TQ).  The ease of redn. of PQ and TQ was studied in chem. and biol. systems.  PQ, TQ, and ubiquinone-10 (UQ) were rapidly reduced to their resp. hydroquinones (PQH2, TQH2, and UQH2) at pH 7.3 by NADH plus FAD.  Whole blood reduced PQ rapidly at 37° to PQH2 but did not reduce TQ to TQH2.  Human peripheral blood mononuclear cells took up TQ from a bovine serum albumin complex and reduced it to TQH2.  Ingestion of TQ (350 mg) by one of the authors resulted in the formation of TQH2 during a 5 h period.  These results demonstrate that several biol. systems are able to reduce TQ to TQH2 and that it is a reaction that may occur normally in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpysiytCHG0ubVg90H21EOLACvtfcHk0lhWLUQ0tH2sMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmsFKntbg%253D&md5=7b4796b28d3ef0c4f55cf6cb136429c9</span></div><a href="/servlet/linkout?suffix=cit48b&amp;dbid=16384&amp;doi=10.1016%2F0891-5849%2895%2900010-U&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0891-5849%252895%252900010-U%26sid%3Dliteratum%253Aachs%26aulast%3DKohar%26aufirst%3DI.%26aulast%3DBaca%26aufirst%3DM.%26aulast%3DSuarna%26aufirst%3DC.%26aulast%3DStocker%26aufirst%3DR.%26aulast%3DSouthwell-Keely%26aufirst%3DP.%2BT.%26atitle%3DIs%2520%25CE%25B1-tocopherol%2520a%2520reservoir%2520for%2520%25CE%25B1-tocopheryl%2520hydroquinone%253F%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D1995%26volume%3D19%26spage%3D197%26epage%3D207%26doi%3D10.1016%2F0891-5849%2895%2900010-U" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit48c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Takaaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akio, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mamoru, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hharuhisa, S.</span></span> <span> </span><span class="NLM_article-title">Reduction of α-tocopherolquinone to α-tocopherolhydroquinone in rat hepatocytes</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">489</span>– <span class="NLM_lpage">493</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(92)90440-T</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2F0006-2952%2892%2990440-T" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1510699" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1992&pages=489-493&author=H.+Takaakiauthor=K.+Akioauthor=N.+Masaoauthor=T.+Mamoruauthor=S.+Hharuhisa&title=Reduction+of+%CE%B1-tocopherolquinone+to+%CE%B1-tocopherolhydroquinone+in+rat+hepatocytes&doi=10.1016%2F0006-2952%2892%2990440-T"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48c&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2892%2990440-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252892%252990440-T%26sid%3Dliteratum%253Aachs%26aulast%3DTakaaki%26aufirst%3DH.%26aulast%3DAkio%26aufirst%3DK.%26aulast%3DMasao%26aufirst%3DN.%26aulast%3DMamoru%26aufirst%3DT.%26aulast%3DHharuhisa%26aufirst%3DS.%26atitle%3DReduction%2520of%2520%25CE%25B1-tocopherolquinone%2520to%2520%25CE%25B1-tocopherolhydroquinone%2520in%2520rat%2520hepatocytes%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1992%26volume%3D44%26spage%3D489%26epage%3D493%26doi%3D10.1016%2F0006-2952%2892%2990440-T" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yenes, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Commandeur, J. N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vermeulen, N. P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messeguer, A.</span></span> <span> </span><span class="NLM_article-title">In vitro biotransformation of 3,4-dihydro-6-hydroxy-2,2-dimethyl-7-methoxy-1(2H)-benzopyran (CR-6), a potent lipid peroxidation inhibitor and nitric oxide scavenger, in rat liver microsomes</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">904</span>– <span class="NLM_lpage">913</span>, <span class="refDoi"> DOI: 10.1021/tx030036f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx030036f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkvVSisLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2004&pages=904-913&author=S.+Yenesauthor=J.+N.+M.+Commandeurauthor=N.+P.+E.+Vermeulenauthor=A.+Messeguer&title=In+vitro+biotransformation+of+3%2C4-dihydro-6-hydroxy-2%2C2-dimethyl-7-methoxy-1%282H%29-benzopyran+%28CR-6%29%2C+a+potent+lipid+peroxidation+inhibitor+and+nitric+oxide+scavenger%2C+in+rat+liver+microsomes&doi=10.1021%2Ftx030036f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">In Vitro Biotransformation of 3,4-Dihydro-6-hydroxy-2,2-dimethyl-7-methoxy-1(2H)-Benzopyran (CR-6), a Potent Lipid Peroxidation Inhibitor and Nitric Oxide Scavenger, in Rat Liver Microsomes</span></div><div class="casAuthors">Yenes, Susana; Commandeur, Jan N. M.; Vermeulen, Nico P. E.; Messeguer, Angel</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">904-913</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The in vitro metab. of 3,4-dihydro-6-hydroxy-2,2-dimethyl-7-methoxy-1(2H)-benzopyran (CR-6), a potent lipid peroxidn. inhibitor and scavenger of nitric oxide and peroxynitrite species that is currently in phase II trials for antitumoral therapy, has been investigated in rat liver microsomes in the presence of NADP(H).  Five major metabolites were identified by comparison with authentic stds., namely, the quinone 2-3'-hydroxy-3'-methylbutyl-5-methoxy-1,4-benzoquinone (2a) and its ring-closed spiro form oxaspiro[4.5]-2,2-dimethyl-8-methoxy-dec-8-ene-7,10-dione (2b), the hydroquinone 2-(3'-hydroxy-3'-methylbutyl)-5-methoxyhydroquinone (3), the hydroxylated metabolite 3,4-dihydro-4,6-dihydroxy-2,2-dimethyl-7-methoxy-1(2H)-benzopyran (4), and the catechol 3,4-dihydro-6,7-dihydroxy-2,2-dimethyl-1(2H)-benzopyran (5).  When the incubations were carried out in the presence of GSH, the HPLC peaks corresponding to the quinone metabolites 2a/b were absent and two novel products were formed showing MS fragmentation patterns consistent with the structure of GSH conjugates of quinone 2a.  The time dependence on the formation of metabolites 2a,b and 3 was measured in incubations induced with phenobarbital (PB), dexamethasone, and β-naphthoflavone (βNF).  For the dexamethasone-induced microsomes, the amt. of hydroquinone 3 decreased from minute 10 to minute 30 while that of 2a,b increased in a complementary manner.  Similar effects were obsd. for the incubations carried out using PB- and βNF-induced microsomes.  On the other hand, CR-6 inhibited 7-ethoxyresorufin O-dealkylation activity (IC50 = 25 μM) in incubations with βNF-induced microsomes.  Likewise, addn. of pentoxyresorufin to the incubations of CR-6 with PB-induced microsomes showed a time-dependent inhibition (IC50= 75 μM) of the dealkylation activity.  These results are in agreement with the putative generation of reactive metabolites from CR-6 that could deactivate P 450 1A and P 450 2B, resp.  When these incubations were carried out in the presence of 10 mM GSH, the inhibition of P 450 2B could be partially prevented.  Finally, preincubation of CR-6 with liver microsomes from PB-induced rats resulted in a strong increase in microsomal glutathione S-transferase (mGST) activity (up to a max. of approx. 5-fold).  When the preincubation was carried out in the presence of 10 mM GSH, the activation of mGST was blocked.  Overall, these results suggest that CR-6 undergoes in vitro biotransformation indicative of the involvement of thiol-reactive metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsdg9PTGGNVbVg90H21EOLACvtfcHk0lhWLUQ0tH2sMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkvVSisLw%253D&md5=68f6f2463ff51d09fe7cdd08333cef2d</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Ftx030036f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx030036f%26sid%3Dliteratum%253Aachs%26aulast%3DYenes%26aufirst%3DS.%26aulast%3DCommandeur%26aufirst%3DJ.%2BN.%2BM.%26aulast%3DVermeulen%26aufirst%3DN.%2BP.%2BE.%26aulast%3DMesseguer%26aufirst%3DA.%26atitle%3DIn%2520vitro%2520biotransformation%2520of%25203%252C4-dihydro-6-hydroxy-2%252C2-dimethyl-7-methoxy-1%25282H%2529-benzopyran%2520%2528CR-6%2529%252C%2520a%2520potent%2520lipid%2520peroxidation%2520inhibitor%2520and%2520nitric%2520oxide%2520scavenger%252C%2520in%2520rat%2520liver%2520microsomes%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2004%26volume%3D17%26spage%3D904%26epage%3D913%26doi%3D10.1021%2Ftx030036f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Słoczyńska, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunia-Krzyżak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koczurkiewicz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wójcik-Pszczoła, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Żelaszczyk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popiół, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pękala, E.</span></span> <span> </span><span class="NLM_article-title">Metabolic stability and its role in the discovery of new chemical entities</span>. <i>Acta Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">345</span>– <span class="NLM_lpage">361</span>, <span class="refDoi"> DOI: 10.2478/acph-2019-0024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.2478%2Facph-2019-0024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=31259741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BB3cXntFWhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2019&pages=345-361&author=K.+S%C5%82oczy%C5%84skaauthor=A.+Gunia-Krzy%C5%BCakauthor=P.+Koczurkiewiczauthor=K.+W%C3%B3jcik-Pszczo%C5%82aauthor=D.+%C5%BBelaszczykauthor=J.+Popi%C3%B3%C5%82author=E.+P%C4%99kala&title=Metabolic+stability+and+its+role+in+the+discovery+of+new+chemical+entities&doi=10.2478%2Facph-2019-0024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic stability and its role in the discovery of new chemical entities</span></div><div class="casAuthors">Sloczynska, Karolina; Gunia-Krzyzak, Agnieszka; Koczurkiewicz, Paulina; Wojcik-Pszczola, Katarzyna; Zelaszczyk, Dorota; Popiol, Justyna; Pekala, Elzbieta</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmaceutica (Warsaw, Poland)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">345-361</span>CODEN:
                <span class="NLM_cas:coden">ACPHEE</span>;
        ISSN:<span class="NLM_cas:issn">1846-9558</span>.
    
            (<span class="NLM_cas:orgname">Sciendo</span>)
        </div><div class="casAbstract">A review.  Detn. of metabolic profiles of new chem. entities is a key step in the process of drug discovery, since it influences pharmacokinetic characteristics of therapeutic compds.  One of the main challenges of medicinal chem. is not only to design compds. demonstrating beneficial activity, but also mols. exhibiting favorable pharmacokinetic parameters.  Chem. compds. can be divided into those which are metabolized relatively fast and those which undergo slow biotransformation.  Rapid biotransformation reduces exposure to the maternal compd. and may lead to the generation of active, non-active or toxic metabolites.  In contrast, high metabolic stability may promote interactions between drugs and lead to parent compd. toxicity.  In the present paper, issues of compd. metabolic stability will be discussed, with special emphasis on its significance, in vitro metabolic stability testing, dilemmas regarding in vitro-in vivo extrapolation of the results and some aspects relating to different preclin. species used in in vitro metabolic stability assessment of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq_ccE3-PW9bVg90H21EOLACvtfcHk0li8gaC3iK5ubQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXntFWhtg%253D%253D&md5=2dfad07056bce4e4cc32264c8ce07040</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.2478%2Facph-2019-0024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2478%252Facph-2019-0024%26sid%3Dliteratum%253Aachs%26aulast%3DS%25C5%2582oczy%25C5%2584ska%26aufirst%3DK.%26aulast%3DGunia-Krzy%25C5%25BCak%26aufirst%3DA.%26aulast%3DKoczurkiewicz%26aufirst%3DP.%26aulast%3DW%25C3%25B3jcik-Pszczo%25C5%2582a%26aufirst%3DK.%26aulast%3D%25C5%25BBelaszczyk%26aufirst%3DD.%26aulast%3DPopi%25C3%25B3%25C5%2582%26aufirst%3DJ.%26aulast%3DP%25C4%2599kala%26aufirst%3DE.%26atitle%3DMetabolic%2520stability%2520and%2520its%2520role%2520in%2520the%2520discovery%2520of%2520new%2520chemical%2520entities%26jtitle%3DActa%2520Pharm.%26date%3D2019%26volume%3D69%26spage%3D345%26epage%3D361%26doi%3D10.2478%2Facph-2019-0024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cornish-Bowden, A.</span></span> <span> </span><span class="NLM_article-title">A simple graphical method for determining the inhibition constants of mixed, uncompetitive and non-competitive inhibitors</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1974</span>,  <span class="NLM_volume"><i>137</i></span>, <span class="NLM_elocation-id">143e144</span> <span class="refDoi"> DOI: 10.1042/bj1370143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1042%2Fbj1370143" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=1974&author=A.+Cornish-Bowden&title=A+simple+graphical+method+for+determining+the+inhibition+constants+of+mixed%2C+uncompetitive+and+non-competitive+inhibitors&doi=10.1042%2Fbj1370143"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1042%2Fbj1370143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj1370143%26sid%3Dliteratum%253Aachs%26aulast%3DCornish-Bowden%26aufirst%3DA.%26atitle%3DA%2520simple%2520graphical%2520method%2520for%2520determining%2520the%2520inhibition%2520constants%2520of%2520mixed%252C%2520uncompetitive%2520and%2520non-competitive%2520inhibitors%26jtitle%3DBiochem.%2520J.%26date%3D1974%26volume%3D137%26doi%3D10.1042%2Fbj1370143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, R. B.</span></span> <i>The Organic Chemistry of Enzyme-Catalyzed Reactions</i>, <span class="NLM_edition">1</span>st ed.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">San Diego</span>, <span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&author=R.+B.+Silverman&title=The+Organic+Chemistry+of+Enzyme-Catalyzed+Reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26btitle%3DThe%2520Organic%2520Chemistry%2520of%2520Enzyme-Catalyzed%2520Reactions%26pub%3DAcademic%2520Press%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lwebuga-Mukasa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lappi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rademacher, J.</span></span> <span> </span><span class="NLM_article-title">Propidium – a fluorescent probe for a peripheral anionic site on acetylcholinesterase</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1974</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">703</span>– <span class="NLM_lpage">708</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADyaE2cXltFKmu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1974&pages=703-708&author=P.+Taylorauthor=J.+Lwebuga-Mukasaauthor=S.+Lappiauthor=J.+Rademacher&title=Propidium+%E2%80%93+a+fluorescent+probe+for+a+peripheral+anionic+site+on+acetylcholinesterase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53aR"><div class="casContent"><span class="casTitleNuber">53a</span><div class="casTitle"><span class="NLM_cas:atitle">Propidium.  Fluorescence probe for a peripheral anionic site on acetylcholinesterase</span></div><div class="casAuthors">Taylor, Palmer; Lwebuga-Mukasa, Jamson; Lappi, Shelley; Rademacher, James</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1974</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">703-8</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">Propidium [(3,8-diamino-5-(3-diethylmethylaminopropyl)-6-phenylphenanthridium diiodide] (I) was bound with high affinity to a purified acetylcholinesterase isolated by lytic procedures from Torpedo californica.  Complex formation resulted in a 10-fold enhancement of fluorescence for the ligand in the bound state.  The fluorescent ligand could be dissocd. from the enzyme by back-titrn. with d-tubocurarine and gallamine under conditions of low ionic strength (γ/2 ≃ 0.001).  At higher ionic strength, in 0.1M NaCl, 0.04M MgCl2, and 0.01M Tris-Cl, pH 8.0 (γ/2 = 0.23), the above ligands were relatively ineffective in dissocg. propidium from the enzyme.  Edrophonium, an inhibitor that appears specific for the active center, did not dissoc. propidium under conditions of high and low ionic strength.  This specificity is consistent with propidium acting as a fluorescence probe for a peripheral anionic site on acetylcholinesterase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy22LfQ6F2j7Vg90H21EOLACvtfcHk0li8gaC3iK5ubQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXltFKmu70%253D&md5=3256818b8da823e9154f830b796616fa</span></div><a href="/servlet/linkout?suffix=cit53a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DP.%26aulast%3DLwebuga-Mukasa%26aufirst%3DJ.%26aulast%3DLappi%26aufirst%3DS.%26aulast%3DRademacher%26aufirst%3DJ.%26atitle%3DPropidium%2520%25E2%2580%2593%2520a%2520fluorescent%2520probe%2520for%2520a%2520peripheral%2520anionic%2520site%2520on%2520acetylcholinesterase%26jtitle%3DMol.%2520Pharmacol.%26date%3D1974%26volume%3D10%26spage%3D703%26epage%3D708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit53b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lappi, S.</span></span> <span> </span><span class="NLM_article-title">Interaction of fluorescence probes with acetylcholinesterase, the site and specificity of propidium binding</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1989</span>– <span class="NLM_lpage">1997</span>, <span class="refDoi"> DOI: 10.1021/bi00680a029</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00680a029" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADyaE2MXktVemu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1975&pages=1989-1997&author=P.+Taylorauthor=S.+Lappi&title=Interaction+of+fluorescence+probes+with+acetylcholinesterase%2C+the+site+and+specificity+of+propidium+binding&doi=10.1021%2Fbi00680a029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53bR"><div class="casContent"><span class="casTitleNuber">53b</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction of fluorescence probes with acetylcholinesterase.  Site and specificity of propidium binding</span></div><div class="casAuthors">Taylor, Palmer; Lappi, Shelley</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1989-97</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">A bis-quaternary fluorescence probe, propidium diiodide, exhibited a 10-fold enhancement of fluorescence when bound to acetylcholinesterase from Torpedo californica.  The complex was characterized by a high affinity, KD = 3.0 × 10-7M, and 1:1 stoichiometry with the 82,000 mol. wt. subunit of acetylcholinesterase.  A wide variety of other quaternary ammonium ligands such as decamethonium, gallamine, d-tubocurarine, tetraethylammonium, and tetramethylammonium completely dissocd. propidium from the enzyme as did monovalent and divalent inorg. cations.  Whereas a directly competitive relation was illustrated macroscopically, the various quaternary ligands showed a different susceptibility toward inorg. cation displacement.  The affinity of propidium relative to gallamine increased with ionic strength, indicating that there is not complete equivalence in the neg. subsites to which quaternary groups bind.  Although edrophonium also displaced propidium from the enzyme, the dissocn. const. obtained from this competitive relation was 3 5 orders of magnitude greater than the consts. obtained for inhibition of catalysis.  Based on competitve displacement titrns., the primary binding site of edrophonium was distinct from that of propidium and a ternary complex with the 2 ligands can form on each subunit.  In contrast to edrophonium, the binding of propidium was unaffected by methanesulfonylation of the active center serine and was uncompetitive with the carbamylating substrate, N-methyl-7-dimethylcarbamoxyquinolinium.  Thus, propidium associates with a peripheral anionic center on the enzyme.  Although propidium and edrophonium assocd. at sep. sites on acetylcholinesterase, bis-quaternary ligands where the quaternary N atoms are sepd. by 14 Å displaced both ligands from the enzyme with equal effectiveness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqaxfzE7WsY7Vg90H21EOLACvtfcHk0lhHjUL3tXx3Vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXktVemu74%253D&md5=0c4b7b9afdc79270927cb12f79d4168a</span></div><a href="/servlet/linkout?suffix=cit53b&amp;dbid=16384&amp;doi=10.1021%2Fbi00680a029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00680a029%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DP.%26aulast%3DLappi%26aufirst%3DS.%26atitle%3DInteraction%2520of%2520fluorescence%2520probes%2520with%2520acetylcholinesterase%252C%2520the%2520site%2520and%2520specificity%2520of%2520propidium%2520binding%26jtitle%3DBiochemistry%26date%3D1975%26volume%3D14%26spage%3D1989%26epage%3D1997%26doi%3D10.1021%2Fbi00680a029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nunes-Tavares, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nery da Matta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batista e Silva, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Araújo, G. M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louro, S. R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassón-Voloch, A.</span></span> <span> </span><span class="NLM_article-title">Inhibition of acetylcholinesterase from <i>Electrophorus electricus</i> (L.) by tricyclic antidepressants</span>. <i>Int. J. Biochem. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1071</span>– <span class="NLM_lpage">1079</span>, <span class="refDoi"> DOI: 10.1016/S1357-2725(02)00027-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2FS1357-2725%2802%2900027-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=12009302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFynsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2002&pages=1071-1079&author=N.+Nunes-Tavaresauthor=A.+Nery+da+Mattaauthor=C.+M.+Batista+e+Silvaauthor=G.+M.+N.+Ara%C3%BAjoauthor=S.+R.+W.+Louroauthor=A.+Hass%C3%B3n-Voloch&title=Inhibition+of+acetylcholinesterase+from+Electrophorus+electricus+%28L.%29+by+tricyclic+antidepressants&doi=10.1016%2FS1357-2725%2802%2900027-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of acetylcholinesterase from Electrophorus electricus (L.) by tricyclic antidepressants</span></div><div class="casAuthors">Nunes-Tavares, N.; Nery da Matta, A.; Batista e Silva, C. M.; Araujo, G. M. N.; Louro, S. R. W.; Hasson-Voloch, A.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1071-1079</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The effects of tricyclic antidepressants drugs (TCA) amitriptyline, imipramine and nortriptyline, on purified Electrophorus electricus (L.) acetylcholinesterase (AChE; acetylcholine hydrolase, EC 3.1.1.7) were studied using kinetic methods and specific fluorescent probe propidium.  The antidepressants inhibited AChE activity by a non-competitive mechanism.  Inhibition consts. range from 200 to 400 μM.  Dimethylated amitriptyline and imipramine were more potent inhibitors than the monomethylated nortriptyline.  Fluorescence measurements using bis-quaternary ligand propidium were used to monitor ligand-binding properties of these cationic antidepressants to the AChE peripheral anionic site (PAS).  This ligand exhibited an eight-fold fluorescence enhancement upon binding to the peripheral anionic site of AChE from E. electricus (L.) with KD=7×10-7 M.  It was obsd. that TCA drugs displaced propidium from the enzyme.  On the basis of the displacement expts. antidepressant dissocn. consts. were detd.  Similar values for the inhibition consts. suggest that these drugs have similar affinity to the peripheral anionic site.  The results also indicate that the catalytic active center of AChE does not participate in the interaction of enzyme with tricyclic antidepressants.  These studies suggest that the binding site for tricyclic antidepressants is located at the peripheral anionic site of E. electricus (L.) acetylcholinesterase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryPgDAp502jbVg90H21EOLACvtfcHk0lhHjUL3tXx3Vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFynsrw%253D&md5=b9516cc41f34d8d811af0bdf0a73e572</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2FS1357-2725%2802%2900027-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1357-2725%252802%252900027-4%26sid%3Dliteratum%253Aachs%26aulast%3DNunes-Tavares%26aufirst%3DN.%26aulast%3DNery%2Bda%2BMatta%26aufirst%3DA.%26aulast%3DBatista%2Be%2BSilva%26aufirst%3DC.%2BM.%26aulast%3DAra%25C3%25BAjo%26aufirst%3DG.%2BM.%2BN.%26aulast%3DLouro%26aufirst%3DS.%2BR.%2BW.%26aulast%3DHass%25C3%25B3n-Voloch%26aufirst%3DA.%26atitle%3DInhibition%2520of%2520acetylcholinesterase%2520from%2520Electrophorus%2520electricus%2520%2528L.%2529%2520by%2520tricyclic%2520antidepressants%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2002%26volume%3D34%26spage%3D1071%26epage%3D1079%26doi%3D10.1016%2FS1357-2725%2802%2900027-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bourne, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolb, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radić, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpless, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchot, P.</span></span> <span> </span><span class="NLM_article-title">Freeze-frame inhibitor captures acetylcholinesterase in a unique conformation</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">1449</span>– <span class="NLM_lpage">1454</span>, <span class="refDoi"> DOI: 10.1073/pnas.0308206100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1073%2Fpnas.0308206100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=14757816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFaqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=1449-1454&author=Y.+Bourneauthor=H.+C.+Kolbauthor=Z.+Radi%C4%87author=K.+B.+Sharplessauthor=P.+Taylorauthor=P.+Marchot&title=Freeze-frame+inhibitor+captures+acetylcholinesterase+in+a+unique+conformation&doi=10.1073%2Fpnas.0308206100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Freeze-frame inhibitor captures acetylcholinesterase in a unique conformation</span></div><div class="casAuthors">Bourne, Yves; Kolb, Hartmuth C.; Radic, Zoran; Sharpless, K. Barry; Taylor, Palmer; Marchot, Pascale</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1449-1454</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The 1,3-dipolar cycloaddn. reaction between unactivated azides and acetylenes proceeds exceedingly slowly at room temp.  However, considerable rate acceleration is obsd. when this reaction occurs inside the active center gorge of acetylcholinesterase (AChE) between certain azide and acetylene reactants, attached via methylene chains to specific inhibitor moieties selective for the active center and peripheral site of the enzyme.  AChE catalyzes the formation of its own inhibitor in a highly selective fashion: only a single syn1-triazole regioisomer with defined substitution positions and linker distances is generated from a series of reagent combinations.  Inhibition measurements revealed this syn1-triazole isomer to be the highest affinity reversible org. inhibitor of AChE with assocn. rate consts. near the diffusion limit.  The corresponding anti1 isomer, not formed by the enzyme, proved to be a respectable but weaker inhibitor.  The crystal structures of the syn1- and anti1-mouse AChE complexes at 2.45- to 2.65-Å resoln. reveal not only substantial binding contributions from the triazole moieties, but also that binding of the syn1 isomer induces large and unprecedented enzyme conformational changes not obsd. in the anti1 complex nor predicted from structures of the apoenzyme and complexes with the precursor reactants.  Hence, the freeze-frame reaction offers both a strategically original approach for drug discovery and a means for kinetically controlled capture, as a high-affinity complex between the enzyme and its self-created inhibitor, of a highly reactive minor abundance conformer of a fluctuating protein template.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo09vBdE-ZyAbVg90H21EOLACvtfcHk0lhHjUL3tXx3Vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFaqsL8%253D&md5=b464de567eca2991d3c15f66c25f587e</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0308206100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0308206100%26sid%3Dliteratum%253Aachs%26aulast%3DBourne%26aufirst%3DY.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26aulast%3DRadi%25C4%2587%26aufirst%3DZ.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26aulast%3DTaylor%26aufirst%3DP.%26aulast%3DMarchot%26aufirst%3DP.%26atitle%3DFreeze-frame%2520inhibitor%2520captures%2520acetylcholinesterase%2520in%2520a%2520unique%2520conformation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2004%26volume%3D101%26spage%3D1449%26epage%3D1454%26doi%3D10.1073%2Fpnas.0308206100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dighe, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deora, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De la
Mora, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nachon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parat, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brazzolotto, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, B. P.</span></span> <span> </span><span class="NLM_article-title">Discovery and structure–activity relationships of a highly selective butyrylcholinesterase inhibitor by structure-based virtual screening</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">7683</span>– <span class="NLM_lpage">7689</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00356</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00356" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFKms7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7683-7689&author=S.+N.+Digheauthor=G.+S.+Deoraauthor=E.+De+la%0AMoraauthor=F.+Nachonauthor=S.+Chanauthor=M.+O.+Paratauthor=X.+Brazzolottoauthor=B.+P.+Ross&title=Discovery+and+structure%E2%80%93activity+relationships+of+a+highly+selective+butyrylcholinesterase+inhibitor+by+structure-based+virtual+screening&doi=10.1021%2Facs.jmedchem.6b00356"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Structure-Activity Relationships of a Highly Selective Butyrylcholinesterase Inhibitor by Structure-Based Virtual Screening</span></div><div class="casAuthors">Dighe, Satish N.; Deora, Girdhar Singh; De la Mora, Eugenio; Nachon, Florian; Chan, Stephen; Parat, Marie-Odile; Brazzolotto, Xavier; Ross, Benjamin P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7683-7689</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structure-based virtual screening of two libraries contg. 567,981 mols. was used to discover novel, selective BuChE inhibitors, which are potentially superior symptomatic treatments in late-stage Alzheimer's disease.  Compd. 16 was identified as a highly selective submicromolar inhibitor of BuChE (huBuChE IC50 = 0.443 μM) with high permeability in the PAMPA-BBB model.  The X-ray crystal structure of huBuChE in complex with 16 revealed the at.-level interactions and offers opportunities for further development of the series.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv1ksvUfyu5LVg90H21EOLACvtfcHk0liQhXKD2bBFcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFKms7jJ&md5=3ec174639c0eb448f823f223bafdaad4</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00356%26sid%3Dliteratum%253Aachs%26aulast%3DDighe%26aufirst%3DS.%2BN.%26aulast%3DDeora%26aufirst%3DG.%2BS.%26aulast%3DDe%2Bla%2BMora%26aufirst%3DE.%26aulast%3DNachon%26aufirst%3DF.%26aulast%3DChan%26aufirst%3DS.%26aulast%3DParat%26aufirst%3DM.%2BO.%26aulast%3DBrazzolotto%26aufirst%3DX.%26aulast%3DRoss%26aufirst%3DB.%2BP.%26atitle%3DDiscovery%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%2520a%2520highly%2520selective%2520butyrylcholinesterase%2520inhibitor%2520by%2520structure-based%2520virtual%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7683%26epage%3D7689%26doi%3D10.1021%2Facs.jmedchem.6b00356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nachon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carletti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trovaslet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolet, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jean, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renard, P. Y.</span></span> <span> </span><span class="NLM_article-title">Crystal structures of human cholinesterases in complex with huprine W and tacrine: elements of specificity for anti-Alzheimer’s drugs targeting acetyl- and butyryl-cholinesterase</span>. <i>Biochem J.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>453</i></span>,  <span class="NLM_fpage">393</span>– <span class="NLM_lpage">399</span>, <span class="refDoi"> DOI: 10.1042/BJ20130013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1042%2FBJ20130013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=23679855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtF2it7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=453&publication_year=2013&pages=393-399&author=F.+Nachonauthor=E.+Carlettiauthor=C.+Roncoauthor=M.+Trovasletauthor=Y.+Nicoletauthor=L.+Jeanauthor=P.+Y.+Renard&title=Crystal+structures+of+human+cholinesterases+in+complex+with+huprine+W+and+tacrine%3A+elements+of+specificity+for+anti-Alzheimer%E2%80%99s+drugs+targeting+acetyl-+and+butyryl-cholinesterase&doi=10.1042%2FBJ20130013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structures of human cholinesterases in complex with huprine W and tacrine: elements of specificity for anti-Alzheimer's drugs targeting acetyl- and butyryl-cholinesterase</span></div><div class="casAuthors">Nachon, Florian; Carletti, Eugenie; Ronco, Cyril; Trovaslet, Marie; Nicolet, Yvain; Jean, Ludovic; Renard, Pierre-Yves</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">453</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">393-399</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The multifunctional nature of Alzheimer's disease calls for MTDLs (multitarget-directed ligands) to act on different components of the pathol., like the cholinergic dysfunction and amyloid aggregation.  Such MTDLs are usually on the basis of cholinesterase inhibitors (e.g. tacrine or huprine) coupled with another active mol. aimed at a different target.  To aid in the design of these MTDLs, the authors report the crystal structures of hAChE (human acetylcholinesterase) in complex with FAS-2 (fasciculin 2) and a hydroxylated deriv. of huprine (huprine W), and of hBChE (human butyrylcholinesterase) in complex with tacrine.  Huprine W in hAChE and tacrine in hBChE reside in strikingly similar positions highlighting the conservation of key interactions, namely, π-π/cation-π interactions with Trp86 (Trp82), and hydrogen bonding with the main chain carbonyl of the catalytic histidine residue.  Huprine W forms addnl. interactions with hAChE, which explains its superior affinity: the isoquinoline moiety is assocd. with a group of arom. residues (Tyr337, Phe338 and Phe295 not present in hBChE) in addn. to Trp86; the hydroxyl group is hydrogen bonded to both the catalytic serine residue and residues in the oxyanion hole; and the chlorine substituent is nested in a hydrophobic pocket interacting strongly with Trp439.  There is no pocket in hBChE that is able to accommodate the chlorine substituent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovCptRaIZE_rVg90H21EOLACvtfcHk0liQhXKD2bBFcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtF2it7fM&md5=a36d3b1007c83c59c639a08f17d26bb7</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1042%2FBJ20130013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20130013%26sid%3Dliteratum%253Aachs%26aulast%3DNachon%26aufirst%3DF.%26aulast%3DCarletti%26aufirst%3DE.%26aulast%3DRonco%26aufirst%3DC.%26aulast%3DTrovaslet%26aufirst%3DM.%26aulast%3DNicolet%26aufirst%3DY.%26aulast%3DJean%26aufirst%3DL.%26aulast%3DRenard%26aufirst%3DP.%2BY.%26atitle%3DCrystal%2520structures%2520of%2520human%2520cholinesterases%2520in%2520complex%2520with%2520huprine%2520W%2520and%2520tacrine%253A%2520elements%2520of%2520specificity%2520for%2520anti-Alzheimer%25E2%2580%2599s%2520drugs%2520targeting%2520acetyl-%2520and%2520butyryl-cholinesterase%26jtitle%3DBiochem%2520J.%26date%3D2013%26volume%3D453%26spage%3D393%26epage%3D399%26doi%3D10.1042%2FBJ20130013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Camps, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Achab, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morral, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baños, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vivas, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barril, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orozco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span> <span> </span><span class="NLM_article-title">New tacrine-huperzine A hybrids (huprines): highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">4657</span>– <span class="NLM_lpage">4666</span>, <span class="refDoi"> DOI: 10.1021/jm000980y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000980y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnvFarsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4657-4666&author=P.+Campsauthor=R.+El+Achabauthor=J.+Morralauthor=D.+Mu%C3%B1oz-Torreroauthor=A.+Badiaauthor=J.+E.+Ba%C3%B1osauthor=N.+M.+Vivasauthor=X.+Barrilauthor=M.+Orozcoauthor=F.+J.+Luque&title=New+tacrine-huperzine+A+hybrids+%28huprines%29%3A+highly+potent+tight-binding+acetylcholinesterase+inhibitors+of+interest+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm000980y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">New tacrine-huperzine A hybrids (huprines): highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Camps, Pelayo; El Achab, Rachid; Morral, Jordi; Munoz-Torrero, Diego; Badia, Albert; Banos, Josep Eladi; Vivas, Nuria Maria; Barril, Xavier; Orozco, Modesto; Luque, Francisco Javier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4657-4666</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Several new 12-amino-6,7,10,11-tetrahydro-7,11-methanocycloocta[b]quinoline derivs. (tacrine-huperzine A hybrids, huprines) (I) (R = Me, Et; R1, R3 = H, F, Me, Cl; R2 = H, Cl) have been synthesized and tested as acetylcholinesterase (AChE) inhibitors.  All of the new compds. contain either a Me or Et group at position 9 and one or two (chloro, fluoro, or methyl) substituents at positions 1, 2, or 3.  Among the monosubstituted derivs., the more active are those substituted at position 3, their activity following the order 3-chloro > 3-fluoro > 3-Me > 3-hydrogen.  For the 1,3-difluoro and 1,3-di-Me derivs., the effect of the substituents is roughly additive.  No significant differences were obsd. for the inhibitory activity of 9-Me vs 9-Et derivs. mono- or disubstituted at positions 1 and/or 3.  The levorotatory enantiomers of these hybrid compds. are much more active (eutomers) than the dextrorotatory forms (distomers) as AChE inhibitors.  Compds. rac- and (-)-I (R = Me, R3 = Cl) (II), rac- and (-)-I (R = Et, R3 = F) (III), rac- and (-)-I (R = Et, R3 = Cl) (IV) and rac-I (R = Et; R1, R3 = Cl) (V) showed human AChE inhibitory activities up to 28.5-fold higher than for the corresponding bovine enzyme. Also, rac-I (R = Me; R1, R3 = F) , (-)-II, (-)-IV, and rac-V were very selective for human AChE vs butyrylcholinesterase (BChE), the AChE inhibitory activities being 438-871-fold higher than for BChE.  Several hybrid compds., specially (-)-II and (-)-IV, exhibited tight-binding character, showing higher activity after incubation of the enzyme with the inhibitor than without incubation, though the reversible nature of the enzyme-inhibitor interaction was demonstrated by dialysis.  The results of the ex vivo expts. also supported the tight-binding character of compds. (-)-II and (-)-IV and showed their ability to cross the blood-brain barrier.  Mol. modeling simulations of the AChE-inhibitor complex provided a basis to explain the differences in inhibitory activity of these compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsF13Zjc-Ak7Vg90H21EOLACvtfcHk0liQhXKD2bBFcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnvFarsbk%253D&md5=6ec0e45bc36f91124d1ba17f1c1f4957</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjm000980y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000980y%26sid%3Dliteratum%253Aachs%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DEl%2BAchab%26aufirst%3DR.%26aulast%3DMorral%26aufirst%3DJ.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DBadia%26aufirst%3DA.%26aulast%3DBa%25C3%25B1os%26aufirst%3DJ.%2BE.%26aulast%3DVivas%26aufirst%3DN.%2BM.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DOrozco%26aufirst%3DM.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26atitle%3DNew%2520tacrine-huperzine%2520A%2520hybrids%2520%2528huprines%2529%253A%2520highly%2520potent%2520tight-binding%2520acetylcholinesterase%2520inhibitors%2520of%2520interest%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4657%26epage%3D4666%26doi%3D10.1021%2Fjm000980y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Case, D. A.</span>; <span class="NLM_string-name">Babin, V.</span>; <span class="NLM_string-name">Berryman, J. T.</span>; <span class="NLM_string-name">Betz, R. M.</span>; <span class="NLM_string-name">Cai, Q.</span>; <span class="NLM_string-name">Cerutti, D. S.</span>; <span class="NLM_string-name">Cheatham, T. E.,  III</span>; <span class="NLM_string-name">Darden, T. A.</span>; <span class="NLM_string-name">Duke, R. E.</span>; <span class="NLM_string-name">Gohlke, H.</span>; <span class="NLM_string-name">Goetz, A. W.</span>; <span class="NLM_string-name">Gusarov, S.</span>; <span class="NLM_string-name">Homeyer, N.</span>; <span class="NLM_string-name">Janowski, P.</span>; <span class="NLM_string-name">Kaus, J.</span>; <span class="NLM_string-name">Kolossváry, I.</span>; <span class="NLM_string-name">Kovalenko, A.</span>; <span class="NLM_string-name">Lee, T. S.</span>; <span class="NLM_string-name">LeGrand, S.</span>; <span class="NLM_string-name">Luchko, T.</span>; <span class="NLM_string-name">Luo, R.</span>; <span class="NLM_string-name">Madej, B.</span>; <span class="NLM_string-name">Merz, K. M.</span>; <span class="NLM_string-name">Paesani, F.</span>; <span class="NLM_string-name">Roe, D. R.</span>; <span class="NLM_string-name">Roitberg, A.</span>; <span class="NLM_string-name">Sagui, C.</span>; <span class="NLM_string-name">Salomon-Ferrer, R.</span>; <span class="NLM_string-name">Seabra, G.</span>; <span class="NLM_string-name">Simmerling, C. L.</span>; <span class="NLM_string-name">Smith, W.</span>; <span class="NLM_string-name">Swails, J.</span>; <span class="NLM_string-name">Walker, R. C.</span>; <span class="NLM_string-name">Wang, J.</span>; <span class="NLM_string-name">Wolf, R. M.</span>; <span class="NLM_string-name">Wu, X.</span>; <span class="NLM_string-name">Kollman, P. A.</span></span> <i>AMBER 14</i>; <span class="NLM_publisher-name">University of California</span>: <span class="NLM_publisher-loc">San Francisco</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=D.+A.+Case&author=V.+Babin&author=J.+T.+Berryman&author=R.+M.+Betz&author=Q.+Cai&author=D.+S.+Cerutti&author=T.+E.+Cheatham&author=T.+A.+Darden&author=R.+E.+Duke&author=H.+Gohlke&author=A.+W.+Goetz&author=S.+Gusarov&author=N.+Homeyer&author=P.+Janowski&author=J.+Kaus&author=I.+Kolossv%C3%A1ry&author=A.+Kovalenko&author=T.+S.+Lee&author=S.+LeGrand&author=T.+Luchko&author=R.+Luo&author=B.+Madej&author=K.+M.+Merz&author=F.+Paesani&author=D.+R.+Roe&author=A.+Roitberg&author=C.+Sagui&author=R.+Salomon-Ferrer&author=G.+Seabra&author=C.+L.+Simmerling&author=W.+Smith&author=J.+Swails&author=R.+C.+Walker&author=J.+Wang&author=R.+M.+Wolf&author=X.+Wu&author=P.+A.+Kollman&title=AMBER+14"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DCase%26aufirst%3DD.%2BA.%26jtitle%3DAMBER%252014%26pub%3DUniversity%2520of%2520California%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kollman, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Case, D. A.</span></span> <span> </span><span class="NLM_article-title">Development and testing of a general Amber force field</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1157</span>– <span class="NLM_lpage">1174</span>, <span class="refDoi"> DOI: 10.1002/jcc.20035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1002%2Fjcc.20035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=15116359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksFakurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=1157-1174&author=J.+Wangauthor=R.+M.+Wolfauthor=J.+W.+Caldwellauthor=P.+A.+Kollmanauthor=D.+A.+Case&title=Development+and+testing+of+a+general+Amber+force+field&doi=10.1002%2Fjcc.20035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Development and testing of a general Amber force field</span></div><div class="casAuthors">Wang, Junmei; Wolf, Romain M.; Caldwell, James W.; Kollman, Peter A.; Case, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1157-1174</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">We describe here a general Amber force field (GAFF) for org. mols.  GAFF is designed to be compatible with existing Amber force fields for proteins and nucleic acids, and has parameters for most org. and pharmaceutical mols. that are composed of H, C, N, O, S, P, and halogens.  It uses a simple functional form and a limited no. of atom types, but incorporates both empirical and heuristic models to est. force consts. and partial at. charges.  The performance of GAFF in test cases is encouraging.  In test I, 74 crystallog. structures were compared to GAFF minimized structures, with a root-mean-square displacement of 0.26 Å, which is comparable to that of the Tripos 5.2 force field (0.25 Å) and better than those of MMFF 94 and CHARMm (0.47 and 0.44 Å, resp.).  In test II, gas phase minimizations were performed on 22 nucleic acid base pairs, and the minimized structures and intermol. energies were compared to MP2/6-31G* results.  The RMS of displacements and relative energies were 0.25 Å and 1.2 kcal/mol, resp.  These data are comparable to results from Parm99/RESP (0.16 Å and 1.18 kcal/mol, resp.), which were parameterized to these base pairs.  Test III looked at the relative energies of 71 conformational pairs that were used in development of the Parm99 force field.  The RMS error in relative energies (compared to expt.) is about 0.5 kcal/mol.  GAFF can be applied to wide range of mols. in an automatic fashion, making it suitable for rational drug design and database searching.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfW8Gsf8IiW7Vg90H21EOLACvtfcHk0liypwX-PeR6ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksFakurc%253D&md5=2992017a8cf51f89290ae2562403b115</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20035%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWolf%26aufirst%3DR.%2BM.%26aulast%3DCaldwell%26aufirst%3DJ.%2BW.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26aulast%3DCase%26aufirst%3DD.%2BA.%26atitle%3DDevelopment%2520and%2520testing%2520of%2520a%2520general%2520Amber%2520force%2520field%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2004%26volume%3D25%26spage%3D1157%26epage%3D1174%26doi%3D10.1002%2Fjcc.20035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frisch, M. J.</span>; <span class="NLM_string-name">Trucks, G. W.</span>; <span class="NLM_string-name">Schlegel, H. B.</span>; <span class="NLM_string-name">Scuseria, G. E.</span>; <span class="NLM_string-name">Robb, M. A.</span>; <span class="NLM_string-name">Cheeseman, J. R.</span>; <span class="NLM_string-name">Scalmani, G.</span>; <span class="NLM_string-name">Barone, V.</span>; <span class="NLM_string-name">Mennucci, B.</span>; <span class="NLM_string-name">Petersson, G. A.</span>; <span class="NLM_string-name">Nakatsuji, H.</span>; <span class="NLM_string-name">Caricato, M.</span>; <span class="NLM_string-name">Li, X.</span>; <span class="NLM_string-name">Hratchian, H. P.</span>; <span class="NLM_string-name">Izmaylov, A. F.</span>; <span class="NLM_string-name">Bloino, J.</span>; <span class="NLM_string-name">Zheng, G.</span>; <span class="NLM_string-name">Sonnenberg, J. L.</span>; <span class="NLM_string-name">Hada, M.</span>; <span class="NLM_string-name">Ehara, M.</span>; <span class="NLM_string-name">Toyota, K.</span>; <span class="NLM_string-name">Fukuda, R.</span>; <span class="NLM_string-name">Hasegawa, J.</span>; <span class="NLM_string-name">Ishida, M.</span>; <span class="NLM_string-name">Nakajima, T.</span>; <span class="NLM_string-name">Honda, Y.</span>; <span class="NLM_string-name">Kitao, O.</span>; <span class="NLM_string-name">Nakai, H.</span>; <span class="NLM_string-name">Vreven, T.</span>; <span class="NLM_string-name">Montgomery, J. A.,  Jr.</span>; <span class="NLM_string-name">Peralta, J. E.</span>; <span class="NLM_string-name">Ogliaro, F.</span>; <span class="NLM_string-name">Bearpark, M.</span>; <span class="NLM_string-name">Heyd, J. J.</span>; <span class="NLM_string-name">Brothers, E.</span>; <span class="NLM_string-name">Kudin, K. N.</span>; <span class="NLM_string-name">Staroverov, V. N.</span>; <span class="NLM_string-name">Kobayashi, R.</span>; <span class="NLM_string-name">Normand, J.</span>; <span class="NLM_string-name">Raghavachari, K.</span>; <span class="NLM_string-name">Rendell, A.</span>; <span class="NLM_string-name">Burant, J. C.</span>; <span class="NLM_string-name">Iyengar, S. S.</span>; <span class="NLM_string-name">Tomasi, J.</span>; <span class="NLM_string-name">Cossi, M.</span>; <span class="NLM_string-name">Rega, N.</span>; <span class="NLM_string-name">Millam, J. M.</span>; <span class="NLM_string-name">Klene, M.</span>; <span class="NLM_string-name">Knox, J. E.</span>; <span class="NLM_string-name">Cross, J. B.</span>; <span class="NLM_string-name">Bakken, V.</span>; <span class="NLM_string-name">Adamo, C.</span>; <span class="NLM_string-name">Jaramillo, J.</span>; <span class="NLM_string-name">Gomperts, R.</span>; <span class="NLM_string-name">Stratmann, R. E.</span>; <span class="NLM_string-name">Yazyev, O.</span>; <span class="NLM_string-name">Austin, A. J.</span>; <span class="NLM_string-name">Cammi, R.</span>; <span class="NLM_string-name">Pomelli, C.</span>; <span class="NLM_string-name">Ochterski, J. W.</span>; <span class="NLM_string-name">Martin, R. L.</span>; <span class="NLM_string-name">Morokuma, K.</span>; <span class="NLM_string-name">Zakrzewski, V. G.</span>; <span class="NLM_string-name">Voth, G. A.</span>; <span class="NLM_string-name">Salvador, P.</span>; <span class="NLM_string-name">Dannenberg, J. J.</span>; <span class="NLM_string-name">Dapprich, S.</span>; <span class="NLM_string-name">Daniels, A. D.</span>; <span class="NLM_string-name">Farkas, Ö.</span>; <span class="NLM_string-name">Foresman, J. B.</span>; <span class="NLM_string-name">Ortiz, J. V.</span>; <span class="NLM_string-name">Cioslowski, J.</span>; <span class="NLM_string-name">Fox, D. J.</span></span> <i>Gaussian 09</i>; <span class="NLM_publisher-name">Gaussian, Inc.</span>: <span class="NLM_publisher-loc">Wallingford, CT</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=M.+J.+Frisch&author=G.+W.+Trucks&author=H.+B.+Schlegel&author=G.+E.+Scuseria&author=M.+A.+Robb&author=J.+R.+Cheeseman&author=G.+Scalmani&author=V.+Barone&author=B.+Mennucci&author=G.+A.+Petersson&author=H.+Nakatsuji&author=M.+Caricato&author=X.+Li&author=H.+P.+Hratchian&author=A.+F.+Izmaylov&author=J.+Bloino&author=G.+Zheng&author=J.+L.+Sonnenberg&author=M.+Hada&author=M.+Ehara&author=K.+Toyota&author=R.+Fukuda&author=J.+Hasegawa&author=M.+Ishida&author=T.+Nakajima&author=Y.+Honda&author=O.+Kitao&author=H.+Nakai&author=T.+Vreven&author=J.+A.+Montgomery&author=J.+E.+Peralta&author=F.+Ogliaro&author=M.+Bearpark&author=J.+J.+Heyd&author=E.+Brothers&author=K.+N.+Kudin&author=V.+N.+Staroverov&author=R.+Kobayashi&author=J.+Normand&author=K.+Raghavachari&author=A.+Rendell&author=J.+C.+Burant&author=S.+S.+Iyengar&author=J.+Tomasi&author=M.+Cossi&author=N.+Rega&author=J.+M.+Millam&author=M.+Klene&author=J.+E.+Knox&author=J.+B.+Cross&author=V.+Bakken&author=C.+Adamo&author=J.+Jaramillo&author=R.+Gomperts&author=R.+E.+Stratmann&author=O.+Yazyev&author=A.+J.+Austin&author=R.+Cammi&author=C.+Pomelli&author=J.+W.+Ochterski&author=R.+L.+Martin&author=K.+Morokuma&author=V.+G.+Zakrzewski&author=G.+A.+Voth&author=P.+Salvador&author=J.+J.+Dannenberg&author=S.+Dapprich&author=A.+D.+Daniels&author=%C3%96.+Farkas&author=J.+B.+Foresman&author=J.+V.+Ortiz&author=J.+Cioslowski&author=D.+J.+Fox&title=Gaussian+09"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DFrisch%26aufirst%3DM.%2BJ.%26btitle%3DGaussian%252009%26pub%3DGaussian%252C%2520Inc%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cieplak, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kollman, P. A.</span></span> <span> </span><span class="NLM_article-title">How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules?</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1049</span>– <span class="NLM_lpage">1074</span>, <span class="refDoi"> DOI: 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1002%2F1096-987X%28200009%2921%3A12%3C1049%3A%3AAID-JCC3%3E3.0.CO%3B2-F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlsVylt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=1049-1074&author=J.+Wangauthor=P.+Cieplakauthor=P.+A.+Kollman&title=How+well+does+a+restrained+electrostatic+potential+%28RESP%29+model+perform+in+calculating+conformational+energies+of+organic+and+biological+molecules%3F&doi=10.1002%2F1096-987X%28200009%2921%3A12%3C1049%3A%3AAID-JCC3%3E3.0.CO%3B2-F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules?</span></div><div class="casAuthors">Wang, Junmei; Cieplak, Piotr; Kollman, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1049-1074</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The authors present conformational energies for a mol. mech. model (Parm99) developed for org. and biol. mols. using the restrained electrostatic potential (RESP) approach to derive the partial charges.  This approach uses the simple generic force field model (Parm94), and attempts to add a minimal no. of extra Fourier components to the torsional energies, but doing so only when there is a phys. justification.  The results are quite encouraging, not only for the 34-mol. set that was studied by both the highest level ab initio model (GVB/LMP2) and expt., but also for the 55-mol. set for which high-quality exptl. data are available.  Considering the 55 mols. studied by all the force field models for which there are exptl. data, the av. abs. errors (AAEs) are 0.28 (this model), 0.52 (MM3), 0.57 (CHARMm [MSI]), and 0.43 kcal/mol (MMFF).  For the 34-mol. set, the AAEs of this model vs. expt. and ab initio are 0.28 and 0.27 kcal/mol, resp.  This is a lower error than found with MM3 and CHARMm, and is comparable to that found with MMFF (0.31 and 0.22 kcal/mol).  The authors also present 2 examples of how well the torsional parameters are transferred from the training set to the test set.  The abs. errors of mols. in the test set are only slightly larger than in the training set (differences of <0.1 kcal/mol).  Therefore, a simple generic force field with a limited no. of specific torsional parameters can describe intra- and intermol. interactions, although all comparison mols. were selected from 82-compd. training set.  Also this effective 2-body model can be extended for use with a nonadditive force field (NAFF), both with and without lone pairs.  Without changing the torsional parameters, the use of more accurate charges and polarization increases av. abs. error compared with expt., but adjustment of the parameters restores the level of agreement found with the additive model.  After reoptimizing the Ψ, Φ torsional parameters in peptides using alanine dipeptide (6 conformational pairs) and alanine tetrapeptide (11 conformational pairs), the new model gives better energies than the Cornell et al. force field.  The av. abs. error of this model for high-level ab initio calcn. is 0.82 kcal/mol for alanine dipeptide and tetrapeptide as compared with 1.80 kcal/mol for the Cornell et al. model.  For nucleosides, the new model also gives improved energies compared with the Cornell et al. model.  To optimize force field parameters, the authors developed a program called parmscan, which can iteratively scan the torsional parameters in a systematic manner and finally obtain the vest torsional potentials.  Besides the org. mols. in test set, parmscan was also successful in optimizing the Ψ, Φ torsional parameters in peptides to significantly improve agreement between mol. mech. and high-level ab initio energies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0dHME9_PfT7Vg90H21EOLACvtfcHk0liAf80HCzZfnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsVylt78%253D&md5=c81631289cf58f63917e2a9fa9547ab6</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1002%2F1096-987X%28200009%2921%3A12%3C1049%3A%3AAID-JCC3%3E3.0.CO%3B2-F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1096-987X%2528200009%252921%253A12%253C1049%253A%253AAID-JCC3%253E3.0.CO%253B2-F%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DCieplak%26aufirst%3DP.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26atitle%3DHow%2520well%2520does%2520a%2520restrained%2520electrostatic%2520potential%2520%2528RESP%2529%2520model%2520perform%2520in%2520calculating%2520conformational%2520energies%2520of%2520organic%2520and%2520biological%2520molecules%253F%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2000%26volume%3D21%26spage%3D1049%26epage%3D1074%26doi%3D10.1002%2F1096-987X%28200009%2921%3A12%3C1049%3A%3AAID-JCC3%3E3.0.CO%3B2-F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Søndergaard, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, M. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rostkowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, J. H.</span></span> <span> </span><span class="NLM_article-title">Improved treatment of ligands and coupling effects in empirical calculation and rationalization of pKa values</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">2284</span>– <span class="NLM_lpage">2295</span>, <span class="refDoi"> DOI: 10.1021/ct200133y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ct200133y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnt1Gnsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=2284-2295&author=C.+R.+S%C3%B8ndergaardauthor=M.+H.+M.+Olssonauthor=M.+Rostkowskiauthor=J.+H.+Jensen&title=Improved+treatment+of+ligands+and+coupling+effects+in+empirical+calculation+and+rationalization+of+pKa+values&doi=10.1021%2Fct200133y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63aR"><div class="casContent"><span class="casTitleNuber">63a</span><div class="casTitle"><span class="NLM_cas:atitle">Improved Treatment of Ligands and Coupling Effects in Empirical Calculation and Rationalization of pKa Values</span></div><div class="casAuthors">Sondergaard, Chresten R.; Olsson, Mats H. M.; Rostkowski, Michal; Jensen, Jan H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2284-2295</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The new empirical rules for protein pKa predictions implemented in the PROPKA3.0 software package have been extended to the prediction of pKa shifts of active site residues and ionizable ligand groups in protein-ligand complexes.  The authors present new algorithms that allow pKa shifts due to inductive (i.e., covalently coupled) intraligand interactions, as well as noncovalently coupled interligand interactions in multiligand complexes, to be included in the prediction.  The no. of different ligand chem. groups that are automatically recognized has been increased to 18, and the general implementation has been changed so that new functional groups can be added easily by the user, aided by a new and more general protonation scheme.  Except for a few cases, the new algorithms in PROPKA3.1 are found to yield results similar to or better than those obtained with PROPKA2.0.  Finally, the authors present a novel algorithm that identifies noncovalently coupled ionizable groups, where pKa prediction may be esp. difficult.  This is a general improvement to PROPKA and is applied to proteins with and without ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVEiJYZqkno7Vg90H21EOLACvtfcHk0liAf80HCzZfnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnt1Gnsrs%253D&md5=cf4d4e20d6daa70de6ac623915e78160</span></div><a href="/servlet/linkout?suffix=cit63a&amp;dbid=16384&amp;doi=10.1021%2Fct200133y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fct200133y%26sid%3Dliteratum%253Aachs%26aulast%3DS%25C3%25B8ndergaard%26aufirst%3DC.%2BR.%26aulast%3DOlsson%26aufirst%3DM.%2BH.%2BM.%26aulast%3DRostkowski%26aufirst%3DM.%26aulast%3DJensen%26aufirst%3DJ.%2BH.%26atitle%3DImproved%2520treatment%2520of%2520ligands%2520and%2520coupling%2520effects%2520in%2520empirical%2520calculation%2520and%2520rationalization%2520of%2520pKa%2520values%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2011%26volume%3D7%26spage%3D2284%26epage%3D2295%26doi%3D10.1021%2Fct200133y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit63b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, M. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Søndergaard, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rostkowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, J. H.</span></span> <span> </span><span class="NLM_article-title">PROPKA3: consistent treatment of internal and surface residues in empirical pKa predictions</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">525</span>– <span class="NLM_lpage">537</span>, <span class="refDoi"> DOI: 10.1021/ct100578z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ct100578z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC3MXit1aqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=525-537&author=M.+H.+M.+Olssonauthor=C.+R.+S%C3%B8ndergaardauthor=M.+Rostkowskiauthor=J.+H.+Jensen&title=PROPKA3%3A+consistent+treatment+of+internal+and+surface+residues+in+empirical+pKa+predictions&doi=10.1021%2Fct100578z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63bR"><div class="casContent"><span class="casTitleNuber">63b</span><div class="casTitle"><span class="NLM_cas:atitle">PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKa Predictions</span></div><div class="casAuthors">Olsson, Mats H. M.; Sondergaard, Chresten R.; Rostkowski, Michal; Jensen, Jan H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">525-537</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors have revised the rules and parameters for one of the most commonly used empirical pKa predictors, PROPKA, based on better phys. description of the desolvation and dielec. response for the protein.  The authors have introduced a new and consistent approach to interpolate the description between the previously distinct classifications into internal and surface residues, which otherwise is found to give rise to an erratic and discontinuous behavior.  Since the goal of this study is to lay out the framework and validate the concept, it focuses on Asp and Glu residues where the protein pKa values and structures are assumed to be more reliable.  The new and improved implementation is evaluated and discussed; it is found to agree better with expt. than the previous implementation (in parentheses): rmsd = 0.79 (0.91) for Asp and Glu, 0.75 (0.97) for Tyr, 0.65 (0.72) for Lys, and 1.00 (1.37) for His residues.  The most significant advance, however, is in reducing the no. of outliers and removing unreasonable sensitivity to small structural changes that arise from classifying residues as either internal or surface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm6urTZNdjY7Vg90H21EOLACvtfcHk0ljFnfJazlcvhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXit1aqsA%253D%253D&md5=9b1666b1c56e1129789e62948eb4d001</span></div><a href="/servlet/linkout?suffix=cit63b&amp;dbid=16384&amp;doi=10.1021%2Fct100578z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fct100578z%26sid%3Dliteratum%253Aachs%26aulast%3DOlsson%26aufirst%3DM.%2BH.%2BM.%26aulast%3DS%25C3%25B8ndergaard%26aufirst%3DC.%2BR.%26aulast%3DRostkowski%26aufirst%3DM.%26aulast%3DJensen%26aufirst%3DJ.%2BH.%26atitle%3DPROPKA3%253A%2520consistent%2520treatment%2520of%2520internal%2520and%2520surface%2520residues%2520in%2520empirical%2520pKa%2520predictions%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2011%26volume%3D7%26spage%3D525%26epage%3D537%26doi%3D10.1021%2Fct100578z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrasekhar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madura, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Impey, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, M. L.</span></span> <span> </span><span class="NLM_article-title">Comparison of simple potential functions for simulating liquid water</span>. <i>J. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">926</span>– <span class="NLM_lpage">935</span>, <span class="refDoi"> DOI: 10.1063/1.445869</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1063%2F1.445869" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADyaL3sXksF2htL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1983&pages=926-935&author=W.+L.+Jorgensenauthor=J.+Chandrasekharauthor=J.+D.+Maduraauthor=R.+W.+Impeyauthor=M.+L.+Klein&title=Comparison+of+simple+potential+functions+for+simulating+liquid+water&doi=10.1063%2F1.445869"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of simple potential functions for simulating liquid water</span></div><div class="casAuthors">Jorgensen, William L.; Chandrasekhar, Jayaraman; Madura, Jeffry D.; Impey, Roger W.; Klein, Michael L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">926-35</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    </div><div class="casAbstract">Classical Monte Carlo simulations were carried out for liq. H2O in the NPT ensemble at 25° and 1 atm using 6 of the simpler intermol. potential functions for the dimer.  Comparisons were made with exptl. thermodn. and structural data including the neutron diffraction results of Thiessen and Narten (1982).  The computed densities and potential energies agree with expt. except for the original Bernal-Fowler model, which yields an 18% overest. of the d. and poor structural results.  The discrepancy may be due to the correction terms needed in processing the neutron data or to an effect uniformly neglected in the computations.  Comparisons were made for the self-diffusion coeffs. obtained from mol. dynamics simulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK4QUFMvwYFrVg90H21EOLACvtfcHk0ljFnfJazlcvhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXksF2htL4%253D&md5=a1161334e381746be8c9b15a5e56f704</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1063%2F1.445869&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.445869%26sid%3Dliteratum%253Aachs%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DChandrasekhar%26aufirst%3DJ.%26aulast%3DMadura%26aufirst%3DJ.%2BD.%26aulast%3DImpey%26aufirst%3DR.%2BW.%26aulast%3DKlein%26aufirst%3DM.%2BL.%26atitle%3DComparison%2520of%2520simple%2520potential%2520functions%2520for%2520simulating%2520liquid%2520water%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1983%26volume%3D79%26spage%3D926%26epage%3D935%26doi%3D10.1063%2F1.445869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schalk, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehret-Sabatier, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouet, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goeldner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirth, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Axelsen, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sussman, J. L.</span></span> <span> </span><span class="NLM_article-title">Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">9031</span>– <span class="NLM_lpage">9035</span>, <span class="refDoi"> DOI: 10.1073/pnas.90.19.9031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1073%2Fpnas.90.19.9031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=8415649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADyaK3sXmsVCgtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1993&pages=9031-9035&author=M.+Harelauthor=I.+Schalkauthor=L.+Ehret-Sabatierauthor=F.+Bouetauthor=M.+Goeldnerauthor=C.+Hirthauthor=P.+H.+Axelsenauthor=I.+Silmanauthor=J.+L.+Sussman&title=Quaternary+ligand+binding+to+aromatic+residues+in+the+active-site+gorge+of+acetylcholinesterase&doi=10.1073%2Fpnas.90.19.9031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase</span></div><div class="casAuthors">Harel, M.; Schalk, I.; Ehret-Sabatier, L.; Bouet, F.; Goeldner, M.; Hirth, C.; Axelsen, P. H.; Silman, I.; Sussman, J. L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">9031-5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The binding sites of Torpedo acetylcholinesterase (AChE; EC 3.1.1.7) for quaternary ligands were investigated by x-ray crystallog. and photoaffinity labeling.  The crystal structures of complexes with ligands were detd. at 2.8-Å resoln.  In a complex with edrophonium, the quaternary N atom of the ligand interacted with the indole of Trp-84, and its m-OH group displayed bifurcated H-bonding to 2 members of the catalytic triad, Ser-200 and His-440.  In a complex with tacrine, the acridine was stacked against the indole of Trp-84.  The bisquaternary ligand, decamethonium, was oriented along the narrow gorge leading to the active site; one quaternary group was apposed to the indole of Trp-84 and the other to that of Trp-279, near the top of the gorge.  The only major conformational difference between the 3 complexes was in the orientation of the Ph ring of Phe-330.  In the decamethonium complex, it lay parallel to the surface of the gorge; in the other 2 complexes it was positioned to make contact with the bound ligand.  This close interaction was confirmed by photoaffinity labeling by the photosensitive probe, 3H-labeled p-(N,N-dimethylamino)benzenediazonium fluoroborate, which labeled, predominantly, Phe-330 within the active site.  The labeling of Trp-279 was also obsd.  One mole of label was incorporated per mol of AChE inactivated, indicating that the labeling of Trp-279 and that of Phe-330 were mutually exclusive.  The structural and chem. data, together, showed the important role of arom. groups as binding sites for quaternary ligands, and they provided complementary evidence assigning Trp-84 and Phe-330 to the anionic subsite of the active site and Trp-279 to the peripheral anionic site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVCccIwJSrW7Vg90H21EOLACvtfcHk0lhit67kFwemsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXmsVCgtrc%253D&md5=6ee8dbaf1919d254a1cb62895f1a4444</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1073%2Fpnas.90.19.9031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.90.19.9031%26sid%3Dliteratum%253Aachs%26aulast%3DHarel%26aufirst%3DM.%26aulast%3DSchalk%26aufirst%3DI.%26aulast%3DEhret-Sabatier%26aufirst%3DL.%26aulast%3DBouet%26aufirst%3DF.%26aulast%3DGoeldner%26aufirst%3DM.%26aulast%3DHirth%26aufirst%3DC.%26aulast%3DAxelsen%26aufirst%3DP.%2BH.%26aulast%3DSilman%26aufirst%3DI.%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26atitle%3DQuaternary%2520ligand%2520binding%2520to%2520aromatic%2520residues%2520in%2520the%2520active-site%2520gorge%2520of%2520acetylcholinesterase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1993%26volume%3D90%26spage%3D9031%26epage%3D9035%26doi%3D10.1073%2Fpnas.90.19.9031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ryckaert, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciccotti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berendsen, H. J. C.</span></span> <span> </span><span class="NLM_article-title">Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes</span>. <i>J. Comput. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">327</span>– <span class="NLM_lpage">341</span>, <span class="refDoi"> DOI: 10.1016/0021-9991(77)90098-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2F0021-9991%2877%2990098-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADyaE2sXktVGhsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1977&pages=327-341&author=J.-P.+Ryckaertauthor=G.+Ciccottiauthor=H.+J.+C.+Berendsen&title=Numerical+integration+of+the+cartesian+equations+of+motion+of+a+system+with+constraints%3A+molecular+dynamics+of+n-alkanes&doi=10.1016%2F0021-9991%2877%2990098-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Numerical integration of the Cartesian equations of motion of a system with constraints:  molecular dynamics of n-alkanes</span></div><div class="casAuthors">Ryckaert, Jean Paul; Ciccotti, Giovanni; Berendsen, Herman J. C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Physics</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">327-41</span>CODEN:
                <span class="NLM_cas:coden">JCTPAH</span>;
        ISSN:<span class="NLM_cas:issn">0021-9991</span>.
    </div><div class="casAbstract">A numerical algorithm integrating the 3N Cartesian equation of motion of a system of N points subject to holonomic constraints is applied to mol. dynamics simulation of a liq. of 64 butane mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYPlhG1U3Uw7Vg90H21EOLACvtfcHk0lhit67kFwemsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXktVGhsL4%253D&md5=b4aecddfde149117813a5ea4f5353ce2</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2F0021-9991%2877%2990098-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0021-9991%252877%252990098-5%26sid%3Dliteratum%253Aachs%26aulast%3DRyckaert%26aufirst%3DJ.-P.%26aulast%3DCiccotti%26aufirst%3DG.%26aulast%3DBerendsen%26aufirst%3DH.%2BJ.%2BC.%26atitle%3DNumerical%2520integration%2520of%2520the%2520cartesian%2520equations%2520of%2520motion%2520of%2520a%2520system%2520with%2520constraints%253A%2520molecular%2520dynamics%2520of%2520n-alkanes%26jtitle%3DJ.%2520Comput.%2520Phys.%26date%3D1977%26volume%3D23%26spage%3D327%26epage%3D341%26doi%3D10.1016%2F0021-9991%2877%2990098-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Darden, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">York, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedersen, L.</span></span> <span> </span><span class="NLM_article-title">Particle mesh Ewald: an N·log(N) method for Ewald sums in large systems</span>. <i>J. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">10089</span>– <span class="NLM_lpage">10092</span>, <span class="refDoi"> DOI: 10.1063/1.464397</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1063%2F1.464397" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADyaK3sXks1Ohsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=1993&pages=10089-10092&author=T.+Dardenauthor=D.+Yorkauthor=L.+Pedersen&title=Particle+mesh+Ewald%3A+an+N%C2%B7log%28N%29+method+for+Ewald+sums+in+large+systems&doi=10.1063%2F1.464397"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Particle mesh Ewald: an N·log(N) method for Ewald sums in large systems</span></div><div class="casAuthors">Darden, Tom; York, Darrin; Pedersen, Lee</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">10089-92</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    </div><div class="casAbstract">An N·log(N) method for evaluating electrostatic energies and forces of large periodic systems is presented.  The method is based on interpolation of the reciprocal space Ewald sums and evaluation of the resulting convolution using fast Fourier transforms.  Timings and accuracies are presented for three large cryst. ionic systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDIJavf7AZPbVg90H21EOLACvtfcHk0lhit67kFwemsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXks1Ohsr0%253D&md5=3c9f230bd01b7b714fd096d4d2e755f6</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1063%2F1.464397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.464397%26sid%3Dliteratum%253Aachs%26aulast%3DDarden%26aufirst%3DT.%26aulast%3DYork%26aufirst%3DD.%26aulast%3DPedersen%26aufirst%3DL.%26atitle%3DParticle%2520mesh%2520Ewald%253A%2520an%2520N%25C2%25B7log%2528N%2529%2520method%2520for%2520Ewald%2520sums%2520in%2520large%2520systems%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1993%26volume%3D98%26spage%3D10089%26epage%3D10092%26doi%3D10.1063%2F1.464397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berendsen, H. J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Postma, J. P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van
Gunsteren, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiNola, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haak, J. R.</span></span> <span> </span><span class="NLM_article-title">Molecular dynamics with coupling to an external bath</span>. <i>J. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">3684</span>– <span class="NLM_lpage">3690</span>, <span class="refDoi"> DOI: 10.1063/1.448118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1063%2F1.448118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADyaL2cXmtlGksbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1984&pages=3684-3690&author=H.+J.+C.+Berendsenauthor=J.+P.+M.+Postmaauthor=W.+F.+van%0AGunsterenauthor=A.+DiNolaauthor=J.+R.+Haak&title=Molecular+dynamics+with+coupling+to+an+external+bath&doi=10.1063%2F1.448118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular dynamics with coupling to an external bath</span></div><div class="casAuthors">Berendsen, H. J. C.; Postma, J. P. M.; Van Gunsteren, W. F.; DiNola, A.; Haak, J. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3684-90</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    </div><div class="casAbstract">In mol. dynamics (MD) simulations, the need often arises to maintain such parameters as temp. or pressure rather than energy and vol., or to impose gradients for studying transport properties in nonequil. MD.  A method is described to realize coupling to an external bath with const. temp. or pressure with adjustable time consts. for the coupling.  The method is easily extendable to other variables and to gradients, and can be applied also to polyat. mols. involving internal constraints.  The influence of coupling time consts. on dynamical variables is evaluated.  A leap-frog algorithm is presented for the general case involving constraints with coupling to both a const. temp. and a const. pressure bath.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoecrpUZWkh37Vg90H21EOLACvtfcHk0lh_Daa-nSji3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXmtlGksbY%253D&md5=5510dc00297d63b91ee3a7a4ae5aacb1</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1063%2F1.448118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.448118%26sid%3Dliteratum%253Aachs%26aulast%3DBerendsen%26aufirst%3DH.%2BJ.%2BC.%26aulast%3DPostma%26aufirst%3DJ.%2BP.%2BM.%26aulast%3Dvan%2BGunsteren%26aufirst%3DW.%2BF.%26aulast%3DDiNola%26aufirst%3DA.%26aulast%3DHaak%26aufirst%3DJ.%2BR.%26atitle%3DMolecular%2520dynamics%2520with%2520coupling%2520to%2520an%2520external%2520bath%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1984%26volume%3D81%26spage%3D3684%26epage%3D3690%26doi%3D10.1063%2F1.448118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Molyneux, P.</span></span> <span> </span><span class="NLM_article-title">The use of the stable free radical diphenylpicrylhydrazyl (DPPH) for estimating antioxidant activity</span>. <i>Songklanakarin J. Sci. Technol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">211</span>– <span class="NLM_lpage">219</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltFajt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2004&pages=211-219&author=P.+Molyneux&title=The+use+of+the+stable+free+radical+diphenylpicrylhydrazyl+%28DPPH%29+for+estimating+antioxidant+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">The use of the stable free radical diphenylpicrylhydrazyl (DPPH) for estimating antioxidant activity</span></div><div class="casAuthors">Molyneux, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Songklanakarin Journal of Science and Technology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">211-219</span>CODEN:
                <span class="NLM_cas:coden">SJSTA2</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Songklanakarin Journal of Science and Technology</span>)
        </div><div class="casAbstract">A review on the use of the stable free radical diphenylpicrylhydrazyl (DPPH) for estg. antioxidant activity.  The use of the stable free radical diphenylpicrylhydrazyl (DPPH) to est. the activity of antioxidants is reviewed.  Current applications of the method are examd., particularly the use of the parameter EC50 (substrate concn. to produce 50% redn. of the DPPH).  Some recommendations are made as to the most suitable ways of carrying out this assay and evaluating the data produced.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4PYkn8ojVo7Vg90H21EOLACvtfcHk0lh_Daa-nSji3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltFajt7o%253D&md5=24ef1ad35fcbcded3b458f643bf4c50c</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMolyneux%26aufirst%3DP.%26atitle%3DThe%2520use%2520of%2520the%2520stable%2520free%2520radical%2520diphenylpicrylhydrazyl%2520%2528DPPH%2529%2520for%2520estimating%2520antioxidant%2520activity%26jtitle%3DSongklanakarin%2520J.%2520Sci.%2520Technol.%26date%3D2004%26volume%3D26%26spage%3D211%26epage%3D219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tarozzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piazzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valgimigli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amorati, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolondi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djemil, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrisano, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rampa, A.</span></span> <span> </span><span class="NLM_article-title">From the dual function lead AP2238 to AP2469, a multi-target-directed ligand for the treatment of Alzheimer’s disease</span>. <i>Pharmacol. Res. Perspect.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>2</i></span>, <span class="NLM_elocation-id">e00023</span> <span class="refDoi"> DOI: 10.1002/prp2.23</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1002%2Fprp2.23" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=25505579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFOlsbjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&author=A.+Tarozziauthor=M.+Bartoliniauthor=L.+Piazziauthor=L.+Valgimigliauthor=R.+Amoratiauthor=C.+Bolondiauthor=A.+Djemilauthor=F.+Manciniauthor=V.+Andrisanoauthor=A.+Rampa&title=From+the+dual+function+lead+AP2238+to+AP2469%2C+a+multi-target-directed+ligand+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1002%2Fprp2.23"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">From the dual function lead AP2238 to AP2469, a multi-target-directed ligand for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Tarozzi, Andrea; Bartolini, Manuela; Piazzi, Lorna; Valgimigli, Luca; Amorati, Riccardo; Bolondi, Cecilia; Djemil, Alice; Mancini, Francesca; Andrisano, Vincenza; Rampa, Angela</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology Research & Perspectives</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e00023/1-e00023/14</span>CODEN:
                <span class="NLM_cas:coden">PRPHCA</span>;
        ISSN:<span class="NLM_cas:issn">2052-1707</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">The development of drugs with different pharmacol. properties appears to be an innovative therapeutic approach for Alzheimer's disease.  In this article, we describe a simple structural modification of AP2238, a first dual function lead, in particular the introduction of the catechol moiety performed in order to search for multi-target ligands.  The new compd. AP2469 retains anti-acetylcholinesterase (AChE) and beta-site amyloid precursor protein cleaving enzyme (BACE)1 activities compared to the ref., and is also able to inhibit Aβ42 self-aggregation, Aβ42 oligomer-binding to cell membrane and subsequently reactive oxygen species formation in both neuronal and microglial cells.  The ability of AP2469 to interfere with Aβ42 oligomer-binding to neuron and microglial cell membrane gives this mol. both neuroprotective and anti-inflammatory properties.  These findings, together with its strong chain-breaking antioxidant performance, make AP2469 a potential drug able to modify the course of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWXudykiJm47Vg90H21EOLACvtfcHk0lh_Daa-nSji3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFOlsbjP&md5=2fa3d47b4f38b26adc80914410f7409b</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1002%2Fprp2.23&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprp2.23%26sid%3Dliteratum%253Aachs%26aulast%3DTarozzi%26aufirst%3DA.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DPiazzi%26aufirst%3DL.%26aulast%3DValgimigli%26aufirst%3DL.%26aulast%3DAmorati%26aufirst%3DR.%26aulast%3DBolondi%26aufirst%3DC.%26aulast%3DDjemil%26aufirst%3DA.%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DRampa%26aufirst%3DA.%26atitle%3DFrom%2520the%2520dual%2520function%2520lead%2520AP2238%2520to%2520AP2469%252C%2520a%2520multi-target-directed%2520ligand%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DPharmacol.%2520Res.%2520Perspect.%26date%3D2014%26volume%3D2%26doi%3D10.1002%2Fprp2.23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clark, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gebhart, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonder, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keeling, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohn, D. F.</span></span> <span> </span><span class="NLM_article-title">The 1996 guide for the care and use of laboratory animals</span>. <i>ILAR J.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">41</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1093/ilar.38.1.41</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1093%2Filar.38.1.41" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=11528046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A280%3ADC%252BC2srjs1GqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1997&pages=41-48&author=J.+D.+Clarkauthor=G.+F.+Gebhartauthor=J.+C.+Gonderauthor=M.+E.+Keelingauthor=D.+F.+Kohn&title=The+1996+guide+for+the+care+and+use+of+laboratory+animals&doi=10.1093%2Filar.38.1.41"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Special Report: The 1996 Guide for the Care and Use of Laboratory Animals</span></div><div class="casAuthors">Clark J. Derrell; Gebhart Gerald F.; Gonder Janet C.; Keeling Michale E.; Kohn Dennis F.</div><div class="citationInfo"><span class="NLM_cas:title">ILAR journal</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-48</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTp4mVi1DOWUTQLBVDQn4bCfW6udTcc2eYBZ7ZyXqcKWLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2srjs1GqtA%253D%253D&md5=db8f111640eb343af8bf6e1787bb9a24</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1093%2Filar.38.1.41&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Filar.38.1.41%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DJ.%2BD.%26aulast%3DGebhart%26aufirst%3DG.%2BF.%26aulast%3DGonder%26aufirst%3DJ.%2BC.%26aulast%3DKeeling%26aufirst%3DM.%2BE.%26aulast%3DKohn%26aufirst%3DD.%2BF.%26atitle%3DThe%25201996%2520guide%2520for%2520the%2520care%2520and%2520use%2520of%2520laboratory%2520animals%26jtitle%3DILAR%2520J.%26date%3D1997%26volume%3D38%26spage%3D41%26epage%3D48%26doi%3D10.1093%2Filar.38.1.41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4a','cit4b'],'ref5':['cit5'],'ref6':['cit6a','cit6b','cit6c','cit6d','cit6e'],'ref7':['cit7a','cit7b','cit7c','cit7d','cit7e','cit7f','cit7g'],'ref8':['cit8'],'ref9':['cit9a','cit9b'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17a','cit17b','cit17c','cit17d'],'ref18':['cit18'],'ref19':['cit19a','cit19b','cit19c','cit19d'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26a','cit26b'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29a','cit29b','cit29c','cit29d'],'ref30':['cit30'],'ref31':['cit31a','cit31b'],'ref32':['cit32a','cit32b'],'ref33':['cit33'],'ref34':['cit34a','cit34b'],'ref35':['cit35'],'ref36':['cit36a','cit36b'],'ref37':['cit37a','cit37b','cit37c'],'ref38':['cit38a','cit38b'],'ref39':['cit39a','cit39b'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45a','cit45b','cit45c'],'ref46':['cit46'],'ref47':['cit47a','cit47b'],'ref48':['cit48a','cit48b','cit48c'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53a','cit53b'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63a','cit63b'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 8 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Hong Yao, Giuseppe Uras, Pengfei Zhang, Shengtao Xu, Ying Yin, Jie Liu, Shuai Qin, Xinuo Li, Stephanie Allen, Renren Bai, Qi Gong, Haiyan Zhang, Zheying Zhu, <span class="NLM_string-name hlFld-ContribAuthor">Jinyi Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Tacrine–Pyrimidone Hybrids as Potent Dual AChE/GSK-3 Inhibitors for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (11)
                                     , 7483-7506. <a href="https://doi.org/10.1021/acs.jmedchem.1c00160" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00160</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00160%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BTacrine%2525E2%252580%252593Pyrimidone%252BHybrids%252Bas%252BPotent%252BDual%252BAChE%25252FGSK-3%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DYao%26aufirst%3DHong%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D28012021%26date%3D24052021%26volume%3D64%26issue%3D11%26spage%3D7483%26epage%3D7506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Anna Pasieka, Dawid Panek, Natalia Szałaj, Alba Espargaró, Anna Więckowska, Barbara Malawska, Raimon Sabaté, <span class="NLM_string-name hlFld-ContribAuthor">Marek Bajda</span>. </span><span class="cited-content_cbyCitation_article-title">Dual Inhibitors of Amyloid-β and Tau Aggregation with Amyloid-β Disaggregating Properties: Extended In Cellulo, In Silico, and Kinetic Studies of Multifunctional Anti-Alzheimer’s Agents. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2021,</strong> <em>12 </em>
                                    (11)
                                     , 2057-2068. <a href="https://doi.org/10.1021/acschemneuro.1c00235" title="DOI URL">https://doi.org/10.1021/acschemneuro.1c00235</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.1c00235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.1c00235%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DDual%252BInhibitors%252Bof%252BAmyloid-%2525CE%2525B2%252Band%252BTau%252BAggregation%252Bwith%252BAmyloid-%2525CE%2525B2%252BDisaggregating%252BProperties%25253A%252BExtended%252BIn%252BCellulo%25252C%252BIn%252BSilico%25252C%252Band%252BKinetic%252BStudies%252Bof%252BMultifunctional%252BAnti-Alzheimer%2525E2%252580%252599s%252BAgents%26aulast%3DPasieka%26aufirst%3DAnna%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D13042021%26date%3D14052021%26date%3D21052021%26volume%3D12%26issue%3D11%26spage%3D2057%26epage%3D2068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Elisabet Viayna, Nicolas Coquelle, Monika Cieslikiewicz-Bouet, Pedro Cisternas, Carolina A. Oliva, Elena Sánchez-López, Miren Ettcheto, Manuela Bartolini, Angela De Simone, Mattia Ricchini, Marisa Rendina, Mégane Pons, Omidreza Firuzi, Belén Pérez, Luciano Saso, Vincenza Andrisano, Florian Nachon, Xavier Brazzolotto, Maria Luisa García, Antoni Camins, Israel Silman, Ludovic Jean, Nibaldo C. Inestrosa, Jacques-Philippe Colletier, Pierre-Yves Renard, <span class="NLM_string-name hlFld-ContribAuthor">Diego Muñoz-Torrero</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (1)
                                     , 812-839. <a href="https://doi.org/10.1021/acs.jmedchem.0c01775" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01775</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01775%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%252BDual%252BInhibitor%252Bof%252BAcetylcholinesterase%252Band%252BButyrylcholinesterase%252Bwith%252BAntioxidant%252BActivity%252Bthat%252BAlleviates%252BAlzheimer-like%252BPathology%252Bin%252BOld%252BAPP%25252FPS1%252BMice%26aulast%3DViayna%26aufirst%3DElisabet%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D09102020%26date%3D28122020%26volume%3D64%26issue%3D1%26spage%3D812%26epage%3D839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giselle  de Andrade Ramos</span>, <span class="hlFld-ContribAuthor ">Andressa  Souza de Oliveira</span>, <span class="hlFld-ContribAuthor ">Manuela  Bartolini</span>, <span class="hlFld-ContribAuthor ">Marina  Naldi</span>, <span class="hlFld-ContribAuthor ">Irene  Liparulo</span>, <span class="hlFld-ContribAuthor ">Christian  Bergamini</span>, <span class="hlFld-ContribAuthor ">Elisa  Uliassi</span>, <span class="hlFld-ContribAuthor ">Ling  Wu</span>, <span class="hlFld-ContribAuthor ">Paul E.  Fraser</span>, <span class="hlFld-ContribAuthor ">Monica  Abreu</span>, <span class="hlFld-ContribAuthor ">Alessandra Sofia  Kiametis</span>, <span class="hlFld-ContribAuthor ">Ricardo  Gargano</span>, <span class="hlFld-ContribAuthor ">Edilberto Rocha  Silveira</span>, <span class="hlFld-ContribAuthor ">Guilherme D.  Brand</span>, <span class="hlFld-ContribAuthor ">Lukas  Prchal</span>, <span class="hlFld-ContribAuthor ">Ondřej  Soukup</span>, <span class="hlFld-ContribAuthor ">Jan  Korábečný</span>, <span class="hlFld-ContribAuthor ">Maria Laura  Bolognesi</span>, <span class="hlFld-ContribAuthor ">Luiz Antonio  Soares Romeiro</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of sustainable drugs for Alzheimer's disease: cardanol-derived cholinesterase inhibitors with antioxidant and anti-amyloid properties. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2021,</strong> <em>12 </em>
                                    (7)
                                     , 1154-1163. <a href="https://doi.org/10.1039/D1MD00046B" title="DOI URL">https://doi.org/10.1039/D1MD00046B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1MD00046B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1MD00046B%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bsustainable%252Bdrugs%252Bfor%252BAlzheimer%252527s%252Bdisease%25253A%252Bcardanol-derived%252Bcholinesterase%252Binhibitors%252Bwith%252Bantioxidant%252Band%252Banti-amyloid%252Bproperties%26aulast%3Dde%2BAndrade%2BRamos%26aufirst%3DGiselle%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D7%26spage%3D1154%26epage%3D1163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heng  Zhang</span>, <span class="hlFld-ContribAuthor ">Qing  Song</span>, <span class="hlFld-ContribAuthor ">Guangjun  Yu</span>, <span class="hlFld-ContribAuthor ">Zhongcheng  Cao</span>, <span class="hlFld-ContribAuthor ">Xiaoming  Qiang</span>, <span class="hlFld-ContribAuthor ">Xiuxiu  Liu</span>, <span class="hlFld-ContribAuthor ">Yong  Deng</span>. </span><span class="cited-content_cbyCitation_article-title">Phthalimide‐(
              N
              ‐alkylbenzylamine) cysteamide hybrids as multifunctional agents against Alzheimer’s disease: Design, synthesis, and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2021,</strong> <em>8 </em><a href="https://doi.org/10.1111/cbdd.13905" title="DOI URL">https://doi.org/10.1111/cbdd.13905</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13905&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13905%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DPhthalimide%2525E2%252580%252590%252528%252BN%252B%2525E2%252580%252590alkylbenzylamine%252529%252Bcysteamide%252Bhybrids%252Bas%252Bmultifunctional%252Bagents%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252Bdisease%25253A%252BDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%26aulast%3DZhang%26aufirst%3DHeng%26date%3D2021%26date%3D2021%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Pasieka</span>, <span class="hlFld-ContribAuthor ">Dawid  Panek</span>, <span class="hlFld-ContribAuthor ">Jakub  Jończyk</span>, <span class="hlFld-ContribAuthor ">Justyna  Godyń</span>, <span class="hlFld-ContribAuthor ">Natalia  Szałaj</span>, <span class="hlFld-ContribAuthor ">Gniewomir  Latacz</span>, <span class="hlFld-ContribAuthor ">Julia  Tabor</span>, <span class="hlFld-ContribAuthor ">Eva  Mezeiova</span>, <span class="hlFld-ContribAuthor ">Fabien  Chantegreil</span>, <span class="hlFld-ContribAuthor ">José  Dias</span>, <span class="hlFld-ContribAuthor ">Damijan  Knez</span>, <span class="hlFld-ContribAuthor ">Junfeng  Lu</span>, <span class="hlFld-ContribAuthor ">Rongbiao  Pi</span>, <span class="hlFld-ContribAuthor ">Jan  Korabecny</span>, <span class="hlFld-ContribAuthor ">Xavier  Brazzolotto</span>, <span class="hlFld-ContribAuthor ">Stanislav  Gobec</span>, <span class="hlFld-ContribAuthor ">Georg  Höfner</span>, <span class="hlFld-ContribAuthor ">Klaus  Wanner</span>, <span class="hlFld-ContribAuthor ">Anna  Więckowska</span>, <span class="hlFld-ContribAuthor ">Barbara  Malawska</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of multifunctional anti-Alzheimer’s agents with a unique mechanism of action including inhibition of the enzyme butyrylcholinesterase and γ-aminobutyric acid transporters. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>218 </em>, 113397. <a href="https://doi.org/10.1016/j.ejmech.2021.113397" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113397</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113397%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bmultifunctional%252Banti-Alzheimer%2525E2%252580%252599s%252Bagents%252Bwith%252Ba%252Bunique%252Bmechanism%252Bof%252Baction%252Bincluding%252Binhibition%252Bof%252Bthe%252Benzyme%252Bbutyrylcholinesterase%252Band%252B%2525CE%2525B3-aminobutyric%252Bacid%252Btransporters%26aulast%3DPasieka%26aufirst%3DAnna%26date%3D2021%26volume%3D218%26spage%3D113397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karar T.  Shukur</span>, <span class="hlFld-ContribAuthor ">Tugba  Ercetin</span>, <span class="hlFld-ContribAuthor ">Chiara  Luise</span>, <span class="hlFld-ContribAuthor ">Wolfgang  Sippl</span>, <span class="hlFld-ContribAuthor ">Okan  Sirkecioglu</span>, <span class="hlFld-ContribAuthor ">Mert  Ulgen</span>, <span class="hlFld-ContribAuthor ">Goknil P.  Coskun</span>, <span class="hlFld-ContribAuthor ">Mine  Yarim</span>, <span class="hlFld-ContribAuthor ">Mustafa  Gazi</span>, <span class="hlFld-ContribAuthor ">Hayrettin O.  Gulcan</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of new urolithin amides as multitarget agents against Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2021,</strong> <em>354 </em>
                                    (5)
                                     , 2000467. <a href="https://doi.org/10.1002/ardp.202000467" title="DOI URL">https://doi.org/10.1002/ardp.202000467</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.202000467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.202000467%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bnew%252Burolithin%252Bamides%252Bas%252Bmultitarget%252Bagents%252Bagainst%252BAlzheimer%252527s%252Bdisease%26aulast%3DShukur%26aufirst%3DKarar%2BT.%26date%3D2021%26date%3D2021%26volume%3D354%26issue%3D5%26spage%3D2000467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniela  Malafaia</span>, <span class="hlFld-ContribAuthor ">Hélio M.T.  Albuquerque</span>, <span class="hlFld-ContribAuthor ">Artur M.S.  Silva</span>. </span><span class="cited-content_cbyCitation_article-title">Amyloid-β and tau aggregation dual-inhibitors: A synthetic and structure-activity relationship focused review. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>214 </em>, 113209. <a href="https://doi.org/10.1016/j.ejmech.2021.113209" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113209</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113209%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAmyloid-%2525CE%2525B2%252Band%252Btau%252Baggregation%252Bdual-inhibitors%25253A%252BA%252Bsynthetic%252Band%252Bstructure-activity%252Brelationship%252Bfocused%252Breview%26aulast%3DMalafaia%26aufirst%3DDaniela%26date%3D2021%26volume%3D214%26spage%3D113209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/medium/jm0c00528_0022.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00528&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/medium/jm0c00528_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design strategy of the CR-6–chlorotacrine hybrids.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00528&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/medium/jm0c00528_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0016.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the CR-6–(Chloro)tacrine Hybrids <b>4a</b>–<b>d</b>, <b>11a</b>–<b>c</b>, <b>11e</b>, <b>12a</b>–<b>c</b>, and <b>12e</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00528&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) diamine, 1-pentanol, reflux or closed vessel, 18–24 h, 59% (<b>10a</b>), 69% (<b>10b</b>), 59% (<b>10c</b>), 77% (<b>10d</b>), 32% (<b>10e</b>); (b) <b>7</b> or <b>8</b>, <i>N</i>-(3-dimethylaminopropyl)-<i>N</i>′-ethylcarbodiimide hydrochloride (EDC·HCl), 1-hydroxy-1<i>H</i>-benzotriazole (HOBt), Et<sub>3</sub>N, EtOAc/dimethylformamide (DMF), room temperature (rt), 15 min; then, <b>10a</b>–<b>e</b>, EtOAc/DMF, rt, 24 h, 67% (<b>4a</b>), 67% (<b>4b</b>), 86% (<b>4c</b>), 91% (<b>4d</b>), 83% (<b>11a</b>), 92% (<b>11b</b>), 90% (<b>11c</b>), 100% (<b>11e</b>); (c) H<sub>2</sub> (1 atm), 10% w/w Pd/C, EtOH, rt, overnight, 72% (<b>12a</b>), 99% (<b>12b</b>), 99% (<b>12c</b>), 99% (<b>12e</b>).</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/medium/jm0c00528_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0017.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of the CR-6–Chlorotacrine Hybrids <b>5a</b>–<b>c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00528&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <b>13a</b>–<b>c</b>, 40% methanolic KOH, reflux, 3 h; H<sub>2</sub>O, reflux, overnight; HCl in dioxane or Et<sub>2</sub>O; resulting carboxylic acid, EDC·HCl, HOBt, Et<sub>3</sub>N, EtOAc/DMF, rt, 15 min; then, <b>14</b>, EtOAc/DMF, rt, 24 h, 87% (<b>5a</b>), 55% (<b>5b</b>), 52% (<b>5c</b>).</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/medium/jm0c00528_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0018.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of the CR-6–Chlorotacrine Hybrids <b>6a</b>–<b>d</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00528&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) H<sub>2</sub> (1 atm), 10% w/w Pd/C, tetrahydrofuran (THF), rt, overnight, 90%; (b) Et<sub>3</sub>N, CH<sub>3</sub>CN, 80 °C, 48 h, 24% (<b>6a</b>), 57% (<b>6b</b>), 59% (<b>6c</b>), 30% (<b>6d</b>).</p></p></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/medium/jm0c00528_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Mechanism of inhibition of hAChE by hybrid <b>6b</b>. Left, overlaid Lineweaver–Burk reciprocal plots showing the variation of the initial velocity rate (<i>v</i>) as a function of increasing substrate (acetylthiocholine, ATCh) in the absence and presence of increasing concentrations of <b>6b</b>. The mechanism of inhibition was assessed by two independent experiments, each performed in triplicate. Right, propidium displacement studies to determine the affinity for the PAS of AChE: P and I stand for propidium iodide and inhibitor (<b>6b</b>), respectively; <i>F</i><sub>e</sub> is the initial fluorescence intensity when enzyme sites are saturated with P; <i>F</i><sub>P</sub> is the fluorescence intensity when propidium is completely displaced from the enzyme; and <i>F</i> denotes the fluorescence intensity after adding a determined amount of displacing agent during the titration experiment. Data are the average of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00528&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/medium/jm0c00528_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Representative snapshots of the complexes of (A) (<i>R</i>)-<b>6b</b> and (B) (<i>S</i>)-<b>6b</b> bound to hAChE taken from molecular dynamics simulations (started from PDB structure <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Q83">1Q83</a>). Bottom panels show details of the interactions at the CAS and along the gorge. Density maps for structural water molecules (shown as red spheres) within the catalytic site are depicted as a red isomesh. Selected interactions are shown as yellow dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00528&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/medium/jm0c00528_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Representative snapshots of the complexes of (A) (<i>R</i>)-<b>12a</b> and (B) (<i>S</i>)-<b>12a</b> bound to hBChE taken from molecular dynamics simulations (started from PDB structure <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5K5E">5K5E</a>). Bottom panels show details of the interactions at the catalytic site and along the gorge. Density maps for structural water molecules (shown as red spheres) within the catalytic site are depicted as a red isomesh. Selected interactions are shown as yellow dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00528&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/medium/jm0c00528_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. In vitro biological profile of the selected compounds for in vivo efficacy studies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00528&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/medium/jm0c00528_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0007.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Flow diagram of in vivo efficacy studies with the novel CR-6–chlorotacrine hybrids <b>4b</b> and <b>11b</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00528&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/medium/jm0c00528_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0008.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Memory performance in the two-object recognition test of male wild-type (WT vehicle, <i>n</i> = 6; WT <b>4b</b>, <i>n</i> = 5; WT <b>11b</b>, <i>n</i> = 6) and male APP/PS1 mice (APP/PS1 vehicle, <i>n</i> = 5; APP/PS1 <b>4b</b>, <i>n</i> = 7; APP/PS1 <b>11b</b>, <i>n</i> = 6) after chronic treatment with the novel hybrids <b>4b</b> and <b>11b</b> (10 mg/(kg day), 4 weeks, ip). APP/PS1 mice chronically treated with vehicle, but not with <b>4b</b> or <b>11b</b>, exhibit a significant reduction in the recognition index when compared to corresponding WT littermates. Data are expressed as the mean values ± SEM. Data were analyzed by two-way ANOVA with genotype (<i>p</i> < 0.01) and treatment as between factors, followed by two-tailed Student’s <i>t</i>-test to compare between genotypes (*<i>p</i> < 0.05).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00528&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/medium/jm0c00528_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0009.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (A) Representative images of Aβ immunoreactivity in cortical sections of male APP/PS1 mice subjected to chronic vehicle (<i>n</i> = 5), <b>4b</b> (<i>n</i> = 7), or <b>11b</b> (<i>n</i> = 6) treatment. The scale bar represents 200 μm. (B) Aβ burden quantification reveals a tendency to decrease in the cortex of <b>4b</b>-treated APP/PS1 mice. (C) Soluble Aβ<sub>40</sub> and Aβ<sub>42</sub> levels are not significantly modified by chronic <b>4b</b> or <b>11b</b> treatment in cortical homogenates of APP/PS1 mice. Data are expressed as the mean values ± SEM and were analyzed by one-way ANOVA with treatment as between factors (not significant in any case).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00528&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/medium/jm0c00528_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0010.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Gene expression of (A) <i>Adam10</i> (<i>α-secretase</i>) and (B) <i>Bace1</i> (<i>β-secretase</i>); representative Western blot and quantification for (C) ADAM10, (D) BACE-1, (E) sAPPα, and (F) sAPPβ in cortical samples from treated male mice (WT vehicle, <i>n</i> = 6; WT <b>4b</b>, <i>n</i> = 5; WT <b>11b</b>, <i>n</i> = 6; APP/PS1 vehicle, <i>n</i> = 5; APP/PS1 <b>4b</b>, <i>n</i> = 7; APP/PS1 <b>11b</b>, <i>n</i> = 6). Data are expressed as the mean values ± SEM. Data were analyzed by two-way ANOVA with genotype and as between factors, followed by two-tailed Student’s <i>t</i>-test to compare between genotypes or Tukey’s post hoc test to compare between treatments. *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001; and ****<i>p</i> < 0.0001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00528&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/medium/jm0c00528_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0011.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. (A) Representative immunoblot for oxidized proteins (upper panel) and corresponding β-tubulin loading control (lower panel) from cortical samples of treated male mice (WT vehicle, <i>n</i> = 6; WT <b>4b</b>, <i>n</i> = 5; WT <b>11b</b>, <i>n</i> = 6; APP/PS1 vehicle, <i>n</i> = 5; APP/PS1 <b>4b</b>, <i>n</i> = 7; APP/PS1 <b>11b</b>, <i>n</i> = 6). Black triangular arrows indicate the molecular weight of proteins. (B) Optical density quantification of the immunoblots normalized with respect to the WT-vehicle group. Data are expressed as the mean values ± SEM and were analyzed by two-way ANOVA with genotype (<i>p</i> < 0.05) and treatment as between factors, followed by two-tailed Student’s <i>t</i>-test to compare between genotypes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00528&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/medium/jm0c00528_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0012.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. (A) Representative images of double SOD2 (green) and Aβ (red) immunostaining in cortical sections of male APP/PS1 mice chronically treated with vehicle (<i>n</i> = 5), <b>4b</b> (<i>n</i> = 7), or <b>11b</b> (<i>n</i> = 6). The scale bar represents 50 μm. (B) Quantification of the SOD2 staining around the Aβ plaques reveals a tendency to increase the levels of this enzyme involved in ROS neutralization in <b>11b</b>-treated APP/PS1 mice with respect to vehicle-treated mice, but this increase does not reach the statistical significance. Data are expressed as the mean values ± SEM and were analyzed by one-way ANOVA with treatment as between factors (not significant).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00528&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/medium/jm0c00528_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0013.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Representative Western blot and quantification for Nrf2 (A), catalase (B), and GPX1 (C) in cortical samples from treated male mice (WT vehicle, <i>n</i> = 6; WT <b>4b</b>, <i>n</i> = 5; WT <b>11b</b>, <i>n</i> = 6; APP/PS1 vehicle, <i>n</i> = 5; APP/PS1 <b>4b</b>, <i>n</i> = 7; APP/PS1 <b>11b</b>, <i>n</i> = 6). Data show a tendency to increase in antioxidant defense markers in APP/PS1 mice treated with the novel hybrids <b>4b</b> or <b>11b</b>. Moreover, <b>4b</b> treatment increases GPX1 levels in APP/PS1 mice compared to the vehicle group. Representative gene expression of <i>Hmox1</i> (D) and <i>iNOS</i> (E). Hybrids <b>4b</b> and <b>11b</b> seem to increase <i>Hmox1</i> and <i>iNOS</i> gene expression, but only <b>4b</b> in the first case reaches statistical significance. Data are expressed as the mean values ± SEM and were analyzed by two-way ANOVA with genotype and as between factors, followed by two-tailed Student’s <i>t</i>-test to compare between genotypes or Tukey’s post hoc test to compare between treatments. *<i>p</i> < 0.05, **<i>p</i> < 0.01, and ***<i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00528&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/medium/jm0c00528_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0014.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Reported metabolic transformation of chroman derivatives.<a onclick="showRef(event, 'ref46 ref47 ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref46 ref47 ref48 ref49">(46−49)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00528&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/medium/jm0c00528_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0015.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Metabolites of compound <b>4b</b> found after incubation with human, mouse, and rat liver microsomes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-17/acs.jmedchem.0c00528/20200903/images/large/jm0c00528_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00528&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i81">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85488" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85488" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 71 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Alzheimer’s Disease
International</span>.  <i>World Alzheimer Report
2018: The State of the Art of Dementia Research: New Frontiers</i>; <span class="NLM_publisher-name">Alzheimer’s Disease International</span>: <span class="NLM_publisher-loc">London</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=Alzheimer%E2%80%99s+Disease%0AInternational&title=World+Alzheimer+Report%0A2018%3A+The+State+of+the+Art+of+Dementia+Research%3A+New+Frontiers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26btitle%3DWorld%2520Alzheimer%2520Report%250A2018%253A%2520The%2520State%2520of%2520the%2520Art%2520of%2520Dementia%2520Research%253A%2520New%2520Frontiers%26pub%3DAlzheimer%25E2%2580%2599s%2520Disease%2520International%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Alzheimer’s Disease
International</span>.  <i>World Alzheimer Report
2019: Attitudes to Dementia</i>; <span class="NLM_publisher-name">Alzheimer’s
Disease International</span>: <span class="NLM_publisher-loc">London</span>, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=Alzheimer%E2%80%99s+Disease%0AInternational&title=World+Alzheimer+Report%0A2019%3A+Attitudes+to+Dementia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26btitle%3DWorld%2520Alzheimer%2520Report%250A2019%253A%2520Attitudes%2520to%2520Dementia%26pub%3DAlzheimer%25E2%2580%2599s%250ADisease%2520International%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cavalli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognesi, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minarini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumiatti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Recanatini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melchiorre, C.</span></span> <span> </span><span class="NLM_article-title">Multi-target-directed ligands to combat neurodegenerative diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">372</span>, <span class="refDoi"> DOI: 10.1021/jm7009364</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm7009364" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=347-372&author=A.+Cavalliauthor=M.+L.+Bolognesiauthor=A.+Minariniauthor=M.+Rosiniauthor=V.+Tumiattiauthor=M.+Recanatiniauthor=C.+Melchiorre&title=Multi-target-directed+ligands+to+combat+neurodegenerative+diseases&doi=10.1021%2Fjm7009364"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target-Directed Ligands to Combat Neurodegenerative Diseases</span></div><div class="casAuthors">Cavalli, Andrea; Bolognesi, Maria Laura; Minarini, Anna; Rosini, Michela; Tumiatti, Vincenzo; Recanatini, Maurizio; Melchiorre, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-372</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The authors review the investigations reported in the past decade that illustrate the ability of medicinal chemists to design multi-target-directed ligands (MTDLs) to confront neurodegenerative diseases.  The authors briefly illustrate the multifactorial nature of these diseases before discussing the possible development of MTDLs in light of the known mol. bases of the main neurodegenerative pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYY0I0UHEir7Vg90H21EOLACvtfcHk0ljEG_f0qjW_pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D&md5=c682235151489316d043cf97f78e56f3</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fjm7009364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7009364%26sid%3Dliteratum%253Aachs%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DMulti-target-directed%2520ligands%2520to%2520combat%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D347%26epage%3D372%26doi%3D10.1021%2Fjm7009364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lemke, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serrano, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chioua, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ismaili, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez-Grau, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beadle, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vetman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dato, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartz, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elsinghorst, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iriepa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wille, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marco-Contelles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gütschow, M.</span></span> <span> </span><span class="NLM_article-title">Chromenones as multineurotargeting inhibitors of human enzymes</span>. <i>ACS Omega</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">22161</span>– <span class="NLM_lpage">22168</span>, <span class="refDoi"> DOI: 10.1021/acsomega.9b03409</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsomega.9b03409" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlGgtLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2019&pages=22161-22168&author=C.+Lemkeauthor=J.+Christmannauthor=J.+Yinauthor=J.+M.+Alonsoauthor=E.+Serranoauthor=M.+Chiouaauthor=L.+Ismailiauthor=M.+A.+Mart%C3%ADnez-Grauauthor=C.+D.+Beadleauthor=T.+Vetmanauthor=F.+M.+Datoauthor=U.+Bartzauthor=P.+W.+Elsinghorstauthor=M.+Pietschauthor=C.+E.+M%C3%BCllerauthor=I.+Iriepaauthor=T.+Willeauthor=J.+Marco-Contellesauthor=M.+G%C3%BCtschow&title=Chromenones+as+multineurotargeting+inhibitors+of+human+enzymes&doi=10.1021%2Facsomega.9b03409"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Chromenones as Multineurotargeting Inhibitors of Human Enzymes</span></div><div class="casAuthors">Lemke, Carina; Christmann, Joscha; Yin, Jiafei; Alonso, Jose M.; Serrano, Estefania; Chioua, Mourad; Ismaili, Lhassane; Martinez-Grau, Maria Angeles; Beadle, Christopher D.; Vetman, Tatiana; Dato, Florian M.; Bartz, Ulrike; Elsinghorst, Paul W.; Pietsch, Markus; Mueller, Christa E.; Iriepa, Isabel; Wille, Timo; Marco-Contelles, Jose; Guetschow, Michael</div><div class="citationInfo"><span class="NLM_cas:title">ACS Omega</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">22161-22168</span>CODEN:
                <span class="NLM_cas:coden">ACSODF</span>;
        ISSN:<span class="NLM_cas:issn">2470-1343</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The complex nature of multifactorial diseases, such as Morbus Alzheimer, has produced a strong need to design multitarget-directed ligands to address the involved complementary pathways.  A purposive structural modification of a tetratarget small-mol. contilisant and generated a combinatorial library of substituted chromen-4-ones I (R = pyrrolidin-1-yl, piperidin-1-yl, morpholin-4-yl, etc.; n = 2, 3, 4, 5) is reported.  The compds. comprise a basic moiety which is linker-connected to the 6-position of the heterocyclic chromenone core.  The syntheses were accomplished by Mitsunobu- or Williamson-type ether formations.  The resulting library members were evaluated at a panel of seven human enzymes, all of which being involved in the pathophysiol. of neurodegeneration.  A concomitant inhibition of human acetylcholinesterase and human monoamine oxidase B, with IC50 values of 5.58 and 7.20 μM, resp., was achieved with the dual-target 6-(4-(piperidin-1-yl)butoxy)-4H-chromen-4-one.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrT8Gk0MaAG-LVg90H21EOLACvtfcHk0ljEG_f0qjW_pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlGgtLrJ&md5=c085988b2602da09746e24c4616becd7</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1021%2Facsomega.9b03409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsomega.9b03409%26sid%3Dliteratum%253Aachs%26aulast%3DLemke%26aufirst%3DC.%26aulast%3DChristmann%26aufirst%3DJ.%26aulast%3DYin%26aufirst%3DJ.%26aulast%3DAlonso%26aufirst%3DJ.%2BM.%26aulast%3DSerrano%26aufirst%3DE.%26aulast%3DChioua%26aufirst%3DM.%26aulast%3DIsmaili%26aufirst%3DL.%26aulast%3DMart%25C3%25ADnez-Grau%26aufirst%3DM.%2BA.%26aulast%3DBeadle%26aufirst%3DC.%2BD.%26aulast%3DVetman%26aufirst%3DT.%26aulast%3DDato%26aufirst%3DF.%2BM.%26aulast%3DBartz%26aufirst%3DU.%26aulast%3DElsinghorst%26aufirst%3DP.%2BW.%26aulast%3DPietsch%26aufirst%3DM.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26aulast%3DIriepa%26aufirst%3DI.%26aulast%3DWille%26aufirst%3DT.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26aulast%3DG%25C3%25BCtschow%26aufirst%3DM.%26atitle%3DChromenones%2520as%2520multineurotargeting%2520inhibitors%2520of%2520human%2520enzymes%26jtitle%3DACS%2520Omega%26date%3D2019%26volume%3D4%26spage%3D22161%26epage%3D22168%26doi%3D10.1021%2Facsomega.9b03409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, A. S. C.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of orally bioavailable quinoline–indole derivatives as innovative multitarget-directed ligands: promotion of cell proliferation in the adult murine hippocampus for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1871</span>– <span class="NLM_lpage">1894</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01417</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01417" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVGktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=1871-1894&author=Z.+Wangauthor=J.+Huauthor=X.+Yangauthor=X.+Fengauthor=X.+Liauthor=L.+Huangauthor=A.+S.+C.+Chan&title=Design%2C+synthesis%2C+and+evaluation+of+orally+bioavailable+quinoline%E2%80%93indole+derivatives+as+innovative+multitarget-directed+ligands%3A+promotion+of+cell+proliferation+in+the+adult+murine+hippocampus+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.7b01417"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Evaluation of Orally Bioavailable Quinoline-Indole Derivatives as Innovative Multitarget-Directed Ligands: Promotion of Cell Proliferation in the Adult Murine Hippocampus for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Wang, Zhiren; Hu, Jinhui; Yang, Xiaoping; Feng, Xing; Li, Xingshu; Huang, Ling; Chan, Albert S. C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1871-1894</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of quinoline-indole derivs., e.g., I, were synthesized and evaluated as multitarget-directed ligands for the treatment of Alzheimer's disease (AD).  Biol. evaluation revealed that the derivs. had multifunctional profiles including antioxidant effects, blood-brain barrier (BBB) penetration, biometal chelation, Aβ aggregation modulation, neurotrophic and neuroprotective properties.  Moreover, several representative target derivs. demonstrated hippocampal cell proliferation in living adult mice by intracerebroventricular (icv) injection or oral administration.  Further drug-like property anal. demonstrated that the optimized compd., I (WI-1758), had liver microsomal metabolic stability, was well tolerated (>2000 mg/kg), and had a rational pharmacokinetic profile, as well as an oral bioavailability of 14.1% and a pos. log BB (-0.19) to cross the BBB in vivo.  Pharmacodynamics studies demonstrated that chronic oral administration of I·HCl substantially ameliorated the cognitive and spatial memory deficits in APP/PS1 AD mice and noticeably reduced overall cerebral β-amyloid deposits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWqZm6XKZY47Vg90H21EOLACvtfcHk0ljZzyZ91E2F3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVGktrg%253D&md5=7a152c6307ee80a9e334225776d55d25</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01417%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DFeng%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DChan%26aufirst%3DA.%2BS.%2BC.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520orally%2520bioavailable%2520quinoline%25E2%2580%2593indole%2520derivatives%2520as%2520innovative%2520multitarget-directed%2520ligands%253A%2520promotion%2520of%2520cell%2520proliferation%2520in%2520the%2520adult%2520murine%2520hippocampus%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D1871%26epage%3D1894%26doi%3D10.1021%2Facs.jmedchem.7b01417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span> <span> </span><span class="NLM_article-title">Multitarget anti-Alzheimer Hybrid Compounds: Do They Work in Vivo?</span>. In  <i>Design of Hybrid Molecules for Drug Development</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, M.</span></span>, Ed.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">Amsterdam</span>, <span class="NLM_year">2017</span>; pp  <span class="NLM_fpage">167</span>– <span class="NLM_lpage">192</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2FB978-0-08-101011-2.00006-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&pages=167-192&author=D.+Mu%C3%B1oz-Torreroauthor=M.+Decker&title=Design+of+Hybrid+Molecules+for+Drug+Development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FB978-0-08-101011-2.00006-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-08-101011-2.00006-4%26sid%3Dliteratum%253Aachs%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DMultitarget%2520anti-Alzheimer%2520Hybrid%2520Compounds%253A%2520Do%2520They%2520Work%2520in%2520Vivo%253F%26btitle%3DDesign%2520of%2520Hybrid%2520Molecules%2520for%2520Drug%2520Development%26aulast%3DDecker%26aufirst%3DM.%26pub%3DElsevier%26date%3D2017%26spage%3D167%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bajda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Łażewska, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godyń, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaręba, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuder, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagenow, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Łątka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stawarska, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stark, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieć-Kononowicz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malawska, B.</span></span> <span> </span><span class="NLM_article-title">Search for new multi-target compounds against Alzheimer’s disease among histamine H3 receptor ligands</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>185</i></span>, <span class="NLM_elocation-id">111785</span> <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.111785</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2Fj.ejmech.2019.111785" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=31669851" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitVGmtbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=2020&author=M.+Bajdaauthor=D.+%C5%81a%C5%BCewskaauthor=J.+Gody%C5%84author=P.+Zar%C4%99baauthor=K.+Kuderauthor=S.+Hagenowauthor=K.+%C5%81%C4%85tkaauthor=E.+Stawarskaauthor=H.+Starkauthor=K.+Kie%C4%87-Kononowiczauthor=B.+Malawska&title=Search+for+new+multi-target+compounds+against+Alzheimer%E2%80%99s+disease+among+histamine+H3+receptor+ligands&doi=10.1016%2Fj.ejmech.2019.111785"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Search for new multi-target compounds against Alzheimer's disease among histamine H3 receptor ligands</span></div><div class="casAuthors">Bajda, Marek; Lazewska, Dorota; Godyn, Justyna; Zareba, Paula; Kuder, Kamil; Hagenow, Stefanie; Latka, Kamil; Stawarska, Ewelina; Stark, Holger; Kiec-Kononowicz, Katarzyna; Malawska, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">185</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">111785</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Multitarget-directed ligands seem to be an interesting approach to the treatment of complex disorders such as Alzheimer's disease.  The aim of the present study was to find novel multifunctional compds. in a nonimidazole histamine H3 receptor ligand library.  Docking-based virtual screening was applied for selection of twenty-six hits which were subsequently evaluated in Ellman's assay for the inhibitory potency toward acetyl- (AChE) and butyrylcholinesterase (BuChE).  The virtual screening with high success ratio enabled to choose multitarget-directed ligands.  Based on docking results, all selected ligands were able to bind both catalytic and peripheral sites of AChE and BuChE.  The most promising derivs. combined the flavone moiety via a six carbon atom linker with a heterocyclic moiety, such as azepane, piperidine or 3-methylpiperidine.  They showed the highest inhibitory activities toward cholinesterases as well as well-balanced potencies against H3R and both enzymes.  Two derivs. were chosen - 5 (IC50 = 0.46μM (AChE); 0.44μM (BuChE); Ki = 159.8 nM (H3R)) and 17 (IC50 = 0.50μM (AChE); 0.76μM (BuChE); Ki = 228.2 nM (H3R)), and their inhibition mechanism was evaluated in kinetic studies.  Both compds. displayed noncompetitive mode of AChE and BuChE inhibition.  Compds. 5 and 17 might serve as good lead structures for further optimization and development of novel multitarget anti-Alzheimer's agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUpZqYTa3jErVg90H21EOLACvtfcHk0ljZzyZ91E2F3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitVGmtbnJ&md5=dab560ad799afa024d4b594403a14701</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.111785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.111785%26sid%3Dliteratum%253Aachs%26aulast%3DBajda%26aufirst%3DM.%26aulast%3D%25C5%2581a%25C5%25BCewska%26aufirst%3DD.%26aulast%3DGody%25C5%2584%26aufirst%3DJ.%26aulast%3DZar%25C4%2599ba%26aufirst%3DP.%26aulast%3DKuder%26aufirst%3DK.%26aulast%3DHagenow%26aufirst%3DS.%26aulast%3D%25C5%2581%25C4%2585tka%26aufirst%3DK.%26aulast%3DStawarska%26aufirst%3DE.%26aulast%3DStark%26aufirst%3DH.%26aulast%3DKie%25C4%2587-Kononowicz%26aufirst%3DK.%26aulast%3DMalawska%26aufirst%3DB.%26atitle%3DSearch%2520for%2520new%2520multi-target%2520compounds%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%2520among%2520histamine%2520H3%2520receptor%2520ligands%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2020%26volume%3D185%26doi%3D10.1016%2Fj.ejmech.2019.111785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mesiti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavarria, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaspar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcaro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, F.</span></span> <span> </span><span class="NLM_article-title">The chemistry toolbox of multitarget-directed ligands for Alzheimer’s disease</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>181</i></span>, <span class="NLM_elocation-id">111572</span> <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.111572</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2Fj.ejmech.2019.111572" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=31404859" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFyjsrvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=2019&author=F.+Mesitiauthor=D.+Chavarriaauthor=A.+Gasparauthor=S.+Alcaroauthor=F.+Borges&title=The+chemistry+toolbox+of+multitarget-directed+ligands+for+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2019.111572"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">The chemistry toolbox of multitarget-directed ligands for Alzheimer's disease</span></div><div class="casAuthors">Mesiti, Francesco; Chavarria, Daniel; Gaspar, Alexandra; Alcaro, Stefano; Borges, Fernanda</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">181</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">111572</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  The discovery and development of multitarget-directed ligands (MTDLs) is a promising strategy to find new therapeutic solns. for neurodegenerative diseases (NDs), in particular for Alzheimer's disease (AD).  Currently approved drugs for the clin. management of AD are based on a single-target strategy and focus on restoring neurotransmitter homeostasis.  Finding disease-modifying therapies AD and other NDs remains an urgent unmet clin. need.  The growing consensus that AD is a multifactorial disease, with several interconnected and deregulated pathol. pathways, boosted an intensive research in the design of MTDLs.  Due to this scientific boom, the knowledge behind the development of MTDLs remains diffuse and lacks balanced guidelines.  To rationalize the large amt. of data obtained in this field, the authors herein revise the progress made over the last 5 years on the development of MTDLs inspired by drugs approved for AD.  Due to their putative therapeutic benefit in AD, MTDLs based on MAO-B inhibitors will also be discussed in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGret0oXDxuClLVg90H21EOLACvtfcHk0liX9MFdRiky8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFyjsrvE&md5=e2703287dc0dbdc2be5ea7b5e9e9fee1</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.111572&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.111572%26sid%3Dliteratum%253Aachs%26aulast%3DMesiti%26aufirst%3DF.%26aulast%3DChavarria%26aufirst%3DD.%26aulast%3DGaspar%26aufirst%3DA.%26aulast%3DAlcaro%26aufirst%3DS.%26aulast%3DBorges%26aufirst%3DF.%26atitle%3DThe%2520chemistry%2520toolbox%2520of%2520multitarget-directed%2520ligands%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D181%26doi%3D10.1016%2Fj.ejmech.2019.111572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span> <span> </span><span class="NLM_article-title">Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer’s disease</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>169</i></span>,  <span class="NLM_fpage">200</span>– <span class="NLM_lpage">223</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.02.076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2Fj.ejmech.2019.02.076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=30884327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1MXltFGhs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2019&pages=200-223&author=T.+Wangauthor=X.+Liuauthor=J.+Guanauthor=S.+Geauthor=M.-B.+Wuauthor=J.+Linauthor=L.+Yang&title=Advancement+of+multi-target+drug+discoveries+and+promising+applications+in+the+field+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2019.02.076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer's disease</span></div><div class="casAuthors">Wang, Tao; Liu, Xiao-huan; Guan, Jing; Ge, Shun; Wu, Mian-Bin; Lin, Jian-ping; Yang, Li-rong</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">200-223</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Complex diseases (e.g., Alzheimer's disease) or infectious diseases are usually caused by complicated and varied factors, including environmental and genetic factors.  Multi-target (polypharmacol.) drugs have been suggested and have emerged as powerful and promising alternative paradigms in modern medicinal chem. for the development of versatile chemotherapeutic agents to solve these medical challenges.  The multifunctional agents capable of modulating multiple biol. targets simultaneously display great advantages of higher efficacy, improved safety profile, and simpler administration compared to single-targeted agents.  Therefore, multifunctional agents would certainly open novel avenues to rationally design the next generation of more effective but less toxic therapeutic agents.  Herein, the authors review the recent progress made in the discovery and design processes of selective multi-targeted agents, esp. the successful application of multi-target drugs for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraLSyazoHkBbVg90H21EOLACvtfcHk0liX9MFdRiky8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXltFGhs7g%253D&md5=11e82288f25c5b2421184be0c568f9f8</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.02.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.02.076%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DGuan%26aufirst%3DJ.%26aulast%3DGe%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DM.-B.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DL.%26atitle%3DAdvancement%2520of%2520multi-target%2520drug%2520discoveries%2520and%2520promising%2520applications%2520in%2520the%2520field%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D169%26spage%3D200%26epage%3D223%26doi%3D10.1016%2Fj.ejmech.2019.02.076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gontijo, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viegas, F. P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortiz, C. J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Freitas Silva, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damasio, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosa, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campos, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couto, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tranches Dias, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viegas, C.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Molecular hybridization as a tool in the design of multi-target directed drug candidates for neurodegenerative diseases</span>. <i>Curr. Neuropharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">348</span>– <span class="NLM_lpage">407</span>, <span class="refDoi"> DOI: 10.2174/1385272823666191021124443</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.2174%2F1385272823666191021124443" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=31631821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtVyiurfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2020&pages=348-407&author=V.+S.+Gontijoauthor=F.+P.+D.+Viegasauthor=C.+J.+C.+Ortizauthor=M.+de+Freitas+Silvaauthor=C.+M.+Damasioauthor=M.+C.+Rosaauthor=T.+G.+Camposauthor=D.+S.+Coutoauthor=K.+S.+Tranches+Diasauthor=C.+Viegas&title=Molecular+hybridization+as+a+tool+in+the+design+of+multi-target+directed+drug+candidates+for+neurodegenerative+diseases&doi=10.2174%2F1385272823666191021124443"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6dR"><div class="casContent"><span class="casTitleNuber">6d</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Hybridization as a Tool in the Design of Multi-target Directed Drug Candidates for Neurodegenerative Diseases</span></div><div class="casAuthors">Gontijo, Vanessa Silva; Dias Viegas, Flavia P.; Cristancho Ortiz, Cindy Juliet; de Freitas Silva, Matheus; Damasio, Caio Miranda; Rosa, Mayara Chagas; Campos, Thamara Gaspar; Couto, Dyecika Souza; Tranches Dias, Kris Simone; Viegas, Claudio</div><div class="citationInfo"><span class="NLM_cas:title">Current Neuropharmacology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">348-407</span>CODEN:
                <span class="NLM_cas:coden">CNUEAN</span>;
        ISSN:<span class="NLM_cas:issn">1875-6190</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Neurodegenerative Diseases (NDs) are progressive multifactorial neurol. pathologies related to neuronal impairment and functional loss from different brain regions.  Currently, no effective treatments are available for any NDs, and this lack of efficacy has been attributed to the multitude of interconnected factors involved in their pathophysiol.  In the last two decades, a new approach for the rational design of new drug candidates, also called multitarget-directed ligands (MTDLs) strategy, has emerged and has been used in the design and for the development of a variety of hybrid compds. capable to act simultaneously in diverse biol. targets.  Based on the polypharmacol. concept, this new paradigm has been thought as a more secure and effective way for modulating concomitantly two or more biochem. pathways responsible for the onset and progress of NDs, trying to overcome low therapeutical effectiveness.  As a complement to our previous review article (Curr. Med. Chem. 2007, 14 (17), 1829-1852. https://doi.org/10.2174/092986707781058805), herein we aimed to cover the period from 2008 to 2019 and highlight the most recent advances of the exploitation of Mol. Hybridization (MH) as a tool in the rational design of innovative multifunctional drug candidate prototypes for the treatment of NDs, specially focused on AD, PD, HD and ALS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMj4ASlxgG-LVg90H21EOLACvtfcHk0liX9MFdRiky8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtVyiurfI&md5=82ca2f766a86b5329719aa4ae2bb1d6c</span></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=10.2174%2F1385272823666191021124443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1385272823666191021124443%26sid%3Dliteratum%253Aachs%26aulast%3DGontijo%26aufirst%3DV.%2BS.%26aulast%3DViegas%26aufirst%3DF.%2BP.%2BD.%26aulast%3DOrtiz%26aufirst%3DC.%2BJ.%2BC.%26aulast%3Dde%2BFreitas%2BSilva%26aufirst%3DM.%26aulast%3DDamasio%26aufirst%3DC.%2BM.%26aulast%3DRosa%26aufirst%3DM.%2BC.%26aulast%3DCampos%26aufirst%3DT.%2BG.%26aulast%3DCouto%26aufirst%3DD.%2BS.%26aulast%3DTranches%2BDias%26aufirst%3DK.%2BS.%26aulast%3DViegas%26aufirst%3DC.%26atitle%3DMolecular%2520hybridization%2520as%2520a%2520tool%2520in%2520the%2520design%2520of%2520multi-target%2520directed%2520drug%2520candidates%2520for%2520neurodegenerative%2520diseases%26jtitle%3DCurr.%2520Neuropharmacol.%26date%3D2020%26volume%3D18%26spage%3D348%26epage%3D407%26doi%3D10.2174%2F1385272823666191021124443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gandini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tedesco, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Gonzalez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roca, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campillo, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaldivar-Diez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuccheri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feoli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castellano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petralla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moda, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Legname, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognesi, M. L.</span></span> <span> </span><span class="NLM_article-title">Tau-centric multitarget approach for Alzheimer’s disease: Development of first-in-class dual glycogen synthase kinase 3β and tau-aggregation inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">7640</span>– <span class="NLM_lpage">7656</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00610</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00610" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVChu7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=7640-7656&author=A.+Gandiniauthor=M.+Bartoliniauthor=D.+Tedescoauthor=L.+Martinez-Gonzalezauthor=C.+Rocaauthor=N.+E.+Campilloauthor=J.+Zaldivar-Diezauthor=C.+Perezauthor=G.+Zuccheriauthor=A.+Mitiauthor=A.+Feoliauthor=S.+Castellanoauthor=S.+Petrallaauthor=B.+Montiauthor=M.+Rossiauthor=F.+Modaauthor=G.+Legnameauthor=A.+Martinezauthor=M.+L.+Bolognesi&title=Tau-centric+multitarget+approach+for+Alzheimer%E2%80%99s+disease%3A+Development+of+first-in-class+dual+glycogen+synthase+kinase+3%CE%B2+and+tau-aggregation+inhibitors&doi=10.1021%2Facs.jmedchem.8b00610"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6eR"><div class="casContent"><span class="casTitleNuber">6e</span><div class="casTitle"><span class="NLM_cas:atitle">Tau-Centric Multitarget Approach for Alzheimer's Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors</span></div><div class="casAuthors">Gandini, Annachiara; Bartolini, Manuela; Tedesco, Daniele; Martinez-Gonzalez, Loreto; Roca, Carlos; Campillo, Nuria E.; Zaldivar-Diez, Josefa; Perez, Concepcion; Zuccheri, Giampaolo; Miti, Andrea; Feoli, Alessandra; Castellano, Sabrina; Petralla, Sabrina; Monti, Barbara; Rossi, Martina; Moda, Fabio; Legname, Giuseppe; Martinez, Ana; Bolognesi, Maria Laura</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7640-7656</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Several findings propose the altered tau protein network as an important target for Alzheimer's disease (AD).  Particularly, two points of pharmacol. intervention can be envisaged: inhibition of phosphorylating tau kinase GSK-3β and tau aggregation process.  On the basis of this consideration and on the authors' interest in multitarget paradigms in AD, the authors report on the discovery of 2,4-thiazolidinedione derivs. endowed with such a profile. 28 and 30 displayed micromolar IC50 values toward GSK-3β, together with the capacity of inhibiting AcPHF6 aggregation of 60% and 80% at 10 μM, resp.  In addn., they showed PAMPA-BBB permeability, together with a suitable cellular safety profile. 30 also displayed inhibition of both K18 and full-length tau aggregations.  Finally, both compds. were able to improve cell viability in an okadaic acid-induced neurodegeneration cell model.  To the best of the authors' knowledge, 28 and 30 are the first balanced, nontoxic, dual-acting compds. hitting tau cascade at two different hubs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6bQV6XoAhyrVg90H21EOLACvtfcHk0lhy6P_DnHJx4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVChu7%252FL&md5=34b7e2f2556f3e96c768dd87fb3f0e6d</span></div><a href="/servlet/linkout?suffix=cit6e&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00610%26sid%3Dliteratum%253Aachs%26aulast%3DGandini%26aufirst%3DA.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DTedesco%26aufirst%3DD.%26aulast%3DMartinez-Gonzalez%26aufirst%3DL.%26aulast%3DRoca%26aufirst%3DC.%26aulast%3DCampillo%26aufirst%3DN.%2BE.%26aulast%3DZaldivar-Diez%26aufirst%3DJ.%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DZuccheri%26aufirst%3DG.%26aulast%3DMiti%26aufirst%3DA.%26aulast%3DFeoli%26aufirst%3DA.%26aulast%3DCastellano%26aufirst%3DS.%26aulast%3DPetralla%26aufirst%3DS.%26aulast%3DMonti%26aufirst%3DB.%26aulast%3DRossi%26aufirst%3DM.%26aulast%3DModa%26aufirst%3DF.%26aulast%3DLegname%26aufirst%3DG.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26atitle%3DTau-centric%2520multitarget%2520approach%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Development%2520of%2520first-in-class%2520dual%2520glycogen%2520synthase%2520kinase%25203%25CE%25B2%2520and%2520tau-aggregation%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D7640%26epage%3D7656%26doi%3D10.1021%2Facs.jmedchem.8b00610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ran, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James Chou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span> <span> </span><span class="NLM_article-title">Tacrine-hydroxamate derivatives as multitarget-directed ligands for the treatment of Alzheimer’s disease: design, synthesis, and biological evaluation</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>98</i></span>, <span class="NLM_elocation-id">103721</span> <span class="refDoi"> DOI: 10.1016/j.bioorg.2020.103721</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2Fj.bioorg.2020.103721" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=32193030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BB3cXlt1eltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2020&author=A.+Xuauthor=F.+Heauthor=X.+Zhangauthor=X.+Liauthor=Y.+Ranauthor=C.+Weiauthor=C.+James+Chouauthor=R.+Zhangauthor=J.+Wu&title=Tacrine-hydroxamate+derivatives+as+multitarget-directed+ligands+for+the+treatment+of+Alzheimer%E2%80%99s+disease%3A+design%2C+synthesis%2C+and+biological+evaluation&doi=10.1016%2Fj.bioorg.2020.103721"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Tacrine-hydroxamate derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation</span></div><div class="casAuthors">Xu, Ana; He, Feng; Zhang, Xiangna; Li, Xiaoyang; Ran, Yingying; Wei, Chao; James Chou, C.; Zhang, Rui; Wu, Jingde</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103721</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In order to develop multitarget-directed ligands as potential treatments for Alzheimer's disease, twenty-eight new tacrine-hydroxamate derivs. were designed, synthesized, and biol. evaluated.  As expected, most of the compds. exhibited inhibitory activities against cholinesterases (ChEs) and histone deacetylase (HDACs).  Among the tested compds., I showed not only potent and selective inhibition on AChE at sub-nanomolar potency (AChEIC50 = 0.12 nM, BChEIC50 = 361.52 nM) but also potent inhibition on HDAC (IC50 = 0.23 nM).  Moreover, I exhibited inhibitory activity on Aβ1-42 self-aggregation as well as disaggregation activity on pre-formed Aβ fibrils.  Furthermore, I exhibited antioxidant activity and metal chelating properties.  Further mechanistic studies demonstrated that I is a pan-inhibitor of HDACs and a mixed-type inhibitor for AChE.  It was shown that I is a BBB penetrant by online prediction.  Taken together, the results indicate that I can serve as a lead compd. to develop promising candidate analogs as AD therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLE3wLayb4i7Vg90H21EOLACvtfcHk0lhy6P_DnHJx4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXlt1eltLw%253D&md5=e2b820af806ce7651f90fc66d4a1f1cb</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2020.103721&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2020.103721%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DA.%26aulast%3DHe%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DRan%26aufirst%3DY.%26aulast%3DWei%26aufirst%3DC.%26aulast%3DJames%2BChou%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DJ.%26atitle%3DTacrine-hydroxamate%2520derivatives%2520as%2520multitarget-directed%2520ligands%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520design%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%26jtitle%3DBioorg.%2520Chem.%26date%3D2020%26volume%3D98%26doi%3D10.1016%2Fj.bioorg.2020.103721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Duarte, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutiérrez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adasme-Carreño, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Gutierrez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alzate-Morales, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santana, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uriarte, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Álvarez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matos, M. J.</span></span> <span> </span><span class="NLM_article-title">Novel coumarin-quinoline hybrids: design of multitarget compounds for Alzheimer’s disease</span>. <i>ChemistrySelect</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">551</span>– <span class="NLM_lpage">558</span>, <span class="refDoi"> DOI: 10.1002/slct.201803222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1002%2Fslct.201803222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVOgtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2019&pages=551-558&author=Y.+Duarteauthor=A.+Fonsecaauthor=M.+Guti%C3%A9rrezauthor=F.+Adasme-Carre%C3%B1oauthor=C.+Mu%C3%B1oz-Gutierrezauthor=J.+Alzate-Moralesauthor=L.+Santanaauthor=E.+Uriarteauthor=R.+%C3%81lvarezauthor=M.+J.+Matos&title=Novel+coumarin-quinoline+hybrids%3A+design+of+multitarget+compounds+for+Alzheimer%E2%80%99s+disease&doi=10.1002%2Fslct.201803222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Coumarin-Quinoline Hybrids: Design of Multitarget Compounds for Alzheimer's Disease</span></div><div class="casAuthors">Duarte, Yorley; Fonseca, Andre; Gutierrez, Margarita; Adasme-Carreno, Francisco; Munoz-Gutierrez, Camila; Alzate-Morales, Jans; Santana, Lourdes; Uriarte, Eugenio; Alvarez, Rocio; Matos, Maria Joao</div><div class="citationInfo"><span class="NLM_cas:title">ChemistrySelect</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">551-558</span>CODEN:
                <span class="NLM_cas:coden">CHEMUD</span>;
        ISSN:<span class="NLM_cas:issn">2365-6549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is the most prevalent neurodegenerative disease, presenting the most devastating consequences on human health and life quality.  Coumarin-quinoline hybrids were synthesized following a very efficient and versatile strategy.  Small structural variations contributed to dual acetyl/butyrylcholinesterases (AChE/BuChE) activity or selectivity towards one of these enzymes.  In addn., some of the studied compds. are interesting iron chelators, presenting a tendency to be neuroprotective.  Moreover, the compds. are not cytotoxic for SH-SY5Y neuroblastoma cells.  Compd. 9c proved to be the most interesting compd. of the studied series.  This compd. is selective against AChE and proved to be an excellent iron chelating agent (iron chelation at 100 μM=72.87%).  Mol. docking studies were performed to establish the nature of the interaction between the studied compds. and the binding pockets, leading to a rationalization of structure-activity relationships.  Compd. 9c forms a well-defined π-stacking interaction with Phe330 and interacts with Tyr121 residue via a hydrogen bond, while the inactive compds. cannot establish these interactions.  Important preliminary results against different targets, as well as some structure-activity relationships, were concluded from the exptl. results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpO_EBmjZxDfbVg90H21EOLACvtfcHk0ljgKy-xdNHnlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVOgtbw%253D&md5=299c5cfca47a068c32fe204044cc31bd</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1002%2Fslct.201803222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fslct.201803222%26sid%3Dliteratum%253Aachs%26aulast%3DDuarte%26aufirst%3DY.%26aulast%3DFonseca%26aufirst%3DA.%26aulast%3DGuti%25C3%25A9rrez%26aufirst%3DM.%26aulast%3DAdasme-Carre%25C3%25B1o%26aufirst%3DF.%26aulast%3DMu%25C3%25B1oz-Gutierrez%26aufirst%3DC.%26aulast%3DAlzate-Morales%26aufirst%3DJ.%26aulast%3DSantana%26aufirst%3DL.%26aulast%3DUriarte%26aufirst%3DE.%26aulast%3D%25C3%2581lvarez%26aufirst%3DR.%26aulast%3DMatos%26aufirst%3DM.%2BJ.%26atitle%3DNovel%2520coumarin-quinoline%2520hybrids%253A%2520design%2520of%2520multitarget%2520compounds%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DChemistrySelect%26date%3D2019%26volume%3D4%26spage%3D551%26epage%3D558%26doi%3D10.1002%2Fslct.201803222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span> <span> </span><span class="NLM_article-title">Multi-target design strategies for the improved treatment of Alzheimer’s disease</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>176</i></span>,  <span class="NLM_fpage">228</span>– <span class="NLM_lpage">247</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.05.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2Fj.ejmech.2019.05.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=31103902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1MXpvVGnsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2019&pages=228-247&author=P.+Zhangauthor=S.+Xuauthor=Z.+Zhuauthor=J.+Xu&title=Multi-target+design+strategies+for+the+improved+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2019.05.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target design strategies for the improved treatment of Alzheimer's disease</span></div><div class="casAuthors">Zhang, Pengfei; Xu, Shengtao; Zhu, Zheying; Xu, Jinyi</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">228-247</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a multifactorial syndrome resulting in profound misery and poses a substantial burden on human health, economy, and society throughout the world.  Based on the numerous AD-related targets in the disease network, multi-target design strategy is a crucial direction to seek for enhanced therapy, and multi-target drugs have the ability to regulate more targets than single-target drugs, affecting the disease network with more potency.  Herein, we highlight nine major targets assocd. with AD, which are acetylcholine esterase (AChE), beta-site amyloid precursor protein cleaving enzyme 1 (β-secretase, BACE-1), glycogen synthase kinase 3 beta (GSK-3β), monoamine oxidases (MAOs), metal ions in the brain, N-methyl-D-aspartate (NMDA) receptor, 5-hydroxytryptamine (5-HT) receptors, the third subtype of histamine receptor (H3 receptor), and phosphodiesterases (PDEs), and their resp. relationship to the disease network.  Furthermore, eleven multi-target design strategies classified by the involvement of AChE and related promising compds. for improved therapy of AD in recent years are described based on the nine major targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRXynXSn84-bVg90H21EOLACvtfcHk0ljgKy-xdNHnlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXpvVGnsb8%253D&md5=86555914b4ef65fae2d38caedb87f1aa</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.05.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.05.020%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DJ.%26atitle%3DMulti-target%2520design%2520strategies%2520for%2520the%2520improved%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D176%26spage%3D228%26epage%3D247%26doi%3D10.1016%2Fj.ejmech.2019.05.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lalut, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karila, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecoutey, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nachon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sussman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dallemagne, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rochais, C.</span></span> <span> </span><span class="NLM_article-title">Novel multitarget-directed ligands targeting acetylcholinesterase and σ1 receptors as lead compounds for treatment of Alzheimer’s disease: synthesis, evaluation, and structural characterization of their complexes with acetylcholinesterase</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>162</i></span>,  <span class="NLM_fpage">234</span>– <span class="NLM_lpage">248</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.10.064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2Fj.ejmech.2018.10.064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=30447434" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1ChsbjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=2019&pages=234-248&author=J.+Lalutauthor=G.+Santoniauthor=D.+Karilaauthor=C.+Lecouteyauthor=A.+Davisauthor=F.+Nachonauthor=I.+Silmanauthor=J.+Sussmanauthor=M.+Weikauthor=T.+Mauriceauthor=P.+Dallemagneauthor=C.+Rochais&title=Novel+multitarget-directed+ligands+targeting+acetylcholinesterase+and+%CF%831+receptors+as+lead+compounds+for+treatment+of+Alzheimer%E2%80%99s+disease%3A+synthesis%2C+evaluation%2C+and+structural+characterization+of+their+complexes+with+acetylcholinesterase&doi=10.1016%2Fj.ejmech.2018.10.064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7dR"><div class="casContent"><span class="casTitleNuber">7d</span><div class="casTitle"><span class="NLM_cas:atitle">Novel multitarget-directed ligands targeting acetylcholinesterase and σ1 receptors as lead compounds for treatment of Alzheimer's disease: Synthesis, evaluation, and structural characterization of their complexes with acetylcholinesterase</span></div><div class="casAuthors">Lalut, Julien; Santoni, Gianluca; Karila, Delphine; Lecoutey, Cedric; Davis, Audrey; Nachon, Florian; Silman, Israel; Sussman, Joel; Weik, Martin; Maurice, Tangui; Dallemagne, Patrick; Rochais, Christophe</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">162</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">234-248</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Pleiotropic intervention may be a requirement for effective limitation of the progression of multifactorial diseases such as Alzheimer's disease.  One approach to such intervention is to design a single chem. entity capable of acting on two or more targets of interest, which are accordingly known as multi-target directed ligands (MTDLs).  We recently described donecopride, the first MTDL able to simultaneously inhibit acetylcholinesterase and act as an agonist of the 5-HT4 receptor, which displays promising activities in vivo.  Pharmacomodulation of donecopride allowed us to develop a novel series of indole derivs. possessing interesting in vitro activities toward AChE and the σ1 receptor.  The crystal structures of complexes of the most promising compds. with Torpedo californica AChE were solved in order to further understand their mode of inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrp9tmUk8w_j7Vg90H21EOLACvtfcHk0ljgKy-xdNHnlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1ChsbjF&md5=79dec73e1bf82d5d1b893a81366ea5ef</span></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.10.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.10.064%26sid%3Dliteratum%253Aachs%26aulast%3DLalut%26aufirst%3DJ.%26aulast%3DSantoni%26aufirst%3DG.%26aulast%3DKarila%26aufirst%3DD.%26aulast%3DLecoutey%26aufirst%3DC.%26aulast%3DDavis%26aufirst%3DA.%26aulast%3DNachon%26aufirst%3DF.%26aulast%3DSilman%26aufirst%3DI.%26aulast%3DSussman%26aufirst%3DJ.%26aulast%3DWeik%26aufirst%3DM.%26aulast%3DMaurice%26aufirst%3DT.%26aulast%3DDallemagne%26aufirst%3DP.%26aulast%3DRochais%26aufirst%3DC.%26atitle%3DNovel%2520multitarget-directed%2520ligands%2520targeting%2520acetylcholinesterase%2520and%2520%25CF%25831%2520receptors%2520as%2520lead%2520compounds%2520for%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520synthesis%252C%2520evaluation%252C%2520and%2520structural%2520characterization%2520of%2520their%2520complexes%2520with%2520acetylcholinesterase%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D162%26spage%3D234%26epage%3D248%26doi%3D10.1016%2Fj.ejmech.2018.10.064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pisani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iacobazzi, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rullo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farina, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denora, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cellamare, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altomare, C. D.</span></span> <span> </span><span class="NLM_article-title">Investigating alkyl nitrates as nitric oxide releasing precursors of multitarget acetylcholinesterase-monoamine oxidase B inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>161</i></span>,  <span class="NLM_fpage">292</span>– <span class="NLM_lpage">309</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.10.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2Fj.ejmech.2018.10.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=30366255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVSlsLvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2019&pages=292-309&author=L.+Pisaniauthor=R.+M.+Iacobazziauthor=M.+Cattoauthor=M.+Rulloauthor=R.+Farinaauthor=N.+Denoraauthor=S.+Cellamareauthor=C.+D.+Altomare&title=Investigating+alkyl+nitrates+as+nitric+oxide+releasing+precursors+of+multitarget+acetylcholinesterase-monoamine+oxidase+B+inhibitors&doi=10.1016%2Fj.ejmech.2018.10.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7eR"><div class="casContent"><span class="casTitleNuber">7e</span><div class="casTitle"><span class="NLM_cas:atitle">Investigating alkyl nitrates as nitric oxide releasing precursors of multitarget acetylcholinesterase-monoamine oxidase B inhibitors</span></div><div class="casAuthors">Pisani, Leonardo; Iacobazzi, Rosa Maria; Catto, Marco; Rullo, Mariagrazia; Farina, Roberta; Denora, Nunzio; Cellamare, Saverio; Altomare, Cosimo Damiano</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">292-309</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Herein we envisaged the possibility of exploiting alkyl nitrates as precursors of alc.-bearing dual inhibitors targeting acetylcholinesterase (AChE) and monoamine oxidase B (MAO B), key enzymes in neurodegenerative syndromes such as Alzheimer's disease (AD), through biotransformation unmasking an alc. function upon nitric oxide (NO) release.  The cooperation to neuroprotection of low fluxes of NO and target enzymes' inhibition by the alc. metabolites might return a multitargeting effect.  The in vitro screening towards ChEs and MAOs of a collection of 21 primary alcs. disclosed a subset of dual inhibitors, among which three diverse chemotypes were selected to study the corresponding nitrates.  Nitrate 14 proved to be a brain permeant, potent AChE-MAO B inhibitor by itself.  Moreover, it protected human SH-SY5Y lines against rotenone and hydrogen peroxide with a poor inherent cytotoxicity and showed a slow conversion profile to its alc. metabolite 9d that still behaved as bimodal and neuroprotective mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1S4JAn66ncbVg90H21EOLACvtfcHk0liKBLDRBWgp1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVSlsLvK&md5=67fbdaa172ec319a6c4223df42c6e9f5</span></div><a href="/servlet/linkout?suffix=cit7e&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.10.016%26sid%3Dliteratum%253Aachs%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DIacobazzi%26aufirst%3DR.%2BM.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DRullo%26aufirst%3DM.%26aulast%3DFarina%26aufirst%3DR.%26aulast%3DDenora%26aufirst%3DN.%26aulast%3DCellamare%26aufirst%3DS.%26aulast%3DAltomare%26aufirst%3DC.%2BD.%26atitle%3DInvestigating%2520alkyl%2520nitrates%2520as%2520nitric%2520oxide%2520releasing%2520precursors%2520of%2520multitarget%2520acetylcholinesterase-monoamine%2520oxidase%2520B%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D161%26spage%3D292%26epage%3D309%26doi%3D10.1016%2Fj.ejmech.2018.10.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mezeiova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chalupova, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nepovimova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorecki, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prchal, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malinak, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuca, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soukup, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korabecny, J.</span></span> <span> </span><span class="NLM_article-title">Donepezil derivatives targeting amyloid-β cascade in Alzheimer’s disease</span>. <i>Curr. Alzheimer Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">772</span>– <span class="NLM_lpage">800</span>, <span class="refDoi"> DOI: 10.2174/1567205016666190228122956</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.2174%2F1567205016666190228122956" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=30819078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitVymtLnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2019&pages=772-800&author=E.+Mezeiovaauthor=K.+Chalupovaauthor=E.+Nepovimovaauthor=L.+Goreckiauthor=L.+Prchalauthor=D.+Malinakauthor=K.+Kucaauthor=O.+Soukupauthor=J.+Korabecny&title=Donepezil+derivatives+targeting+amyloid-%CE%B2+cascade+in+Alzheimer%E2%80%99s+disease&doi=10.2174%2F1567205016666190228122956"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7fR"><div class="casContent"><span class="casTitleNuber">7f</span><div class="casTitle"><span class="NLM_cas:atitle">Donepezil Derivatives Targeting Amyloid-β Cascade in Alzheimer's Disease</span></div><div class="casAuthors">Mezeiova, Eva; Chalupova, Katarina; Nepovimova, Eugenie; Gorecki, Lukas; Prchal, Lukas; Malinak, David; Kuca, Kamil; Soukup, Ondrej; Korabecny, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">772-800</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's Disease (AD) is a neurodegenerative disorder with an increasing impact on society.  Because currently available therapy has only a short-term effect, a huge no. of novel compds. are developed every year exploiting knowledge of the various aspects of AD pathophysiol.  To better address the pathol. complexity of AD, one of the most extensively pursued strategies by medicinal chemists is based on Multi-target-directed Ligands (MTDLs).  Donepezil is one of the currently approved drugs for AD therapy acting as an acetylcholinesterase inhibitor.  In this review, we have made an extensive literature survey focusing on donepezil-derived MTDL hybrids primarily targeting on different levels cholinesterases and amyloid beta (Aβ) peptide.  The targeting includes direct interaction of the compds. with Aβ, AChE-induced Aβ aggregation, inhibition of BACE-1 enzyme, and modulation of biometal balance thus impeding Aβ assembly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLMwWvPdLefLVg90H21EOLACvtfcHk0liKBLDRBWgp1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitVymtLnM&md5=c4c83de08738d56bafeb9224d6d5f9e8</span></div><a href="/servlet/linkout?suffix=cit7f&amp;dbid=16384&amp;doi=10.2174%2F1567205016666190228122956&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1567205016666190228122956%26sid%3Dliteratum%253Aachs%26aulast%3DMezeiova%26aufirst%3DE.%26aulast%3DChalupova%26aufirst%3DK.%26aulast%3DNepovimova%26aufirst%3DE.%26aulast%3DGorecki%26aufirst%3DL.%26aulast%3DPrchal%26aufirst%3DL.%26aulast%3DMalinak%26aufirst%3DD.%26aulast%3DKuca%26aufirst%3DK.%26aulast%3DSoukup%26aufirst%3DO.%26aulast%3DKorabecny%26aufirst%3DJ.%26atitle%3DDonepezil%2520derivatives%2520targeting%2520amyloid-%25CE%25B2%2520cascade%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2019%26volume%3D16%26spage%3D772%26epage%3D800%26doi%3D10.2174%2F1567205016666190228122956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Areales, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turcu, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barniol-Xicota, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pont, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pivetta, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espargaró, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Simone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrisano, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabate, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sureda, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vázquez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span> <span> </span><span class="NLM_article-title">A novel class of multitarget anti-Alzheimer benzohomoadamantane–chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>180</i></span>,  <span class="NLM_fpage">613</span>– <span class="NLM_lpage">626</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.07.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2Fj.ejmech.2019.07.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=31351393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsVGrsbfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2019&pages=613-626&author=F.+J.+P%C3%A9rez-Arealesauthor=A.+L.+Turcuauthor=M.+Barniol-Xicotaauthor=C.+Pontauthor=D.+Pivettaauthor=A.+Espargar%C3%B3author=M.+Bartoliniauthor=A.+De+Simoneauthor=V.+Andrisanoauthor=B.+P%C3%A9rezauthor=R.+Sabateauthor=F.+X.+Suredaauthor=S.+V%C3%A1zquezauthor=D.+Mu%C3%B1oz-Torrero&title=A+novel+class+of+multitarget+anti-Alzheimer+benzohomoadamantane%E2%80%93chlorotacrine+hybrids+modulating+cholinesterases+and+glutamate+NMDA+receptors&doi=10.1016%2Fj.ejmech.2019.07.051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7gR"><div class="casContent"><span class="casTitleNuber">7g</span><div class="casTitle"><span class="NLM_cas:atitle">A novel class of multitarget anti-Alzheimer benzohomoadamantane-chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors</span></div><div class="casAuthors">Perez-Areales, F. Javier; Turcu, Andreea L.; Barniol-Xicota, Marta; Pont, Caterina; Pivetta, Deborah; Espargaro, Alba; Bartolini, Manuela; De Simone, Angela; Andrisano, Vincenza; Perez, Belen; Sabate, Raimon; Sureda, Francesc X.; Vazquez, Santiago; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">613-626</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The development of multitarget compds. against multifactorial diseases, such as Alzheimer's disease, is an area of very intensive research, due to the expected superior therapeutic efficacy that should arise from the simultaneous modulation of several key targets of the complex pathol. network.  Here we describe the synthesis and multitarget biol. profiling of a new class of compds. designed by mol. hybridization of an NMDA receptor antagonist fluorobenzohomoadamantanamine with the potent acetylcholinesterase (AChE) inhibitor 6-chlorotacrine, using two different linker lengths and linkage positions, to preserve or not the memantine-like polycyclic unsubstituted primary amine.  The best hybrids, e.g., I, exhibit greater potencies than parent compds. against AChE (IC50 0.33 nM in the best case, 44-fold increased potency over 6-chlorotacrine), butyrylcholinesterase (IC50 21 nM in the best case, 24-fold increased potency over 6-chlorotacrine), and NMDA receptors (IC50 0.89 μM in the best case, 2-fold increased potency over the parent benzohomoadamantanamine and memantine), which suggests an additive effect of both pharmacophoric moieties in the interaction with the primary targets.  Moreover, most of these compds. have been predicted to be brain permeable.  This set of biol. properties makes them promising leads for further anti-Alzheimer drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQXvbwMzIWJbVg90H21EOLACvtfcHk0liKBLDRBWgp1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsVGrsbfP&md5=676e6005d48fa5fdc44a967801d79ca0</span></div><a href="/servlet/linkout?suffix=cit7g&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.07.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.07.051%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A9rez-Areales%26aufirst%3DF.%2BJ.%26aulast%3DTurcu%26aufirst%3DA.%2BL.%26aulast%3DBarniol-Xicota%26aufirst%3DM.%26aulast%3DPont%26aufirst%3DC.%26aulast%3DPivetta%26aufirst%3DD.%26aulast%3DEspargar%25C3%25B3%26aufirst%3DA.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DP%25C3%25A9rez%26aufirst%3DB.%26aulast%3DSabate%26aufirst%3DR.%26aulast%3DSureda%26aufirst%3DF.%2BX.%26aulast%3DV%25C3%25A1zquez%26aufirst%3DS.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DA%2520novel%2520class%2520of%2520multitarget%2520anti-Alzheimer%2520benzohomoadamantane%25E2%2580%2593chlorotacrine%2520hybrids%2520modulating%2520cholinesterases%2520and%2520glutamate%2520NMDA%2520receptors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D180%26spage%3D613%26epage%3D626%26doi%3D10.1016%2Fj.ejmech.2019.07.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Domenico, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barone, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perluigi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butterfield, D. A.</span></span> <span> </span><span class="NLM_article-title">Strategy to reduce free radical species in Alzheimer’s disease: an update of selected antioxidants</span>. <i>Expert Rev. Neurother.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1586/14737175.2015.955853</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1586%2F14737175.2015.955853" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=25243342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsFChuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=19-40&author=F.+Di%0ADomenicoauthor=E.+Baroneauthor=M.+Perluigiauthor=D.+A.+Butterfield&title=Strategy+to+reduce+free+radical+species+in+Alzheimer%E2%80%99s+disease%3A+an+update+of+selected+antioxidants&doi=10.1586%2F14737175.2015.955853"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Strategy to reduce free radical species in Alzheimer's disease: an update of selected antioxidants</span></div><div class="casAuthors">Di Domenico, Fabio; Barone, Eugenio; Perluigi, Marzia; Butterfield, D. Allan</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Neurotherapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-40</span>CODEN:
                <span class="NLM_cas:coden">ERNXAR</span>;
        ISSN:<span class="NLM_cas:issn">1473-7175</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD), characterized by progressive loss of memory, language, reasoning and other cognitive functions, including dementia, is characterized pathol. by the presence of senile plaques, neurofibrillary tangles and synapse loss.  Increased oxidative/nitrosative stress, decreased antioxidants, mitochondrial damage and other factors play major roles in the development and progression of AD.  Strategies to reduce pro-oxidant species to ameliorate AD pathol. have been proposed with mixed results.  In this review, the authors focus on the most recent in vitro and in vivo antioxidant approaches for removing oxidant species with relevance to AD, including N-acetyl-l-cysteine, vitamin D, vitamin E, ferulic acid, tricyclodecan-9-yl-xanthogenate, selenium and melatonin as therapeutic stratagems in AD management.  In addn., the authors reviewed the most effective mitochondria targeted antioxidants such as coenzyme Q10 and lipoic acid.  The authors suggest the use of multitargeted approaches by formulas contg. one or more antioxidant compds. may be more promising than single-agent approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF8woGMiCOhbVg90H21EOLACvtfcHk0ljjVZbOkbDuiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsFChuw%253D%253D&md5=76d9f5344f84fb79e37c0b118145ae32</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1586%2F14737175.2015.955853&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737175.2015.955853%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BDomenico%26aufirst%3DF.%26aulast%3DBarone%26aufirst%3DE.%26aulast%3DPerluigi%26aufirst%3DM.%26aulast%3DButterfield%26aufirst%3DD.%2BA.%26atitle%3DStrategy%2520to%2520reduce%2520free%2520radical%2520species%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520an%2520update%2520of%2520selected%2520antioxidants%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2015%26volume%3D15%26spage%3D19%26epage%3D40%26doi%3D10.1586%2F14737175.2015.955853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Rosini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simoni, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minarini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melchiorre, C.</span></span> <span> </span><span class="NLM_article-title">Oxidative stress in Alzheimer’s disease: are we connecting the dots?</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">2821</span>– <span class="NLM_lpage">2831</span>, <span class="refDoi"> DOI: 10.1021/jm400970m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400970m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1ejt7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2821-2831&author=M.+Rosiniauthor=E.+Simoniauthor=A.+Milelliauthor=A.+Minariniauthor=C.+Melchiorre&title=Oxidative+stress+in+Alzheimer%E2%80%99s+disease%3A+are+we+connecting+the+dots%3F&doi=10.1021%2Fjm400970m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative Stress in Alzheimer's Disease: Are We Connecting the Dots?</span></div><div class="casAuthors">Rosini, Michela; Simoni, Elena; Milelli, Andrea; Minarini, Anna; Melchiorre, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2821-2831</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Redox impairment is a prominent feature of Alzheimer's disease (AD).  It has led to the "oxidative stress hypothesis", which proposes antioxidants as beneficial therapeutic tools in AD treatment.  To date, a wide variety of antioxidants have been examd. as neuroprotectants.  However, success has been elusive in clin. trials.  Several factors have contributed to this failure, including the complexity of the redox system in vivo.  Potentially crit. aspects include the fine-tuned equil. between antioxidant defenses and free radical prodn., the lack of specific antioxidant target(s), and the inherent difficulty in delivering antioxidants where they are needed.  Herein, the authors highlight significant progress in the field.  Future directions of antioxidant research are also presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonuV4RR1IRPLVg90H21EOLACvtfcHk0ljjVZbOkbDuiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1ejt7fM&md5=907927f3b3b6d6bcb1402fedf6080e35</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1021%2Fjm400970m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400970m%26sid%3Dliteratum%253Aachs%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DSimoni%26aufirst%3DE.%26aulast%3DMilelli%26aufirst%3DA.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DOxidative%2520stress%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520are%2520we%2520connecting%2520the%2520dots%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2821%26epage%3D2831%26doi%3D10.1021%2Fjm400970m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">von
Bernhardi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eugenín, J.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s disease: redox dysregulation as a common denominator for diverse pathogenic mechanisms</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">974</span>– <span class="NLM_lpage">1031</span>, <span class="refDoi"> DOI: 10.1089/ars.2011.4082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1089%2Fars.2011.4082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=22122400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1Witr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2012&pages=974-1031&author=R.+von%0ABernhardiauthor=J.+Eugen%C3%ADn&title=Alzheimer%E2%80%99s+disease%3A+redox+dysregulation+as+a+common+denominator+for+diverse+pathogenic+mechanisms&doi=10.1089%2Fars.2011.4082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's Disease: Redox Dysregulation As a Common Denominator for Diverse Pathogenic Mechanisms</span></div><div class="casAuthors">von Bernhardi, Rommy; Eugenin, Jaime</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">974-1031</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is the most common cause of dementia and a progressive neurodegeneration that appears to result from multiple pathogenic mechanisms (including protein misfolding/aggregation, involved in both amyloid β-dependent senile plaques and tau-dependent neurofibrillary tangles), metabolic and mitochondrial dysfunction, excitoxicity, calcium handling impairment, glial cell dysfunction, neuroinflammation, and oxidative stress.  Oxidative stress, which could be secondary to several of the other pathophysiol. mechanisms, appears to be a major determinant of the pathogenesis and progression of AD.  The identification of oxidized proteins common for mild cognitive impairment and AD suggests that key oxidn. pathways are triggered early and are involved in the initial progression of the neurodegenerative process.  Abundant data support that oxidative stress, also considered as a main factor for aging, the major risk factor for AD, can be a common key element capable of articulating the divergent nature of the proposed pathogenic factors.  Pathogenic mechanisms influence each other at different levels.  Evidence suggests that it will be difficult to define a single-target therapy resulting in the arrest of progression or the improvement of AD deterioration.  Since oxidative stress is present from early stages of disease, it appears as one of the main targets to be included in a clin. trial.  Exploring the articulation of AD pathogenic mechanisms by oxidative stress will provide clues for better understanding the pathogenesis and progression of this dementing disorder and for the development of effective therapies to treat this disease.  Antioxid. Redox Signal. 16, 974-1031.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpryYzkfbRDM7Vg90H21EOLACvtfcHk0ljjVZbOkbDuiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1Witr8%253D&md5=185ff14a3d3192a5a1ef186bf5ad3385</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1089%2Fars.2011.4082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2011.4082%26sid%3Dliteratum%253Aachs%26aulast%3Dvon%2BBernhardi%26aufirst%3DR.%26aulast%3DEugen%25C3%25ADn%26aufirst%3DJ.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520redox%2520dysregulation%2520as%2520a%2520common%2520denominator%2520for%2520diverse%2520pathogenic%2520mechanisms%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2012%26volume%3D16%26spage%3D974%26epage%3D1031%26doi%3D10.1089%2Fars.2011.4082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mecocci, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polidori, M. C.</span></span> <span> </span><span class="NLM_article-title">Antioxidant clinical trials in mild cognitive impairment and Alzheimer’s disease</span>. <i>Biochim. Biophys. Acta, Mol. Basis Dis.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>1822</i></span>,  <span class="NLM_fpage">631</span>– <span class="NLM_lpage">638</span>, <span class="refDoi"> DOI: 10.1016/j.bbadis.2011.10.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2Fj.bbadis.2011.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=22019723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1GrtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1822&publication_year=2012&pages=631-638&author=P.+Mecocciauthor=M.+C.+Polidori&title=Antioxidant+clinical+trials+in+mild+cognitive+impairment+and+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bbadis.2011.10.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease</span></div><div class="casAuthors">Mecocci, Patrizia; Polidori, Maria Cristina</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">1822</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">631-638</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a highly disabling progressive neurodegenerative disorder characterized by a steadily growing no. of patients, by the absence of a cure for the disease and by great difficulties in diagnosing in the preclin. phase.  Progresses in defining the complex etiopathogenesis of AD consider oxidative stress a core aspect as far as both AD onset and progression are concerned.  However, clin. trials of antioxidants in AD have brought conflicting conclusions.  In this review, we report the main results of clin. trials with antioxidants in mild cognitive impairment (MCI) and AD.  Although available data do not warrant the doubtless use of antioxidants in AD, they are characterized by extremely poor comparability and the absence of a substantial clin. benefit of antioxidants in AD is not disproved to date.  Furthermore, the role of vascular damage that contributes to oxidative stress in AD should be addressed in testing antioxidant treatments.  This article is part of a Special Issue entitled: Antioxidants and Antioxidant Treatment in Disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCzulb0gczwrVg90H21EOLACvtfcHk0ljibbNAqxQ32g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1GrtbY%253D&md5=516667c4e9e8840318acc5f92cf325a6</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.bbadis.2011.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbadis.2011.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DMecocci%26aufirst%3DP.%26aulast%3DPolidori%26aufirst%3DM.%2BC.%26atitle%3DAntioxidant%2520clinical%2520trials%2520in%2520mild%2520cognitive%2520impairment%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D2012%26volume%3D1822%26spage%3D631%26epage%3D638%26doi%3D10.1016%2Fj.bbadis.2011.10.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kukreti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saso, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kukreti, S.</span></span> <span> </span><span class="NLM_article-title">Oxidative stress: a key modulator in neurodegenerative diseases</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>24</i></span>, <span class="NLM_elocation-id">1583</span> <span class="refDoi"> DOI: 10.3390/molecules24081583</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.3390%2Fmolecules24081583" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1MXpslyhtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2019&author=A.+Singhauthor=R.+Kukretiauthor=L.+Sasoauthor=S.+Kukreti&title=Oxidative+stress%3A+a+key+modulator+in+neurodegenerative+diseases&doi=10.3390%2Fmolecules24081583"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress: a key modulator in neurodegenerative diseases</span></div><div class="casAuthors">Singh, Anju; Kukreti, Ritushree; Saso, Luciano; Kukreti, Shrikant</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1583</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Oxidative stress is proposed as a regulatory element in ageing and various neurol. disorders.  The excess of oxidants causes a redn. of antioxidants, which in turn produce an oxidn.-redn. imbalance in organisms.  Paucity of the antioxidant system generates oxidative-stress, characterized by elevated levels of reactive species (oxygen, hydroxyl free radical, and so on).  Mitochondria play a key role in ATP supply to cells via oxidative phosphorylation, as well as synthesis of essential biol. mols.  Various redox reactions catalyzed by enzymes take place in the oxidative phosphorylation process.  An inefficient oxidative phosphorylation may generate reactive oxygen species (ROS), leading to mitochondrial dysfunction.  Mitochondrial redox metab., phospholipid metab., and proteolytic pathways are found to be the major and potential source of free radicals.  A lower concn. of ROS is essential for normal cellular signaling, whereas the higher concn. and long-time exposure of ROS cause damage to cellular macromols. such as DNA, lipids and proteins, ultimately resulting in necrosis and apoptotic cell death.  Normal and proper functioning of the central nervous system (CNS) is entirely dependent on the chem. integrity of brain.  It is well established that the brain consumes a large amt. of oxygen and is highly rich in lipid content, becoming prone to oxidative stress.  A high consumption of oxygen leads to excessive prodn. of ROS.  Apart from this, the neuronal membranes are found to be rich in polyunsatd. fatty acids, which are highly susceptible to ROS.  Various neurodegenerative diseases such as Parkinson's disease (PD), Alzheimer's disease (AD), Huntington's disease (HD), and amyotrophic lateral sclerosis (ALS), among others, can be the result of biochem. alteration (due to oxidative stress) in bimol. components.  There is a need to understand the processes and role of oxidative stress in neurodegenerative diseases.  This review is an effort towards improving our understanding of the pivotal role played by OS in neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGEciNcg9o1bVg90H21EOLACvtfcHk0ljibbNAqxQ32g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXpslyhtLo%253D&md5=0ad3baa7ddcf0a81b3f22db5c51a2880</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.3390%2Fmolecules24081583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules24081583%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DA.%26aulast%3DKukreti%26aufirst%3DR.%26aulast%3DSaso%26aufirst%3DL.%26aulast%3DKukreti%26aufirst%3DS.%26atitle%3DOxidative%2520stress%253A%2520a%2520key%2520modulator%2520in%2520neurodegenerative%2520diseases%26jtitle%3DMolecules%26date%3D2019%26volume%3D24%26doi%3D10.3390%2Fmolecules24081583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Casas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorchs, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez-Baeza, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teixidor, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messeguer, A.</span></span> <span> </span><span class="NLM_article-title">Inhibition of rat liver microsomal lipid peroxidation elicited by simple 2,2-dimethylchromenes and chromans structurally related to precocenes</span>. <i>J. Agric. Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">585</span>– <span class="NLM_lpage">590</span>, <span class="refDoi"> DOI: 10.1021/jf00016a011</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jf00016a011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADyaK38XhvV2gsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1992&pages=585-590&author=J.+Casasauthor=G.+Gorchsauthor=F.+S%C3%A1nchez-Baezaauthor=P.+Teixidorauthor=A.+Messeguer&title=Inhibition+of+rat+liver+microsomal+lipid+peroxidation+elicited+by+simple+2%2C2-dimethylchromenes+and+chromans+structurally+related+to+precocenes&doi=10.1021%2Fjf00016a011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of rat liver microsomal lipid peroxidation elicited by simple 2,2-dimethylchromenes and chromans structurally related to precocenes</span></div><div class="casAuthors">Casas, Josefina; Gorchs, Gloria; Sanchez-Baeza, Francisco; Teixidor, Pilar; Messeguer, Angel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Agricultural and Food Chemistry</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">585-90</span>CODEN:
                <span class="NLM_cas:coden">JAFCAU</span>;
        ISSN:<span class="NLM_cas:issn">0021-8561</span>.
    </div><div class="casAbstract">The effects on rat liver microsomal lipid peroxidn. elicited by 2,2-dimethylchromenes and chromans structurally related to precocenes was investigated in NADPH-dependent incubations by using the thiobarbituric acid-reactive substances (TBARS) and oxygen uptake rate tests as evaluation methods.  Precocene II (I) exhibited an unexpected inhibitory activity on lipid peroxidn. (IC50 = 11.4 μM, TBARS prodn. test).  Among the compds. tested, those which had a hydroxyl group on the arom. ring, particularly at the C-6 position (i.e., 6-hydroxy-7-methoxy-2,2-dimethyl-1-2H-benzopyran and its 3,4-dihydro deriv. (II), appeared to be the best inhibitors.  In this context, the inhibitory effect elicited by the hydroxychroman II (IC50 = 0.3 μM, TBARS prodn. test) was higher than that shown by BHT.  These results suggested that the lipid peroxidn. inhibitory effect exhibited by I and related derivs. could be due to a vitamin E-like free radical scavenger-based mechanism.  The identification of phenolic metabolites in the incubations performed with I or its benzopyranyl analogs lacking arom. hydroxyl substituents supported the above postulated mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoymXzIKzsb97Vg90H21EOLACvtfcHk0ljibbNAqxQ32g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XhvV2gsLs%253D&md5=d615c730eef799809508446c3102eb34</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjf00016a011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf00016a011%26sid%3Dliteratum%253Aachs%26aulast%3DCasas%26aufirst%3DJ.%26aulast%3DGorchs%26aufirst%3DG.%26aulast%3DS%25C3%25A1nchez-Baeza%26aufirst%3DF.%26aulast%3DTeixidor%26aufirst%3DP.%26aulast%3DMesseguer%26aufirst%3DA.%26atitle%3DInhibition%2520of%2520rat%2520liver%2520microsomal%2520lipid%2520peroxidation%2520elicited%2520by%2520simple%25202%252C2-dimethylchromenes%2520and%2520chromans%2520structurally%2520related%2520to%2520precocenes%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D1992%26volume%3D40%26spage%3D585%26epage%3D590%26doi%3D10.1021%2Fjf00016a011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Montoliu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llansola, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sáez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yenes, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messeguer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felipo, V.</span></span> <span> </span><span class="NLM_article-title">Prevention of glutamate neurotoxicity in cultured neurons by 3,4-dihydro-6-hydroxy-7-methoxy-2,2-dimethyl-1(2H)-benzopyran (CR-6), a scavenger of nitric oxide</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">255</span>– <span class="NLM_lpage">261</span>, <span class="refDoi"> DOI: 10.1016/S0006-2952(99)00104-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2FS0006-2952%2899%2900104-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10423166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADyaK1MXktVSjsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1999&pages=255-261&author=C.+Montoliuauthor=M.+Llansolaauthor=R.+S%C3%A1ezauthor=S.+Yenesauthor=A.+Messeguerauthor=V.+Felipo&title=Prevention+of+glutamate+neurotoxicity+in+cultured+neurons+by+3%2C4-dihydro-6-hydroxy-7-methoxy-2%2C2-dimethyl-1%282H%29-benzopyran+%28CR-6%29%2C+a+scavenger+of+nitric+oxide&doi=10.1016%2FS0006-2952%2899%2900104-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Prevention of glutamate neurotoxicity in cultured neurons by 3,4-dihydro-6-hydroxy-7-methoxy-2,2-dimethyl-1(2H)-benzopyran (CR-6), a scavenger of nitric oxide</span></div><div class="casAuthors">Montoliu, Carmina; Llansola, Marta; Saez, Rosana; Yenes, Susana; Messeguer, Angel; Felipo, Vicente</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">255-261</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Glutamate neurotoxicity in cerebellar neurons in culture is mediated by excessive prodn. of nitric oxide (NO).  We anticipated that 3,4-dihydro-6-hydroxy-7-methoxy-2,2-dimethyl-1(2H)-benzopyran (CR-6) could act as a scavenger of NO since it contains a position (C-5) highly activated towards nitration reaction.  The aim of this work was to assess whether CR-6 acts as an NO scavenger and prevents glutamate neurotoxicity in cultures of cerebellar neurons.  It was shown that CR-6 reduced, in a dose-dependent manner, glutamate-induced formation of cGMP (EC50 ≈ 15 μM) and prevented glutamate neurotoxicity.  The protection was ≈50% at 3-10 μM and nearly complete at 100 μM.  CR-6 did not prevent glutamate-induced activation of NO synthase, but interfered with the glutamate-NO-cGMP pathway at a later step.  CR-6 reduced the formation of cGMP induced by S-nitroso-N-acetylpenicillamine (SNAP), an NO-generating agent, indicating that CR-6 acts as a scavenger of NO in cultured neurons.  This was further supported by expts. showing that in neurons treated with CR-6 and glutamate, the 5-nitro deriv. of CR-6 was formed, as detd. by GC-MS analyses.  Moreover, in vitro incubation of CR-6 with SNAP also produced the 5-nitroderivative, thus confirming that CR-6 directly reacts with NO.  The results reported indicate that CR-6 acts as an NO scavenger in neurons and prevents glutamate neurotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo7e9KdvBwArVg90H21EOLACvtfcHk0liMgSN4R_PSZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktVSjsro%253D&md5=a0fec322f97a773359d2819e81ab03cf</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0006-2952%2899%2900104-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-2952%252899%252900104-5%26sid%3Dliteratum%253Aachs%26aulast%3DMontoliu%26aufirst%3DC.%26aulast%3DLlansola%26aufirst%3DM.%26aulast%3DS%25C3%25A1ez%26aufirst%3DR.%26aulast%3DYenes%26aufirst%3DS.%26aulast%3DMesseguer%26aufirst%3DA.%26aulast%3DFelipo%26aufirst%3DV.%26atitle%3DPrevention%2520of%2520glutamate%2520neurotoxicity%2520in%2520cultured%2520neurons%2520by%25203%252C4-dihydro-6-hydroxy-7-methoxy-2%252C2-dimethyl-1%25282H%2529-benzopyran%2520%2528CR-6%2529%252C%2520a%2520scavenger%2520of%2520nitric%2520oxide%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1999%26volume%3D58%26spage%3D255%26epage%3D261%26doi%3D10.1016%2FS0006-2952%2899%2900104-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanvicens, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gómez-Vicente, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messeguer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cotter, T. G.</span></span> <span> </span><span class="NLM_article-title">The radical scavenger CR-6 protects SH-SY5Y neuroblastoma cells from oxidative stress-induced apoptosis: effect on survival pathways</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">735</span>– <span class="NLM_lpage">747</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.2006.03914.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1111%2Fj.1471-4159.2006.03914.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=16787420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD28XovFGhsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2006&pages=735-747&author=N.+Sanvicensauthor=V.+G%C3%B3mez-Vicenteauthor=A.+Messeguerauthor=T.+G.+Cotter&title=The+radical+scavenger+CR-6+protects+SH-SY5Y+neuroblastoma+cells+from+oxidative+stress-induced+apoptosis%3A+effect+on+survival+pathways&doi=10.1111%2Fj.1471-4159.2006.03914.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The radical scavenger CR-6 protects SH-SY5Y neuroblastoma cells from oxidative stress-induced apoptosis: effect on survival pathways</span></div><div class="casAuthors">Sanvicens, Nuria; Gomez-Vicente, Violeta; Messeguer, Angel; Cotter, Thomas G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">735-747</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Reactive oxygen species (ROS) and oxidative stress have long been linked to cell death of neurons in many neurodegenerative conditions.  However, the exact mol. mechanisms triggered by oxidative stress in neurodegeneration are at present unclear.  In the current work we have used the human neuroblastoma SH-SY5Y cell line as a model for studying the mol. events occurring after inducing apoptosis with H2O2.  We show that treatment of SH-SY5Y cells with H2O2 up-regulates survival pathways during early stages of apoptosis.  Subsequently, the decline of anti-apoptotic protein levels leads to the activation of the calcium-dependent proteases calpains and the cysteine proteases caspases.  Addnl., we demonstrate that CR-6 (3,4-dihydro-6-hydroxy-7-methoxy-2,2-dimethyl-1(2H)-benzopyran) acts as a scavenger of ROS and prevents apoptosis by enhancing and prolonging up-regulation of survival pathways.  Furthermore, we show that pre-treatment of SH-SY5Y cells with a cocktail contg. CR-6, the pan-caspase inhibitor zVAD-fmk (zVal-Ala-Asp-fluoro-methylketone) and the calpain inhibitor SJA6017 confers almost total protection against apoptosis.  In summary, the present work characterizes the mol. mechanisms involved in oxidative stress-induced apoptosis in SH-SY5Y cells.  Our findings highlight the relevance of CR-6, alone or in combination with other drugs, as potential therapeutic strategy for the treatment of neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyFGSaGpP8f7Vg90H21EOLACvtfcHk0liMgSN4R_PSZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XovFGhsLc%253D&md5=22053eb8352d45afcdc8749eec93681c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2006.03914.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2006.03914.x%26sid%3Dliteratum%253Aachs%26aulast%3DSanvicens%26aufirst%3DN.%26aulast%3DG%25C3%25B3mez-Vicente%26aufirst%3DV.%26aulast%3DMesseguer%26aufirst%3DA.%26aulast%3DCotter%26aufirst%3DT.%2BG.%26atitle%3DThe%2520radical%2520scavenger%2520CR-6%2520protects%2520SH-SY5Y%2520neuroblastoma%2520cells%2520from%2520oxidative%2520stress-induced%2520apoptosis%253A%2520effect%2520on%2520survival%2520pathways%26jtitle%3DJ.%2520Neurochem.%26date%3D2006%26volume%3D98%26spage%3D735%26epage%3D747%26doi%3D10.1111%2Fj.1471-4159.2006.03914.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Asensio, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de la
Rosa, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez-Altayó, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorina, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messeguer, À.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vila, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chamorro, À.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Planas, A. M.</span></span> <span> </span><span class="NLM_article-title">Antioxidant CR-6 protects against reperfusion injury after a transient episode of focal brain ischemia in rats</span>. <i>J. Cereb. Blood Flow Metab.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">638</span>– <span class="NLM_lpage">652</span>, <span class="refDoi"> DOI: 10.1038/jcbfm.2009.237</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1038%2Fjcbfm.2009.237" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=19904289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisF2htbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=638-652&author=F.+J.+P%C3%A9rez-Asensioauthor=X.+de+la%0ARosaauthor=F.+Jim%C3%A9nez-Altay%C3%B3author=R.+Gorinaauthor=E.+Mart%C3%ADnezauthor=%C3%80.+Messeguerauthor=E.+Vilaauthor=%C3%80.+Chamorroauthor=A.+M.+Planas&title=Antioxidant+CR-6+protects+against+reperfusion+injury+after+a+transient+episode+of+focal+brain+ischemia+in+rats&doi=10.1038%2Fjcbfm.2009.237"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Antioxidant CR-6 protects against reperfusion injury after a transient episode of focal brain ischemia in rats</span></div><div class="casAuthors">Perez-Asensio, Fernando J.; de la Rosa, Xavier; Jimenez-Altayo, Francesc; Gorina, Roser; Martinez, Emili; Messeguer, Angel; Vila, Elisabet; Chamorro, Angel; Planas, Anna M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow & Metabolism</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">638-652</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Oxidative and nitrosative stress are targets for intervention after ischemia/reperfusion.  The aim of this study was to explore the effect of CR-6, a vitamin-E analog that is antioxidant and scavenger of nitrogen-reactive species.  Sprague-Dawley rats had the middle cerebral artery (MCA) occluded either for 90 mins or permanently.  Cortical perfusion was continuously monitored by laser-Doppler flowmetry.  CR-6 (100 mg/kg) was administered orally either at 2 and 8 h after MCA occlusion, or at 2 h only.  Infarct vol., neurol. deficit, and signs of reperfusion injury were evaluated.  CR-6 was detected in plasma and brain by HPLC.  CR-6 reduced glutathione consumption in the ischemic brain and superoxide generation in the isolated MCA.  CR-6 decreased infarct vol. and attenuated the neurol. deficit at 1 and 7 days after ischemia/reperfusion, but not after permanent ischemia.  Immediately after reperfusion, cortical blood flow values returned to their baseline (±20%) in several animals, whereas others showed hyper-perfusion (>20% of baseline).  Reactive hyperemia was assocd. with adverse events such as increased cortical BBB leakage, edema, protein nitrotyrosination, COX-2 expression, and neutrophil accumulation; and with a poorer outcome, and CR-6 attenuated these effects.  In conclusion, oral CR-6 administration after transient ischemia protects the brain from reperfusion injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqefaGrWNPBZ7Vg90H21EOLACvtfcHk0lg-XamTagXonQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisF2htbc%253D&md5=9e09296f0d11cc38e98f64911f174a10</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fjcbfm.2009.237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fjcbfm.2009.237%26sid%3Dliteratum%253Aachs%26aulast%3DP%25C3%25A9rez-Asensio%26aufirst%3DF.%2BJ.%26aulast%3Dde%2Bla%2BRosa%26aufirst%3DX.%26aulast%3DJim%25C3%25A9nez-Altay%25C3%25B3%26aufirst%3DF.%26aulast%3DGorina%26aufirst%3DR.%26aulast%3DMart%25C3%25ADnez%26aufirst%3DE.%26aulast%3DMesseguer%26aufirst%3D%25C3%2580.%26aulast%3DVila%26aufirst%3DE.%26aulast%3DChamorro%26aufirst%3D%25C3%2580.%26aulast%3DPlanas%26aufirst%3DA.%2BM.%26atitle%3DAntioxidant%2520CR-6%2520protects%2520against%2520reperfusion%2520injury%2520after%2520a%2520transient%2520episode%2520of%2520focal%2520brain%2520ischemia%2520in%2520rats%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D2010%26volume%3D30%26spage%3D638%26epage%3D652%26doi%3D10.1038%2Fjcbfm.2009.237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vázquez-Jiménez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrido, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miceli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prats, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer-Montiel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teixidó, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimeno, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messeguer, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and in vitro, ex-vivo and in vivo activity of hybrid compounds linking a potent ROS and RNS scavenger activity with diverse substrates addressed to pass across the blood-brain barrier</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">788</span>– <span class="NLM_lpage">802</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.08.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2Fj.ejmech.2016.08.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=27541262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlOrt7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2016&pages=788-802&author=L.+V%C3%A1zquez-Jim%C3%A9nezauthor=M.+Garridoauthor=M.+Miceliauthor=E.+Pratsauthor=A.+Ferrer-Montielauthor=M.+Teixid%C3%B3author=C.+Jimenoauthor=A.+Messeguer&title=Synthesis+and+in+vitro%2C+ex-vivo+and+in+vivo+activity+of+hybrid+compounds+linking+a+potent+ROS+and+RNS+scavenger+activity+with+diverse+substrates+addressed+to+pass+across+the+blood-brain+barrier&doi=10.1016%2Fj.ejmech.2016.08.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in vitro, ex-vivo and in vivo activity of hybrid compounds linking a potent ROS and RNS scavenger activity with diverse substrates addressed to pass across the blood-brain barrier</span></div><div class="casAuthors">Vazquez-Jimenez, Laura; Garrido, Maria; Miceli, Martina; Prats, Eva; Ferrer-Montiel, Antonio; Teixido, Meritxell; Jimeno, Ciril; Messeguer, Angel</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">788-802</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The synthesis of a small library of CR-6 (a potent ROS and RNS scavenger agent) derivs. bearing covalent linkage with different endogen nutrients that have specific transport through the blood-brain barrier (BBB) is reported.  The synthetic sequence involved the prepn. of a common precursor ester 6 derived from CR-6, which was easily converted into the carboxylic acid 7a or the amino deriv. 11, for its further coupling with the required substrates through amide bonds.  Antioxidant in vitro (DPPH) and cellular assays (CAA) with the SH-S5SY cell line performed on these library members revealed that the couplings did not affect the antioxidant activity elicited by CR-6 itself.  More interestingly, results from the i.p. administration of selected library components in rats showed that compds. 2b, 2c and 2d were able to pass across the BBB.  In particular, the amino acid compd. 2d was the most penetrating deriv. (15.8 ± 1.7 nmol/g brain with respect to the 4.0 ± 1.2 nmol/g brain found for the parent CR-6).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2lUfcMzU5WrVg90H21EOLACvtfcHk0ljAN58DuYr0Tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlOrt7vL&md5=b44d3cf711192dffccdf982db5df9456</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.08.007%26sid%3Dliteratum%253Aachs%26aulast%3DV%25C3%25A1zquez-Jim%25C3%25A9nez%26aufirst%3DL.%26aulast%3DGarrido%26aufirst%3DM.%26aulast%3DMiceli%26aufirst%3DM.%26aulast%3DPrats%26aufirst%3DE.%26aulast%3DFerrer-Montiel%26aufirst%3DA.%26aulast%3DTeixid%25C3%25B3%26aufirst%3DM.%26aulast%3DJimeno%26aufirst%3DC.%26aulast%3DMesseguer%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520in%2520vitro%252C%2520ex-vivo%2520and%2520in%2520vivo%2520activity%2520of%2520hybrid%2520compounds%2520linking%2520a%2520potent%2520ROS%2520and%2520RNS%2520scavenger%2520activity%2520with%2520diverse%2520substrates%2520addressed%2520to%2520pass%2520across%2520the%2520blood-brain%2520barrier%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D123%26spage%3D788%26epage%3D802%26doi%3D10.1016%2Fj.ejmech.2016.08.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanhed, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kansara, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mecwan, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Upadhyay, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prajapati, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murumkar, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, M. R.</span></span> <span> </span><span class="NLM_article-title">Novel multitarget directed triazinoindole derivatives as anti-Alzheimer agents</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">3635</span>– <span class="NLM_lpage">3661</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.9b00226</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.9b00226" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtl2jtLrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=3635-3661&author=D.+V.+Patelauthor=N.+R.+Patelauthor=A.+M.+Kanhedauthor=S.+P.+Patelauthor=A.+Sinhaauthor=D.+D.+Kansaraauthor=A.+R.+Mecwanauthor=S.+B.+Patelauthor=P.+N.+Upadhyayauthor=K.+B.+Patelauthor=D.+B.+Shahauthor=N.+K.+Prajapatiauthor=P.+R.+Murumkarauthor=K.+V.+Patelauthor=M.+R.+Yadav&title=Novel+multitarget+directed+triazinoindole+derivatives+as+anti-Alzheimer+agents&doi=10.1021%2Facschemneuro.9b00226"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17a</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Multitarget Directed Triazinoindole Derivatives as Anti-Alzheimer Agents</span></div><div class="casAuthors">Patel, Dushyant V.; Patel, Nirav R.; Kanhed, Ashish M.; Patel, Sagar P.; Sinha, Anshuman; Kansara, Deep D.; Mecwan, Annie R.; Patel, Sarvangee B.; Upadhyay, Pragnesh N.; Patel, Kishan B.; Shah, Dharti B.; Prajapati, Navnit K.; Murumkar, Prashant R.; Patel, Kirti V.; Yadav, Mange Ram</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3635-3661</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The multifaceted nature of Alzheimer's disease (AD) demands treatment with multitarget-directed ligands (MTDLs) to confront the key pathol. aberrations.  A novel series of triazinoindole derivs. were designed and synthesized.  In vitro studies revealed that all the compds. showed moderate to good anticholinesterase activity; the most active compd. 23e showed an IC50 value of 0.56 ± 0.02 μM for AChE and an IC50 value of 1.17 ± 0.09 μM for BuChE.  These derivs. are also endowed with potent antioxidant activity.  To understand the plausible binding mode of the compd. 23e, mol. docking studies and mol. dynamics simulation studies were performed, and the results indicated significant interactions of 23e within the active sites of AChE as well as BuChE.  Compd. 23e successfully diminished H2O2-induced oxidative stress in SH-SY5Y cells and displayed excellent neuroprotective activity against H2O2 as well as Aβ-induced toxicity in SH-SY5Y cells in a concn. dependent manner.  Furthermore, it did not show any significant toxicity in neuronal SH-SY5Y cells in the cytotoxicity assay.  Compd. 23e did not show any acute toxicity in rats at doses up to 2000 mg/kg, and it significantly reversed scopolamine-induced memory deficit in mice model.  Addnl., compd. 23e showed notable in silico ADMET properties.  Taken collectively, these findings project compd. 23e as a potential balanced MTDL in the evolution process of novel anti-AD drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFrn4aKD5fUrVg90H21EOLACvtfcHk0ljAN58DuYr0Tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtl2jtLrP&md5=662353ea8e5f6d29d01ee1e4456dbaee</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.9b00226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.9b00226%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DD.%2BV.%26aulast%3DPatel%26aufirst%3DN.%2BR.%26aulast%3DKanhed%26aufirst%3DA.%2BM.%26aulast%3DPatel%26aufirst%3DS.%2BP.%26aulast%3DSinha%26aufirst%3DA.%26aulast%3DKansara%26aufirst%3DD.%2BD.%26aulast%3DMecwan%26aufirst%3DA.%2BR.%26aulast%3DPatel%26aufirst%3DS.%2BB.%26aulast%3DUpadhyay%26aufirst%3DP.%2BN.%26aulast%3DPatel%26aufirst%3DK.%2BB.%26aulast%3DShah%26aufirst%3DD.%2BB.%26aulast%3DPrajapati%26aufirst%3DN.%2BK.%26aulast%3DMurumkar%26aufirst%3DP.%2BR.%26aulast%3DPatel%26aufirst%3DK.%2BV.%26aulast%3DYadav%26aufirst%3DM.%2BR.%26atitle%3DNovel%2520multitarget%2520directed%2520triazinoindole%2520derivatives%2520as%2520anti-Alzheimer%2520agents%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2019%26volume%3D10%26spage%3D3635%26epage%3D3661%26doi%3D10.1021%2Facschemneuro.9b00226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Nesi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sestito, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Digiacomo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rapposelli, S.</span></span> <span> </span><span class="NLM_article-title">Oxidative stress, mitochondrial abnormalities and proteins deposition: multitarget approaches in Alzheimer’s disease</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">3062</span>– <span class="NLM_lpage">3079</span>, <span class="refDoi"> DOI: 10.2174/1568026617666170607114232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.2174%2F1568026617666170607114232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=28595557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A280%3ADC%252BC1cnmsVWlsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=3062-3079&author=G.+Nesiauthor=S.+Sestitoauthor=M.+Digiacomoauthor=S.+Rapposelli&title=Oxidative+stress%2C+mitochondrial+abnormalities+and+proteins+deposition%3A+multitarget+approaches+in+Alzheimer%E2%80%99s+disease&doi=10.2174%2F1568026617666170607114232"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative Stress, Mitochondrial Abnormalities and Proteins Deposition: Multitarget Approaches in Alzheimer's Disease</span></div><div class="casAuthors">Nesi Giulia; Sestito Simona; Digiacomo Maria; Rapposelli Simona</div><div class="citationInfo"><span class="NLM_cas:title">Current topics in medicinal chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">3062-3079</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Alzheimer Diseases (AD) is a multifactorial pathology characterized by a complex etiology.  The hallmarks of AD, such as Aβ deposits in senile plaque and Neurofibrillary Tangles (NFT), are strongly intertwined with Reactive Oxygen Species (ROS) production and oxidative stress (OS), which are considered the common effectors of the cascade of degenerative events.  An increasing body of evidence reveals that both mitochondrial abnormalities and metal accumulations synergistically act as major producers of ROS, thus contributing to neuronal toxicity.  Consequently, the detrimental role of ROS production together with the neurodegenerative events involved in AD has been widely investigated as new potential therapeutic strategies.  This review will concisely summarize the link between OS and the hallmarks of AD, emphasizing on their strong correlation with neurodegenerative events and elucidating the pivotal role of ROS in AD pathology.  Furthermore, through this review, we will provide a short account of some of the efforts, challenges and opportunities in developing multitarget drugs by addressing ROS production, metal accumulation and protein depositions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQhCycVI-AnQSnGiHuhFGv8fW6udTcc2eZ1khJSsFQngLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cnmsVWlsA%253D%253D&md5=657c47e53aa814d02ce01df506044eb0</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.2174%2F1568026617666170607114232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026617666170607114232%26sid%3Dliteratum%253Aachs%26aulast%3DNesi%26aufirst%3DG.%26aulast%3DSestito%26aufirst%3DS.%26aulast%3DDigiacomo%26aufirst%3DM.%26aulast%3DRapposelli%26aufirst%3DS.%26atitle%3DOxidative%2520stress%252C%2520mitochondrial%2520abnormalities%2520and%2520proteins%2520deposition%253A%2520multitarget%2520approaches%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2017%26volume%3D17%26spage%3D3062%26epage%3D3079%26doi%3D10.2174%2F1568026617666170607114232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit17c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Franco, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernández-Bachiller, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernández-Ledesma, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolomé, B.</span></span> <span> </span><span class="NLM_article-title">Novel tacrine–melatonin hybrids as dual-acting drugs for Alzheimer disease, with improved acetylcholinesterase inhibitory and antioxidant properties</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">459</span>– <span class="NLM_lpage">462</span>, <span class="refDoi"> DOI: 10.1021/jm050746d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050746d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlWmurfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=459-462&author=M.+I.+Rodr%C3%ADguez-Francoauthor=M.+I.+Fern%C3%A1ndez-Bachillerauthor=C.+P%C3%A9rezauthor=B.+Hern%C3%A1ndez-Ledesmaauthor=B.+Bartolom%C3%A9&title=Novel+tacrine%E2%80%93melatonin+hybrids+as+dual-acting+drugs+for+Alzheimer+disease%2C+with+improved+acetylcholinesterase+inhibitory+and+antioxidant+properties&doi=10.1021%2Fjm050746d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17cR"><div class="casContent"><span class="casTitleNuber">17c</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Tacrine-Melatonin Hybrids as Dual-Acting Drugs for Alzheimer Disease, with Improved Acetylcholinesterase Inhibitory and Antioxidant Properties</span></div><div class="casAuthors">Rodriguez-Franco, Maria Isabel; Fernandez-Bachiller, Maria Isabel; Perez, Concepcion; Hernandez-Ledesma, Blanca; Bartolome, Begona</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">459-462</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tacrine and melatonin are well-known drugs with activities as an acetylcholinesterase (AChE) inhibitor and free radical scavenger, resp.  In this work, the authors report new hybrids of both drugs that display higher in vitro properties than the sum of their parts.  As selective inhibitors of human AChE, their IC50 values range from sub-nanomolar to picomolar.  They exhibit a higher oxygen radical absorbance capacity than does melatonin and are predicted to be able to cross the blood-brain barrier to reach their targets in the central nervous system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJx8cNT0dPfrVg90H21EOLACvtfcHk0lidsSp6WWjFSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlWmurfM&md5=ee924cb63a2f3263853a6449e40cb69f</span></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=10.1021%2Fjm050746d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050746d%26sid%3Dliteratum%253Aachs%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DFern%25C3%25A1ndez-Bachiller%26aufirst%3DM.%2BI.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%26aulast%3DHern%25C3%25A1ndez-Ledesma%26aufirst%3DB.%26aulast%3DBartolom%25C3%25A9%26aufirst%3DB.%26atitle%3DNovel%2520tacrine%25E2%2580%2593melatonin%2520hybrids%2520as%2520dual-acting%2520drugs%2520for%2520Alzheimer%2520disease%252C%2520with%2520improved%2520acetylcholinesterase%2520inhibitory%2520and%2520antioxidant%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D459%26epage%3D462%26doi%3D10.1021%2Fjm050746d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit17d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fernández-Bachiller, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campillo, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Páez, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González-Muñoz, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Usán, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Palomero, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villarroya, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Franco, M. I.</span></span> <span> </span><span class="NLM_article-title">Tacrine-melatonin hybrids as multifunctional agents for Alzheimer’s disease, with cholinergic, antioxidant, and neuroprotective properties</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">828</span>– <span class="NLM_lpage">841</span>, <span class="refDoi"> DOI: 10.1002/cmdc.200800414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1002%2Fcmdc.200800414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=19308922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD1MXls1Kgt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=828-841&author=M.+I.+Fern%C3%A1ndez-Bachillerauthor=C.+P%C3%A9rezauthor=N.+E.+Campilloauthor=J.+A.+P%C3%A1ezauthor=G.+C.+Gonz%C3%A1lez-Mu%C3%B1ozauthor=P.+Us%C3%A1nauthor=E.+Garc%C3%ADa-Palomeroauthor=M.+G.+L%C3%B3pezauthor=M.+Villarroyaauthor=A.+G.+Garc%C3%ADaauthor=A.+Mart%C3%ADnezauthor=M.+I.+Rodr%C3%ADguez-Franco&title=Tacrine-melatonin+hybrids+as+multifunctional+agents+for+Alzheimer%E2%80%99s+disease%2C+with+cholinergic%2C+antioxidant%2C+and+neuroprotective+properties&doi=10.1002%2Fcmdc.200800414"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17dR"><div class="casContent"><span class="casTitleNuber">17d</span><div class="casTitle"><span class="NLM_cas:atitle">Tacrine-Melatonin Hybrids as Multifunctional Agents for Alzheimer's Disease, with Cholinergic, Antioxidant, and Neuroprotective Properties</span></div><div class="casAuthors">Fernandez-Bachiller, Maria Isabel; Perez, Concepcion; Campillo, Nuria Eugenia; Paez, Juan Antonio; Gonzalez-Munoz, Gema Cristina; Usan, Paola; Garcia-Palomero, Esther; Lopez, Manuela G.; Villarroya, Mercedes; Garcia, Antonio G.; Martinez, Ana; Rodriguez-Franco, Maria Isabel</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">828-841</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Tacrine-melatonin hybrids are potential multifunctional drugs for Alzheimer's disease that may simultaneously palliate intellectual deficits and protect the brain against both β-amyloid peptide and oxidative stress.  Mol. modeling studies show that they target both the catalytic active site (CAS) and the peripheral anionic site (PAS) of AChE.  They are nontoxic and may be able to penetrate the CNS, according to in vitro PAMPA-BBB assays.  Tacrine-melatonin hybrids were designed and synthesized as new multifunctional drug candidates for Alzheimer's disease.  These compds. may simultaneously palliate intellectual deficits and protect the brain against both β-amyloid (Aβ) peptide and oxidative stress.  They show improved cholinergic and antioxidant properties, and are more potent and selective inhibitors of human acetylcholinesterase (hAChE) than tacrine.  They also capture free radicals better than melatonin.  Mol. modeling studies show that these hybrids target both the catalytic active site (CAS) and the peripheral anionic site (PAS) of AChE.  At sub-micromolar concns. they efficiently displace the binding of propidium iodide from the PAS and could thus inhibit Aβ peptide aggregation promoted by AChE.  Moreover, they also inhibit Aβ self-aggregation and display neuroprotective properties in a human neuroblastoma line against cell death induced by various toxic insults, such as Aβ25-35, H2O2, and rotenone.  Finally, they exhibit low toxicity and may be able to penetrate the central nervous system according to an in vitro parallel artificial membrane permeability assay for the blood-brain barrier (PAMPA-BBB).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf8mEFq1tgJ7Vg90H21EOLACvtfcHk0lidsSp6WWjFSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXls1Kgt7g%253D&md5=67c7f37e4d3ec3b28387d1b2d19abbbd</span></div><a href="/servlet/linkout?suffix=cit17d&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200800414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200800414%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez-Bachiller%26aufirst%3DM.%2BI.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%26aulast%3DCampillo%26aufirst%3DN.%2BE.%26aulast%3DP%25C3%25A1ez%26aufirst%3DJ.%2BA.%26aulast%3DGonz%25C3%25A1lez-Mu%25C3%25B1oz%26aufirst%3DG.%2BC.%26aulast%3DUs%25C3%25A1n%26aufirst%3DP.%26aulast%3DGarc%25C3%25ADa-Palomero%26aufirst%3DE.%26aulast%3DL%25C3%25B3pez%26aufirst%3DM.%2BG.%26aulast%3DVillarroya%26aufirst%3DM.%26aulast%3DGarc%25C3%25ADa%26aufirst%3DA.%2BG.%26aulast%3DMart%25C3%25ADnez%26aufirst%3DA.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26atitle%3DTacrine-melatonin%2520hybrids%2520as%2520multifunctional%2520agents%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%252C%2520with%2520cholinergic%252C%2520antioxidant%252C%2520and%2520neuroprotective%2520properties%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D828%26epage%3D841%26doi%3D10.1002%2Fcmdc.200800414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panda, G.</span></span> <span> </span><span class="NLM_article-title">Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer’s disease (1998–2018)</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">895</span>– <span class="NLM_lpage">930</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2019.01.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2Fj.bmc.2019.01.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=30744931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1MXivVWlt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2019&pages=895-930&author=P.+Mishraauthor=A.+Kumarauthor=G.+Panda&title=Anti-cholinesterase+hybrids+as+multi-target-directed+ligands+against+Alzheimer%E2%80%99s+disease+%281998%E2%80%932018%29&doi=10.1016%2Fj.bmc.2019.01.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer's disease (1998-2018)</span></div><div class="casAuthors">Mishra, Pankaj; Kumar, Amit; Panda, Gautam</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">895-930</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a genetically complex, progressive and irreversible neurodegenerative disorder of the brain which involves multiple assocd. etiol. targets.  The complex pathogenesis of AD gave rise to multi-target-directed ligands (MTDLs) principle to combat this dreaded disease.  Within this approach, the design and synthesis of hybrids prevailed greatly because of their capability to simultaneously target the intertwined pathogenesis components of the disease.  The hybrids include pharmacophoric hybridization of two or more established chem. scaffolds endowed with the desired pharmacol. properties into a single moiety.  In AD, the primary foundation of medication therapy and drug design strategies includes the inhibition of cholinesterase (ChE) enzymes.  Hence the development of ChE inhibition based hybrids is the central choice of AD medicinal chem. research.  To illustrate the progress of ChE inhibition based hybrids and novel targets, we reviewed the medicinal chem. and pharmacol. properties of the multi-target mols. published since 1998-Dec. 2018.  We hope that this article will allow the readers to easily follow the evolution of this prominent medicinal chem. approach to develop a more efficient inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp6n_9YGJjsrVg90H21EOLACvtfcHk0lhySL-cdrQFIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXivVWlt7g%253D&md5=5941878ce58266e56b041f4d239d2b63</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2019.01.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2019.01.025%26sid%3Dliteratum%253Aachs%26aulast%3DMishra%26aufirst%3DP.%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DPanda%26aufirst%3DG.%26atitle%3DAnti-cholinesterase%2520hybrids%2520as%2520multi-target-directed%2520ligands%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%2520%25281998%25E2%2580%25932018%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2019%26volume%3D27%26spage%3D895%26epage%3D930%26doi%3D10.1016%2Fj.bmc.2019.01.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Viayna, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sola, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Simone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tapia-Rojas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serrano, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabaté, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juárez-Jiménez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrisano, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clos, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inestrosa, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span> <span> </span><span class="NLM_article-title">Synthesis and multitarget biological profiling of a novel family of rhein derivatives as disease-modifying anti-Alzheimer agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">2549</span>– <span class="NLM_lpage">2567</span>, <span class="refDoi"> DOI: 10.1021/jm401824w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401824w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtVeqsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=2549-2567&author=E.+Viaynaauthor=I.+Solaauthor=M.+Bartoliniauthor=A.+De+Simoneauthor=C.+Tapia-Rojasauthor=F.+G.+Serranoauthor=R.+Sabat%C3%A9author=J.+Ju%C3%A1rez-Jim%C3%A9nezauthor=B.+P%C3%A9rezauthor=F.+J.+Luqueauthor=V.+Andrisanoauthor=M.+V.+Closauthor=N.+C.+Inestrosaauthor=D.+Mu%C3%B1oz-Torrero&title=Synthesis+and+multitarget+biological+profiling+of+a+novel+family+of+rhein+derivatives+as+disease-modifying+anti-Alzheimer+agents&doi=10.1021%2Fjm401824w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19a</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Multitarget Biological Profiling of a Novel Family of Rhein Derivatives As Disease-Modifying Anti-Alzheimer Agents</span></div><div class="casAuthors">Viayna, Elisabet; Sola, Irene; Bartolini, Manuela; De Simone, Angela; Tapia-Rojas, Cheril; Serrano, Felipe G.; Sabate, Raimon; Juarez-Jimenez, Jordi; Perez, Belen; Luque, F. Javier; Andrisano, Vincenza; Clos, M. Victoria; Inestrosa, Nibaldo C.; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2549-2567</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have synthesized a family of rhein-huprine hybrids I [X = (CH2)n, n = 5-11; X = CH2-p-phenylene-CH2] to hit several key targets for Alzheimer's disease.  Biol. screening performed in vitro and in Escherichia coli cells has shown that these hybrids exhibit potent inhibitory activities against human acetylcholinesterase, butyrylcholinesterase, and BACE-1, dual Aβ42 and tau antiaggregating activity, and brain permeability.  Ex vivo studies with the leads (+)- and (-)-I [X = (CH2)9] (II) in brain slices of C57bl6 mice have revealed that they efficiently protect against the Aβ-induced synaptic dysfunction, preventing the loss of synaptic proteins and/or have a pos. effect on the induction of long-term potentiation.  In vivo studies in APP-PS1 transgenic mice treated i.p. for 4 wk with (+)- and (-)-II have shown a central sol. Aβ lowering effect, accompanied by an increase in the levels of mature amyloid precursor protein (APP).  Thus, (+)- and (-)-II emerge as very promising disease-modifying anti-Alzheimer drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeoyGkrcOQArVg90H21EOLACvtfcHk0lhySL-cdrQFIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtVeqsrc%253D&md5=711450b3c2289a3fb2037d536e9a7a7b</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1021%2Fjm401824w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401824w%26sid%3Dliteratum%253Aachs%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DSola%26aufirst%3DI.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DTapia-Rojas%26aufirst%3DC.%26aulast%3DSerrano%26aufirst%3DF.%2BG.%26aulast%3DSabat%25C3%25A9%26aufirst%3DR.%26aulast%3DJu%25C3%25A1rez-Jim%25C3%25A9nez%26aufirst%3DJ.%26aulast%3DP%25C3%25A9rez%26aufirst%3DB.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DInestrosa%26aufirst%3DN.%2BC.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DSynthesis%2520and%2520multitarget%2520biological%2520profiling%2520of%2520a%2520novel%2520family%2520of%2520rhein%2520derivatives%2520as%2520disease-modifying%2520anti-Alzheimer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D2549%26epage%3D2567%26doi%3D10.1021%2Fjm401824w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Galdeano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viayna, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sola, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Formosa, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camps, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clos, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Relat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrisano, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salmona, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minguillón, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">González-Muñoz, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Franco, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bidon-Chanal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span> <span> </span><span class="NLM_article-title">Huprine–tacrine heterodimers as anti-amyloidogenic compounds of potential interest against Alzheimer’s and prion diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">661</span>– <span class="NLM_lpage">669</span>, <span class="refDoi"> DOI: 10.1021/jm200840c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200840c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ersLnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=661-669&author=C.+Galdeanoauthor=E.+Viaynaauthor=I.+Solaauthor=X.+Formosaauthor=P.+Campsauthor=A.+Badiaauthor=M.+V.+Closauthor=J.+Relatauthor=M.+Ratiaauthor=M.+Bartoliniauthor=F.+Manciniauthor=V.+Andrisanoauthor=M.+Salmonaauthor=C.+Minguill%C3%B3nauthor=G.+C.+Gonz%C3%A1lez-Mu%C3%B1ozauthor=M.+I.+Rodr%C3%ADguez-Francoauthor=A.+Bidon-Chanalauthor=F.+J.+Luqueauthor=D.+Mu%C3%B1oz-Torrero&title=Huprine%E2%80%93tacrine+heterodimers+as+anti-amyloidogenic+compounds+of+potential+interest+against+Alzheimer%E2%80%99s+and+prion+diseases&doi=10.1021%2Fjm200840c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19b</span><div class="casTitle"><span class="NLM_cas:atitle">Huprine-Tacrine Heterodimers as Anti-Amyloidogenic Compounds of Potential Interest against Alzheimer's and Prion Diseases</span></div><div class="casAuthors">Galdeano, Carles; Viayna, Elisabet; Sola, Irene; Formosa, Xavier; Camps, Pelayo; Badia, Albert; Clos, M. Victoria; Relat, Julia; Ratia, Miriam; Bartolini, Manuela; Mancini, Francesca; Andrisano, Vincenza; Salmona, Mario; Minguillon, Cristina; Gonzalez-Munoz, Gema C.; Rodriguez-Franco, M. Isabel; Bidon-Chanal, Axel; Luque, F. Javier; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">661-669</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A family of huprine-tacrine heterodimers has been developed to simultaneously block the active and peripheral sites of acetylcholinesterase (AChE).  Their dual site binding for AChE, supported by kinetic and mol. modeling studies, results in a highly potent inhibition of the catalytic activity of human AChE and, more importantly, in the in vitro neutralization of the pathol. chaperoning effect of AChE toward the aggregation of both the β-amyloid peptide (Aβ) and a prion peptide with a key role in the aggregation of the prion protein.  Huprine-tacrine heterodimers take on added value in that they display a potent in vitro inhibitory activity toward human butyrylcholinesterase, self-induced Aβ aggregation, and β-secretase.  Finally, they are able to cross the blood-brain barrier, as predicted in an artificial membrane model assay and demonstrated in ex vivo expts. with OF1 mice, reaching their multiple biol. targets in the central nervous system.  Overall, these compds. are promising lead compds. for the treatment of Alzheimer's and prion diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSrojS0ckMVLVg90H21EOLACvtfcHk0lhySL-cdrQFIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ersLnN&md5=e0fbec47bca527df4e8ed73c847383e9</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1021%2Fjm200840c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200840c%26sid%3Dliteratum%253Aachs%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DSola%26aufirst%3DI.%26aulast%3DFormosa%26aufirst%3DX.%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DBadia%26aufirst%3DA.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DRelat%26aufirst%3DJ.%26aulast%3DRatia%26aufirst%3DM.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DSalmona%26aufirst%3DM.%26aulast%3DMinguill%25C3%25B3n%26aufirst%3DC.%26aulast%3DGonz%25C3%25A1lez-Mu%25C3%25B1oz%26aufirst%3DG.%2BC.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DBidon-Chanal%26aufirst%3DA.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DHuprine%25E2%2580%2593tacrine%2520heterodimers%2520as%2520anti-amyloidogenic%2520compounds%2520of%2520potential%2520interest%2520against%2520Alzheimer%25E2%2580%2599s%2520and%2520prion%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D661%26epage%3D669%26doi%3D10.1021%2Fjm200840c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit19c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Camps, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Formosa, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galdeano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramı́rez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gómez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isambert, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavilla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clos, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrisano, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arce, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Franco, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huertas, Ó.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dafni, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span> <span> </span><span class="NLM_article-title">Pyrano[3,2-c]quinoline–6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and β-amyloid-directed anti-Alzheimer compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">5365</span>– <span class="NLM_lpage">5379</span>, <span class="refDoi"> DOI: 10.1021/jm900859q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900859q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsFaktLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5365-5379&author=P.+Campsauthor=X.+Formosaauthor=C.+Galdeanoauthor=D.+Mu%C3%B1oz-Torreroauthor=L.+Ram%C4%B1%CC%81rezauthor=E.+G%C3%B3mezauthor=N.+Isambertauthor=R.+Lavillaauthor=A.+Badiaauthor=M.+V.+Closauthor=M.+Bartoliniauthor=F.+Manciniauthor=V.+Andrisanoauthor=M.+P.+Arceauthor=M.+I.+Rodr%C3%ADguez-Francoauthor=%C3%93.+Huertasauthor=T.+Dafniauthor=F.+J.+Luque&title=Pyrano%5B3%2C2-c%5Dquinoline%E2%80%936-chlorotacrine+hybrids+as+a+novel+family+of+acetylcholinesterase-+and+%CE%B2-amyloid-directed+anti-Alzheimer+compounds&doi=10.1021%2Fjm900859q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19cR"><div class="casContent"><span class="casTitleNuber">19c</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrano[3,2-c]quinoline-6-Chlorotacrine Hybrids as a Novel Family of Acetylcholinesterase- and β-Amyloid-Directed Anti-Alzheimer Compounds</span></div><div class="casAuthors">Camps, Pelayo; Formosa, Xavier; Galdeano, Carles; Munoz-Torrero, Diego; Ramirez, Lorena; Gomez, Elena; Isambert, Nicolas; Lavilla, Rodolfo; Badia, Albert; Clos, M. Victoria; Bartolini, Manuela; Mancini, Francesca; Andrisano, Vincenza; Arce, Mariana P.; Rodriguez-Franco, M. Isabel; Huertas, Oscar; Dafni, Thomai; Luque, F. Javier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5365-5379</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two isomeric series of dual binding site acetylcholinesterase (AChE) inhibitors have been designed, synthesized, and tested for their ability to inhibit AChE, butyrylcholinesterase, AChE-induced and self-induced β-amyloid (Aβ) aggregation, and β-secretase (BACE-1) and to cross blood-brain barrier.  The new hybrids consist of a unit of 6-chlorotacrine and a multicomponent reaction-derived pyrano[3,2-c]quinoline scaffold as the active-site and peripheral-site interacting moieties, resp., connected through an oligomethylene linker contg. an amido group at variable position.  Indeed, mol. modeling and kinetic studies have confirmed the dual site binding of these compds.  The new hybrids, and particularly I, retain the potent and selective human AChE inhibitory activity of the parent 6-chlorotacrine while exhibiting a significant in vitro inhibitory activity toward the AChE-induced and self-induced Aβ aggregation and toward BACE-1, as well as ability to enter the central nervous system, which makes them promising anti-Alzheimer lead compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0N9CfOYI1erVg90H21EOLACvtfcHk0ljQhSturWSMbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsFaktLg%253D&md5=f2bfb696419b7634076cf7a16a4ae94b</span></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=10.1021%2Fjm900859q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900859q%26sid%3Dliteratum%253Aachs%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DFormosa%26aufirst%3DX.%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DRam%25C4%25B1%25CC%2581rez%26aufirst%3DL.%26aulast%3DG%25C3%25B3mez%26aufirst%3DE.%26aulast%3DIsambert%26aufirst%3DN.%26aulast%3DLavilla%26aufirst%3DR.%26aulast%3DBadia%26aufirst%3DA.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DArce%26aufirst%3DM.%2BP.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26aulast%3DHuertas%26aufirst%3D%25C3%2593.%26aulast%3DDafni%26aufirst%3DT.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26atitle%3DPyrano%255B3%252C2-c%255Dquinoline%25E2%2580%25936-chlorotacrine%2520hybrids%2520as%2520a%2520novel%2520family%2520of%2520acetylcholinesterase-%2520and%2520%25CE%25B2-amyloid-directed%2520anti-Alzheimer%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5365%26epage%3D5379%26doi%3D10.1021%2Fjm900859q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit19d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Di Pietro, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Areales, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juárez-Jiménez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espargaró, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clos, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lavilla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabaté, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span> <span> </span><span class="NLM_article-title">Tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrids as a new family of anti-Alzheimer agents targeting β-amyloid, tau, and cholinesterase pathologies</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">117</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.07.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2Fj.ejmech.2014.07.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=25016233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Grs7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2014&pages=107-117&author=O.+Di+Pietroauthor=F.+J.+P%C3%A9rez-Arealesauthor=J.+Ju%C3%A1rez-Jim%C3%A9nezauthor=A.+Espargar%C3%B3author=M.+V.+Closauthor=B.+P%C3%A9rezauthor=R.+Lavillaauthor=R.+Sabat%C3%A9author=F.+J.+Luqueauthor=D.+Mu%C3%B1oz-Torrero&title=Tetrahydrobenzo%5Bh%5D%5B1%2C6%5Dnaphthyridine-6-chlorotacrine+hybrids+as+a+new+family+of+anti-Alzheimer+agents+targeting+%CE%B2-amyloid%2C+tau%2C+and+cholinesterase+pathologies&doi=10.1016%2Fj.ejmech.2014.07.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19dR"><div class="casContent"><span class="casTitleNuber">19d</span><div class="casTitle"><span class="NLM_cas:atitle">Tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrids as a new family of anti-Alzheimer agents targeting β-amyloid, tau, and cholinesterase pathologies</span></div><div class="casAuthors">Di Pietro, Ornella; Perez-Areales, F. Javier; Juarez-Jimenez, Jordi; Espargaro, Alba; Clos, M. Victoria; Perez, Belen; Lavilla, Rodolfo; Sabate, Raimon; Luque, F. Javier; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">107-117</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Optimization of an essentially inactive 3,4-dihydro-2H-pyrano[3,2-c]quinoline carboxylic ester deriv. as acetylcholinesterase (AChE) peripheral anionic site (PAS)-binding motif by double O → NH bioisosteric replacement, combined with mol. hybridization with the AChE catalytic anionic site (CAS) inhibitor 6-chlorotacrine and mol. dynamics-driven optimization of the length of the linker has resulted in the development of the trimethylene-linked 1,2,3,4-tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrid I as a picomolar inhibitor of human AChE (hAChE).  The tetra-, penta-, and octamethylene-linked homologs I [X = (CH2)4, (CH2)5, (CH2)8] have been also synthesized for comparison purposes, and found to retain the nanomolar hAChE inhibitory potency of the parent 6-chlorotacrine.  Further biol. profiling of hybrids I has shown that they are also potent inhibitors of human butyrylcholinesterase and moderately potent Aβ42 and tau antiaggregating agents, with IC50 values in the submicromolar and low micromolar range, resp.  Also, in vitro studies using an artificial membrane model have predicted a good brain permeability for hybrids I, and hence, their ability to reach their targets in the central nervous system.  The multitarget profile of the novel hybrids makes them promising leads for developing anti-Alzheimer drug candidates with more balanced biol. activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOcQV1Ii0VkbVg90H21EOLACvtfcHk0ljQhSturWSMbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Grs7fI&md5=c52fbb0243247cd8088d94a368c33186</span></div><a href="/servlet/linkout?suffix=cit19d&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.07.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.07.021%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BPietro%26aufirst%3DO.%26aulast%3DP%25C3%25A9rez-Areales%26aufirst%3DF.%2BJ.%26aulast%3DJu%25C3%25A1rez-Jim%25C3%25A9nez%26aufirst%3DJ.%26aulast%3DEspargar%25C3%25B3%26aufirst%3DA.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DP%25C3%25A9rez%26aufirst%3DB.%26aulast%3DLavilla%26aufirst%3DR.%26aulast%3DSabat%25C3%25A9%26aufirst%3DR.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DTetrahydrobenzo%255Bh%255D%255B1%252C6%255Dnaphthyridine-6-chlorotacrine%2520hybrids%2520as%2520a%2520new%2520family%2520of%2520anti-Alzheimer%2520agents%2520targeting%2520%25CE%25B2-amyloid%252C%2520tau%252C%2520and%2520cholinesterase%2520pathologies%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D84%26spage%3D107%26epage%3D117%26doi%3D10.1016%2Fj.ejmech.2014.07.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Espargaró, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pont, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabate, R.</span></span> <span> </span><span class="NLM_article-title">Amyloid pan-inhibitors: one family of compounds to cope with all conformational diseases</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1311</span>– <span class="NLM_lpage">1317</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.8b00398</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.8b00398" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVCisbnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=1311-1317&author=A.+Espargar%C3%B3author=C.+Pontauthor=P.+Gamezauthor=D.+Mu%C3%B1oz-Torreroauthor=R.+Sabate&title=Amyloid+pan-inhibitors%3A+one+family+of+compounds+to+cope+with+all+conformational+diseases&doi=10.1021%2Facschemneuro.8b00398"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid Pan-inhibitors: One Family of Compounds To Cope with All Conformational Diseases</span></div><div class="casAuthors">Espargaro, Alba; Pont, Caterina; Gamez, Patrick; Munoz-Torrero, Diego; Sabate, Raimon</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1311-1317</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Amyloids are ubiquitous protein aggregates sharing common internal structural features; they are present in all organisms, from prokaryotes to eukaryotes, where they play physiol. or pathol. roles.  Importantly, amyloids, which are generated by aggregation of a range of distinct proteins, could be a key factor in a no. of major human disorders, the so-called conformational diseases.  Because all amyloids exhibit similar cross-β motifs, one may envisage that mols. capable of blocking the formation of β-sheet structures could abolish aggregation of all amyloid proteins, albeit with different efficacies.  Herein, two different β-sheet blockers were tested against a selection of amyloidogenic proteins, encompassing all the major types of amyloid-based disorders.  Anal. of their blocking efficiency, using a simple but contrasted cell-based screening procedure, unequivocally confirms that they indeed behave as aggregation pan-inhibitors.  The significant inhibitory effects obsd. for these compds. against all tested amyloidogenic proteins could spur a broader biol. evaluation of other known and new amyloid aggregation inhibitors to further det. the potential use of this class of compds. for the universal treatment of conformational diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgY8Nl1j3237Vg90H21EOLACvtfcHk0ljQhSturWSMbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVCisbnN&md5=51e904c0d077435c27bd3fd11df07f5e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.8b00398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.8b00398%26sid%3Dliteratum%253Aachs%26aulast%3DEspargar%25C3%25B3%26aufirst%3DA.%26aulast%3DPont%26aufirst%3DC.%26aulast%3DGamez%26aufirst%3DP.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DSabate%26aufirst%3DR.%26atitle%3DAmyloid%2520pan-inhibitors%253A%2520one%2520family%2520of%2520compounds%2520to%2520cope%2520with%2520all%2520conformational%2520diseases%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2019%26volume%3D10%26spage%3D1311%26epage%3D1317%26doi%3D10.1021%2Facschemneuro.8b00398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Pietro, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juárez-Jiménez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laughton, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span> <span> </span><span class="NLM_article-title">Unveiling a novel transient druggable pocket in BACE-1 through molecular simulations: conformational analysis and binding mode of multisite inhibitors</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>, <span class="NLM_elocation-id">e0177683</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0177683</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1371%2Fjournal.pone.0177683" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=28505196" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsF2nsrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&author=O.+Di%0APietroauthor=J.+Ju%C3%A1rez-Jim%C3%A9nezauthor=D.+Mu%C3%B1oz-Torreroauthor=C.+A.+Laughtonauthor=F.+J.+Luque&title=Unveiling+a+novel+transient+druggable+pocket+in+BACE-1+through+molecular+simulations%3A+conformational+analysis+and+binding+mode+of+multisite+inhibitors&doi=10.1371%2Fjournal.pone.0177683"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Unveiling a novel transient druggable pocket in bace-1 through molecular simulations: conformational analysis and binding mode of multisite inhibitors</span></div><div class="casAuthors">Di Pietro, Ornella; Juarez-Jimenez, Jordi; Munoz-Torrero, Diego; Laughton, Charles A.; Luque, F. Javier</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e0177683/1-e0177683/22</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The crit. role of BACE-1 in the formation of neurotoxic β-amyloid peptides in the brain makes it an attractive target for an efficacious treatment of Alzheimer's disease.  However, the development of clin. useful BACE-1 inhibitors has proven to be extremely challenging.  In this study we examine the binding mode of a novel potent inhibitor (compd. 1, with IC50 80 nM) designed by synergistic combination of two fragments-huprine and rhein- that individually are endowed with very low activity against BACE-1.  Examn. of crystal structures reveals no appropriate binding site large enough to accommodate 1.  Therefore we have examd. the conformational flexibility of BACE-1 through extended mol. dynamics simulations, paying attention to the highly flexible region shaped by loops 8-14, 154-169 and 307-318.  The anal. of the protein dynamics, together with studies of pocket druggability, has allowed us to detect the transient formation of a secondary binding site, which contains Arg307 as a key residue for the interaction with small mols., at the edge of the catalytic cleft.  The formation of this druggable "floppy" pocket would enable the binding of multisite inhibitors targeting both catalytic and secondary sites.  Mol. dynamics simulations of BACE-1 bound to huprine-rhein hybrid compds. support the feasibility of this hypothesis.  The results provide a basis to explain the high inhibitory potency of the two enantiomeric forms of 1, together with the large dependence on the length of the oligomethylenic linker.  Furthermore, the multisite hypothesis has allowed us to rationalize the inhibitory potency of a series of tacrine-chromene hybrid compds., specifically regarding the apparent lack of sensitivity of the inhibition const. to the chem. modifications introduced in the chromene unit.  Overall, these findings pave the way for the exploration of novel functionalities in the design of optimized BACE-1 multisite inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPkTHdHnmrSrVg90H21EOLACvtfcHk0ljPu_5GMhF3_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsF2nsrrL&md5=bf8948c5989a213ae21b2570ae96d993</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0177683&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0177683%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BPietro%26aufirst%3DO.%26aulast%3DJu%25C3%25A1rez-Jim%25C3%25A9nez%26aufirst%3DJ.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DLaughton%26aufirst%3DC.%2BA.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26atitle%3DUnveiling%2520a%2520novel%2520transient%2520druggable%2520pocket%2520in%2520BACE-1%2520through%2520molecular%2520simulations%253A%2520conformational%2520analysis%2520and%2520binding%2520mode%2520of%2520multisite%2520inhibitors%26jtitle%3DPLoS%2520One%26date%3D2017%26volume%3D12%26doi%3D10.1371%2Fjournal.pone.0177683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Ruiz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Palomero, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorronsoro, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">del Monte-Millán, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenzuela, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Usán, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Austria, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrisano, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bidon-Chanal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orozco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez, A.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors: new disease-modifying agents for Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">7223</span>– <span class="NLM_lpage">7233</span>, <span class="refDoi"> DOI: 10.1021/jm0503289</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0503289" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtV2nu7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7223-7233&author=P.+Mu%C3%B1oz-Ruizauthor=L.+Rubioauthor=E.+Garc%C3%ADa-Palomeroauthor=I.+Dorronsoroauthor=M.+del+Monte-Mill%C3%A1nauthor=R.+Valenzuelaauthor=P.+Us%C3%A1nauthor=C.+de+Austriaauthor=M.+Bartoliniauthor=V.+Andrisanoauthor=A.+Bidon-Chanalauthor=M.+Orozcoauthor=F.+J.+Luqueauthor=M.+Medinaauthor=A.+Mart%C3%ADnez&title=Design%2C+synthesis%2C+and+biological+evaluation+of+dual+binding+site+acetylcholinesterase+inhibitors%3A+new+disease-modifying+agents+for+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm0503289"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of Dual Binding Site Acetylcholinesterase Inhibitors: New Disease-Modifying Agents for Alzheimer's Disease</span></div><div class="casAuthors">Munoz-Ruiz, Pilar; Rubio, Laura; Garcia-Palomero, Esther; Dorronsoro, Isabel; Monte-Millan, Maria del; Valenzuela, Rita; Usan, Paola; de Austria, Celia; Bartolini, Manuela; Andrisano, Vincenza; Bidon-Chanal, Axel; Orozco, Modesto; Luque, F. Javier; Medina, Miguel; Martinez, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7223-7233</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">New dual binding site acetylcholinesterase (AChE) inhibitors have been designed and synthesized as new potent drugs that may simultaneously alleviate cognitive deficits and behave as disease-modifying agents by inhibiting the β-amyloid (Aβ) peptide aggregation through binding to both catalytic and peripheral sites of the enzyme.  Particularly, compds. 5 and 6 emerged as the most potent heterodimers reported so far, displaying IC50 values for AChE inhibition of 20 and 60 pM, resp.  More importantly, these dual AChE inhibitors inhibit the AChE-induced Aβ peptide aggregation with IC50 values 1 order of magnitude lower than that of propidium, thus being the most potent derivs. with this activity reported up to date.  We therefore conclude that these compds. are very promising disease-modifying agents for the treatment of Alzheimer's disease (AD).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryN7Kwa5OXZ7Vg90H21EOLACvtfcHk0ljPu_5GMhF3_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtV2nu7%252FO&md5=bb5781896d759075a46bbe2222bbca03</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm0503289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0503289%26sid%3Dliteratum%253Aachs%26aulast%3DMu%25C3%25B1oz-Ruiz%26aufirst%3DP.%26aulast%3DRubio%26aufirst%3DL.%26aulast%3DGarc%25C3%25ADa-Palomero%26aufirst%3DE.%26aulast%3DDorronsoro%26aufirst%3DI.%26aulast%3Ddel%2BMonte-Mill%25C3%25A1n%26aufirst%3DM.%26aulast%3DValenzuela%26aufirst%3DR.%26aulast%3DUs%25C3%25A1n%26aufirst%3DP.%26aulast%3Dde%2BAustria%26aufirst%3DC.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBidon-Chanal%26aufirst%3DA.%26aulast%3DOrozco%26aufirst%3DM.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DMedina%26aufirst%3DM.%26aulast%3DMart%25C3%25ADnez%26aufirst%3DA.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520dual%2520binding%2520site%2520acetylcholinesterase%2520inhibitors%253A%2520new%2520disease-modifying%2520agents%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7223%26epage%3D7233%26doi%3D10.1021%2Fjm0503289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pi, R.</span>; <span class="NLM_string-name">Ye, M.</span>; <span class="NLM_string-name">Cheng, Z.</span>; <span class="NLM_string-name">Liu, P.</span></span> <span> </span><span class="NLM_article-title">Preparation of Tacrine–Ferulic Acid Containing Compounds for Treatment of Alzheimer’s Disease</span>. <span class="NLM_patent">CN101284812 A</span>, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=R.+Pi&author=M.+Ye&author=Z.+Cheng&author=P.+Liu&title=Preparation+of+Tacrine%E2%80%93Ferulic+Acid+Containing+Compounds+for+Treatment+of+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPi%26aufirst%3DR.%26atitle%3DPreparation%2520of%2520Tacrine%25E2%2580%2593Ferulic%2520Acid%2520Containing%2520Compounds%2520for%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, M.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.-F.</span></span> <span> </span><span class="NLM_article-title">A Facile synthesis of bis-tacrine isosteres</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">1815</span>– <span class="NLM_lpage">1818</span>, <span class="refDoi"> DOI: 10.1016/S0040-4039(00)00036-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2FS0040-4039%2800%2900036-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD3cXitFyjtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2000&pages=1815-1818&author=M.-K.+Huauthor=C.-F.+Lu&title=A+Facile+synthesis+of+bis-tacrine+isosteres&doi=10.1016%2FS0040-4039%2800%2900036-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">A facile synthesis of bis-tacrine isosteres</span></div><div class="casAuthors">Hu, Ming-Kuan; Lu, Chih-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1815-1818</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">An efficient synthesis of highly potent and selective acetylcholinesterase (AChE) inhibitors (no data), bis-tacrines and their isosteres I (R = H, Cl, F; Y = CH, N; m = 0, 1, 2; n = 6, 7, 8), was accomplished by bis-amination of 9-chloro-tetrahydroacridine and its analogs.  The crit. intermediates were concisely prepd. in situ by heating the corresponding ortho-amino arom. acids and cycloketones in the presence of phosphorus oxychloride.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreB1JHH-X0lLVg90H21EOLACvtfcHk0ljPu_5GMhF3_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXitFyjtLo%253D&md5=b1e8ac5bd3aea126380ae89bcaa9f165</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2800%2900036-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252800%252900036-8%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DM.-K.%26aulast%3DLu%26aufirst%3DC.-F.%26atitle%3DA%2520Facile%2520synthesis%2520of%2520bis-tacrine%2520isosteres%26jtitle%3DTetrahedron%2520Lett.%26date%3D2000%26volume%3D41%26spage%3D1815%26epage%3D1818%26doi%3D10.1016%2FS0040-4039%2800%2900036-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sola, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artigas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Areales, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viayna, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clos, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of N-cyanoalkyl-, N-aminoalkyl-, and N-guanidinoalkyl-substituted 4-aminoquinoline derivatives as potent, selective, brain permeable antitrypanosomal agents</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">5162</span>– <span class="NLM_lpage">5171</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.08.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2Fj.bmc.2016.08.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=27591008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVCgsrfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=5162-5171&author=I.+Solaauthor=A.+Artigasauthor=M.+C.+Taylorauthor=F.+J.+P%C3%A9rez-Arealesauthor=E.+Viaynaauthor=M.+V.+Closauthor=B.+P%C3%A9rezauthor=C.+W.+Wrightauthor=J.+M.+Kellyauthor=D.+Mu%C3%B1oz-Torrero&title=Synthesis+and+biological+evaluation+of+N-cyanoalkyl-%2C+N-aminoalkyl-%2C+and+N-guanidinoalkyl-substituted+4-aminoquinoline+derivatives+as+potent%2C+selective%2C+brain+permeable+antitrypanosomal+agents&doi=10.1016%2Fj.bmc.2016.08.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of N-cyanoalkyl-, N-aminoalkyl- and N-guanidinoalkyl-substituted 4-aminoquinoline derivatives as potent, selective, brain permeable antitrypanosomal agents</span></div><div class="casAuthors">Sola, Irene; Artigas, Albert; Taylor, Martin C.; Perez-Areales, F. Javier; Viayna, Elisabet; Clos, M. Victoria; Perez, Belen; Wright, Colin W.; Kelly, John M.; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5162-5171</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The evaluation of a small inhouse library and a second generation of newly synthesized derivs., which was led to the identification of 13 side chain modified 4-aminoquinolines I [R = H, n = 7, 9; R = Cl, n = 7, 8, 9], II [R1 = H, n = 7, 9; R1 = Cl, n = 9] and III [R2 = H, n = 7, 9; R2 = Cl, n = 9] with submicromolar potencies against T. brucei was described.  Among these compds., the guanidinononyltacrine III [R2 = H, n = 9] exhibited a 5-fold increased antitrypanosomal potency, 10-fold increased selectivity and 100-fold decreased anticholinesterasic activity relative to the parent huprine Y.  Its biol. profile, lower mol. wt. relative to dimeric compds., reduced lipophilicity and ease of synthesis, made it an interesting anti-HAT lead, amenable to further optimization to eliminate its remaining anticholinesterasic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG3NNWlrfvILVg90H21EOLACvtfcHk0liEh9R01H1J6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVCgsrfK&md5=a1a2ded9007bbbefcc2e45992609fdb9</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.08.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.08.036%26sid%3Dliteratum%253Aachs%26aulast%3DSola%26aufirst%3DI.%26aulast%3DArtigas%26aufirst%3DA.%26aulast%3DTaylor%26aufirst%3DM.%2BC.%26aulast%3DP%25C3%25A9rez-Areales%26aufirst%3DF.%2BJ.%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DP%25C3%25A9rez%26aufirst%3DB.%26aulast%3DWright%26aufirst%3DC.%2BW.%26aulast%3DKelly%26aufirst%3DJ.%2BM.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520N-cyanoalkyl-%252C%2520N-aminoalkyl-%252C%2520and%2520N-guanidinoalkyl-substituted%25204-aminoquinoline%2520derivatives%2520as%2520potent%252C%2520selective%252C%2520brain%2520permeable%2520antitrypanosomal%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D5162%26epage%3D5171%26doi%3D10.1016%2Fj.bmc.2016.08.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Camps, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sánchez, L.</span></span> <span> </span><span class="NLM_article-title">Stereoselective synthesis of both enantiomers of N-Boc-α-aryl-γ-aminobutyric acids</span>. <i>Tetrahedron Asymmetry</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">311</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1016/j.tetasy.2003.10.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2Fj.tetasy.2003.10.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktVSrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2004&pages=311-321&author=P.+Campsauthor=D.+Mu%C3%B1oz-Torreroauthor=L.+S%C3%A1nchez&title=Stereoselective+synthesis+of+both+enantiomers+of+N-Boc-%CE%B1-aryl-%CE%B3-aminobutyric+acids&doi=10.1016%2Fj.tetasy.2003.10.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26aR"><div class="casContent"><span class="casTitleNuber">26a</span><div class="casTitle"><span class="NLM_cas:atitle">Stereoselective synthesis of both enantiomers of N-Boc-α-aryl-γ-aminobutyric acids</span></div><div class="casAuthors">Camps, Pelayo; Munoz-Torrero, Diego; Sanchez, Laura</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron: Asymmetry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">311-321</span>CODEN:
                <span class="NLM_cas:coden">TASYE3</span>;
        ISSN:<span class="NLM_cas:issn">0957-4166</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Esterification of racemic α-aryl-β-cyanopropionic acid chlorides with either (R)- or (S)-N-phenylpantolactam as the chiral auxiliary in the presence of Et3N resulted in the predominant formation of (αR,3'R)- or (αS,3'S)-configured pantolactam cyano ester, resp., in nearly quant. yields with diastereomeric ratios of up to 93:7.  Column chromatog. of the diastereoenriched cyano esters, followed by hydrolysis of the resulting diastereopure cyano esters under essentially nonracemizing conditions gave enantiopure α-aryl-β-cyanopropionic acids, which were readily converted in high yields into enantiopure (αR)- and (αS)-configured N-tert-butoxycarbonyl-α-aryl-γ-aminobutyric acid (GABA) derivs. of potential biol. interest.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSo6e3H77ZnbVg90H21EOLACvtfcHk0liEh9R01H1J6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktVSrtw%253D%253D&md5=1eb714608405f93ea77dffa5c259cad4</span></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.1016%2Fj.tetasy.2003.10.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetasy.2003.10.035%26sid%3Dliteratum%253Aachs%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DS%25C3%25A1nchez%26aufirst%3DL.%26atitle%3DStereoselective%2520synthesis%2520of%2520both%2520enantiomers%2520of%2520N-Boc-%25CE%25B1-aryl-%25CE%25B3-aminobutyric%2520acids%26jtitle%3DTetrahedron%2520Asymmetry%26date%3D2004%26volume%3D15%26spage%3D311%26epage%3D321%26doi%3D10.1016%2Fj.tetasy.2003.10.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit26b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Camps, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span> <span> </span><span class="NLM_article-title">Synthesis and applications of (R)- and (S)-pantolactone as chiral auxiliaries</span>. <i>Curr. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1339</span>– <span class="NLM_lpage">1380</span>, <span class="refDoi"> DOI: 10.2174/1385272043369944</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.2174%2F1385272043369944" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntFOmt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2004&pages=1339-1380&author=P.+Campsauthor=D.+Mu%C3%B1oz-Torrero&title=Synthesis+and+applications+of+%28R%29-+and+%28S%29-pantolactone+as+chiral+auxiliaries&doi=10.2174%2F1385272043369944"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26bR"><div class="casContent"><span class="casTitleNuber">26b</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and applications of (R)- and (S)-pantolactone as chiral auxiliaries</span></div><div class="casAuthors">Camps, Pelayo; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">Current Organic Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1339-1380</span>CODEN:
                <span class="NLM_cas:coden">CORCFE</span>;
        ISSN:<span class="NLM_cas:issn">1385-2728</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Chiral auxiliary-based reactions constitute one the most intense research areas in org. chem.  During the last three decades (R)-pantolactone and to a minor extent its (S)-enantiomer were used as very efficient chiral auxiliaries, thus contributing to the development of chiral auxiliary-based asym. synthesis as a common approach for the prepn. of enantiomerically pure compds.  This review covers the syntheses of both (R)- and (S)-pantolactone, as well as their applications not only as chiral auxiliaries in asym. synthesis, but also in racemate resolns. and as chiral templates.  The development and applications of several analogs of pantolactone with improved profile is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYMAZXVBvvXLVg90H21EOLACvtfcHk0lhkqVBfq9wQHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntFOmt7o%253D&md5=e9063f3bed14f6ad7d5976f8abc732c8</span></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=10.2174%2F1385272043369944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1385272043369944%26sid%3Dliteratum%253Aachs%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DSynthesis%2520and%2520applications%2520of%2520%2528R%2529-%2520and%2520%2528S%2529-pantolactone%2520as%2520chiral%2520auxiliaries%26jtitle%3DCurr.%2520Org.%2520Chem.%26date%3D2004%26volume%3D8%26spage%3D1339%26epage%3D1380%26doi%3D10.2174%2F1385272043369944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ellman, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courtney, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andres, V.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Featherstone, R. M.</span></span> <span> </span><span class="NLM_article-title">A new and rapid colorimetric determination of acetylcholinesterase activity</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1961</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">88</span>– <span class="NLM_lpage">95</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(61)90145-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2F0006-2952%2861%2990145-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=13726518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADyaF3MXht1Gns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1961&pages=88-95&author=G.+L.+Ellmanauthor=K.+D.+Courtneyauthor=V.+Andresauthor=R.+M.+Featherstone&title=A+new+and+rapid+colorimetric+determination+of+acetylcholinesterase+activity&doi=10.1016%2F0006-2952%2861%2990145-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A new and rapid colorimetric determination of acetylcholinesterase activity</span></div><div class="casAuthors">Ellman, George L.; Courtney, K. Diane; Andres, Valentino, Jr.; Featherstone, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">88-95</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">A photometric method for detg. acetylcholinesterase activity of tissue exts., homogenates, cell suspensions, etc. was described.  The enzyme activity of acetylcholinesterase was measured by following the increase of yellow color produced from thiocholine when it reacts with dithiobisnitrobenzoate ion, based on the reactions: acetylthiocholine (enzyme.rdblhar.) thioeholine + acetate.  Thiocholine + dithiobisnitrobenzoate .rdblhar. yellow color.  The method was used to study the enzyme in human erythrocytes and homogenates of rat brain, kidney, lungs, liver, and muscle tissue.  Hydrolysis rates [(moles/l./min.) × 10-6/g. tissue] by these homogenates of tissues on acetylthiocholine were 10.31, 0.28, 1.63, 1.07, and 1.82, and on butyrylthiocholine were 0.31, 0.21, 0.54, 0.65, and 0.12, resp.  Data obtained with acetylthiocholine as substrate were similar to those with acetylcholine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq21LY6gwNKrVg90H21EOLACvtfcHk0lhkqVBfq9wQHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF3MXht1Gns7o%253D&md5=46f891b7e338036a7c7d4333b82b6874</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2861%2990145-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252861%252990145-9%26sid%3Dliteratum%253Aachs%26aulast%3DEllman%26aufirst%3DG.%2BL.%26aulast%3DCourtney%26aufirst%3DK.%2BD.%26aulast%3DAndres%26aufirst%3DV.%26aulast%3DFeatherstone%26aufirst%3DR.%2BM.%26atitle%3DA%2520new%2520and%2520rapid%2520colorimetric%2520determination%2520of%2520acetylcholinesterase%2520activity%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1961%26volume%3D7%26spage%3D88%26epage%3D95%26doi%3D10.1016%2F0006-2952%2861%2990145-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wlodek, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antosiewicz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCammon, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straatsma, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilson, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briggs, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humblet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sussman, J. L.</span></span> <span> </span><span class="NLM_article-title">Binding of tacrine and 6-chlorotacrine by acetylcholinesterase</span>. <i>Biopolymers</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">117</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1097-0282(199601)38:13.0.CO;2-#</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1002%2F%28SICI%291097-0282%28199601%2938%3A1%3C109%3A%3AAID-BIP9%3E3.0.CO%3B2-%23" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=8679940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADyaK28XpvVen" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1996&pages=109-117&author=S.+T.+Wlodekauthor=J.+Antosiewiczauthor=J.+A.+McCammonauthor=T.+P.+Straatsmaauthor=M.+K.+Gilsonauthor=J.+M.+Briggsauthor=C.+Humbletauthor=J.+L.+Sussman&title=Binding+of+tacrine+and+6-chlorotacrine+by+acetylcholinesterase&doi=10.1002%2F%28SICI%291097-0282%28199601%2938%3A13.0.CO%3B2-%23"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Binding of tacrine and 6-chlorotacrine by acetylcholinesterase</span></div><div class="casAuthors">Wlodek, S. T.; Antosiewicz, J.; McCammon, J. A.; Straatsma, T. P.; Gilson, M. K.; Briggs, J. M.; Humblet, C.; Sussman, J. L.</div><div class="citationInfo"><span class="NLM_cas:title">Biopolymers</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">109-17</span>CODEN:
                <span class="NLM_cas:coden">BIPMAA</span>;
        ISSN:<span class="NLM_cas:issn">0006-3525</span>.
    
            (<span class="NLM_cas:orgname">Wiley</span>)
        </div><div class="casAbstract">Multiconfiguration thermodn. integration was used to det. the relative binding strength of tacrine and 6-chlorotacrine by Torpedo californica acetylcholinesterase.  6-Chlorotacrine appears to be bound stronger by 0.7 kcal/mol than unsubstituted tacrine when the active site triad residue His-440 is deprotonated.  This result is in excellent agreement with exptl. inhibition data on elec. eel acetylcholinesterase.  Electrostatic Poisson-Boltzmann calcns. confirm that order of binding strength, resulting in ΔG of binding of -2.9 and -3.3 kcal/mol for tacrine and chlorotacrine, resp., and suggest inhibitor binding does not occur when His-440 is charged.  The results suggest that electron d. redistribution upon tacrine chlorination is mainly responsible for the increased attraction potential between protonated inhibitor mol. and adjacent arom. groups of Phe-330 and Trp-84.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyOgkYp6yoQbVg90H21EOLACvtfcHk0lhkqVBfq9wQHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XpvVen&md5=1bd5e7dd789fbca5832152ed75db0f5b</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0282%28199601%2938%3A1%3C109%3A%3AAID-BIP9%3E3.0.CO%3B2-%23&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0282%2528199601%252938%253A1%253C109%253A%253AAID-BIP9%253E3.0.CO%253B2-%2523%26sid%3Dliteratum%253Aachs%26aulast%3DWlodek%26aufirst%3DS.%2BT.%26aulast%3DAntosiewicz%26aufirst%3DJ.%26aulast%3DMcCammon%26aufirst%3DJ.%2BA.%26aulast%3DStraatsma%26aufirst%3DT.%2BP.%26aulast%3DGilson%26aufirst%3DM.%2BK.%26aulast%3DBriggs%26aufirst%3DJ.%2BM.%26aulast%3DHumblet%26aufirst%3DC.%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26atitle%3DBinding%2520of%2520tacrine%2520and%25206-chlorotacrine%2520by%2520acetylcholinesterase%26jtitle%3DBiopolymers%26date%3D1996%26volume%3D38%26spage%3D109%26epage%3D117%26doi%3D10.1002%2F%28SICI%291097-0282%28199601%2938%3A13.0.CO%3B2-%23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Scheiner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolles, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunesch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabissi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marinelli, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naldi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petralla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poeta, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falkeis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vieth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gmeiner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maitra, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, M.</span></span> <span> </span><span class="NLM_article-title">Dual-acting cholinesterase–human cannabinoid receptor 2 ligands show pronounced neuroprotection in vitro and overadditive and disease-modifying neuroprotective effects in vivo</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">9078</span>– <span class="NLM_lpage">9102</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00623</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00623" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFCrs7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=9078-9102&author=M.+Scheinerauthor=D.+Dollesauthor=S.+Guneschauthor=M.+Hoffmannauthor=M.+Nabissiauthor=O.+Marinelliauthor=M.+Naldiauthor=M.+Bartoliniauthor=S.+Petrallaauthor=E.+Poetaauthor=B.+Montiauthor=C.+Falkeisauthor=M.+Viethauthor=H.+H%C3%BCbnerauthor=P.+Gmeinerauthor=R.+Maitraauthor=T.+Mauriceauthor=M.+Decker&title=Dual-acting+cholinesterase%E2%80%93human+cannabinoid+receptor+2+ligands+show+pronounced+neuroprotection+in+vitro+and+overadditive+and+disease-modifying+neuroprotective+effects+in+vivo&doi=10.1021%2Facs.jmedchem.9b00623"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29aR"><div class="casContent"><span class="casTitleNuber">29a</span><div class="casTitle"><span class="NLM_cas:atitle">Dual-Acting Cholinesterase-Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo</span></div><div class="casAuthors">Scheiner, Matthias; Dolles, Dominik; Gunesch, Sandra; Hoffmann, Matthias; Nabissi, Massimo; Marinelli, Oliviero; Naldi, Marina; Bartolini, Manuela; Petralla, Sabrina; Poeta, Eleonora; Monti, Barbara; Falkeis, Christina; Vieth, Michael; Huebner, Harald; Gmeiner, Peter; Maitra, Rangan; Maurice, Tangui; Decker, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">9078-9102</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have designed and synthesized a series of 14 hybrid mols. out of the cholinesterase (ChE) inhibitor tacrine and a benzimidazole-based human cannabinoid receptor subtype 2 (hCB2R) agonist and investigated them in vitro and in vivo.  The compds. are potent ChE inhibitors, and for the most promising hybrids, the mechanism of human acetylcholinesterase (hAChE) inhibition as well as their ability to interfere with AChE-induced aggregation of β-amyloid (Aβ), and Aβ self-aggregation was assessed.  All hybrids were evaluated for affinity and selectivity for hCB1R and hCB2R.  To ensure that the hybrids retained their agonist character, the expression of cAMP-regulated genes was quantified, and potency and efficacy were detd.  Addnl., the effects of the hybrids on microglia activation and neuroprotection on HT-22 cells were investigated.  The most promising in vitro hybrids showed pronounced neuroprotection in an Alzheimer's mouse model at low dosage (0.1 mg/kg, i.p.), lacking hepatotoxicity even at high dose (3 mg/kg, i.p.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGRfz6xatTXLVg90H21EOLACvtfcHk0lgtqitLnm4TIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFCrs7%252FM&md5=f0148c8ba51a2d0cbe83a26bb388a446</span></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00623%26sid%3Dliteratum%253Aachs%26aulast%3DScheiner%26aufirst%3DM.%26aulast%3DDolles%26aufirst%3DD.%26aulast%3DGunesch%26aufirst%3DS.%26aulast%3DHoffmann%26aufirst%3DM.%26aulast%3DNabissi%26aufirst%3DM.%26aulast%3DMarinelli%26aufirst%3DO.%26aulast%3DNaldi%26aufirst%3DM.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DPetralla%26aufirst%3DS.%26aulast%3DPoeta%26aufirst%3DE.%26aulast%3DMonti%26aufirst%3DB.%26aulast%3DFalkeis%26aufirst%3DC.%26aulast%3DVieth%26aufirst%3DM.%26aulast%3DH%25C3%25BCbner%26aufirst%3DH.%26aulast%3DGmeiner%26aufirst%3DP.%26aulast%3DMaitra%26aufirst%3DR.%26aulast%3DMaurice%26aufirst%3DT.%26aulast%3DDecker%26aufirst%3DM.%26atitle%3DDual-acting%2520cholinesterase%25E2%2580%2593human%2520cannabinoid%2520receptor%25202%2520ligands%2520show%2520pronounced%2520neuroprotection%2520in%2520vitro%2520and%2520overadditive%2520and%2520disease-modifying%2520neuroprotective%2520effects%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D9078%26epage%3D9102%26doi%3D10.1021%2Facs.jmedchem.9b00623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit29b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Maspero, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volpato, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cirillo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan Chen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messerer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotriffer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Amici, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holzgrabe, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dallanoce, C.</span></span> <span> </span><span class="NLM_article-title">Tacrine-xanomeline and tacrine-iperoxo hybrid ligands: synthesis and biological evaluation at acetylcholinesterase and M1 muscarinic acetylcholine receptors</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">103633</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2020.103633</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2Fj.bioorg.2020.103633" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=32032848" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisV2ntbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2020&pages=103633&author=M.+Masperoauthor=D.+Volpatoauthor=D.+Cirilloauthor=N.+Yuan+Chenauthor=R.+Messererauthor=C.+Sotrifferauthor=M.+De+Amiciauthor=U.+Holzgrabeauthor=C.+Dallanoce&title=Tacrine-xanomeline+and+tacrine-iperoxo+hybrid+ligands%3A+synthesis+and+biological+evaluation+at+acetylcholinesterase+and+M1+muscarinic+acetylcholine+receptors&doi=10.1016%2Fj.bioorg.2020.103633"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29bR"><div class="casContent"><span class="casTitleNuber">29b</span><div class="casTitle"><span class="NLM_cas:atitle">Tacrine-xanomeline and tacrine-iperoxo hybrid ligands: Synthesis and biological evaluation at acetylcholinesterase and M1 muscarinic acetylcholine receptors</span></div><div class="casAuthors">Maspero, Marco; Volpato, Daniela; Cirillo, Davide; Yuan Chen, Natalia; Messerer, Regina; Sotriffer, Christoph; De Amici, Marco; Holzgrabe, Ulrike; Dallanoce, Clelia</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103633</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A set of new hybrid derivs., in which apolymethylene spacer chain of variable length connected the pharmacophoric moiety of xanomeline are synthesized ,anM1/M4preferring orthosteric muscarinic agonist, with that of tacrine, a well-known acetylcholinesterase (AChE) inhibitor abletoallosterically modulatemuscarinicacetylcholinereceptors(mAChRs).  When tested in vitro in a colorimetric assay for their ability to inhibit AChE, the new compds. showed higher or similar potency compared to that of tacrine.  Docking analyses were performed on the most potent inhibitors to rationalize their exptl. inhibitory power against AChE.  Next, the signaling cascade at M1 mAChRs by exploring the interaction of Gαq-PLC-β3 proteins through split luciferase assays and the myo-Inositol 1 phosphate (IP1) accumulation in cells is evaluated.  The results were compared with those obtained on the known derivs., two quite potent AChE inhibitors in which tacrine is linked to iperoxo, an exceptionally potent muscarinic orthosteric activator.  Interestingly, it was found that iprexo tacrine hybrids behaved as partial agonists of the M1 mAChR, at variance with hybrids contg. xanomeline as the orthosteric mol. fragment, which were all unable to activate the receptor subtype response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphmTAZqGXNK7Vg90H21EOLACvtfcHk0lgtqitLnm4TIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisV2ntbk%253D&md5=8ac4f30f17c6ea4d4db5a148cf91095a</span></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2020.103633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2020.103633%26sid%3Dliteratum%253Aachs%26aulast%3DMaspero%26aufirst%3DM.%26aulast%3DVolpato%26aufirst%3DD.%26aulast%3DCirillo%26aufirst%3DD.%26aulast%3DYuan%2BChen%26aufirst%3DN.%26aulast%3DMesserer%26aufirst%3DR.%26aulast%3DSotriffer%26aufirst%3DC.%26aulast%3DDe%2BAmici%26aufirst%3DM.%26aulast%3DHolzgrabe%26aufirst%3DU.%26aulast%3DDallanoce%26aufirst%3DC.%26atitle%3DTacrine-xanomeline%2520and%2520tacrine-iperoxo%2520hybrid%2520ligands%253A%2520synthesis%2520and%2520biological%2520evaluation%2520at%2520acetylcholinesterase%2520and%2520M1%2520muscarinic%2520acetylcholine%2520receptors%26jtitle%3DBioorg.%2520Chem.%26date%3D2020%26volume%3D96%26spage%3D103633%26doi%3D10.1016%2Fj.bioorg.2020.103633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit29c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fancellu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chand, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomás, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlandini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piemontese, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardoso, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaves, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, M. A.</span></span> <span> </span><span class="NLM_article-title">Novel tacrine–benzofuran hybrids as potential multi-target drug candidates for the treatment of Alzheimer’s disease</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">211</span>– <span class="NLM_lpage">226</span>, <span class="refDoi"> DOI: 10.1080/14756366.2019.1689237</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1080%2F14756366.2019.1689237" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=31760822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1amurjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2020&pages=211-226&author=G.+Fancelluauthor=K.+Chandauthor=D.+Tom%C3%A1sauthor=E.+Orlandiniauthor=L.+Piemonteseauthor=D.+F.+Silvaauthor=S.+M.+Cardosoauthor=S.+Chavesauthor=M.+A.+Santos&title=Novel+tacrine%E2%80%93benzofuran+hybrids+as+potential+multi-target+drug+candidates+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1080%2F14756366.2019.1689237"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29cR"><div class="casContent"><span class="casTitleNuber">29c</span><div class="casTitle"><span class="NLM_cas:atitle">Novel tacrine-benzofuran hybrids as potential multi-target drug candidates for the treatment of Alzheimer's Disease</span></div><div class="casAuthors">Fancellu, Gaia; Chand, Karam; Tomas, Daniel; Orlandini, Elisabetta; Piemontese, Luca; Silva, Diana F.; Cardoso, Sandra M.; Chaves, Silvia; Santos, M. Amelia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">211-226</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Pursuing the widespread interest on multi-target drugs to combat Alzheimer's disease (AD), a new series of hybrids was designed and developed based on the repositioning of the well-known acetylcholinesterase (AChE) inhibitor, tacrine (TAC), by its coupling to benzofuran (BF) derivs.  The BF framework aims to endow the conjugate mols. with ability for inhibition of AChE (bimodal way) and of amyloid-beta peptide aggregation, besides providing metal (Fe, Cu) chelating ability and concomitant extra anti-oxidant activity, for the hybrids with hydroxyl substitution.  The new TAC-BF conjugates showed very good activity for AChE inhibition (sub-micromolar range) and good capacity for the inhibition of self- and Cu-mediated Aβ aggregation, with dependence on the linker size and substituent groups of each main moiety.  Neuroprotective effects were also found for the compds. through viability assays of neuroblastoma cells, after Aβ1-42 induced toxicity.  Structure-activity relationship anal. provides insights on the best structural parameters, to take in consideration for future studies in view of potential applications in AD therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqc04kwJBmWDrVg90H21EOLACvtfcHk0lgtqitLnm4TIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1amurjO&md5=bb015d132ddbc0efa4e3af677ddeedcd</span></div><a href="/servlet/linkout?suffix=cit29c&amp;dbid=16384&amp;doi=10.1080%2F14756366.2019.1689237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756366.2019.1689237%26sid%3Dliteratum%253Aachs%26aulast%3DFancellu%26aufirst%3DG.%26aulast%3DChand%26aufirst%3DK.%26aulast%3DTom%25C3%25A1s%26aufirst%3DD.%26aulast%3DOrlandini%26aufirst%3DE.%26aulast%3DPiemontese%26aufirst%3DL.%26aulast%3DSilva%26aufirst%3DD.%2BF.%26aulast%3DCardoso%26aufirst%3DS.%2BM.%26aulast%3DChaves%26aufirst%3DS.%26aulast%3DSantos%26aufirst%3DM.%2BA.%26atitle%3DNovel%2520tacrine%25E2%2580%2593benzofuran%2520hybrids%2520as%2520potential%2520multi-target%2520drug%2520candidates%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2020%26volume%3D35%26spage%3D211%26epage%3D226%26doi%3D10.1080%2F14756366.2019.1689237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit29d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newell, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span> <span> </span><span class="NLM_article-title">Tacrine–hydrogen sulfide donor hybrid ameliorates cognitive impairment in the aluminum chloride mouse model of Alzheimer’s disease</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">3500</span>– <span class="NLM_lpage">3509</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.9b00120</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.9b00120" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVyjs7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=3500-3509&author=X.+Chengauthor=J.+Guauthor=Y.+Pangauthor=J.+Liuauthor=T.+Xuauthor=X.+Liauthor=Y.+Huaauthor=K.+A.+Newellauthor=X.-F.+Huangauthor=Y.+Yuauthor=Y.+Liu&title=Tacrine%E2%80%93hydrogen+sulfide+donor+hybrid+ameliorates+cognitive+impairment+in+the+aluminum+chloride+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facschemneuro.9b00120"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29dR"><div class="casContent"><span class="casTitleNuber">29d</span><div class="casTitle"><span class="NLM_cas:atitle">Tacrine-Hydrogen Sulfide Donor Hybrid Ameliorates Cognitive Impairment in the Aluminum Chloride Mouse Model of Alzheimer's Disease</span></div><div class="casAuthors">Cheng, Xiao-jing; Gu, Jing-xue; Pang, Yi-peng; Liu, Jiao; Xu, Ting; Li, Xin-rui; Hua, Yu-zhou; Newell, Kelly A.; Huang, Xu-Feng; Yu, Yinghua; Liu, Yi</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3500-3509</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a neurodegenerative disorder, characterized by progressive loss of memory and cognitive function, and is assocd. with the deficiency of synaptic acetylcholine, as well as chronic neuroinflammation.  Tacrine, a potent acetylcholinesterase (AChE) inhibitor, was previously a prescribed clin. therapeutic agent for AD, but was recently withdrawn because it caused widespread hepatotoxicity.  Hydrogen sulfide (H2S) has neuroprotective, hepatoprotective and anti-inflammatory effects.  In this study, we synthesized a new compd., a tacrine- H2S donor hybrid (THS) by introducing H2S-releasing moieties (ACS81) to tacrine.  Subsequently, pharmacol. and biol. evaluations of THS were conducted in the aluminum trichloride (AlCl3)-induced AD mice model.  We found that THS (15mmol/kg) improved cognitive and locomotor activity in AD mice in the step-through test and open field test resp.  THS showed strong AChE inhibitory activity in the serum and hippocampus of AD mice and induced increased hippocampal H2S levels.  Furthermore, THS reduced mRNA expression of the proinflammatory cytokines, TNF-α, IL-6, and IL-1β and increased synapse-assocd. proteins (synaptophysin and postsynaptic d. protein 95) in the hippocampus of AD mice.  Importantly, THS, unlike tacrine, did not increase liver transaminases (alanine transaminase and aspartate transaminase) or proinflammatory cytokines, indicating THS is much safer than tacrine.  Therefore, the multifunctional effects of this new hybrid compd. of tacrine and H2S indicate it is a promising compd. for further research into the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe7gbzMI_ZO7Vg90H21EOLACvtfcHk0ljvR7Vt7XGLtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVyjs7jK&md5=c71d4daf33dc809487d9b0e06fb276ec</span></div><a href="/servlet/linkout?suffix=cit29d&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.9b00120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.9b00120%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DGu%26aufirst%3DJ.%26aulast%3DPang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DHua%26aufirst%3DY.%26aulast%3DNewell%26aufirst%3DK.%2BA.%26aulast%3DHuang%26aufirst%3DX.-F.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DY.%26atitle%3DTacrine%25E2%2580%2593hydrogen%2520sulfide%2520donor%2520hybrid%2520ameliorates%2520cognitive%2520impairment%2520in%2520the%2520aluminum%2520chloride%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2019%26volume%3D10%26spage%3D3500%26epage%3D3509%26doi%3D10.1021%2Facschemneuro.9b00120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Savini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaeta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fattorusso, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catalanotti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campiani, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiasserini, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellerano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novellino, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKissic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saxena, A.</span></span> <span> </span><span class="NLM_article-title">Specific targeting of acetylcholinesterase and butyrylcholinesterase recognition sites. Rational design of novel, selective, and highly potent cholinesterase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">4</span>, <span class="refDoi"> DOI: 10.1021/jm0255668</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0255668" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpt1yntb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1-4&author=L.+Saviniauthor=A.+Gaetaauthor=C.+Fattorussoauthor=B.+Catalanottiauthor=G.+Campianiauthor=L.+Chiasseriniauthor=C.+Pelleranoauthor=E.+Novellinoauthor=D.+McKissicauthor=A.+Saxena&title=Specific+targeting+of+acetylcholinesterase+and+butyrylcholinesterase+recognition+sites.+Rational+design+of+novel%2C+selective%2C+and+highly+potent+cholinesterase+inhibitors&doi=10.1021%2Fjm0255668"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Specific Targeting of Acetylcholinesterase and Butyrylcholinesterase Recognition Sites. Rational Design of Novel, Selective, and Highly Potent Cholinesterase Inhibitors</span></div><div class="casAuthors">Savini, Luisa; Gaeta, Alessandra; Fattorusso, Caterina; Catalanotti, Bruno; Campiani, Giuseppe; Chiasserini, Luisa; Pellerano, Cesare; Novellino, Ettore; McKissic, Dawn; Saxena, Ashima</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-4</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tacrine-based AChE and BuChE inhibitors were designed by investigating the topol. of the active site gorge of the two enzymes.  The homobivalent ligands characterized by a nitrogen-bridged atom at the tether level could be considered among the most potent and selective cholinesterase inhibitors described to date.  The nitrogen-contg. homobivalent ligands and the sulfur-contg. ligand validated the hypothesis of extra sites of interaction in the AChE and BuChE active site gorges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-lepg2tVtZLVg90H21EOLACvtfcHk0ljvR7Vt7XGLtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpt1yntb8%253D&md5=1d9abc2e1f63f01686a7c4a79bab57c9</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm0255668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0255668%26sid%3Dliteratum%253Aachs%26aulast%3DSavini%26aufirst%3DL.%26aulast%3DGaeta%26aufirst%3DA.%26aulast%3DFattorusso%26aufirst%3DC.%26aulast%3DCatalanotti%26aufirst%3DB.%26aulast%3DCampiani%26aufirst%3DG.%26aulast%3DChiasserini%26aufirst%3DL.%26aulast%3DPellerano%26aufirst%3DC.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DMcKissic%26aufirst%3DD.%26aulast%3DSaxena%26aufirst%3DA.%26atitle%3DSpecific%2520targeting%2520of%2520acetylcholinesterase%2520and%2520butyrylcholinesterase%2520recognition%2520sites.%2520Rational%2520design%2520of%2520novel%252C%2520selective%252C%2520and%2520highly%2520potent%2520cholinesterase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1%26epage%3D4%26doi%3D10.1021%2Fjm0255668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Recanatini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavalli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belluti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piazzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rampa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bisi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobbi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrisano, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavrini, V.</span></span> <span> </span><span class="NLM_article-title">SAR of 9-amino-1,2,3,4-tetrahydroacridine-based acetylcholinesterase inhibitors: synthesis, enzyme inhibitory activity, QSAR, and structure-based CoMFA of tacrine analogues</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">2007</span>– <span class="NLM_lpage">2018</span>, <span class="refDoi"> DOI: 10.1021/jm990971t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990971t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD3cXis1Gnu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2007-2018&author=M.+Recanatiniauthor=A.+Cavalliauthor=F.+Bellutiauthor=L.+Piazziauthor=A.+Rampaauthor=A.+Bisiauthor=S.+Gobbiauthor=P.+Valentiauthor=V.+Andrisanoauthor=M.+Bartoliniauthor=V.+Cavrini&title=SAR+of+9-amino-1%2C2%2C3%2C4-tetrahydroacridine-based+acetylcholinesterase+inhibitors%3A+synthesis%2C+enzyme+inhibitory+activity%2C+QSAR%2C+and+structure-based+CoMFA+of+tacrine+analogues&doi=10.1021%2Fjm990971t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31aR"><div class="casContent"><span class="casTitleNuber">31a</span><div class="casTitle"><span class="NLM_cas:atitle">SAR of 9-Amino-1,2,3,4-tetrahydroacridine-Based Acetylcholinesterase Inhibitors: Synthesis, Enzyme Inhibitory Activity, QSAR, and Structure-Based CoMFA of Tacrine Analogues</span></div><div class="casAuthors">Recanatini, Maurizio; Cavalli, Andrea; Belluti, Federica; Piazzi, Lorna; Rampa, Angela; Bisi, Alessandra; Gobbi, Silvia; Valenti, Piero; Andrisano, Vincenza; Bartolini, Manuela; Cavrini, Vanni</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2007-2018</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this study, we attempted to derive a comprehensive SAR picture for the class of acetylcholinesterase (AChE) inhibitors related to tacrine, a drug currently in use for the treatment of the Alzheimer's disease.  Toward this aim, we synthesized and tested a series of 9-amino-1,2,3,4-tetrahydroacridine derivs. substituted at positions 6 and 7 of the acridine nucleus and bearing selected groups on the 9-amino function.  By means of the Hansch approach, QSAR equations were obtained, quant. accounting for both the detrimental steric effect of substituents in position 7 and the favorable electron-attracting effect exerted by substituents in positions 6 and 7 of the 9-amino-1,2,3,4-tetrahydroacridine derivs.  The three-dimensional (3D) properties of the inhibitors were taken into consideration by performing a comparative mol. field anal. (CoMFA) on the series of AChE inhibitors made by twelve 9-amino-1,2,3,4-tetrahydroacridines and thirteen 11H-indeno[1,2-b]quinolin-10-ylamines previously developed in our lab.  The alignment of the mols. to be submitted to the CoMFA procedure was carried out by taking advantage of docking models calcd. for the interactions of both the unsubstituted 9-amino-1,2,3,4-tetrahydroacridine and 11H-indeno[1,2-b]quinolin-10-ylamine with the target enzyme.  A highly significant CoMFA model was obtained using the steric field alone, and the features of such a 3D QSAR model were compared with the classical QSAR equations previously calcd.  The two models appeared to be consistent with one another, with the following main aspects in common: (a) individuation of the strongly neg. contribution of substituents in position 7 of tacrine, and (b) tentative assignment of hydrophobic character to the favorable effect exerted by the substituents in position 6.  Finally, to test the predictive ability of the QSAR models, 6-bromo-9-amino-1,2,3,4-tetrahydroacridine, a new tacrine deriv. designed on the basis of both classical and 3D QSAR equations was synthesized and kinetically evaluated.  This compd. was predicted to have a pIC50 value of 7.31 by the classical QSAR model and 7.40 by the CoMFA model; its exptl. IC50 value was equal to 0.066 (±0.009) μM, which corresponds to a pIC50 of 7.18, and shows reasonable agreement with the predicted AChE inhibition data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3DgmKhtx11LVg90H21EOLACvtfcHk0ljvR7Vt7XGLtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXis1Gnu74%253D&md5=f9e8a7eb7bb347bfd80953e2870a789c</span></div><a href="/servlet/linkout?suffix=cit31a&amp;dbid=16384&amp;doi=10.1021%2Fjm990971t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990971t%26sid%3Dliteratum%253Aachs%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBelluti%26aufirst%3DF.%26aulast%3DPiazzi%26aufirst%3DL.%26aulast%3DRampa%26aufirst%3DA.%26aulast%3DBisi%26aufirst%3DA.%26aulast%3DGobbi%26aufirst%3DS.%26aulast%3DValenti%26aufirst%3DP.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DCavrini%26aufirst%3DV.%26atitle%3DSAR%2520of%25209-amino-1%252C2%252C3%252C4-tetrahydroacridine-based%2520acetylcholinesterase%2520inhibitors%253A%2520synthesis%252C%2520enzyme%2520inhibitory%2520activity%252C%2520QSAR%252C%2520and%2520structure-based%2520CoMFA%2520of%2520tacrine%2520analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2007%26epage%3D2018%26doi%3D10.1021%2Fjm990971t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit31b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wlodek, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antosiewicz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCammon, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Straatsma, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilson, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briggs, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humblet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sussman, J. L.</span></span> <span> </span><span class="NLM_article-title">Binding of tacrine and 6-chlorotacrine by acetylcholinesterase</span>. <i>Biopolymers</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">117</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1097-0282(199601)38:13.0.CO;2-#</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1002%2F%28SICI%291097-0282%28199601%2938%3A1%3C109%3A%3AAID-BIP9%3E3.0.CO%3B2-%23" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=8679940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADyaK28XpvVen" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1996&pages=109-117&author=S.+T.+Wlodekauthor=J.+Antosiewiczauthor=J.+A.+McCammonauthor=T.+P.+Straatsmaauthor=M.+K.+Gilsonauthor=J.+M.+Briggsauthor=C.+Humbletauthor=J.+L.+Sussman&title=Binding+of+tacrine+and+6-chlorotacrine+by+acetylcholinesterase&doi=10.1002%2F%28SICI%291097-0282%28199601%2938%3A13.0.CO%3B2-%23"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31bR"><div class="casContent"><span class="casTitleNuber">31b</span><div class="casTitle"><span class="NLM_cas:atitle">Binding of tacrine and 6-chlorotacrine by acetylcholinesterase</span></div><div class="casAuthors">Wlodek, S. T.; Antosiewicz, J.; McCammon, J. A.; Straatsma, T. P.; Gilson, M. K.; Briggs, J. M.; Humblet, C.; Sussman, J. L.</div><div class="citationInfo"><span class="NLM_cas:title">Biopolymers</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">109-17</span>CODEN:
                <span class="NLM_cas:coden">BIPMAA</span>;
        ISSN:<span class="NLM_cas:issn">0006-3525</span>.
    
            (<span class="NLM_cas:orgname">Wiley</span>)
        </div><div class="casAbstract">Multiconfiguration thermodn. integration was used to det. the relative binding strength of tacrine and 6-chlorotacrine by Torpedo californica acetylcholinesterase.  6-Chlorotacrine appears to be bound stronger by 0.7 kcal/mol than unsubstituted tacrine when the active site triad residue His-440 is deprotonated.  This result is in excellent agreement with exptl. inhibition data on elec. eel acetylcholinesterase.  Electrostatic Poisson-Boltzmann calcns. confirm that order of binding strength, resulting in ΔG of binding of -2.9 and -3.3 kcal/mol for tacrine and chlorotacrine, resp., and suggest inhibitor binding does not occur when His-440 is charged.  The results suggest that electron d. redistribution upon tacrine chlorination is mainly responsible for the increased attraction potential between protonated inhibitor mol. and adjacent arom. groups of Phe-330 and Trp-84.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyOgkYp6yoQbVg90H21EOLACvtfcHk0lhCzUAmOIHpNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XpvVen&md5=1bd5e7dd789fbca5832152ed75db0f5b</span></div><a href="/servlet/linkout?suffix=cit31b&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291097-0282%28199601%2938%3A1%3C109%3A%3AAID-BIP9%3E3.0.CO%3B2-%23&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291097-0282%2528199601%252938%253A1%253C109%253A%253AAID-BIP9%253E3.0.CO%253B2-%2523%26sid%3Dliteratum%253Aachs%26aulast%3DWlodek%26aufirst%3DS.%2BT.%26aulast%3DAntosiewicz%26aufirst%3DJ.%26aulast%3DMcCammon%26aufirst%3DJ.%2BA.%26aulast%3DStraatsma%26aufirst%3DT.%2BP.%26aulast%3DGilson%26aufirst%3DM.%2BK.%26aulast%3DBriggs%26aufirst%3DJ.%2BM.%26aulast%3DHumblet%26aufirst%3DC.%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26atitle%3DBinding%2520of%2520tacrine%2520and%25206-chlorotacrine%2520by%2520acetylcholinesterase%26jtitle%3DBiopolymers%26date%3D1996%26volume%3D38%26spage%3D109%26epage%3D117%26doi%3D10.1002%2F%28SICI%291097-0282%28199601%2938%3A13.0.CO%3B2-%23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stiller, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endres, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheiner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunesch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotriffer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, M.</span></span> <span> </span><span class="NLM_article-title">Highly selective butyrylcholinesterase inhibitors with tunable duration of action by chemical modification of transferable carbamate units exhibit pronounced neuroprotective effect in an Alzheimer’s disease mouse model</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">9116</span>– <span class="NLM_lpage">9140</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01012</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFCrs7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=9116-9140&author=M.+Hoffmannauthor=C.+Stillerauthor=E.+Endresauthor=M.+Scheinerauthor=S.+Guneschauthor=C.+Sotrifferauthor=T.+Mauriceauthor=M.+Decker&title=Highly+selective+butyrylcholinesterase+inhibitors+with+tunable+duration+of+action+by+chemical+modification+of+transferable+carbamate+units+exhibit+pronounced+neuroprotective+effect+in+an+Alzheimer%E2%80%99s+disease+mouse+model&doi=10.1021%2Facs.jmedchem.9b01012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32aR"><div class="casContent"><span class="casTitleNuber">32a</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Selective Butyrylcholinesterase Inhibitors with Tunable Duration of Action by Chemical Modification of Transferable Carbamate Units Exhibit Pronounced Neuroprotective Effect in an Alzheimer's Disease Mouse Model</span></div><div class="casAuthors">Hoffmann, Matthias; Stiller, Carina; Endres, Erik; Scheiner, Matthias; Gunesch, Sandra; Sotriffer, Christoph; Maurice, Tangui; Decker, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">9116-9140</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In this study, the carbamate structure of pseudo-irreversible butyrylcholinesterase (BChE) inhibitors was optimized with regard to a longer binding to the enzyme.  A set of compds. bearing different heterocycles (e.g., morpholine, tetrahydroisoquinoline, benzimidazole, piperidine) and alkylene spacers (2 to 10 methylene groups between carbamate and heterocycle) in the carbamate residue was synthesized and characterized in vitro for their binding affinity, binding kinetics, and carbamate hydrolysis.  These novel BChE inhibitors are highly selective for hBChE over human acetycholinesterase (hAChE), yielding short-, medium-, and long-acting nanomolar hBChE inhibitors (with a half-life of the carbamoylated enzyme ranging from 1 to 28 h).  The inhibitors show neuroprotective properties in a murine hippocampal cell line and a pharmacol. mouse model of Alzheimer's disease (AD), suggesting a significant benefit of BChE inhibition for a disease-modifying treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXA4e0pcqAhrVg90H21EOLACvtfcHk0lhCzUAmOIHpNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFCrs7zO&md5=458d5ab7ffce4864702a39d981b6dc29</span></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01012%26sid%3Dliteratum%253Aachs%26aulast%3DHoffmann%26aufirst%3DM.%26aulast%3DStiller%26aufirst%3DC.%26aulast%3DEndres%26aufirst%3DE.%26aulast%3DScheiner%26aufirst%3DM.%26aulast%3DGunesch%26aufirst%3DS.%26aulast%3DSotriffer%26aufirst%3DC.%26aulast%3DMaurice%26aufirst%3DT.%26aulast%3DDecker%26aufirst%3DM.%26atitle%3DHighly%2520selective%2520butyrylcholinesterase%2520inhibitors%2520with%2520tunable%2520duration%2520of%2520action%2520by%2520chemical%2520modification%2520of%2520transferable%2520carbamate%2520units%2520exhibit%2520pronounced%2520neuroprotective%2520effect%2520in%2520an%2520Alzheimer%25E2%2580%2599s%2520disease%2520mouse%2520model%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D9116%26epage%3D9140%26doi%3D10.1021%2Facs.jmedchem.9b01012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit32b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Darvesh, S.</span></span> <span> </span><span class="NLM_article-title">Butyrylcholinesterase as a diagnostic and therapeutic target for Alzheimer’s disease</span>. <i>Curr. Alzheimer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1173</span>– <span class="NLM_lpage">1177</span>, <span class="refDoi"> DOI: 10.2174/1567205013666160404120542</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.2174%2F1567205013666160404120542" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=27040140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVOiu7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2016&pages=1173-1177&author=S.+Darvesh&title=Butyrylcholinesterase+as+a+diagnostic+and+therapeutic+target+for+Alzheimer%E2%80%99s+disease&doi=10.2174%2F1567205013666160404120542"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32bR"><div class="casContent"><span class="casTitleNuber">32b</span><div class="casTitle"><span class="NLM_cas:atitle">Butyrylcholinesterase as a Diagnostic and Therapeutic Target for Alzheimer's Disease</span></div><div class="casAuthors">Darvesh, Sultan</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1173-1177</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">The serine hydrolase butyrylcholinesterase (BChE), like the related enzyme acetylcholinesterase (AChE), co-regulates metab. of the neurotransmitter acetylcholine.  In the human brain BChE is mainly expressed in white matter and glia and in distinct populations of neurons in regions that are important in cognition and behavior, functions compromised in Alzheimer's disease (AD).  AD is a neurodegenerative disorder causing dementia with no cure nor means for definitive diagnosis during life.  In AD, BChE is found in assocn. with pathol., such as -amyloid (A) plaques, particularly in the cerebral cortex where BChE is not normally found in quantity.  Up to 30% of cognitively normal older adults have abundant A deposition in the brain.  We have designed an imaging agent that can detect, through autoradiog., BChE-assocd. A plaques in the cerebral cortex of AD brains, but does not visualize A plaques in brains of cognitively normal individuals.  Furthermore, in an AD mouse model with BChE gene knocked out, there are up to 70% fewer fibrillar A brain plaques, suggesting diminished BChE activity could prove beneficial as a curative approach to AD.  To that end, we have examd. numerous N-10-carbonyl phenothiazines that are specific inhibitors of human BChE, revealing important details of the enzyme's active site gorge.  These phenothiazines can be designed without potential side effects caused by neurotransmitter receptor interactions.  In conclusion, BChE is potentially an important target for diagnosis and treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpd5KdWGb-He7Vg90H21EOLACvtfcHk0lhCzUAmOIHpNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVOiu7vP&md5=f3db5212c9d4c0f697011addeebd6c03</span></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=10.2174%2F1567205013666160404120542&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1567205013666160404120542%26sid%3Dliteratum%253Aachs%26aulast%3DDarvesh%26aufirst%3DS.%26atitle%3DButyrylcholinesterase%2520as%2520a%2520diagnostic%2520and%2520therapeutic%2520target%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2016%26volume%3D13%26spage%3D1173%26epage%3D1177%26doi%3D10.2174%2F1567205013666160404120542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elsinghorst, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cieslik, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohr, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tränkle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gütschow, M.</span></span> <span> </span><span class="NLM_article-title">First gallamine–tacrine hybrid: design and characterization at cholinesterases and the M<sub>2</sub> muscarinic receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">5685</span>– <span class="NLM_lpage">5695</span>, <span class="refDoi"> DOI: 10.1021/jm070859s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070859s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFOitbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5685-5695&author=P.+W.+Elsinghorstauthor=J.+S.+Cieslikauthor=K.+Mohrauthor=C.+Tr%C3%A4nkleauthor=M.+G%C3%BCtschow&title=First+gallamine%E2%80%93tacrine+hybrid%3A+design+and+characterization+at+cholinesterases+and+the+M2+muscarinic+receptor&doi=10.1021%2Fjm070859s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">First Gallamine-Tacrine Hybrid: Design and Characterization at Cholinesterases and the M2 Muscarinic Receptor</span></div><div class="casAuthors">Elsinghorst, Paul W.; Cieslik, Julia S.; Mohr, Klaus; Traenkle, Christian; Guetschow, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5685-5695</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Gallamine and tacrine are allosteric antagonists at muscarinic M2 acetylcholine receptors and inhibitors of acetylcholinesterase.  At both acetylcholine-binding proteins, gallamine and tacrine are known to occupy two different binding sites: in M2 receptors within the allosteric binding area and in acetylcholinesterase at its catalytic and its peripheral site.  To find new ligands of both targets, the authors designed a gallamine-tacrine dimer and several derived hybrid compds. to address the two binding sites.  Their M2 receptor allosteric and acetylcholinesterase inhibitory potential was detd.  The hybrid compds. revealed an allosteric potency in the low nanomolar range exceeding the allosteric potency of gallamine and tacrine by factors of 100 and 4800, resp.  Cholinesterase inhibition was augmented by hybrid formation, and all compds. exhibited IC50 values in the lower nanomolar range.  Thus, gallamine-tacrine hybrid formation is a valuable approach toward high affinity ligands concurrently targeting these acetylcholine-binding proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1Rozawsc7bLVg90H21EOLACvtfcHk0lhrRsVxwzv-eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFOitbvN&md5=a6497e4ea0a428470c3476ea5ad2700e</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm070859s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070859s%26sid%3Dliteratum%253Aachs%26aulast%3DElsinghorst%26aufirst%3DP.%2BW.%26aulast%3DCieslik%26aufirst%3DJ.%2BS.%26aulast%3DMohr%26aufirst%3DK.%26aulast%3DTr%25C3%25A4nkle%26aufirst%3DC.%26aulast%3DG%25C3%25BCtschow%26aufirst%3DM.%26atitle%3DFirst%2520gallamine%25E2%2580%2593tacrine%2520hybrid%253A%2520design%2520and%2520characterization%2520at%2520cholinesterases%2520and%2520the%2520M2%2520muscarinic%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5685%26epage%3D5695%26doi%3D10.1021%2Fjm070859s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Camps, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Formosa, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galdeano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gómez, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scarpellini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viayna, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clos, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camins, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallàs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrisano, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estelrich, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lizondo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bidon-Chanal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span> <span> </span><span class="NLM_article-title">Novel donepezil-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced β-amyloid aggregation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">3588</span>– <span class="NLM_lpage">3598</span>, <span class="refDoi"> DOI: 10.1021/jm8001313</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8001313" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD1cXms1Gisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3588-3598&author=P.+Campsauthor=X.+Formosaauthor=C.+Galdeanoauthor=T.+G%C3%B3mezauthor=D.+Mu%C3%B1oz-Torreroauthor=M.+Scarpelliniauthor=E.+Viaynaauthor=A.+Badiaauthor=M.+V.+Closauthor=A.+Caminsauthor=M.+Pall%C3%A0sauthor=M.+Bartoliniauthor=F.+Manciniauthor=V.+Andrisanoauthor=J.+Estelrichauthor=M.+Lizondoauthor=A.+Bidon-Chanalauthor=F.+J.+Luque&title=Novel+donepezil-based+inhibitors+of+acetyl-+and+butyrylcholinesterase+and+acetylcholinesterase-induced+%CE%B2-amyloid+aggregation&doi=10.1021%2Fjm8001313"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34aR"><div class="casContent"><span class="casTitleNuber">34a</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Donepezil-Based Inhibitors of Acetyl- and Butyrylcholinesterase and Acetylcholinesterase-Induced β-Amyloid Aggregation</span></div><div class="casAuthors">Camps, Pelayo; Formosa, Xavier; Galdeano, Carles; Gomez, Tania; Munoz-Torrero, Diego; Scarpellini, Michele; Viayna, Elisabet; Badia, Albert; Clos, M. Victoria; Camins, Antoni; Pallas, Merce; Bartolini, Manuela; Mancini, Francesca; Andrisano, Vincenza; Estelrich, Joan; Lizondo, Monica; Bidon-Chanal, Axel; Luque, F. Javier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3588-3598</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of donepezil-tacrine hybrids, e.g. I, designed to simultaneously interact with the active, peripheral and midgorge binding sites of acetylcholinesterase (AChE) have been synthesized and tested for their ability to inhibit AChE, butyrylcholinesterase (BChE), and AChE-induced Aβ aggregation.  These compds. consist of a unit of tacrine or 6-chlorotacrine, which occupies the same position as tacrine at the AChE active site, and the 5,6-dimethoxy-2-[(4-piperidinyl)methyl]-1-indanone moiety of donepezil (or the indane deriv. thereof), whose position along the enzyme gorge and the peripheral site can be modulated by a suitable tether that connects tacrine and donepezil fragments.  All of the new compds. are highly potent inhibitors of bovine and human AChE and BChE, exhibiting IC50 values in the subnanomolar or low nanomolar range in most cases.  Moreover, six out of the eight hybrids of the series, particularly those bearing an indane moiety, exhibit a significant Aβ antiaggregating activity, which makes them promising anti-Alzheimer drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsEDGOt9jXTLVg90H21EOLACvtfcHk0lhrRsVxwzv-eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXms1Gisbc%253D&md5=a27c555a51f971ff6c642f832d761aab</span></div><a href="/servlet/linkout?suffix=cit34a&amp;dbid=16384&amp;doi=10.1021%2Fjm8001313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8001313%26sid%3Dliteratum%253Aachs%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DFormosa%26aufirst%3DX.%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DG%25C3%25B3mez%26aufirst%3DT.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DScarpellini%26aufirst%3DM.%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DBadia%26aufirst%3DA.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DCamins%26aufirst%3DA.%26aulast%3DPall%25C3%25A0s%26aufirst%3DM.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DEstelrich%26aufirst%3DJ.%26aulast%3DLizondo%26aufirst%3DM.%26aulast%3DBidon-Chanal%26aufirst%3DA.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26atitle%3DNovel%2520donepezil-based%2520inhibitors%2520of%2520acetyl-%2520and%2520butyrylcholinesterase%2520and%2520acetylcholinesterase-induced%2520%25CE%25B2-amyloid%2520aggregation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3588%26epage%3D3598%26doi%3D10.1021%2Fjm8001313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit34b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorronsoro, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Palomero, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Del Monte, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bidon-Chanal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orozco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez, A.</span></span> <span> </span><span class="NLM_article-title">Donepezil-tacrine hybrid related derivatives as new dual binding site inhibitors of AChE</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">6588</span>– <span class="NLM_lpage">6597</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2005.09.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2Fj.bmc.2005.09.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=16230018" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFyksrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=6588-6597&author=D.+Alonsoauthor=I.+Dorronsoroauthor=L.+Rubioauthor=P.+Mu%C3%B1ozauthor=E.+Garc%C3%ADa-Palomeroauthor=M.+Del+Monteauthor=A.+Bidon-Chanalauthor=M.+Orozcoauthor=F.+J.+Luqueauthor=A.+Castroauthor=M.+Medinaauthor=A.+Mart%C3%ADnez&title=Donepezil-tacrine+hybrid+related+derivatives+as+new+dual+binding+site+inhibitors+of+AChE&doi=10.1016%2Fj.bmc.2005.09.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34bR"><div class="casContent"><span class="casTitleNuber">34b</span><div class="casTitle"><span class="NLM_cas:atitle">Donepezil-tacrine hybrid related derivatives as new dual binding site inhibitors of AChE</span></div><div class="casAuthors">Alonso, D.; Dorronsoro, I.; Rubio, L.; Munoz, P.; Garcia-Palomero, E.; Del Monte, M.; Bidon-Chanal, A.; Orozco, M.; Luque, F. J.; Castro, A.; Medina, M.; Martinez, A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6588-6597</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A new series of donepezil-tacrine hybrid related derivs. have been synthesized as dual acetylcholinesterase inhibitors that could bind simultaneously to the peripheral and catalytic sites of the enzyme.  These new hybrids combined a tacrine, 6-chlorotacrine or acridine unit as catalytic binding site and indanone (the heterocycle present in donepezil) or phthalimide moiety as peripheral binding site of the enzyme, connected through a different linker tether length.  One of the synthesized compds. emerged as a potent and selective AChE inhibitor, which is able to displace propidium in a competition assay.  These results seem to confirm the ability of this inhibitor to bind simultaneously to both sites of the enzyme and make it a promising lead for developing disease-modifying drugs for the future treatment of Alzheimer's disease.  To gain insight into the mol. determinants that modulate the inhibitory activity of these compds., a mol. modeling study was performed to explore their binding to the enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp_JWdGHk3L7Vg90H21EOLACvtfcHk0lhrRsVxwzv-eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFyksrnL&md5=ce98b55631de4dbe9f52a89889b3e204</span></div><a href="/servlet/linkout?suffix=cit34b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2005.09.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2005.09.029%26sid%3Dliteratum%253Aachs%26aulast%3DAlonso%26aufirst%3DD.%26aulast%3DDorronsoro%26aufirst%3DI.%26aulast%3DRubio%26aufirst%3DL.%26aulast%3DMu%25C3%25B1oz%26aufirst%3DP.%26aulast%3DGarc%25C3%25ADa-Palomero%26aufirst%3DE.%26aulast%3DDel%2BMonte%26aufirst%3DM.%26aulast%3DBidon-Chanal%26aufirst%3DA.%26aulast%3DOrozco%26aufirst%3DM.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DCastro%26aufirst%3DA.%26aulast%3DMedina%26aufirst%3DM.%26aulast%3DMart%25C3%25ADnez%26aufirst%3DA.%26atitle%3DDonepezil-tacrine%2520hybrid%2520related%2520derivatives%2520as%2520new%2520dual%2520binding%2520site%2520inhibitors%2520of%2520AChE%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D6588%26epage%3D6597%26doi%3D10.1016%2Fj.bmc.2005.09.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dvir, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barril, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orozco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camps, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberry, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sussman, J. L.</span></span> <span> </span><span class="NLM_article-title">3D structure of <i>Torpedo californica</i> acetylcholinesterase complexed with huprine X at 2.1 Å resolution: kinetic and molecular dynamic correlates</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">2970</span>– <span class="NLM_lpage">2981</span>, <span class="refDoi"> DOI: 10.1021/bi011652i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi011652i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD38Xps1altw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=2970-2981&author=H.+Dvirauthor=D.+M.+Wongauthor=M.+Harelauthor=X.+Barrilauthor=M.+Orozcoauthor=F.+J.+Luqueauthor=D.+Mu%C3%B1oz-Torreroauthor=P.+Campsauthor=T.+L.+Rosenberryauthor=I.+Silmanauthor=J.+L.+Sussman&title=3D+structure+of+Torpedo+californica+acetylcholinesterase+complexed+with+huprine+X+at+2.1+%C3%85+resolution%3A+kinetic+and+molecular+dynamic+correlates&doi=10.1021%2Fbi011652i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">3D Structure of Torpedo californica acetylcholinesterase complexed with huprine X at 2.1 Å resolution: Kinetic and molecular dynamic correlates</span></div><div class="casAuthors">Dvir, H.; Wong, D. M.; Harel, M.; Barril, X.; Orozco, M.; Luque, F. J.; Munoz-Torrero, D.; Camps, P.; Rosenberry, T. L.; Silman, I.; Sussman, J. L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2970-2981</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Huprine X (HX) is a novel acetylcholinesterase (AChE) inhibitor, with one of the highest affinities reported for a reversible inhibitor.  HX is a synthetic hybrid that contains the 4-aminoquinoline substructure of one anti-Alzheimer drug, tacrine, and a carbobicyclic moiety resembling that of another AChE inhibitor, (-)-huperzine A.  Cocrystn. of HX with T. californica AChE yielded crystals whose 3-dimensional (3D) structure was detd. to 2.1 Å resoln.  The inhibitor was found to bind to the anionic site and also to hinder access to the esteratic site.  Its arom. portion occupied the same binding site as tacrine, stacking between the arom. rings of Trp-84 and Phe-330, whereas the carbobicyclic unit occupied the same binding pocket as (-)-huperzine A.  Its Cl substituent was found to lie in a hydrophobic pocket interacting with the rings of arom. residues Trp-432 and Phe-330 and with the Me groups of Met-436 and Ile-439.  Steady-state inhibition data showed that HX bound to human AChE and Torpedo AChE 28- and 54-fold, resp., more tightly than tacrine.  This difference apparently stems from the fact that the aminoquinoline moiety of HX makes interactions similar to those made by tacrine, but that addnl. bonds to the enzyme are made by the huperzine-like substructure and the Cl atom.  Furthermore, both tacrine and HX bound more tightly to Torpedo AChE than to human AChE, suggesting that their quinoline substructures interact better with Phe-330 than with Tyr-337, the corresponding residue in the human AChE structure.  Both (-)-huperzine A and HX displayed slow binding properties, but only binding of the former caused a peptide flip of Gly-117.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqVXtCPjzM1LVg90H21EOLACvtfcHk0li9x1gJbSUkAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xps1altw%253D%253D&md5=ea8b56b44818d899843be48d59fa2553</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fbi011652i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi011652i%26sid%3Dliteratum%253Aachs%26aulast%3DDvir%26aufirst%3DH.%26aulast%3DWong%26aufirst%3DD.%2BM.%26aulast%3DHarel%26aufirst%3DM.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DOrozco%26aufirst%3DM.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DRosenberry%26aufirst%3DT.%2BL.%26aulast%3DSilman%26aufirst%3DI.%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26atitle%3D3D%2520structure%2520of%2520Torpedo%2520californica%2520acetylcholinesterase%2520complexed%2520with%2520huprine%2520X%2520at%25202.1%2520%25C3%2585%2520resolution%253A%2520kinetic%2520and%2520molecular%2520dynamic%2520correlates%26jtitle%3DBiochemistry%26date%3D2002%26volume%3D41%26spage%3D2970%26epage%3D2981%26doi%3D10.1021%2Fbi011652i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Blois, M. S.</span></span> <span> </span><span class="NLM_article-title">Antioxidant determinations by the use of a stable free radical</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1958</span>,  <span class="NLM_volume"><i>181</i></span>,  <span class="NLM_fpage">1199</span>– <span class="NLM_lpage">1200</span>, <span class="refDoi"> DOI: 10.1038/1811199a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1038%2F1811199a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADyaG1cXptF2ntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=1958&pages=1199-1200&author=M.+S.+Blois&title=Antioxidant+determinations+by+the+use+of+a+stable+free+radical&doi=10.1038%2F1811199a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36aR"><div class="casContent"><span class="casTitleNuber">36a</span><div class="casTitle"><span class="NLM_cas:atitle">Antioxidant determinations by the use of a stable free radical</span></div><div class="casAuthors">Blois, Marsden S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1958</span>),
    <span class="NLM_cas:volume">181</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1199-200</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">The 2,2-diphenyl-1-picrylhydrazyl free radical (I) will oxidize (and be decolored by) cysteine, glutathione, ascorbic acid, tocopherol, polyhydroxy aromatic compds. (hydroquinone, pyrogallol, etc.), and aromatic amines (p-phenylenediamine, p-aminophenol, etc.), commonly employed antioxidants.  The SH groups of proteins are oxidized, though probably not quantitatively, since proteins are pptd. under the conditions of testing.  I does not have a high enough oxidation-reduction potential to oxidize glucose, and does not, apparently, under ordinary conditions, oxidize purines, pyrimidines, or aromatic compds. with only a single hydroxyl group, as in tyrosine.  At 517 mμ and at a pH of 5.0-6.5 (acetate buffer) quant. measurements of antioxidants can be made based on the decolorization of I in concns. of approx. 5 × 10-4M.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZKlbXv_jIw7Vg90H21EOLACvtfcHk0li9x1gJbSUkAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG1cXptF2ntw%253D%253D&md5=58b5d2491941b7e53ec794e2e0e76b7c</span></div><a href="/servlet/linkout?suffix=cit36a&amp;dbid=16384&amp;doi=10.1038%2F1811199a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F1811199a0%26sid%3Dliteratum%253Aachs%26aulast%3DBlois%26aufirst%3DM.%2BS.%26atitle%3DAntioxidant%2520determinations%2520by%2520the%2520use%2520of%2520a%2520stable%2520free%2520radical%26jtitle%3DNature%26date%3D1958%26volume%3D181%26spage%3D1199%26epage%3D1200%26doi%3D10.1038%2F1811199a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit36b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Brand-Williams, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuvelier, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berset, C.</span></span> <span> </span><span class="NLM_article-title">Use of a free radical method to evaluate antioxidant activity</span>. <i>LWT—Food Sci. Technol.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">30</span>, <span class="refDoi"> DOI: 10.1016/S0023-6438(95)80008-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2FS0023-6438%2895%2980008-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADyaK2MXjvV2itLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1995&pages=25-30&author=W.+Brand-Williamsauthor=M.+E.+Cuvelierauthor=C.+Berset&title=Use+of+a+free+radical+method+to+evaluate+antioxidant+activity&doi=10.1016%2FS0023-6438%2895%2980008-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36bR"><div class="casContent"><span class="casTitleNuber">36b</span><div class="casTitle"><span class="NLM_cas:atitle">Use of a free radical method to evaluate antioxidant activity</span></div><div class="casAuthors">Brand-WIlliams, W.; Cuvelier, M. E.; Berset, C.</div><div class="citationInfo"><span class="NLM_cas:title">Food Science & Technology (London)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-30</span>CODEN:
                <span class="NLM_cas:coden">LBWTAP</span>;
        ISSN:<span class="NLM_cas:issn">0023-6438</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">The antiradical activities of various antioxidants were detd. using the free radical, 2,2-Diphenyl-1-picrylhydrazyl (DPPH•).  In its radical form, DPPH• has an absorption band at 515 nm which disappears upon redn. by an antiradical compd.  Twenty compds. were reacted with the DPPH• and shown to follow one of three possible reaction kinetic types.  Ascorbic acid, isoascorbic acid and isoeugenol reacted quickly with the DPPH•, reaching a steady state immediately.  Rosmarinic acid and δ-tocopherol reacted a little slower and reached a steady state within 30 min.  The remaining compds. reacted more progressively with the DPPH•, reaching a steady state in 1-6 h.  Caffeic acid, gentisic acid and gallic acid showed the highest antiradical activities with a stoichiometry of 4 to 6 reduced DPPH• mols. per mol. of antioxidant.  Vanillin, phenol, γ-resorcylic acid and vanillic acid were found to be poor antiradical compds.  The stoichiometry for the other 13 phenolic compds. varied from one to three reduced DPPH• mols. per mol. of antioxidant.  Possible mechanisms are proposed to explain the exptl. results.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdgt6zsPPpvLVg90H21EOLACvtfcHk0li9x1gJbSUkAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjvV2itLw%253D&md5=0568c73ee9d55ec1d5b72153416e7e4a</span></div><a href="/servlet/linkout?suffix=cit36b&amp;dbid=16384&amp;doi=10.1016%2FS0023-6438%2895%2980008-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0023-6438%252895%252980008-5%26sid%3Dliteratum%253Aachs%26aulast%3DBrand-Williams%26aufirst%3DW.%26aulast%3DCuvelier%26aufirst%3DM.%2BE.%26aulast%3DBerset%26aufirst%3DC.%26atitle%3DUse%2520of%2520a%2520free%2520radical%2520method%2520to%2520evaluate%2520antioxidant%2520activity%26jtitle%3DLWT%25E2%2580%2594Food%2520Sci.%2520Technol.%26date%3D1995%26volume%3D28%26spage%3D25%26epage%3D30%26doi%3D10.1016%2FS0023-6438%2895%2980008-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span> <span> </span><span class="NLM_article-title">Structure-based survey of the binding modes of BACE1 inhibitors</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">880</span>– <span class="NLM_lpage">889</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.8b00420</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.8b00420" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVyhsrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=880-889&author=H.+Huauthor=Z.+Chenauthor=X.+Xuauthor=Y.+Xu&title=Structure-based+survey+of+the+binding+modes+of+BACE1+inhibitors&doi=10.1021%2Facschemneuro.8b00420"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37aR"><div class="casContent"><span class="casTitleNuber">37a</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Survey of the Binding Modes of BACE1 Inhibitors</span></div><div class="casAuthors">Hu, Hangchen; Chen, Zhaoqiang; Xu, Xiang; Xu, Yechun</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">880-889</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  BACE1 is a key aspartic protease that cleaves the amyloid precursor protein to generate of the amyloid peptide that is believed to be responsible for the Alzheimer's disease amyloid cascade.  It is thus recognized as a promising therapeutic target for Alzheimer's disease treatment, and large efforts have been made in the discovery of novel BACE1 inhibitors.  This Review presents a systematic mining of BACE1 inhibitors based on 354 crystal structures of the BACE1 catalytic domain in complex with ligands in the Protein Data Bank.  A thorough exploration on the frequency as well as the patterns of residue-ligand interactions enables us to subdivide the ligand binding pocket into 10 subsites and then identify favorable substructures of ligands for each subsite.  In addn., it is found that the assembly of subsites with an 8-like shape is responsible to bind all inhibitors and four major ligand binding modes are revealed.  Thus, such a systematic survey deepens our understanding of the structural requirements for establishment of BACE1-ligand interactions that det. the affinity of a ligand to BACE1, which is pivotal for structure-based lead optimization and design of novel inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwvv_EbX_3ALVg90H21EOLACvtfcHk0lj-eY_IXUTu0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVyhsrfF&md5=3157eb17033dae864aee238751e055ca</span></div><a href="/servlet/linkout?suffix=cit37a&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.8b00420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.8b00420%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DY.%26atitle%3DStructure-based%2520survey%2520of%2520the%2520binding%2520modes%2520of%2520BACE1%2520inhibitors%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2019%26volume%3D10%26spage%3D880%26epage%3D889%26doi%3D10.1021%2Facschemneuro.8b00420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit37b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Hsiao, C.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rombouts, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsen, H. J. M.</span></span> <span> </span><span class="NLM_article-title">New evolutions in the BACE1 inhibitor field from 2014 to 2018</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">761</span>– <span class="NLM_lpage">777</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2018.12.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2Fj.bmcl.2018.12.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=30709653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlCmu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=761-777&author=C.-C.+Hsiaoauthor=F.+Romboutsauthor=H.+J.+M.+Gijsen&title=New+evolutions+in+the+BACE1+inhibitor+field+from+2014+to+2018&doi=10.1016%2Fj.bmcl.2018.12.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37bR"><div class="casContent"><span class="casTitleNuber">37b</span><div class="casTitle"><span class="NLM_cas:atitle">New evolutions in the BACE1 inhibitor field from 2014 to 2018</span></div><div class="casAuthors">Hsiao, Chien-Chi; Rombouts, Frederik; Gijsen, Harrie J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">761-777</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors offer the potential of disease-modifying treatment for Alzheimer's disease (AD).  Since 2014, major breakthroughs have appeared in the field of BACE1 inhibitors.  This review provides an overview of amidine-based BACE1 inhibitors between 2014 and 2018.  Herein are summarized (i) the structure-activity relationship, (ii) the physiol. results and (iii) the potential risks from a lack of selectivity.  This review also summarizes clin. scope, results and outlook of the compds. that have been or are currently under development in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3OfI_B-BJ-LVg90H21EOLACvtfcHk0lj-eY_IXUTu0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlCmu7s%253D&md5=049eda6ce97b31a04b5b579afd3e11e5</span></div><a href="/servlet/linkout?suffix=cit37b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2018.12.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2018.12.049%26sid%3Dliteratum%253Aachs%26aulast%3DHsiao%26aufirst%3DC.-C.%26aulast%3DRombouts%26aufirst%3DF.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%2BM.%26atitle%3DNew%2520evolutions%2520in%2520the%2520BACE1%2520inhibitor%2520field%2520from%25202014%2520to%25202018%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D29%26spage%3D761%26epage%3D777%26doi%3D10.1016%2Fj.bmcl.2018.12.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit37c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mancini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Simone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrisano, V.</span></span> <span> </span><span class="NLM_article-title">Beta-secretase as a target for Alzheimer’s disease drug discovery: an overview of in vitro methods for characterization of inhibitors</span>. <i>Anal. Bioanal. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>400</i></span>,  <span class="NLM_fpage">1979</span>– <span class="NLM_lpage">1996</span>, <span class="refDoi"> DOI: 10.1007/s00216-011-4963-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1007%2Fs00216-011-4963-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=21503735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkvVaqs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=400&publication_year=2011&pages=1979-1996&author=F.+Manciniauthor=A.+De+Simoneauthor=V.+Andrisano&title=Beta-secretase+as+a+target+for+Alzheimer%E2%80%99s+disease+drug+discovery%3A+an+overview+of+in+vitro+methods+for+characterization+of+inhibitors&doi=10.1007%2Fs00216-011-4963-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37cR"><div class="casContent"><span class="casTitleNuber">37c</span><div class="casTitle"><span class="NLM_cas:atitle">Beta-secretase as a target for Alzheimer's disease drug discovery: an overview of in vitro methods for characterization of inhibitors</span></div><div class="casAuthors">Mancini, Francesca; De Simone, Angela; Andrisano, Vincenza</div><div class="citationInfo"><span class="NLM_cas:title">Analytical and Bioanalytical Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">400</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1979-1996</span>CODEN:
                <span class="NLM_cas:coden">ABCNBP</span>;
        ISSN:<span class="NLM_cas:issn">1618-2642</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  β-Secretase 1 (BACE1) is the enzyme involved in the abnormal prodn. of the amyloidogenic peptide Aβ42, one of the major causes of histol. hallmarks of Alzheimer's disease.  Thus, BACE1 represents a key target protein in the development of new potential drugs for the non-symptomatic treatment of Alzheimer's disease.  Since the discovery of BACE1 one decade ago, both in the pharmaceutical industry and in academia there was an intense search for novel inhibitors to be developed as new effective drugs.  There is a great deal of interest in the discovery of selective non-peptide BACE1 inhibitors with a new chem. skeleton, suited for central nervous system penetration and endowed with more appropriate pharmacokinetic properties.  Therefore, the selection of appropriate methods for screening and characterization of BACE1 inhibitors is crucial.  This review focuses on the description of the in vitro methods to test BACE1 activity and inhibition, with particular emphasis on fluorescence resonance energy transfer (FRET) methods, aiming at critically highlighting advantages and drawbacks.  An overview of BACE1 inhibitors is given, underlying the variability of the FRET methods reported in the literature, and the structure evolution of inhibitors active in cellular cultures and in vivo, from peptide to small synthetic and natural structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2vOWtGCN8erVg90H21EOLACvtfcHk0lj-eY_IXUTu0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkvVaqs70%253D&md5=49509fa46d06db030b5e549c5af2e002</span></div><a href="/servlet/linkout?suffix=cit37c&amp;dbid=16384&amp;doi=10.1007%2Fs00216-011-4963-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00216-011-4963-x%26sid%3Dliteratum%253Aachs%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DDe%2BSimone%26aufirst%3DA.%26aulast%3DAndrisano%26aufirst%3DV.%26atitle%3DBeta-secretase%2520as%2520a%2520target%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%2520drug%2520discovery%253A%2520an%2520overview%2520of%2520in%2520vitro%2520methods%2520for%2520characterization%2520of%2520inhibitors%26jtitle%3DAnal.%2520Bioanal.%2520Chem.%26date%3D2011%26volume%3D400%26spage%3D1979%26epage%3D1996%26doi%3D10.1007%2Fs00216-011-4963-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fernández-Bachiller, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monjas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rademann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez-Franco, M. I.</span></span> <span> </span><span class="NLM_article-title">New tacrine–4-oxo-4H-chromene hybrids as multifunctional agents for the treatment of Alzheimer’s disease, with cholinergic, antioxidant, and β-amyloid-reducing properties</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1303</span>– <span class="NLM_lpage">1317</span>, <span class="refDoi"> DOI: 10.1021/jm201460y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201460y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC38XntFKisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1303-1317&author=M.+I.+Fern%C3%A1ndez-Bachillerauthor=C.+P%C3%A9rezauthor=L.+Monjasauthor=J.+Rademannauthor=M.+I.+Rodr%C3%ADguez-Franco&title=New+tacrine%E2%80%934-oxo-4H-chromene+hybrids+as+multifunctional+agents+for+the+treatment+of+Alzheimer%E2%80%99s+disease%2C+with+cholinergic%2C+antioxidant%2C+and+%CE%B2-amyloid-reducing+properties&doi=10.1021%2Fjm201460y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38aR"><div class="casContent"><span class="casTitleNuber">38a</span><div class="casTitle"><span class="NLM_cas:atitle">New Tacrine-4-Oxo-4H-chromene Hybrids as Multifunctional Agents for the Treatment of Alzheimer's Disease, with Cholinergic, Antioxidant, and β-Amyloid-Reducing Properties</span></div><div class="casAuthors">Fernandez-Bachiller, Maria Isabel; Perez, Concepcion; Monjas, Leticia; Rademann, Jorg; Rodriguez-Franco, Maria Isabel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1303-1317</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">By using fragments endowed with interesting and complementary properties for the treatment of Alzheimer's disease (AD), a new family of tacrine-4-oxo-4H-chromene hybrids has been designed, synthesized, and evaluated biol.  The tacrine fragment was selected for its inhibition of cholinesterases, and the flavonoid scaffold derived from 4-oxo-4H -chromene was chosen for its radical capture and β-secretase 1 (BACE-1) inhibitory activities.  At nano- and picomolar concns., the new tacrine-4-oxo-4H-chromene hybrids inhibit human acetyl- and butyrylcholinesterase (h-AChE and h-BuChE), being more potent than the parent inhibitor, tacrine.  They are also potent inhibitors of human BACE-1, better than the parent flavonoid, apigenin.  They show interesting antioxidant properties and could be able to penetrate into the CNS according to the in vitro PAMPA-BBB assay.  Among the hybrids investigated, 6-hydroxy-4-oxo- N-{10-[(1,2,3,4-tetrahydroacridin-9-yl)amino]decyl}-4 H-chromene-2-carboxamide (I) shows potent combined inhibition of human BACE-1 and ChEs, as well as good antioxidant and CNS-permeable properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiMx-NagCpeLVg90H21EOLACvtfcHk0lgSlLi2i9QueQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntFKisw%253D%253D&md5=9391af9439e43f5eda518919839bd473</span></div><a href="/servlet/linkout?suffix=cit38a&amp;dbid=16384&amp;doi=10.1021%2Fjm201460y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201460y%26sid%3Dliteratum%253Aachs%26aulast%3DFern%25C3%25A1ndez-Bachiller%26aufirst%3DM.%2BI.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%26aulast%3DMonjas%26aufirst%3DL.%26aulast%3DRademann%26aufirst%3DJ.%26aulast%3DRodr%25C3%25ADguez-Franco%26aufirst%3DM.%2BI.%26atitle%3DNew%2520tacrine%25E2%2580%25934-oxo-4H-chromene%2520hybrids%2520as%2520multifunctional%2520agents%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%252C%2520with%2520cholinergic%252C%2520antioxidant%252C%2520and%2520%25CE%25B2-amyloid-reducing%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1303%26epage%3D1317%26doi%3D10.1021%2Fjm201460y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit38b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, N. T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsim, K. W. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youdim, M. B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Y.</span></span> <span> </span><span class="NLM_article-title">Promising anti-Alzheimer’s dimer bis(7)-tacrine reduces β-amyloid generation by directly inhibiting BACE-1 activity</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>366</i></span>,  <span class="NLM_fpage">631</span>– <span class="NLM_lpage">636</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2007.11.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2Fj.bbrc.2007.11.068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=18039469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD1cXivVeitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2008&pages=631-636&author=H.+Fuauthor=W.+Liauthor=J.+Luoauthor=N.+T.+K.+Leeauthor=M.+Liauthor=K.+W.+K.+Tsimauthor=Y.+Pangauthor=M.+B.+H.+Youdimauthor=Y.+Han&title=Promising+anti-Alzheimer%E2%80%99s+dimer+bis%287%29-tacrine+reduces+%CE%B2-amyloid+generation+by+directly+inhibiting+BACE-1+activity&doi=10.1016%2Fj.bbrc.2007.11.068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38bR"><div class="casContent"><span class="casTitleNuber">38b</span><div class="casTitle"><span class="NLM_cas:atitle">Promising anti-Alzheimer's dimer bis(7)-tacrine reduces β-amyloid generation by directly inhibiting BACE-1 activity</span></div><div class="casAuthors">Fu, Hongjun; Li, Wenming; Luo, Jialie; Lee, Nelson T. K.; Li, Mingtao; Tsim, Karl W. K.; Pang, Yuanping; Youdim, Moussa B. H.; Han, Yifan</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">366</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">631-636</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The regulation of α-, β-, (BACE-1), and γ-secretase activities to alter β-amyloid (Aβ) generation is considered to be one of the most promising disease-modifying therapeutics for Alzheimer's disease.  In this study, the effect and mechanisms of bis(7)-tacrine (a promising anti-Alzheimer's dimer) on Aβ generation were investigated.  Bis(7)-tacrine (0.1-3 μM) substantially reduced the amts. of both secreted and intracellular Aβ in Neuro2a APPswe cells without altering the expression of APP. sAPPα and CTFα increased, while sAPPβ and CTFβ decreased significantly in Neuro2a APPswe cells following the treatment with bis(7)-tacrine, indicating that bis(7)-tacrine might activate α-secretase and/or inhibit BACE-1 activity.  Furthermore, bis(7)-tacrine concn.-dependently inhibited BACE-1 activity in cultured cells, and also in recombinant human BACE-1 in a non-competitive manner with an IC50 of 7.5 μM, but did not directly affect activities of BACE-2, Cathepsin D, α- or γ-secretase.  Taken together, our results not only suggest that bis(7)-tacrine may reduce the biosynthesis of Aβ mainly by directly inhibiting BACE-1 activity, but also provide new insights into the rational design of novel anti-Alzheimer's dimers that might have disease-modifying properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-O2pNL8PuuLVg90H21EOLACvtfcHk0lgSlLi2i9QueQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXivVeitQ%253D%253D&md5=b449178e17faab740f72afe5b7fd101f</span></div><a href="/servlet/linkout?suffix=cit38b&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2007.11.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2007.11.068%26sid%3Dliteratum%253Aachs%26aulast%3DFu%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DN.%2BT.%2BK.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DTsim%26aufirst%3DK.%2BW.%2BK.%26aulast%3DPang%26aufirst%3DY.%26aulast%3DYoudim%26aufirst%3DM.%2BB.%2BH.%26aulast%3DHan%26aufirst%3DY.%26atitle%3DPromising%2520anti-Alzheimer%25E2%2580%2599s%2520dimer%2520bis%25287%2529-tacrine%2520reduces%2520%25CE%25B2-amyloid%2520generation%2520by%2520directly%2520inhibiting%2520BACE-1%2520activity%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2008%26volume%3D366%26spage%3D631%26epage%3D636%26doi%3D10.1016%2Fj.bbrc.2007.11.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Espargaró, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Pietro, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabate, R.</span></span> <span> </span><span class="NLM_article-title">Ultra rapid in vivo screening for anti-Alzheimer anti-amyloid drugs</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">23349</span> <span class="refDoi"> DOI: 10.1038/srep23349</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1038%2Fsrep23349" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=27000658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvVers7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&author=A.+Espargar%C3%B3author=A.+Medinaauthor=O.+Di+Pietroauthor=D.+Mu%C3%B1oz-Torreroauthor=R.+Sabate&title=Ultra+rapid+in+vivo+screening+for+anti-Alzheimer+anti-amyloid+drugs&doi=10.1038%2Fsrep23349"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39aR"><div class="casContent"><span class="casTitleNuber">39a</span><div class="casTitle"><span class="NLM_cas:atitle">Ultra rapid in vivo screening for anti-Alzheimer anti-amyloid drugs</span></div><div class="casAuthors">Espargaro, Alba; Medina, Aina; Di Pietro, Ornella; Munoz-Torrero, Diego; Sabate, Raimon</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">23349</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">More than 46 million people worldwide suffer from Alzheimer's disease.  A large no. of potential treatments have been proposed; among these, the inhibition of the aggregation of amyloid β-peptide (Aβ), considered one of the main culprits in Alzheimer's disease.  Limitations in monitoring the aggregation of Aβ in cells and tissues restrict the screening of anti-amyloid drugs to in vitro studies in most cases.  We have developed a simple but powerful method to track Aβ aggregation in vivo in real-time, using bacteria as in vivo amyloid reservoir.  We use the specific amyloid dye Thioflavin-S (Th-S) to stain bacterial inclusion bodies (IBs), in this case mainly formed of Aβ in amyloid conformation.  Th-S binding to amyloids leads to an increment of fluorescence that can be monitored.  The quantification of the Th-S fluorescence along the time allows tracking Aβ aggregation and the effect of potential anti-aggregating agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdTgLJrIvKz7Vg90H21EOLACvtfcHk0lgSlLi2i9QueQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvVers7w%253D&md5=15f43a569820e604bad4c4ec7e6a6649</span></div><a href="/servlet/linkout?suffix=cit39a&amp;dbid=16384&amp;doi=10.1038%2Fsrep23349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep23349%26sid%3Dliteratum%253Aachs%26aulast%3DEspargar%25C3%25B3%26aufirst%3DA.%26aulast%3DMedina%26aufirst%3DA.%26aulast%3DDi%2BPietro%26aufirst%3DO.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DSabate%26aufirst%3DR.%26atitle%3DUltra%2520rapid%2520in%2520vivo%2520screening%2520for%2520anti-Alzheimer%2520anti-amyloid%2520drugs%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26doi%3D10.1038%2Fsrep23349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit39b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pouplana, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espargaró, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galdeano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viayna, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sola, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ventura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabate, R.</span></span> <span> </span><span class="NLM_article-title">Thioflavin-S staining of bacterial inclusion bodies for the fast, simple, and inexpensive screening of amyloid aggregation inhibitors</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1152</span>– <span class="NLM_lpage">1159</span>, <span class="refDoi"> DOI: 10.2174/09298673113206660256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.2174%2F09298673113206660256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=24059241" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjtlyrtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=1152-1159&author=S.+Pouplanaauthor=A.+Espargar%C3%B3author=C.+Galdeanoauthor=E.+Viaynaauthor=I.+Solaauthor=S.+Venturaauthor=D.+Mu%C3%B1oz-Torreroauthor=R.+Sabate&title=Thioflavin-S+staining+of+bacterial+inclusion+bodies+for+the+fast%2C+simple%2C+and+inexpensive+screening+of+amyloid+aggregation+inhibitors&doi=10.2174%2F09298673113206660256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39bR"><div class="casContent"><span class="casTitleNuber">39b</span><div class="casTitle"><span class="NLM_cas:atitle">Thioflavin-S Staining of Bacterial Inclusion Bodies for the Fast, Simple, and Inexpensive Screening of Amyloid Aggregation Inhibitors</span></div><div class="casAuthors">Pouplana, S.; Espargaro, A.; Galdeano, C.; Viayna, E.; Sola, I.; Ventura, S.; Munoz-Torrero, D.; Sabate, R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1152-1159</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Amyloid aggregation is linked to a large no. of human disorders, from neurodegenerative diseases as Alzheimer's disease (AD) or spongiform encephalopathies to non-neuropathic localized diseases as type II diabetes and cataracts.  Because the formation of insol. inclusion bodies (IBs) during recombinant protein prodn. in bacteria has been recently shown to share mechanistic features with amyloid self-assembly, bacteria have emerged as a tool to study amyloid aggregation.  Herein we present a fast, simple, inexpensive and quant. method for the screening of potential anti-aggregating drugs.  This method is based on monitoring the changes in the binding of thioflavin-S to intracellular IBs in intact Escherichia coli cells in the presence of small chem. compds.  This in vivo technique fairly recapitulates previous in vitro data.  Here we mainly use the Alzheimer's related β -amyloid peptide as a model system, but the technique can be easily implemented for screening inhibitors relevant for other conformational diseases simply by changing the recombinant amyloid protein target.  Indeed, we show that this methodol. can be also applied to the evaluation of inhibitors of the aggregation of tau protein, another amyloidogenic protein with a key role in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpcODp_BtMQrVg90H21EOLACvtfcHk0lhl9aIV6iOWMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjtlyrtLs%253D&md5=c8c28e9aac732ce9000afc90cf7309fd</span></div><a href="/servlet/linkout?suffix=cit39b&amp;dbid=16384&amp;doi=10.2174%2F09298673113206660256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F09298673113206660256%26sid%3Dliteratum%253Aachs%26aulast%3DPouplana%26aufirst%3DS.%26aulast%3DEspargar%25C3%25B3%26aufirst%3DA.%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DViayna%26aufirst%3DE.%26aulast%3DSola%26aufirst%3DI.%26aulast%3DVentura%26aufirst%3DS.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DSabate%26aufirst%3DR.%26atitle%3DThioflavin-S%2520staining%2520of%2520bacterial%2520inclusion%2520bodies%2520for%2520the%2520fast%252C%2520simple%252C%2520and%2520inexpensive%2520screening%2520of%2520amyloid%2520aggregation%2520inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2014%26volume%3D21%26spage%3D1152%26epage%3D1159%26doi%3D10.2174%2F09298673113206660256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerns, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McConnell, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, G. T.</span></span> <span> </span><span class="NLM_article-title">High throughput artificial membrane permeability assay for blood–brain barrier</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">232</span>, <span class="refDoi"> DOI: 10.1016/S0223-5234(03)00012-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2FS0223-5234%2803%2900012-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=12667689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=223-232&author=L.+Diauthor=E.+H.+Kernsauthor=K.+Fanauthor=O.+J.+McConnellauthor=G.+T.+Carter&title=High+throughput+artificial+membrane+permeability+assay+for+blood%E2%80%93brain+barrier&doi=10.1016%2FS0223-5234%2803%2900012-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">High throughput artificial membrane permeability assay for blood-brain barrier</span></div><div class="casAuthors">Di, Li; Kerns, Edward H.; Fan, Kristi; McConnell, Oliver J.; Carter, Guy T.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">223-232</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">The recent advances in high throughput screening for biol. activities and combinatorial chem. have greatly expanded the no. of drug candidates.  Rapid screening for BBB penetration potential early in drug discovery programs provides important information for compd. selection and guidance of synthesis for desirable CNS properties.  In this paper, we discuss a modification of the parallel artificial membrane permeation assay (PAMPA) for the prediction of blood-brain barrier penetration (PAMPA-BBB).  The assay was developed with 30 structurally diverse com. drugs and validated with 14 Wyeth Research compds.  The PAMPA-BBB assay has the advantages of: predicting passive blood-brain barrier penetration with high success, high throughput, low cost, and reproducibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZCg9Ka4mziLVg90H21EOLACvtfcHk0lhl9aIV6iOWMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXitlKju7c%253D&md5=d228d5808ba8df23deed92c5e2bf3863</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2FS0223-5234%2803%2900012-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0223-5234%252803%252900012-6%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DKerns%26aufirst%3DE.%2BH.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DMcConnell%26aufirst%3DO.%2BJ.%26aulast%3DCarter%26aufirst%3DG.%2BT.%26atitle%3DHigh%2520throughput%2520artificial%2520membrane%2520permeability%2520assay%2520for%2520blood%25E2%2580%2593brain%2520barrier%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2003%26volume%3D38%26spage%3D223%26epage%3D232%26doi%3D10.1016%2FS0223-5234%2803%2900012-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sola, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aso, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frattini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-González, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espargaró, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabaté, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Pietro, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clos, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span> <span> </span><span class="NLM_article-title">Novel levetiracetam derivatives that are effective against the Alzheimer-like phenotype in mice: synthesis, in vitro, ex vivo, and in vivo efficacy studies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6018</span>– <span class="NLM_lpage">6032</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00624</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00624" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFOlsLnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6018-6032&author=I.+Solaauthor=E.+Asoauthor=D.+Frattiniauthor=I.+L%C3%B3pez-Gonz%C3%A1lezauthor=A.+Espargar%C3%B3author=R.+Sabat%C3%A9author=O.+Di+Pietroauthor=F.+J.+Luqueauthor=M.+V.+Closauthor=I.+Ferrerauthor=D.+Mu%C3%B1oz-Torrero&title=Novel+levetiracetam+derivatives+that+are+effective+against+the+Alzheimer-like+phenotype+in+mice%3A+synthesis%2C+in+vitro%2C+ex+vivo%2C+and+in+vivo+efficacy+studies&doi=10.1021%2Facs.jmedchem.5b00624"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Levetiracetam Derivatives That Are Effective against the Alzheimer-like Phenotype in Mice: Synthesis, in Vitro, ex Vivo, and in Vivo Efficacy Studies</span></div><div class="casAuthors">Sola, Irene; Aso, Ester; Frattini, Daniela; Lopez-Gonzalez, Irene; Espargaro, Alba; Sabate, Raimon; Di Pietro, Ornella; Luque, F. Javier; Clos, M. Victoria; Ferrer, Isidro; Munoz-Torrero, Diego</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6018-6032</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have synthesized a series of heptamethylene-linked levetiracetam-huprine and levetiracetam-(6-chloro)tacrine hybrids to hit amyloid, tau, and cholinergic pathologies as well as β-amyloid (Aβ)-induced epileptiform activity, some of the mechanisms that eventually lead to cognitive deficits in Alzheimer's disease patients.  These hybrids are potent inhibitors of human acetylcholinesterase and butyrylcholinesterase in vitro and moderately potent Aβ42 and tau antiaggregating agents in a simple E. coli model of amyloid aggregation.  Ex vivo detn. of the brain acetylcholinesterase inhibitory activity of these compds. after i.p. injection to C57BL6J mice has demonstrated their ability to enter the brain.  The levetiracetam-huprine hybrid I significantly reduced the incidence of epileptic seizures, cortical amyloid burden, and neuroinflammation in APP/PS1 mice after a 4-wk treatment with a 5 mg/kg dose.  Moreover, the hybrid I rescued transgenic mice from cognitive deficits, thereby emerging as an interesting disease-modifying anti-Alzheimer drug candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqd__ieGH6QxrVg90H21EOLACvtfcHk0lhl9aIV6iOWMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFOlsLnM&md5=f275a5233c2cdd59410e22b615634698</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00624%26sid%3Dliteratum%253Aachs%26aulast%3DSola%26aufirst%3DI.%26aulast%3DAso%26aufirst%3DE.%26aulast%3DFrattini%26aufirst%3DD.%26aulast%3DL%25C3%25B3pez-Gonz%25C3%25A1lez%26aufirst%3DI.%26aulast%3DEspargar%25C3%25B3%26aufirst%3DA.%26aulast%3DSabat%25C3%25A9%26aufirst%3DR.%26aulast%3DDi%2BPietro%26aufirst%3DO.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26aulast%3DClos%26aufirst%3DM.%2BV.%26aulast%3DFerrer%26aufirst%3DI.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26atitle%3DNovel%2520levetiracetam%2520derivatives%2520that%2520are%2520effective%2520against%2520the%2520Alzheimer-like%2520phenotype%2520in%2520mice%253A%2520synthesis%252C%2520in%2520vitro%252C%2520ex%2520vivo%252C%2520and%2520in%2520vivo%2520efficacy%2520studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6018%26epage%3D6032%26doi%3D10.1021%2Facs.jmedchem.5b00624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Borchelt, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratovitski, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Lare, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sisodia, S. S.</span></span> <span> </span><span class="NLM_article-title">Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">939</span>– <span class="NLM_lpage">945</span>, <span class="refDoi"> DOI: 10.1016/S0896-6273(00)80974-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2FS0896-6273%2800%2980974-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=9354339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADyaK2sXntFersbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1997&pages=939-945&author=D.+R.+Borcheltauthor=T.+Ratovitskiauthor=J.+van+Lareauthor=M.+K.+Leeauthor=V.+Gonzalesauthor=N.+A.+Jenkinsauthor=N.+G.+Copelandauthor=D.+L.+Priceauthor=S.+S.+Sisodia&title=Accelerated+amyloid+deposition+in+the+brains+of+transgenic+mice+coexpressing+mutant+presenilin+1+and+amyloid+precursor+proteins&doi=10.1016%2FS0896-6273%2800%2980974-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins</span></div><div class="casAuthors">Borchelt, David R.; Ratovitski, Tamara; Van Lare, Judy; Lee, Michael K.; Gonzales, Vicki; Jenkins, Nancy A.; Copeland, Neal G.; Price, Donald L.; Sisodia, Sangram S.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">939-945</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Missense mutations in two related genes, termed presenilin 1 (PS1) and presenilin 2 (PS2), cause dementia in a subset of early-onset familial Alzheimer's disease (FAD) pedigrees.  In a variety of exptl. in vitro and in vivo settings, FAD-linked presenilin variants influence the processing of the amyloid precursor protein (APP), leading to elevated levels of the highly fibrilogenic Aβ1-42 peptides that are preferentially deposited in the brains of Alzheimer Disease (AD) patients.  In this report, we demonstrate that transgenic animals that coexpress an FAD-linked human PS1 variant (A246E) and a chimeric mouse/human APP harboring mutations linked to Swedish FAD kindreds (APP swe) develop numerous amyloid deposits much earlier than age-matched mice expressing APP swe and wild-type Hu PS1 or APP swe alone.  These results provide evidence for the view that one pathogenic mechanism by which FAD-linked mutant PS1 causes AD is to accelerate the rate of β-amyloid deposition in brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE6fPtRz3ferVg90H21EOLACvtfcHk0lgMAagt6R0flw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXntFersbo%253D&md5=8377c31c3b35cb4cdca7d648f2161062</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2FS0896-6273%2800%2980974-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0896-6273%252800%252980974-5%26sid%3Dliteratum%253Aachs%26aulast%3DBorchelt%26aufirst%3DD.%2BR.%26aulast%3DRatovitski%26aufirst%3DT.%26aulast%3Dvan%2BLare%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DM.%2BK.%26aulast%3DGonzales%26aufirst%3DV.%26aulast%3DJenkins%26aufirst%3DN.%2BA.%26aulast%3DCopeland%26aufirst%3DN.%2BG.%26aulast%3DPrice%26aufirst%3DD.%2BL.%26aulast%3DSisodia%26aufirst%3DS.%2BS.%26atitle%3DAccelerated%2520amyloid%2520deposition%2520in%2520the%2520brains%2520of%2520transgenic%2520mice%2520coexpressing%2520mutant%2520presenilin%25201%2520and%2520amyloid%2520precursor%2520proteins%26jtitle%3DNeuron%26date%3D1997%26volume%3D19%26spage%3D939%26epage%3D945%26doi%3D10.1016%2FS0896-6273%2800%2980974-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vogel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcotte, E. M.</span></span> <span> </span><span class="NLM_article-title">Insights into the regulation of protein abundance from proteomic and transcriptomic analyses</span>. <i>Nat. Rev. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">227</span>– <span class="NLM_lpage">232</span>, <span class="refDoi"> DOI: 10.1038/nrg3185</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1038%2Fnrg3185" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=22411467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1Wgurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=227-232&author=C.+Vogelauthor=E.+M.+Marcotte&title=Insights+into+the+regulation+of+protein+abundance+from+proteomic+and+transcriptomic+analyses&doi=10.1038%2Fnrg3185"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into the regulation of protein abundance from proteomic and transcriptomic analyses</span></div><div class="casAuthors">Vogel, Christine; Marcotte, Edward M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Genetics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">227-232</span>CODEN:
                <span class="NLM_cas:coden">NRGAAM</span>;
        ISSN:<span class="NLM_cas:issn">1471-0056</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Recent advances in next-generation DNA sequencing and proteomics provide an unprecedented ability to survey mRNA and protein abundances.  Such proteome-wide surveys are illuminating the extent to which different aspects of gene expression help to regulate cellular protein abundances.  Current data demonstrate a substantial role for regulatory processes occurring after mRNA is made - i.e., post-transcriptional, translational and protein degrdn. regulation - in controlling steady-state protein abundances.  Intriguing observations are also emerging in relation to cells following perturbation, single-cell studies and the apparent evolutionary conservation of protein and mRNA abundances.  Here, we summarize current understanding of the major factors regulating protein expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNVg9UPb6f0rVg90H21EOLACvtfcHk0lgMAagt6R0flw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1Wgurs%253D&md5=cc06a788506765eb137f9d42461586c8</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fnrg3185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrg3185%26sid%3Dliteratum%253Aachs%26aulast%3DVogel%26aufirst%3DC.%26aulast%3DMarcotte%26aufirst%3DE.%2BM.%26atitle%3DInsights%2520into%2520the%2520regulation%2520of%2520protein%2520abundance%2520from%2520proteomic%2520and%2520transcriptomic%2520analyses%26jtitle%3DNat.%2520Rev.%2520Genet.%26date%3D2012%26volume%3D13%26spage%3D227%26epage%3D232%26doi%3D10.1038%2Fnrg3185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheignon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnefont-Rousselot, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faller, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hureau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collin, F.</span></span> <span> </span><span class="NLM_article-title">Oxidative stress and the amyloid beta peptide in Alzheimer’s disease</span>. <i>Redox Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">450</span>– <span class="NLM_lpage">464</span>, <span class="refDoi"> DOI: 10.1016/j.redox.2017.10.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2Fj.redox.2017.10.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=29080524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslans73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=450-464&author=C.+Cheignonauthor=M.+Tomasauthor=D.+Bonnefont-Rousselotauthor=P.+Fallerauthor=C.+Hureauauthor=F.+Collin&title=Oxidative+stress+and+the+amyloid+beta+peptide+in+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.redox.2017.10.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative stress and the amyloid beta peptide in Alzheimer's disease</span></div><div class="casAuthors">Cheignon, C.; Tomas, M.; Bonnefont-Rousselot, D.; Faller, P.; Hureau, C.; Collin, F.</div><div class="citationInfo"><span class="NLM_cas:title">Redox Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">450-464</span>CODEN:
                <span class="NLM_cas:coden">RBEIB3</span>;
        ISSN:<span class="NLM_cas:issn">2213-2317</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Oxidative stress is known to play an important role in the pathogenesis of a no. of diseases.  In particular, it is linked to the etiol. of Alzheimer's disease (AD), an age-related neurodegenerative disease and the most common cause of dementia in the elderly.  Histopathol. hallmarks of AD are intracellular neurofibrillary tangles and extracellular formation of senile plaques composed of the amyloid-beta peptide (Aβ) in aggregated form along with metal-ions such as copper, iron or zinc.  Redox active metal ions, as for example copper, can catalyze the prodn. of Reactive Oxygen Species (ROS) when bound to the amyloid-β (Aβ).  The ROS thus produced, in particular the hydroxyl radical which is the most reactive one, may contribute to oxidative damage on both the Aβ peptide itself and on surrounding mol. (proteins, lipids, ...).  This review highlights the existing link between oxidative stress and AD, and the consequences towards the Aβ peptide and surrounding mols. in terms of oxidative damage.  In addn., the implication of metal ions in AD, their interaction with the Aβ peptide and redox properties leading to ROS prodn. are discussed, along with both in vitro and in vivo oxidn. of the Aβ peptide, at the mol. level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAsJM-PSPjNrVg90H21EOLACvtfcHk0lgMAagt6R0flw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslans73L&md5=f61600ab9e355cd49838961d26de5c4f</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.redox.2017.10.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.redox.2017.10.014%26sid%3Dliteratum%253Aachs%26aulast%3DCheignon%26aufirst%3DC.%26aulast%3DTomas%26aufirst%3DM.%26aulast%3DBonnefont-Rousselot%26aufirst%3DD.%26aulast%3DFaller%26aufirst%3DP.%26aulast%3DHureau%26aufirst%3DC.%26aulast%3DCollin%26aufirst%3DF.%26atitle%3DOxidative%2520stress%2520and%2520the%2520amyloid%2520beta%2520peptide%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DRedox%2520Biol.%26date%3D2018%26volume%3D14%26spage%3D450%26epage%3D464%26doi%3D10.1016%2Fj.redox.2017.10.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Patocka, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuca, K.</span></span> <span> </span><span class="NLM_article-title">Possible role of hydroxylated metabolites of tacrine in drug toxicity and therapy of Alzheimer’s disease</span>. <i>Curr. Drug Metab.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">332</span>– <span class="NLM_lpage">335</span>, <span class="refDoi"> DOI: 10.2174/138920008784220619</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.2174%2F138920008784220619" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=18473751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD1cXls1aitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=332-335&author=J.+Patockaauthor=D.+Junauthor=K.+Kuca&title=Possible+role+of+hydroxylated+metabolites+of+tacrine+in+drug+toxicity+and+therapy+of+Alzheimer%E2%80%99s+disease&doi=10.2174%2F138920008784220619"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45aR"><div class="casContent"><span class="casTitleNuber">45a</span><div class="casTitle"><span class="NLM_cas:atitle">Possible role of hydroxylated metabolites of tacrine in drug toxicity and therapy of Alzheimer's disease</span></div><div class="casAuthors">Patocka, Jiri; Jun, Daniel; Kuca, Kamil</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Metabolism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">332-335</span>CODEN:
                <span class="NLM_cas:coden">CDMUBU</span>;
        ISSN:<span class="NLM_cas:issn">1389-2002</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Tacrine belongs to the group of acetylcholinesterase (AChE) inhibitors used as drugs for treatment of Alzheimer's disease (AD).  The formation of hydroxyderivatives of tacrine is well-established step in the metabolization of this drug in liver by microsomal cytochrome P 450 enzymes family.  Genetic polymorphism of cytochrome P 450 enzymes is probably responsible for balance between a no. of stable and non-toxic metabolites and highly protein-reactive and toxic ones.  By this manner may be explained why the hepatotoxicity of tacrine was obsd. only in the part of persons and why not every patient with AD responds to the treatment by this drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUeG2em7see7Vg90H21EOLACvtfcHk0lgcECwrLK60Jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXls1aitb4%253D&md5=90794c1e82da53f0506f31d7400b260c</span></div><a href="/servlet/linkout?suffix=cit45a&amp;dbid=16384&amp;doi=10.2174%2F138920008784220619&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920008784220619%26sid%3Dliteratum%253Aachs%26aulast%3DPatocka%26aufirst%3DJ.%26aulast%3DJun%26aufirst%3DD.%26aulast%3DKuca%26aufirst%3DK.%26atitle%3DPossible%2520role%2520of%2520hydroxylated%2520metabolites%2520of%2520tacrine%2520in%2520drug%2520toxicity%2520and%2520therapy%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2008%26volume%3D9%26spage%3D332%26epage%3D335%26doi%3D10.2174%2F138920008784220619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit45b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Spaldin, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madden, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pool, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolf, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B.</span></span> <span> </span><span class="NLM_article-title">The effect of enzyme inhibition on the metabolism and activation of tacrine by human liver microsomes</span>. <i>Br. J. Clin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2125.1994.tb04316.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1111%2Fj.1365-2125.1994.tb04316.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=7946932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADyaK2cXmt1Squ7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1994&pages=15-22&author=V.+Spaldinauthor=S.+Maddenauthor=W.+Poolauthor=T.+Woolfauthor=B.+Park&title=The+effect+of+enzyme+inhibition+on+the+metabolism+and+activation+of+tacrine+by+human+liver+microsomes&doi=10.1111%2Fj.1365-2125.1994.tb04316.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45bR"><div class="casContent"><span class="casTitleNuber">45b</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of enzyme inhibition on the metabolism and activation of tacrine by human liver microsomes</span></div><div class="casAuthors">Spaldin, Vanessa; Madden, Stephen; Pool, William F.; Woolf, Thomas F.; Park, B. Kevin</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-22</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    </div><div class="casAbstract">Tacrine (1,2,3,4-tetrahydro-9-aminoacridine-hydrochloride: THA) underwent metab. in vitro by a panel (n = 12) of human liver microsomes genotyped for CYP2D6, in the presence of NADPH, to both protein-reactive and stable metabolites.  There was considerable variation in the extent of THA metab. amongst human livers.  Protein-reactive metabolite formation showed a 10-fold variation (0.6 ± 0.1%-5.2 ± 0.8% of incubated radioactivity mg-1 protein) while stable metabolites showed a 3-fold variation (24.3 ± 1.7%-78.6 ± 2.6% of incubated radioactivity).  Using cytochrome P 450 isoform specific inhibitors, CYP1A2 was identified as the major enzyme involved in all routes of THA metab.  There was a high correlation between arom. and alicyclic hydroxylation (r = 0.92, P < 0.0001) consistent with these biotransformations being catalyzed by the same enzymes.  Enoxacin (ENOX), cimetidine (CIM) and chloroquine (CQ) inhibited THA metab. by a preferential decrease in the bioactivation to protein-reactive, and hence potentially toxic, species.  The inhibitory potency of ENOX and CIM was increased significantly upon pre-incubation with microsomes and NADPH.  Covalent binding correlated with 7-OH-THA formation before (r = 0.792, P < 0.0001) and after (r = 0.73, P < 0.0001) inhibition by CIM, consistent with a two-step mechanism in the formation of protein-reactive metabolite(s) via a 7-OH intermediate.  The use of enzyme inhibitors may provide a useful tool for examg. the relationship between the metab. and toxicity of THA in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8-WddvBnzXLVg90H21EOLACvtfcHk0lgcECwrLK60Jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXmt1Squ7g%253D&md5=bb873b19f38a811b9e3c88cac7df91ac</span></div><a href="/servlet/linkout?suffix=cit45b&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.1994.tb04316.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.1994.tb04316.x%26sid%3Dliteratum%253Aachs%26aulast%3DSpaldin%26aufirst%3DV.%26aulast%3DMadden%26aufirst%3DS.%26aulast%3DPool%26aufirst%3DW.%26aulast%3DWoolf%26aufirst%3DT.%26aulast%3DPark%26aufirst%3DB.%26atitle%3DThe%2520effect%2520of%2520enzyme%2520inhibition%2520on%2520the%2520metabolism%2520and%2520activation%2520of%2520tacrine%2520by%2520human%2520liver%2520microsomes%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D1994%26volume%3D38%26spage%3D15%26epage%3D22%26doi%3D10.1111%2Fj.1365-2125.1994.tb04316.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit45c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Madden, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolf, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pool, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, B. K.</span></span> <span> </span><span class="NLM_article-title">An investigation into the formation of stable, protein-reactive and cytotoxic metabolites from tacrine in vitro</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">20</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(93)90342-T</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2F0006-2952%2893%2990342-T" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=8347124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADyaK3sXlvFGmtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1993&pages=13-20&author=S.+Maddenauthor=T.+F.+Woolfauthor=W.+F.+Poolauthor=B.+K.+Park&title=An+investigation+into+the+formation+of+stable%2C+protein-reactive+and+cytotoxic+metabolites+from+tacrine+in+vitro&doi=10.1016%2F0006-2952%2893%2990342-T"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45cR"><div class="casContent"><span class="casTitleNuber">45c</span><div class="casTitle"><span class="NLM_cas:atitle">An investigation into the formation of stable, protein-reactive and cytotoxic metabolites from tacrine in vitro: studies with human and rat liver microsomes</span></div><div class="casAuthors">Madden, Stephen; Woolf, Thomas F.; Pool, William F.; Park, B. Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-20</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">Tacrine (1,2,3,4-tetrahydro-9-aminoacridine hydrochloride; THA) is known to undergo extensive oxidative metab. to a variety of mono- and dihydroxylated metabolites in animals and humans.  The potential for tacrine to undergo metab. to stable, protein-reactive and cytotoxic metabolites has been investigated in incubations with human and rat liver microsomes.  Using lymphocytes as sensitive markers to quantify cytotoxicity, THA (50 μM) underwent NADPH-dependent bioactivation to a cytotoxic metabolite(s).  Stable and protein-reactive metabolites were also formed in microsomes from both species.  These accounted for 28.2 and 1.22% of incubated radioactivity in human microsomes and 6.4 and 0.4% of incubated radioactivity in rat microsomes.  Reduced glutathione (500 μM) completely blocked NADPH-dependent cytotoxicity and inhibited protein-reactive metabolite formation by 60%.  Ascorbic acid (500 μM) inhibited the generation of cytotoxic and protein-reactive metabolites by 75 and 35%, resp.  Cyclohexene oxide was without effect.  Human serum albumin was found to protect the lymphocytes against toxicity.  In microsomes prepd. from the livers of four donors known to have been smokers there were no significant differences in the generation of metabolites from THA compared with microsomes prepd. from livers of non-smokers.  Enoxacin, a specific inhibitor of cytochrome P 450 1A2 significantly inhibited all routes of THA metab.  The authors have therefore demonstrated that THA may be oxidatively metabolized to stable, protein-reactive and cytotoxic metabolites in human and rat liver microsomes.  A no. of inhibitors may affect these processes, whilst inhibition by enoxacin indicates a role for cytochrome P 450 1A2 in THA metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBVISRfdBJzrVg90H21EOLACvtfcHk0lgcECwrLK60Jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXlvFGmtbw%253D&md5=7394d4697031eb18e4daada87d00f539</span></div><a href="/servlet/linkout?suffix=cit45c&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2893%2990342-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252893%252990342-T%26sid%3Dliteratum%253Aachs%26aulast%3DMadden%26aufirst%3DS.%26aulast%3DWoolf%26aufirst%3DT.%2BF.%26aulast%3DPool%26aufirst%3DW.%2BF.%26aulast%3DPark%26aufirst%3DB.%2BK.%26atitle%3DAn%2520investigation%2520into%2520the%2520formation%2520of%2520stable%252C%2520protein-reactive%2520and%2520cytotoxic%2520metabolites%2520from%2520tacrine%2520in%2520vitro%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1993%26volume%3D46%26spage%3D13%26epage%3D20%26doi%3D10.1016%2F0006-2952%2893%2990342-T" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nepovimova, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korabecny, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolezal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babkova, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ondrejicek, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sepsova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hrabinova, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soukup, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bukum, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jost, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muckova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malinak, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuca, K.</span></span> <span> </span><span class="NLM_article-title">Tacrine–trolox hybrids: A novel class of centrally active, nonhepatotoxic multi-target-directed ligands exerting anticholinesterase and antioxidant activities with low in vivo toxicity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">8985</span>– <span class="NLM_lpage">9003</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01325</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01325" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslWlt7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8985-9003&author=E.+Nepovimovaauthor=J.+Korabecnyauthor=R.+Dolezalauthor=K.+Babkovaauthor=A.+Ondrejicekauthor=D.+Junauthor=V.+Sepsovaauthor=A.+Horovaauthor=M.+Hrabinovaauthor=O.+Soukupauthor=N.+Bukumauthor=P.+Jostauthor=L.+Muckovaauthor=J.+Kassaauthor=D.+Malinakauthor=M.+Andrsauthor=K.+Kuca&title=Tacrine%E2%80%93trolox+hybrids%3A+A+novel+class+of+centrally+active%2C+nonhepatotoxic+multi-target-directed+ligands+exerting+anticholinesterase+and+antioxidant+activities+with+low+in+vivo+toxicity&doi=10.1021%2Facs.jmedchem.5b01325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Tacrine-trolox hybrids: a novel class of centrally active, nonhepatotoxic multi-target-directed ligands exerting anticholinesterase and antioxidant activities with low in vivo toxicity</span></div><div class="casAuthors">Nepovimova, Eugenie; Korabecny, Jan; Dolezal, Rafael; Babkova, Katerina; Ondrejicek, Ales; Jun, Daniel; Sepsova, Vendula; Horova, Anna; Hrabinova, Martina; Soukup, Ondrej; Bukum, Neslihan; Jost, Petr; Muckova, Lubica; Kassa, Jiri; Malinak, David; Andrs, Martin; Kuca, Kamil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">8985-9003</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Coupling of two distinct pharmacophores, tacrine and trolox, endowed with different biol. properties, afforded 21 hybrid compds. as novel multifunctional candidates against Alzheimer's disease.  Several of them showed improved inhibitory properties toward acetylcholinesterase (AChE) in relation to tacrine.  These hybrids also scavenged free radicals.  Mol. modeling studies in tandem with kinetic anal. exhibited that these hybrids target both catalytic active site as well as peripheral anionic site of AChE.  In addn., incorporation of the moiety bearing antioxidant abilities displayed negligible toxicity on human hepatic cells.  This striking effect was explained by formation of nontoxic metabolites after 1 h incubation in human liver microsomes system.  Finally, tacrine-trolox hybrids exhibited low in vivo toxicity after i.m. administration in rats and potential to penetrate across blood-brain barrier.  All of these outstanding in vitro results in combination with promising in vivo outcomes highlighted deriv. I as the lead structure worthy of further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWjX4tC8Sy17Vg90H21EOLACvtfcHk0li0X5tTC3-8xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslWlt7vI&md5=550bddcd59b5bbb90d77e67faca28839</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01325%26sid%3Dliteratum%253Aachs%26aulast%3DNepovimova%26aufirst%3DE.%26aulast%3DKorabecny%26aufirst%3DJ.%26aulast%3DDolezal%26aufirst%3DR.%26aulast%3DBabkova%26aufirst%3DK.%26aulast%3DOndrejicek%26aufirst%3DA.%26aulast%3DJun%26aufirst%3DD.%26aulast%3DSepsova%26aufirst%3DV.%26aulast%3DHorova%26aufirst%3DA.%26aulast%3DHrabinova%26aufirst%3DM.%26aulast%3DSoukup%26aufirst%3DO.%26aulast%3DBukum%26aufirst%3DN.%26aulast%3DJost%26aufirst%3DP.%26aulast%3DMuckova%26aufirst%3DL.%26aulast%3DKassa%26aufirst%3DJ.%26aulast%3DMalinak%26aufirst%3DD.%26aulast%3DAndrs%26aufirst%3DM.%26aulast%3DKuca%26aufirst%3DK.%26atitle%3DTacrine%25E2%2580%2593trolox%2520hybrids%253A%2520A%2520novel%2520class%2520of%2520centrally%2520active%252C%2520nonhepatotoxic%2520multi-target-directed%2520ligands%2520exerting%2520anticholinesterase%2520and%2520antioxidant%2520activities%2520with%2520low%2520in%2520vivo%2520toxicity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8985%26epage%3D9003%26doi%3D10.1021%2Facs.jmedchem.5b01325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kamal-Eldin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appelqvist, L.-Å.</span></span> <span> </span><span class="NLM_article-title">The chemistry and antioxidant properties of tocopherols and tocotrienols</span>. <i>Lipids</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">671</span>– <span class="NLM_lpage">701</span>, <span class="refDoi"> DOI: 10.1007/BF02522884</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1007%2FBF02522884" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=8827691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADyaK28XktlKkt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1996&pages=671-701&author=A.+Kamal-Eldinauthor=L.-%C3%85.+Appelqvist&title=The+chemistry+and+antioxidant+properties+of+tocopherols+and+tocotrienols&doi=10.1007%2FBF02522884"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47aR"><div class="casContent"><span class="casTitleNuber">47a</span><div class="casTitle"><span class="NLM_cas:atitle">The chemistry and antioxidant properties of tocopherols and tocotrienols</span></div><div class="casAuthors">Kamal-Eldin, Afaf; Appelqvist, Lars-Aake</div><div class="citationInfo"><span class="NLM_cas:title">Lipids</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">671-701</span>CODEN:
                <span class="NLM_cas:coden">LPDSAP</span>;
        ISSN:<span class="NLM_cas:issn">0024-4201</span>.
    
            (<span class="NLM_cas:orgname">AOCS Press</span>)
        </div><div class="casAbstract">A review, with 324 refs.  This article is a review of the fundamental chem. of the tocopherols and tocotrienols relevant to their antioxidant action.  Despite the general agreement that α-tocopherol is the most efficient antioxidant and vitamin E homolog in vivo, there was always a considerable discrepancy in its "abs." and "relative" antioxidant effectiveness in vitro, esp. when compared to γ-tocopherol.  Many chem., phys., biochem., physicochem., and other factors seem responsible for the obsd. discrepancy between the relative antioxidant potencies of the tocopherols in vivo and in vitro.  This paper aims at highlighting some possible reasons for the obsd. differences between the tocopherols (α-, β-, γ-, and δ-) in relation to their interactions with the important chem. species involved in lipid peroxidn., specifically trace metal ions, singlet oxygen, nitrogen oxides, and antioxidant synergists.  Although literature reports related to the chem. of the tocotrienols are quite meager, they also were included in the discussion in virtue of their structural and functional resemblance to the tocopherols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRb1rKjoGt-rVg90H21EOLACvtfcHk0li0X5tTC3-8xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XktlKkt74%253D&md5=8b442b54e788f8003569a50ec6ac0182</span></div><a href="/servlet/linkout?suffix=cit47a&amp;dbid=16384&amp;doi=10.1007%2FBF02522884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02522884%26sid%3Dliteratum%253Aachs%26aulast%3DKamal-Eldin%26aufirst%3DA.%26aulast%3DAppelqvist%26aufirst%3DL.-%25C3%2585.%26atitle%3DThe%2520chemistry%2520and%2520antioxidant%2520properties%2520of%2520tocopherols%2520and%2520tocotrienols%26jtitle%3DLipids%26date%3D1996%26volume%3D31%26spage%3D671%26epage%3D701%26doi%3D10.1007%2FBF02522884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit47b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Christen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodall, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shigenaga, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Southwell-Keely, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duncan, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ames, B. N.</span></span> <span> </span><span class="NLM_article-title">γ-Tocopherol traps mutagenic electrophiles such as NOx and complements α-tocopherol: Physiological implications</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">3217</span>– <span class="NLM_lpage">3222</span>, <span class="refDoi"> DOI: 10.1073/pnas.94.7.3217</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1073%2Fpnas.94.7.3217" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=9096373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADyaK2sXisVKgur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=3217-3222&author=S.+Christenauthor=A.+A.+Woodallauthor=M.+K.+Shigenagaauthor=P.+T.+Southwell-Keelyauthor=M.+W.+Duncanauthor=B.+N.+Ames&title=%CE%B3-Tocopherol+traps+mutagenic+electrophiles+such+as+NOx+and+complements+%CE%B1-tocopherol%3A+Physiological+implications&doi=10.1073%2Fpnas.94.7.3217"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47bR"><div class="casContent"><span class="casTitleNuber">47b</span><div class="casTitle"><span class="NLM_cas:atitle">γ-Tocopherol traps mutagenic electrophiles such as NOx and complements α-tocopherol: physiological implications</span></div><div class="casAuthors">Christen, Stephan; Woodall, Alan A.; Shigenaga, Mark K.; Southwell-Keely, Peter T.; Duncan, Mark W.; Ames, Bruce N.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3217-3222</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Peroxynitrite, a powerful mutagenic oxidant and nitrating species, is formed by the near diffusion-limited reaction of ·NO and O2-· during activation of phagocytes.  Chronic inflammation induced by phagocytes is a major contributor to cancer and other degenerative diseases.  We examd. how γ-tocopherol (γT), the principal form of vitamin E in the United States diet, and α-tocopherol (αT), the major form in supplements, protect against peroxynitrite-induced lipid oxidn.  Lipid hydroperoxide formation in liposomes (but not isolated low-d. lipoprotein) exposed to peroxynitrite or the ·NO and O2-· generator SIN-1 (3-morpholinosydnonimine) was inhibited more effectively by γT than αT.  More importantly, nitration of γT at the nucleophilic 5-position, which proceeded in both liposomes and human low d. lipoprotein at yields of ≈50% and ≈70%, resp., was not affected by the presence of αT.  These results suggest that despite αT's action as an antioxidant γT is required to effectively remove the peroxynitrite-derived nitrating species.  We postulate that γT acts in vivo as a trap for membrane-sol. electrophilic nitrogen oxides and other electrophilic mutagens, forming stable carbon-centered adducts through the nucleophilic 5-position, which is blocked in αT.  Because large doses of dietary αT displace γT in plasma and other tissues, the current wisdom of vitamin E supplementation with primarily αT should be reconsidered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooNMZj00oHr7Vg90H21EOLACvtfcHk0li0X5tTC3-8xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXisVKgur4%253D&md5=4b9507680802d7a9639c5b46bdc858bd</span></div><a href="/servlet/linkout?suffix=cit47b&amp;dbid=16384&amp;doi=10.1073%2Fpnas.94.7.3217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.94.7.3217%26sid%3Dliteratum%253Aachs%26aulast%3DChristen%26aufirst%3DS.%26aulast%3DWoodall%26aufirst%3DA.%2BA.%26aulast%3DShigenaga%26aufirst%3DM.%2BK.%26aulast%3DSouthwell-Keely%26aufirst%3DP.%2BT.%26aulast%3DDuncan%26aufirst%3DM.%2BW.%26aulast%3DAmes%26aufirst%3DB.%2BN.%26atitle%3D%25CE%25B3-Tocopherol%2520traps%2520mutagenic%2520electrophiles%2520such%2520as%2520NOx%2520and%2520complements%2520%25CE%25B1-tocopherol%253A%2520Physiological%2520implications%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1997%26volume%3D94%26spage%3D3217%26epage%3D3222%26doi%3D10.1073%2Fpnas.94.7.3217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolton, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burr, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liebler, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span> <span> </span><span class="NLM_article-title">The reduction of α-tocopherolquinone by human NAD(P)H:quinone oxidoreductase: The role of α-tocopherolhydroquinone as a cellular antioxidant</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">300</span>– <span class="NLM_lpage">305</span>, <span class="refDoi"> DOI: 10.1124/mol.52.2.300</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1124%2Fmol.52.2.300" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=9271353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADyaK2sXlvVeisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1997&pages=300-305&author=D.+Siegelauthor=E.+M.+Boltonauthor=J.+A.+Burrauthor=D.+C.+Lieblerauthor=D.+Ross&title=The+reduction+of+%CE%B1-tocopherolquinone+by+human+NAD%28P%29H%3Aquinone+oxidoreductase%3A+The+role+of+%CE%B1-tocopherolhydroquinone+as+a+cellular+antioxidant&doi=10.1124%2Fmol.52.2.300"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48aR"><div class="casContent"><span class="casTitleNuber">48a</span><div class="casTitle"><span class="NLM_cas:atitle">The reduction of α-tocopherolquinone by human NAD(P)H:quinone oxidoreductase: the role of α-tocopherolhydroquinone as a cellular antioxidant</span></div><div class="casAuthors">Siegel, David; Bolton, Emiko M.; Burr, Jeanne A.; Liebler, Daniel C.; Ross, David</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">300-305</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">α-Tocopherolquinone (TQ), a product of α-tocopherol oxidn., can function as an antioxidant after redn. to α-tocopherolhydroquinone (TQH2).  We examd. the ability of human NAD(P)H:quinone oxidoreductase (NQO1) to catalyze the redn. of TQ to TQH2 in cell-free and cellular systems.  In reactions with purified human NQO1, TQ was reduced to TQH2.  Kinetic parameters for the redn. of TQ by NQO1 (Km = 370 μM; Kcat = 5.6×103 min-1; Kcat/Km = 15 min-1 · μM-1) indicate that NQO1 can efficiently reduce TQ to TQH2.  A comparison of the rate of redn. of TQ and coenzyme Q10 by NQO1 showed that TQ is reduced more efficiently than coenzyme Q10.  Expts. with either Chinese hamster ovary (CHO) cells stably transfected with human NQO1 or CHO cell sonicates demonstrated a correlation between NQO1 activity and TQ redn. to TQH2.  CHO cells with elevated NQO1 generated and maintained higher levels of TQH2 after treatment with TQ relative to NQO1-deficient CHO cells.  TQH2 generated from NQO1-mediated redn. of TQ prevented cumene hydroperoxide-induced lipid peroxidn. in rat liver microsomes.  In addn., cumene hydroperoxide-induced lipid peroxidn. was inhibited more efficiently by TQ in CHO cell lines with elevated NQO1 activity.  These data demonstrate that NQO1 can reduce TQ to TQH2 and that TQH2 can function as an efficient antioxidant.  This work suggests that one of the physiol. functions of NQO1 may be to regenerate antioxidant forms of α-tocopherol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7hheEy1pEkrVg90H21EOLACvtfcHk0li0X5tTC3-8xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlvVeisL0%253D&md5=e47dd2badd49122471d740cbe00eee22</span></div><a href="/servlet/linkout?suffix=cit48a&amp;dbid=16384&amp;doi=10.1124%2Fmol.52.2.300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.52.2.300%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DBolton%26aufirst%3DE.%2BM.%26aulast%3DBurr%26aufirst%3DJ.%2BA.%26aulast%3DLiebler%26aufirst%3DD.%2BC.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3DThe%2520reduction%2520of%2520%25CE%25B1-tocopherolquinone%2520by%2520human%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%253A%2520The%2520role%2520of%2520%25CE%25B1-tocopherolhydroquinone%2520as%2520a%2520cellular%2520antioxidant%26jtitle%3DMol.%2520Pharmacol.%26date%3D1997%26volume%3D52%26spage%3D300%26epage%3D305%26doi%3D10.1124%2Fmol.52.2.300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit48b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Kohar, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baca, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suarna, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stocker, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Southwell-Keely, P. T.</span></span> <span> </span><span class="NLM_article-title">Is α-tocopherol a reservoir for α-tocopheryl hydroquinone?</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">197</span>– <span class="NLM_lpage">207</span>, <span class="refDoi"> DOI: 10.1016/0891-5849(95)00010-U</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2F0891-5849%2895%2900010-U" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=7649491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADyaK2MXmsFKntbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1995&pages=197-207&author=I.+Koharauthor=M.+Bacaauthor=C.+Suarnaauthor=R.+Stockerauthor=P.+T.+Southwell-Keely&title=Is+%CE%B1-tocopherol+a+reservoir+for+%CE%B1-tocopheryl+hydroquinone%3F&doi=10.1016%2F0891-5849%2895%2900010-U"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48bR"><div class="casContent"><span class="casTitleNuber">48b</span><div class="casTitle"><span class="NLM_cas:atitle">Is α-tocopherol a reservoir for α-tocopheryl hydroquinone?</span></div><div class="casAuthors">Kohar, Indra; Baca, Manuel; Suarna, Cacang; Stocker, Roland; Southwell-Keely, Peter T.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">197-207</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The products of oxidn. of the α-tocopherol model compd., 2,2,5,7,8-pentamethyl-6-chromanol (PH) by t-Bu hydroperoxide in chloroform varied with the amt. of water present.  In the presence of a trace of water, the main products were the spirodimer (PSD) and spirotrimer (PST).  As the content of water increased, the main product became 2-(3-hydroxy-3-methylbutyl)-3,5,6-trimethyl-1,4-benzoquinone (PQ).  Oxidn. of PH in aq. liposome suspension also produced PQ as the major product.  These results suggested that, in aq. solns., the major oxidn. product of PH would be PQ and of α-tocopherol (TH) would be α-tocopheryl quinone (TQ).  The ease of redn. of PQ and TQ was studied in chem. and biol. systems.  PQ, TQ, and ubiquinone-10 (UQ) were rapidly reduced to their resp. hydroquinones (PQH2, TQH2, and UQH2) at pH 7.3 by NADH plus FAD.  Whole blood reduced PQ rapidly at 37° to PQH2 but did not reduce TQ to TQH2.  Human peripheral blood mononuclear cells took up TQ from a bovine serum albumin complex and reduced it to TQH2.  Ingestion of TQ (350 mg) by one of the authors resulted in the formation of TQH2 during a 5 h period.  These results demonstrate that several biol. systems are able to reduce TQ to TQH2 and that it is a reaction that may occur normally in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpysiytCHG0ubVg90H21EOLACvtfcHk0ljYXtSPk-CI3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmsFKntbg%253D&md5=7b4796b28d3ef0c4f55cf6cb136429c9</span></div><a href="/servlet/linkout?suffix=cit48b&amp;dbid=16384&amp;doi=10.1016%2F0891-5849%2895%2900010-U&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0891-5849%252895%252900010-U%26sid%3Dliteratum%253Aachs%26aulast%3DKohar%26aufirst%3DI.%26aulast%3DBaca%26aufirst%3DM.%26aulast%3DSuarna%26aufirst%3DC.%26aulast%3DStocker%26aufirst%3DR.%26aulast%3DSouthwell-Keely%26aufirst%3DP.%2BT.%26atitle%3DIs%2520%25CE%25B1-tocopherol%2520a%2520reservoir%2520for%2520%25CE%25B1-tocopheryl%2520hydroquinone%253F%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D1995%26volume%3D19%26spage%3D197%26epage%3D207%26doi%3D10.1016%2F0891-5849%2895%2900010-U" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit48c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Takaaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akio, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masao, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mamoru, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hharuhisa, S.</span></span> <span> </span><span class="NLM_article-title">Reduction of α-tocopherolquinone to α-tocopherolhydroquinone in rat hepatocytes</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">489</span>– <span class="NLM_lpage">493</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(92)90440-T</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2F0006-2952%2892%2990440-T" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1510699" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1992&pages=489-493&author=H.+Takaakiauthor=K.+Akioauthor=N.+Masaoauthor=T.+Mamoruauthor=S.+Hharuhisa&title=Reduction+of+%CE%B1-tocopherolquinone+to+%CE%B1-tocopherolhydroquinone+in+rat+hepatocytes&doi=10.1016%2F0006-2952%2892%2990440-T"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48c&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2892%2990440-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252892%252990440-T%26sid%3Dliteratum%253Aachs%26aulast%3DTakaaki%26aufirst%3DH.%26aulast%3DAkio%26aufirst%3DK.%26aulast%3DMasao%26aufirst%3DN.%26aulast%3DMamoru%26aufirst%3DT.%26aulast%3DHharuhisa%26aufirst%3DS.%26atitle%3DReduction%2520of%2520%25CE%25B1-tocopherolquinone%2520to%2520%25CE%25B1-tocopherolhydroquinone%2520in%2520rat%2520hepatocytes%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1992%26volume%3D44%26spage%3D489%26epage%3D493%26doi%3D10.1016%2F0006-2952%2892%2990440-T" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yenes, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Commandeur, J. N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vermeulen, N. P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messeguer, A.</span></span> <span> </span><span class="NLM_article-title">In vitro biotransformation of 3,4-dihydro-6-hydroxy-2,2-dimethyl-7-methoxy-1(2H)-benzopyran (CR-6), a potent lipid peroxidation inhibitor and nitric oxide scavenger, in rat liver microsomes</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">904</span>– <span class="NLM_lpage">913</span>, <span class="refDoi"> DOI: 10.1021/tx030036f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx030036f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkvVSisLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2004&pages=904-913&author=S.+Yenesauthor=J.+N.+M.+Commandeurauthor=N.+P.+E.+Vermeulenauthor=A.+Messeguer&title=In+vitro+biotransformation+of+3%2C4-dihydro-6-hydroxy-2%2C2-dimethyl-7-methoxy-1%282H%29-benzopyran+%28CR-6%29%2C+a+potent+lipid+peroxidation+inhibitor+and+nitric+oxide+scavenger%2C+in+rat+liver+microsomes&doi=10.1021%2Ftx030036f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">In Vitro Biotransformation of 3,4-Dihydro-6-hydroxy-2,2-dimethyl-7-methoxy-1(2H)-Benzopyran (CR-6), a Potent Lipid Peroxidation Inhibitor and Nitric Oxide Scavenger, in Rat Liver Microsomes</span></div><div class="casAuthors">Yenes, Susana; Commandeur, Jan N. M.; Vermeulen, Nico P. E.; Messeguer, Angel</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">904-913</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The in vitro metab. of 3,4-dihydro-6-hydroxy-2,2-dimethyl-7-methoxy-1(2H)-benzopyran (CR-6), a potent lipid peroxidn. inhibitor and scavenger of nitric oxide and peroxynitrite species that is currently in phase II trials for antitumoral therapy, has been investigated in rat liver microsomes in the presence of NADP(H).  Five major metabolites were identified by comparison with authentic stds., namely, the quinone 2-3'-hydroxy-3'-methylbutyl-5-methoxy-1,4-benzoquinone (2a) and its ring-closed spiro form oxaspiro[4.5]-2,2-dimethyl-8-methoxy-dec-8-ene-7,10-dione (2b), the hydroquinone 2-(3'-hydroxy-3'-methylbutyl)-5-methoxyhydroquinone (3), the hydroxylated metabolite 3,4-dihydro-4,6-dihydroxy-2,2-dimethyl-7-methoxy-1(2H)-benzopyran (4), and the catechol 3,4-dihydro-6,7-dihydroxy-2,2-dimethyl-1(2H)-benzopyran (5).  When the incubations were carried out in the presence of GSH, the HPLC peaks corresponding to the quinone metabolites 2a/b were absent and two novel products were formed showing MS fragmentation patterns consistent with the structure of GSH conjugates of quinone 2a.  The time dependence on the formation of metabolites 2a,b and 3 was measured in incubations induced with phenobarbital (PB), dexamethasone, and β-naphthoflavone (βNF).  For the dexamethasone-induced microsomes, the amt. of hydroquinone 3 decreased from minute 10 to minute 30 while that of 2a,b increased in a complementary manner.  Similar effects were obsd. for the incubations carried out using PB- and βNF-induced microsomes.  On the other hand, CR-6 inhibited 7-ethoxyresorufin O-dealkylation activity (IC50 = 25 μM) in incubations with βNF-induced microsomes.  Likewise, addn. of pentoxyresorufin to the incubations of CR-6 with PB-induced microsomes showed a time-dependent inhibition (IC50= 75 μM) of the dealkylation activity.  These results are in agreement with the putative generation of reactive metabolites from CR-6 that could deactivate P 450 1A and P 450 2B, resp.  When these incubations were carried out in the presence of 10 mM GSH, the inhibition of P 450 2B could be partially prevented.  Finally, preincubation of CR-6 with liver microsomes from PB-induced rats resulted in a strong increase in microsomal glutathione S-transferase (mGST) activity (up to a max. of approx. 5-fold).  When the preincubation was carried out in the presence of 10 mM GSH, the activation of mGST was blocked.  Overall, these results suggest that CR-6 undergoes in vitro biotransformation indicative of the involvement of thiol-reactive metabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsdg9PTGGNVbVg90H21EOLACvtfcHk0ljYXtSPk-CI3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkvVSisLw%253D&md5=68f6f2463ff51d09fe7cdd08333cef2d</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Ftx030036f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx030036f%26sid%3Dliteratum%253Aachs%26aulast%3DYenes%26aufirst%3DS.%26aulast%3DCommandeur%26aufirst%3DJ.%2BN.%2BM.%26aulast%3DVermeulen%26aufirst%3DN.%2BP.%2BE.%26aulast%3DMesseguer%26aufirst%3DA.%26atitle%3DIn%2520vitro%2520biotransformation%2520of%25203%252C4-dihydro-6-hydroxy-2%252C2-dimethyl-7-methoxy-1%25282H%2529-benzopyran%2520%2528CR-6%2529%252C%2520a%2520potent%2520lipid%2520peroxidation%2520inhibitor%2520and%2520nitric%2520oxide%2520scavenger%252C%2520in%2520rat%2520liver%2520microsomes%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2004%26volume%3D17%26spage%3D904%26epage%3D913%26doi%3D10.1021%2Ftx030036f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Słoczyńska, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunia-Krzyżak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koczurkiewicz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wójcik-Pszczoła, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Żelaszczyk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popiół, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pękala, E.</span></span> <span> </span><span class="NLM_article-title">Metabolic stability and its role in the discovery of new chemical entities</span>. <i>Acta Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">345</span>– <span class="NLM_lpage">361</span>, <span class="refDoi"> DOI: 10.2478/acph-2019-0024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.2478%2Facph-2019-0024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=31259741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BB3cXntFWhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2019&pages=345-361&author=K.+S%C5%82oczy%C5%84skaauthor=A.+Gunia-Krzy%C5%BCakauthor=P.+Koczurkiewiczauthor=K.+W%C3%B3jcik-Pszczo%C5%82aauthor=D.+%C5%BBelaszczykauthor=J.+Popi%C3%B3%C5%82author=E.+P%C4%99kala&title=Metabolic+stability+and+its+role+in+the+discovery+of+new+chemical+entities&doi=10.2478%2Facph-2019-0024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic stability and its role in the discovery of new chemical entities</span></div><div class="casAuthors">Sloczynska, Karolina; Gunia-Krzyzak, Agnieszka; Koczurkiewicz, Paulina; Wojcik-Pszczola, Katarzyna; Zelaszczyk, Dorota; Popiol, Justyna; Pekala, Elzbieta</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmaceutica (Warsaw, Poland)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">345-361</span>CODEN:
                <span class="NLM_cas:coden">ACPHEE</span>;
        ISSN:<span class="NLM_cas:issn">1846-9558</span>.
    
            (<span class="NLM_cas:orgname">Sciendo</span>)
        </div><div class="casAbstract">A review.  Detn. of metabolic profiles of new chem. entities is a key step in the process of drug discovery, since it influences pharmacokinetic characteristics of therapeutic compds.  One of the main challenges of medicinal chem. is not only to design compds. demonstrating beneficial activity, but also mols. exhibiting favorable pharmacokinetic parameters.  Chem. compds. can be divided into those which are metabolized relatively fast and those which undergo slow biotransformation.  Rapid biotransformation reduces exposure to the maternal compd. and may lead to the generation of active, non-active or toxic metabolites.  In contrast, high metabolic stability may promote interactions between drugs and lead to parent compd. toxicity.  In the present paper, issues of compd. metabolic stability will be discussed, with special emphasis on its significance, in vitro metabolic stability testing, dilemmas regarding in vitro-in vivo extrapolation of the results and some aspects relating to different preclin. species used in in vitro metabolic stability assessment of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq_ccE3-PW9bVg90H21EOLACvtfcHk0ljhsWbeGRfF7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXntFWhtg%253D%253D&md5=2dfad07056bce4e4cc32264c8ce07040</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.2478%2Facph-2019-0024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2478%252Facph-2019-0024%26sid%3Dliteratum%253Aachs%26aulast%3DS%25C5%2582oczy%25C5%2584ska%26aufirst%3DK.%26aulast%3DGunia-Krzy%25C5%25BCak%26aufirst%3DA.%26aulast%3DKoczurkiewicz%26aufirst%3DP.%26aulast%3DW%25C3%25B3jcik-Pszczo%25C5%2582a%26aufirst%3DK.%26aulast%3D%25C5%25BBelaszczyk%26aufirst%3DD.%26aulast%3DPopi%25C3%25B3%25C5%2582%26aufirst%3DJ.%26aulast%3DP%25C4%2599kala%26aufirst%3DE.%26atitle%3DMetabolic%2520stability%2520and%2520its%2520role%2520in%2520the%2520discovery%2520of%2520new%2520chemical%2520entities%26jtitle%3DActa%2520Pharm.%26date%3D2019%26volume%3D69%26spage%3D345%26epage%3D361%26doi%3D10.2478%2Facph-2019-0024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cornish-Bowden, A.</span></span> <span> </span><span class="NLM_article-title">A simple graphical method for determining the inhibition constants of mixed, uncompetitive and non-competitive inhibitors</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1974</span>,  <span class="NLM_volume"><i>137</i></span>, <span class="NLM_elocation-id">143e144</span> <span class="refDoi"> DOI: 10.1042/bj1370143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1042%2Fbj1370143" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=1974&author=A.+Cornish-Bowden&title=A+simple+graphical+method+for+determining+the+inhibition+constants+of+mixed%2C+uncompetitive+and+non-competitive+inhibitors&doi=10.1042%2Fbj1370143"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1042%2Fbj1370143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj1370143%26sid%3Dliteratum%253Aachs%26aulast%3DCornish-Bowden%26aufirst%3DA.%26atitle%3DA%2520simple%2520graphical%2520method%2520for%2520determining%2520the%2520inhibition%2520constants%2520of%2520mixed%252C%2520uncompetitive%2520and%2520non-competitive%2520inhibitors%26jtitle%3DBiochem.%2520J.%26date%3D1974%26volume%3D137%26doi%3D10.1042%2Fbj1370143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silverman, R. B.</span></span> <i>The Organic Chemistry of Enzyme-Catalyzed Reactions</i>, <span class="NLM_edition">1</span>st ed.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">San Diego</span>, <span class="NLM_year">2000</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&author=R.+B.+Silverman&title=The+Organic+Chemistry+of+Enzyme-Catalyzed+Reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26btitle%3DThe%2520Organic%2520Chemistry%2520of%2520Enzyme-Catalyzed%2520Reactions%26pub%3DAcademic%2520Press%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lwebuga-Mukasa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lappi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rademacher, J.</span></span> <span> </span><span class="NLM_article-title">Propidium – a fluorescent probe for a peripheral anionic site on acetylcholinesterase</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1974</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">703</span>– <span class="NLM_lpage">708</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADyaE2cXltFKmu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1974&pages=703-708&author=P.+Taylorauthor=J.+Lwebuga-Mukasaauthor=S.+Lappiauthor=J.+Rademacher&title=Propidium+%E2%80%93+a+fluorescent+probe+for+a+peripheral+anionic+site+on+acetylcholinesterase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53aR"><div class="casContent"><span class="casTitleNuber">53a</span><div class="casTitle"><span class="NLM_cas:atitle">Propidium.  Fluorescence probe for a peripheral anionic site on acetylcholinesterase</span></div><div class="casAuthors">Taylor, Palmer; Lwebuga-Mukasa, Jamson; Lappi, Shelley; Rademacher, James</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">1974</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">703-8</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    </div><div class="casAbstract">Propidium [(3,8-diamino-5-(3-diethylmethylaminopropyl)-6-phenylphenanthridium diiodide] (I) was bound with high affinity to a purified acetylcholinesterase isolated by lytic procedures from Torpedo californica.  Complex formation resulted in a 10-fold enhancement of fluorescence for the ligand in the bound state.  The fluorescent ligand could be dissocd. from the enzyme by back-titrn. with d-tubocurarine and gallamine under conditions of low ionic strength (γ/2 ≃ 0.001).  At higher ionic strength, in 0.1M NaCl, 0.04M MgCl2, and 0.01M Tris-Cl, pH 8.0 (γ/2 = 0.23), the above ligands were relatively ineffective in dissocg. propidium from the enzyme.  Edrophonium, an inhibitor that appears specific for the active center, did not dissoc. propidium under conditions of high and low ionic strength.  This specificity is consistent with propidium acting as a fluorescence probe for a peripheral anionic site on acetylcholinesterase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy22LfQ6F2j7Vg90H21EOLACvtfcHk0ljhsWbeGRfF7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXltFKmu70%253D&md5=3256818b8da823e9154f830b796616fa</span></div><a href="/servlet/linkout?suffix=cit53a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DP.%26aulast%3DLwebuga-Mukasa%26aufirst%3DJ.%26aulast%3DLappi%26aufirst%3DS.%26aulast%3DRademacher%26aufirst%3DJ.%26atitle%3DPropidium%2520%25E2%2580%2593%2520a%2520fluorescent%2520probe%2520for%2520a%2520peripheral%2520anionic%2520site%2520on%2520acetylcholinesterase%26jtitle%3DMol.%2520Pharmacol.%26date%3D1974%26volume%3D10%26spage%3D703%26epage%3D708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit53b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lappi, S.</span></span> <span> </span><span class="NLM_article-title">Interaction of fluorescence probes with acetylcholinesterase, the site and specificity of propidium binding</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1989</span>– <span class="NLM_lpage">1997</span>, <span class="refDoi"> DOI: 10.1021/bi00680a029</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi00680a029" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADyaE2MXktVemu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1975&pages=1989-1997&author=P.+Taylorauthor=S.+Lappi&title=Interaction+of+fluorescence+probes+with+acetylcholinesterase%2C+the+site+and+specificity+of+propidium+binding&doi=10.1021%2Fbi00680a029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53bR"><div class="casContent"><span class="casTitleNuber">53b</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction of fluorescence probes with acetylcholinesterase.  Site and specificity of propidium binding</span></div><div class="casAuthors">Taylor, Palmer; Lappi, Shelley</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1989-97</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    </div><div class="casAbstract">A bis-quaternary fluorescence probe, propidium diiodide, exhibited a 10-fold enhancement of fluorescence when bound to acetylcholinesterase from Torpedo californica.  The complex was characterized by a high affinity, KD = 3.0 × 10-7M, and 1:1 stoichiometry with the 82,000 mol. wt. subunit of acetylcholinesterase.  A wide variety of other quaternary ammonium ligands such as decamethonium, gallamine, d-tubocurarine, tetraethylammonium, and tetramethylammonium completely dissocd. propidium from the enzyme as did monovalent and divalent inorg. cations.  Whereas a directly competitive relation was illustrated macroscopically, the various quaternary ligands showed a different susceptibility toward inorg. cation displacement.  The affinity of propidium relative to gallamine increased with ionic strength, indicating that there is not complete equivalence in the neg. subsites to which quaternary groups bind.  Although edrophonium also displaced propidium from the enzyme, the dissocn. const. obtained from this competitive relation was 3 5 orders of magnitude greater than the consts. obtained for inhibition of catalysis.  Based on competitve displacement titrns., the primary binding site of edrophonium was distinct from that of propidium and a ternary complex with the 2 ligands can form on each subunit.  In contrast to edrophonium, the binding of propidium was unaffected by methanesulfonylation of the active center serine and was uncompetitive with the carbamylating substrate, N-methyl-7-dimethylcarbamoxyquinolinium.  Thus, propidium associates with a peripheral anionic center on the enzyme.  Although propidium and edrophonium assocd. at sep. sites on acetylcholinesterase, bis-quaternary ligands where the quaternary N atoms are sepd. by 14 Å displaced both ligands from the enzyme with equal effectiveness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqaxfzE7WsY7Vg90H21EOLACvtfcHk0ljhsWbeGRfF7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXktVemu74%253D&md5=0c4b7b9afdc79270927cb12f79d4168a</span></div><a href="/servlet/linkout?suffix=cit53b&amp;dbid=16384&amp;doi=10.1021%2Fbi00680a029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00680a029%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DP.%26aulast%3DLappi%26aufirst%3DS.%26atitle%3DInteraction%2520of%2520fluorescence%2520probes%2520with%2520acetylcholinesterase%252C%2520the%2520site%2520and%2520specificity%2520of%2520propidium%2520binding%26jtitle%3DBiochemistry%26date%3D1975%26volume%3D14%26spage%3D1989%26epage%3D1997%26doi%3D10.1021%2Fbi00680a029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nunes-Tavares, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nery da Matta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batista e Silva, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Araújo, G. M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louro, S. R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassón-Voloch, A.</span></span> <span> </span><span class="NLM_article-title">Inhibition of acetylcholinesterase from <i>Electrophorus electricus</i> (L.) by tricyclic antidepressants</span>. <i>Int. J. Biochem. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1071</span>– <span class="NLM_lpage">1079</span>, <span class="refDoi"> DOI: 10.1016/S1357-2725(02)00027-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2FS1357-2725%2802%2900027-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=12009302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFynsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2002&pages=1071-1079&author=N.+Nunes-Tavaresauthor=A.+Nery+da+Mattaauthor=C.+M.+Batista+e+Silvaauthor=G.+M.+N.+Ara%C3%BAjoauthor=S.+R.+W.+Louroauthor=A.+Hass%C3%B3n-Voloch&title=Inhibition+of+acetylcholinesterase+from+Electrophorus+electricus+%28L.%29+by+tricyclic+antidepressants&doi=10.1016%2FS1357-2725%2802%2900027-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of acetylcholinesterase from Electrophorus electricus (L.) by tricyclic antidepressants</span></div><div class="casAuthors">Nunes-Tavares, N.; Nery da Matta, A.; Batista e Silva, C. M.; Araujo, G. M. N.; Louro, S. R. W.; Hasson-Voloch, A.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biochemistry & Cell Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1071-1079</span>CODEN:
                <span class="NLM_cas:coden">IJBBFU</span>;
        ISSN:<span class="NLM_cas:issn">1357-2725</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The effects of tricyclic antidepressants drugs (TCA) amitriptyline, imipramine and nortriptyline, on purified Electrophorus electricus (L.) acetylcholinesterase (AChE; acetylcholine hydrolase, EC 3.1.1.7) were studied using kinetic methods and specific fluorescent probe propidium.  The antidepressants inhibited AChE activity by a non-competitive mechanism.  Inhibition consts. range from 200 to 400 μM.  Dimethylated amitriptyline and imipramine were more potent inhibitors than the monomethylated nortriptyline.  Fluorescence measurements using bis-quaternary ligand propidium were used to monitor ligand-binding properties of these cationic antidepressants to the AChE peripheral anionic site (PAS).  This ligand exhibited an eight-fold fluorescence enhancement upon binding to the peripheral anionic site of AChE from E. electricus (L.) with KD=7×10-7 M.  It was obsd. that TCA drugs displaced propidium from the enzyme.  On the basis of the displacement expts. antidepressant dissocn. consts. were detd.  Similar values for the inhibition consts. suggest that these drugs have similar affinity to the peripheral anionic site.  The results also indicate that the catalytic active center of AChE does not participate in the interaction of enzyme with tricyclic antidepressants.  These studies suggest that the binding site for tricyclic antidepressants is located at the peripheral anionic site of E. electricus (L.) acetylcholinesterase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryPgDAp502jbVg90H21EOLACvtfcHk0liUtFVWXo-vYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFynsrw%253D&md5=b9516cc41f34d8d811af0bdf0a73e572</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2FS1357-2725%2802%2900027-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1357-2725%252802%252900027-4%26sid%3Dliteratum%253Aachs%26aulast%3DNunes-Tavares%26aufirst%3DN.%26aulast%3DNery%2Bda%2BMatta%26aufirst%3DA.%26aulast%3DBatista%2Be%2BSilva%26aufirst%3DC.%2BM.%26aulast%3DAra%25C3%25BAjo%26aufirst%3DG.%2BM.%2BN.%26aulast%3DLouro%26aufirst%3DS.%2BR.%2BW.%26aulast%3DHass%25C3%25B3n-Voloch%26aufirst%3DA.%26atitle%3DInhibition%2520of%2520acetylcholinesterase%2520from%2520Electrophorus%2520electricus%2520%2528L.%2529%2520by%2520tricyclic%2520antidepressants%26jtitle%3DInt.%2520J.%2520Biochem.%2520Cell%2520Biol.%26date%3D2002%26volume%3D34%26spage%3D1071%26epage%3D1079%26doi%3D10.1016%2FS1357-2725%2802%2900027-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bourne, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolb, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radić, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharpless, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchot, P.</span></span> <span> </span><span class="NLM_article-title">Freeze-frame inhibitor captures acetylcholinesterase in a unique conformation</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">1449</span>– <span class="NLM_lpage">1454</span>, <span class="refDoi"> DOI: 10.1073/pnas.0308206100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1073%2Fpnas.0308206100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=14757816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFaqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=1449-1454&author=Y.+Bourneauthor=H.+C.+Kolbauthor=Z.+Radi%C4%87author=K.+B.+Sharplessauthor=P.+Taylorauthor=P.+Marchot&title=Freeze-frame+inhibitor+captures+acetylcholinesterase+in+a+unique+conformation&doi=10.1073%2Fpnas.0308206100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Freeze-frame inhibitor captures acetylcholinesterase in a unique conformation</span></div><div class="casAuthors">Bourne, Yves; Kolb, Hartmuth C.; Radic, Zoran; Sharpless, K. Barry; Taylor, Palmer; Marchot, Pascale</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1449-1454</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The 1,3-dipolar cycloaddn. reaction between unactivated azides and acetylenes proceeds exceedingly slowly at room temp.  However, considerable rate acceleration is obsd. when this reaction occurs inside the active center gorge of acetylcholinesterase (AChE) between certain azide and acetylene reactants, attached via methylene chains to specific inhibitor moieties selective for the active center and peripheral site of the enzyme.  AChE catalyzes the formation of its own inhibitor in a highly selective fashion: only a single syn1-triazole regioisomer with defined substitution positions and linker distances is generated from a series of reagent combinations.  Inhibition measurements revealed this syn1-triazole isomer to be the highest affinity reversible org. inhibitor of AChE with assocn. rate consts. near the diffusion limit.  The corresponding anti1 isomer, not formed by the enzyme, proved to be a respectable but weaker inhibitor.  The crystal structures of the syn1- and anti1-mouse AChE complexes at 2.45- to 2.65-Å resoln. reveal not only substantial binding contributions from the triazole moieties, but also that binding of the syn1 isomer induces large and unprecedented enzyme conformational changes not obsd. in the anti1 complex nor predicted from structures of the apoenzyme and complexes with the precursor reactants.  Hence, the freeze-frame reaction offers both a strategically original approach for drug discovery and a means for kinetically controlled capture, as a high-affinity complex between the enzyme and its self-created inhibitor, of a highly reactive minor abundance conformer of a fluctuating protein template.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo09vBdE-ZyAbVg90H21EOLACvtfcHk0liUtFVWXo-vYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFaqsL8%253D&md5=b464de567eca2991d3c15f66c25f587e</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0308206100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0308206100%26sid%3Dliteratum%253Aachs%26aulast%3DBourne%26aufirst%3DY.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26aulast%3DRadi%25C4%2587%26aufirst%3DZ.%26aulast%3DSharpless%26aufirst%3DK.%2BB.%26aulast%3DTaylor%26aufirst%3DP.%26aulast%3DMarchot%26aufirst%3DP.%26atitle%3DFreeze-frame%2520inhibitor%2520captures%2520acetylcholinesterase%2520in%2520a%2520unique%2520conformation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2004%26volume%3D101%26spage%3D1449%26epage%3D1454%26doi%3D10.1073%2Fpnas.0308206100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dighe, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deora, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De la
Mora, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nachon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parat, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brazzolotto, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, B. P.</span></span> <span> </span><span class="NLM_article-title">Discovery and structure–activity relationships of a highly selective butyrylcholinesterase inhibitor by structure-based virtual screening</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">7683</span>– <span class="NLM_lpage">7689</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00356</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00356" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFKms7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7683-7689&author=S.+N.+Digheauthor=G.+S.+Deoraauthor=E.+De+la%0AMoraauthor=F.+Nachonauthor=S.+Chanauthor=M.+O.+Paratauthor=X.+Brazzolottoauthor=B.+P.+Ross&title=Discovery+and+structure%E2%80%93activity+relationships+of+a+highly+selective+butyrylcholinesterase+inhibitor+by+structure-based+virtual+screening&doi=10.1021%2Facs.jmedchem.6b00356"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Structure-Activity Relationships of a Highly Selective Butyrylcholinesterase Inhibitor by Structure-Based Virtual Screening</span></div><div class="casAuthors">Dighe, Satish N.; Deora, Girdhar Singh; De la Mora, Eugenio; Nachon, Florian; Chan, Stephen; Parat, Marie-Odile; Brazzolotto, Xavier; Ross, Benjamin P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7683-7689</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structure-based virtual screening of two libraries contg. 567,981 mols. was used to discover novel, selective BuChE inhibitors, which are potentially superior symptomatic treatments in late-stage Alzheimer's disease.  Compd. 16 was identified as a highly selective submicromolar inhibitor of BuChE (huBuChE IC50 = 0.443 μM) with high permeability in the PAMPA-BBB model.  The X-ray crystal structure of huBuChE in complex with 16 revealed the at.-level interactions and offers opportunities for further development of the series.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv1ksvUfyu5LVg90H21EOLACvtfcHk0liUtFVWXo-vYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFKms7jJ&md5=3ec174639c0eb448f823f223bafdaad4</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00356%26sid%3Dliteratum%253Aachs%26aulast%3DDighe%26aufirst%3DS.%2BN.%26aulast%3DDeora%26aufirst%3DG.%2BS.%26aulast%3DDe%2Bla%2BMora%26aufirst%3DE.%26aulast%3DNachon%26aufirst%3DF.%26aulast%3DChan%26aufirst%3DS.%26aulast%3DParat%26aufirst%3DM.%2BO.%26aulast%3DBrazzolotto%26aufirst%3DX.%26aulast%3DRoss%26aufirst%3DB.%2BP.%26atitle%3DDiscovery%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%2520a%2520highly%2520selective%2520butyrylcholinesterase%2520inhibitor%2520by%2520structure-based%2520virtual%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7683%26epage%3D7689%26doi%3D10.1021%2Facs.jmedchem.6b00356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nachon, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carletti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trovaslet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolet, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jean, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renard, P. Y.</span></span> <span> </span><span class="NLM_article-title">Crystal structures of human cholinesterases in complex with huprine W and tacrine: elements of specificity for anti-Alzheimer’s drugs targeting acetyl- and butyryl-cholinesterase</span>. <i>Biochem J.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>453</i></span>,  <span class="NLM_fpage">393</span>– <span class="NLM_lpage">399</span>, <span class="refDoi"> DOI: 10.1042/BJ20130013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1042%2FBJ20130013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=23679855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtF2it7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=453&publication_year=2013&pages=393-399&author=F.+Nachonauthor=E.+Carlettiauthor=C.+Roncoauthor=M.+Trovasletauthor=Y.+Nicoletauthor=L.+Jeanauthor=P.+Y.+Renard&title=Crystal+structures+of+human+cholinesterases+in+complex+with+huprine+W+and+tacrine%3A+elements+of+specificity+for+anti-Alzheimer%E2%80%99s+drugs+targeting+acetyl-+and+butyryl-cholinesterase&doi=10.1042%2FBJ20130013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structures of human cholinesterases in complex with huprine W and tacrine: elements of specificity for anti-Alzheimer's drugs targeting acetyl- and butyryl-cholinesterase</span></div><div class="casAuthors">Nachon, Florian; Carletti, Eugenie; Ronco, Cyril; Trovaslet, Marie; Nicolet, Yvain; Jean, Ludovic; Renard, Pierre-Yves</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">453</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">393-399</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The multifunctional nature of Alzheimer's disease calls for MTDLs (multitarget-directed ligands) to act on different components of the pathol., like the cholinergic dysfunction and amyloid aggregation.  Such MTDLs are usually on the basis of cholinesterase inhibitors (e.g. tacrine or huprine) coupled with another active mol. aimed at a different target.  To aid in the design of these MTDLs, the authors report the crystal structures of hAChE (human acetylcholinesterase) in complex with FAS-2 (fasciculin 2) and a hydroxylated deriv. of huprine (huprine W), and of hBChE (human butyrylcholinesterase) in complex with tacrine.  Huprine W in hAChE and tacrine in hBChE reside in strikingly similar positions highlighting the conservation of key interactions, namely, π-π/cation-π interactions with Trp86 (Trp82), and hydrogen bonding with the main chain carbonyl of the catalytic histidine residue.  Huprine W forms addnl. interactions with hAChE, which explains its superior affinity: the isoquinoline moiety is assocd. with a group of arom. residues (Tyr337, Phe338 and Phe295 not present in hBChE) in addn. to Trp86; the hydroxyl group is hydrogen bonded to both the catalytic serine residue and residues in the oxyanion hole; and the chlorine substituent is nested in a hydrophobic pocket interacting strongly with Trp439.  There is no pocket in hBChE that is able to accommodate the chlorine substituent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovCptRaIZE_rVg90H21EOLACvtfcHk0lhpBdt-0ojyXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtF2it7fM&md5=a36d3b1007c83c59c639a08f17d26bb7</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1042%2FBJ20130013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20130013%26sid%3Dliteratum%253Aachs%26aulast%3DNachon%26aufirst%3DF.%26aulast%3DCarletti%26aufirst%3DE.%26aulast%3DRonco%26aufirst%3DC.%26aulast%3DTrovaslet%26aufirst%3DM.%26aulast%3DNicolet%26aufirst%3DY.%26aulast%3DJean%26aufirst%3DL.%26aulast%3DRenard%26aufirst%3DP.%2BY.%26atitle%3DCrystal%2520structures%2520of%2520human%2520cholinesterases%2520in%2520complex%2520with%2520huprine%2520W%2520and%2520tacrine%253A%2520elements%2520of%2520specificity%2520for%2520anti-Alzheimer%25E2%2580%2599s%2520drugs%2520targeting%2520acetyl-%2520and%2520butyryl-cholinesterase%26jtitle%3DBiochem%2520J.%26date%3D2013%26volume%3D453%26spage%3D393%26epage%3D399%26doi%3D10.1042%2FBJ20130013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Camps, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Achab, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morral, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muñoz-Torrero, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baños, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vivas, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barril, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orozco, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque, F. J.</span></span> <span> </span><span class="NLM_article-title">New tacrine-huperzine A hybrids (huprines): highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">4657</span>– <span class="NLM_lpage">4666</span>, <span class="refDoi"> DOI: 10.1021/jm000980y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000980y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnvFarsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4657-4666&author=P.+Campsauthor=R.+El+Achabauthor=J.+Morralauthor=D.+Mu%C3%B1oz-Torreroauthor=A.+Badiaauthor=J.+E.+Ba%C3%B1osauthor=N.+M.+Vivasauthor=X.+Barrilauthor=M.+Orozcoauthor=F.+J.+Luque&title=New+tacrine-huperzine+A+hybrids+%28huprines%29%3A+highly+potent+tight-binding+acetylcholinesterase+inhibitors+of+interest+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm000980y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">New tacrine-huperzine A hybrids (huprines): highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Camps, Pelayo; El Achab, Rachid; Morral, Jordi; Munoz-Torrero, Diego; Badia, Albert; Banos, Josep Eladi; Vivas, Nuria Maria; Barril, Xavier; Orozco, Modesto; Luque, Francisco Javier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4657-4666</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Several new 12-amino-6,7,10,11-tetrahydro-7,11-methanocycloocta[b]quinoline derivs. (tacrine-huperzine A hybrids, huprines) (I) (R = Me, Et; R1, R3 = H, F, Me, Cl; R2 = H, Cl) have been synthesized and tested as acetylcholinesterase (AChE) inhibitors.  All of the new compds. contain either a Me or Et group at position 9 and one or two (chloro, fluoro, or methyl) substituents at positions 1, 2, or 3.  Among the monosubstituted derivs., the more active are those substituted at position 3, their activity following the order 3-chloro > 3-fluoro > 3-Me > 3-hydrogen.  For the 1,3-difluoro and 1,3-di-Me derivs., the effect of the substituents is roughly additive.  No significant differences were obsd. for the inhibitory activity of 9-Me vs 9-Et derivs. mono- or disubstituted at positions 1 and/or 3.  The levorotatory enantiomers of these hybrid compds. are much more active (eutomers) than the dextrorotatory forms (distomers) as AChE inhibitors.  Compds. rac- and (-)-I (R = Me, R3 = Cl) (II), rac- and (-)-I (R = Et, R3 = F) (III), rac- and (-)-I (R = Et, R3 = Cl) (IV) and rac-I (R = Et; R1, R3 = Cl) (V) showed human AChE inhibitory activities up to 28.5-fold higher than for the corresponding bovine enzyme. Also, rac-I (R = Me; R1, R3 = F) , (-)-II, (-)-IV, and rac-V were very selective for human AChE vs butyrylcholinesterase (BChE), the AChE inhibitory activities being 438-871-fold higher than for BChE.  Several hybrid compds., specially (-)-II and (-)-IV, exhibited tight-binding character, showing higher activity after incubation of the enzyme with the inhibitor than without incubation, though the reversible nature of the enzyme-inhibitor interaction was demonstrated by dialysis.  The results of the ex vivo expts. also supported the tight-binding character of compds. (-)-II and (-)-IV and showed their ability to cross the blood-brain barrier.  Mol. modeling simulations of the AChE-inhibitor complex provided a basis to explain the differences in inhibitory activity of these compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsF13Zjc-Ak7Vg90H21EOLACvtfcHk0lhpBdt-0ojyXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnvFarsbk%253D&md5=6ec0e45bc36f91124d1ba17f1c1f4957</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjm000980y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000980y%26sid%3Dliteratum%253Aachs%26aulast%3DCamps%26aufirst%3DP.%26aulast%3DEl%2BAchab%26aufirst%3DR.%26aulast%3DMorral%26aufirst%3DJ.%26aulast%3DMu%25C3%25B1oz-Torrero%26aufirst%3DD.%26aulast%3DBadia%26aufirst%3DA.%26aulast%3DBa%25C3%25B1os%26aufirst%3DJ.%2BE.%26aulast%3DVivas%26aufirst%3DN.%2BM.%26aulast%3DBarril%26aufirst%3DX.%26aulast%3DOrozco%26aufirst%3DM.%26aulast%3DLuque%26aufirst%3DF.%2BJ.%26atitle%3DNew%2520tacrine-huperzine%2520A%2520hybrids%2520%2528huprines%2529%253A%2520highly%2520potent%2520tight-binding%2520acetylcholinesterase%2520inhibitors%2520of%2520interest%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4657%26epage%3D4666%26doi%3D10.1021%2Fjm000980y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Case, D. A.</span>; <span class="NLM_string-name">Babin, V.</span>; <span class="NLM_string-name">Berryman, J. T.</span>; <span class="NLM_string-name">Betz, R. M.</span>; <span class="NLM_string-name">Cai, Q.</span>; <span class="NLM_string-name">Cerutti, D. S.</span>; <span class="NLM_string-name">Cheatham, T. E.,  III</span>; <span class="NLM_string-name">Darden, T. A.</span>; <span class="NLM_string-name">Duke, R. E.</span>; <span class="NLM_string-name">Gohlke, H.</span>; <span class="NLM_string-name">Goetz, A. W.</span>; <span class="NLM_string-name">Gusarov, S.</span>; <span class="NLM_string-name">Homeyer, N.</span>; <span class="NLM_string-name">Janowski, P.</span>; <span class="NLM_string-name">Kaus, J.</span>; <span class="NLM_string-name">Kolossváry, I.</span>; <span class="NLM_string-name">Kovalenko, A.</span>; <span class="NLM_string-name">Lee, T. S.</span>; <span class="NLM_string-name">LeGrand, S.</span>; <span class="NLM_string-name">Luchko, T.</span>; <span class="NLM_string-name">Luo, R.</span>; <span class="NLM_string-name">Madej, B.</span>; <span class="NLM_string-name">Merz, K. M.</span>; <span class="NLM_string-name">Paesani, F.</span>; <span class="NLM_string-name">Roe, D. R.</span>; <span class="NLM_string-name">Roitberg, A.</span>; <span class="NLM_string-name">Sagui, C.</span>; <span class="NLM_string-name">Salomon-Ferrer, R.</span>; <span class="NLM_string-name">Seabra, G.</span>; <span class="NLM_string-name">Simmerling, C. L.</span>; <span class="NLM_string-name">Smith, W.</span>; <span class="NLM_string-name">Swails, J.</span>; <span class="NLM_string-name">Walker, R. C.</span>; <span class="NLM_string-name">Wang, J.</span>; <span class="NLM_string-name">Wolf, R. M.</span>; <span class="NLM_string-name">Wu, X.</span>; <span class="NLM_string-name">Kollman, P. A.</span></span> <i>AMBER 14</i>; <span class="NLM_publisher-name">University of California</span>: <span class="NLM_publisher-loc">San Francisco</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=D.+A.+Case&author=V.+Babin&author=J.+T.+Berryman&author=R.+M.+Betz&author=Q.+Cai&author=D.+S.+Cerutti&author=T.+E.+Cheatham&author=T.+A.+Darden&author=R.+E.+Duke&author=H.+Gohlke&author=A.+W.+Goetz&author=S.+Gusarov&author=N.+Homeyer&author=P.+Janowski&author=J.+Kaus&author=I.+Kolossv%C3%A1ry&author=A.+Kovalenko&author=T.+S.+Lee&author=S.+LeGrand&author=T.+Luchko&author=R.+Luo&author=B.+Madej&author=K.+M.+Merz&author=F.+Paesani&author=D.+R.+Roe&author=A.+Roitberg&author=C.+Sagui&author=R.+Salomon-Ferrer&author=G.+Seabra&author=C.+L.+Simmerling&author=W.+Smith&author=J.+Swails&author=R.+C.+Walker&author=J.+Wang&author=R.+M.+Wolf&author=X.+Wu&author=P.+A.+Kollman&title=AMBER+14"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DCase%26aufirst%3DD.%2BA.%26jtitle%3DAMBER%252014%26pub%3DUniversity%2520of%2520California%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kollman, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Case, D. A.</span></span> <span> </span><span class="NLM_article-title">Development and testing of a general Amber force field</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1157</span>– <span class="NLM_lpage">1174</span>, <span class="refDoi"> DOI: 10.1002/jcc.20035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1002%2Fjcc.20035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=15116359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksFakurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=1157-1174&author=J.+Wangauthor=R.+M.+Wolfauthor=J.+W.+Caldwellauthor=P.+A.+Kollmanauthor=D.+A.+Case&title=Development+and+testing+of+a+general+Amber+force+field&doi=10.1002%2Fjcc.20035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Development and testing of a general Amber force field</span></div><div class="casAuthors">Wang, Junmei; Wolf, Romain M.; Caldwell, James W.; Kollman, Peter A.; Case, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1157-1174</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">We describe here a general Amber force field (GAFF) for org. mols.  GAFF is designed to be compatible with existing Amber force fields for proteins and nucleic acids, and has parameters for most org. and pharmaceutical mols. that are composed of H, C, N, O, S, P, and halogens.  It uses a simple functional form and a limited no. of atom types, but incorporates both empirical and heuristic models to est. force consts. and partial at. charges.  The performance of GAFF in test cases is encouraging.  In test I, 74 crystallog. structures were compared to GAFF minimized structures, with a root-mean-square displacement of 0.26 Å, which is comparable to that of the Tripos 5.2 force field (0.25 Å) and better than those of MMFF 94 and CHARMm (0.47 and 0.44 Å, resp.).  In test II, gas phase minimizations were performed on 22 nucleic acid base pairs, and the minimized structures and intermol. energies were compared to MP2/6-31G* results.  The RMS of displacements and relative energies were 0.25 Å and 1.2 kcal/mol, resp.  These data are comparable to results from Parm99/RESP (0.16 Å and 1.18 kcal/mol, resp.), which were parameterized to these base pairs.  Test III looked at the relative energies of 71 conformational pairs that were used in development of the Parm99 force field.  The RMS error in relative energies (compared to expt.) is about 0.5 kcal/mol.  GAFF can be applied to wide range of mols. in an automatic fashion, making it suitable for rational drug design and database searching.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfW8Gsf8IiW7Vg90H21EOLACvtfcHk0li149whKG-lPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksFakurc%253D&md5=2992017a8cf51f89290ae2562403b115</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20035%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWolf%26aufirst%3DR.%2BM.%26aulast%3DCaldwell%26aufirst%3DJ.%2BW.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26aulast%3DCase%26aufirst%3DD.%2BA.%26atitle%3DDevelopment%2520and%2520testing%2520of%2520a%2520general%2520Amber%2520force%2520field%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2004%26volume%3D25%26spage%3D1157%26epage%3D1174%26doi%3D10.1002%2Fjcc.20035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frisch, M. J.</span>; <span class="NLM_string-name">Trucks, G. W.</span>; <span class="NLM_string-name">Schlegel, H. B.</span>; <span class="NLM_string-name">Scuseria, G. E.</span>; <span class="NLM_string-name">Robb, M. A.</span>; <span class="NLM_string-name">Cheeseman, J. R.</span>; <span class="NLM_string-name">Scalmani, G.</span>; <span class="NLM_string-name">Barone, V.</span>; <span class="NLM_string-name">Mennucci, B.</span>; <span class="NLM_string-name">Petersson, G. A.</span>; <span class="NLM_string-name">Nakatsuji, H.</span>; <span class="NLM_string-name">Caricato, M.</span>; <span class="NLM_string-name">Li, X.</span>; <span class="NLM_string-name">Hratchian, H. P.</span>; <span class="NLM_string-name">Izmaylov, A. F.</span>; <span class="NLM_string-name">Bloino, J.</span>; <span class="NLM_string-name">Zheng, G.</span>; <span class="NLM_string-name">Sonnenberg, J. L.</span>; <span class="NLM_string-name">Hada, M.</span>; <span class="NLM_string-name">Ehara, M.</span>; <span class="NLM_string-name">Toyota, K.</span>; <span class="NLM_string-name">Fukuda, R.</span>; <span class="NLM_string-name">Hasegawa, J.</span>; <span class="NLM_string-name">Ishida, M.</span>; <span class="NLM_string-name">Nakajima, T.</span>; <span class="NLM_string-name">Honda, Y.</span>; <span class="NLM_string-name">Kitao, O.</span>; <span class="NLM_string-name">Nakai, H.</span>; <span class="NLM_string-name">Vreven, T.</span>; <span class="NLM_string-name">Montgomery, J. A.,  Jr.</span>; <span class="NLM_string-name">Peralta, J. E.</span>; <span class="NLM_string-name">Ogliaro, F.</span>; <span class="NLM_string-name">Bearpark, M.</span>; <span class="NLM_string-name">Heyd, J. J.</span>; <span class="NLM_string-name">Brothers, E.</span>; <span class="NLM_string-name">Kudin, K. N.</span>; <span class="NLM_string-name">Staroverov, V. N.</span>; <span class="NLM_string-name">Kobayashi, R.</span>; <span class="NLM_string-name">Normand, J.</span>; <span class="NLM_string-name">Raghavachari, K.</span>; <span class="NLM_string-name">Rendell, A.</span>; <span class="NLM_string-name">Burant, J. C.</span>; <span class="NLM_string-name">Iyengar, S. S.</span>; <span class="NLM_string-name">Tomasi, J.</span>; <span class="NLM_string-name">Cossi, M.</span>; <span class="NLM_string-name">Rega, N.</span>; <span class="NLM_string-name">Millam, J. M.</span>; <span class="NLM_string-name">Klene, M.</span>; <span class="NLM_string-name">Knox, J. E.</span>; <span class="NLM_string-name">Cross, J. B.</span>; <span class="NLM_string-name">Bakken, V.</span>; <span class="NLM_string-name">Adamo, C.</span>; <span class="NLM_string-name">Jaramillo, J.</span>; <span class="NLM_string-name">Gomperts, R.</span>; <span class="NLM_string-name">Stratmann, R. E.</span>; <span class="NLM_string-name">Yazyev, O.</span>; <span class="NLM_string-name">Austin, A. J.</span>; <span class="NLM_string-name">Cammi, R.</span>; <span class="NLM_string-name">Pomelli, C.</span>; <span class="NLM_string-name">Ochterski, J. W.</span>; <span class="NLM_string-name">Martin, R. L.</span>; <span class="NLM_string-name">Morokuma, K.</span>; <span class="NLM_string-name">Zakrzewski, V. G.</span>; <span class="NLM_string-name">Voth, G. A.</span>; <span class="NLM_string-name">Salvador, P.</span>; <span class="NLM_string-name">Dannenberg, J. J.</span>; <span class="NLM_string-name">Dapprich, S.</span>; <span class="NLM_string-name">Daniels, A. D.</span>; <span class="NLM_string-name">Farkas, Ö.</span>; <span class="NLM_string-name">Foresman, J. B.</span>; <span class="NLM_string-name">Ortiz, J. V.</span>; <span class="NLM_string-name">Cioslowski, J.</span>; <span class="NLM_string-name">Fox, D. J.</span></span> <i>Gaussian 09</i>; <span class="NLM_publisher-name">Gaussian, Inc.</span>: <span class="NLM_publisher-loc">Wallingford, CT</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=M.+J.+Frisch&author=G.+W.+Trucks&author=H.+B.+Schlegel&author=G.+E.+Scuseria&author=M.+A.+Robb&author=J.+R.+Cheeseman&author=G.+Scalmani&author=V.+Barone&author=B.+Mennucci&author=G.+A.+Petersson&author=H.+Nakatsuji&author=M.+Caricato&author=X.+Li&author=H.+P.+Hratchian&author=A.+F.+Izmaylov&author=J.+Bloino&author=G.+Zheng&author=J.+L.+Sonnenberg&author=M.+Hada&author=M.+Ehara&author=K.+Toyota&author=R.+Fukuda&author=J.+Hasegawa&author=M.+Ishida&author=T.+Nakajima&author=Y.+Honda&author=O.+Kitao&author=H.+Nakai&author=T.+Vreven&author=J.+A.+Montgomery&author=J.+E.+Peralta&author=F.+Ogliaro&author=M.+Bearpark&author=J.+J.+Heyd&author=E.+Brothers&author=K.+N.+Kudin&author=V.+N.+Staroverov&author=R.+Kobayashi&author=J.+Normand&author=K.+Raghavachari&author=A.+Rendell&author=J.+C.+Burant&author=S.+S.+Iyengar&author=J.+Tomasi&author=M.+Cossi&author=N.+Rega&author=J.+M.+Millam&author=M.+Klene&author=J.+E.+Knox&author=J.+B.+Cross&author=V.+Bakken&author=C.+Adamo&author=J.+Jaramillo&author=R.+Gomperts&author=R.+E.+Stratmann&author=O.+Yazyev&author=A.+J.+Austin&author=R.+Cammi&author=C.+Pomelli&author=J.+W.+Ochterski&author=R.+L.+Martin&author=K.+Morokuma&author=V.+G.+Zakrzewski&author=G.+A.+Voth&author=P.+Salvador&author=J.+J.+Dannenberg&author=S.+Dapprich&author=A.+D.+Daniels&author=%C3%96.+Farkas&author=J.+B.+Foresman&author=J.+V.+Ortiz&author=J.+Cioslowski&author=D.+J.+Fox&title=Gaussian+09"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DFrisch%26aufirst%3DM.%2BJ.%26btitle%3DGaussian%252009%26pub%3DGaussian%252C%2520Inc%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cieplak, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kollman, P. A.</span></span> <span> </span><span class="NLM_article-title">How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules?</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1049</span>– <span class="NLM_lpage">1074</span>, <span class="refDoi"> DOI: 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1002%2F1096-987X%28200009%2921%3A12%3C1049%3A%3AAID-JCC3%3E3.0.CO%3B2-F" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlsVylt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=1049-1074&author=J.+Wangauthor=P.+Cieplakauthor=P.+A.+Kollman&title=How+well+does+a+restrained+electrostatic+potential+%28RESP%29+model+perform+in+calculating+conformational+energies+of+organic+and+biological+molecules%3F&doi=10.1002%2F1096-987X%28200009%2921%3A12%3C1049%3A%3AAID-JCC3%3E3.0.CO%3B2-F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules?</span></div><div class="casAuthors">Wang, Junmei; Cieplak, Piotr; Kollman, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1049-1074</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The authors present conformational energies for a mol. mech. model (Parm99) developed for org. and biol. mols. using the restrained electrostatic potential (RESP) approach to derive the partial charges.  This approach uses the simple generic force field model (Parm94), and attempts to add a minimal no. of extra Fourier components to the torsional energies, but doing so only when there is a phys. justification.  The results are quite encouraging, not only for the 34-mol. set that was studied by both the highest level ab initio model (GVB/LMP2) and expt., but also for the 55-mol. set for which high-quality exptl. data are available.  Considering the 55 mols. studied by all the force field models for which there are exptl. data, the av. abs. errors (AAEs) are 0.28 (this model), 0.52 (MM3), 0.57 (CHARMm [MSI]), and 0.43 kcal/mol (MMFF).  For the 34-mol. set, the AAEs of this model vs. expt. and ab initio are 0.28 and 0.27 kcal/mol, resp.  This is a lower error than found with MM3 and CHARMm, and is comparable to that found with MMFF (0.31 and 0.22 kcal/mol).  The authors also present 2 examples of how well the torsional parameters are transferred from the training set to the test set.  The abs. errors of mols. in the test set are only slightly larger than in the training set (differences of <0.1 kcal/mol).  Therefore, a simple generic force field with a limited no. of specific torsional parameters can describe intra- and intermol. interactions, although all comparison mols. were selected from 82-compd. training set.  Also this effective 2-body model can be extended for use with a nonadditive force field (NAFF), both with and without lone pairs.  Without changing the torsional parameters, the use of more accurate charges and polarization increases av. abs. error compared with expt., but adjustment of the parameters restores the level of agreement found with the additive model.  After reoptimizing the Ψ, Φ torsional parameters in peptides using alanine dipeptide (6 conformational pairs) and alanine tetrapeptide (11 conformational pairs), the new model gives better energies than the Cornell et al. force field.  The av. abs. error of this model for high-level ab initio calcn. is 0.82 kcal/mol for alanine dipeptide and tetrapeptide as compared with 1.80 kcal/mol for the Cornell et al. model.  For nucleosides, the new model also gives improved energies compared with the Cornell et al. model.  To optimize force field parameters, the authors developed a program called parmscan, which can iteratively scan the torsional parameters in a systematic manner and finally obtain the vest torsional potentials.  Besides the org. mols. in test set, parmscan was also successful in optimizing the Ψ, Φ torsional parameters in peptides to significantly improve agreement between mol. mech. and high-level ab initio energies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0dHME9_PfT7Vg90H21EOLACvtfcHk0li149whKG-lPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsVylt78%253D&md5=c81631289cf58f63917e2a9fa9547ab6</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1002%2F1096-987X%28200009%2921%3A12%3C1049%3A%3AAID-JCC3%3E3.0.CO%3B2-F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1096-987X%2528200009%252921%253A12%253C1049%253A%253AAID-JCC3%253E3.0.CO%253B2-F%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DCieplak%26aufirst%3DP.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26atitle%3DHow%2520well%2520does%2520a%2520restrained%2520electrostatic%2520potential%2520%2528RESP%2529%2520model%2520perform%2520in%2520calculating%2520conformational%2520energies%2520of%2520organic%2520and%2520biological%2520molecules%253F%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2000%26volume%3D21%26spage%3D1049%26epage%3D1074%26doi%3D10.1002%2F1096-987X%28200009%2921%3A12%3C1049%3A%3AAID-JCC3%3E3.0.CO%3B2-F" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Søndergaard, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, M. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rostkowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, J. H.</span></span> <span> </span><span class="NLM_article-title">Improved treatment of ligands and coupling effects in empirical calculation and rationalization of pKa values</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">2284</span>– <span class="NLM_lpage">2295</span>, <span class="refDoi"> DOI: 10.1021/ct200133y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ct200133y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnt1Gnsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=2284-2295&author=C.+R.+S%C3%B8ndergaardauthor=M.+H.+M.+Olssonauthor=M.+Rostkowskiauthor=J.+H.+Jensen&title=Improved+treatment+of+ligands+and+coupling+effects+in+empirical+calculation+and+rationalization+of+pKa+values&doi=10.1021%2Fct200133y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63aR"><div class="casContent"><span class="casTitleNuber">63a</span><div class="casTitle"><span class="NLM_cas:atitle">Improved Treatment of Ligands and Coupling Effects in Empirical Calculation and Rationalization of pKa Values</span></div><div class="casAuthors">Sondergaard, Chresten R.; Olsson, Mats H. M.; Rostkowski, Michal; Jensen, Jan H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2284-2295</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The new empirical rules for protein pKa predictions implemented in the PROPKA3.0 software package have been extended to the prediction of pKa shifts of active site residues and ionizable ligand groups in protein-ligand complexes.  The authors present new algorithms that allow pKa shifts due to inductive (i.e., covalently coupled) intraligand interactions, as well as noncovalently coupled interligand interactions in multiligand complexes, to be included in the prediction.  The no. of different ligand chem. groups that are automatically recognized has been increased to 18, and the general implementation has been changed so that new functional groups can be added easily by the user, aided by a new and more general protonation scheme.  Except for a few cases, the new algorithms in PROPKA3.1 are found to yield results similar to or better than those obtained with PROPKA2.0.  Finally, the authors present a novel algorithm that identifies noncovalently coupled ionizable groups, where pKa prediction may be esp. difficult.  This is a general improvement to PROPKA and is applied to proteins with and without ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVEiJYZqkno7Vg90H21EOLACvtfcHk0li149whKG-lPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnt1Gnsrs%253D&md5=cf4d4e20d6daa70de6ac623915e78160</span></div><a href="/servlet/linkout?suffix=cit63a&amp;dbid=16384&amp;doi=10.1021%2Fct200133y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fct200133y%26sid%3Dliteratum%253Aachs%26aulast%3DS%25C3%25B8ndergaard%26aufirst%3DC.%2BR.%26aulast%3DOlsson%26aufirst%3DM.%2BH.%2BM.%26aulast%3DRostkowski%26aufirst%3DM.%26aulast%3DJensen%26aufirst%3DJ.%2BH.%26atitle%3DImproved%2520treatment%2520of%2520ligands%2520and%2520coupling%2520effects%2520in%2520empirical%2520calculation%2520and%2520rationalization%2520of%2520pKa%2520values%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2011%26volume%3D7%26spage%3D2284%26epage%3D2295%26doi%3D10.1021%2Fct200133y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit63b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Olsson, M. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Søndergaard, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rostkowski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, J. H.</span></span> <span> </span><span class="NLM_article-title">PROPKA3: consistent treatment of internal and surface residues in empirical pKa predictions</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">525</span>– <span class="NLM_lpage">537</span>, <span class="refDoi"> DOI: 10.1021/ct100578z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ct100578z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC3MXit1aqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=525-537&author=M.+H.+M.+Olssonauthor=C.+R.+S%C3%B8ndergaardauthor=M.+Rostkowskiauthor=J.+H.+Jensen&title=PROPKA3%3A+consistent+treatment+of+internal+and+surface+residues+in+empirical+pKa+predictions&doi=10.1021%2Fct100578z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63bR"><div class="casContent"><span class="casTitleNuber">63b</span><div class="casTitle"><span class="NLM_cas:atitle">PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKa Predictions</span></div><div class="casAuthors">Olsson, Mats H. M.; Sondergaard, Chresten R.; Rostkowski, Michal; Jensen, Jan H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">525-537</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors have revised the rules and parameters for one of the most commonly used empirical pKa predictors, PROPKA, based on better phys. description of the desolvation and dielec. response for the protein.  The authors have introduced a new and consistent approach to interpolate the description between the previously distinct classifications into internal and surface residues, which otherwise is found to give rise to an erratic and discontinuous behavior.  Since the goal of this study is to lay out the framework and validate the concept, it focuses on Asp and Glu residues where the protein pKa values and structures are assumed to be more reliable.  The new and improved implementation is evaluated and discussed; it is found to agree better with expt. than the previous implementation (in parentheses): rmsd = 0.79 (0.91) for Asp and Glu, 0.75 (0.97) for Tyr, 0.65 (0.72) for Lys, and 1.00 (1.37) for His residues.  The most significant advance, however, is in reducing the no. of outliers and removing unreasonable sensitivity to small structural changes that arise from classifying residues as either internal or surface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm6urTZNdjY7Vg90H21EOLACvtfcHk0ljQF0pq_45riQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXit1aqsA%253D%253D&md5=9b1666b1c56e1129789e62948eb4d001</span></div><a href="/servlet/linkout?suffix=cit63b&amp;dbid=16384&amp;doi=10.1021%2Fct100578z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fct100578z%26sid%3Dliteratum%253Aachs%26aulast%3DOlsson%26aufirst%3DM.%2BH.%2BM.%26aulast%3DS%25C3%25B8ndergaard%26aufirst%3DC.%2BR.%26aulast%3DRostkowski%26aufirst%3DM.%26aulast%3DJensen%26aufirst%3DJ.%2BH.%26atitle%3DPROPKA3%253A%2520consistent%2520treatment%2520of%2520internal%2520and%2520surface%2520residues%2520in%2520empirical%2520pKa%2520predictions%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2011%26volume%3D7%26spage%3D525%26epage%3D537%26doi%3D10.1021%2Fct100578z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chandrasekhar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madura, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Impey, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, M. L.</span></span> <span> </span><span class="NLM_article-title">Comparison of simple potential functions for simulating liquid water</span>. <i>J. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">926</span>– <span class="NLM_lpage">935</span>, <span class="refDoi"> DOI: 10.1063/1.445869</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1063%2F1.445869" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADyaL3sXksF2htL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1983&pages=926-935&author=W.+L.+Jorgensenauthor=J.+Chandrasekharauthor=J.+D.+Maduraauthor=R.+W.+Impeyauthor=M.+L.+Klein&title=Comparison+of+simple+potential+functions+for+simulating+liquid+water&doi=10.1063%2F1.445869"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of simple potential functions for simulating liquid water</span></div><div class="casAuthors">Jorgensen, William L.; Chandrasekhar, Jayaraman; Madura, Jeffry D.; Impey, Roger W.; Klein, Michael L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">926-35</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    </div><div class="casAbstract">Classical Monte Carlo simulations were carried out for liq. H2O in the NPT ensemble at 25° and 1 atm using 6 of the simpler intermol. potential functions for the dimer.  Comparisons were made with exptl. thermodn. and structural data including the neutron diffraction results of Thiessen and Narten (1982).  The computed densities and potential energies agree with expt. except for the original Bernal-Fowler model, which yields an 18% overest. of the d. and poor structural results.  The discrepancy may be due to the correction terms needed in processing the neutron data or to an effect uniformly neglected in the computations.  Comparisons were made for the self-diffusion coeffs. obtained from mol. dynamics simulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK4QUFMvwYFrVg90H21EOLACvtfcHk0ljQF0pq_45riQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXksF2htL4%253D&md5=a1161334e381746be8c9b15a5e56f704</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1063%2F1.445869&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.445869%26sid%3Dliteratum%253Aachs%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DChandrasekhar%26aufirst%3DJ.%26aulast%3DMadura%26aufirst%3DJ.%2BD.%26aulast%3DImpey%26aufirst%3DR.%2BW.%26aulast%3DKlein%26aufirst%3DM.%2BL.%26atitle%3DComparison%2520of%2520simple%2520potential%2520functions%2520for%2520simulating%2520liquid%2520water%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1983%26volume%3D79%26spage%3D926%26epage%3D935%26doi%3D10.1063%2F1.445869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schalk, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehret-Sabatier, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouet, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goeldner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirth, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Axelsen, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sussman, J. L.</span></span> <span> </span><span class="NLM_article-title">Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">9031</span>– <span class="NLM_lpage">9035</span>, <span class="refDoi"> DOI: 10.1073/pnas.90.19.9031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1073%2Fpnas.90.19.9031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=8415649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADyaK3sXmsVCgtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1993&pages=9031-9035&author=M.+Harelauthor=I.+Schalkauthor=L.+Ehret-Sabatierauthor=F.+Bouetauthor=M.+Goeldnerauthor=C.+Hirthauthor=P.+H.+Axelsenauthor=I.+Silmanauthor=J.+L.+Sussman&title=Quaternary+ligand+binding+to+aromatic+residues+in+the+active-site+gorge+of+acetylcholinesterase&doi=10.1073%2Fpnas.90.19.9031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase</span></div><div class="casAuthors">Harel, M.; Schalk, I.; Ehret-Sabatier, L.; Bouet, F.; Goeldner, M.; Hirth, C.; Axelsen, P. H.; Silman, I.; Sussman, J. L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">9031-5</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">The binding sites of Torpedo acetylcholinesterase (AChE; EC 3.1.1.7) for quaternary ligands were investigated by x-ray crystallog. and photoaffinity labeling.  The crystal structures of complexes with ligands were detd. at 2.8-Å resoln.  In a complex with edrophonium, the quaternary N atom of the ligand interacted with the indole of Trp-84, and its m-OH group displayed bifurcated H-bonding to 2 members of the catalytic triad, Ser-200 and His-440.  In a complex with tacrine, the acridine was stacked against the indole of Trp-84.  The bisquaternary ligand, decamethonium, was oriented along the narrow gorge leading to the active site; one quaternary group was apposed to the indole of Trp-84 and the other to that of Trp-279, near the top of the gorge.  The only major conformational difference between the 3 complexes was in the orientation of the Ph ring of Phe-330.  In the decamethonium complex, it lay parallel to the surface of the gorge; in the other 2 complexes it was positioned to make contact with the bound ligand.  This close interaction was confirmed by photoaffinity labeling by the photosensitive probe, 3H-labeled p-(N,N-dimethylamino)benzenediazonium fluoroborate, which labeled, predominantly, Phe-330 within the active site.  The labeling of Trp-279 was also obsd.  One mole of label was incorporated per mol of AChE inactivated, indicating that the labeling of Trp-279 and that of Phe-330 were mutually exclusive.  The structural and chem. data, together, showed the important role of arom. groups as binding sites for quaternary ligands, and they provided complementary evidence assigning Trp-84 and Phe-330 to the anionic subsite of the active site and Trp-279 to the peripheral anionic site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVCccIwJSrW7Vg90H21EOLACvtfcHk0ljQF0pq_45riQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXmsVCgtrc%253D&md5=6ee8dbaf1919d254a1cb62895f1a4444</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1073%2Fpnas.90.19.9031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.90.19.9031%26sid%3Dliteratum%253Aachs%26aulast%3DHarel%26aufirst%3DM.%26aulast%3DSchalk%26aufirst%3DI.%26aulast%3DEhret-Sabatier%26aufirst%3DL.%26aulast%3DBouet%26aufirst%3DF.%26aulast%3DGoeldner%26aufirst%3DM.%26aulast%3DHirth%26aufirst%3DC.%26aulast%3DAxelsen%26aufirst%3DP.%2BH.%26aulast%3DSilman%26aufirst%3DI.%26aulast%3DSussman%26aufirst%3DJ.%2BL.%26atitle%3DQuaternary%2520ligand%2520binding%2520to%2520aromatic%2520residues%2520in%2520the%2520active-site%2520gorge%2520of%2520acetylcholinesterase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1993%26volume%3D90%26spage%3D9031%26epage%3D9035%26doi%3D10.1073%2Fpnas.90.19.9031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ryckaert, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciccotti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berendsen, H. J. C.</span></span> <span> </span><span class="NLM_article-title">Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes</span>. <i>J. Comput. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">327</span>– <span class="NLM_lpage">341</span>, <span class="refDoi"> DOI: 10.1016/0021-9991(77)90098-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1016%2F0021-9991%2877%2990098-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADyaE2sXktVGhsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1977&pages=327-341&author=J.-P.+Ryckaertauthor=G.+Ciccottiauthor=H.+J.+C.+Berendsen&title=Numerical+integration+of+the+cartesian+equations+of+motion+of+a+system+with+constraints%3A+molecular+dynamics+of+n-alkanes&doi=10.1016%2F0021-9991%2877%2990098-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Numerical integration of the Cartesian equations of motion of a system with constraints:  molecular dynamics of n-alkanes</span></div><div class="casAuthors">Ryckaert, Jean Paul; Ciccotti, Giovanni; Berendsen, Herman J. C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Physics</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">327-41</span>CODEN:
                <span class="NLM_cas:coden">JCTPAH</span>;
        ISSN:<span class="NLM_cas:issn">0021-9991</span>.
    </div><div class="casAbstract">A numerical algorithm integrating the 3N Cartesian equation of motion of a system of N points subject to holonomic constraints is applied to mol. dynamics simulation of a liq. of 64 butane mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYPlhG1U3Uw7Vg90H21EOLACvtfcHk0liQ9Vn-2YSsfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXktVGhsL4%253D&md5=b4aecddfde149117813a5ea4f5353ce2</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2F0021-9991%2877%2990098-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0021-9991%252877%252990098-5%26sid%3Dliteratum%253Aachs%26aulast%3DRyckaert%26aufirst%3DJ.-P.%26aulast%3DCiccotti%26aufirst%3DG.%26aulast%3DBerendsen%26aufirst%3DH.%2BJ.%2BC.%26atitle%3DNumerical%2520integration%2520of%2520the%2520cartesian%2520equations%2520of%2520motion%2520of%2520a%2520system%2520with%2520constraints%253A%2520molecular%2520dynamics%2520of%2520n-alkanes%26jtitle%3DJ.%2520Comput.%2520Phys.%26date%3D1977%26volume%3D23%26spage%3D327%26epage%3D341%26doi%3D10.1016%2F0021-9991%2877%2990098-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Darden, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">York, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedersen, L.</span></span> <span> </span><span class="NLM_article-title">Particle mesh Ewald: an N·log(N) method for Ewald sums in large systems</span>. <i>J. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">10089</span>– <span class="NLM_lpage">10092</span>, <span class="refDoi"> DOI: 10.1063/1.464397</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1063%2F1.464397" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADyaK3sXks1Ohsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=1993&pages=10089-10092&author=T.+Dardenauthor=D.+Yorkauthor=L.+Pedersen&title=Particle+mesh+Ewald%3A+an+N%C2%B7log%28N%29+method+for+Ewald+sums+in+large+systems&doi=10.1063%2F1.464397"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Particle mesh Ewald: an N·log(N) method for Ewald sums in large systems</span></div><div class="casAuthors">Darden, Tom; York, Darrin; Pedersen, Lee</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">10089-92</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    </div><div class="casAbstract">An N·log(N) method for evaluating electrostatic energies and forces of large periodic systems is presented.  The method is based on interpolation of the reciprocal space Ewald sums and evaluation of the resulting convolution using fast Fourier transforms.  Timings and accuracies are presented for three large cryst. ionic systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDIJavf7AZPbVg90H21EOLACvtfcHk0liQ9Vn-2YSsfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXks1Ohsr0%253D&md5=3c9f230bd01b7b714fd096d4d2e755f6</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1063%2F1.464397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.464397%26sid%3Dliteratum%253Aachs%26aulast%3DDarden%26aufirst%3DT.%26aulast%3DYork%26aufirst%3DD.%26aulast%3DPedersen%26aufirst%3DL.%26atitle%3DParticle%2520mesh%2520Ewald%253A%2520an%2520N%25C2%25B7log%2528N%2529%2520method%2520for%2520Ewald%2520sums%2520in%2520large%2520systems%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1993%26volume%3D98%26spage%3D10089%26epage%3D10092%26doi%3D10.1063%2F1.464397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berendsen, H. J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Postma, J. P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van
Gunsteren, W. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiNola, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haak, J. R.</span></span> <span> </span><span class="NLM_article-title">Molecular dynamics with coupling to an external bath</span>. <i>J. Chem. Phys.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">3684</span>– <span class="NLM_lpage">3690</span>, <span class="refDoi"> DOI: 10.1063/1.448118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1063%2F1.448118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADyaL2cXmtlGksbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1984&pages=3684-3690&author=H.+J.+C.+Berendsenauthor=J.+P.+M.+Postmaauthor=W.+F.+van%0AGunsterenauthor=A.+DiNolaauthor=J.+R.+Haak&title=Molecular+dynamics+with+coupling+to+an+external+bath&doi=10.1063%2F1.448118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular dynamics with coupling to an external bath</span></div><div class="casAuthors">Berendsen, H. J. C.; Postma, J. P. M.; Van Gunsteren, W. F.; DiNola, A.; Haak, J. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3684-90</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    </div><div class="casAbstract">In mol. dynamics (MD) simulations, the need often arises to maintain such parameters as temp. or pressure rather than energy and vol., or to impose gradients for studying transport properties in nonequil. MD.  A method is described to realize coupling to an external bath with const. temp. or pressure with adjustable time consts. for the coupling.  The method is easily extendable to other variables and to gradients, and can be applied also to polyat. mols. involving internal constraints.  The influence of coupling time consts. on dynamical variables is evaluated.  A leap-frog algorithm is presented for the general case involving constraints with coupling to both a const. temp. and a const. pressure bath.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoecrpUZWkh37Vg90H21EOLACvtfcHk0liQ9Vn-2YSsfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXmtlGksbY%253D&md5=5510dc00297d63b91ee3a7a4ae5aacb1</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1063%2F1.448118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.448118%26sid%3Dliteratum%253Aachs%26aulast%3DBerendsen%26aufirst%3DH.%2BJ.%2BC.%26aulast%3DPostma%26aufirst%3DJ.%2BP.%2BM.%26aulast%3Dvan%2BGunsteren%26aufirst%3DW.%2BF.%26aulast%3DDiNola%26aufirst%3DA.%26aulast%3DHaak%26aufirst%3DJ.%2BR.%26atitle%3DMolecular%2520dynamics%2520with%2520coupling%2520to%2520an%2520external%2520bath%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1984%26volume%3D81%26spage%3D3684%26epage%3D3690%26doi%3D10.1063%2F1.448118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Molyneux, P.</span></span> <span> </span><span class="NLM_article-title">The use of the stable free radical diphenylpicrylhydrazyl (DPPH) for estimating antioxidant activity</span>. <i>Songklanakarin J. Sci. Technol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">211</span>– <span class="NLM_lpage">219</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltFajt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2004&pages=211-219&author=P.+Molyneux&title=The+use+of+the+stable+free+radical+diphenylpicrylhydrazyl+%28DPPH%29+for+estimating+antioxidant+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">The use of the stable free radical diphenylpicrylhydrazyl (DPPH) for estimating antioxidant activity</span></div><div class="casAuthors">Molyneux, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Songklanakarin Journal of Science and Technology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">211-219</span>CODEN:
                <span class="NLM_cas:coden">SJSTA2</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Songklanakarin Journal of Science and Technology</span>)
        </div><div class="casAbstract">A review on the use of the stable free radical diphenylpicrylhydrazyl (DPPH) for estg. antioxidant activity.  The use of the stable free radical diphenylpicrylhydrazyl (DPPH) to est. the activity of antioxidants is reviewed.  Current applications of the method are examd., particularly the use of the parameter EC50 (substrate concn. to produce 50% redn. of the DPPH).  Some recommendations are made as to the most suitable ways of carrying out this assay and evaluating the data produced.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4PYkn8ojVo7Vg90H21EOLACvtfcHk0liQ9Vn-2YSsfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltFajt7o%253D&md5=24ef1ad35fcbcded3b458f643bf4c50c</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMolyneux%26aufirst%3DP.%26atitle%3DThe%2520use%2520of%2520the%2520stable%2520free%2520radical%2520diphenylpicrylhydrazyl%2520%2528DPPH%2529%2520for%2520estimating%2520antioxidant%2520activity%26jtitle%3DSongklanakarin%2520J.%2520Sci.%2520Technol.%26date%3D2004%26volume%3D26%26spage%3D211%26epage%3D219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tarozzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piazzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valgimigli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amorati, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolondi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djemil, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrisano, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rampa, A.</span></span> <span> </span><span class="NLM_article-title">From the dual function lead AP2238 to AP2469, a multi-target-directed ligand for the treatment of Alzheimer’s disease</span>. <i>Pharmacol. Res. Perspect.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>2</i></span>, <span class="NLM_elocation-id">e00023</span> <span class="refDoi"> DOI: 10.1002/prp2.23</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1002%2Fprp2.23" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=25505579" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFOlsbjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&author=A.+Tarozziauthor=M.+Bartoliniauthor=L.+Piazziauthor=L.+Valgimigliauthor=R.+Amoratiauthor=C.+Bolondiauthor=A.+Djemilauthor=F.+Manciniauthor=V.+Andrisanoauthor=A.+Rampa&title=From+the+dual+function+lead+AP2238+to+AP2469%2C+a+multi-target-directed+ligand+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1002%2Fprp2.23"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">From the dual function lead AP2238 to AP2469, a multi-target-directed ligand for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Tarozzi, Andrea; Bartolini, Manuela; Piazzi, Lorna; Valgimigli, Luca; Amorati, Riccardo; Bolondi, Cecilia; Djemil, Alice; Mancini, Francesca; Andrisano, Vincenza; Rampa, Angela</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology Research & Perspectives</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e00023/1-e00023/14</span>CODEN:
                <span class="NLM_cas:coden">PRPHCA</span>;
        ISSN:<span class="NLM_cas:issn">2052-1707</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">The development of drugs with different pharmacol. properties appears to be an innovative therapeutic approach for Alzheimer's disease.  In this article, we describe a simple structural modification of AP2238, a first dual function lead, in particular the introduction of the catechol moiety performed in order to search for multi-target ligands.  The new compd. AP2469 retains anti-acetylcholinesterase (AChE) and beta-site amyloid precursor protein cleaving enzyme (BACE)1 activities compared to the ref., and is also able to inhibit Aβ42 self-aggregation, Aβ42 oligomer-binding to cell membrane and subsequently reactive oxygen species formation in both neuronal and microglial cells.  The ability of AP2469 to interfere with Aβ42 oligomer-binding to neuron and microglial cell membrane gives this mol. both neuroprotective and anti-inflammatory properties.  These findings, together with its strong chain-breaking antioxidant performance, make AP2469 a potential drug able to modify the course of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWXudykiJm47Vg90H21EOLACvtfcHk0lhvfFaX62dkzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFOlsbjP&md5=2fa3d47b4f38b26adc80914410f7409b</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1002%2Fprp2.23&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprp2.23%26sid%3Dliteratum%253Aachs%26aulast%3DTarozzi%26aufirst%3DA.%26aulast%3DBartolini%26aufirst%3DM.%26aulast%3DPiazzi%26aufirst%3DL.%26aulast%3DValgimigli%26aufirst%3DL.%26aulast%3DAmorati%26aufirst%3DR.%26aulast%3DBolondi%26aufirst%3DC.%26aulast%3DDjemil%26aufirst%3DA.%26aulast%3DMancini%26aufirst%3DF.%26aulast%3DAndrisano%26aufirst%3DV.%26aulast%3DRampa%26aufirst%3DA.%26atitle%3DFrom%2520the%2520dual%2520function%2520lead%2520AP2238%2520to%2520AP2469%252C%2520a%2520multi-target-directed%2520ligand%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DPharmacol.%2520Res.%2520Perspect.%26date%3D2014%26volume%3D2%26doi%3D10.1002%2Fprp2.23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clark, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gebhart, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonder, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keeling, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohn, D. F.</span></span> <span> </span><span class="NLM_article-title">The 1996 guide for the care and use of laboratory animals</span>. <i>ILAR J.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">41</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1093/ilar.38.1.41</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=10.1093%2Filar.38.1.41" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=11528046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;key=1%3ACAS%3A280%3ADC%252BC2srjs1GqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1997&pages=41-48&author=J.+D.+Clarkauthor=G.+F.+Gebhartauthor=J.+C.+Gonderauthor=M.+E.+Keelingauthor=D.+F.+Kohn&title=The+1996+guide+for+the+care+and+use+of+laboratory+animals&doi=10.1093%2Filar.38.1.41"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Special Report: The 1996 Guide for the Care and Use of Laboratory Animals</span></div><div class="casAuthors">Clark J. Derrell; Gebhart Gerald F.; Gonder Janet C.; Keeling Michale E.; Kohn Dennis F.</div><div class="citationInfo"><span class="NLM_cas:title">ILAR journal</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-48</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTp4mVi1DOWUTQLBVDQn4bCfW6udTcc2eYkfaua-POwq7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2srjs1GqtA%253D%253D&md5=db8f111640eb343af8bf6e1787bb9a24</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1093%2Filar.38.1.41&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Filar.38.1.41%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DJ.%2BD.%26aulast%3DGebhart%26aufirst%3DG.%2BF.%26aulast%3DGonder%26aufirst%3DJ.%2BC.%26aulast%3DKeeling%26aufirst%3DM.%2BE.%26aulast%3DKohn%26aufirst%3DD.%2BF.%26atitle%3DThe%25201996%2520guide%2520for%2520the%2520care%2520and%2520use%2520of%2520laboratory%2520animals%26jtitle%3DILAR%2520J.%26date%3D1997%26volume%3D38%26spage%3D41%26epage%3D48%26doi%3D10.1093%2Filar.38.1.41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Q83" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Q83','PDB','1Q83'); return false;">PDB: 1Q83</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5K5E" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5K5E','PDB','5K5E'); return false;">PDB: 5K5E</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1E66" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1E66','PDB','1E66'); return false;">PDB: 1E66</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BDS" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4BDS','PDB','4BDS'); return false;">PDB: 4BDS</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i77"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00528">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_44260"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00528?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00528</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">RMSD analyses of the binding of <b>6b</b> to hAChE and hBChE and of <b>12a</b> to hBChE; MD-averaged <b>6b</b>–hBChE complexes; PAMPA-BBB permeabilities of commercial drugs used for assay validation; antibodies and primers used in Western blot and qPCR studies; relative MS peak areas in the identification of metabolites in human, mouse, and rat liver microsomes; binding mode of the <i>p</i>-benzoquinone metabolite of <b>4b</b> within hAChE; and copies of <sup>1</sup>H and <sup>13</sup>C NMR spectra and HPLC chromatograms of target compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_002.xls">XLS</a>)</p></li><li><p class="inline">FigS2A_R_pose1 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_003.pdb">PDB</a>)</p></li><li><p class="inline">FigS2A_R_pose2 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_004.pdb">PDB</a>)</p></li><li><p class="inline">FigS2A_R_pose3 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_005.pdb">PDB</a>)</p></li><li><p class="inline">FigS2B_S_pose1 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_006.pdb">PDB</a>)</p></li><li><p class="inline">FigS2B_S_pose2 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_007.pdb">PDB</a>)</p></li><li><p class="inline">FigS2B_S_pose3 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_008.pdb">PDB</a>)</p></li><li><p class="inline">Fig3A_R-6b+AChE (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_009.pdb">PDB</a>)</p></li><li><p class="inline">Fig3B_S-6b+AChE (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_010.pdb">PDB</a>)</p></li><li><p class="inline">Fig4A_R-12a+BChE (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_011.pdb">PDB</a>)</p></li><li><p class="inline">Fig4B_S-12a+BChE (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_012.pdb">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_001.pdf">jm0c00528_si_001.pdf (5.92 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_002.xls">jm0c00528_si_002.xls (26.0 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_003.pdb">jm0c00528_si_003.pdb (664.14 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_004.pdb">jm0c00528_si_004.pdb (664.14 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_005.pdb">jm0c00528_si_005.pdb (664.14 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_006.pdb">jm0c00528_si_006.pdb (664.14 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_007.pdb">jm0c00528_si_007.pdb (664.14 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_008.pdb">jm0c00528_si_008.pdb (664.14 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_009.pdb">jm0c00528_si_009.pdb (661.93 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_010.pdb">jm0c00528_si_010.pdb (661.93 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_011.pdb">jm0c00528_si_011.pdb (663.75 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00528/suppl_file/jm0c00528_si_012.pdb">jm0c00528_si_012.pdb (663.75 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c00528&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c00528%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-17%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c00528" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679905ec1dbc3d24","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
